"","X.1","X","miRNA","mRNA","PCC.cor","p_value","adjusted_p_value","score","energy","query_start_end","subject_start_end","total_bp_shared","query_similar","subject_similar","V3","Protein.names","Organism","Gene.Ontology..biological.process.","Gene.Ontology.IDs"
"1",1,300,"Cluster_9149","Peve_00009100",-0.477251674802156,0.683266023614316,0.978262075707395,168,-20.39,"2 21","322 343",19,"73.68%","84.21%","Q92005","Elongation factor 1-alpha (EF-1-alpha)","Danio rerio (Zebrafish) (Brachydanio rerio)","translation [GO:0006412]; translational elongation [GO:0006414]","GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414"
"2",2,300,"Cluster_9149","Peve_00009100",-0.477251674802156,0.683266023614316,0.978262075707395,168,-20.39,"2 21","661 682",19,"73.68%","84.21%","Q92005","Elongation factor 1-alpha (EF-1-alpha)","Danio rerio (Zebrafish) (Brachydanio rerio)","translation [GO:0006412]; translational elongation [GO:0006414]","GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414"
"3",3,335,"Cluster_6914","Peve_00009103",0.453964509159405,0.700018570003482,0.978262075707395,169,-21.38,"2 20","302 321",18,"83.33%","88.89%","Q9NR30","Nucleolar RNA helicase 2 (EC 3.6.4.13) (DEAD box protein 21) (Gu-alpha) (Nucleolar RNA helicase Gu) (Nucleolar RNA helicase II) (RH II/Gu)","Homo sapiens (Human)","chromatin remodeling [GO:0006338]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; osteoblast differentiation [GO:0001649]; positive regulation of histone acetylation [GO:0035066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; R-loop processing [GO:0062176]; response to exogenous dsRNA [GO:0043330]; rRNA processing [GO:0006364]; transcription by RNA polymerase II [GO:0006366]","GO:0001649; GO:0002735; GO:0003723; GO:0003724; GO:0003725; GO:0005524; GO:0005654; GO:0005694; GO:0005730; GO:0005739; GO:0005829; GO:0006338; GO:0006364; GO:0006366; GO:0016020; GO:0016887; GO:0019843; GO:0030515; GO:0035066; GO:0035198; GO:0042802; GO:0043123; GO:0043330; GO:0045087; GO:0045943; GO:0045944; GO:0045945; GO:0051607; GO:0062176; GO:0097322; GO:0110016"
"4",4,1234,"Cluster_6906","Peve_00018268",-0.686063329690759,0.518674561276582,0.978262075707395,150,-22.14,"2 16","36 60",17,"76.47%","76.47%",NA,NA,NA,NA,NA
"5",5,1847,"Cluster_589","Peve_00028953",-0.958159297400556,0.184807938297357,0.978262075707395,152,-23.43,"2 13","168 189",11,"90.91%","90.91%","P08775","DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit)","Mus musculus (Mouse)","cellular response to oxygen levels [GO:0071453]; DNA-templated transcription termination [GO:0006353]; positive regulation of RNA splicing [GO:0033120]; response to organic cyclic compound [GO:0014070]; transcription by RNA polymerase II [GO:0006366]","GO:0000791; GO:0000974; GO:0001046; GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005737; GO:0006353; GO:0006366; GO:0008022; GO:0014070; GO:0019900; GO:0031625; GO:0033120; GO:0046872; GO:0071453; GO:1990841"
"6",6,2211,"Cluster_2787","Peve_00018488",0.867933894665659,0.330895275232091,0.978262075707395,163,-22.5,"2 21","241 264",21,"71.43%","80.95%",NA,NA,NA,NA,NA
"7",7,2437,"Cluster_2854","Peve_00004351",-0.854036371945205,0.34829511323424,0.978262075707395,167,-20.27,"2 21","118 140",20,"80.00%","80.00%","P10894","1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-beta-1) (PLC-beta-1)","Bos taurus (Bovine)","interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; lipid catabolic process [GO:0016042]; memory [GO:0007613]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of JNK cascade [GO:0046330]","GO:0004435; GO:0005096; GO:0005509; GO:0005516; GO:0005546; GO:0005737; GO:0005829; GO:0007613; GO:0016042; GO:0016607; GO:0019899; GO:0031965; GO:0035722; GO:0035723; GO:0046330; GO:0046488; GO:0048015; GO:0070498"
"8",8,2481,"Cluster_2787","Peve_00009105",0.867933894665659,0.330895275232091,0.978262075707395,161,-22.23,"2 20","545 565",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"9",9,2852,"Cluster_6904","Peve_00031158",-0.951310992493219,0.199475076059675,0.978262075707395,152,-20.61,"2 17","390 411",15,"73.33%","80.00%",NA,NA,NA,NA,NA
"10",10,3062,"Cluster_589","Peve_00000508",0.89265946901885,0.297673769512557,0.978262075707395,155,-21.63,"2 12","139 160",10,"100.00%","100.00%","Q62717","Calcium-dependent secretion activator 1 (Calcium-dependent activator protein for secretion 1) (CAPS-1) (rCAPS)","Rattus norvegicus (Rat)","catecholamine secretion [GO:0050432]; establishment of localization in cell [GO:0051649]; exocytosis [GO:0006887]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of exocytosis [GO:0045921]; presynaptic dense core vesicle exocytosis [GO:0099525]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; synaptic vesicle priming [GO:0016082]; vesicle organization [GO:0016050]","GO:0005509; GO:0005546; GO:0006887; GO:0015031; GO:0016050; GO:0016082; GO:0019901; GO:0031045; GO:0031410; GO:0045055; GO:0045921; GO:0045956; GO:0050432; GO:0051649; GO:0098674; GO:0098793; GO:0098978; GO:0099525"
"11",11,3186,"Cluster_11134","Peve_00000502",-0.0195622829453675,0.987545469442176,0.999448381576871,151,-20.27,"2 21","492 514",20,"65.00%","75.00%","O73792","Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)","Danio rerio (Zebrafish) (Brachydanio rerio)","angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; endothelial cell-cell adhesion [GO:0071603]; heart development [GO:0007507]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculature development [GO:0001944]","GO:0001525; GO:0001568; GO:0001944; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0007507; GO:0033674; GO:0043235; GO:0045766; GO:0071603"
"12",12,3816,"Cluster_11134","Peve_00003970",0.875640822838247,0.320878802775509,0.978262075707395,159,-22.3,"2 21","497 519",20,"70.00%","80.00%",NA,NA,NA,NA,NA
"13",13,4102,"Cluster_2854","Peve_00040567",-0.957255331744831,0.186807945938679,0.978262075707395,161,-22.84,"2 14","457 478",12,"91.67%","100.00%",NA,NA,NA,NA,NA
"14",14,4766,"Cluster_14999","Peve_00021924",0.525134194156591,0.64803024914489,0.978262075707395,169,-20.78,"2 20","671 691",18,"83.33%","88.89%","P11617","Adenosine receptor A2a","Canis lupus familiaris (Dog) (Canis familiaris)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic signaling pathway [GO:0097190]; eating behavior [GO:0042755]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; G protein-coupled receptor signaling pathway [GO:0007186]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of inflammatory response [GO:0050728]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; response to amphetamine [GO:0001975]; response to inorganic substance [GO:0010035]; response to purine-containing compound [GO:0014074]; synaptic transmission, dopaminergic [GO:0001963]","GO:0001609; GO:0001963; GO:0001973; GO:0001975; GO:0004930; GO:0005886; GO:0007186; GO:0007189; GO:0007626; GO:0008289; GO:0010035; GO:0014074; GO:0019899; GO:0032230; GO:0042755; GO:0042802; GO:0046636; GO:0050728; GO:0060080; GO:0097190; GO:0098794; GO:2001235"
"15",15,4778,"Cluster_2882","Peve_00021927",-0.892924110050365,0.297299769223052,0.978262075707395,170,-28.51,"2 20","163 187",21,"80.95%","80.95%","Q9NW07","Zinc finger protein 358","Homo sapiens (Human)","embryonic forelimb morphogenesis [GO:0035115]; neural tube development [GO:0021915]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]","GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0019827; GO:0021915; GO:0035115; GO:0046872"
"16",16,5055,"Cluster_5882","Peve_00022603",0.435789685184326,0.71293829531919,0.979663631127656,153,-20.48,"2 19","224 246",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"17",17,5140,"Cluster_4080","Peve_00008995",-0.971045671478489,0.153569641017152,0.978262075707395,170,-20.07,"2 19","520 541",17,"82.35%","88.24%",NA,NA,NA,NA,NA
"18",18,6139,"Cluster_6906","Peve_00041017",-0.686063329690759,0.518674561276582,0.978262075707395,155,-20.43,"2 17","385 407",16,"75.00%","87.50%",NA,NA,NA,NA,NA
"19",19,6850,"Cluster_4080","Peve_00027432",-0.962123501271326,0.175776353057003,0.978262075707395,154,-20.4,"2 21","764 789",23,"69.57%","73.91%","Q7RTR2","NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","Homo sapiens (Human)","I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223"
"20",20,6882,"Cluster_15726","Peve_00027432",-0.99995514319204,0.00602991134659825,0.573710369894872,156,-20.62,"2 21","242 264",22,"72.73%","77.27%","Q7RTR2","NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","Homo sapiens (Human)","I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223"
"21",21,7123,"Cluster_4735","Peve_00036295",-0.852895805300287,0.349688398936474,0.978262075707395,150,-22.91,"2 19","688 707",17,"76.47%","82.35%","P20749","B-cell lymphoma 3 protein (BCL-3) (Proto-oncogene BCL3)","Homo sapiens (Human)","antimicrobial humoral response [GO:0019730]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of T cell apoptotic process [GO:0070233]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of type II interferon production [GO:0032729]; protein import into nucleus [GO:0006606]; regulation of apoptotic process [GO:0042981]; regulation of DNA binding [GO:0051101]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T cell apoptotic process [GO:0070231]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064]","GO:0002268; GO:0002315; GO:0002455; GO:0002467; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006606; GO:0006974; GO:0007249; GO:0009615; GO:0010225; GO:0019730; GO:0030198; GO:0030330; GO:0030496; GO:0030674; GO:0032088; GO:0032717; GO:0032720; GO:0032729; GO:0032733; GO:0032991; GO:0032996; GO:0033257; GO:0042088; GO:0042742; GO:0042771; GO:0042826; GO:0042832; GO:0042981; GO:0043066; GO:0043231; GO:0045064; GO:0045727; GO:0045892; GO:0045893; GO:0045944; GO:0046426; GO:0048471; GO:0048536; GO:0051101; GO:0070231; GO:0070233; GO:0140297; GO:1901222"
"22",22,7400,"Cluster_6914","Peve_00023536",0.983583822690962,0.11551198723578,0.978262075707395,158,-21.61,"2 20","751 774",21,"71.43%","76.19%",NA,NA,NA,NA,NA
"23",23,8096,"Cluster_14999","Peve_00024162",0.554217104380676,0.626035468965994,0.978262075707395,166,-23.03,"2 20","808 830",19,"78.95%","84.21%","Q7Z7L1","Schlafen family member 11 (EC 3.6.-.-)","Homo sapiens (Human)","cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; negative regulation of DNA replication [GO:0008156]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of cell death [GO:0010942]; replication fork arrest [GO:0043111]","GO:0000049; GO:0002376; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006974; GO:0008156; GO:0010942; GO:0016887; GO:0043111; GO:0051607; GO:0090734; GO:2000134"
"24",24,8206,"Cluster_6255","Peve_00024166",0.14696818568836,0.906097009741613,0.999448381576871,164,-20.33,"2 20","302 321",18,"77.78%","88.89%","Q5T6L9","Endoplasmic reticulum membrane-associated RNA degradation protein (ER membrane-associated RNA degradation protein)","Homo sapiens (Human)","","GO:0005789"
"25",25,8251,"Cluster_6255","Peve_00024167",0.579354837652673,0.606609131763246,0.978262075707395,164,-20.33,"2 20","302 321",18,"77.78%","88.89%",NA,NA,NA,NA,NA
"26",27,9357,"Cluster_15726","Peve_00021264",-0.868839489372007,0.329732672528259,0.978262075707395,158,-20.43,"2 21","161 187",24,"70.83%","75.00%","O15050","TPR and ankyrin repeat-containing protein 1 (Lupus brain antigen 1 homolog)","Homo sapiens (Human)","",""
"27",28,9402,"Cluster_15726","Peve_00021265",0.347175490793444,0.774281638798566,0.992080413497249,158,-20.43,"2 21","161 187",24,"70.83%","75.00%","Q3KNI6","Dynein axonemal assembly factor 6 (PIH1 domain-containing protein 3)","Mus musculus (Mouse)","axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158]","GO:0003341; GO:0005737; GO:0005802; GO:0030317; GO:0036158; GO:0036159; GO:0045505; GO:0051087; GO:0070286"
"28",29,9546,"Cluster_2787","Peve_00021261",0.946064772237234,0.210040456651987,0.978262075707395,156,-20.1,"2 21","498 518",20,"75.00%","80.00%","Q2EMV9","Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14)","Mus musculus (Mouse)","innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein poly-ADP-ribosylation [GO:0070212]","GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016779; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:1902216; GO:1990404"
"29",30,10134,"Cluster_4079","Peve_00034267",-0.736471247319451,0.472981319904014,0.978262075707395,157,-22.72,"2 14","842 863",12,"91.67%","91.67%",NA,NA,NA,NA,NA
"30",31,10206,"Cluster_11134","Peve_00012359",-0.206138384221755,0.867820587841691,0.996991458252342,166,-24.26,"2 21","899 923",22,"77.27%","81.82%","Q9BX70","BTB/POZ domain-containing protein 2","Homo sapiens (Human)","neurogenesis [GO:0022008]","GO:0000932; GO:0005829; GO:0022008"
"31",32,10251,"Cluster_11134","Peve_00012351",-0.00459214192079096,0.997076541380776,0.999448381576871,160,-23.53,"2 21","2 23",19,"57.89%","89.47%","Q6PHS9","Voltage-dependent calcium channel subunit alpha-2/delta-2 (Protein ducky) (Voltage-gated calcium channel subunit alpha-2/delta-2) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-2; Voltage-dependent calcium channel subunit delta-2]","Mus musculus (Mouse)","calcium ion transport [GO:0006816]; muscle cell development [GO:0055001]; neuromuscular junction development [GO:0007528]; organ growth [GO:0035265]; positive regulation of organ growth [GO:0046622]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of multicellular organism growth [GO:0040014]; rhythmic synaptic transmission [GO:0060024]","GO:0005245; GO:0005886; GO:0005891; GO:0006816; GO:0007528; GO:0008016; GO:0034765; GO:0035265; GO:0040014; GO:0046622; GO:0046872; GO:0055001; GO:0060024"
"32",33,10356,"Cluster_2787","Peve_00042714",0.867933894665659,0.330895275232091,0.978262075707395,158,-23.39,"2 16","954 976",15,"80.00%","93.33%",NA,NA,NA,NA,NA
"33",34,10370,"Cluster_6914","Peve_00042714",0.853558462702337,0.34887952241865,0.978262075707395,159,-20.72,"2 20","709 727",18,"77.78%","88.89%",NA,NA,NA,NA,NA
"34",35,10402,"Cluster_2854","Peve_00021480",-0.921491639051535,0.25394296861445,0.978262075707395,163,-21.86,"2 17","877 899",16,"87.50%","87.50%","Q5PRC1","LHFPL tetraspan subfamily member 6 protein","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0016020"
"35",36,10806,"Cluster_2787","Peve_00045095",0.781241154543022,0.429173830812632,0.978262075707395,159,-21.11,"2 21","817 840",21,"71.43%","76.19%","P48442","Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR)","Rattus norvegicus (Rat)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; apoptotic process [GO:0006915]; bile acid secretion [GO:0032782]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to peptide [GO:1901653]; cellular response to vitamin D [GO:0071305]; chloride transmembrane transport [GO:1902476]; detection of calcium ion [GO:0005513]; fat pad development [GO:0060613]; G protein-coupled receptor signaling pathway [GO:0007186]; JNK cascade [GO:0007254]; ossification [GO:0001503]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of vasoconstriction [GO:0045907]; regulation of calcium ion transport [GO:0051924]; response to calcium ion [GO:0051592]; response to fibroblast growth factor [GO:0071774]; response to ischemia [GO:0002931]; response to metal ion [GO:0010038]; response to organic cyclic compound [GO:0014070]; vasodilation [GO:0042311]","GO:0001503; GO:0002931; GO:0004930; GO:0005178; GO:0005509; GO:0005513; GO:0005634; GO:0005737; GO:0005886; GO:0006874; GO:0006915; GO:0007186; GO:0007193; GO:0007200; GO:0007254; GO:0008284; GO:0009986; GO:0010038; GO:0010628; GO:0014070; GO:0016020; GO:0016323; GO:0016324; GO:0016597; GO:0019901; GO:0030424; GO:0032024; GO:0032781; GO:0032782; GO:0035729; GO:0042311; GO:0042803; GO:0043005; GO:0043025; GO:0043679; GO:0044325; GO:0045907; GO:0048754; GO:0050927; GO:0051592; GO:0051924; GO:0060613; GO:0070374; GO:0070509; GO:0071305; GO:0071333; GO:0071404; GO:0071456; GO:0071774; GO:0090280; GO:1901653; GO:1902476"
"36",37,10838,"Cluster_11997","Peve_00045095",-0.925750201402595,0.246869420228106,0.978262075707395,178,-20.15,"2 21","93 113",19,"84.21%","94.74%","P48442","Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR)","Rattus norvegicus (Rat)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; apoptotic process [GO:0006915]; bile acid secretion [GO:0032782]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to peptide [GO:1901653]; cellular response to vitamin D [GO:0071305]; chloride transmembrane transport [GO:1902476]; detection of calcium ion [GO:0005513]; fat pad development [GO:0060613]; G protein-coupled receptor signaling pathway [GO:0007186]; JNK cascade [GO:0007254]; ossification [GO:0001503]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of vasoconstriction [GO:0045907]; regulation of calcium ion transport [GO:0051924]; response to calcium ion [GO:0051592]; response to fibroblast growth factor [GO:0071774]; response to ischemia [GO:0002931]; response to metal ion [GO:0010038]; response to organic cyclic compound [GO:0014070]; vasodilation [GO:0042311]","GO:0001503; GO:0002931; GO:0004930; GO:0005178; GO:0005509; GO:0005513; GO:0005634; GO:0005737; GO:0005886; GO:0006874; GO:0006915; GO:0007186; GO:0007193; GO:0007200; GO:0007254; GO:0008284; GO:0009986; GO:0010038; GO:0010628; GO:0014070; GO:0016020; GO:0016323; GO:0016324; GO:0016597; GO:0019901; GO:0030424; GO:0032024; GO:0032781; GO:0032782; GO:0035729; GO:0042311; GO:0042803; GO:0043005; GO:0043025; GO:0043679; GO:0044325; GO:0045907; GO:0048754; GO:0050927; GO:0051592; GO:0051924; GO:0060613; GO:0070374; GO:0070509; GO:0071305; GO:0071333; GO:0071404; GO:0071456; GO:0071774; GO:0090280; GO:1901653; GO:1902476"
"37",39,11511,"Cluster_11134","Peve_00043447",0.495145859811942,0.670229233806936,0.978262075707395,162,-24.88,"2 19","26 47",17,"76.47%","82.35%",NA,NA,NA,NA,NA
"38",40,12054,"Cluster_13502","Peve_00011191",-0.0830090964863612,0.947093890502283,0.999448381576871,154,-20.67,"2 21","858 878",19,"68.42%","78.95%","Q711G3","Isoamyl acetate-hydrolyzing esterase 1 homolog (EC 3.1.-.-) (Hypertrophic agonist-responsive protein B64)","Rattus norvegicus (Rat)","lipid catabolic process [GO:0016042]","GO:0016042; GO:0016787; GO:0042802"
"39",41,13152,"Cluster_4629","Peve_00010241",-0.170224835442477,0.891101203143093,0.999448381576871,166,-27.23,"2 19","832 853",17,"76.47%","88.24%","Q60598","Src substrate cortactin","Mus musculus (Mouse)","actin cytoskeleton reorganization [GO:0031532]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; modification of postsynaptic actin cytoskeleton [GO:0098885]; modification of postsynaptic structure [GO:0099010]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of chemotaxis [GO:0050921]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of axon extension [GO:0030516]; regulation of cell projection assembly [GO:0060491]; substrate-dependent cell migration, cell extension [GO:0006930]","GO:0001726; GO:0002102; GO:0005522; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0005884; GO:0005886; GO:0005905; GO:0005925; GO:0005938; GO:0006886; GO:0006898; GO:0006930; GO:0008076; GO:0030027; GO:0030054; GO:0030426; GO:0030427; GO:0030516; GO:0030833; GO:0030838; GO:0030863; GO:0030864; GO:0031532; GO:0043197; GO:0043231; GO:0045987; GO:0048041; GO:0048812; GO:0048870; GO:0050921; GO:0051015; GO:0060491; GO:0070064; GO:0071933; GO:0097062; GO:0097191; GO:0097581; GO:0098794; GO:0098871; GO:0098885; GO:0098978; GO:0099010; GO:1903146; GO:1990023; GO:2001237"
"40",42,13332,"Cluster_4629","Peve_00010246",-0.207273055601144,0.867082288631313,0.996797108809734,157,-24.94,"2 21","200 219",19,"68.42%","84.21%","Q6AYD3","Proliferation-associated protein 2G4","Rattus norvegicus (Rat)","negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]","GO:0003676; GO:0003714; GO:0003723; GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0006417; GO:0031625; GO:0043066; GO:0045597; GO:0045892; GO:1990904"
"41",43,14492,"Cluster_589","Peve_00017735",0.159680919674548,0.897906931664995,0.999448381576871,162,-23.3,"2 20","560 582",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"42",44,14502,"Cluster_4629","Peve_00017735",0.997938030915672,0.0408894104551393,0.909359886114279,145,-20.33,"2 20","661 685",21,"66.67%","71.43%",NA,NA,NA,NA,NA
"43",45,14929,"Cluster_10934","Peve_00013607",-0.186191770769431,0.880770853788395,0.998936964780341,164,-25.04,"2 18","857 880",18,"77.78%","88.89%","O57382","Tolloid-like protein 2 (EC 3.4.24.-) (Metalloprotease xolloid) (Xenopus tolloid)","Xenopus laevis (African clawed frog)","cell differentiation [GO:0030154]; proteolysis [GO:0006508]","GO:0004222; GO:0005509; GO:0005576; GO:0006508; GO:0008270; GO:0030154"
"44",46,18660,"Cluster_9149","Peve_00018389",-0.0144469601543533,0.990802459552625,0.999448381576871,146,-26.79,"2 15","284 305",13,"69.23%","84.62%","G1SMR7",NA,NA,NA,NA
"45",47,18847,"Cluster_11135","Peve_00018385",0.539061895281283,0.637557768857293,0.978262075707395,172,-21.96,"2 17","846 867",15,"86.67%","100.00%","P50398","Rab GDP dissociation inhibitor alpha (Rab GDI alpha) (Guanosine diphosphate dissociation inhibitor 1) (GDI-1)","Rattus norvegicus (Rat)","negative regulation of axonogenesis [GO:0050771]; negative regulation of protein targeting to membrane [GO:0090315]; positive regulation of axon extension [GO:0045773]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; response to calcium ion [GO:0051592]; vesicle-mediated transport [GO:0016192]","GO:0005093; GO:0005096; GO:0005737; GO:0005794; GO:0015031; GO:0016192; GO:0030424; GO:0030496; GO:0031267; GO:0032482; GO:0032991; GO:0043005; GO:0043025; GO:0043209; GO:0045773; GO:0050771; GO:0051592; GO:0090315; GO:0099523"
"46",48,19746,"Cluster_11134","Peve_00028856",-0.0195622829453675,0.987545469442176,0.999448381576871,155,-20.67,"2 20","28 49",18,"72.22%","72.22%",NA,NA,NA,NA,NA
"47",49,19881,"Cluster_11134","Peve_00028855",-0.0195622829453675,0.987545469442176,0.999448381576871,155,-20.67,"2 20","28 49",18,"72.22%","72.22%",NA,NA,NA,NA,NA
"48",50,20027,"Cluster_589","Peve_00001499",-0.934753615028442,0.231240264998328,0.978262075707395,160,-23.07,"2 18","778 800",17,"76.47%","88.24%",NA,NA,NA,NA,NA
"49",51,20366,"Cluster_8884","Peve_00023082",0.195666758587174,0.874625817801006,0.997476741937264,172,-20.23,"2 19","599 621",19,"89.47%","89.47%",NA,NA,NA,NA,NA
"50",52,20367,"Cluster_8887","Peve_00023082",-0.0823630340017489,0.947506599925429,0.999448381576871,172,-20.23,"2 19","599 621",19,"89.47%","89.47%",NA,NA,NA,NA,NA
"51",53,20368,"Cluster_8888","Peve_00023082",-0.734978994113776,0.474383987054699,0.978262075707395,172,-20.47,"2 19","599 621",19,"89.47%","89.47%",NA,NA,NA,NA,NA
"52",54,20398,"Cluster_4735","Peve_00023083",0.738667385884432,0.470910881271277,0.978262075707395,152,-22.04,"2 21","796 817",19,"63.16%","73.68%",NA,NA,NA,NA,NA
"53",55,21521,"Cluster_4115","Peve_00001149",-0.89741603213802,0.290883690589596,0.978262075707395,161,-20.54,"2 19","529 552",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"54",56,21602,"Cluster_589","Peve_00001144",-0.232675687588727,0.850503866504239,0.995934364227446,145,-20.94,"2 10","739 760",8,"100.00%","100.00%",NA,NA,NA,NA,NA
"55",57,22755,"Cluster_9149","Peve_00005492",-0.263309258144145,0.83037207981889,0.995934364227446,148,-20.86,"2 21","547 568",19,"57.89%","73.68%",NA,NA,NA,NA,NA
"56",58,22955,"Cluster_1167","Peve_00039164",-0.498667552497731,0.667645721478609,0.978262075707395,156,-23.78,"2 17","262 283",15,"80.00%","80.00%",NA,NA,NA,NA,NA
"57",59,23086,"Cluster_29","Peve_00030011",-0.62077240343352,0.573638206347232,0.978262075707395,157,-21.35,"2 20","932 955",20,"75.00%","80.00%","Q6IPU0","Centromere protein P (CENP-P)","Homo sapiens (Human)","CENP-A containing chromatin assembly [GO:0034080]","GO:0000775; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0034080"
"58",60,23691,"Cluster_7053","Peve_00039167",0.985904950443676,0.107013819384959,0.978262075707395,167,-21.07,"2 20","640 661",18,"66.67%","94.44%","P0CZ23","Acyl-coenzyme A oxidase 3, peroxisomal (AOX 3) (Acyl-CoA oxidase 3) (EC 1.3.3.6) (Medium-chain acyl-CoA oxidase) (AtCX3)","Arabidopsis thaliana (Mouse-ear cress)","fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]; medium-chain fatty acid metabolic process [GO:0051791]","GO:0003997; GO:0005504; GO:0005576; GO:0005777; GO:0006635; GO:0033540; GO:0050660; GO:0051791; GO:0055088; GO:0071949"
"59",61,24771,"Cluster_7053","Peve_00027337",-0.955159070421268,0.191367763024833,0.978262075707395,174,-23.71,"2 21","889 909",19,"84.21%","89.47%",NA,NA,NA,NA,NA
"60",62,24959,"Cluster_8988","Peve_00026950",-0.905823201447666,0.278506848201881,0.978262075707395,166,-20.47,"2 20","516 538",19,"73.68%","89.47%",NA,NA,NA,NA,NA
"61",63,26105,"Cluster_1167","Peve_00027602",-0.488318552853167,0.675220836384604,0.978262075707395,145,-20.42,"2 19","555 577",18,"66.67%","72.22%",NA,NA,NA,NA,NA
"62",64,26458,"Cluster_15890","Peve_00027609",-0.636113669286926,0.561081863769882,0.978262075707395,170,-21.41,"2 21","916 936",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"63",65,26490,"Cluster_9149","Peve_00012530",-0.842643270773274,0.361996620360583,0.978262075707395,150,-20.76,"2 15","968 989",13,"76.92%","84.62%","Q9H173","Nucleotide exchange factor SIL1 (BiP-associated protein) (BAP)","Homo sapiens (Human)","cotranslational protein targeting to membrane [GO:0006613]; intracellular protein transport [GO:0006886]; protein folding [GO:0006457]","GO:0000774; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0006613; GO:0006886; GO:0042802; GO:0051082"
"64",66,26494,"Cluster_10934","Peve_00012530",0.909492486295747,0.272940990557926,0.978262075707395,159,-21.34,"2 21","698 721",21,"71.43%","76.19%","Q9H173","Nucleotide exchange factor SIL1 (BiP-associated protein) (BAP)","Homo sapiens (Human)","cotranslational protein targeting to membrane [GO:0006613]; intracellular protein transport [GO:0006886]; protein folding [GO:0006457]","GO:0000774; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0006613; GO:0006886; GO:0042802; GO:0051082"
"65",67,27552,"Cluster_4629","Peve_00020071",-0.953710125485242,0.194458893587065,0.978262075707395,157,-23.58,"2 20","347 371",21,"76.19%","76.19%",NA,NA,NA,NA,NA
"66",68,27725,"Cluster_1167","Peve_00020387",0.997608159669892,0.0440400511406639,0.923878309135209,156,-20.73,"2 21","935 956",19,"68.42%","73.68%","C3YWU0","Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase)","Branchiostoma floridae (Florida lancelet) (Amphioxus)","fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]","GO:0004560; GO:0005576; GO:0005764; GO:0006004; GO:0016139"
"67",69,27856,"Cluster_29","Peve_00020382",-0.0230715466621076,0.985310893859818,0.999448381576871,159,-21.68,"2 21","29 53",22,"68.18%","77.27%",NA,NA,NA,NA,NA
"68",70,27936,"Cluster_11134","Peve_00020383",0.670361831724153,0.53227780786993,0.978262075707395,167,-21.66,"2 17","674 696",16,"87.50%","93.75%",NA,NA,NA,NA,NA
"69",71,28407,"Cluster_4629","Peve_00024685",-0.541494717457592,0.635717235347563,0.978262075707395,159,-25.2,"2 20","687 708",18,"66.67%","83.33%",NA,NA,NA,NA,NA
"70",72,28581,"Cluster_2787","Peve_00013726",0.867933894665659,0.330895275232091,0.978262075707395,165,-20.65,"2 21","508 527",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"71",73,29121,"Cluster_2787","Peve_00041345",0.883199615485101,0.310769186952407,0.978262075707395,153,-21.51,"2 21","347 366",19,"73.68%","73.68%","Q96MS0","Roundabout homolog 3 (Roundabout-like protein 3)","Homo sapiens (Human)","axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0005886; GO:0007156; GO:0007411; GO:0016020; GO:0016199; GO:0030424; GO:0070593; GO:0098632"
"72",74,29189,"Cluster_8988","Peve_00041348",0.339743343905754,0.779319578105575,0.993357725916099,163,-23.67,"2 21","632 654",20,"70.00%","85.00%","P35546","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Mus musculus (Mouse)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; anatomical structure morphogenesis [GO:0009653]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0006919; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0009653; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:2001241"
"73",75,29350,"Cluster_4080","Peve_00044641",0.967032058835356,0.163923591756877,0.978262075707395,158,-21.17,"2 20","417 441",21,"66.67%","80.95%","Q80T79","CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3)","Mus musculus (Mouse)","negative regulation of complement activation, classical pathway [GO:0045959]; regulation of dendrite development [GO:0050773]","GO:0005615; GO:0005886; GO:0045959; GO:0050773"
"74",76,30063,"Cluster_796","Peve_00020926",0.99976239721897,0.0138780829858655,0.720093853779252,161,-25.6,"2 21","197 216",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"75",77,31160,"Cluster_6914","Peve_00012096",0.491149649949668,0.673153635859973,0.978262075707395,162,-22.58,"2 20","427 448",19,"73.68%","84.21%","O08912","Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form]","Mus musculus (Mouse)","protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]","GO:0004653; GO:0005576; GO:0005794; GO:0006493; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0032580; GO:0048471"
"76",78,31235,"Cluster_1167","Peve_00012094",0.903208049381211,0.282411016339115,0.978262075707395,160,-25.03,"2 21","632 653",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"77",79,31311,"Cluster_11134","Peve_00012093",0.135349197658078,0.913568746942343,0.999448381576871,154,-22.61,"2 16","35 58",16,"81.25%","81.25%","Q1LZ71","Protein lifeguard 2 (Fas apoptotic inhibitory molecule 2)","Bos taurus (Bovine)","apoptotic signaling pathway [GO:0097190]; cerebellar granular layer development [GO:0021681]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum development [GO:0021549]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; regulation of neuron apoptotic process [GO:0043523]; response to ischemia [GO:0002931]","GO:0002931; GO:0005783; GO:0005794; GO:0016020; GO:0021549; GO:0021680; GO:0021681; GO:0021702; GO:0043523; GO:0043524; GO:0045121; GO:0045211; GO:0051402; GO:0097190; GO:1902042; GO:2001234"
"78",80,32093,"Cluster_2882","Peve_00043872",-0.221661772972479,0.857703825740684,0.995934364227446,142,-21.59,"2 20","623 651",25,"60.00%","64.00%","P35555","Fibrillin-1 [Cleaved into: Asprosin]","Homo sapiens (Human)","activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of appetite [GO:0032100]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]","GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0009653; GO:0010737; GO:0030023; GO:0031012; GO:0032100; GO:0033627; GO:0034199; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0062023; GO:0071560; GO:1990314; GO:2001205"
"79",81,32430,"Cluster_9149","Peve_00015373",-0.716432687710147,0.491547372396074,0.978262075707395,155,-23.3,"2 17","95 117",16,"75.00%","87.50%","A5A761","Sideroflexin-1","Sus scrofa (Pig)","L-alanine transport [GO:0015808]; L-serine transport [GO:0015825]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]","GO:0005743; GO:0006730; GO:0015180; GO:0015194; GO:0015808; GO:0015825; GO:0022857; GO:0022889; GO:0140300; GO:1990542"
"80",82,32777,"Cluster_6904","Peve_00018631",0.942871445939377,0.216227680823179,0.978262075707395,151,-20.95,"2 17","522 544",16,"75.00%","81.25%","P97259","Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)]","Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)","negative regulation of protein tyrosine phosphatase activity [GO:1903614]; positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0000139; GO:0004864; GO:0005576; GO:0018279; GO:0030144; GO:0030145; GO:0030335; GO:1903614; GO:1904894"
"81",83,32970,"Cluster_9149","Peve_00018638",-0.5,0.666666666666667,0.978262075707395,150,-24.37,"2 11","229 250",9,"100.00%","100.00%",NA,NA,NA,NA,NA
"82",84,33114,"Cluster_13502","Peve_00015952",0.997844556977271,0.0418062711782387,0.909359886114279,162,-21.27,"2 19","471 492",17,"76.47%","82.35%",NA,NA,NA,NA,NA
"83",85,33261,"Cluster_2787","Peve_00015956",0.867933894665659,0.330895275232091,0.978262075707395,142,-20.15,"2 21","603 631",26,"61.54%","65.38%",NA,NA,NA,NA,NA
"84",86,33351,"Cluster_2787","Peve_00015954",0.915469496120001,0.263639000703321,0.978262075707395,162,-23.27,"2 16","605 627",15,"86.67%","93.33%",NA,NA,NA,NA,NA
"85",87,33381,"Cluster_11134","Peve_00015954",0.0859761032553724,0.945198256029055,0.999448381576871,168,-24.82,"2 17","911 932",15,"86.67%","93.33%",NA,NA,NA,NA,NA
"86",89,33977,"Cluster_589","Peve_00043253",0.254676094397093,0.836062299150708,0.995934364227446,155,-23.55,"2 12","237 258",10,"100.00%","100.00%","Q5D013","EEF1A lysine methyltransferase 2 (EC 2.1.1.-) (Methyltransferase-like protein 10) (Protein-lysine N-methyltransferase mettl10)","Danio rerio (Zebrafish) (Brachydanio rerio)","peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine monomethylation [GO:0018026]","GO:0005634; GO:0005737; GO:0008168; GO:0016279; GO:0018022; GO:0018024; GO:0018026; GO:0018027"
"87",90,34205,"Cluster_1167","Peve_00043255",0.934594582589545,0.231525051438805,0.978262075707395,151,-20.58,"2 16","972 993",14,"78.57%","78.57%","Q9UIH9","Krueppel-like factor 15 (Kidney-enriched krueppel-like factor)","Homo sapiens (Human)","cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular glucose homeostasis [GO:0001678]; cellular response to peptide [GO:1901653]; glial cell differentiation [GO:0010001]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; podocyte differentiation [GO:0072112]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of Wnt signaling pathway [GO:0030111]; response to insulin [GO:0032868]","GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001678; GO:0005634; GO:0005654; GO:0006357; GO:0010001; GO:0014898; GO:0016607; GO:0030111; GO:0032868; GO:0043231; GO:0045944; GO:0046326; GO:0046872; GO:0072112; GO:1901653; GO:1990837; GO:2000757"
"88",91,34291,"Cluster_29","Peve_00014796",-0.368569774287229,0.759695126986102,0.988219883885475,163,-20.09,"2 21","290 313",21,"66.67%","85.71%",NA,NA,NA,NA,NA
"89",92,35625,"Cluster_9149","Peve_00000950",-0.530914621111018,0.643696967318726,0.978262075707395,149,-23.36,"2 19","654 671",17,"76.47%","76.47%","Q6DF78","Pyridoxal-dependent decarboxylase domain-containing protein 1 (EC 4.1.1.-)","Xenopus laevis (African clawed frog)","carboxylic acid metabolic process [GO:0019752]","GO:0016831; GO:0019752; GO:0030170"
"90",93,36177,"Cluster_15726","Peve_00040751",0.409472213034631,0.731425729304172,0.984875474239448,150,-23.49,"2 21","228 248",19,"68.42%","73.68%","Q804X9","Melanopsin-A (Opsin-4A)","Gadus morhua (Atlantic cod)","phototransduction [GO:0007602]; visual perception [GO:0007601]","GO:0004930; GO:0005886; GO:0007601; GO:0007602; GO:0009881"
"91",94,36677,"Cluster_589","Peve_00035550",-0.975813921435687,0.140299809445224,0.978262075707395,155,-23.55,"2 12","730 751",10,"100.00%","100.00%","Q9I8E6","Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP)","Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)","intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005198; GO:0006886; GO:0016192; GO:0030126"
"92",95,36902,"Cluster_589","Peve_00033788",0.159680919674548,0.897906931664995,0.999448381576871,156,-20.9,"2 20","619 638",18,"72.22%","83.33%",NA,NA,NA,NA,NA
"93",96,37162,"Cluster_11135","Peve_00033785",0.389287341276078,0.745442633743431,0.987366286869687,163,-20.89,"2 21","808 830",20,"70.00%","85.00%",NA,NA,NA,NA,NA
"94",97,37666,"Cluster_29","Peve_00041803",-0.95795731448529,0.185256641609839,0.978262075707395,160,-22.47,"2 20","751 775",21,"76.19%","85.71%",NA,NA,NA,NA,NA
"95",98,38075,"Cluster_1167","Peve_00044326",0.87966160096372,0.315538117094371,0.978262075707395,141,-21.22,"2 16","477 504",20,"70.00%","70.00%","Q6DEJ5","Alanyl-tRNA editing protein Aarsd1 (Alanyl-tRNA synthetase domain-containing protein 1)","Danio rerio (Zebrafish) (Brachydanio rerio)","regulation of translational fidelity [GO:0006450]; translation [GO:0006412]; tRNA aminoacylation [GO:0043039]","GO:0002196; GO:0004812; GO:0005524; GO:0005737; GO:0006412; GO:0006450; GO:0043039; GO:0046872"
"96",99,38075,"Cluster_1167","Peve_00044326",0.87966160096372,0.315538117094371,0.978262075707395,144,-20.02,"2 18","241 264",18,"66.67%","72.22%","Q6DEJ5","Alanyl-tRNA editing protein Aarsd1 (Alanyl-tRNA synthetase domain-containing protein 1)","Danio rerio (Zebrafish) (Brachydanio rerio)","regulation of translational fidelity [GO:0006450]; translation [GO:0006412]; tRNA aminoacylation [GO:0043039]","GO:0002196; GO:0004812; GO:0005524; GO:0005737; GO:0006412; GO:0006450; GO:0043039; GO:0046872"
"97",100,38075,"Cluster_1167","Peve_00044326",0.87966160096372,0.315538117094371,0.978262075707395,144,-20.61,"2 18","709 732",18,"66.67%","72.22%","Q6DEJ5","Alanyl-tRNA editing protein Aarsd1 (Alanyl-tRNA synthetase domain-containing protein 1)","Danio rerio (Zebrafish) (Brachydanio rerio)","regulation of translational fidelity [GO:0006450]; translation [GO:0006412]; tRNA aminoacylation [GO:0043039]","GO:0002196; GO:0004812; GO:0005524; GO:0005737; GO:0006412; GO:0006450; GO:0043039; GO:0046872"
"98",101,38145,"Cluster_9149","Peve_00044327",0.892711956251587,0.297599627259818,0.978262075707395,152,-20.37,"2 21","587 605",19,"73.68%","73.68%","A8WFT6","Hydroxylysine kinase (5-hydroxy-L-lysine kinase) (EC 2.7.1.81)","Danio rerio (Zebrafish) (Brachydanio rerio)","phosphorylation [GO:0016310]","GO:0005737; GO:0016310; GO:0019202; GO:0047992"
"99",102,38189,"Cluster_8988","Peve_00044324",0.00830668455821486,0.994711739550347,0.999448381576871,164,-21.12,"2 17","116 137",15,"80.00%","93.33%","P35546","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Mus musculus (Mouse)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; anatomical structure morphogenesis [GO:0009653]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0006919; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0009653; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:2001241"
"100",103,38353,"Cluster_4735","Peve_00004507",-0.499055763751742,0.667360561442896,0.978262075707395,157,-20.5,"2 20","108 128",18,"72.22%","83.33%",NA,NA,NA,NA,NA
"101",104,38705,"Cluster_1167","Peve_00032789",0.4610628902044,0.694936498274576,0.978262075707395,153,-21.53,"2 21","313 340",25,"72.00%","72.00%",NA,NA,NA,NA,NA
"102",105,38885,"Cluster_1167","Peve_00010863",0.992234890982229,0.0793871715760993,0.978262075707395,145,-20.42,"2 19","49 71",18,"66.67%","72.22%",NA,NA,NA,NA,NA
"103",106,39602,"Cluster_589","Peve_00019220",-0.801271959357038,0.408314024815898,0.978262075707395,165,-28.04,"2 20","802 822",18,"77.78%","88.89%",NA,NA,NA,NA,NA
"104",107,40170,"Cluster_9149","Peve_00038781",-0.0820144647626005,0.94772925930155,0.999448381576871,166,-21.35,"2 19","122 143",17,"82.35%","82.35%","Q96KE9","BTB/POZ domain-containing protein 6 (Lens BTB domain protein)","Homo sapiens (Human)","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"105",108,40682,"Cluster_589","Peve_00029609",-0.642203340279065,0.556040956302545,0.978262075707395,155,-23.41,"2 12","527 548",10,"100.00%","100.00%","Q9DBG3","AP-2 complex subunit beta (AP105B) (Adaptor protein complex AP-2 subunit beta) (Adaptor-related protein complex 2 subunit beta) (Beta-2-adaptin) (Beta-adaptin) (Clathrin assembly protein complex 2 beta large chain) (Plasma membrane adaptor HA2/AP2 adaptin beta subunit)","Mus musculus (Mouse)","aorta development [GO:0035904]; cardiac septum development [GO:0003279]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; coronary vasculature development [GO:0060976]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; negative regulation of neuron death [GO:1901215]; neurotransmitter receptor internalization [GO:0099590]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein localization to membrane [GO:1905477]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; synaptic vesicle endocytosis [GO:0048488]; ventricular septum development [GO:0003281]; vesicle-mediated transport [GO:0016192]","GO:0001822; GO:0003279; GO:0003281; GO:0006886; GO:0007507; GO:0009898; GO:0016192; GO:0030118; GO:0030122; GO:0030131; GO:0030276; GO:0035904; GO:0044877; GO:0045202; GO:0045807; GO:0048268; GO:0048488; GO:0060976; GO:0072583; GO:0098794; GO:0098884; GO:0098894; GO:0098978; GO:0099590; GO:1901215; GO:1905477"
"106",109,40745,"Cluster_6914","Peve_00016568",0.95678183695816,0.187847289465867,0.978262075707395,157,-22.5,"2 20","286 308",20,"70.00%","85.00%",NA,NA,NA,NA,NA
"107",110,41252,"Cluster_10060","Peve_00014061",-0.732992461699907,0.47624607954137,0.978262075707395,166,-22.52,"2 20","384 408",21,"76.19%","80.95%",NA,NA,NA,NA,NA
"108",112,43116,"Cluster_2787","Peve_00005044",0.867933894665659,0.330895275232091,0.978262075707395,156,-21.57,"2 13","504 525",11,"90.91%","100.00%",NA,NA,NA,NA,NA
"109",113,43781,"Cluster_14999","Peve_00023299",-0.90594181020657,0.278328563669732,0.978262075707395,167,-21.66,"2 17","154 176",16,"87.50%","93.75%","P51029","Protein Wnt-8b","Danio rerio (Zebrafish) (Brachydanio rerio)","canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; negative regulation of anterior neural cell fate commitment of the neural plate by Wnt signaling pathway [GO:0022002]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]","GO:0001654; GO:0005109; GO:0005125; GO:0005615; GO:0009880; GO:0021854; GO:0021879; GO:0022002; GO:0030182; GO:0030900; GO:0043049; GO:0045165; GO:0060070; GO:0060898; GO:0070654; GO:0071679"
"110",114,43890,"Cluster_5882","Peve_00023293",-0.968739261167441,0.159599910760673,0.978262075707395,161,-21.18,"2 19","36 58",18,"72.22%","88.89%","Q5EBD9","Elongator complex protein 2 (ELP2)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","proteasome assembly [GO:0043248]; transcription elongation by RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098]","GO:0000502; GO:0002098; GO:0005634; GO:0005737; GO:0006368; GO:0033588; GO:0043248; GO:0061133"
"111",116,44805,"Cluster_9149","Peve_00006532",-0.771388877632978,0.439124742327824,0.978262075707395,142,-22.63,"2 21","374 398",22,"59.09%","72.73%","P09874","Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-) [Cleaved into: Poly [ADP-ribose] polymerase 1, processed C-terminus (Poly [ADP-ribose] polymerase 1, 89-kDa form); Poly [ADP-ribose] polymerase 1, processed N-terminus (NT-PARP-1) (Poly [ADP-ribose] polymerase 1, 24-kDa form) (Poly [ADP-ribose] polymerase 1, 28-kDa form)]","Homo sapiens (Human)","apoptotic process [GO:0006915]; ATP generation from poly-ADP-D-ribose [GO:1990966]; carbohydrate biosynthetic process [GO:0016051]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; cellular response to zinc ion [GO:0071294]; decidualization [GO:0046697]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of innate immune response [GO:0045824]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of myofibroblast differentiation [GO:1904762]; positive regulation of necroptotic process [GO:0060545]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of single strand break repair [GO:1903518]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein auto-ADP-ribosylation [GO:0070213]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; regulation of catalytic activity [GO:0050790]; regulation of circadian sleep/wake cycle, non-REM sleep [GO:0045188]; regulation of DNA methylation [GO:0044030]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of protein localization [GO:0032880]; regulation of SMAD protein complex assembly [GO:0010990]; replication fork reversal [GO:0071932]; response to aldosterone [GO:1904044]; response to gamma radiation [GO:0010332]; signal transduction involved in regulation of gene expression [GO:0023019]; telomere maintenance [GO:0000723]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0000122; GO:0000723; GO:0000781; GO:0000785; GO:0003677; GO:0003684; GO:0003723; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0005829; GO:0006281; GO:0006302; GO:0006366; GO:0006915; GO:0006974; GO:0007005; GO:0007179; GO:0008270; GO:0010332; GO:0010613; GO:0010990; GO:0016020; GO:0016051; GO:0016540; GO:0016604; GO:0016779; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0030331; GO:0030592; GO:0031491; GO:0032042; GO:0032869; GO:0032880; GO:0032991; GO:0032993; GO:0033148; GO:0034599; GO:0034644; GO:0035861; GO:0036211; GO:0042802; GO:0042803; GO:0042826; GO:0043504; GO:0043596; GO:0044030; GO:0045087; GO:0045188; GO:0045824; GO:0045944; GO:0046697; GO:0047485; GO:0050790; GO:0051287; GO:0051901; GO:0060391; GO:0060545; GO:0061629; GO:0070212; GO:0070213; GO:0070412; GO:0071294; GO:0071932; GO:0090734; GO:0140294; GO:0140805; GO:0140806; GO:0140807; GO:0140808; GO:0140815; GO:1900182; GO:1901216; GO:1903376; GO:1903518; GO:1904044; GO:1904357; GO:1904646; GO:1904762; GO:1905168; GO:1990090; GO:1990404; GO:1990966; GO:2000679; GO:2001170"
"112",121,45507,"Cluster_4629","Peve_00035611",0.0558367272176816,0.964434738537409,0.999448381576871,163,-25.59,"2 21","533 555",20,"65.00%","90.00%","Q96A58","Ras-related and estrogen-regulated growth inhibitor (EC 3.6.5.2)","Homo sapiens (Human)","negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; Ras protein signal transduction [GO:0007265]; response to hormone [GO:0009725]; small GTPase mediated signal transduction [GO:0007264]","GO:0001650; GO:0003924; GO:0003925; GO:0005525; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0007264; GO:0007265; GO:0008285; GO:0009725; GO:0019003; GO:0030308; GO:0030331"
"113",122,47073,"Cluster_796","Peve_00027101",0.954017724036939,0.193806668464751,0.978262075707395,155,-21.46,"2 20","77 98",18,"66.67%","77.78%","Q7Z442","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Homo sapiens (Human)","detection of mechanical stimulus [GO:0050982]","GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"114",123,47415,"Cluster_9149","Peve_00011253",-0.551370623074399,0.628210062882611,0.978262075707395,152,-21.89,"2 21","961 982",19,"63.16%","73.68%",NA,NA,NA,NA,NA
"115",124,48322,"Cluster_11135","Peve_00013094",0.641626448829066,0.556519923539791,0.978262075707395,157,-22.08,"2 19","626 649",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"116",125,48364,"Cluster_10934","Peve_00013095",-0.0420352317209879,0.973231653297393,0.999448381576871,163,-22.92,"2 21","937 959",20,"75.00%","80.00%",NA,NA,NA,NA,NA
"117",126,48373,"Cluster_15890","Peve_00013095",-0.99757658370632,0.0443299128918105,0.926127022176621,180,-23.84,"2 21","676 697",19,"84.21%","89.47%",NA,NA,NA,NA,NA
"118",127,48450,"Cluster_9149","Peve_00013097",-0.809770565233956,0.399183099170274,0.978262075707395,157,-20.88,"2 14","588 609",12,"91.67%","91.67%","Q66IM5","Protein NATD1 (N-acetyltransferase domain-containing protein 1)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","",""
"119",128,48594,"Cluster_13502","Peve_00039257",0.257303735391603,0.834331830140354,0.995934364227446,200,-40.02,"2 21","850 871",19,"100.00%","100.00%",NA,NA,NA,NA,NA
"120",129,49672,"Cluster_11135","Peve_00020221",0.844443877729655,0.359862212804899,0.978262075707395,160,-20.87,"2 18","322 344",17,"82.35%","82.35%","P51029","Protein Wnt-8b","Danio rerio (Zebrafish) (Brachydanio rerio)","canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; negative regulation of anterior neural cell fate commitment of the neural plate by Wnt signaling pathway [GO:0022002]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]","GO:0001654; GO:0005109; GO:0005125; GO:0005615; GO:0009880; GO:0021854; GO:0021879; GO:0022002; GO:0030182; GO:0030900; GO:0043049; GO:0045165; GO:0060070; GO:0060898; GO:0070654; GO:0071679"
"121",130,50767,"Cluster_2854","Peve_00044378",-0.743122849152393,0.466687574853706,0.978262075707395,160,-20.79,"2 18","377 401",19,"73.68%","84.21%","P56839","Phosphoenolpyruvate phosphomutase (PEP mutase) (PEP phosphomutase) (Phosphoenolpyruvate mutase) (EC 5.4.2.9)","Mytilus edulis (Blue mussel)","organic phosphonate biosynthetic process [GO:0032923]","GO:0032923; GO:0046872; GO:0050188"
"122",131,51128,"Cluster_2882","Peve_00041686",-0.898389711968954,0.289475524970989,0.978262075707395,168,-22.11,"2 21","226 247",19,"68.42%","89.47%","Q5ZLC8","Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C (PP6-ARS-C) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-C)","Gallus gallus (Chicken)","protein localization to T-tubule [GO:0036371]; regulation of cardiac muscle contraction [GO:0055117]","GO:0030315; GO:0036371; GO:0055117"
"123",132,51686,"Cluster_8884","Peve_00043934",0.844023627644647,0.360361376930212,0.978262075707395,195,-34.9,"2 20","707 727",18,"100.00%","100.00%",NA,NA,NA,NA,NA
"124",133,51687,"Cluster_8887","Peve_00043934",0.95919344463284,0.182493794656647,0.978262075707395,195,-37.56,"2 20","707 727",18,"100.00%","100.00%",NA,NA,NA,NA,NA
"125",134,51688,"Cluster_8888","Peve_00043934",0.897592589889809,0.290628818214082,0.978262075707395,195,-39.19,"2 20","707 727",18,"100.00%","100.00%",NA,NA,NA,NA,NA
"126",135,52476,"Cluster_2787","Peve_00043687",-0.972545288651367,0.149521009442806,0.978262075707395,151,-20.33,"2 17","289 311",16,"75.00%","81.25%",NA,NA,NA,NA,NA
"127",136,52971,"Cluster_2787","Peve_00019753",0.950413624646263,0.201320237615395,0.978262075707395,161,-22.27,"2 18","895 916",16,"75.00%","87.50%","O16025","Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (AOS) (EC 4.2.1.-) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)]","Plexaura homomalla (Black sea rod)","arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; lipid oxidation [GO:0034440]; oxylipin biosynthetic process [GO:0031408]","GO:0005506; GO:0005737; GO:0006633; GO:0009978; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0034440; GO:0047677"
"128",137,53091,"Cluster_11134","Peve_00015233",-0.856078539892879,0.345787863891157,0.978262075707395,151,-20.75,"2 12","524 545",10,"90.00%","100.00%",NA,NA,NA,NA,NA
"129",138,53112,"Cluster_4629","Peve_00015231",-0.341885224710884,0.777869179595863,0.993041249086501,167,-29.78,"2 21","638 661",21,"76.19%","80.95%","Q5RA50","Protein FAM124A","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","",""
"130",139,53250,"Cluster_5882","Peve_00015234",0.490154400272193,0.673880773766397,0.978262075707395,151,-21.4,"2 21","783 805",20,"60.00%","80.00%",NA,NA,NA,NA,NA
"131",140,54119,"Cluster_8988","Peve_00036930",-0.246168907684073,0.841656410474464,0.995934364227446,159,-22.71,"2 21","894 919",23,"65.22%","78.26%",NA,NA,NA,NA,NA
"132",141,54570,"Cluster_9149","Peve_00004063",-0.795749857374899,0.414154010727954,0.978262075707395,148,-20.56,"2 19","98 118",17,"64.71%","82.35%",NA,NA,NA,NA,NA
"133",142,54615,"Cluster_9149","Peve_00001233",-0.5,0.666666666666667,0.978262075707395,161,-26.19,"2 14","601 622",12,"91.67%","100.00%","G3V9H8","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Rattus norvegicus (Rat)","cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797"
"134",143,55277,"Cluster_6904","Peve_00030428",0.742592842212241,0.467191590606991,0.978262075707395,158,-27.77,"2 21","574 597",21,"66.67%","85.71%","Q96SF7","T-box transcription factor TBX15 (T-box protein 15) (T-box transcription factor TBX14) (T-box protein 14)","Homo sapiens (Human)","cell fate specification [GO:0001708]; embryonic cranial skeleton morphogenesis [GO:0048701]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001708; GO:0006357; GO:0042803; GO:0045893; GO:0048701; GO:0090571; GO:1990837"
"135",144,55279,"Cluster_6906","Peve_00030428",0.973101367926096,0.147992105390084,0.978262075707395,166,-28.49,"2 21","574 597",21,"71.43%","90.48%","Q96SF7","T-box transcription factor TBX15 (T-box protein 15) (T-box transcription factor TBX14) (T-box protein 14)","Homo sapiens (Human)","cell fate specification [GO:0001708]; embryonic cranial skeleton morphogenesis [GO:0048701]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001708; GO:0006357; GO:0042803; GO:0045893; GO:0048701; GO:0090571; GO:1990837"
"136",145,55342,"Cluster_11135","Peve_00030429",0.537378723899158,0.638829168067299,0.978262075707395,155,-21.46,"2 21","813 836",21,"66.67%","76.19%","E7F7V7","Galanin receptor 2b","Danio rerio (Zebrafish) (Brachydanio rerio)","adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; neuropeptide signaling pathway [GO:0007218]","GO:0004966; GO:0005886; GO:0007188; GO:0007218; GO:0008528"
"137",146,55677,"Cluster_4629","Peve_00034505",0.997938030915673,0.0408894104551382,0.909359886114279,158,-20.97,"2 20","824 846",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"138",147,56042,"Cluster_6904","Peve_00018190",-0.951310992493219,0.199475076059675,0.978262075707395,159,-21.81,"2 20","723 744",18,"66.67%","83.33%",NA,NA,NA,NA,NA
"139",148,56460,"Cluster_9149","Peve_00007170",-0.702482477624325,0.504149839908326,0.978262075707395,146,-21.3,"2 11","1 16",9,"88.89%","100.00%","A3KMV2","UV excision repair protein RAD23 homolog A","Bos taurus (Bovine)","nucleotide-excision repair [GO:0006289]; positive regulation of cell cycle [GO:0045787]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of viral genome replication [GO:0045070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]","GO:0000502; GO:0003684; GO:0005654; GO:0005794; GO:0005829; GO:0006289; GO:0019900; GO:0031593; GO:0031648; GO:0032436; GO:0043130; GO:0043161; GO:0045070; GO:0045787; GO:0070628; GO:1990381"
"140",149,56492,"Cluster_6904","Peve_00007171",0.807934326017399,0.40117113687066,0.978262075707395,155,-20.16,"2 18","611 631",16,"81.25%","81.25%","Q13042","Cell division cycle protein 16 homolog (Anaphase-promoting complex subunit 6) (APC6) (CDC16 homolog) (CDC16Hs) (Cyclosome subunit 6)","Homo sapiens (Human)","anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]","GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005829; GO:0007091; GO:0007346; GO:0016567; GO:0031145; GO:0045842; GO:0051301; GO:0051445; GO:0070979; GO:0072686"
"141",150,56530,"Cluster_4080","Peve_00035488",-0.763288241353977,0.447167268224907,0.978262075707395,166,-20.17,"2 21","81 104",21,"76.19%","85.71%",NA,NA,NA,NA,NA
"142",151,56808,"Cluster_6905","Peve_00023820",-0.91209508067308,0.268927766945705,0.978262075707395,148,-23.48,"2 13","431 452",11,"81.82%","90.91%","O60645","Exocyst complex component 3 (Exocyst complex component Sec6)","Homo sapiens (Human)","exocyst localization [GO:0051601]; exocytosis [GO:0006887]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]","GO:0000145; GO:0000149; GO:0000281; GO:0005794; GO:0005829; GO:0006887; GO:0006904; GO:0015031; GO:0030426; GO:0030496; GO:0030667; GO:0042734; GO:0045296; GO:0048471; GO:0051601; GO:0090148; GO:0090522"
"143",152,56841,"Cluster_2787","Peve_00023821",0.0495528258027282,0.968440766795971,0.999448381576871,158,-21.33,"2 21","86 110",22,"68.18%","81.82%",NA,NA,NA,NA,NA
"144",153,57927,"Cluster_4629","Peve_00007823",0.967684759055735,0.16228386362466,0.978262075707395,151,-20.66,"2 21","542 565",21,"66.67%","71.43%","Q5ZM55","Protein fem-1 homolog B (FEM1b) (FEM1-beta)","Gallus gallus (Chicken)","apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756; GO:2000001"
"145",154,58191,"Cluster_2787","Peve_00027347",0.630578672858647,0.565635234611323,0.978262075707395,161,-24.48,"2 20","68 91",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"146",155,58236,"Cluster_2787","Peve_00027346",0.981358557231542,0.123115251235074,0.978262075707395,161,-24.48,"2 20","68 91",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"147",156,59002,"Cluster_2854","Peve_00009466",-0.845973210128434,0.358040470050356,0.978262075707395,157,-20.21,"2 21","45 67",21,"71.43%","80.95%","P27590","Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","Rattus norvegicus (Rat)","antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; calcium ion homeostasis [GO:0055074]; cellular calcium ion homeostasis [GO:0006874]; cellular chloride ion homeostasis [GO:0030644]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to unfolded protein [GO:0034620]; cellular sodium ion homeostasis [GO:0006883]; chaperone-mediated protein folding [GO:0061077]; chemical homeostasis [GO:0048878]; chloride ion homeostasis [GO:0055064]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; creatinine homeostasis [GO:0097273]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; gene expression [GO:0010467]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; ion homeostasis [GO:0050801]; juxtaglomerular apparatus development [GO:0072051]; kidney development [GO:0001822]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; loop of Henle development [GO:0072070]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; multicellular organismal homeostasis [GO:0048871]; multicellular organismal response to stress [GO:0033555]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; peptidyl-threonine phosphorylation [GO:0018107]; phosphate ion homeostasis [GO:0055062]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein phosphorylation [GO:0006468]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; response to organic substance [GO:0010033]; response to unfolded protein [GO:0006986]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; sodium ion homeostasis [GO:0055078]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent ERAD pathway [GO:0030433]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918]; water homeostasis [GO:0030104]","GO:0000922; GO:0001822; GO:0002251; GO:0003091; GO:0003094; GO:0005201; GO:0005509; GO:0005615; GO:0005783; GO:0005794; GO:0005886; GO:0005929; GO:0006468; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006915; GO:0006954; GO:0006986; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008380; GO:0009410; GO:0009414; GO:0009986; GO:0010033; GO:0010467; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0018107; GO:0019864; GO:0030104; GO:0030433; GO:0030643; GO:0030644; GO:0031410; GO:0032496; GO:0033209; GO:0033555; GO:0034620; GO:0034976; GO:0035809; GO:0044861; GO:0045121; GO:0045177; GO:0046720; GO:0048871; GO:0048878; GO:0050801; GO:0050829; GO:0051223; GO:0055062; GO:0055064; GO:0055074; GO:0055075; GO:0055078; GO:0060073; GO:0060170; GO:0061077; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072070; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097273; GO:0097709; GO:0097744; GO:0140367; GO:1990266"
"148",157,59375,"Cluster_6914","Peve_00029413",0.992714239036179,0.0768947365714533,0.978262075707395,173,-21.1,"2 18","833 853",16,"87.50%","93.75%",NA,NA,NA,NA,NA
"149",158,60336,"Cluster_11134","Peve_00030746",-0.290272080189818,0.812508380380798,0.995934364227446,154,-20.28,"2 21","709 729",19,"63.16%","84.21%","Q9Y222","Cyclin-D-binding Myb-like transcription factor 1 (hDMTF1) (Cyclin-D-interacting Myb-like protein 1) (hDMP1)","Homo sapiens (Human)","cell cycle [GO:0007049]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0007049"
"150",159,60492,"Cluster_4629","Peve_00031293",-0.390719037694159,0.744452806396853,0.987197309954181,155,-21.77,"2 21","285 309",22,"63.64%","77.27%",NA,NA,NA,NA,NA
"151",160,61046,"Cluster_8884","Peve_00020751",-0.994265595189033,0.0682098427573981,0.978262075707395,170,-23.5,"2 20","62 83",19,"78.95%","89.47%","Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"152",161,61047,"Cluster_8887","Peve_00020751",-0.985201616566502,0.109657739516166,0.978262075707395,170,-23.5,"2 20","62 83",19,"78.95%","89.47%","Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"153",162,61048,"Cluster_8888","Peve_00020751",-0.609450322193467,0.582780352386895,0.978262075707395,170,-23.74,"2 20","62 83",19,"78.95%","89.47%","Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"154",163,61136,"Cluster_8884","Peve_00020753",-0.947118896471404,0.207959151134339,0.978262075707395,170,-23.5,"2 20","62 83",19,"78.95%","89.47%","Q9P0L9","Polycystic kidney disease 2-like 1 protein (Polycystin-2 homolog) (Polycystin-2L1) (Polycystin-L) (Polycystin-L1)","Homo sapiens (Human)","cation transport [GO:0006812]; cellular response to acidic pH [GO:0071468]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of chemical stimulus involved in sensory perception of taste [GO:0050912]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; response to water [GO:0009415]; sensory perception of sour taste [GO:0050915]; smoothened signaling pathway [GO:0007224]; sodium ion transmembrane transport [GO:0035725]","GO:0001581; GO:0005227; GO:0005261; GO:0005262; GO:0005272; GO:0005509; GO:0005783; GO:0005829; GO:0005886; GO:0006812; GO:0007224; GO:0008092; GO:0009415; GO:0009986; GO:0015269; GO:0015629; GO:0016020; GO:0031410; GO:0033040; GO:0034704; GO:0035725; GO:0042802; GO:0043231; GO:0043235; GO:0050912; GO:0050915; GO:0050982; GO:0051289; GO:0051371; GO:0051393; GO:0060170; GO:0071468; GO:0071805; GO:0097730; GO:0098662"
"155",164,61137,"Cluster_8887","Peve_00020753",-0.821901473199095,0.385826733407904,0.978262075707395,170,-23.5,"2 20","62 83",19,"78.95%","89.47%","Q9P0L9","Polycystic kidney disease 2-like 1 protein (Polycystin-2 homolog) (Polycystin-2L1) (Polycystin-L) (Polycystin-L1)","Homo sapiens (Human)","cation transport [GO:0006812]; cellular response to acidic pH [GO:0071468]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of chemical stimulus involved in sensory perception of taste [GO:0050912]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; response to water [GO:0009415]; sensory perception of sour taste [GO:0050915]; smoothened signaling pathway [GO:0007224]; sodium ion transmembrane transport [GO:0035725]","GO:0001581; GO:0005227; GO:0005261; GO:0005262; GO:0005272; GO:0005509; GO:0005783; GO:0005829; GO:0005886; GO:0006812; GO:0007224; GO:0008092; GO:0009415; GO:0009986; GO:0015269; GO:0015629; GO:0016020; GO:0031410; GO:0033040; GO:0034704; GO:0035725; GO:0042802; GO:0043231; GO:0043235; GO:0050912; GO:0050915; GO:0050982; GO:0051289; GO:0051371; GO:0051393; GO:0060170; GO:0071468; GO:0071805; GO:0097730; GO:0098662"
"156",165,61138,"Cluster_8888","Peve_00020753",-0.219753560508399,0.858949346278634,0.995934364227446,170,-23.74,"2 20","62 83",19,"78.95%","89.47%","Q9P0L9","Polycystic kidney disease 2-like 1 protein (Polycystin-2 homolog) (Polycystin-2L1) (Polycystin-L) (Polycystin-L1)","Homo sapiens (Human)","cation transport [GO:0006812]; cellular response to acidic pH [GO:0071468]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of chemical stimulus involved in sensory perception of taste [GO:0050912]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; response to water [GO:0009415]; sensory perception of sour taste [GO:0050915]; smoothened signaling pathway [GO:0007224]; sodium ion transmembrane transport [GO:0035725]","GO:0001581; GO:0005227; GO:0005261; GO:0005262; GO:0005272; GO:0005509; GO:0005783; GO:0005829; GO:0005886; GO:0006812; GO:0007224; GO:0008092; GO:0009415; GO:0009986; GO:0015269; GO:0015629; GO:0016020; GO:0031410; GO:0033040; GO:0034704; GO:0035725; GO:0042802; GO:0043231; GO:0043235; GO:0050912; GO:0050915; GO:0050982; GO:0051289; GO:0051371; GO:0051393; GO:0060170; GO:0071468; GO:0071805; GO:0097730; GO:0098662"
"157",166,61777,"Cluster_11135","Peve_00006706",0.330394430175901,0.785636471795003,0.994879653208015,150,-20.76,"2 19","592 613",17,"58.82%","82.35%",NA,NA,NA,NA,NA
"158",167,61911,"Cluster_11134","Peve_00006705",0.875640822838247,0.320878802775509,0.978262075707395,150,-21.92,"2 16","971 993",15,"73.33%","86.67%","Q2M3R5","Solute carrier family 35 member G1 (Partner of STIM1) (Transmembrane protein 20)","Homo sapiens (Human)","calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]","GO:0005789; GO:0005886; GO:0016020; GO:0051480; GO:1990034"
"159",168,62049,"Cluster_13502","Peve_00006701",0.063055306810569,0.959831096479895,0.999448381576871,170,-25.38,"2 19","120 141",17,"76.47%","94.12%","Q0P5W1","Vacuolar protein sorting-associated protein 8 homolog","Mus musculus (Mouse)","endosomal vesicle fusion [GO:0034058]; protein targeting to vacuole [GO:0006623]","GO:0005769; GO:0006623; GO:0033263; GO:0034058; GO:0046872"
"160",169,62470,"Cluster_4080","Peve_00021405",0.0966894033674828,0.938349297926935,0.999448381576871,175,-22.04,"2 20","76 97",18,"83.33%","88.89%","Q9V3L1","Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase) (Sulfateless) [Includes: Heparan sulfate N-deacetylase (EC 3.-.-.-); Heparan sulfate N-sulfotransferase (EC 2.8.2.-)]","Drosophila melanogaster (Fruit fly)","epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of imaginal disc growth [GO:0045570]; segment polarity determination [GO:0007367]; spermatogenesis [GO:0007283]; sulfur compound metabolic process [GO:0006790]; Wnt signaling pathway [GO:0016055]","GO:0000137; GO:0000139; GO:0005783; GO:0005794; GO:0006024; GO:0006790; GO:0007283; GO:0007367; GO:0007427; GO:0007474; GO:0007509; GO:0008146; GO:0008543; GO:0008587; GO:0015012; GO:0015014; GO:0015016; GO:0016055; GO:0019213; GO:0030210; GO:0045570; GO:0102140"
"161",170,63434,"Cluster_8988","Peve_00012936",0.758542187632656,0.45182390691845,0.978262075707395,158,-20.01,"2 21","408 428",19,"63.16%","89.47%","Q6UW02","Cytochrome P450 20A1 (EC 1.14.-.-)","Homo sapiens (Human)","","GO:0004497; GO:0005506; GO:0016020; GO:0016705; GO:0020037"
"162",171,63615,"Cluster_9149","Peve_00029784",-0.5,0.666666666666667,0.978262075707395,161,-23.72,"2 18","807 828",16,"75.00%","87.50%","P35546","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Mus musculus (Mouse)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; anatomical structure morphogenesis [GO:0009653]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0006919; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0009653; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:2001241"
"163",172,63767,"Cluster_589","Peve_00024867",0.215454912020844,0.86175314051756,0.996611113450215,170,-24.15,"2 19","94 115",17,"82.35%","88.24%","B3DM66","G-protein coupled receptor 161","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]","GO:0004930; GO:0005929; GO:0007189; GO:0055037; GO:0060170; GO:1901621"
"164",173,64290,"Cluster_9149","Peve_00010792",-0.673819341236973,0.529305197194449,0.978262075707395,163,-23.82,"2 20","266 287",18,"72.22%","83.33%","P70704","Phospholipid-transporting ATPase IA (EC 7.6.2.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) (P4-ATPase flippase complex alpha subunit ATP8A1)","Mus musculus (Mouse)","aminophospholipid translocation [GO:0140331]; learning [GO:0007612]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]","GO:0000287; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007612; GO:0016887; GO:0030335; GO:0030672; GO:0031090; GO:0031410; GO:0042584; GO:0043231; GO:0045202; GO:0045332; GO:0061092; GO:0090556; GO:0140326; GO:0140331; GO:0140346; GO:1990531"
"165",174,64682,"Cluster_6904","Peve_00011776",-0.951310992493219,0.199475076059675,0.978262075707395,143,-20.99,"2 21","834 858",22,"59.09%","68.18%",NA,NA,NA,NA,NA
"166",175,65672,"Cluster_6904","Peve_00010423",-0.951310992493219,0.199475076059675,0.978262075707395,158,-21.6,"2 21","893 913",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"167",176,65674,"Cluster_6906","Peve_00010423",-0.686063329690759,0.518674561276582,0.978262075707395,158,-21.6,"2 21","893 913",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"168",177,65781,"Cluster_11134","Peve_00010429",0.0856826438312012,0.945385770056313,0.999448381576871,148,-21.39,"2 14","52 75",14,"78.57%","85.71%","Q9ULT8","E3 ubiquitin-protein ligase HECTD1 (EC 2.3.2.26) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1)","Homo sapiens (Human)","anatomical structure development [GO:0048856]; aorta development [GO:0035904]; heart valve development [GO:0003170]; natural killer cell differentiation [GO:0001779]; negative regulation of protein localization to plasma membrane [GO:1903077]; neural tube closure [GO:0001843]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein localization to plasma membrane [GO:0072659]; protein polyubiquitination [GO:0000209]; spongiotrophoblast differentiation [GO:0060708]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]","GO:0000209; GO:0001779; GO:0001843; GO:0003170; GO:0003281; GO:0016607; GO:0032436; GO:0035904; GO:0043161; GO:0046872; GO:0048856; GO:0051865; GO:0060707; GO:0060708; GO:0061630; GO:0070534; GO:0072659; GO:1903077"
"169",178,66840,"Cluster_5882","Peve_00039041",0.415049322538645,0.727528637816425,0.983792337076078,167,-27.87,"2 17","546 569",17,"88.24%","88.24%","Q9NRR4","Ribonuclease 3 (EC 3.1.26.3) (Protein Drosha) (Ribonuclease III) (RNase III) (p241)","Homo sapiens (Human)","defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]","GO:0001530; GO:0003723; GO:0003725; GO:0004525; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006396; GO:0010468; GO:0010586; GO:0010628; GO:0014069; GO:0017151; GO:0031053; GO:0031054; GO:0042803; GO:0045589; GO:0046332; GO:0046872; GO:0050727; GO:0050829; GO:0050830; GO:0070412; GO:0070877; GO:0070878; GO:0098978; GO:2000628"
"170",179,67107,"Cluster_4629","Peve_00029667",0.997938030915673,0.0408894104551382,0.909359886114279,154,-20.44,"2 19","313 334",17,"70.59%","76.47%","Q9I8C7","Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10)","Gallus gallus (Chicken)","chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996]; signal transduction [GO:0007165]","GO:0004888; GO:0005231; GO:0005262; GO:0005886; GO:0005892; GO:0007165; GO:0007268; GO:0010996; GO:0022848; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051899; GO:1904315"
"171",180,67337,"Cluster_6904","Peve_00012158",0.342003598131734,0.777788986723782,0.993032175831671,152,-20.36,"2 18","977 999",17,"70.59%","82.35%",NA,NA,NA,NA,NA
"172",181,67339,"Cluster_6906","Peve_00012158",-0.151760475211785,0.903011528059311,0.999448381576871,152,-20.81,"2 18","977 999",17,"70.59%","82.35%",NA,NA,NA,NA,NA
"173",182,67422,"Cluster_4629","Peve_00002471",-0.765254522086073,0.445226213975171,0.978262075707395,166,-26.6,"2 20","975 997",19,"78.95%","84.21%","Q9EPL8","Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7)","Mus musculus (Mouse)","innate immune response [GO:0045087]; protein import into nucleus [GO:0006606]","GO:0005635; GO:0005654; GO:0005829; GO:0006606; GO:0031267; GO:0042393; GO:0045087; GO:0046332"
"174",183,68050,"Cluster_4080","Peve_00042986",0.995069943523853,0.0632411347771786,0.978262075707395,166,-21.48,"2 20","837 859",19,"73.68%","89.47%",NA,NA,NA,NA,NA
"175",184,68272,"Cluster_2854","Peve_00041187",-0.945089156654587,0.211949200042434,0.978262075707395,149,-20.22,"2 21","117 140",22,"63.64%","77.27%",NA,NA,NA,NA,NA
"176",185,68277,"Cluster_4629","Peve_00041187",0.705857228187026,0.501124001282144,0.978262075707395,154,-22.16,"2 19","715 736",17,"64.71%","82.35%",NA,NA,NA,NA,NA
"177",186,69246,"Cluster_11134","Peve_00016481",0.372888029894863,0.756735108869313,0.988219883885475,153,-21.17,"2 15","397 419",14,"78.57%","92.86%",NA,NA,NA,NA,NA
"178",190,70662,"Cluster_4629","Peve_00018306",-0.776276454607042,0.434212176619684,0.978262075707395,154,-20.11,"2 20","51 73",19,"68.42%","78.95%","A6TSF6","Putative hydro-lyase Amet_2975 (EC 4.2.1.-)","Alkaliphilus metalliredigens (strain QYMF)","","GO:0016829"
"179",192,71040,"Cluster_9149","Peve_00043765",-0.5,0.666666666666667,0.978262075707395,144,-20.94,"2 14","336 358",13,"69.23%","92.31%",NA,NA,NA,NA,NA
"180",193,71062,"Cluster_2854","Peve_00009049",0.631991411802078,0.564475571308171,0.978262075707395,153,-20.14,"2 20","189 209",18,"72.22%","77.78%","O54922","Exocyst complex component 7 (Exocyst complex component Exo70) (rExo70)","Rattus norvegicus (Rat)","exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]","GO:0000145; GO:0005546; GO:0005815; GO:0005829; GO:0006887; GO:0015031; GO:0032584; GO:0034451; GO:0090543; GO:2000535"
"181",194,71432,"Cluster_6904","Peve_00004167",-0.933456081010809,0.233554126103048,0.978262075707395,163,-20.65,"2 21","457 479",20,"75.00%","80.00%","Q62165","Dystroglycan 1 (Dystroglycan) (Dystrophin-associated glycoprotein 1) [Cleaved into: Alpha-dystroglycan (Alpha-DG); Beta-dystroglycan (Beta-DG)]","Mus musculus (Mouse)","aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; axon guidance [GO:0007411]; axon regeneration [GO:0031103]; basement membrane organization [GO:0071711]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium-dependent cell-matrix adhesion [GO:0016340]; cellular response to cholesterol [GO:0071397]; cellular response to mechanical stimulus [GO:0071260]; commissural neuron axon guidance [GO:0071679]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; membrane protein ectodomain proteolysis [GO:0006509]; microtubule anchoring [GO:0034453]; morphogenesis of an epithelial sheet [GO:0002011]; morphogenesis of an epithelium [GO:0002009]; muscle attachment [GO:0016203]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell migration [GO:0030336]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase B signaling [GO:0051898]; nerve development [GO:0021675]; nerve maturation [GO:0021682]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein kinase activity [GO:0045860]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synapse organization [GO:0050807]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to peptide hormone [GO:0043434]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; Schwann cell development [GO:0014044]; skeletal muscle tissue regeneration [GO:0043403]","GO:0001618; GO:0001954; GO:0002009; GO:0002011; GO:0002162; GO:0003779; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005856; GO:0005886; GO:0005911; GO:0005912; GO:0005925; GO:0006509; GO:0007411; GO:0007568; GO:0008307; GO:0009897; GO:0010470; GO:0010717; GO:0014044; GO:0014894; GO:0015631; GO:0016010; GO:0016011; GO:0016020; GO:0016203; GO:0016323; GO:0016340; GO:0017166; GO:0021675; GO:0021682; GO:0022011; GO:0030027; GO:0030175; GO:0030336; GO:0031103; GO:0031643; GO:0033268; GO:0034399; GO:0034453; GO:0042169; GO:0042383; GO:0043034; GO:0043231; GO:0043236; GO:0043237; GO:0043403; GO:0043409; GO:0043434; GO:0044853; GO:0045121; GO:0045202; GO:0045211; GO:0045860; GO:0048714; GO:0050807; GO:0051393; GO:0051898; GO:0060055; GO:0060441; GO:0060445; GO:0070938; GO:0071260; GO:0071397; GO:0071679; GO:0071711; GO:0098696; GO:0098942; GO:0098978; GO:0098982; GO:0099524; GO:1904261"
"182",195,71434,"Cluster_6906","Peve_00004167",-0.646152951927077,0.552753611319955,0.978262075707395,161,-22.57,"2 20","455 479",21,"76.19%","80.95%","Q62165","Dystroglycan 1 (Dystroglycan) (Dystrophin-associated glycoprotein 1) [Cleaved into: Alpha-dystroglycan (Alpha-DG); Beta-dystroglycan (Beta-DG)]","Mus musculus (Mouse)","aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; axon guidance [GO:0007411]; axon regeneration [GO:0031103]; basement membrane organization [GO:0071711]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium-dependent cell-matrix adhesion [GO:0016340]; cellular response to cholesterol [GO:0071397]; cellular response to mechanical stimulus [GO:0071260]; commissural neuron axon guidance [GO:0071679]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; membrane protein ectodomain proteolysis [GO:0006509]; microtubule anchoring [GO:0034453]; morphogenesis of an epithelial sheet [GO:0002011]; morphogenesis of an epithelium [GO:0002009]; muscle attachment [GO:0016203]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell migration [GO:0030336]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase B signaling [GO:0051898]; nerve development [GO:0021675]; nerve maturation [GO:0021682]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein kinase activity [GO:0045860]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synapse organization [GO:0050807]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to peptide hormone [GO:0043434]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; Schwann cell development [GO:0014044]; skeletal muscle tissue regeneration [GO:0043403]","GO:0001618; GO:0001954; GO:0002009; GO:0002011; GO:0002162; GO:0003779; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005856; GO:0005886; GO:0005911; GO:0005912; GO:0005925; GO:0006509; GO:0007411; GO:0007568; GO:0008307; GO:0009897; GO:0010470; GO:0010717; GO:0014044; GO:0014894; GO:0015631; GO:0016010; GO:0016011; GO:0016020; GO:0016203; GO:0016323; GO:0016340; GO:0017166; GO:0021675; GO:0021682; GO:0022011; GO:0030027; GO:0030175; GO:0030336; GO:0031103; GO:0031643; GO:0033268; GO:0034399; GO:0034453; GO:0042169; GO:0042383; GO:0043034; GO:0043231; GO:0043236; GO:0043237; GO:0043403; GO:0043409; GO:0043434; GO:0044853; GO:0045121; GO:0045202; GO:0045211; GO:0045860; GO:0048714; GO:0050807; GO:0051393; GO:0051898; GO:0060055; GO:0060441; GO:0060445; GO:0070938; GO:0071260; GO:0071397; GO:0071679; GO:0071711; GO:0098696; GO:0098942; GO:0098978; GO:0098982; GO:0099524; GO:1904261"
"183",196,71732,"Cluster_589","Peve_00041794",-0.924128317504035,0.249585804013924,0.978262075707395,156,-22.9,"2 13","163 184",11,"90.91%","100.00%",NA,NA,NA,NA,NA
"184",197,73083,"Cluster_796","Peve_00031940",-0.999663016871668,0.0165276609923165,0.773377054133803,155,-20.27,"2 21","182 200",19,"78.95%","78.95%","Q90WU3","ATP-dependent RNA helicase DDX1 (EC 3.6.4.13) (DEAD box protein 1)","Gallus gallus (Chicken)","DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]","GO:0003677; GO:0003682; GO:0003712; GO:0003724; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006388; GO:0006397; GO:0008143; GO:0016887; GO:0032508; GO:0033677; GO:0072669"
"185",198,73432,"Cluster_11135","Peve_00040446",-0.886103284710592,0.306804453861767,0.978262075707395,155,-20.06,"2 21","587 610",21,"71.43%","71.43%","P70196","TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6)","Mus musculus (Mouse)","activation of NF-kappaB-inducing kinase activity [GO:0007250]; activation of protein kinase activity [GO:0032147]; animal organ morphogenesis [GO:0009887]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; bone remodeling [GO:0046849]; bone resorption [GO:0045453]; cell development [GO:0048468]; cellular response to cytokine stimulus [GO:0071345]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; JNK cascade [GO:0007254]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; response to interleukin-1 [GO:0070555]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0000122; GO:0000209; GO:0001503; GO:0001701; GO:0001843; GO:0002637; GO:0002726; GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0005938; GO:0006955; GO:0006974; GO:0007165; GO:0007249; GO:0007250; GO:0007254; GO:0008270; GO:0009887; GO:0009898; GO:0016567; GO:0019221; GO:0019886; GO:0019901; GO:0030316; GO:0031435; GO:0031624; GO:0031625; GO:0031663; GO:0031666; GO:0031996; GO:0032147; GO:0032735; GO:0032743; GO:0032755; GO:0032813; GO:0032991; GO:0033209; GO:0035631; GO:0042088; GO:0042102; GO:0042475; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043122; GO:0043123; GO:0043422; GO:0043507; GO:0045453; GO:0045672; GO:0045892; GO:0045944; GO:0046330; GO:0046849; GO:0047485; GO:0048468; GO:0048471; GO:0048661; GO:0050852; GO:0051091; GO:0051092; GO:0051865; GO:0061630; GO:0070498; GO:0070534; GO:0070555; GO:0071222; GO:0071345; GO:0097400; GO:1901224; GO:1904996; GO:2000679"
"186",199,73576,"Cluster_29","Peve_00006149",0.907597902972438,0.275827978672121,0.978262075707395,160,-21.07,"2 21","440 461",19,"68.42%","78.95%","Q17QQ2","Thiopurine S-methyltransferase (EC 2.1.1.67) (Thiopurine methyltransferase)","Bos taurus (Bovine)","methylation [GO:0032259]; xenobiotic metabolic process [GO:0006805]","GO:0005737; GO:0006805; GO:0008119; GO:0032259; GO:1904047"
"187",200,73848,"Cluster_796","Peve_00006142",0.898740270652305,0.288966974174018,0.978262075707395,152,-20.04,"2 13","647 668",11,"90.91%","90.91%",NA,NA,NA,NA,NA
"188",201,74676,"Cluster_7053","Peve_00029236",0.952065282808391,0.197911245090166,0.978262075707395,151,-20.83,"2 21","198 225",25,"60.00%","72.00%","P78417","Glutathione S-transferase omega-1 (GSTO-1) (EC 2.5.1.18) (Glutathione S-transferase omega 1-1) (GSTO 1-1) (Glutathione-dependent dehydroascorbate reductase) (EC 1.8.5.1) (Monomethylarsonic acid reductase) (MMA(V) reductase) (EC 1.20.4.2) (S-(Phenacyl)glutathione reductase) (SPG-R)","Homo sapiens (Human)","cellular response to arsenic-containing substance [GO:0071243]; glutathione metabolic process [GO:0006749]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178]","GO:0004364; GO:0005737; GO:0005829; GO:0006749; GO:0010880; GO:0010881; GO:0014810; GO:0016491; GO:0019852; GO:0042178; GO:0045174; GO:0050610; GO:0060315; GO:0060316; GO:0070062; GO:0071243"
"189",202,75327,"Cluster_15726","Peve_00033549",-0.585772412293421,0.601582487125945,0.978262075707395,163,-21.09,"2 17","972 994",16,"87.50%","87.50%","O15182","Centrin-3","Homo sapiens (Human)","cell division [GO:0051301]; centrosome cycle [GO:0007098]; mRNA transport [GO:0051028]; protein transport [GO:0015031]","GO:0005509; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005815; GO:0007098; GO:0008017; GO:0015031; GO:0031683; GO:0032391; GO:0036064; GO:0044615; GO:0051028; GO:0051301; GO:0070390"
"190",203,75603,"Cluster_796","Peve_00032636",-0.942124636958267,0.217650239823641,0.978262075707395,152,-22.58,"2 13","771 792",11,"90.91%","90.91%","Q7TPS5","C2 domain-containing protein 5 (138 kDa C2 domain-containing phosphoprotein)","Mus musculus (Mouse)","cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein localization to plasma membrane [GO:0072659]; vesicle fusion [GO:0006906]","GO:0005509; GO:0005544; GO:0005829; GO:0005886; GO:0005938; GO:0006906; GO:0010828; GO:0030659; GO:0031340; GO:0032587; GO:0032869; GO:0034451; GO:0038028; GO:0046326; GO:0065002; GO:0072659; GO:0090314"
"191",204,75636,"Cluster_11134","Peve_00032636",-0.700593518750502,0.505837316560166,0.978262075707395,150,-22.34,"2 16","110 132",15,"66.67%","93.33%","Q7TPS5","C2 domain-containing protein 5 (138 kDa C2 domain-containing phosphoprotein)","Mus musculus (Mouse)","cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein localization to plasma membrane [GO:0072659]; vesicle fusion [GO:0006906]","GO:0005509; GO:0005544; GO:0005829; GO:0005886; GO:0005938; GO:0006906; GO:0010828; GO:0030659; GO:0031340; GO:0032587; GO:0032869; GO:0034451; GO:0038028; GO:0046326; GO:0065002; GO:0072659; GO:0090314"
"192",205,75797,"Cluster_6904","Peve_00002130",-0.951310992493219,0.199475076059675,0.978262075707395,157,-23.8,"2 21","435 456",20,"70.00%","85.00%","Q20191","Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13)","Caenorhabditis elegans","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"193",206,75799,"Cluster_6906","Peve_00002130",-0.686063329690759,0.518674561276582,0.978262075707395,157,-23.8,"2 21","435 456",20,"70.00%","85.00%","Q20191","Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13)","Caenorhabditis elegans","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"194",207,76007,"Cluster_589","Peve_00002136",-0.555760407907552,0.624854380309451,0.978262075707395,162,-24.16,"2 21","913 933",19,"73.68%","84.21%","Q6L9W6","Beta-1,4-N-acetylgalactosaminyltransferase 3 (B4GalNAcT3) (Beta4GalNAc-T3) (Beta4GalNAcT3) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase III) (N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2) (NGalNAc-T2)","Homo sapiens (Human)","","GO:0005794; GO:0008376; GO:0032580; GO:0033842; GO:0043231"
"195",208,76153,"Cluster_4735","Peve_00029350",0.644278130490032,0.554315847460093,0.978262075707395,163,-21.75,"2 21","476 498",20,"75.00%","80.00%",NA,NA,NA,NA,NA
"196",209,76311,"Cluster_11134","Peve_00029351",0.991583114162827,0.0826562936743634,0.978262075707395,171,-21.21,"2 20","264 285",18,"77.78%","88.89%","Q91770","Homeobox protein not2 (Xnot-2) (Xnot2)","Xenopus laevis (African clawed frog)","negative regulation of DNA-templated transcription [GO:0045892]; notochord formation [GO:0014028]","GO:0000981; GO:0003677; GO:0005634; GO:0014028; GO:0045892"
"197",210,76463,"Cluster_2882","Peve_00037043",-0.544471551986986,0.633460458451411,0.978262075707395,163,-21.36,"2 20","565 586",18,"72.22%","83.33%",NA,NA,NA,NA,NA
"198",211,76476,"Cluster_7053","Peve_00037043",-0.925819170224858,0.246753280096262,0.978262075707395,167,-20.78,"2 21","877 899",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"199",212,76476,"Cluster_7053","Peve_00037043",-0.925819170224858,0.246753280096262,0.978262075707395,171,-22.94,"2 21","637 659",20,"80.00%","85.00%",NA,NA,NA,NA,NA
"200",213,76476,"Cluster_7053","Peve_00037043",-0.925819170224858,0.246753280096262,0.978262075707395,175,-25.92,"2 21","397 419",20,"80.00%","90.00%",NA,NA,NA,NA,NA
"201",214,76476,"Cluster_7053","Peve_00037043",-0.925819170224858,0.246753280096262,0.978262075707395,175,-25.99,"2 21","517 539",20,"80.00%","90.00%",NA,NA,NA,NA,NA
"202",215,76558,"Cluster_4735","Peve_00037047",-0.499055763751742,0.667360561442895,0.978262075707395,163,-26.07,"2 21","659 683",22,"72.73%","77.27%",NA,NA,NA,NA,NA
"203",216,76879,"Cluster_6906","Peve_00008275",-0.287038038235336,0.814658772056752,0.995934364227446,157,-21.93,"2 18","868 887",16,"87.50%","87.50%",NA,NA,NA,NA,NA
"204",217,76890,"Cluster_9149","Peve_00008275",1,0,0,159,-24.67,"2 20","190 211",18,"66.67%","83.33%",NA,NA,NA,NA,NA
"205",218,77225,"Cluster_1167","Peve_00008279",0.999909726776791,0.00855416971793915,0.573710369894872,146,-21.82,"2 20","557 582",22,"63.64%","68.18%",NA,NA,NA,NA,NA
"206",219,77502,"Cluster_4629","Peve_00025419",-0.554554668634826,0.625777256211528,0.978262075707395,161,-28.36,"2 14","621 642",12,"91.67%","100.00%","J3S6Y1","Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR)","Mus musculus (Mouse)","hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505]","GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170"
"207",220,77807,"Cluster_589","Peve_00022767",-0.922014532371985,0.253084525731878,0.978262075707395,160,-22.78,"2 21","31 52",19,"63.16%","84.21%","Q0KK59","Protein unc-79 homolog","Mus musculus (Mouse)","adult behavior [GO:0030534]; behavioral response to ethanol [GO:0048149]; multicellular organism growth [GO:0035264]","GO:0005886; GO:0030534; GO:0035264; GO:0048149"
"208",221,77841,"Cluster_11134","Peve_00022767",-0.0538503549308481,0.965701208708626,0.999448381576871,156,-21.6,"2 21","46 67",19,"63.16%","78.95%","Q0KK59","Protein unc-79 homolog","Mus musculus (Mouse)","adult behavior [GO:0030534]; behavioral response to ethanol [GO:0048149]; multicellular organism growth [GO:0035264]","GO:0005886; GO:0030534; GO:0035264; GO:0048149"
"209",222,77875,"Cluster_8634","Peve_00022764",0.993926028285142,0.0702023375078182,0.978262075707395,159,-20.74,"2 21","765 791",24,"66.67%","75.00%","Q54H45","Probable serine/threonine-protein kinase drkB (EC 2.7.11.1) (Receptor-like kinase 2) (Receptor-like kinase B) (Vesicle-associated receptor tyrosine kinase-like protein 2)","Dictyostelium discoideum (Social amoeba)","protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]","GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0016020; GO:0106310"
"210",223,77920,"Cluster_8634","Peve_00022765",0.990698671905369,0.0868970042571136,0.978262075707395,159,-20.74,"2 21","765 791",24,"66.67%","75.00%","Q54H45","Probable serine/threonine-protein kinase drkB (EC 2.7.11.1) (Receptor-like kinase 2) (Receptor-like kinase B) (Vesicle-associated receptor tyrosine kinase-like protein 2)","Dictyostelium discoideum (Social amoeba)","protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]","GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0016020; GO:0106310"
"211",224,78155,"Cluster_10965","Peve_00036392",0.483757356742845,0.678543446197093,0.978262075707395,164,-24.61,"2 18","190 212",17,"82.35%","88.24%","Q9H5Z1","Probable ATP-dependent RNA helicase DHX35 (EC 3.6.4.13) (DEAH box protein 35)","Homo sapiens (Human)","in utero embryonic development [GO:0001701]; mRNA splicing, via spliceosome [GO:0000398]","GO:0000398; GO:0001701; GO:0003723; GO:0003724; GO:0005524; GO:0016887; GO:0071013"
"212",225,78842,"Cluster_589","Peve_00036024",-0.0203883298816381,0.98701948666725,0.999448381576871,155,-23.55,"2 12","825 846",10,"100.00%","100.00%",NA,NA,NA,NA,NA
"213",226,78894,"Cluster_4079","Peve_00036026",-0.125755588100116,0.919728976410948,0.999448381576871,146,-20.12,"2 21","234 254",19,"63.16%","73.68%",NA,NA,NA,NA,NA
"214",227,80292,"Cluster_4629","Peve_00024339",-0.443383362280846,0.707556077121805,0.978262075707395,158,-20.68,"2 20","725 748",20,"75.00%","75.00%",NA,NA,NA,NA,NA
"215",228,80781,"Cluster_2787","Peve_00025689",0.687903751078886,0.517062213170483,0.978262075707395,162,-26.87,"2 21","135 158",21,"71.43%","85.71%","P39061","Collagen alpha-1(XVIII) chain [Cleaved into: Endostatin; Non-collagenous domain 1 (NC1)]","Mus musculus (Mouse)","angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell adhesion [GO:0007155]; endothelial cell apoptotic process [GO:0072577]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; vascular endothelial cell proliferation [GO:0101023]","GO:0001525; GO:0001886; GO:0005201; GO:0005581; GO:0005604; GO:0005615; GO:0007155; GO:0030198; GO:0031012; GO:0042802; GO:0043534; GO:0043536; GO:0046872; GO:0062023; GO:0072577; GO:0101023; GO:1905564; GO:2000353"
"216",229,80902,"Cluster_11135","Peve_00031556",0.739329101072857,0.470285593378197,0.978262075707395,153,-20.22,"2 19","857 879",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"217",230,80998,"Cluster_15890","Peve_00031558",-0.964136793870915,0.171011859319738,0.978262075707395,162,-22.31,"2 21","12 32",19,"73.68%","84.21%","D3Z8N4","Kelch-like protein 20","Rattus norvegicus (Rat)","Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]","GO:0003779; GO:0004842; GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390"
"218",231,81600,"Cluster_5882","Peve_00012019",-0.27814091057559,0.820563558554478,0.995934364227446,164,-21.04,"2 21","429 447",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"219",232,82142,"Cluster_6904","Peve_00026650",-0.998173851896017,0.0384794833063837,0.909359886114279,147,-20.08,"2 21","106 132",24,"58.33%","70.83%","Q7ZVH1","Membrane progestin receptor gamma-A (mPR gamma-A) (Progestin and adipoQ receptor family member V-A)","Danio rerio (Zebrafish) (Brachydanio rerio)","oogenesis [GO:0048477]","GO:0005496; GO:0016020; GO:0038023; GO:0048477"
"220",233,82386,"Cluster_11134","Peve_00038832",0.103283973196012,0.934129912175115,0.999448381576871,150,-22.27,"2 21","412 435",21,"61.90%","80.95%","P21941","Cartilage matrix protein (Matrilin-1)","Homo sapiens (Human)","extracellular matrix organization [GO:0030198]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; protein-containing complex assembly [GO:0065003]; regulation of bone mineralization [GO:0030500]","GO:0003429; GO:0005201; GO:0005509; GO:0005576; GO:0030198; GO:0030500; GO:0031012; GO:0062023; GO:0065003; GO:0120216"
"221",234,82836,"Cluster_11134","Peve_00041787",0.990515839147113,0.0877482407140044,0.978262075707395,162,-22.75,"2 20","238 260",19,"73.68%","84.21%","Q0VGT4","Protein ZGRF1 (GRF-type zinc finger domain-containing protein 1)","Mus musculus (Mouse)","replication fork reversal [GO:0071932]","GO:0003723; GO:0004386; GO:0005737; GO:0008270; GO:0016020; GO:0017108; GO:0071932"
"222",235,82840,"Cluster_14500","Peve_00041787",0.585623600589538,0.601699369348769,0.978262075707395,163,-20.11,"2 19","499 520",18,"83.33%","88.89%","Q0VGT4","Protein ZGRF1 (GRF-type zinc finger domain-containing protein 1)","Mus musculus (Mouse)","replication fork reversal [GO:0071932]","GO:0003723; GO:0004386; GO:0005737; GO:0008270; GO:0016020; GO:0017108; GO:0071932"
"223",236,83009,"Cluster_8988","Peve_00043568",-0.182580101176373,0.883110226567367,0.999448381576871,167,-22.42,"2 20","124 145",18,"72.22%","88.89%","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"224",237,83121,"Cluster_2787","Peve_00043560",-0.735591321891915,0.47380882585705,0.978262075707395,152,-20.02,"2 21","348 367",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"225",238,83151,"Cluster_11134","Peve_00043560",-0.947224049964755,0.207750429468684,0.978262075707395,156,-20.88,"2 21","868 889",19,"57.89%","84.21%",NA,NA,NA,NA,NA
"226",239,84156,"Cluster_2787","Peve_00011630",0.867933894665659,0.330895275232091,0.978262075707395,162,-24.89,"2 21","372 396",22,"72.73%","81.82%",NA,NA,NA,NA,NA
"227",240,84522,"Cluster_4629","Peve_00010321",-0.554554668634826,0.625777256211528,0.978262075707395,145,-23.15,"2 20","900 926",23,"60.87%","73.91%","Q91X17","Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","Mus musculus (Mouse)","antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; calcium ion homeostasis [GO:0055074]; cellular calcium ion homeostasis [GO:0006874]; cellular chloride ion homeostasis [GO:0030644]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to unfolded protein [GO:0034620]; cellular sodium ion homeostasis [GO:0006883]; chaperone-mediated protein folding [GO:0061077]; chemical homeostasis [GO:0048878]; chloride ion homeostasis [GO:0055064]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; creatinine homeostasis [GO:0097273]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; gene expression [GO:0010467]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; ion homeostasis [GO:0050801]; juxtaglomerular apparatus development [GO:0072051]; kidney development [GO:0001822]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; loop of Henle development [GO:0072070]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; multicellular organismal homeostasis [GO:0048871]; multicellular organismal response to stress [GO:0033555]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; peptidyl-threonine phosphorylation [GO:0018107]; phosphate ion homeostasis [GO:0055062]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein phosphorylation [GO:0006468]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; response to unfolded protein [GO:0006986]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; sodium ion homeostasis [GO:0055078]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent ERAD pathway [GO:0030433]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918]; water homeostasis [GO:0030104]","GO:0000922; GO:0001822; GO:0002251; GO:0003091; GO:0003094; GO:0005201; GO:0005509; GO:0005615; GO:0005783; GO:0005794; GO:0005886; GO:0005929; GO:0006468; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006915; GO:0006954; GO:0006986; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008380; GO:0009410; GO:0009414; GO:0009986; GO:0010467; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0018107; GO:0019864; GO:0030104; GO:0030433; GO:0030643; GO:0030644; GO:0031410; GO:0032496; GO:0033209; GO:0033555; GO:0034620; GO:0034976; GO:0035809; GO:0044861; GO:0045121; GO:0045177; GO:0046720; GO:0048871; GO:0048878; GO:0050801; GO:0050829; GO:0051223; GO:0055062; GO:0055064; GO:0055074; GO:0055075; GO:0055078; GO:0060073; GO:0060170; GO:0061077; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072070; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097273; GO:0097709; GO:0097744; GO:0140367; GO:1990266"
"228",241,84776,"Cluster_14999","Peve_00035621",0.439714619377981,0.710159176093093,0.978783142421603,168,-20.01,"2 21","426 447",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"229",243,85795,"Cluster_8634","Peve_00033707",0.956227319072805,0.189057429551567,0.978262075707395,170,-20.13,"2 19","118 139",17,"76.47%","94.12%",NA,NA,NA,NA,NA
"230",244,86057,"Cluster_6904","Peve_00033701",-0.919418116231973,0.257320419910275,0.978262075707395,148,-22.25,"2 17","585 606",15,"73.33%","73.33%",NA,NA,NA,NA,NA
"231",245,86059,"Cluster_6906","Peve_00033701",-0.617217272830715,0.576519905127182,0.978262075707395,148,-20.82,"2 17","585 606",15,"73.33%","73.33%",NA,NA,NA,NA,NA
"232",246,86420,"Cluster_6914","Peve_00029133",0.961244058619257,0.177818508880799,0.978262075707395,160,-21.89,"2 20","335 355",19,"78.95%","84.21%","Q5T8P6","RNA-binding protein 26 (CTCL tumor antigen se70-2) (RNA-binding motif protein 26)","Homo sapiens (Human)","mRNA processing [GO:0006397]","GO:0003723; GO:0005634; GO:0006397; GO:0046872"
"233",247,87173,"Cluster_2882","Peve_00029688",-0.898389711968954,0.289475524970989,0.978262075707395,167,-20.49,"2 21","443 466",21,"76.19%","80.95%",NA,NA,NA,NA,NA
"234",248,88950,"Cluster_9149","Peve_00015522",-0.401772374444164,0.736788610954024,0.986293296896526,152,-23.19,"2 17","153 174",15,"66.67%","86.67%",NA,NA,NA,NA,NA
"235",249,89198,"Cluster_2882","Peve_00036627",-0.919415129497883,0.257325254607975,0.978262075707395,145,-22.3,"2 20","323 350",24,"62.50%","70.83%",NA,NA,NA,NA,NA
"236",250,89867,"Cluster_589","Peve_00001622",-0.977545772888776,0.135163736203567,0.978262075707395,154,-22.39,"2 15","230 251",13,"84.62%","84.62%",NA,NA,NA,NA,NA
"237",251,90281,"Cluster_4115","Peve_00014699",-0.930026219102899,0.239567750774005,0.978262075707395,162,-22.75,"2 21","776 796",19,"68.42%","89.47%",NA,NA,NA,NA,NA
"238",252,92262,"Cluster_4629","Peve_00029918",0.741572060823306,0.468161069288347,0.978262075707395,157,-20.76,"2 14","703 724",12,"91.67%","91.67%","P49739","Maternal DNA replication licensing factor mcm3 (EC 3.6.4.12) (Maternal minichromosome maintenance protein 3) (mMCM3) (xMCM3) (P1 homolog) (XRLF subunit beta) (p100)","Xenopus laevis (African clawed frog)","cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-templated DNA replication initiation [GO:0030174]","GO:0000785; GO:0003677; GO:0004386; GO:0005524; GO:0006268; GO:0006270; GO:0007049; GO:0016887; GO:0030174; GO:0042555; GO:0071162"
"239",253,92554,"Cluster_10934","Peve_00030117",0.970763893315925,0.154318750146841,0.978262075707395,149,-20.27,"2 21","638 659",20,"70.00%","75.00%","Q90YT3","60S ribosomal protein L35a","Ictalurus punctatus (Channel catfish) (Silurus punctatus)","translation [GO:0006412]","GO:0000049; GO:0003735; GO:0005737; GO:0005840; GO:0006412; GO:1990904"
"240",254,93360,"Cluster_9149","Peve_00020406",-0.956603735522006,0.188236788447912,0.978262075707395,155,-20.25,"2 21","592 614",20,"60.00%","85.00%","P34897","Serine hydroxymethyltransferase, mitochondrial (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)","Homo sapiens (Human)","folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell population proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; purine nucleobase biosynthetic process [GO:0009113]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]","GO:0000900; GO:0002082; GO:0003682; GO:0004372; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0005829; GO:0006544; GO:0006563; GO:0006564; GO:0006565; GO:0006730; GO:0008270; GO:0008284; GO:0008732; GO:0009113; GO:0015630; GO:0019264; GO:0030170; GO:0034340; GO:0035999; GO:0042645; GO:0042803; GO:0046653; GO:0046655; GO:0048027; GO:0051262; GO:0051289; GO:0070062; GO:0070129; GO:0070536; GO:0070552; GO:0070905; GO:1903715"
"241",255,94169,"Cluster_8988","Peve_00021856",0.936748984242786,0.22763813606805,0.978262075707395,158,-20.44,"2 21","339 359",19,"63.16%","89.47%","Q60467","Collagen alpha-1(V) chain","Cricetulus longicaudatus (Long-tailed dwarf hamster) (Chinese hamster)","","GO:0005201; GO:0005576; GO:0005581; GO:0008201"
"242",256,95723,"Cluster_2882","Peve_00027186",-0.675294983765118,0.528032649137889,0.978262075707395,144,-20.21,"2 16","133 152",14,"78.57%","78.57%","Q5RG45","Centrosomal protein of 135 kDa (Cep135)","Danio rerio (Zebrafish) (Brachydanio rerio)","centriole replication [GO:0007099]","GO:0005737; GO:0005813; GO:0005814; GO:0007099"
"243",257,95807,"Cluster_589","Peve_00027183",-0.514014604913458,0.656315416356396,0.978262075707395,153,-27.84,"2 19","463 490",23,"65.22%","73.91%","P53349","Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1)","Mus musculus (Mouse)","apoptotic mitochondrial changes [GO:0008637]; camera-type eye development [GO:0043010]; epithelial cell morphogenesis [GO:0003382]; eyelid development in camera-type eye [GO:0061029]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of actin filament bundle assembly [GO:0032232]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein polyubiquitination [GO:0000209]; regulation of cell migration [GO:0030334]; response to osmotic stress [GO:0006970]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]; wound healing [GO:0042060]","GO:0000165; GO:0000209; GO:0002011; GO:0003382; GO:0004672; GO:0004674; GO:0004706; GO:0004708; GO:0004709; GO:0004842; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0006511; GO:0006970; GO:0007179; GO:0007254; GO:0008092; GO:0008270; GO:0008432; GO:0008637; GO:0016020; GO:0018105; GO:0019901; GO:0030054; GO:0030334; GO:0030838; GO:0031434; GO:0031941; GO:0032232; GO:0042060; GO:0043010; GO:0043065; GO:0043406; GO:0043410; GO:0043507; GO:0044877; GO:0045893; GO:0045944; GO:0046330; GO:0046625; GO:0046777; GO:0050434; GO:0051019; GO:0061029; GO:0090263; GO:0106310"
"244",258,96708,"Cluster_796","Peve_00010129",0.181234373760855,0.883981479572485,0.999448381576871,158,-23.89,"2 21","492 516",22,"72.73%","77.27%",NA,NA,NA,NA,NA
"245",259,96729,"Cluster_7855","Peve_00010129",0.954066768790834,0.193702478395375,0.978262075707395,167,-23.73,"2 21","1 23",20,"70.00%","90.00%",NA,NA,NA,NA,NA
"246",260,96762,"Cluster_4629","Peve_00010128",0.997938030915672,0.0408894104551393,0.909359886114279,142,-20.17,"2 20","86 111",22,"59.09%","68.18%",NA,NA,NA,NA,NA
"247",261,96989,"Cluster_5563","Peve_00027725",0.986318357174225,0.105429135870563,0.978262075707395,163,-20.55,"2 22","462 486",22,"77.27%","77.27%",NA,NA,NA,NA,NA
"248",262,97522,"Cluster_2854","Peve_00023402",-0.507486347355159,0.661149542463894,0.978262075707395,159,-20.54,"2 18","165 185",16,"81.25%","87.50%","Q9VBP3","Poly [ADP-ribose] polymerase tankyrase (dTNKS) (EC 2.4.2.30) (Poly [ADP-ribose] polymerase) (Protein poly-ADP-ribosyltransferase tankyrase) (EC 2.4.2.-)","Drosophila melanogaster (Fruit fly)","positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of telomere capping [GO:1904355]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]","GO:0003950; GO:0005634; GO:0005737; GO:0016779; GO:0032436; GO:0045732; GO:0046872; GO:0070198; GO:0070212; GO:0090263; GO:1904355; GO:2000060"
"249",263,97815,"Cluster_9149","Peve_00010695",-0.517985157364133,0.653364481959649,0.978262075707395,163,-24.61,"2 21","36 58",20,"75.00%","80.00%",NA,NA,NA,NA,NA
"250",264,97860,"Cluster_9149","Peve_00010694",-0.801554449786517,0.408013346552774,0.978262075707395,163,-24.61,"2 21","36 58",20,"75.00%","80.00%",NA,NA,NA,NA,NA
"251",265,98974,"Cluster_6906","Peve_00029665",-0.997478929018431,0.0452146257420912,0.931728931996319,159,-21.73,"2 21","933 956",21,"71.43%","76.19%",NA,NA,NA,NA,NA
"252",266,99463,"Cluster_4735","Peve_00013605",0.955783635569494,0.190020305694475,0.978262075707395,151,-20.39,"2 21","382 408",24,"62.50%","70.83%",NA,NA,NA,NA,NA
"253",267,99542,"Cluster_589","Peve_00001925",-0.992234814287107,0.0793875641331162,0.978262075707395,159,-22.19,"2 21","816 838",20,"70.00%","80.00%","Q5M8H5","2-acylglycerol O-acyltransferase 2 (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 2) (MGAT2) (Monoacylglycerol O-acyltransferase 2)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","glycerol metabolic process [GO:0006071]; monoacylglycerol biosynthetic process [GO:0006640]; triglyceride biosynthetic process [GO:0019432]","GO:0003846; GO:0005789; GO:0006071; GO:0006640; GO:0019432; GO:1990578"
"254",268,99825,"Cluster_5882","Peve_00013572",-0.983875401391946,0.114478749967452,0.978262075707395,161,-21.75,"2 21","849 874",23,"73.91%","82.61%","B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"255",269,101021,"Cluster_14999","Peve_00045160",0.47443735243041,0.685303084188443,0.978262075707395,167,-20.5,"2 21","374 396",20,"80.00%","80.00%","Q9TV36","Fibrillin-1 [Cleaved into: Asprosin]","Sus scrofa (Pig)","activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein kinase A signaling [GO:0010737]","GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0008201; GO:0009653; GO:0010737; GO:0031012; GO:0034199; GO:0042593"
"256",270,101466,"Cluster_11134","Peve_00026440",0.875640822838247,0.320878802775509,0.978262075707395,155,-21.25,"2 21","876 898",20,"60.00%","85.00%",NA,NA,NA,NA,NA
"257",271,101496,"Cluster_7053","Peve_00026446",-0.651871021090641,0.547968690754946,0.978262075707395,155,-20.25,"2 12","454 475",10,"100.00%","100.00%","P53708","Integrin alpha-8 [Cleaved into: Integrin alpha-8 heavy chain; Integrin alpha-8 light chain]","Homo sapiens (Human)","brain development [GO:0007420]; cell adhesion mediated by integrin [GO:0033627]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; establishment of protein localization [GO:0045184]; extracellular matrix organization [GO:0030198]; inner ear morphogenesis [GO:0042472]; integrin-mediated signaling pathway [GO:0007229]; kidney development [GO:0001822]; memory [GO:0007613]; mesodermal cell differentiation [GO:0048333]; metanephros development [GO:0001656]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; smooth muscle cell differentiation [GO:0051145]; smooth muscle tissue development [GO:0048745]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0001656; GO:0001822; GO:0005178; GO:0005783; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0007420; GO:0007613; GO:0008305; GO:0009897; GO:0009986; GO:0030030; GO:0030198; GO:0030511; GO:0032591; GO:0033627; GO:0034446; GO:0034678; GO:0042472; GO:0043204; GO:0045177; GO:0045184; GO:0045944; GO:0046872; GO:0048333; GO:0048745; GO:0051145; GO:0098609; GO:0098839; GO:0098978"
"258",272,102030,"Cluster_5882","Peve_00018338",-0.659735742347397,0.54133642093896,0.978262075707395,156,-21.6,"2 20","249 270",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"259",274,102637,"Cluster_11135","Peve_00039988",0.790409187706606,0.419735920277807,0.978262075707395,159,-21.65,"2 17","918 940",16,"81.25%","87.50%","Q8IN35","Neuropeptide SIFamide receptor","Drosophila melanogaster (Fruit fly)","determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]","GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016020; GO:0042277; GO:0048047"
"260",275,102855,"Cluster_9149","Peve_00043064",-0.5,0.666666666666667,0.978262075707395,153,-22.35,"2 20","400 420",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"261",276,102957,"Cluster_15726","Peve_00043066",-0.901990453156969,0.284211671961097,0.978262075707395,166,-21.99,"2 19","618 639",17,"76.47%","88.24%","P09525","Annexin A4 (35-beta calcimedin) (Annexin IV) (Annexin-4) (Carbohydrate-binding protein p33/p41) (Chromobindin-4) (Endonexin I) (Lipocortin IV) (P32.5) (PP4-X) (Placental anticoagulant protein II) (PAP-II) (Protein II)","Homo sapiens (Human)","epithelial cell differentiation [GO:0030855]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; Notch signaling pathway [GO:0007219]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]","GO:0004859; GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0005886; GO:0006357; GO:0007165; GO:0007219; GO:0009986; GO:0012506; GO:0030855; GO:0031410; GO:0031965; GO:0032088; GO:0032717; GO:0042802; GO:0043066; GO:0048306; GO:0048471; GO:0051059; GO:0062023; GO:0070062"
"262",277,103446,"Cluster_11134","Peve_00013486",-0.940890786411763,0.219981172543431,0.978262075707395,143,-20.98,"2 14","388 408",12,"75.00%","91.67%",NA,NA,NA,NA,NA
"263",278,103446,"Cluster_11134","Peve_00013486",-0.940890786411763,0.219981172543431,0.978262075707395,146,-20.72,"2 18","522 543",17,"70.59%","82.35%",NA,NA,NA,NA,NA
"264",279,103446,"Cluster_11134","Peve_00013486",-0.940890786411763,0.219981172543431,0.978262075707395,150,-20.6,"2 16","404 426",15,"66.67%","93.33%",NA,NA,NA,NA,NA
"265",280,103446,"Cluster_11134","Peve_00013486",-0.940890786411763,0.219981172543431,0.978262075707395,150,-20.6,"2 16","935 957",15,"66.67%","93.33%",NA,NA,NA,NA,NA
"266",281,103446,"Cluster_11134","Peve_00013486",-0.940890786411763,0.219981172543431,0.978262075707395,150,-20.6,"2 16","98 120",15,"66.67%","93.33%",NA,NA,NA,NA,NA
"267",282,103446,"Cluster_11134","Peve_00013486",-0.940890786411763,0.219981172543431,0.978262075707395,153,-22.99,"2 20","718 741",20,"60.00%","90.00%",NA,NA,NA,NA,NA
"268",283,103446,"Cluster_11134","Peve_00013486",-0.940890786411763,0.219981172543431,0.978262075707395,154,-20.71,"2 16","260 282",15,"73.33%","93.33%",NA,NA,NA,NA,NA
"269",284,103446,"Cluster_11134","Peve_00013486",-0.940890786411763,0.219981172543431,0.978262075707395,154,-20.71,"2 16","503 525",15,"73.33%","93.33%",NA,NA,NA,NA,NA
"270",285,103446,"Cluster_11134","Peve_00013486",-0.940890786411763,0.219981172543431,0.978262075707395,154,-20.71,"2 16","872 894",15,"73.33%","93.33%",NA,NA,NA,NA,NA
"271",286,103446,"Cluster_11134","Peve_00013486",-0.940890786411763,0.219981172543431,0.978262075707395,155,-20.54,"2 19","675 696",18,"72.22%","88.89%",NA,NA,NA,NA,NA
"272",287,103446,"Cluster_11134","Peve_00013486",-0.940890786411763,0.219981172543431,0.978262075707395,155,-21.42,"2 18","11 31",16,"75.00%","87.50%",NA,NA,NA,NA,NA
"273",288,103446,"Cluster_11134","Peve_00013486",-0.940890786411763,0.219981172543431,0.978262075707395,158,-23.5,"2 16","620 642",15,"80.00%","93.33%",NA,NA,NA,NA,NA
"274",289,104070,"Cluster_9149","Peve_00034585",1,9.48637384723993e-09,6.86838308108347e-06,147,-22.51,"2 12","409 430",10,"80.00%","100.00%",NA,NA,NA,NA,NA
"275",290,104586,"Cluster_2787","Peve_00038292",0.928840237224988,0.241613945302735,0.978262075707395,151,-20.76,"2 21","957 981",22,"63.64%","72.73%",NA,NA,NA,NA,NA
"276",291,105348,"Cluster_796","Peve_00041960",0.0183046244356579,0.98834626331461,0.999448381576871,142,-20.48,"2 20","319 341",19,"63.16%","68.42%",NA,NA,NA,NA,NA
"277",292,106072,"Cluster_2854","Peve_00044249",-0.609445514567311,0.582784212791901,0.978262075707395,166,-23.63,"2 20","910 933",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"278",293,106392,"Cluster_4629","Peve_00006849",-0.716384588095692,0.4915912623246,0.978262075707395,158,-25.79,"2 21","377 397",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"279",294,106512,"Cluster_15726","Peve_00001819",-0.85433488962482,0.347929624944163,0.978262075707395,150,-20.1,"2 20","128 152",21,"66.67%","71.43%","Q8R151","NFX1-type zinc finger-containing protein 1","Mus musculus (Mouse)","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; RNA-mediated heterochromatin formation [GO:0031048]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607"
"280",295,107021,"Cluster_4115","Peve_00002544",0.783271532591398,0.427098915892661,0.978262075707395,169,-22.8,"2 19","525 548",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"281",296,107396,"Cluster_8884","Peve_00029290",-0.585197571454179,0.60203390272629,0.978262075707395,174,-27.17,"2 20","214 235",19,"78.95%","94.74%",NA,NA,NA,NA,NA
"282",297,107397,"Cluster_8887","Peve_00029290",-0.338883514665589,0.779901484999854,0.993496328413544,174,-26.8,"2 20","214 235",19,"78.95%","94.74%",NA,NA,NA,NA,NA
"283",298,107398,"Cluster_8888","Peve_00029290",0.387067749479753,0.746975902129417,0.987849942797518,174,-27.18,"2 20","214 235",19,"78.95%","94.74%",NA,NA,NA,NA,NA
"284",299,107455,"Cluster_14500","Peve_00029297",-0.573579988060621,0.611108350827487,0.978262075707395,171,-22.1,"2 21","716 739",21,"80.95%","80.95%",NA,NA,NA,NA,NA
"285",300,107535,"Cluster_9149","Peve_00032244",0.311274132403833,0.798488528824511,0.995934364227446,156,-21.02,"2 21","690 711",19,"63.16%","78.95%","Q91XQ0","Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8)","Mus musculus (Mouse)","cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]","GO:0003341; GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959"
"286",301,107788,"Cluster_4735","Peve_00032242",-0.863020982987557,0.337139001335564,0.978262075707395,171,-22.92,"2 21","604 626",20,"80.00%","85.00%",NA,NA,NA,NA,NA
"287",302,108042,"Cluster_15726","Peve_00032249",-0.154593892960582,0.901186176183033,0.999448381576871,161,-22.08,"2 14","319 340",12,"91.67%","100.00%","O35587","Transmembrane emp24 domain-containing protein 10 (Protein TMED10) (21 kDa transmembrane-trafficking protein) (Integral membrane protein p23) (Transmembrane protein Tmp21) (p24 family protein delta-1) (p24delta1)","Mesocricetus auratus (Golden hamster)","COPI-coated vesicle budding [GO:0035964]; cytosol to ERGIC protein transport [GO:0106273]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of protein secretion [GO:0050714]; protein localization to ERGIC [GO:0106272]; regulated exocytosis [GO:0045055]; regulation of amyloid-beta formation [GO:1902003]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0000139; GO:0005789; GO:0005793; GO:0005886; GO:0006886; GO:0006890; GO:0007030; GO:0008320; GO:0019905; GO:0030137; GO:0030140; GO:0030658; GO:0032732; GO:0033116; GO:0035964; GO:0042470; GO:0042589; GO:0045055; GO:0050714; GO:0070765; GO:0106272; GO:0106273; GO:1902003; GO:1902960"
"288",303,108210,"Cluster_9149","Peve_00022113",-0.591580878452503,0.597008082607608,0.978262075707395,143,-20.34,"2 14","582 602",12,"75.00%","91.67%","B3EWY9","Mucin-like protein","Acropora millepora (Staghorn coral) (Heteropora millepora)","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0007160; GO:0016020"
"289",304,108885,"Cluster_9149","Peve_00000031",0.347175490793444,0.774281638798566,0.992080413497249,154,-25.94,"2 21","964 990",24,"66.67%","75.00%",NA,NA,NA,NA,NA
"290",305,109127,"Cluster_589","Peve_00031744",-0.934753615028442,0.231240264998328,0.978262075707395,151,-22.58,"2 21","586 609",21,"66.67%","71.43%",NA,NA,NA,NA,NA
"291",306,109127,"Cluster_589","Peve_00031744",-0.934753615028442,0.231240264998328,0.978262075707395,156,-22.41,"2 14","46 68",13,"92.31%","92.31%",NA,NA,NA,NA,NA
"292",307,109840,"Cluster_14500","Peve_00005124",-0.892359012078568,0.298097859379402,0.978262075707395,161,-21.03,"2 20","490 514",21,"76.19%","80.95%",NA,NA,NA,NA,NA
"293",308,110303,"Cluster_2882","Peve_00023398",0.796007936118648,0.413882648183818,0.978262075707395,162,-24.47,"2 15","855 876",13,"84.62%","100.00%",NA,NA,NA,NA,NA
"294",309,110488,"Cluster_4735","Peve_00023390",-0.397248955143328,0.739929892810296,0.986697151420032,163,-23.13,"2 20","839 860",18,"77.78%","77.78%","C3YWU0","Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase)","Branchiostoma floridae (Florida lancelet) (Amphioxus)","fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]","GO:0004560; GO:0005576; GO:0005764; GO:0006004; GO:0016139"
"295",310,111556,"Cluster_29","Peve_00006473",-0.368569774287229,0.759695126986102,0.988219883885475,165,-20.19,"2 21","510 531",20,"80.00%","85.00%",NA,NA,NA,NA,NA
"296",311,111579,"Cluster_7855","Peve_00006473",0.0325945714784778,0.979245975351128,0.999448381576871,169,-20.56,"2 19","514 537",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"297",312,111832,"Cluster_2854","Peve_00022931",-0.957684536225645,0.185860945555817,0.978262075707395,158,-22.08,"2 21","681 707",24,"70.83%","75.00%","Q14692","Ribosome biogenesis protein BMS1 homolog (Ribosome assembly protein BMS1 homolog)","Homo sapiens (Human)","endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]","GO:0000462; GO:0000479; GO:0003723; GO:0003924; GO:0005524; GO:0005525; GO:0005654; GO:0005694; GO:0005730; GO:0030686; GO:0034511"
"298",313,112022,"Cluster_6904","Peve_00005879",-0.951310992493219,0.199475076059675,0.978262075707395,159,-20.42,"2 16","259 280",14,"85.71%","85.71%",NA,NA,NA,NA,NA
"299",314,112024,"Cluster_6906","Peve_00005879",-0.686063329690759,0.518674561276582,0.978262075707395,157,-20.42,"2 14","259 280",12,"91.67%","91.67%",NA,NA,NA,NA,NA
"300",315,113541,"Cluster_2787","Peve_00026137",0.977818427268543,0.134337527610324,0.978262075707395,145,-20.62,"2 21","798 820",21,"66.67%","71.43%","P08836","Farnesyl pyrophosphate synthase (FPP synthase) (FPS) (EC 2.5.1.10) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Geranyltranstransferase)","Gallus gallus (Chicken)","cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]","GO:0004161; GO:0004337; GO:0005737; GO:0006695; GO:0033384; GO:0045337; GO:0046872"
"301",316,113614,"Cluster_10934","Peve_00026136",0.197266356577725,0.873587240643426,0.997476741937264,167,-21.01,"2 21","941 963",20,"75.00%","85.00%","P52551","Myb-related protein B (B-Myb) (Myb-like protein 2) (Myb-related protein 1) (XMYB1)","Xenopus laevis (African clawed frog)","","GO:0003677; GO:0005634"
"302",317,113627,"Cluster_589","Peve_00026135",0.975139750271958,0.142249816787601,0.978262075707395,142,-22.15,"2 20","482 508",23,"60.87%","65.22%","Q9CWF6","Bardet-Biedl syndrome 2 protein homolog","Mus musculus (Mouse)","adult behavior [GO:0030534]; artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; response to leptin [GO:0044321]; sperm axoneme assembly [GO:0007288]; striatum development [GO:0021756]; vasodilation [GO:0042311]; visual perception [GO:0007601]","GO:0005737; GO:0005902; GO:0007288; GO:0007601; GO:0008104; GO:0010467; GO:0010629; GO:0014824; GO:0016020; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0031514; GO:0032420; GO:0033210; GO:0033365; GO:0034464; GO:0036064; GO:0038108; GO:0040015; GO:0040018; GO:0042311; GO:0043001; GO:0043005; GO:0044321; GO:0045444; GO:0045494; GO:0048854; GO:0051216; GO:0060170; GO:0060271; GO:0060296; GO:0061629; GO:1905515"
"303",318,113861,"Cluster_4115","Peve_00008964",-0.999794894490907,0.0128941051315395,0.697679744941,171,-22.26,"2 20","61 82",18,"77.78%","88.89%","Q6P9Z4","Protein fem-1 homolog A (FEM1a) (FEM1-alpha)","Danio rerio (Zebrafish) (Brachydanio rerio)","negative regulation of inflammatory response [GO:0050728]; positive regulation of inflammatory response [GO:0050729]; protein ubiquitination [GO:0016567]; regulation of ubiquitin-protein transferase activity [GO:0051438]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","GO:0000151; GO:0005739; GO:0006511; GO:0016567; GO:0031462; GO:0050728; GO:0050729; GO:0051438; GO:0140627; GO:1990756"
"304",319,113919,"Cluster_7855","Peve_00008965",0.110604066145318,0.929442905598846,0.999448381576871,167,-20.08,"2 21","753 775",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"305",320,114442,"Cluster_2854","Peve_00022251",-0.866168742180652,0.333150783883797,0.978262075707395,158,-22.45,"2 21","540 563",21,"71.43%","80.95%",NA,NA,NA,NA,NA
"306",321,114442,"Cluster_2854","Peve_00022251",-0.866168742180652,0.333150783883797,0.978262075707395,163,-21.51,"2 21","525 547",20,"70.00%","85.00%",NA,NA,NA,NA,NA
"307",322,114477,"Cluster_15726","Peve_00022251",-0.870467148569657,0.327633659681025,0.978262075707395,157,-27.78,"2 21","244 263",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"308",323,114762,"Cluster_4629","Peve_00011443",0.219685042919552,0.858994058558448,0.995936227948861,171,-33.73,"2 21","43 65",20,"75.00%","90.00%",NA,NA,NA,NA,NA
"309",324,115056,"Cluster_11134","Peve_00017846",-0.856078539892879,0.345787863891157,0.978262075707395,166,-21.13,"2 19","302 323",17,"76.47%","88.24%",NA,NA,NA,NA,NA
"310",325,116399,"Cluster_8988","Peve_00010713",-0.974427360136803,0.144282206944335,0.978262075707395,160,-22.67,"2 21","724 745",19,"63.16%","84.21%","Q7RTR2","NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","Homo sapiens (Human)","I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223"
"311",326,116692,"Cluster_2854","Peve_00023739",0.999976082283725,0.004403072548434,0.54328949385489,157,-22.98,"2 20","334 359",22,"72.73%","77.27%",NA,NA,NA,NA,NA
"312",327,117034,"Cluster_10934","Peve_00012400",-0.332926482556834,0.783927803910233,0.994487684309172,144,-20.86,"2 21","687 708",19,"57.89%","68.42%","D3ZH22","Sugar transporter SWEET1 (RAG1-activating protein 1) (Solute carrier family 50 member 1)","Rattus norvegicus (Rat)","carbohydrate transport [GO:0008643]","GO:0000139; GO:0005794; GO:0005886; GO:0008643; GO:0012505; GO:0016020; GO:0042947; GO:0051119"
"313",328,117327,"Cluster_4629","Peve_00017159",0.971877840168919,0.151336093873417,0.978262075707395,149,-25.17,"2 20","102 128",23,"65.22%","73.91%",NA,NA,NA,NA,NA
"314",329,117822,"Cluster_4629","Peve_00044088",-0.406931360863743,0.733197634473302,0.985373983818115,165,-23.01,"2 20","931 951",18,"77.78%","88.89%","Q06A37","Chromodomain-helicase-DNA-binding protein 7 (CHD-7) (EC 3.6.4.12) (ATP-dependent helicase CHD7)","Gallus gallus (Chicken)","adult heart development [GO:0007512]; adult walking behavior [GO:0007628]; aorta morphogenesis [GO:0035909]; atrioventricular canal development [GO:0036302]; blood circulation [GO:0008015]; blood vessel remodeling [GO:0001974]; cardiac septum morphogenesis [GO:0060411]; central nervous system development [GO:0007417]; chordate embryonic development [GO:0043009]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; cranial nerve development [GO:0021545]; embryonic hindlimb morphogenesis [GO:0035116]; epithelium development [GO:0060429]; face development [GO:0060324]; female genitalia development [GO:0030540]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; innervation [GO:0060384]; nose development [GO:0043584]; olfactory behavior [GO:0042048]; olfactory bulb development [GO:0021772]; olfactory nerve development [GO:0021553]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of growth hormone secretion [GO:0060123]; regulation of neurogenesis [GO:0050767]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; response to bacterium [GO:0009617]; retina development in camera-type eye [GO:0060041]; right ventricular compact myocardium morphogenesis [GO:0003226]; rRNA processing [GO:0006364]; secondary palate development [GO:0062009]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; T cell differentiation [GO:0030217]; transcription by RNA polymerase II [GO:0006366]; ventricular trabecula myocardium morphogenesis [GO:0003222]","GO:0000785; GO:0000978; GO:0001501; GO:0001974; GO:0003007; GO:0003222; GO:0003226; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0006364; GO:0006366; GO:0007417; GO:0007512; GO:0007605; GO:0007628; GO:0008015; GO:0009617; GO:0010468; GO:0010880; GO:0016887; GO:0021545; GO:0021553; GO:0021772; GO:0030217; GO:0030540; GO:0035116; GO:0035909; GO:0036302; GO:0040018; GO:0042048; GO:0042393; GO:0042472; GO:0043009; GO:0043584; GO:0045944; GO:0048752; GO:0050767; GO:0050890; GO:0060041; GO:0060123; GO:0060324; GO:0060384; GO:0060411; GO:0060429; GO:0062009; GO:0140658; GO:1990841"
"315",331,119432,"Cluster_589","Peve_00045022",-0.982243060472738,0.120150041763187,0.978262075707395,155,-23.55,"2 12","334 355",10,"100.00%","100.00%","Q9P3U4","E3 ubiquitin-protein ligase dbl4 (EC 2.3.2.31) (DNA-break-localizing protein 4) (Histone E3 ligase 1) (RING-type E3 ubiquitin transferase dbl4)","Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)","histone catabolic process [GO:0036205]; histone ubiquitination [GO:0016574]; meiosis I [GO:0007127]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000209; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0007127; GO:0008270; GO:0016574; GO:0031624; GO:0032436; GO:0035861; GO:0036205; GO:0061630"
"316",332,119439,"Cluster_4079","Peve_00045022",-0.889206685104759,0.302514133687244,0.978262075707395,162,-20.6,"2 15","186 207",13,"84.62%","100.00%","Q9P3U4","E3 ubiquitin-protein ligase dbl4 (EC 2.3.2.31) (DNA-break-localizing protein 4) (Histone E3 ligase 1) (RING-type E3 ubiquitin transferase dbl4)","Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)","histone catabolic process [GO:0036205]; histone ubiquitination [GO:0016574]; meiosis I [GO:0007127]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000209; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0007127; GO:0008270; GO:0016574; GO:0031624; GO:0032436; GO:0035861; GO:0036205; GO:0061630"
"317",333,119447,"Cluster_6904","Peve_00045022",-0.88334977405948,0.310565299294816,0.978262075707395,147,-20.4,"2 17","17 39",16,"75.00%","75.00%","Q9P3U4","E3 ubiquitin-protein ligase dbl4 (EC 2.3.2.31) (DNA-break-localizing protein 4) (Histone E3 ligase 1) (RING-type E3 ubiquitin transferase dbl4)","Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)","histone catabolic process [GO:0036205]; histone ubiquitination [GO:0016574]; meiosis I [GO:0007127]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000209; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0007127; GO:0008270; GO:0016574; GO:0031624; GO:0032436; GO:0035861; GO:0036205; GO:0061630"
"318",334,119449,"Cluster_6906","Peve_00045022",-0.549331590964153,0.629764784511723,0.978262075707395,143,-20.13,"2 17","17 39",16,"68.75%","75.00%","Q9P3U4","E3 ubiquitin-protein ligase dbl4 (EC 2.3.2.31) (DNA-break-localizing protein 4) (Histone E3 ligase 1) (RING-type E3 ubiquitin transferase dbl4)","Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)","histone catabolic process [GO:0036205]; histone ubiquitination [GO:0016574]; meiosis I [GO:0007127]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000209; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0007127; GO:0008270; GO:0016574; GO:0031624; GO:0032436; GO:0035861; GO:0036205; GO:0061630"
"319",335,119481,"Cluster_2787","Peve_00045023",0.598077831983001,0.591862709046405,0.978262075707395,160,-20.31,"2 21","328 349",19,"63.16%","84.21%","A7MB10","Protein RRP5 homolog (Programmed cell death protein 11)","Bos taurus (Bovine)","rRNA processing [GO:0006364]","GO:0003723; GO:0005730; GO:0006364; GO:0031090; GO:0032040"
"320",336,120156,"Cluster_2787","Peve_00001493",0.10769152312371,0.931308233100384,0.999448381576871,165,-20.46,"2 20","266 286",18,"83.33%","83.33%",NA,NA,NA,NA,NA
"321",337,120454,"Cluster_10934","Peve_00019650",-0.240618777456196,0.84529928916314,0.995934364227446,159,-23.81,"2 21","106 124",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"322",338,120567,"Cluster_4629","Peve_00004255",0.312288582934615,0.797808829121149,0.995934364227446,158,-22.86,"2 21","78 98",19,"73.68%","78.95%","Q9SAL0","E3 ubiquitin-protein ligase RGLG4 (EC 2.3.2.27) (RING domain ligase 4)","Arabidopsis thaliana (Mouse-ear cress)","defense response to bacterium [GO:0042742]; jasmonic acid mediated signaling pathway [GO:0009867]; protein K63-linked ubiquitination [GO:0070534]; response to wounding [GO:0009611]","GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0009611; GO:0009867; GO:0042742; GO:0046872; GO:0061630; GO:0070534"
"323",339,120720,"Cluster_9149","Peve_00004251",-0.625548135210439,0.569750772910844,0.978262075707395,153,-25.73,"2 20","901 926",22,"68.18%","77.27%",NA,NA,NA,NA,NA
"324",340,120794,"Cluster_5563","Peve_00004258",-0.993178669171328,0.0744006721025078,0.978262075707395,156,-21.06,"2 22","48 67",20,"75.00%","80.00%","Q9UJX3","Anaphase-promoting complex subunit 7 (APC7) (Cyclosome subunit 7)","Homo sapiens (Human)","anaphase-promoting complex-dependent catabolic process [GO:0031145]; brain development [GO:0007420]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]","GO:0000792; GO:0005634; GO:0005654; GO:0005680; GO:0005737; GO:0005819; GO:0005829; GO:0007091; GO:0007346; GO:0007420; GO:0015630; GO:0016567; GO:0019903; GO:0031145; GO:0045842; GO:0051301; GO:0051445; GO:0070979; GO:0140767"
"325",341,121301,"Cluster_8884","Peve_00002946",-0.947118896471404,0.207959151134339,0.978262075707395,165,-22.6,"2 14","51 71",12,"100.00%","100.00%",NA,NA,NA,NA,NA
"326",342,121302,"Cluster_8887","Peve_00002946",-0.821901473199095,0.385826733407904,0.978262075707395,165,-22.6,"2 14","51 71",12,"100.00%","100.00%",NA,NA,NA,NA,NA
"327",343,121506,"Cluster_2787","Peve_00042279",-0.399136417455805,0.738619968241277,0.986697151420032,161,-24.48,"2 20","969 992",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"328",344,121632,"Cluster_15726","Peve_00042277",-0.5,0.666666666666667,0.978262075707395,162,-23.1,"2 21","923 943",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"329",345,121755,"Cluster_9149","Peve_00042273",0.861512999793303,0.33903456419258,0.978262075707395,142,-20.97,"2 21","92 111",21,"66.67%","71.43%",NA,NA,NA,NA,NA
"330",346,121873,"Cluster_4735","Peve_00011122",-0.705388159184919,0.501545429141498,0.978262075707395,152,-20.02,"2 21","17 38",19,"63.16%","73.68%","Q8C0J6","Ankyrin repeat domain-containing protein SOWAHC (Ankyrin repeat domain-containing protein 57) (Protein sosondowah homolog C)","Mus musculus (Mouse)","",""
"331",347,122340,"Cluster_9149","Peve_00001376",-0.406140290823919,0.733748851251901,0.985559944630005,143,-20.34,"2 14","363 383",12,"75.00%","91.67%",NA,NA,NA,NA,NA
"332",348,122340,"Cluster_9149","Peve_00001376",-0.406140290823919,0.733748851251901,0.985559944630005,143,-20.34,"2 14","679 699",12,"75.00%","91.67%",NA,NA,NA,NA,NA
"333",349,122421,"Cluster_7053","Peve_00001375",-0.495321194451039,0.670100750092205,0.978262075707395,167,-22.37,"2 21","58 80",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"334",350,122673,"Cluster_796","Peve_00001378",-0.183401980702563,0.882578015181301,0.999431626804866,155,-21.43,"2 19","464 488",20,"80.00%","80.00%",NA,NA,NA,NA,NA
"335",351,122739,"Cluster_7855","Peve_00001379",-0.499289187411539,0.667189065004492,0.978262075707395,165,-20.29,"2 20","417 440",20,"75.00%","90.00%","P48733","Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","Bos taurus (Bovine)","antibacterial innate immune response [GO:0140367]; defense response to Gram-negative bacterium [GO:0050829]","GO:0000922; GO:0005201; GO:0005509; GO:0005576; GO:0005929; GO:0016020; GO:0016323; GO:0016324; GO:0031012; GO:0050829; GO:0060170; GO:0140367"
"336",352,122886,"Cluster_11134","Peve_00014551",-0.891827450535521,0.298846784476589,0.978262075707395,155,-21.92,"2 12","141 162",10,"100.00%","100.00%","Q9VAC5","ADAM 17-like protease (EC 3.4.24.-)","Drosophila melanogaster (Fruit fly)","membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of cell death [GO:0010942]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0004222; GO:0005886; GO:0006509; GO:0007219; GO:0007220; GO:0010942; GO:0016020; GO:0033209; GO:0040015; GO:0046872; GO:1903427"
"337",353,122942,"Cluster_589","Peve_00018031",-0.95809736425326,0.18494563469868,0.978262075707395,147,-21.37,"2 21","925 947",20,"65.00%","70.00%","Q5R4R4","Protein LSM14 homolog A (Protein FAM61A) (RNA-associated protein 55A)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","mitotic spindle assembly [GO:0090307]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]","GO:0000932; GO:0005737; GO:0010494; GO:0017148; GO:0033962; GO:0072686; GO:0090307; GO:1990904"
"338",354,123660,"Cluster_16738","Peve_00001998",-0.506209111557797,0.662092790877516,0.978262075707395,162,-21.98,"2 17","5 28",17,"88.24%","88.24%",NA,NA,NA,NA,NA
"339",355,123747,"Cluster_15726","Peve_00030678",-0.834249232442946,0.371802845661222,0.978262075707395,164,-21.89,"2 20","390 409",18,"83.33%","83.33%","P48509","CD151 antigen (GP27) (Membrane glycoprotein SFA-1) (Platelet-endothelial tetraspan antigen 3) (PETA-3) (Tetraspanin-24) (Tspan-24) (CD antigen CD151)","Homo sapiens (Human)","cell adhesion [GO:0007155]; cell migration [GO:0016477]; positive regulation of cell migration [GO:0030335]; positive regulation of endocytosis [GO:0045807]; T cell proliferation [GO:0042098]; wound healing, spreading of cells [GO:0044319]","GO:0005178; GO:0005604; GO:0005829; GO:0005886; GO:0005925; GO:0007155; GO:0009986; GO:0016020; GO:0016477; GO:0030335; GO:0042098; GO:0044319; GO:0045807"
"340",356,123876,"Cluster_11134","Peve_00007234",0.318841899178898,0.793412196528941,0.995934364227446,156,-24.24,"2 21","126 147",19,"63.16%","78.95%",NA,NA,NA,NA,NA
"341",357,123995,"Cluster_6914","Peve_00007231",0.708026191532922,0.499171700784645,0.978262075707395,161,-20.82,"2 20","755 774",18,"77.78%","83.33%","Q5RF65","Cytosolic beta-glucosidase (EC 3.2.1.21) (Cytosolic galactosylceramidase) (EC 3.2.1.46) (Cytosolic glucosylceramidase) (EC 3.2.1.45) (Cytosolic glycosylceramidase) (Cytosolic GCase)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","beta-glucoside catabolic process [GO:1901805]; carbohydrate metabolic process [GO:0005975]; galactosylceramide catabolic process [GO:0006683]; glucosylceramide catabolic process [GO:0006680]","GO:0004336; GO:0004348; GO:0004565; GO:0005829; GO:0005975; GO:0006680; GO:0006683; GO:0008422; GO:0017042; GO:0102483; GO:1901805"
"342",358,124205,"Cluster_1167","Peve_00033090",0.400939063549067,0.737367811006479,0.986451347487265,172,-22.68,"2 21","309 330",19,"73.68%","89.47%","P39963","G2/mitotic-specific cyclin-B3","Gallus gallus (Chicken)","cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]","GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0005813; GO:0016538; GO:0044772; GO:0051301"
"343",360,125421,"Cluster_2787","Peve_00036314",0.30222320740736,0.804542409354169,0.995934364227446,161,-24.48,"2 20","969 992",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"344",361,125466,"Cluster_2787","Peve_00036315",0.867933894665659,0.330895275232091,0.978262075707395,161,-24.48,"2 20","467 490",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"345",362,126147,"Cluster_4629","Peve_00022092",-0.879352561651996,0.315951536817072,0.978262075707395,149,-20.73,"2 19","894 916",18,"66.67%","77.78%","Q8K2J9","BTB/POZ domain-containing protein 6","Mus musculus (Mouse)","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"346",363,126193,"Cluster_4735","Peve_00016362",-0.553713626388823,0.626420464481377,0.978262075707395,167,-23.11,"2 21","917 939",20,"75.00%","85.00%","Q96RW7","Hemicentin-1 (Fibulin-6) (FIBL-6)","Homo sapiens (Human)","actin filament reorganization [GO:0090527]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711; GO:0090527"
"347",364,126211,"Cluster_9983","Peve_00016362",0.551604655329943,0.628031457527433,0.978262075707395,162,-21.22,"2 19","567 587",17,"76.47%","82.35%","Q96RW7","Hemicentin-1 (Fibulin-6) (FIBL-6)","Homo sapiens (Human)","actin filament reorganization [GO:0090527]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711; GO:0090527"
"348",365,127093,"Cluster_4735","Peve_00019358",-0.520800257950135,0.651267260672261,0.978262075707395,147,-20.69,"2 18","709 732",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"349",366,127102,"Cluster_7657","Peve_00019358",-0.689119810173849,0.515994727310428,0.978262075707395,163,-20.77,"2 20","911 930",18,"83.33%","88.89%",NA,NA,NA,NA,NA
"350",367,127103,"Cluster_7658","Peve_00019358",-0.0380788629723199,0.975752380672781,0.999448381576871,163,-20.77,"2 20","911 930",18,"83.33%","88.89%",NA,NA,NA,NA,NA
"351",368,127491,"Cluster_2787","Peve_00029512",0.939715883480723,0.222178918119318,0.978262075707395,167,-20.76,"2 20","292 313",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"352",369,127740,"Cluster_9149","Peve_00029519",-0.5,0.666666666666667,0.978262075707395,158,-20.26,"2 19","613 634",17,"76.47%","76.47%",NA,NA,NA,NA,NA
"353",370,127903,"Cluster_4735","Peve_00024009",0.355869213197242,0.768369712783905,0.990527675986719,156,-23.9,"2 21","795 816",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"354",371,128764,"Cluster_6906","Peve_00012820",-0.560270547100008,0.621394333984326,0.978262075707395,162,-20.51,"2 19","290 311",17,"70.59%","88.24%",NA,NA,NA,NA,NA
"355",372,128928,"Cluster_796","Peve_00029579",0.817095018506665,0.391166195700954,0.978262075707395,155,-23.85,"2 21","206 231",23,"69.57%","69.57%","Q99L28","Probable ribosome biogenesis protein RLP24 (Ribosomal L24 domain-containing protein 1) (Ribosomal protein L24-like)","Mus musculus (Mouse)","ribosomal large subunit biogenesis [GO:0042273]; translation [GO:0006412]","GO:0003735; GO:0005654; GO:0005730; GO:0005840; GO:0006412; GO:0042273"
"356",373,129072,"Cluster_4629","Peve_00033555",-0.554554668634826,0.625777256211528,0.978262075707395,159,-20.88,"2 21","485 507",20,"70.00%","80.00%","Q866A2","Neuronal acetylcholine receptor subunit alpha-7","Macaca mulatta (Rhesus macaque)","associative learning [GO:0008306]; B cell activation [GO:0042113]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; dendrite arborization [GO:0140059]; dendritic spine organization [GO:0097061]; endocytosis [GO:0006897]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; generation of ovulation cycle rhythm [GO:0060112]; ion transmembrane transport [GO:0034220]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure [GO:0001988]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of amyloid fibril formation [GO:1905906]; regulation of membrane potential [GO:0042391]; regulation of neuron death [GO:1901214]; regulation of norepinephrine secretion [GO:0014061]; regulation of synaptic transmission, dopaminergic [GO:0032225]; response to amyloid-beta [GO:1904645]; response to cold [GO:0009409]; response to food [GO:0032094]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; short-term memory [GO:0007614]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]; T cell activation [GO:0042110]","GO:0001540; GO:0001666; GO:0001933; GO:0001988; GO:0005231; GO:0005886; GO:0005892; GO:0006816; GO:0006874; GO:0006897; GO:0007165; GO:0007268; GO:0007271; GO:0007614; GO:0008284; GO:0008306; GO:0009409; GO:0009897; GO:0014061; GO:0015464; GO:0015643; GO:0016324; GO:0017081; GO:0022848; GO:0030317; GO:0030594; GO:0030673; GO:0032094; GO:0032225; GO:0032691; GO:0032715; GO:0032720; GO:0033138; GO:0034220; GO:0035094; GO:0035095; GO:0042110; GO:0042113; GO:0042166; GO:0042391; GO:0042734; GO:0042803; GO:0043005; GO:0043410; GO:0045202; GO:0045766; GO:0048149; GO:0050728; GO:0050877; GO:0050890; GO:0050893; GO:0051649; GO:0060112; GO:0070374; GO:0097061; GO:0098839; GO:0098978; GO:0098981; GO:0140059; GO:1900273; GO:1901214; GO:1902004; GO:1904315; GO:1904645; GO:1905906; GO:1905920; GO:2000463"
"357",374,129732,"Cluster_15726","Peve_00020651",-0.998224476405987,0.0379422100483605,0.909359886114279,149,-26.8,"2 21","742 771",27,"66.67%","70.37%","Q6ZPR4","Potassium channel subfamily T member 1","Mus musculus (Mouse)","potassium ion transport [GO:0006813]","GO:0005228; GO:0005267; GO:0005886; GO:0006813; GO:0015271; GO:0016020"
"358",375,129788,"Cluster_2882","Peve_00020653",-0.633853004687652,0.562944824562298,0.978262075707395,153,-20.7,"2 18","483 504",16,"68.75%","81.25%",NA,NA,NA,NA,NA
"359",376,129825,"Cluster_16738","Peve_00020653",-0.101046084709477,0.935562090468825,0.999448381576871,160,-22.45,"2 19","964 989",21,"76.19%","80.95%",NA,NA,NA,NA,NA
"360",377,129996,"Cluster_11134","Peve_00015788",-0.915445083869245,0.263677620824087,0.978262075707395,155,-20.29,"2 21","678 702",22,"63.64%","77.27%","Q8WUF5","RelA-associated inhibitor (Inhibitor of ASPP protein) (Protein iASPP) (NFkB-interacting protein 1) (PPP1R13B-like protein)","Homo sapiens (Human)","apoptotic process [GO:0006915]; cardiac muscle contraction [GO:0060048]; cardiac right ventricle morphogenesis [GO:0003215]; embryonic camera-type eye development [GO:0031076]; hair cycle [GO:0042633]; multicellular organism growth [GO:0035264]; multicellular organismal homeostasis [GO:0048871]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; ventricular cardiac muscle tissue development [GO:0003229]","GO:0000122; GO:0003215; GO:0003229; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006915; GO:0009791; GO:0030054; GO:0031076; GO:0035264; GO:0042633; GO:0042802; GO:0045171; GO:0045296; GO:0045597; GO:0048871; GO:0060048"
"361",378,129996,"Cluster_11134","Peve_00015788",-0.915445083869245,0.263677620824087,0.978262075707395,155,-20.29,"2 21","922 946",22,"63.64%","77.27%","Q8WUF5","RelA-associated inhibitor (Inhibitor of ASPP protein) (Protein iASPP) (NFkB-interacting protein 1) (PPP1R13B-like protein)","Homo sapiens (Human)","apoptotic process [GO:0006915]; cardiac muscle contraction [GO:0060048]; cardiac right ventricle morphogenesis [GO:0003215]; embryonic camera-type eye development [GO:0031076]; hair cycle [GO:0042633]; multicellular organism growth [GO:0035264]; multicellular organismal homeostasis [GO:0048871]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; ventricular cardiac muscle tissue development [GO:0003229]","GO:0000122; GO:0003215; GO:0003229; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006915; GO:0009791; GO:0030054; GO:0031076; GO:0035264; GO:0042633; GO:0042802; GO:0045171; GO:0045296; GO:0045597; GO:0048871; GO:0060048"
"362",379,130462,"Cluster_2854","Peve_00022873",-0.952017369259891,0.198010937107715,0.978262075707395,154,-20.05,"2 20","238 260",19,"68.42%","78.95%","Q09694","Saccharopine dehydrogenase [NAD(+), L-lysine-forming] (SDH) (EC 1.5.1.7) (Lysine--2-oxoglutarate reductase)","Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)","lysine biosynthetic process [GO:0009085]; lysine biosynthetic process via aminoadipic acid [GO:0019878]","GO:0004753; GO:0004754; GO:0005737; GO:0009085; GO:0019878"
"363",380,130815,"Cluster_16738","Peve_00019144",0.619219211640606,0.574898449290945,0.978262075707395,153,-22.86,"2 21","934 961",25,"68.00%","76.00%",NA,NA,NA,NA,NA
"364",381,131132,"Cluster_589","Peve_00027966",0.484423430385905,0.678058843968014,0.978262075707395,155,-23.55,"2 12","523 544",10,"100.00%","100.00%",NA,NA,NA,NA,NA
"365",382,131180,"Cluster_1167","Peve_00027965",0.999909726776791,0.00855416971793389,0.573710369894872,147,-23.67,"2 18","436 460",19,"68.42%","78.95%","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"366",383,132081,"Cluster_2787","Peve_00039215",0.0345543235768873,0.977997654436565,0.999448381576871,159,-22.5,"2 21","615 638",21,"66.67%","80.95%",NA,NA,NA,NA,NA
"367",384,132081,"Cluster_2787","Peve_00039215",0.0345543235768873,0.977997654436565,0.999448381576871,159,-22.5,"2 21","67 90",21,"66.67%","80.95%",NA,NA,NA,NA,NA
"368",385,132477,"Cluster_15726","Peve_00027038",-0.506987707499005,0.661517889613419,0.978262075707395,152,-22.62,"2 21","978 999",19,"63.16%","73.68%","P16157","Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)","Homo sapiens (Human)","cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]","GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030507; GO:0031430; GO:0043005; GO:0044325; GO:0045199; GO:0051117; GO:0072659"
"369",386,132500,"Cluster_6914","Peve_00016567",0.802501391764528,0.407004044738878,0.978262075707395,157,-22.5,"2 20","556 578",20,"70.00%","85.00%","Q12766","HMG domain-containing protein 3 (HMG box-containing protein 3) (Protein SMF)","Homo sapiens (Human)","","GO:0003677; GO:0005634"
"370",387,133737,"Cluster_15726","Peve_00039494",-0.576931921796511,0.608499573041099,0.978262075707395,146,-21.03,"2 21","369 393",22,"63.64%","72.73%",NA,NA,NA,NA,NA
"371",388,134740,"Cluster_4080","Peve_00002333",-0.99984182162055,0.0113233363162533,0.656276085828034,159,-25.73,"2 21","460 487",25,"64.00%","76.00%","Q6DIV6","Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836]","GO:0001762; GO:0006836; GO:0008021; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800"
"372",389,134765,"Cluster_10965","Peve_00002333",0.307291027213789,0.801154990939541,0.995934364227446,156,-24,"2 21","867 888",19,"57.89%","84.21%","Q6DIV6","Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836]","GO:0001762; GO:0006836; GO:0008021; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800"
"373",390,135266,"Cluster_14999","Peve_00044548",-0.709468600252547,0.497870048678612,0.978262075707395,157,-21.41,"2 14","86 107",12,"91.67%","91.67%",NA,NA,NA,NA,NA
"374",392,136205,"Cluster_10965","Peve_00004595",-0.996459015999935,0.0535901951774733,0.970229341206918,165,-22.27,"2 20","746 771",22,"77.27%","81.82%",NA,NA,NA,NA,NA
"375",393,136521,"Cluster_11134","Peve_00041445",-0.00237120398437347,0.998490443244621,0.999693413829402,164,-20.64,"2 20","149 171",20,"80.00%","85.00%","P09917","Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34)","Homo sapiens (Human)","arachidonic acid metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; hepoxilin biosynthetic process [GO:0051122]; humoral immune response [GO:0006959]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; linoleic acid metabolic process [GO:0043651]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426]","GO:0001937; GO:0002232; GO:0002523; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005576; GO:0005615; GO:0005635; GO:0005641; GO:0005654; GO:0005829; GO:0006691; GO:0006959; GO:0016363; GO:0016525; GO:0016702; GO:0016787; GO:0019369; GO:0019370; GO:0019372; GO:0030501; GO:0031965; GO:0034440; GO:0034774; GO:0036336; GO:0036403; GO:0042593; GO:0042759; GO:0043651; GO:0045598; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0051122; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904813; GO:1904999; GO:2001301"
"376",394,136672,"Cluster_2854","Peve_00041441",-0.507486347355159,0.661149542463894,0.978262075707395,153,-20.74,"2 20","433 458",22,"68.18%","77.27%",NA,NA,NA,NA,NA
"377",395,137235,"Cluster_9149","Peve_00014618",-0.869715054300063,0.328605068420819,0.978262075707395,155,-23.62,"2 18","117 141",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"378",396,138327,"Cluster_15726","Peve_00036846",-0.666916828518941,0.535227246514526,0.978262075707395,170,-21.91,"2 15","620 641",13,"100.00%","100.00%",NA,NA,NA,NA,NA
"379",397,138470,"Cluster_1167","Peve_00004045",0.953444630451385,0.195020144189213,0.978262075707395,152,-21.59,"2 13","530 551",11,"90.91%","90.91%","O60290","Zinc finger protein 862","Homo sapiens (Human)","regulation of DNA-templated transcription [GO:0006355]","GO:0005634; GO:0006355; GO:0046872; GO:0046983"
"380",398,139143,"Cluster_796","Peve_00000740",0.839187867539631,0.3660615606056,0.978262075707395,155,-22.36,"2 21","159 182",21,"66.67%","76.19%","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"381",400,139561,"Cluster_6255","Peve_00028021",0.160076887384495,0.897651565927112,0.999448381576871,179,-22.63,"2 20","159 180",18,"88.89%","88.89%",NA,NA,NA,NA,NA
"382",401,139860,"Cluster_16738","Peve_00029992",-0.493765079118584,0.671240542455818,0.978262075707395,171,-21.78,"2 16","48 69",14,"92.86%","100.00%",NA,NA,NA,NA,NA
"383",402,140412,"Cluster_4629","Peve_00031867",0.241005804108841,0.845045429691059,0.995934364227446,159,-25.35,"2 21","869 887",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"384",403,141110,"Cluster_10965","Peve_00003800",-0.853846084715342,0.348527910559181,0.978262075707395,151,-21.59,"2 17","888 912",18,"72.22%","77.78%","Q8VDL9","Zinc finger protein GLIS2 (GLI-similar 2) (Neuronal Krueppel-like protein) (Zinc finger protein GLI5)","Mus musculus (Mouse)","cell differentiation involved in kidney development [GO:0061005]; central nervous system development [GO:0007417]; hematopoietic stem cell homeostasis [GO:0061484]; kidney development [GO:0001822]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001822; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0007417; GO:0016607; GO:0043433; GO:0045879; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0061005; GO:0061484; GO:0097730; GO:1900182; GO:1990837"
"385",404,141567,"Cluster_15726","Peve_00029379",-0.5,0.666666666666667,0.978262075707395,153,-23.67,"2 21","307 336",27,"70.37%","70.37%","P55115","Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15)","Caenorhabditis elegans","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"386",405,142478,"Cluster_2882","Peve_00040019",-0.729873683789183,0.479157715927033,0.978262075707395,153,-20.23,"2 20","429 452",20,"70.00%","80.00%","P49746","Thrombospondin-3","Homo sapiens (Human)","bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931]","GO:0003417; GO:0005509; GO:0005576; GO:0007160; GO:0008201; GO:0043931; GO:0048471; GO:0060346; GO:0062023"
"387",406,142824,"Cluster_13502","Peve_00006976",0.969228037006061,0.158340762752707,0.978262075707395,196,-37.22,"2 21","624 645",19,"94.74%","100.00%","O42574","Beta-1 adrenergic receptor (Beta-1 adrenoreceptor) (Beta-1 adrenoceptor) (x-BETA1AR)","Xenopus laevis (African clawed frog)","adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; positive regulation of GTPase activity [GO:0043547]; positive regulation of heart contraction [GO:0045823]","GO:0004940; GO:0005085; GO:0005769; GO:0005886; GO:0043547; GO:0045823; GO:0071880"
"388",407,143130,"Cluster_9149","Peve_00032772",1,9.48637384723993e-09,6.86838308108347e-06,141,-20.73,"2 14","548 569",12,"66.67%","83.33%",NA,NA,NA,NA,NA
"389",408,143136,"Cluster_11134","Peve_00032772",-0.856078539892879,0.345787863891157,0.978262075707395,159,-21.08,"2 20","571 592",18,"66.67%","83.33%",NA,NA,NA,NA,NA
"390",409,143805,"Cluster_9149","Peve_00040012",-0.618775530467661,0.57525808605551,0.978262075707395,151,-22.17,"2 21","87 115",26,"61.54%","69.23%","P35443","Thrombospondin-4","Homo sapiens (Human)","behavioral response to pain [GO:0048266]; endothelial cell-cell adhesion [GO:0071603]; myoblast migration [GO:0051451]; negative regulation of angiogenesis [GO:0016525]; positive regulation of cell division [GO:0051781]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of tissue remodeling [GO:0034103]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; tissue remodeling [GO:0048771]","GO:0001938; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006986; GO:0008083; GO:0008201; GO:0016525; GO:0016529; GO:0034103; GO:0034976; GO:0048266; GO:0048771; GO:0050731; GO:0051451; GO:0051781; GO:0062023; GO:0070062; GO:0071603; GO:0090023"
"391",410,143952,"Cluster_15726","Peve_00027699",-0.99781061214271,0.0421342959844262,0.911075865480802,168,-24.61,"2 21","27 48",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"392",411,144188,"Cluster_2882","Peve_00028568",-0.979593263475638,0.128831843871888,0.978262075707395,154,-20.03,"2 20","221 238",18,"77.78%","77.78%","Q60HC3","Heterogeneous nuclear ribonucleoprotein F (hnRNP F) [Cleaved into: Heterogeneous nuclear ribonucleoprotein F, N-terminally processed]","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]","GO:0003727; GO:0005654; GO:0005681; GO:0006397; GO:0008380; GO:0043484"
"393",412,144366,"Cluster_2787","Peve_00022682",0.817909550967037,0.390265822467649,0.978262075707395,142,-20.1,"2 21","600 627",25,"60.00%","68.00%","Q8BG19","Protein O-mannosyl-transferase TMTC4 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 4)","Mus musculus (Mouse)","endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked mannosylation [GO:0035269]; sensory perception of sound [GO:0007605]","GO:0000030; GO:0004169; GO:0005783; GO:0007605; GO:0016020; GO:0030968; GO:0032470; GO:0035269; GO:0051117; GO:1905584"
"394",413,144420,"Cluster_5882","Peve_00027693",0.147238332228759,0.905923137581239,0.999448381576871,152,-22.38,"2 20","943 971",25,"72.00%","72.00%",NA,NA,NA,NA,NA
"395",414,144529,"Cluster_10934","Peve_00013063",-0.456234386365879,0.698395722414825,0.978262075707395,160,-23.18,"2 17","873 894",15,"80.00%","86.67%","Q9U8W8","Techylectin-5A","Tachypleus tridentatus (Japanese horseshoe crab)","cell-cell adhesion [GO:0098609]","GO:0005576; GO:0030246; GO:0046872; GO:0098609"
"396",415,145092,"Cluster_4629","Peve_00037853",-0.62893041317032,0.566986062545413,0.978262075707395,148,-22.08,"2 19","699 719",17,"64.71%","82.35%",NA,NA,NA,NA,NA
"397",416,145446,"Cluster_2787","Peve_00022537",0.867933894665659,0.330895275232091,0.978262075707395,156,-21.19,"2 15","145 165",13,"92.31%","92.31%",NA,NA,NA,NA,NA
"398",417,146798,"Cluster_2882","Peve_00020592",-0.112868554327035,0.927992202866395,0.999448381576871,154,-20.55,"2 20","256 278",19,"73.68%","73.68%","Q9JLI7","Sperm-associated antigen 6 (Axoneme central apparatus protein) (Protein PF16 homolog)","Mus musculus (Mouse)","cell division [GO:0051301]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; ear development [GO:0043583]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of localization in cell [GO:0051649]; fibroblast migration [GO:0010761]; filopodium assembly [GO:0046847]; flagellated sperm motility [GO:0030317]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; neuron projection extension [GO:1990138]; non-motile cilium assembly [GO:1905515]; protein localization [GO:0008104]; regulation of cilium beat frequency [GO:0003356]; regulation of establishment of planar polarity [GO:0090175]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]; stress fiber assembly [GO:0043149]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; ventricular system development [GO:0021591]","GO:0001669; GO:0002177; GO:0003341; GO:0003351; GO:0003356; GO:0005576; GO:0005829; GO:0005874; GO:0005930; GO:0006931; GO:0007283; GO:0007288; GO:0008017; GO:0008104; GO:0010761; GO:0015630; GO:0021591; GO:0030317; GO:0031410; GO:0043149; GO:0043583; GO:0044458; GO:0045198; GO:0046847; GO:0051301; GO:0051649; GO:0090175; GO:0090660; GO:0097228; GO:0120197; GO:0120249; GO:1905515; GO:1990138; GO:1990716"
"399",419,148191,"Cluster_2787","Peve_00039908",-0.00382968334855694,0.997561941898757,0.999448381576871,160,-20.92,"2 21","522 541",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"400",420,149262,"Cluster_15726","Peve_00015856",-0.985724827431588,0.107697047532859,0.978262075707395,168,-20.11,"2 21","751 772",19,"73.68%","84.21%","P97390","Vacuolar protein sorting-associated protein 45 (mVps45)","Mus musculus (Mouse)","intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005794; GO:0006886; GO:0008021; GO:0010008; GO:0016020; GO:0016192"
"401",421,149608,"Cluster_8888","Peve_00039111",-0.431858557006394,0.71571592464711,0.980357082132556,174,-20.81,"2 19","469 489",17,"82.35%","94.12%","P18887","DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1)","Homo sapiens (Human)","base-excision repair [GO:0006284]; cerebellum morphogenesis [GO:0021587]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; positive regulation of DNA ligase activity [GO:1904877]; positive regulation of single strand break repair [GO:1903518]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to hydroperoxide [GO:0033194]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033]; response to xenobiotic stimulus [GO:0009410]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819]; voluntary musculoskeletal movement [GO:0050882]","GO:0000012; GO:0000781; GO:0000785; GO:0001666; GO:0005634; GO:0005654; GO:0005730; GO:0006284; GO:0006303; GO:0009410; GO:0010033; GO:0010836; GO:0019899; GO:0021587; GO:0021766; GO:0032356; GO:0033194; GO:0050882; GO:0061819; GO:0070522; GO:0072572; GO:0090734; GO:1903518; GO:1904877; GO:1905765; GO:1990414; GO:1990599"
"402",422,150533,"Cluster_2882","Peve_00014894",-0.974964157106398,0.142753411156355,0.978262075707395,166,-23.86,"2 21","766 786",19,"73.68%","89.47%","P31399","ATP synthase subunit d, mitochondrial (ATPase subunit d) (ATP synthase peripheral stalk subunit d)","Rattus norvegicus (Rat)","ATP metabolic process [GO:0046034]; cellular response to peptide [GO:1901653]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]","GO:0000274; GO:0000276; GO:0005739; GO:0005743; GO:0005753; GO:0015078; GO:0015986; GO:0042776; GO:0044877; GO:0046034; GO:1901653"
"403",424,152271,"Cluster_11134","Peve_00016130",-0.946408038614642,0.209364887223052,0.978262075707395,159,-21.88,"2 21","187 209",20,"75.00%","75.00%","Q176V0","Ubiquitin-fold modifier 1","Aedes aegypti (Yellowfever mosquito) (Culex aegypti)","protein ufmylation [GO:0071569]","GO:0071569"
"404",425,152705,"Cluster_6914","Peve_00032573",0.907092254565505,0.27659371680709,0.978262075707395,164,-22.48,"2 20","443 463",19,"78.95%","89.47%","Q9D8Y8","Inhibitor of growth protein 5","Mus musculus (Mouse)","apoptotic signaling pathway [GO:0097190]; DNA replication-dependent chromatin disassembly [GO:0140889]; fibroblast proliferation [GO:0048144]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of growth [GO:0045926]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of DNA-templated transcription [GO:0045893]; protein acetylation [GO:0006473]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of developmental process [GO:0050793]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of DNA-templated transcription [GO:0006355]; regulation of hemopoiesis [GO:1903706]","GO:0000123; GO:0001558; GO:0003682; GO:0005634; GO:0005654; GO:0006275; GO:0006355; GO:0006473; GO:0008285; GO:0016570; GO:0035064; GO:0043065; GO:0043981; GO:0043982; GO:0043983; GO:0045893; GO:0045926; GO:0046872; GO:0048144; GO:0048147; GO:0050793; GO:0051726; GO:0070776; GO:0097190; GO:0140889; GO:1903706; GO:2000278; GO:2001235"
"405",426,152912,"Cluster_589","Peve_00039139",-0.830316482709592,0.376319309284918,0.978262075707395,152,-22.22,"2 14","628 650",13,"84.62%","92.31%","Q8CGC6","RNA-binding protein 28 (RNA-binding motif protein 28)","Mus musculus (Mouse)","mRNA processing [GO:0006397]; RNA splicing [GO:0008380]","GO:0003723; GO:0005681; GO:0005730; GO:0006397; GO:0008380"
"406",427,154071,"Cluster_11134","Peve_00038429",-0.0732854881320713,0.953303145823176,0.999448381576871,161,-24.35,"2 21","511 532",20,"75.00%","85.00%","Q9GZS1","DNA-directed RNA polymerase I subunit RPA49 (RNA polymerase I subunit A49) (DNA-directed RNA polymerase I subunit E) (RNA polymerase I-associated factor 1) (RNA polymerase I-associated factor 53)","Homo sapiens (Human)","nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; RNA polymerase I preinitiation complex assembly [GO:0001188]; transcription elongation by RNA polymerase I [GO:0006362]","GO:0001179; GO:0001188; GO:0001650; GO:0003677; GO:0005654; GO:0005730; GO:0005736; GO:0006362; GO:0042790"
"407",428,156113,"Cluster_2882","Peve_00042560",0.711712415807238,0.495839849675956,0.978262075707395,155,-20.61,"2 20","973 991",18,"77.78%","77.78%",NA,NA,NA,NA,NA
"408",429,156225,"Cluster_9149","Peve_00016868",-0.5,0.666666666666667,0.978262075707395,161,-20.21,"2 18","164 185",16,"81.25%","81.25%",NA,NA,NA,NA,NA
"409",431,157278,"Cluster_796","Peve_00014798",0.898740270652305,0.288966974174018,0.978262075707395,163,-22.39,"2 18","973 996",18,"83.33%","88.89%",NA,NA,NA,NA,NA
"410",432,157362,"Cluster_15726","Peve_00018231",-0.5,0.666666666666667,0.978262075707395,153,-24.63,"2 21","428 451",22,"72.73%","72.73%","Q8NCT1","Arrestin domain-containing protein 4","Homo sapiens (Human)","extracellular vesicle biogenesis [GO:0140112]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]","GO:0005737; GO:0005768; GO:0005769; GO:0005886; GO:0015031; GO:0016567; GO:0043231; GO:0051443; GO:0140112; GO:1903561; GO:1990756"
"411",433,157608,"Cluster_6905","Peve_00018237",-0.572627756616915,0.611848097284421,0.978262075707395,149,-22.14,"2 21","321 343",21,"66.67%","76.19%","O35762","Homeobox protein Nkx-6.1 (Homeobox protein NK-6 homolog A)","Rattus norvegicus (Rat)","cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to cytokine stimulus [GO:0071345]; cellular response to peptide hormone stimulus [GO:0071375]; central nervous system neuron differentiation [GO:0021953]; endocrine pancreas development [GO:0031018]; negative regulation of glial cell differentiation [GO:0045686]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; oligodendrocyte differentiation [GO:0048709]; pancreatic A cell differentiation [GO:0003310]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of insulin secretion [GO:0032024]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of axon extension [GO:0030516]; regulation of neuron migration [GO:2001222]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase II [GO:0006366]; type B pancreatic cell development [GO:0003323]; type B pancreatic cell differentiation [GO:0003309]; type B pancreatic cell proliferation [GO:0044342]","GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0003309; GO:0003310; GO:0003323; GO:0003682; GO:0003700; GO:0005634; GO:0006357; GO:0006366; GO:0007224; GO:0008283; GO:0009410; GO:0021953; GO:0022008; GO:0030154; GO:0030182; GO:0030516; GO:0031018; GO:0032024; GO:0035094; GO:0043565; GO:0044342; GO:0045666; GO:0045686; GO:0045687; GO:0048709; GO:0048714; GO:0048715; GO:0071345; GO:0071375; GO:2001222"
"412",434,158052,"Cluster_4629","Peve_00009286",0.824574749454762,0.382828876600951,0.978262075707395,167,-26.23,"2 16","580 601",14,"85.71%","100.00%","Q75UQ2","Craniofacial development protein 1 (Bucentaur)","Rattus norvegicus (Rat)","cell adhesion [GO:0007155]; chromatin remodeling [GO:0006338]; fibroblast apoptotic process [GO:0044346]; negative regulation of fibroblast apoptotic process [GO:2000270]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]","GO:0000776; GO:0000812; GO:0005634; GO:0006338; GO:0007155; GO:0008360; GO:0042127; GO:0044346; GO:2000270"
"413",435,158321,"Cluster_4115","Peve_00028965",-0.276496434204161,0.821653202925401,0.995934364227446,155,-21.73,"2 21","240 263",21,"61.90%","80.95%","Q8BUZ1","Actin-binding Rho-activating protein (Striated muscle activator of Rho-dependent signaling) (STARS)","Mus musculus (Mouse)","positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; transcription by RNA polymerase II [GO:0006366]","GO:0003779; GO:0005886; GO:0006366; GO:0006606; GO:0015629; GO:0030016; GO:0030017; GO:0035025; GO:0045893; GO:0045944; GO:0051091"
"414",436,158466,"Cluster_7053","Peve_00014420",-0.621950772537182,0.572680771317188,0.978262075707395,155,-20.8,"2 21","443 466",21,"66.67%","76.19%",NA,NA,NA,NA,NA
"415",437,158683,"Cluster_4735","Peve_00014425",0.985061907228156,0.110175444479324,0.978262075707395,166,-22.51,"2 16","107 129",15,"93.33%","93.33%","P82251","b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)","Homo sapiens (Human)","L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804]; protein-containing complex assembly [GO:0065003]","GO:0005886; GO:0015175; GO:0015179; GO:0015184; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0065003"
"416",438,158794,"Cluster_10934","Peve_00014427",-0.505304931497466,0.662760039039531,0.978262075707395,161,-20.53,"2 21","728 747",19,"73.68%","84.21%","O14662","Syntaxin-16 (Syn16)","Homo sapiens (Human)","endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]","GO:0000139; GO:0000149; GO:0005484; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005925; GO:0006886; GO:0006906; GO:0012505; GO:0016020; GO:0019905; GO:0030672; GO:0031201; GO:0031985; GO:0032456; GO:0032588; GO:0042147; GO:0043231; GO:0048278; GO:0048471"
"417",439,159150,"Cluster_9149","Peve_00008601",-0.973190156200706,0.147746549765807,0.978262075707395,155,-20.28,"2 12","827 848",10,"100.00%","100.00%","Q9DBX7","Hairy/enhancer-of-split related with YRPW motif-like protein (Hairy and enhancer of split-related protein 3) (Hairy-related transcription factor 3) (HRT-3) (mHRT3)","Mus musculus (Mouse)","anterior/posterior pattern specification [GO:0009952]; atrioventricular valve morphogenesis [GO:0003181]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac ventricle morphogenesis [GO:0003208]; cellular response to BMP stimulus [GO:0071773]; endocardial cushion morphogenesis [GO:0003203]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; glomerulus development [GO:0032835]; mesenchymal cell development [GO:0014031]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; outflow tract morphogenesis [GO:0003151]; peripheral nervous system development [GO:0007422]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; ventricular septum morphogenesis [GO:0060412]","GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003151; GO:0003181; GO:0003184; GO:0003198; GO:0003203; GO:0003208; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0007219; GO:0007422; GO:0009952; GO:0010629; GO:0014031; GO:0032835; GO:0035914; GO:0042803; GO:0043433; GO:0043565; GO:0045666; GO:0045892; GO:0045944; GO:0050683; GO:0050767; GO:0060317; GO:0060412; GO:0060766; GO:0071773; GO:0072014"
"418",440,159609,"Cluster_13502","Peve_00005704",-0.744769070545988,0.465119248087666,0.978262075707395,163,-21.31,"2 21","769 791",20,"75.00%","80.00%",NA,NA,NA,NA,NA
"419",441,160254,"Cluster_4079","Peve_00021956",0.922028042287347,0.253062309744281,0.978262075707395,143,-21.38,"2 12","315 336",10,"80.00%","90.00%",NA,NA,NA,NA,NA
"420",443,161286,"Cluster_2787","Peve_00042505",0.0179258320858805,0.988587449592816,0.999448381576871,165,-21.72,"2 18","226 247",16,"81.25%","87.50%",NA,NA,NA,NA,NA
"421",444,161465,"Cluster_1167","Peve_00037461",0.900485371011728,0.286422882083332,0.978262075707395,155,-20.08,"2 21","12 35",21,"66.67%","76.19%","Q54AX5","Leucine-rich repeat protein lrrA","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; culmination involved in sorocarp development [GO:0031154]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin filament polymerization [GO:0030833]","GO:0005737; GO:0007163; GO:0030833; GO:0031152; GO:0031154; GO:0031589; GO:0043326; GO:0043327; GO:0045335; GO:0098609"
"422",445,161681,"Cluster_14999","Peve_00027441",0.58425771984131,0.602771459827883,0.978262075707395,155,-20.65,"2 21","824 847",21,"61.90%","80.95%","P97259","Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)]","Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)","negative regulation of protein tyrosine phosphatase activity [GO:1903614]; positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0000139; GO:0004864; GO:0005576; GO:0018279; GO:0030144; GO:0030145; GO:0030335; GO:1903614; GO:1904894"
"423",447,162366,"Cluster_2787","Peve_00036737",0.909829540540062,0.272424378714125,0.978262075707395,158,-24.2,"2 16","453 476",16,"81.25%","87.50%","Q3T906","N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta]","Homo sapiens (Human)","carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299]","GO:0000139; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016256; GO:0033299; GO:0046835; GO:0070622"
"424",449,163964,"Cluster_8988","Peve_00044002",-0.893157854362088,0.296969070494349,0.978262075707395,165,-20.66,"2 21","161 186",23,"78.26%","82.61%",NA,NA,NA,NA,NA
"425",450,164055,"Cluster_9149","Peve_00044000",-0.61657144216645,0.577042299779249,0.978262075707395,155,-20.87,"2 21","472 494",20,"70.00%","75.00%","Q28199","Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)]","Bos taurus (Bovine)","axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; brain development [GO:0007420]; cerebellum development [GO:0021549]; embryo development ending in birth or egg hatching [GO:0009792]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G1 to G0 transition involved in cell differentiation [GO:0070315]; hippocampus development [GO:0021766]; ionotropic glutamate receptor signaling pathway [GO:0035235]; layer formation in cerebral cortex [GO:0021819]; negative regulation of DNA-templated transcription [GO:0045892]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of dendritic spine morphogenesis [GO:0061001]; rhythmic process [GO:0048511]; serine phosphorylation of STAT protein [GO:0042501]; superior olivary nucleus maturation [GO:0021722]","GO:0000307; GO:0001764; GO:0002020; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0007158; GO:0007213; GO:0007411; GO:0007413; GO:0007420; GO:0009792; GO:0014069; GO:0016020; GO:0016301; GO:0016533; GO:0018107; GO:0019901; GO:0021549; GO:0021722; GO:0021766; GO:0021819; GO:0030182; GO:0030424; GO:0030425; GO:0030426; GO:0031116; GO:0031175; GO:0031594; GO:0032956; GO:0035235; GO:0035255; GO:0042501; GO:0043005; GO:0043014; GO:0043025; GO:0043197; GO:0043204; GO:0043292; GO:0043525; GO:0043539; GO:0045296; GO:0045860; GO:0045892; GO:0048013; GO:0048471; GO:0048487; GO:0048511; GO:0051015; GO:0061001; GO:0061575; GO:0070315; GO:0090314"
"426",451,164582,"Cluster_6904","Peve_00021238",-0.896436608976839,0.292293799174125,0.978262075707395,147,-20.12,"2 17","313 337",18,"72.22%","72.22%",NA,NA,NA,NA,NA
"427",452,164715,"Cluster_5882","Peve_00012303",0.755129932876849,0.455147507633413,0.978262075707395,162,-21.13,"2 21","492 512",19,"73.68%","84.21%","Q804R0","Transcription factor LBX2 (Ladybird homeobox 2) (Ladybird homeobox protein homolog 2)","Danio rerio (Zebrafish) (Brachydanio rerio)","embryonic axis specification [GO:0000578]; muscle cell development [GO:0055001]; muscle cell differentiation [GO:0042692]; positive regulation of convergent extension involved in gastrulation [GO:1904105]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; posterior lateral line neuromast deposition [GO:0048922]; posterior lateral line neuromast primordium migration [GO:0048920]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000578; GO:0000981; GO:0005634; GO:0006357; GO:0042692; GO:0048920; GO:0048922; GO:0055001; GO:0060828; GO:1904105; GO:1990837; GO:2000052"
"428",453,165355,"Cluster_8634","Peve_00014384",-0.224693088757062,0.855724096218234,0.995934364227446,167,-20.72,"2 21","667 690",21,"76.19%","80.95%",NA,NA,NA,NA,NA
"429",454,165591,"Cluster_11134","Peve_00036451",-0.157169847642547,0.899525977237958,0.999448381576871,175,-25.17,"2 20","69 90",18,"77.78%","94.44%","Q6ING9","Protein phosphatase 1K, mitochondrial (EC 3.1.3.16) (Protein phosphatase 2C isoform kappa) (PP2C-kappa)","Xenopus laevis (African clawed frog)","protein dephosphorylation [GO:0006470]","GO:0005759; GO:0006470; GO:0017018; GO:0046872"
"430",455,165956,"Cluster_14999","Peve_00014227",0.644542931508658,0.55409539232916,0.978262075707395,163,-22.35,"2 21","339 361",20,"75.00%","80.00%","Q08BH7","Ubiquitin-conjugating enzyme E2 T (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme T) (Ubiquitin carrier protein T) (Ubiquitin-protein ligase T)","Danio rerio (Zebrafish) (Brachydanio rerio)","cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]","GO:0000209; GO:0003682; GO:0004842; GO:0005524; GO:0005634; GO:0006281; GO:0006513; GO:0006974; GO:0051865; GO:0061631"
"431",456,165978,"Cluster_6905","Peve_00014224",-0.949507609679209,0.203166744702445,0.978262075707395,154,-21.89,"2 21","551 569",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"432",457,166461,"Cluster_2787","Peve_00014229",-0.00382968334855694,0.997561941898757,0.999448381576871,154,-21.98,"2 21","142 162",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"433",458,166461,"Cluster_2787","Peve_00014229",-0.00382968334855694,0.997561941898757,0.999448381576871,161,-20.26,"2 19","520 542",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"434",459,166512,"Cluster_4629","Peve_00043144",-0.443383362280846,0.707556077121805,0.978262075707395,150,-20.71,"2 21","166 186",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"435",460,166780,"Cluster_4080","Peve_00039712",-0.870091104200335,0.32811968755459,0.978262075707395,152,-21.74,"2 20","239 265",23,"69.57%","78.26%","Q64077","Substance-K receptor (SKR) (NK-2 receptor) (NK-2R) (Neurokinin A receptor) (Tachykinin receptor 2)","Cavia porcellus (Guinea pig)","positive regulation of flagellated sperm motility [GO:1902093]; regulation of uterine smooth muscle contraction [GO:0070472]","GO:0004995; GO:0005886; GO:0061827; GO:0070472; GO:0097225; GO:1902093"
"436",461,167773,"Cluster_4735","Peve_00010212",-0.499055763751742,0.667360561442895,0.978262075707395,165,-24.79,"2 19","206 228",18,"83.33%","83.33%",NA,NA,NA,NA,NA
"437",462,168111,"Cluster_11134","Peve_00035711",-0.988789231360038,0.0954155995448231,0.978262075707395,162,-23.92,"2 19","273 294",17,"70.59%","88.24%",NA,NA,NA,NA,NA
"438",463,168342,"Cluster_15726","Peve_00014406",0.924253156919689,0.249377716179978,0.978262075707395,155,-20.02,"2 21","55 77",20,"65.00%","80.00%","Q08DY8","Autophagy-related protein 13","Bos taurus (Bovine)","autophagosome assembly [GO:0000045]; mitophagy [GO:0000423]; negative regulation of cell population proliferation [GO:0008285]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; protein localization to phagophore assembly site [GO:0034497]; regulation of protein lipidation [GO:1903059]; response to mitochondrial depolarisation [GO:0098780]","GO:0000045; GO:0000407; GO:0000423; GO:0005739; GO:0005829; GO:0008285; GO:0010508; GO:0019898; GO:0019901; GO:0034497; GO:0034727; GO:0046777; GO:0098780; GO:1903059; GO:1990316"
"439",464,169062,"Cluster_15726","Peve_00034047",0.314703011339256,0.796190157822943,0.995934364227446,147,-20.67,"2 21","75 98",21,"61.90%","71.43%",NA,NA,NA,NA,NA
"440",465,169653,"Cluster_796","Peve_00001915",0.354335153593591,0.769414411235009,0.990821801628857,162,-22.16,"2 16","906 929",16,"87.50%","87.50%",NA,NA,NA,NA,NA
"441",466,171035,"Cluster_10965","Peve_00002752",-0.0485212361139245,0.969098288242082,0.999448381576871,141,-21.67,"2 10","590 611",8,"87.50%","100.00%",NA,NA,NA,NA,NA
"442",467,171036,"Cluster_11134","Peve_00002752",-0.875851065879396,0.320601560473846,0.978262075707395,150,-21.01,"2 19","230 251",17,"58.82%","82.35%",NA,NA,NA,NA,NA
"443",468,171280,"Cluster_4080","Peve_00022011",-0.540283081291783,0.636634316726067,0.978262075707395,170,-25.71,"2 21","411 434",21,"80.95%","85.71%","P51950","CDK-activating kinase assembly factor MAT1 (CDK7/cyclin-H assembly factor) (Menage a trois) (RING finger protein MAT1)","Marthasterias glacialis (Spiny starfish)","cell cycle [GO:0007049]; cell division [GO:0051301]; nucleotide-excision repair [GO:0006289]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]","GO:0005675; GO:0006289; GO:0007049; GO:0045737; GO:0046872; GO:0051301; GO:0061575"
"444",469,171541,"Cluster_29","Peve_00029045",-0.93286348226991,0.234603642154651,0.978262075707395,163,-20.8,"2 20","144 165",18,"72.22%","83.33%","Q9BRP7","Ferredoxin-fold anticodon-binding domain-containing protein 1 (FDX-ACDB domain-containing protein 1)","Homo sapiens (Human)","rRNA base methylation [GO:0070475]","GO:0005737; GO:0070042; GO:0070475"
"445",470,171821,"Cluster_4115","Peve_00008184",-0.985281640847842,0.10936010972481,0.978262075707395,159,-20.54,"2 21","115 140",23,"69.57%","73.91%",NA,NA,NA,NA,NA
"446",471,171849,"Cluster_13502","Peve_00008184",-0.844710606811768,0.359545077346091,0.978262075707395,171,-23.04,"2 20","414 435",18,"83.33%","83.33%",NA,NA,NA,NA,NA
"447",472,171908,"Cluster_2882","Peve_00032051",0.87101379302054,0.326925962861595,0.978262075707395,169,-20.26,"2 20","357 377",18,"83.33%","88.89%","P78357","Contactin-associated protein 1 (Caspr) (Caspr1) (Neurexin IV) (Neurexin-4) (p190)","Homo sapiens (Human)","axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128]; signal transduction [GO:0007165]","GO:0002175; GO:0005886; GO:0007005; GO:0007010; GO:0007155; GO:0007165; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030913; GO:0033010; GO:0033270; GO:0038023; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227"
"448",473,172065,"Cluster_9149","Peve_00016542",-0.363412950258213,0.763222827304879,0.989154649827488,152,-27.19,"2 18","71 96",20,"70.00%","75.00%","Q5NC57","Protein FAM183B","Mus musculus (Mouse)","","GO:0005737; GO:0005813; GO:0036064; GO:0097546"
"449",474,172657,"Cluster_11135","Peve_00037665",0.434811364954932,0.713630096150132,0.979773261584403,158,-20.49,"2 16","556 578",15,"86.67%","86.67%","Q5ZIN1","Nuclear migration protein nudC (Nuclear distribution protein C homolog)","Gallus gallus (Chicken)","cell division [GO:0051301]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; protein folding [GO:0006457]","GO:0005737; GO:0005874; GO:0006457; GO:0007052; GO:0007080; GO:0030496; GO:0051082; GO:0051301; GO:0072686"
"450",475,172686,"Cluster_7053","Peve_00037664",0.497057324115112,0.668827729448061,0.978262075707395,168,-21.15,"2 18","861 883",17,"82.35%","94.12%","Q29RT6","Kinesin-like protein KIF20A","Bos taurus (Bovine)","microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]","GO:0000281; GO:0001578; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0015031; GO:0016887; GO:0019901; GO:0030496; GO:0032465; GO:0045171; GO:0061952"
"451",476,172848,"Cluster_796","Peve_00009854",0.489221491740848,0.674561940864999,0.978262075707395,164,-23.87,"2 21","255 276",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"452",478,173601,"Cluster_11134","Peve_00031625",-0.00752736399425632,0.995207885992227,0.999448381576871,154,-24.96,"2 21","1 21",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"453",479,173718,"Cluster_6905","Peve_00000669",-0.951572720105216,0.198933797022793,0.978262075707395,156,-20.87,"2 19","836 856",17,"70.59%","88.24%",NA,NA,NA,NA,NA
"454",480,173782,"Cluster_11135","Peve_00000668",-0.591557076268158,0.597026876850873,0.978262075707395,167,-22.36,"2 21","748 772",22,"72.73%","81.82%",NA,NA,NA,NA,NA
"455",481,173961,"Cluster_11134","Peve_00003401",-0.749491006644616,0.460596594054162,0.978262075707395,145,-20.48,"2 19","298 320",18,"66.67%","72.22%",NA,NA,NA,NA,NA
"456",482,174065,"Cluster_1167","Peve_00003404",0.996049274810809,0.0566078442972818,0.978262075707395,142,-21.64,"2 11","82 103",9,"88.89%","88.89%","Q5XI68","Protein Dr1 (Down-regulator of transcription 1) (Negative cofactor 2-beta) (NC2-beta) (TATA-binding protein-associated phosphoprotein)","Rattus norvegicus (Rat)","chromatin remodeling [GO:0006338]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tubulin deacetylation [GO:0090043]; RNA polymerase II preinitiation complex assembly [GO:0051123]","GO:0000122; GO:0001046; GO:0005634; GO:0006338; GO:0006355; GO:0006357; GO:0016251; GO:0017025; GO:0017054; GO:0031063; GO:0043966; GO:0044154; GO:0045944; GO:0045995; GO:0046982; GO:0051123; GO:0051302; GO:0051726; GO:0090043; GO:0090575; GO:0140672"
"457",483,174605,"Cluster_1167","Peve_00023767",0.999909726776791,0.00855416971793389,0.573710369894872,158,-20.46,"2 21","87 107",19,"73.68%","78.95%","Q566X8","Diencephalon/mesencephalon homeobox protein 1-B","Danio rerio (Zebrafish) (Brachydanio rerio)","midbrain development [GO:0030901]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007346; GO:0030901; GO:0050767; GO:0051726; GO:0060041; GO:0061074"
"458",484,174690,"Cluster_16738","Peve_00004757",-0.244501648087998,0.842751282205398,0.995934364227446,173,-23.2,"2 18","33 54",16,"87.50%","93.75%","Q5THR3","EF-hand calcium-binding domain-containing protein 6 (CAP-binding protein complex-interacting protein 1) (DJ-1-binding protein) (DJBP)","Homo sapiens (Human)","","GO:0005509; GO:0005654; GO:0005737; GO:0005856; GO:0042995"
"459",485,174737,"Cluster_589","Peve_00009586",0.737485233007415,0.472026285304988,0.978262075707395,151,-20.84,"2 16","278 299",14,"78.57%","78.57%","P24507","Synaptotagmin-C (Synaptic vesicle protein O-p65-C)","Diplobatis ommata (Ocellated electric ray) (Discopyge ommata)","","GO:0030672; GO:0046872"
"460",486,175204,"Cluster_6906","Peve_00028885",-0.655129675249954,0.545227962778282,0.978262075707395,155,-20.22,"2 19","3 24",18,"77.78%","83.33%","Q3V0J4","Ankyrin repeat domain-containing protein 53","Mus musculus (Mouse)","cell division [GO:0051301]; mitotic metaphase plate congression [GO:0007080]; positive regulation of microtubule polymerization [GO:0031116]; regulation of mitotic cytokinesis [GO:1902412]; regulation of mitotic spindle organization [GO:0060236]","GO:0000922; GO:0005737; GO:0005819; GO:0007080; GO:0031116; GO:0051301; GO:0060236; GO:1902412"
"461",487,175238,"Cluster_2882","Peve_00028884",-0.898389711968954,0.289475524970988,0.978262075707395,173,-23.49,"2 21","476 497",20,"85.00%","90.00%","Q91287","Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (PFR3)","Pleurodeles waltl (Iberian ribbed newt)","apoptotic process [GO:0006915]; positive regulation of cell population proliferation [GO:0008284]","GO:0005007; GO:0005524; GO:0005886; GO:0006915; GO:0008284"
"462",489,176237,"Cluster_6904","Peve_00009321",0.00212543143673658,0.998646907303804,0.999727833677456,153,-20.41,"2 21","340 359",19,"73.68%","73.68%","Q5U4I3","Cyclin-D1-binding protein 1 homolog","Xenopus laevis (African clawed frog)","cell cycle [GO:0007049]; regulation of cell cycle [GO:0051726]","GO:0005634; GO:0005737; GO:0007049; GO:0051726"
"463",490,176237,"Cluster_6904","Peve_00009321",0.00212543143673658,0.998646907303804,0.999727833677456,153,-20.41,"2 21","518 537",19,"73.68%","73.68%","Q5U4I3","Cyclin-D1-binding protein 1 homolog","Xenopus laevis (African clawed frog)","cell cycle [GO:0007049]; regulation of cell cycle [GO:0051726]","GO:0005634; GO:0005737; GO:0007049; GO:0051726"
"464",491,176700,"Cluster_9149","Peve_00031085",-0.5,0.666666666666667,0.978262075707395,153,-20.45,"2 15","468 492",16,"81.25%","81.25%",NA,NA,NA,NA,NA
"465",492,177440,"Cluster_1167","Peve_00025352",0.917746673015248,0.260012747666916,0.978262075707395,143,-21.78,"2 13","397 419",12,"83.33%","83.33%","P05772","Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13)","Oryctolagus cuniculus (Rabbit)","adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; chromatin organization [GO:0006325]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of glucose transmembrane transport [GO:0010827]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0002250; GO:0003682; GO:0004697; GO:0004698; GO:0005524; GO:0005634; GO:0005829; GO:0006325; GO:0006357; GO:0006468; GO:0006915; GO:0008270; GO:0010827; GO:0010829; GO:0016020; GO:0030374; GO:0030949; GO:0035403; GO:0042113; GO:0042393; GO:0043123; GO:0043687; GO:0045766; GO:0046627; GO:0050681; GO:0050853; GO:0050861; GO:0051092; GO:0106310"
"466",493,177900,"Cluster_5882","Peve_00038960",0.983185609942324,0.116908502458861,0.978262075707395,155,-21.85,"2 19","609 630",18,"72.22%","88.89%",NA,NA,NA,NA,NA
"467",494,178302,"Cluster_4629","Peve_00000060",-0.541303346792838,0.635862139378246,0.978262075707395,158,-20.86,"2 19","393 414",17,"76.47%","76.47%","P16066","Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A)","Homo sapiens (Human)","blood vessel diameter maintenance [GO:0097746]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]","GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0006468; GO:0007165; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016525; GO:0016941; GO:0017046; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620"
"468",495,178686,"Cluster_11134","Peve_00030028",-0.999412779421733,0.0218181040468405,0.829411399113453,170,-26.78,"2 20","224 247",20,"75.00%","90.00%",NA,NA,NA,NA,NA
"469",496,178875,"Cluster_16738","Peve_00005932",-0.318002558543939,0.793975877564523,0.995934364227446,161,-23.09,"2 18","225 246",16,"81.25%","81.25%",NA,NA,NA,NA,NA
"470",497,179017,"Cluster_2854","Peve_00005936",-0.651661040408246,0.548144949079857,0.978262075707395,153,-21.17,"2 14","881 902",12,"83.33%","91.67%","Q6NTV6","Inverted formin-2","Xenopus laevis (African clawed frog)","actin cytoskeleton organization [GO:0030036]","GO:0003779; GO:0030036; GO:0031267"
"471",498,179073,"Cluster_6905","Peve_00005937",-0.954850710960378,0.192029646363598,0.978262075707395,151,-21.22,"2 21","630 648",19,"73.68%","78.95%","Q9Y253","DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein)","Homo sapiens (Human)","cellular response to UV-C [GO:0071494]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; pyrimidine dimer repair [GO:0006290]; regulation of DNA repair [GO:0006282]; response to radiation [GO:0009314]; response to UV-C [GO:0010225]","GO:0000731; GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0005657; GO:0005829; GO:0006260; GO:0006281; GO:0006282; GO:0006290; GO:0009314; GO:0010225; GO:0035861; GO:0042276; GO:0046872; GO:0070987; GO:0071494"
"472",499,179543,"Cluster_11997","Peve_00021031",-0.924104436380456,0.249625591379397,0.978262075707395,155,-20.14,"2 17","836 858",16,"81.25%","81.25%","Q9VQ37","Mitochondrial carrier protein Rim2","Drosophila melanogaster (Fruit fly)","cellular respiration [GO:0045333]; deoxynucleotide transport [GO:0030302]; locomotion [GO:0040011]; mitochondrial genome maintenance [GO:0000002]; mitochondrial transcription [GO:0006390]; mitochondrial transport [GO:0006839]; mitochondrion distribution [GO:0048311]; mitochondrion organization [GO:0007005]; pyrimidine nucleotide import into mitochondrion [GO:1990519]","GO:0000002; GO:0005739; GO:0005743; GO:0006390; GO:0006839; GO:0007005; GO:0015218; GO:0030302; GO:0040011; GO:0045333; GO:0048311; GO:1990519"
"473",500,180190,"Cluster_4080","Peve_00008849",-0.943755105052351,0.214532734184959,0.978262075707395,149,-20.93,"2 14","964 985",12,"75.00%","91.67%",NA,NA,NA,NA,NA
"474",501,180332,"Cluster_6904","Peve_00008842",-0.727716998069901,0.481162868437926,0.978262075707395,158,-22.82,"2 15","752 773",13,"76.92%","100.00%","Q9NZJ4","Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)","Homo sapiens (Human)","negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]","GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0042802; GO:0051087; GO:0070628; GO:0070852; GO:0090084"
"475",502,180334,"Cluster_6906","Peve_00008842",-0.30847561839557,0.800362353654833,0.995934364227446,158,-23.8,"2 15","752 773",13,"76.92%","100.00%","Q9NZJ4","Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)","Homo sapiens (Human)","negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]","GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0042802; GO:0051087; GO:0070628; GO:0070852; GO:0090084"
"476",503,180457,"Cluster_2854","Peve_00008846",-0.681918037188022,0.522292137109911,0.978262075707395,166,-26.08,"2 15","325 346",13,"92.31%","100.00%",NA,NA,NA,NA,NA
"477",504,180489,"Cluster_13502","Peve_00008846",-0.237520920015206,0.847330343198889,0.995934364227446,200,-40.02,"2 21","428 449",19,"100.00%","100.00%",NA,NA,NA,NA,NA
"478",505,180718,"Cluster_15890","Peve_00015742",-0.998127395584257,0.0389660099841794,0.909359886114279,157,-20.18,"2 21","849 868",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"479",506,181397,"Cluster_589","Peve_00026925",0.773481186499632,0.437027400970582,0.978262075707395,155,-23.41,"2 12","9 30",10,"100.00%","100.00%","P9WET8","Highly reducing polyketide synthase Preu1 (EC 2.3.1.-) (biosynthesis protein Preu1)","Preussia isomera (Coprophilous fungus) (Honoratia pisana)","fatty acid biosynthetic process [GO:0006633]","GO:0004315; GO:0006633; GO:0016491; GO:0031177"
"480",507,182662,"Cluster_2854","Peve_00010059",0.205076809327103,0.868511161895816,0.997179203169283,152,-21.83,"2 21","127 149",22,"68.18%","77.27%",NA,NA,NA,NA,NA
"481",508,182707,"Cluster_2854","Peve_00010058",-0.993900133965522,0.0703519724445302,0.978262075707395,152,-21.83,"2 21","375 397",22,"68.18%","77.27%",NA,NA,NA,NA,NA
"482",509,182810,"Cluster_6914","Peve_00010050",0.55187256304696,0.627826958898477,0.978262075707395,182,-23.7,"2 19","901 921",17,"94.12%","94.12%","P35869","Aryl hydrocarbon receptor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76)","Homo sapiens (Human)","apoptotic process [GO:0006915]; blood vessel development [GO:0001568]; cAMP-mediated signaling [GO:0019933]; cell cycle [GO:0007049]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; circadian regulation of gene expression [GO:0032922]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adaptive immune response [GO:0002819]; regulation of B cell proliferation [GO:0030888]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; xenobiotic metabolic process [GO:0006805]","GO:0000785; GO:0000976; GO:0000981; GO:0000987; GO:0001094; GO:0001223; GO:0001568; GO:0002819; GO:0002841; GO:0003677; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006805; GO:0006915; GO:0007049; GO:0009410; GO:0009636; GO:0010468; GO:0017025; GO:0019933; GO:0030888; GO:0032922; GO:0032991; GO:0034751; GO:0034752; GO:0034753; GO:0042803; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0051879; GO:0060090; GO:0061629; GO:0070888; GO:0071320; GO:1904322; GO:1904613; GO:1990837"
"483",510,182883,"Cluster_796","Peve_00010052",0.898740270652305,0.288966974174018,0.978262075707395,146,-22.09,"2 20","354 377",20,"65.00%","70.00%","Q3KQG9","Testicular acid phosphatase homolog (EC 3.1.3.2) (Acid phosphatase 4)","Xenopus laevis (African clawed frog)","","GO:0003993; GO:0016020"
"484",511,183161,"Cluster_4115","Peve_00017588",-0.905802416571817,0.278538079606378,0.978262075707395,169,-21.45,"2 20","916 936",18,"83.33%","88.89%","O95263","High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B (HsPDE8B) (EC 3.1.4.53) (Cell proliferation-inducing gene 22 protein)","Homo sapiens (Human)","behavioral fear response [GO:0001662]; cAMP catabolic process [GO:0006198]; negative regulation of steroid hormone biosynthetic process [GO:0090032]; neuromuscular process controlling balance [GO:0050885]; operant conditioning [GO:0035106]; signal transduction [GO:0007165]; visual learning [GO:0008542]","GO:0001662; GO:0004114; GO:0004115; GO:0005829; GO:0006198; GO:0007165; GO:0008542; GO:0035106; GO:0046872; GO:0050885; GO:0090032"
"485",512,183295,"Cluster_4080","Peve_00017587",-0.211126129279827,0.864573839387559,0.996660710141104,167,-20.04,"2 20","770 791",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"486",514,183430,"Cluster_4080","Peve_00017580",-0.999998957645573,0.000919184867929113,0.240277133272295,167,-21.45,"2 20","777 798",18,"77.78%","83.33%","Q864U6","UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1 (Beta-1,3-GalNAc-T1) (EC 2.4.1.79) (Beta-1,3-galactosyltransferase 3) (Beta-1,3-GalTase 3) (Beta3Gal-T3) (Beta3GalT3) (b3Gal-T3) (Beta-3-Gx-T3) (Galactosylgalactosylglucosylceramide beta-D-acetyl-galactosaminyltransferase) (Globoside synthase) (UDP-N-acetylgalactosamine:globotriaosylceramide beta-1,3-N-acetylgalactosaminyltransferase)","Sus scrofa (Pig)","lipid metabolic process [GO:0006629]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]","GO:0000139; GO:0006486; GO:0006629; GO:0008194; GO:0008499; GO:0009312; GO:0016757; GO:0047273"
"487",515,183527,"Cluster_6904","Peve_00002286",-0.883896007150852,0.309822574957935,0.978262075707395,155,-20.16,"2 18","64 84",16,"81.25%","81.25%","Q1ED21","Nuclear receptor 2C2-associated protein (TR4 orphan receptor-associated 16 kDa protein homolog)","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0005634"
"488",516,183549,"Cluster_13502","Peve_00002286",-0.280769909766167,0.818820436743166,0.995934364227446,173,-25.94,"2 20","742 762",18,"83.33%","94.44%","Q1ED21","Nuclear receptor 2C2-associated protein (TR4 orphan receptor-associated 16 kDa protein homolog)","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0005634"
"489",518,184596,"Cluster_2787","Peve_00044631",-0.92612000066493,0.246246088186204,0.978262075707395,156,-20.94,"2 15","599 619",13,"92.31%","92.31%",NA,NA,NA,NA,NA
"490",520,186167,"Cluster_589","Peve_00045277",0.159680919674548,0.897906931664995,0.999448381576871,158,-28.03,"2 20","907 931",21,"66.67%","80.95%","Q4KLQ5","WD repeat-containing protein 76","Xenopus laevis (African clawed frog)","",""
"491",521,186735,"Cluster_9149","Peve_00004515",-0.993893593246917,0.0703897190342674,0.978262075707395,151,-20.86,"2 14","267 287",12,"91.67%","91.67%","Q9WVM7","Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 (Multisynthase complex auxiliary component p38) (Protein JTV-1)","Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)","apoptotic process [GO:0006915]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of aminoacyl-tRNA ligase activity [GO:1903632]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; translation [GO:0006412]; type II pneumocyte differentiation [GO:0060510]","GO:0005634; GO:0005829; GO:0006412; GO:0006915; GO:0008285; GO:0016567; GO:0017101; GO:0031398; GO:0060090; GO:0060510; GO:0065003; GO:1903632"
"492",522,187209,"Cluster_4079","Peve_00010874",-0.223531000474412,0.856483214034593,0.995934364227446,171,-24.34,"2 20","203 224",18,"83.33%","83.33%",NA,NA,NA,NA,NA
"493",523,188748,"Cluster_6905","Peve_00015965",-0.849983478999773,0.35322363873719,0.978262075707395,153,-20.34,"2 18","38 59",16,"68.75%","81.25%","Q9VQX4","Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)","Drosophila melanogaster (Fruit fly)","NAD salvage [GO:0034355]; response to oxidative stress [GO:0006979]","GO:0004516; GO:0005829; GO:0006979; GO:0016740; GO:0034355; GO:0046872"
"494",524,188861,"Cluster_14999","Peve_00015969",-0.988106397150221,0.0982840903644307,0.978262075707395,158,-21.25,"2 21","740 765",23,"73.91%","73.91%","Q8R151","NFX1-type zinc finger-containing protein 1","Mus musculus (Mouse)","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; RNA-mediated heterochromatin formation [GO:0031048]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607"
"495",525,189411,"Cluster_2787","Peve_00043267",0.876552691186865,0.319674754175256,0.978262075707395,159,-21.83,"2 21","110 132",20,"70.00%","80.00%","Q9BY12","S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291)","Homo sapiens (Human)","antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283]","GO:0001547; GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0007283; GO:0008270; GO:0016607; GO:0060041; GO:0061827; GO:0072520; GO:1990917"
"496",528,189822,"Cluster_4629","Peve_00003882",0.775516767147371,0.434978800201566,0.978262075707395,160,-28.14,"2 20","499 521",20,"75.00%","85.00%","Q7SIC1","Fucolectin","Anguilla anguilla (European freshwater eel) (Muraena anguilla)","regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]","GO:0001868; GO:0005509; GO:0005576; GO:0010185; GO:0030246; GO:0042806; GO:0045088"
"497",529,190097,"Cluster_6904","Peve_00035696",0.662350466795544,0.539117999293687,0.978262075707395,164,-24.05,"2 21","459 480",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"498",530,190099,"Cluster_6906","Peve_00035696",0.940924118951479,0.21991851407678,0.978262075707395,160,-22.73,"2 21","459 480",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"499",531,190522,"Cluster_11135","Peve_00033937",0.101351438566922,0.93536669303887,0.999448381576871,167,-23.99,"2 21","670 692",20,"70.00%","90.00%","Q9Y2P8","RNA 3'-terminal phosphate cyclase-like protein","Homo sapiens (Human)","endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]","GO:0000447; GO:0000479; GO:0000480; GO:0004521; GO:0005654; GO:0005730"
"500",532,190605,"Cluster_9149","Peve_00033931",-0.60151848752384,0.589125234560223,0.978262075707395,159,-24.51,"2 21","131 153",20,"70.00%","80.00%","B6MFW3","Protein Hook homolog","Branchiostoma floridae (Florida lancelet) (Amphioxus)","cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; protein transport [GO:0015031]","GO:0005737; GO:0005813; GO:0005874; GO:0008017; GO:0015031; GO:0030705; GO:0031122; GO:0051959"
"501",533,190614,"Cluster_13502","Peve_00033931",-0.32983410584475,0.78601436995135,0.994969309001385,173,-25.67,"2 18","833 854",16,"87.50%","93.75%","B6MFW3","Protein Hook homolog","Branchiostoma floridae (Florida lancelet) (Amphioxus)","cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; protein transport [GO:0015031]","GO:0005737; GO:0005813; GO:0005874; GO:0008017; GO:0015031; GO:0030705; GO:0031122; GO:0051959"
"502",534,190720,"Cluster_4080","Peve_00033939",0.399939192063094,0.738062476267042,0.986604359066427,161,-21.85,"2 19","645 671",22,"72.73%","77.27%","Q8WV37","Zinc finger protein 480","Homo sapiens (Human)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0046872"
"503",535,191526,"Cluster_2787","Peve_00040182",0.395091332491424,0.741425884933683,0.986697151420032,155,-20.05,"2 20","937 958",18,"66.67%","77.78%","O43683","Mitotic checkpoint serine/threonine-protein kinase BUB1 (hBUB1) (EC 2.7.11.1) (BUB1A)","Homo sapiens (Human)","apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein phosphorylation [GO:0006468]; regulation of chromosome segregation [GO:0051983]; regulation of sister chromatid cohesion [GO:0007063]","GO:0000776; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0006915; GO:0007063; GO:0007094; GO:0008283; GO:0016020; GO:0043231; GO:0051301; GO:0051754; GO:0051983; GO:0106310"
"504",536,191730,"Cluster_9149","Peve_00040187",-0.881136658060054,0.31355796409293,0.978262075707395,147,-20.04,"2 21","668 690",20,"60.00%","75.00%",NA,NA,NA,NA,NA
"505",537,191805,"Cluster_5882","Peve_00040185",-0.08346725948634,0.946801199142609,0.999448381576871,163,-28.51,"2 21","909 933",22,"68.18%","81.82%","B6NXD5","BRISC and BRCA1-A complex member 2 (BRCA1-A complex subunit BRE) (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein)","Branchiostoma floridae (Florida lancelet) (Amphioxus)","apoptotic process [GO:0006915]; cell division [GO:0051301]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of DNA repair [GO:0045739]; response to ionizing radiation [GO:0010212]","GO:0005634; GO:0005737; GO:0006302; GO:0006325; GO:0006915; GO:0007095; GO:0010212; GO:0031593; GO:0045739; GO:0051301; GO:0070531; GO:0070552"
"506",539,192232,"Cluster_11135","Peve_00033208",-0.234573012886353,0.849261614557932,0.995934364227446,167,-20.04,"2 16","935 956",14,"85.71%","100.00%",NA,NA,NA,NA,NA
"507",540,192786,"Cluster_2787","Peve_00042854",-0.00382968334855694,0.997561941898757,0.999448381576871,159,-20.32,"2 20","903 924",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"508",541,193108,"Cluster_4735","Peve_00016085",-0.239320789805155,0.846150485491126,0.995934364227446,159,-22.58,"2 21","91 113",20,"70.00%","80.00%","B3S3D5","DDRGK domain-containing protein 1","Trichoplax adhaerens (Trichoplax reptans)","",""
"509",542,194790,"Cluster_9149","Peve_00037587",-0.997642761939907,0.0437202051657,0.921378164792108,140,-21.11,"2 9","365 386",7,"100.00%","100.00%","Q29496","Cytochrome P450 3A24 (EC 1.14.14.1) (CYPIIIA24)","Ovis aries (Sheep)","","GO:0004497; GO:0005506; GO:0005789; GO:0020037; GO:0070330"
"510",543,194817,"Cluster_4629","Peve_00037588",-0.732663638067628,0.476553738807204,0.978262075707395,144,-22.42,"2 20","751 778",24,"66.67%","70.83%","Q0VFZ6","Cilia- and flagella- associated protein 210 (Coiled-coil domain-containing protein 173)","Homo sapiens (Human)","","GO:0005879"
"511",544,195939,"Cluster_4079","Peve_00000141",-0.125755588100116,0.919728976410948,0.999448381576871,168,-20.19,"2 21","947 968",19,"68.42%","89.47%",NA,NA,NA,NA,NA
"512",545,196153,"Cluster_15890","Peve_00018473",-0.857080053031532,0.344552272909308,0.978262075707395,162,-21.58,"2 21","149 169",19,"73.68%","84.21%","Q4LDE5","Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)","Homo sapiens (Human)","cell adhesion [GO:0007155]; epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193]","GO:0003017; GO:0003682; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0007155; GO:0008544; GO:0010467; GO:0016020; GO:0036303; GO:0048014; GO:0120193"
"513",546,197245,"Cluster_4080","Peve_00025147",-0.285143816017805,0.815917273885304,0.995934364227446,170,-27.33,"2 21","45 71",24,"79.17%","79.17%","Q5I2E5","Ficolin-2 (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (L-ficolin)","Bos taurus (Bovine)","complement activation, lectin pathway [GO:0001867]","GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0030246; GO:0046872; GO:0062023; GO:0097367"
"514",547,197670,"Cluster_9149","Peve_00036782",-0.860058832675139,0.340853452647755,0.978262075707395,159,-22.73,"2 16","620 641",14,"85.71%","85.71%","O73791","Tyrosine-protein kinase receptor Tie-2 (EC 2.7.10.1) (Tyrosine kinase with Ig and EGF homology domains-2)","Danio rerio (Zebrafish) (Brachydanio rerio)","angiogenesis [GO:0001525]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0001525; GO:0001935; GO:0004714; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0014068; GO:0033674; GO:0043235; GO:0043410; GO:0045766; GO:0051897"
"515",548,197732,"Cluster_589","Peve_00020519",-0.996533446665439,0.0530236478659279,0.967811959935699,159,-25.9,"2 21","947 969",20,"75.00%","75.00%","Q9WU70","Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1)","Rattus norvegicus (Rat)","exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of protein secretion [GO:0050708]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle priming [GO:0010807]; synaptic vesicle cycle [GO:0099504]","GO:0005096; GO:0005737; GO:0005886; GO:0005892; GO:0006887; GO:0008021; GO:0010807; GO:0015031; GO:0017075; GO:0017157; GO:0019905; GO:0030141; GO:0031201; GO:0031594; GO:0045159; GO:0045921; GO:0050708; GO:0098674; GO:0098685; GO:0098686; GO:0098793; GO:0098888; GO:0099504; GO:0099523; GO:2000300"
"516",550,198570,"Cluster_9149","Peve_00039377",-0.87107625268917,0.326845012530685,0.978262075707395,151,-23.48,"2 21","343 363",21,"71.43%","76.19%",NA,NA,NA,NA,NA
"517",551,198904,"Cluster_1140","Peve_00012766",-0.996587378500746,0.0526093294363309,0.965724438686164,182,-23.01,"2 21","559 579",19,"89.47%","94.74%","Q8K2J9","BTB/POZ domain-containing protein 6","Mus musculus (Mouse)","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"518",552,198937,"Cluster_11135","Peve_00012766",0.927487568429706,0.243927783333975,0.978262075707395,160,-24.15,"2 19","716 736",17,"76.47%","88.24%","Q8K2J9","BTB/POZ domain-containing protein 6","Mus musculus (Mouse)","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"519",553,199225,"Cluster_4080","Peve_00045215",-0.235777127616489,0.848472931070267,0.995934364227446,165,-21.38,"2 21","283 304",20,"80.00%","85.00%",NA,NA,NA,NA,NA
"520",554,199312,"Cluster_2854","Peve_00014673",-0.982894688513379,0.117918413311405,0.978262075707395,155,-21.08,"2 18","250 273",18,"77.78%","83.33%","Q28041","Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (ACTR-I) (Serine/threonine-protein kinase receptor R1) (SKR1)","Bos taurus (Bovine)","BMP signaling pathway [GO:0030509]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; germ cell development [GO:0007281]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; neural crest cell migration [GO:0001755]; protein phosphorylation [GO:0006468]; transforming growth factor beta receptor signaling pathway [GO:0007179]; urogenital system development [GO:0001655]","GO:0001655; GO:0001701; GO:0001755; GO:0004674; GO:0005025; GO:0005524; GO:0005886; GO:0006468; GO:0007179; GO:0007281; GO:0007368; GO:0007507; GO:0009953; GO:0016361; GO:0030509; GO:0043235; GO:0046332; GO:0046872; GO:0048179; GO:0050431; GO:0070724; GO:0071363"
"521",555,200267,"Cluster_6904","Peve_00027179",-0.39670001544008,0.740310645250357,0.986697151420032,157,-23.79,"2 19","181 206",21,"71.43%","76.19%","Q5R733","Cytoplasmic polyadenylation element-binding protein 1 (CPE-BP1) (CPE-binding protein 1) (CPEB-1)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; mRNA processing [GO:0006397]; negative regulation of cytoplasmic translation [GO:2000766]; positive regulation of mRNA polyadenylation [GO:1900365]","GO:0000900; GO:0000932; GO:0005634; GO:0005737; GO:0006397; GO:0014069; GO:0016020; GO:0030425; GO:0032869; GO:0035925; GO:0046872; GO:0071230; GO:0071456; GO:1900365; GO:1990904; GO:2000766"
"522",556,200269,"Cluster_6906","Peve_00027179",0.0933422152731944,0.940489869532737,0.999448381576871,153,-21.77,"2 19","181 206",21,"66.67%","76.19%","Q5R733","Cytoplasmic polyadenylation element-binding protein 1 (CPE-BP1) (CPE-binding protein 1) (CPEB-1)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; mRNA processing [GO:0006397]; negative regulation of cytoplasmic translation [GO:2000766]; positive regulation of mRNA polyadenylation [GO:1900365]","GO:0000900; GO:0000932; GO:0005634; GO:0005737; GO:0006397; GO:0014069; GO:0016020; GO:0030425; GO:0032869; GO:0035925; GO:0046872; GO:0071230; GO:0071456; GO:1900365; GO:1990904; GO:2000766"
"523",557,200431,"Cluster_29","Peve_00011282",-0.377488930510761,0.753575247618877,0.988219883885475,161,-20.67,"2 19","589 611",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"524",559,200710,"Cluster_4080","Peve_00017931",0.731133306670351,0.477983472526603,0.978262075707395,168,-20.02,"2 21","37 58",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"525",560,201339,"Cluster_4079","Peve_00034292",0.532902697908539,0.642202343983514,0.978262075707395,146,-23.22,"2 16","379 404",18,"66.67%","77.78%",NA,NA,NA,NA,NA
"526",561,201642,"Cluster_15726","Peve_00030254",-0.939271462975561,0.223004823606409,0.978262075707395,143,-20.34,"2 21","183 205",20,"65.00%","65.00%","Q9H845","Complex I assembly factor ACAD9, mitochondrial (Acyl-CoA dehydrogenase family member 9) (ACAD-9) (EC 1.3.8.-)","Homo sapiens (Human)","long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981]","GO:0000062; GO:0001676; GO:0003995; GO:0004466; GO:0005634; GO:0005739; GO:0005743; GO:0017099; GO:0030425; GO:0031966; GO:0032981; GO:0050660; GO:0051791; GO:0070991"
"527",562,202380,"Cluster_5882","Peve_00012716",0.471197805148018,0.687643591284266,0.978262075707395,167,-21.2,"2 21","855 877",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"528",564,203003,"Cluster_2882","Peve_00020259",-0.0557857733180246,0.964467227436643,0.999448381576871,154,-20.55,"2 20","454 476",19,"73.68%","73.68%","Q9JLI7","Sperm-associated antigen 6 (Axoneme central apparatus protein) (Protein PF16 homolog)","Mus musculus (Mouse)","cell division [GO:0051301]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; ear development [GO:0043583]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of localization in cell [GO:0051649]; fibroblast migration [GO:0010761]; filopodium assembly [GO:0046847]; flagellated sperm motility [GO:0030317]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; neuron projection extension [GO:1990138]; non-motile cilium assembly [GO:1905515]; protein localization [GO:0008104]; regulation of cilium beat frequency [GO:0003356]; regulation of establishment of planar polarity [GO:0090175]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]; stress fiber assembly [GO:0043149]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; ventricular system development [GO:0021591]","GO:0001669; GO:0002177; GO:0003341; GO:0003351; GO:0003356; GO:0005576; GO:0005829; GO:0005874; GO:0005930; GO:0006931; GO:0007283; GO:0007288; GO:0008017; GO:0008104; GO:0010761; GO:0015630; GO:0021591; GO:0030317; GO:0031410; GO:0043149; GO:0043583; GO:0044458; GO:0045198; GO:0046847; GO:0051301; GO:0051649; GO:0090175; GO:0090660; GO:0097228; GO:0120197; GO:0120249; GO:1905515; GO:1990138; GO:1990716"
"529",565,203046,"Cluster_2787","Peve_00044465",0.692918248596569,0.51264933565654,0.978262075707395,165,-22.98,"2 18","716 737",16,"81.25%","87.50%","P00727","Cytosol aminopeptidase (EC 3.4.11.1) (Cysteinylglycine-S-conjugate dipeptidase) (EC 3.4.13.23) (Leucine aminopeptidase 3) (LAP-3) (Leucyl aminopeptidase) (LAP) (Peptidase S) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)","Bos taurus (Bovine)","proteolysis [GO:0006508]","GO:0004180; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006508; GO:0008233; GO:0016805; GO:0030145; GO:0030496; GO:0070006; GO:0097718"
"530",566,203109,"Cluster_7855","Peve_00044464",0.692476942489646,0.513038871493037,0.978262075707395,166,-20.18,"2 20","419 441",19,"68.42%","94.74%",NA,NA,NA,NA,NA
"531",567,203282,"Cluster_6904","Peve_00044463",0.014857815218074,0.990540873011805,0.999448381576871,146,-22.31,"2 17","492 512",15,"73.33%","80.00%","Q3T0Z7","Dihydropteridine reductase (EC 1.5.1.34) (HDHPR) (Quinoid dihydropteridine reductase)","Bos taurus (Bovine)","L-phenylalanine catabolic process [GO:0006559]; tetrahydrobiopterin biosynthetic process [GO:0006729]","GO:0004155; GO:0005737; GO:0006559; GO:0006729; GO:0016616; GO:0070402; GO:0070404"
"532",568,203284,"Cluster_6906","Peve_00044463",0.493627322511383,0.671341387794899,0.978262075707395,145,-20.63,"2 14","491 512",12,"75.00%","83.33%","Q3T0Z7","Dihydropteridine reductase (EC 1.5.1.34) (HDHPR) (Quinoid dihydropteridine reductase)","Bos taurus (Bovine)","L-phenylalanine catabolic process [GO:0006559]; tetrahydrobiopterin biosynthetic process [GO:0006729]","GO:0004155; GO:0005737; GO:0006559; GO:0006729; GO:0016616; GO:0070402; GO:0070404"
"533",569,203405,"Cluster_1167","Peve_00029690",0.144154339240488,0.907907645314481,0.999448381576871,157,-22.34,"2 20","69 89",18,"77.78%","77.78%",NA,NA,NA,NA,NA
"534",570,203543,"Cluster_2882","Peve_00003140",-0.778878239943844,0.431577971713217,0.978262075707395,150,-20.36,"2 21","361 386",23,"69.57%","69.57%","Q503V9","Uridylate-specific endoribonuclease B (EC 4.6.1.-) (Protein endoU-B)","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0003723; GO:0004521; GO:0016829; GO:0046872"
"535",571,203841,"Cluster_11134","Peve_00032195",-0.420505673765083,0.723705367763309,0.982626393204082,148,-20.89,"2 18","107 132",20,"65.00%","75.00%","Q66JZ4","T-cell activation inhibitor, mitochondrial (Tolerance associated gene-1 protein) (TOAG-1)","Mus musculus (Mouse)","","GO:0005739"
"536",572,204864,"Cluster_7855","Peve_00001787",0.376070852116558,0.754549849938315,0.988219883885475,170,-21.76,"2 21","401 421",19,"78.95%","89.47%","Q58DA0","26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10)","Bos taurus (Bovine)","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]","GO:0005634; GO:0005829; GO:0008540; GO:0022624; GO:0031593; GO:0043161"
"537",573,205614,"Cluster_4079","Peve_00043650",-0.796272454187231,0.413604356922386,0.978262075707395,167,-23.65,"2 21","235 257",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"538",574,206158,"Cluster_4735","Peve_00009172",-0.964206217856802,0.170845255199747,0.978262075707395,166,-23.72,"2 21","583 606",21,"76.19%","85.71%","P46436","Glutathione S-transferase 1 (EC 2.5.1.18) (GST class-sigma)","Ascaris suum (Pig roundworm) (Ascaris lumbricoides)","cellular oxidant detoxification [GO:0098869]","GO:0004364; GO:0004602; GO:0005737; GO:0005903; GO:0098869"
"539",575,207407,"Cluster_589","Peve_00040684",-0.991953589462421,0.0808142327625484,0.978262075707395,145,-21.52,"2 10","932 953",8,"100.00%","100.00%",NA,NA,NA,NA,NA
"540",576,207476,"Cluster_8884","Peve_00040686",-0.878090506188106,0.317634741468354,0.978262075707395,159,-22.16,"2 17","97 120",18,"77.78%","83.33%","Q7SY06","Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase) (HACD) (Protein-tyrosine phosphatase-like A domain-containing protein 1)","Danio rerio (Zebrafish) (Brachydanio rerio)","fatty acid elongation [GO:0030497]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]","GO:0005783; GO:0005789; GO:0018812; GO:0030148; GO:0030497; GO:0042761; GO:0102158; GO:0102343; GO:0102344; GO:0102345"
"541",577,207477,"Cluster_8887","Peve_00040686",-0.712084754968331,0.495502323741918,0.978262075707395,159,-23.75,"2 17","97 120",18,"77.78%","83.33%","Q7SY06","Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase) (HACD) (Protein-tyrosine phosphatase-like A domain-containing protein 1)","Danio rerio (Zebrafish) (Brachydanio rerio)","fatty acid elongation [GO:0030497]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]","GO:0005783; GO:0005789; GO:0018812; GO:0030148; GO:0030497; GO:0042761; GO:0102158; GO:0102343; GO:0102344; GO:0102345"
"542",578,207546,"Cluster_2787","Peve_00040680",0.999851452010528,0.0109732149417988,0.647820986329688,170,-24.52,"2 21","126 149",21,"80.95%","85.71%","Q9HAT8","E3 ubiquitin-protein ligase pellino homolog 2 (Pellino-2) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase pellino homolog 2)","Homo sapiens (Human)","positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; protein polyubiquitination [GO:0000209]; regulation of Toll signaling pathway [GO:0008592]","GO:0000209; GO:0001934; GO:0005829; GO:0008592; GO:0034450; GO:0043123; GO:0043410; GO:0061630"
"543",579,207816,"Cluster_2787","Peve_00035222",0.959132899845335,0.182630063198346,0.978262075707395,170,-25.44,"2 21","125 148",21,"80.95%","85.71%",NA,NA,NA,NA,NA
"544",580,207816,"Cluster_2787","Peve_00035222",0.959132899845335,0.182630063198346,0.978262075707395,170,-25.44,"2 21","430 453",21,"80.95%","85.71%",NA,NA,NA,NA,NA
"545",582,208206,"Cluster_11134","Peve_00001208",0.956914056983779,0.187557623004676,0.978262075707395,146,-21.91,"2 20","45 68",20,"60.00%","75.00%","Q7VWH8","Phosphonoacetaldehyde hydrolase (Phosphonatase) (EC 3.11.1.1) (Phosphonoacetaldehyde phosphonohydrolase)","Bordetella pertussis (strain Tohama I / ATCC BAA-589 / NCTC 13251)","organic phosphonate catabolic process [GO:0019700]","GO:0000287; GO:0019700; GO:0050194"
"546",583,208274,"Cluster_5563","Peve_00001202",0.964118166837386,0.171056533649525,0.978262075707395,171,-21.3,"2 22","9 30",20,"80.00%","85.00%",NA,NA,NA,NA,NA
"547",584,208551,"Cluster_7053","Peve_00001205",-0.953853219047798,0.194155745230749,0.978262075707395,165,-23.83,"2 21","252 271",19,"78.95%","84.21%","A4II73","Esterase OVCA2 (EC 3.1.2.-) (Ovarian cancer-associated gene 2 protein homolog)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0016787"
"548",585,208773,"Cluster_6905","Peve_00030474",0.106610234355624,0.932000588995811,0.999448381576871,164,-21.06,"2 17","631 652",15,"86.67%","86.67%","Q80W94","2-acylglycerol O-acyltransferase 2 (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 2) (MGAT2) (Diacylglycerol acyltransferase 2-like protein 5) (Monoacylglycerol O-acyltransferase 1-like) (Monoacylglycerol O-acyltransferase 2)","Mus musculus (Mouse)","diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; intestinal absorption [GO:0050892]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640]; monoacylglycerol metabolic process [GO:0046462]; triglyceride biosynthetic process [GO:0019432]","GO:0003846; GO:0005783; GO:0005789; GO:0006071; GO:0006629; GO:0006640; GO:0006651; GO:0008374; GO:0016407; GO:0019432; GO:0046462; GO:0050892; GO:1990578"
"549",586,209174,"Cluster_5563","Peve_00040533",0.772135908586366,0.438376878525209,0.978262075707395,164,-21.4,"2 22","51 75",22,"68.18%","81.82%","Q2LMP1","Protein Wnt-3a","Gallus gallus (Chicken)","BMP signaling pathway [GO:0030509]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cornea development in camera-type eye [GO:0061303]; determination of dorsal identity [GO:0048263]; dorsal/ventral pattern formation [GO:0009953]; inner ear morphogenesis [GO:0042472]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; neuron differentiation [GO:0030182]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]","GO:0005109; GO:0005125; GO:0005615; GO:0005640; GO:0005783; GO:0005829; GO:0005886; GO:0009953; GO:0010628; GO:0010831; GO:0030182; GO:0030509; GO:0035108; GO:0040036; GO:0042472; GO:0045165; GO:0045663; GO:0045743; GO:0045944; GO:0048263; GO:0050679; GO:0060070; GO:0060173; GO:0060828; GO:0061303; GO:0090263"
"550",587,209471,"Cluster_14999","Peve_00038265",0.627460240148885,0.568188986265751,0.978262075707395,163,-20.23,"2 21","540 562",20,"70.00%","85.00%","Q921R4","DnaJ homolog subfamily C member 14","Mus musculus (Mouse)","protein transport [GO:0015031]","GO:0001664; GO:0005789; GO:0015031; GO:0050780"
"551",588,209775,"Cluster_9149","Peve_00023731",-0.379618789330091,0.752110315615961,0.988219883885475,150,-21.14,"2 21","2 29",25,"68.00%","68.00%",NA,NA,NA,NA,NA
"552",589,209871,"Cluster_11134","Peve_00007128",-0.0195622829453675,0.987545469442176,0.999448381576871,154,-21.12,"2 20","603 627",21,"61.90%","80.95%","A2A8L5","Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR)","Mus musculus (Mouse)","cell migration [GO:0016477]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell projection organization [GO:0031345]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of neurotrophin TRK receptor signaling pathway [GO:0051387]; negative regulation of receptor binding [GO:1900121]; nervous system development [GO:0007399]; neuron projection regeneration [GO:0031102]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron apoptotic process [GO:0043525]; protein dephosphorylation [GO:0006470]; regulation of axon regeneration [GO:0048679]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of synapse structure or activity [GO:0050803]; synaptic membrane adhesion [GO:0099560]","GO:0001960; GO:0004721; GO:0004725; GO:0005001; GO:0005158; GO:0005768; GO:0005886; GO:0006470; GO:0007156; GO:0007399; GO:0008201; GO:0008285; GO:0010975; GO:0016020; GO:0016477; GO:0030426; GO:0030971; GO:0031102; GO:0031345; GO:0035335; GO:0035373; GO:0042059; GO:0042301; GO:0043005; GO:0043025; GO:0043065; GO:0043231; GO:0043525; GO:0044877; GO:0046627; GO:0048679; GO:0050775; GO:0050803; GO:0050839; GO:0051387; GO:0060076; GO:0098839; GO:0099175; GO:0099560; GO:1900121"
"553",590,209910,"Cluster_9149","Peve_00015538",-0.893931956998883,0.295871434516421,0.978262075707395,151,-21.33,"2 21","844 867",21,"66.67%","71.43%","Q5F477","Lipid droplet-associated hydrolase (EC 3.1.1.-) (Lipid droplet-associated serine hydrolase)","Gallus gallus (Chicken)","lipid storage [GO:0019915]","GO:0004771; GO:0005783; GO:0005811; GO:0019915"
"554",591,209972,"Cluster_589","Peve_00007127",-0.934753615028442,0.231240264998328,0.978262075707395,155,-21.82,"2 12","791 812",10,"100.00%","100.00%",NA,NA,NA,NA,NA
"555",592,210012,"Cluster_15726","Peve_00007127",-0.5,0.666666666666667,0.978262075707395,165,-25.09,"2 21","684 703",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"556",595,212344,"Cluster_10934","Peve_00037798",-0.86455412484238,0.335201876950485,0.978262075707395,164,-21.09,"2 18","482 504",17,"82.35%","88.24%","P0CG13","Chromosome transmission fidelity protein 8 homolog (hCTF8)","Homo sapiens (Human)","DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]","GO:0003677; GO:0005654; GO:0006260; GO:0007064; GO:0031390; GO:0032508; GO:1900264"
"557",597,213752,"Cluster_589","Peve_00031799",0.920185029159845,0.25607614514645,0.978262075707395,155,-23.41,"2 12","431 452",10,"100.00%","100.00%",NA,NA,NA,NA,NA
"558",598,214578,"Cluster_6905","Peve_00034206",-0.368034772210513,0.760061471690722,0.988265195989799,155,-23.16,"2 12","733 754",10,"100.00%","100.00%","Q640L2","Sugar phosphate exchanger 3 (Solute carrier family 37 member 3)","Xenopus laevis (African clawed frog)","carbohydrate transport [GO:0008643]","GO:0005789; GO:0008643; GO:0022857"
"559",599,214622,"Cluster_6904","Peve_00025848",-0.964344330071666,0.17051334027207,0.978262075707395,155,-20.72,"2 17","621 643",16,"81.25%","81.25%","Q13639","5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)","Homo sapiens (Human)","adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; regulation of appetite [GO:0032098]","GO:0004993; GO:0005737; GO:0005768; GO:0005886; GO:0007186; GO:0007187; GO:0007198; GO:0007268; GO:0016020; GO:0030425; GO:0030594; GO:0032098; GO:0045202; GO:0051378"
"560",600,214917,"Cluster_15726","Peve_00005194",-0.5,0.666666666666667,0.978262075707395,176,-21.1,"2 21","463 484",19,"84.21%","84.21%","P10079","Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","Strongylocentrotus purpuratus (Purple sea urchin)","","GO:0005509; GO:0005615; GO:0009374; GO:0031410; GO:0032579"
"561",601,214932,"Cluster_4629","Peve_00031241",-0.940820028737451,0.220114125983636,0.978262075707395,154,-20.97,"2 20","366 391",22,"68.18%","72.73%",NA,NA,NA,NA,NA
"562",602,214972,"Cluster_2854","Peve_00031240",0.376954463843484,0.753942641646548,0.988219883885475,162,-21.97,"2 15","676 697",13,"92.31%","92.31%","Q8WWQ8","Stabilin-2 (FAS1 EGF-like and X-link domain-containing adhesion molecule 2) (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 190 kDa form stabilin-2 (190 kDa hyaluronan receptor for endocytosis)]","Homo sapiens (Human)","angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898]","GO:0001525; GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0005886; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0015035; GO:0030169; GO:0030214; GO:0030666; GO:0042742; GO:0050830"
"563",603,215191,"Cluster_29","Peve_00025268",-0.62077240343352,0.573638206347232,0.978262075707395,163,-22.31,"2 20","45 66",18,"72.22%","83.33%",NA,NA,NA,NA,NA
"564",604,215360,"Cluster_10965","Peve_00019874",0.817385521658532,0.390845284722922,0.978262075707395,173,-20.6,"2 18","220 241",16,"87.50%","93.75%",NA,NA,NA,NA,NA
"565",605,215539,"Cluster_10934","Peve_00020728",-0.368428507333246,0.759791868185418,0.988240089427053,149,-24.72,"2 19","443 465",18,"72.22%","72.22%","G3V9H8","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Rattus norvegicus (Rat)","cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797"
"566",606,215777,"Cluster_589","Peve_00020721",-0.814984982753707,0.393490255056744,0.978262075707395,162,-26.28,"2 21","470 494",22,"77.27%","77.27%",NA,NA,NA,NA,NA
"567",607,215835,"Cluster_5882","Peve_00020722",-0.27814091057559,0.820563558554478,0.995934364227446,162,-21.05,"2 21","549 569",19,"73.68%","84.21%","A2AJ76","Hemicentin-2","Mus musculus (Mouse)","response to stimulus [GO:0050896]","GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023"
"568",608,216687,"Cluster_4629","Peve_00039828",-0.970034990881427,0.156240206779658,0.978262075707395,152,-21.53,"2 21","255 273",19,"68.42%","78.95%","Q5R8X9","Protein AMN1 homolog","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","",""
"569",609,216737,"Cluster_6904","Peve_00039823",-0.839224852938718,0.366018263310084,0.978262075707395,146,-20.36,"2 21","461 486",23,"65.22%","69.57%",NA,NA,NA,NA,NA
"570",610,216739,"Cluster_6906","Peve_00039823",-0.47455534649319,0.685217748526991,0.978262075707395,150,-21.37,"2 21","461 486",23,"65.22%","73.91%",NA,NA,NA,NA,NA
"571",611,216741,"Cluster_7053","Peve_00039823",-0.372091669574588,0.757281400827092,0.988219883885475,152,-20.02,"2 21","918 937",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"572",612,216756,"Cluster_11134","Peve_00039823",0.239685500578544,0.845911343307416,0.995934364227446,169,-22.27,"2 18","939 960",16,"81.25%","93.75%",NA,NA,NA,NA,NA
"573",613,217221,"Cluster_2787","Peve_00043413",0.759201361016774,0.451179531795828,0.978262075707395,156,-21.17,"2 20","483 504",19,"78.95%","78.95%","Q6P8X1","Sorting nexin-6 [Cleaved into: Sorting nexin-6, N-terminally processed]","Mus musculus (Mouse)","cellular response to amyloid-beta [GO:1904646]; cellular response to epidermal growth factor stimulus [GO:0071364]; intracellular protein transport [GO:0006886]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0005634; GO:0005737; GO:0005764; GO:0005768; GO:0005829; GO:0006886; GO:0030512; GO:0030904; GO:0031901; GO:0034452; GO:0034713; GO:0035091; GO:0042147; GO:0042803; GO:0043524; GO:0045892; GO:0071364; GO:0097422; GO:0098978; GO:0099072; GO:1904646"
"574",614,217355,"Cluster_1167","Peve_00043419",0.999909726776791,0.00855416971793389,0.573710369894872,158,-20.65,"2 20","290 312",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"575",615,217360,"Cluster_4080","Peve_00043419",-0.235777127616489,0.848472931070267,0.995934364227446,167,-20.23,"2 21","688 710",20,"80.00%","80.00%",NA,NA,NA,NA,NA
"576",616,217412,"Cluster_6904","Peve_00043418",0.748991920690414,0.461076330568865,0.978262075707395,151,-21.76,"2 21","194 218",22,"63.64%","72.73%",NA,NA,NA,NA,NA
"577",617,219011,"Cluster_14999","Peve_00024854",-0.999571546587002,0.0186364175217764,0.782669382293497,163,-20.02,"2 21","853 876",21,"71.43%","80.95%","Q75ZP8","Pyranose 2-oxidase (P2Ox) (POD) (POx) (PROD) (Pyranose oxidase) (EC 1.1.3.10) (FAD-oxidoreductase) (Glucose 2-oxidase) (Pyranose:oxygen 2-oxidoreductase)","Lyophyllum shimeji (Hon-shimeji) (Tricholoma shimeji)","","GO:0050233; GO:0050660"
"578",618,219561,"Cluster_2787","Peve_00035790",0.961143718820076,0.178050057988666,0.978262075707395,166,-20.01,"2 21","377 397",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"579",619,220356,"Cluster_11134","Peve_00034775",0.847482940254858,0.356233928661878,0.978262075707395,155,-22.55,"2 21","346 372",24,"62.50%","75.00%",NA,NA,NA,NA,NA
"580",620,221389,"Cluster_10934","Peve_00012103",-0.739888838314797,0.469756142643619,0.978262075707395,152,-20.23,"2 21","1 22",19,"68.42%","68.42%","P84239","Histone H3","Urechis caupo (Innkeeper worm) (Spoonworm)","","GO:0000786; GO:0003677; GO:0005634; GO:0030527; GO:0046982"
"581",621,221622,"Cluster_15726","Peve_00012106",-0.822919587076255,0.384687414807069,0.978262075707395,163,-25.98,"2 21","842 865",21,"76.19%","76.19%","Q17QF0","Alanine--glyoxylate aminotransferase 2, mitochondrial (AGT 2) (EC 2.6.1.44) ((R)-3-amino-2-methylpropionate--pyruvate transaminase) (EC 2.6.1.40) (Beta-ALAAT II) (Beta-alanine-pyruvate aminotransferase) (D-AIBAT)","Bos taurus (Bovine)","glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process, by transamination [GO:0019481]","GO:0005739; GO:0008453; GO:0009436; GO:0019481; GO:0030170; GO:0047305"
"582",622,221676,"Cluster_2787","Peve_00002429",0.985240034044419,0.109514955510335,0.978262075707395,153,-22.95,"2 18","875 896",16,"68.75%","81.25%",NA,NA,NA,NA,NA
"583",623,222066,"Cluster_11134","Peve_00004863",-0.856078539892879,0.345787863891157,0.978262075707395,157,-24.61,"2 16","164 184",14,"85.71%","92.86%",NA,NA,NA,NA,NA
"584",624,222192,"Cluster_8887","Peve_00038676",-0.956642706513102,0.188151627726252,0.978262075707395,154,-21.05,"2 20","366 388",20,"65.00%","80.00%",NA,NA,NA,NA,NA
"585",625,222798,"Cluster_796","Peve_00000379",0.946974354776053,0.208245726180332,0.978262075707395,158,-23.94,"2 21","306 331",23,"69.57%","78.26%",NA,NA,NA,NA,NA
"586",626,224192,"Cluster_589","Peve_00042404",-0.895501904591713,0.293633657767217,0.978262075707395,167,-26.49,"2 21","924 946",20,"65.00%","95.00%","Q20191","Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13)","Caenorhabditis elegans","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"587",627,224243,"Cluster_2882","Peve_00042406",0.867660579059443,0.331245429543811,0.978262075707395,166,-21.58,"2 19","468 489",17,"82.35%","82.35%",NA,NA,NA,NA,NA
"588",628,224567,"Cluster_6904","Peve_00016907",-0.839116809981718,0.366144732037031,0.978262075707395,161,-20.18,"2 18","504 525",16,"75.00%","87.50%","A7T167","Protein GDAP2 homolog","Nematostella vectensis (Starlet sea anemone)","",""
"589",629,224569,"Cluster_6906","Peve_00016907",-0.474380474481926,0.685344217253938,0.978262075707395,161,-20.18,"2 18","504 525",16,"75.00%","87.50%","A7T167","Protein GDAP2 homolog","Nematostella vectensis (Starlet sea anemone)","",""
"590",630,225114,"Cluster_7855","Peve_00022654",-0.189448569403113,0.878659943370791,0.998382489332233,170,-21.8,"2 21","945 969",22,"77.27%","86.36%","Q3USB7","Inactive phospholipase C-like protein 1 (PLC-L1) (Phospholipase C-related but catalytically inactive protein) (PRIP)","Mus musculus (Mouse)","gamma-aminobutyric acid signaling pathway [GO:0007214]; lipid metabolic process [GO:0006629]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor binding [GO:1900122]; regulation of synaptic transmission, GABAergic [GO:0032228]","GO:0004435; GO:0005737; GO:0006629; GO:0007214; GO:0032228; GO:0048015; GO:0050811; GO:0120163; GO:1900122"
"591",631,225501,"Cluster_2787","Peve_00019681",0.680521659241578,0.523506435586607,0.978262075707395,148,-20.88,"2 20","229 252",21,"66.67%","76.19%","Q8BYI9","Tenascin-R (TN-R) (Janusin) (Neural recognition molecule J1-160/180) (Restrictin)","Mus musculus (Mouse)","associative learning [GO:0008306]; axon extension [GO:0048675]; axon extension involved in regeneration [GO:0048677]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; locomotory exploration behavior [GO:0035641]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic transmission [GO:0050805]; neuroblast migration [GO:0097402]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of cell migration [GO:0030334]; synapse organization [GO:0050808]; synaptic transmission, glutamatergic [GO:0035249]; telencephalon cell migration [GO:0022029]","GO:0005102; GO:0005178; GO:0005615; GO:0007155; GO:0007158; GO:0007162; GO:0008306; GO:0009986; GO:0010977; GO:0022029; GO:0022408; GO:0030155; GO:0030198; GO:0030334; GO:0030517; GO:0031012; GO:0035249; GO:0035641; GO:0045121; GO:0045595; GO:0046625; GO:0048675; GO:0048677; GO:0048692; GO:0050804; GO:0050805; GO:0050808; GO:0050885; GO:0051968; GO:0051971; GO:0060291; GO:0062023; GO:0072534; GO:0090733; GO:0097402; GO:0098685; GO:0098686; GO:0098965; GO:0098966; GO:0098978"
"592",632,225767,"Cluster_589","Peve_00004281",-0.959306493714395,0.182239089129532,0.978262075707395,154,-22.98,"2 21","298 323",23,"65.22%","78.26%",NA,NA,NA,NA,NA
"593",633,225880,"Cluster_8634","Peve_00004283",0.75799343068847,0.452359765833313,0.978262075707395,173,-21.7,"2 20","538 558",18,"83.33%","94.44%","P25291","Pancreatic secretory granule membrane major glycoprotein GP2 (Pancreatic zymogen granule membrane protein GP-2) (ZAP75)","Canis lupus familiaris (Dog) (Canis familiaris)","antigen transcytosis by M cells in mucosal-associated lymphoid tissue [GO:0002412]; innate immune response [GO:0045087]; neutrophil migration [GO:1990266]","GO:0002412; GO:0005201; GO:0005615; GO:0005768; GO:0009897; GO:0009986; GO:0016324; GO:0042589; GO:0045087; GO:0045121; GO:1990266"
"594",634,227346,"Cluster_2787","Peve_00028803",0.954026597801663,0.193787821170416,0.978262075707395,154,-21.24,"2 21","809 829",19,"68.42%","78.95%","Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"595",635,227392,"Cluster_2854","Peve_00028802",-0.715676610819555,0.492236918386052,0.978262075707395,151,-22.98,"2 14","417 437",12,"91.67%","91.67%","Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"596",636,228827,"Cluster_589","Peve_00005422",-0.77327339078863,0.43723607308956,0.978262075707395,155,-20.92,"2 20","322 343",18,"66.67%","77.78%","Q8CIB6","Transmembrane protein 230","Mus musculus (Mouse)","synaptic vesicle transport [GO:0048489]","GO:0005769; GO:0005770; GO:0005776; GO:0005783; GO:0005802; GO:0008021; GO:0012505; GO:0016020; GO:0048489; GO:0055037"
"597",637,228927,"Cluster_4629","Peve_00005420",-0.572547923731183,0.611910088629261,0.978262075707395,151,-22.83,"2 21","82 108",24,"58.33%","75.00%",NA,NA,NA,NA,NA
"598",638,228965,"Cluster_1167","Peve_00005421",-0.953371995104832,0.195173421345243,0.978262075707395,153,-24.56,"2 19","117 139",18,"66.67%","83.33%","Q8K0U4","Heat shock 70 kDa protein 12A","Mus musculus (Mouse)","","GO:0005524; GO:0005634; GO:0005737"
"599",639,229423,"Cluster_4735","Peve_00031911",-0.790458904306251,0.419684249855267,0.978262075707395,158,-21.55,"2 21","689 712",21,"71.43%","80.95%",NA,NA,NA,NA,NA
"600",640,229912,"Cluster_2854","Peve_00040476",0.780373276450821,0.430058167142665,0.978262075707395,157,-23.04,"2 21","299 327",26,"73.08%","73.08%",NA,NA,NA,NA,NA
"601",641,230002,"Cluster_2854","Peve_00040474",-0.757242403868473,0.453092292093332,0.978262075707395,164,-22.78,"2 17","116 137",15,"86.67%","86.67%",NA,NA,NA,NA,NA
"602",642,230047,"Cluster_2854","Peve_00040475",-0.679535076103835,0.524363078611025,0.978262075707395,164,-22.78,"2 17","116 137",15,"86.67%","86.67%",NA,NA,NA,NA,NA
"603",643,230883,"Cluster_10061","Peve_00002017",0.537726337475304,0.638566727677222,0.978262075707395,154,-20.33,"2 21","534 559",23,"65.22%","78.26%",NA,NA,NA,NA,NA
"604",644,230897,"Cluster_589","Peve_00015215",-0.953734847202864,0.194406552550168,0.978262075707395,151,-20.09,"2 16","573 594",14,"71.43%","85.71%","P48547","Potassium voltage-gated channel subfamily C member 1 (NGK2) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4)","Homo sapiens (Human)","cellular response to xenobiotic stimulus [GO:0071466]; cerebellum development [GO:0021549]; corpus callosum development [GO:0022038]; globus pallidus development [GO:0021759]; optic nerve development [GO:0021554]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein tetramerization [GO:0051262]; response to amine [GO:0014075]; response to auditory stimulus [GO:0010996]; response to fibroblast growth factor [GO:0071774]; response to light intensity [GO:0009642]; response to nerve growth factor [GO:1990089]; response to potassium ion [GO:0035864]; response to toxic substance [GO:0009636]","GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0009636; GO:0009642; GO:0009986; GO:0010996; GO:0014075; GO:0016020; GO:0019894; GO:0021549; GO:0021554; GO:0021759; GO:0022038; GO:0030424; GO:0030673; GO:0032590; GO:0032809; GO:0035864; GO:0042734; GO:0044305; GO:0044325; GO:0045211; GO:0051260; GO:0051262; GO:0071466; GO:0071774; GO:0071805; GO:0099508; GO:1903818; GO:1990089"
"605",645,231230,"Cluster_6914","Peve_00028056",0.702888013473308,0.503786984182825,0.978262075707395,143,-20.7,"2 20","767 792",23,"69.57%","73.91%","Q8NEF3","Coiled-coil domain-containing protein 112 (Mutated in bladder cancer protein 1)","Homo sapiens (Human)","","GO:0005737; GO:0034451"
"606",646,231346,"Cluster_29","Peve_00024714",-0.151880734119308,0.902934070983582,0.999448381576871,168,-25.83,"2 21","644 663",19,"84.21%","89.47%",NA,NA,NA,NA,NA
"607",647,231402,"Cluster_4629","Peve_00028055",-0.592778913552805,0.596061585291983,0.978262075707395,157,-23.52,"2 14","338 359",12,"91.67%","91.67%","O42265","Proteasome subunit alpha type-1 (Macropain subunit C2) (Multicatalytic endopeptidase complex subunit C2) (Proteasome component C2)","Gallus gallus (Chicken)","proteasomal protein catabolic process [GO:0010498]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005634; GO:0005737; GO:0005839; GO:0006511; GO:0010498; GO:0019773"
"608",648,231887,"Cluster_589","Peve_00027650",-0.934753615028442,0.231240264998328,0.978262075707395,158,-22.92,"2 21","488 508",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"609",649,232354,"Cluster_6906","Peve_00020029",-0.974836163209914,0.143119394807662,0.978262075707395,160,-20.79,"2 18","785 807",17,"76.47%","88.24%","Q8NDG6","ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9)","Homo sapiens (Human)","cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of transposition [GO:0010529]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]","GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0007141; GO:0007283; GO:0009566; GO:0010529; GO:0016887; GO:0030154; GO:0034587; GO:0043046; GO:0071547"
"610",650,232500,"Cluster_9149","Peve_00020025",-0.73115795450918,0.477960472220439,0.978262075707395,167,-26.22,"2 21","559 582",21,"71.43%","85.71%",NA,NA,NA,NA,NA
"611",651,232965,"Cluster_16738","Peve_00017503",-0.885177582012331,0.308073527484859,0.978262075707395,163,-21.78,"2 21","748 770",20,"75.00%","80.00%","Q3TC93","HCLS1-binding protein 3 (HS1-binding protein 3) (HSP1BP-3)","Mus musculus (Mouse)","cell surface receptor signaling pathway [GO:0007166]; regulation of apoptotic process [GO:0042981]; T cell differentiation [GO:0030217]","GO:0005739; GO:0005783; GO:0007166; GO:0030217; GO:0035091; GO:0042981"
"612",652,233022,"Cluster_4629","Peve_00017501",-0.539606282997822,0.637146212821157,0.978262075707395,167,-23.84,"2 21","831 853",20,"80.00%","80.00%","Q6GPE5","Protein fem-1 homolog B (FEM1b) (FEM1-beta)","Xenopus laevis (African clawed frog)","apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756; GO:2000001"
"613",653,233023,"Cluster_4735","Peve_00017501",-0.516318955531215,0.654603815280809,0.978262075707395,153,-20.18,"2 21","655 676",20,"75.00%","75.00%","Q6GPE5","Protein fem-1 homolog B (FEM1b) (FEM1-beta)","Xenopus laevis (African clawed frog)","apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756; GO:2000001"
"614",654,233066,"Cluster_4115","Peve_00017508",-0.697579229976041,0.508521038815304,0.978262075707395,155,-21.22,"2 17","865 887",16,"75.00%","87.50%","Q5RH73",NA,NA,NA,NA
"615",655,233125,"Cluster_8634","Peve_00017509",0.734009463957548,0.475293519507015,0.978262075707395,167,-20.98,"2 21","699 721",20,"75.00%","85.00%","Q3UHJ0","AP2-associated protein kinase 1 (EC 2.7.11.1) (Adaptor-associated kinase 1)","Mus musculus (Mouse)","positive regulation of Notch signaling pathway [GO:0045747]; presynaptic endocytosis [GO:0140238]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of clathrin-dependent endocytosis [GO:2000369]; regulation of protein localization [GO:0032880]","GO:0004674; GO:0005112; GO:0005524; GO:0005737; GO:0005905; GO:0006468; GO:0019897; GO:0030136; GO:0031252; GO:0032880; GO:0035612; GO:0043195; GO:0044305; GO:0045747; GO:0046777; GO:0050821; GO:0071439; GO:0098793; GO:0106310; GO:0140238; GO:2000369"
"616",656,233241,"Cluster_2787","Peve_00024306",-0.864104211317102,0.335771391434576,0.978262075707395,158,-25.15,"2 21","904 928",22,"68.18%","81.82%","P15089","Mast cell carboxypeptidase A (MC-CPA) (EC 3.4.17.1) (Carboxypeptidase A3)","Mus musculus (Mouse)","proteolysis [GO:0006508]; regulation of angiotensin levels in blood [GO:0002002]","GO:0002002; GO:0004181; GO:0005615; GO:0006508; GO:0008233; GO:0008270; GO:0030133"
"617",657,233570,"Cluster_6914","Peve_00011830",0.0244174697248888,0.984453810914684,0.999448381576871,170,-20.66,"2 20","633 654",19,"73.68%","94.74%",NA,NA,NA,NA,NA
"618",658,233828,"Cluster_2882","Peve_00025651",0.148334403550368,0.905217609682564,0.999448381576871,154,-22.33,"2 16","486 508",15,"80.00%","86.67%","Q7RTR2","NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","Homo sapiens (Human)","I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223"
"619",660,234946,"Cluster_29","Peve_00021080",0.894671541095829,0.294819206530859,0.978262075707395,151,-21.18,"2 21","836 860",22,"59.09%","77.27%","Q9HAB8","Phosphopantothenate--cysteine ligase (EC 6.3.2.51) (Phosphopantothenoylcysteine synthetase) (PPC synthetase)","Homo sapiens (Human)","acetyl-CoA biosynthetic process [GO:0006085]; coenzyme A biosynthetic process [GO:0015937]; heart process [GO:0003015]","GO:0003015; GO:0004632; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006085; GO:0015937; GO:0042802; GO:0042803"
"620",661,235326,"Cluster_7053","Peve_00020970",-0.427153544381295,0.719032754704227,0.981280089302162,169,-22.18,"2 21","260 279",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"621",662,235536,"Cluster_2787","Peve_00044332",0.569205599840444,0.614501684723606,0.978262075707395,162,-23.1,"2 21","367 387",19,"68.42%","89.47%","B7WFQ1","Uncharacterized skeletal organic matrix protein 2 (Uncharacterized SOMP-2)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0016020"
"622",663,236100,"Cluster_9149","Peve_00042645",-0.488020228578639,0.675438446665287,0.978262075707395,158,-26.9,"2 15","284 305",13,"84.62%","92.31%","Q8T882","Tauropine dehydrogenase (TaDH) (EC 1.5.1.23) (NAD: tauropine oxidoreductase)","Arabella iricolor (Opal worm)","","GO:0050325"
"623",664,236196,"Cluster_11134","Peve_00013994",-0.0195622829453675,0.987545469442176,0.999448381576871,157,-22.49,"2 21","446 465",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"624",665,236225,"Cluster_6914","Peve_00042649",0.539638185158975,0.6371220895627,0.978262075707395,154,-21,"2 19","904 924",17,"70.59%","76.47%",NA,NA,NA,NA,NA
"625",666,236235,"Cluster_9149","Peve_00042649",-0.828469430498972,0.378424099522617,0.978262075707395,144,-22.19,"2 14","709 731",13,"69.23%","92.31%",NA,NA,NA,NA,NA
"626",667,236287,"Cluster_11135","Peve_00042648",0.662955440271475,0.538603745817007,0.978262075707395,154,-21.64,"2 21","23 46",21,"71.43%","76.19%","A5PMX1","Zinc transporter 7 (ZnT-7) (Solute carrier family 30 member 7)","Danio rerio (Zebrafish) (Brachydanio rerio)","cellular zinc ion homeostasis [GO:0006882]; metal ion transport [GO:0030001]; zinc ion import into Golgi lumen [GO:1904257]; zinc ion transport [GO:0006829]","GO:0005385; GO:0005794; GO:0006829; GO:0006882; GO:0016020; GO:0030001; GO:0031410; GO:0046873; GO:1904257"
"627",668,236348,"Cluster_2882","Peve_00013993",-0.942375788764857,0.217172832696183,0.978262075707395,167,-22.85,"2 17","164 186",16,"87.50%","93.75%",NA,NA,NA,NA,NA
"628",671,237662,"Cluster_6904","Peve_00043597",0.0514618020778197,0.967223921497405,0.999448381576871,147,-20.12,"2 17","304 328",18,"72.22%","72.22%",NA,NA,NA,NA,NA
"629",672,238356,"Cluster_11134","Peve_00039612",0.952719554900949,0.196545028898953,0.978262075707395,157,-24.23,"2 15","461 483",14,"85.71%","92.86%","Q5F364","Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)","Gallus gallus (Chicken)","glutathione transmembrane transport [GO:0034775]; lipid transport [GO:0006869]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]","GO:0005524; GO:0006869; GO:0008559; GO:0016020; GO:0016323; GO:0016887; GO:0034634; GO:0034775; GO:0042626; GO:0042908; GO:0055085"
"630",674,238610,"Cluster_6914","Peve_00038059",0.325342805874685,0.789040610369841,0.99566514329025,166,-22.75,"2 20","568 589",19,"78.95%","84.21%","Q9QUQ5","Short transient receptor potential channel 4 (TrpC4) (Capacitative calcium entry channel Trp4) (Receptor-activated cation channel TRP4)","Mus musculus (Mouse)","calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; gamma-aminobutyric acid secretion [GO:0014051]; oligodendrocyte differentiation [GO:0048709]; positive regulation of store-operated calcium entry [GO:0106129]; regulation of action potential firing rate [GO:0099605]; regulation of calcium ion transport [GO:0051924]; regulation of cytosolic calcium ion concentration [GO:0051480]","GO:0005262; GO:0005737; GO:0005886; GO:0005901; GO:0005911; GO:0006816; GO:0008013; GO:0009986; GO:0014051; GO:0015279; GO:0016323; GO:0030863; GO:0032991; GO:0034703; GO:0034704; GO:0045121; GO:0045296; GO:0048709; GO:0051480; GO:0051924; GO:0070509; GO:0070588; GO:0070679; GO:0099605; GO:0106129"
"631",675,238935,"Cluster_9149","Peve_00010317",0.300920751344014,0.805412067013268,0.995934364227446,141,-20.01,"2 10","959 980",8,"87.50%","100.00%","G1SWI6",NA,NA,NA,NA
"632",676,239145,"Cluster_5882","Peve_00010310",-0.0312448688622336,0.980105660853798,0.999448381576871,174,-22.12,"2 19","292 313",17,"82.35%","94.12%",NA,NA,NA,NA,NA
"633",677,239332,"Cluster_7657","Peve_00030228",0.953609293079302,0.194672235644542,0.978262075707395,171,-20.16,"2 16","765 786",14,"92.86%","100.00%","A3KMX8","Damage-control phosphatase ARMT1 (EC 3.1.3.-) (Acidic residue methyltransferase 1) (Protein-glutamate O-methyltransferase) (EC 2.1.1.-) (Sugar phosphate phosphatase ARMT1)","Bos taurus (Bovine)","cellular response to DNA damage stimulus [GO:0006974]; methylation [GO:0032259]; regulation of response to DNA damage stimulus [GO:2001020]","GO:0006974; GO:0008757; GO:0008983; GO:0016791; GO:0032259; GO:0046872; GO:0051998; GO:0097023; GO:0103026; GO:2001020"
"634",678,239333,"Cluster_7658","Peve_00030228",-0.881119802369013,0.313580656372249,0.978262075707395,171,-20.16,"2 16","765 786",14,"92.86%","100.00%","A3KMX8","Damage-control phosphatase ARMT1 (EC 3.1.3.-) (Acidic residue methyltransferase 1) (Protein-glutamate O-methyltransferase) (EC 2.1.1.-) (Sugar phosphate phosphatase ARMT1)","Bos taurus (Bovine)","cellular response to DNA damage stimulus [GO:0006974]; methylation [GO:0032259]; regulation of response to DNA damage stimulus [GO:2001020]","GO:0006974; GO:0008757; GO:0008983; GO:0016791; GO:0032259; GO:0046872; GO:0051998; GO:0097023; GO:0103026; GO:2001020"
"635",679,239895,"Cluster_16738","Peve_00022559",0.710703250286914,0.496753749500653,0.978262075707395,165,-22.31,"2 21","959 983",22,"77.27%","86.36%","Q6P881","Non-structural maintenance of chromosomes element 1 homolog (Non-SMC element 1 homolog) (EC 2.3.2.27)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of response to DNA damage stimulus [GO:2001022]","GO:0000781; GO:0005634; GO:0006281; GO:0006310; GO:0030915; GO:0046872; GO:0046983; GO:0061630; GO:2001022"
"636",680,240239,"Cluster_8988","Peve_00033750",0.460074232621879,0.695645581095835,0.978262075707395,169,-22.17,"2 21","973 992",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"637",681,240589,"Cluster_6906","Peve_00041856",-0.686063329690759,0.518674561276582,0.978262075707395,158,-20.46,"2 21","501 521",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"638",682,240713,"Cluster_2882","Peve_00041853",-0.966631654778492,0.164921605108499,0.978262075707395,169,-20.26,"2 20","581 601",18,"83.33%","88.89%",NA,NA,NA,NA,NA
"639",683,240753,"Cluster_796","Peve_00041852",0.898740270652305,0.288966974174018,0.978262075707395,149,-20.69,"2 16","163 183",14,"78.57%","85.71%",NA,NA,NA,NA,NA
"640",684,240812,"Cluster_6904","Peve_00013393",-0.966134655588607,0.166152231402236,0.978262075707395,155,-20.01,"2 21","153 175",20,"70.00%","75.00%",NA,NA,NA,NA,NA
"641",685,241050,"Cluster_9149","Peve_00034255",-0.208658861251816,0.86618033705838,0.99666494803365,159,-24.13,"2 21","576 598",20,"70.00%","80.00%",NA,NA,NA,NA,NA
"642",686,241292,"Cluster_589","Peve_00035783",-0.997488611107799,0.0451276831430894,0.931124593466766,163,-30.37,"2 21","547 571",22,"72.73%","77.27%",NA,NA,NA,NA,NA
"643",687,241309,"Cluster_6906","Peve_00035783",-0.316413624990426,0.795042509417998,0.995934364227446,157,-20.91,"2 21","274 295",20,"75.00%","80.00%",NA,NA,NA,NA,NA
"644",688,241551,"Cluster_11134","Peve_00013394",-0.113057721594236,0.927870999442256,0.999448381576871,162,-27.02,"2 21","978 998",19,"68.42%","89.47%",NA,NA,NA,NA,NA
"645",689,241569,"Cluster_4079","Peve_00003386",0.303281629880872,0.803835416942515,0.995934364227446,152,-20.06,"2 19","63 83",17,"70.59%","82.35%",NA,NA,NA,NA,NA
"646",690,242039,"Cluster_8988","Peve_00032481",0.574919857380487,0.610066444974445,0.978262075707395,159,-20.95,"2 21","763 787",22,"68.18%","77.27%",NA,NA,NA,NA,NA
"647",691,242084,"Cluster_8988","Peve_00018541",0.428948171467649,0.717768589253689,0.98094467988879,168,-21.61,"2 21","652 673",19,"73.68%","84.21%","Q8NDZ4","Divergent protein kinase domain 2A (Deleted in autism protein 1) (Golgi Protein of 49 kDa) (GoPro49) (Hypoxia and AKT-induced stem cell factor) (HASF)","Homo sapiens (Human)","cardiac muscle cell proliferation [GO:0060038]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; positive regulation of protein kinase C activity [GO:1900020]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]","GO:0000139; GO:0005615; GO:0014066; GO:0030126; GO:0034392; GO:0060038; GO:1900020"
"648",692,242113,"Cluster_4735","Peve_00018540",-0.706080390864832,0.500923406584211,0.978262075707395,165,-21.54,"2 19","616 638",18,"83.33%","83.33%","Q5U584","SH3 domain-binding protein 5-like (SH3BP-5-like)","Xenopus laevis (African clawed frog)","intracellular signal transduction [GO:0035556]","GO:0005085; GO:0035556"
"649",693,242322,"Cluster_15726","Peve_00033285",-0.599355871094906,0.590846897480089,0.978262075707395,171,-20.05,"2 20","142 163",18,"83.33%","83.33%",NA,NA,NA,NA,NA
"650",694,242704,"Cluster_6906","Peve_00016000",-0.283834294816107,0.81678687353313,0.995934364227446,156,-21.13,"2 17","477 498",15,"80.00%","80.00%","Q9NRP7","Serine/threonine-protein kinase 36 (EC 2.7.11.1) (Fused homolog)","Homo sapiens (Human)","axoneme assembly [GO:0035082]; brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of DNA-binding transcription factor activity [GO:0051090]; smoothened signaling pathway [GO:0007224]","GO:0001222; GO:0003351; GO:0004674; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0007224; GO:0007228; GO:0007420; GO:0009791; GO:0035082; GO:0042995; GO:0045880; GO:0046872; GO:0051090; GO:0060271; GO:0106310"
"651",695,242895,"Cluster_9149","Peve_00032150",-0.5,0.666666666666667,0.978262075707395,158,-26.44,"2 21","162 187",23,"69.57%","78.26%","Q64559","Cytosolic acyl coenzyme A thioester hydrolase (EC 3.1.2.2) (ACH1) (ACT) (Acyl-CoA thioesterase 7) (Brain acyl-CoA hydrolase) (BACH) (CTE-IIa) (CTE-IIb) (CTE-II) (LACH1) (Long chain acyl-CoA thioester hydrolase) (MTE-II)","Rattus norvegicus (Rat)","acyl-CoA metabolic process [GO:0006637]; coenzyme A biosynthetic process [GO:0015937]; fatty acid catabolic process [GO:0009062]; fatty acid metabolic process [GO:0006631]; long-chain fatty-acyl-CoA catabolic process [GO:0036116]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; palmitic acid biosynthetic process [GO:1900535]","GO:0000062; GO:0005654; GO:0005737; GO:0005759; GO:0005829; GO:0006631; GO:0006637; GO:0009062; GO:0015937; GO:0016290; GO:0036042; GO:0036114; GO:0036116; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0044297; GO:0047617; GO:0051792; GO:0102991; GO:1900535"
"652",697,243536,"Cluster_14999","Peve_00038739",-0.904314924281761,0.280764751581636,0.978262075707395,164,-20.5,"2 18","461 483",17,"82.35%","88.24%",NA,NA,NA,NA,NA
"653",698,243958,"Cluster_4735","Peve_00003525",-0.700267934162902,0.506127729438183,0.978262075707395,155,-20.18,"2 21","807 833",24,"66.67%","70.83%","P53667","LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1)","Homo sapiens (Human)","actin cytoskeleton organization [GO:0030036]; axon extension [GO:0048675]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; nervous system development [GO:0007399]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon extension [GO:0045773]; positive regulation of stress fiber assembly [GO:0051496]; protein phosphorylation [GO:0006468]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149]","GO:0001673; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005925; GO:0006468; GO:0007165; GO:0007266; GO:0007399; GO:0016020; GO:0016607; GO:0030027; GO:0030036; GO:0031072; GO:0032233; GO:0038096; GO:0043005; GO:0043149; GO:0045773; GO:0046872; GO:0048675; GO:0051444; GO:0051496; GO:0106310"
"654",700,244316,"Cluster_4115","Peve_00003779",-0.842131753786768,0.36260092303543,0.978262075707395,163,-20.55,"2 21","438 463",23,"73.91%","73.91%",NA,NA,NA,NA,NA
"655",701,244316,"Cluster_4115","Peve_00003779",-0.842131753786768,0.36260092303543,0.978262075707395,171,-23.23,"2 21","340 365",23,"78.26%","78.26%",NA,NA,NA,NA,NA
"656",702,244317,"Cluster_4629","Peve_00003779",-0.384409101091682,0.748810428472953,0.988219883885475,151,-21.56,"2 12","728 749",10,"90.00%","100.00%",NA,NA,NA,NA,NA
"657",703,244317,"Cluster_4629","Peve_00003779",-0.384409101091682,0.748810428472953,0.988219883885475,160,-21.72,"2 21","645 666",19,"63.16%","84.21%",NA,NA,NA,NA,NA
"658",704,244331,"Cluster_8884","Peve_00003779",-0.991115218966019,0.0849259788729153,0.978262075707395,157,-20.85,"2 20","234 253",18,"66.67%","88.89%",NA,NA,NA,NA,NA
"659",705,244332,"Cluster_8887","Peve_00003779",-0.916003064502666,0.26279356114648,0.978262075707395,157,-20.85,"2 20","234 253",18,"66.67%","88.89%",NA,NA,NA,NA,NA
"660",707,244853,"Cluster_2882","Peve_00041286",-0.985182230228671,0.109729721754419,0.978262075707395,149,-25.02,"2 20","148 175",24,"66.67%","70.83%",NA,NA,NA,NA,NA
"661",708,245130,"Cluster_5882","Peve_00018121",-0.998399871033844,0.0360189079935825,0.909359886114279,165,-20.08,"2 19","46 68",18,"83.33%","83.33%",NA,NA,NA,NA,NA
"662",709,245391,"Cluster_2787","Peve_00036673",-0.630126256048013,0.56600624341523,0.978262075707395,159,-21.46,"2 21","489 511",20,"75.00%","75.00%","Q9NXC2","Glucose-fructose oxidoreductase domain-containing protein 1 (EC 1.-.-.-)","Homo sapiens (Human)","","GO:0000166; GO:0005576; GO:0016491"
"663",710,245490,"Cluster_5882","Peve_00036674",-0.68201614880421,0.522206737521579,0.978262075707395,156,-20.99,"2 18","288 311",18,"66.67%","88.89%","P78357","Contactin-associated protein 1 (Caspr) (Caspr1) (Neurexin IV) (Neurexin-4) (p190)","Homo sapiens (Human)","axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128]; signal transduction [GO:0007165]","GO:0002175; GO:0005886; GO:0007005; GO:0007010; GO:0007155; GO:0007165; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030913; GO:0033010; GO:0033270; GO:0038023; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227"
"664",711,246485,"Cluster_6914","Peve_00001672",0.16752270999419,0.892846496669963,0.999448381576871,162,-20.45,"2 20","810 831",19,"73.68%","84.21%","Q7ZX53","Solute carrier family 22 member 15-like","Xenopus laevis (African clawed frog)","ion transport [GO:0006811]","GO:0006811; GO:0016020; GO:0022857"
"665",712,246530,"Cluster_6914","Peve_00001671",0.92598748257551,0.24646963219196,0.978262075707395,157,-21.06,"2 20","685 710",23,"73.91%","73.91%","Q504N2","Solute carrier family 22 member 15","Mus musculus (Mouse)","ion transport [GO:0006811]","GO:0006811; GO:0016020; GO:0022857"
"666",713,247107,"Cluster_4629","Peve_00014333",-0.311671470764435,0.798222333496868,0.995934364227446,143,-21.01,"2 21","962 987",23,"56.52%","69.57%",NA,NA,NA,NA,NA
"667",714,247350,"Cluster_9149","Peve_00001960",0.147522351412385,0.905740329063989,0.999448381576871,156,-20.06,"2 13","935 956",11,"90.91%","100.00%","Q96M32","Adenylate kinase 7 (AK 7) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 7)","Homo sapiens (Human)","cell projection organization [GO:0030030]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]","GO:0004017; GO:0004127; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0006165; GO:0009142; GO:0030030; GO:0031514"
"668",715,247406,"Cluster_14999","Peve_00006548",0.763027432542617,0.447424205605782,0.978262075707395,153,-21.4,"2 19","556 582",22,"68.18%","72.73%",NA,NA,NA,NA,NA
"669",716,247707,"Cluster_8887","Peve_00029940",-0.984102821129201,0.113666417824349,0.978262075707395,154,-21.23,"2 20","550 571",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"670",717,247755,"Cluster_9149","Peve_00006544",0.999971585054582,0.00479920788265011,0.551398425649056,145,-20.18,"2 10","1 16",8,"100.00%","100.00%","Q9ZQ31","Serine/threonine-protein kinase STY13 (EC 2.7.11.1) (AtSTYPK) (Serine/threonine/tyrosine-protein kinase 13)","Arabidopsis thaliana (Mouse-ear cress)","protein phosphorylation [GO:0006468]; regulation of embryonic development [GO:0045995]; seed oilbody biogenesis [GO:0010344]; signal transduction [GO:0007165]","GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0010344; GO:0045995; GO:0106310"
"671",718,247761,"Cluster_11134","Peve_00006544",-0.859950459653594,0.340988656008512,0.978262075707395,151,-21.28,"2 18","540 560",16,"75.00%","81.25%","Q9ZQ31","Serine/threonine-protein kinase STY13 (EC 2.7.11.1) (AtSTYPK) (Serine/threonine/tyrosine-protein kinase 13)","Arabidopsis thaliana (Mouse-ear cress)","protein phosphorylation [GO:0006468]; regulation of embryonic development [GO:0045995]; seed oilbody biogenesis [GO:0010344]; signal transduction [GO:0007165]","GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0010344; GO:0045995; GO:0106310"
"672",719,248092,"Cluster_2854","Peve_00039734",-0.573969729621897,0.610805404270918,0.978262075707395,150,-21.45,"2 20","626 651",22,"59.09%","77.27%","Q58116","3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) (EC 1.1.1.34)","Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) (Methanococcus jannaschii)","coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; sterol biosynthetic process [GO:0016126]","GO:0004420; GO:0008299; GO:0015936; GO:0016126"
"673",720,248225,"Cluster_1167","Peve_00021713",-0.727220164487076,0.481623843828572,0.978262075707395,152,-20.85,"2 17","268 289",15,"73.33%","80.00%",NA,NA,NA,NA,NA
"674",721,248233,"Cluster_4735","Peve_00021713",-0.242829001587379,0.843849214563053,0.995934364227446,172,-22.4,"2 21","467 488",19,"73.68%","89.47%",NA,NA,NA,NA,NA
"675",722,248367,"Cluster_4629","Peve_00030141",-0.244893838533967,0.842493777722533,0.995934364227446,152,-20.43,"2 21","615 636",19,"57.89%","78.95%","Q5BIM1","Tripartite motif-containing protein 45","Bos taurus (Bovine)","bone development [GO:0060348]; positive regulation of DNA-templated transcription [GO:0045893]","GO:0000785; GO:0004842; GO:0005654; GO:0005829; GO:0008270; GO:0045171; GO:0045893; GO:0060348"
"676",723,248637,"Cluster_4629","Peve_00030146",-0.569801165578991,0.614040426786479,0.978262075707395,148,-22.28,"2 18","242 265",18,"66.67%","77.78%","Q8UVK2","Transcription elongation factor SPT6 (Protein pandora)","Danio rerio (Zebrafish) (Brachydanio rerio)","embryonic heart tube development [GO:0035050]; heart development [GO:0007507]; mRNA transcription by RNA polymerase II [GO:0042789]; nucleosome organization [GO:0034728]; otic vesicle development [GO:0071599]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; somitogenesis [GO:0001756]; transcription elongation by RNA polymerase II promoter [GO:0006368]; transcription elongation-coupled chromatin remodeling [GO:0140673]","GO:0001756; GO:0003677; GO:0006368; GO:0007507; GO:0008023; GO:0031491; GO:0032968; GO:0034728; GO:0035050; GO:0042393; GO:0042789; GO:0071599; GO:0140673"
"677",724,248813,"Cluster_2882","Peve_00021714",0.0688372031480257,0.956142191637655,0.999448381576871,145,-22.91,"2 10","248 269",8,"100.00%","100.00%",NA,NA,NA,NA,NA
"678",725,249217,"Cluster_2854","Peve_00007635",-0.957255331744831,0.186807945938679,0.978262075707395,169,-28.3,"2 21","510 529",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"679",726,249382,"Cluster_11135","Peve_00007636",0.0416594069809366,0.973471120528434,0.999448381576871,157,-21.55,"2 18","287 308",16,"68.75%","87.50%",NA,NA,NA,NA,NA
"680",728,250131,"Cluster_7053","Peve_00026332",-0.513603509956585,0.65662047497479,0.978262075707395,171,-20.73,"2 18","971 991",16,"93.75%","93.75%","P56380","Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical] (EC 3.6.1.17) (Diadenosine 5',5'''-P1,P4-tetraphosphate asymmetrical hydrolase) (Ap4A hydrolase) (Ap4Aase) (Diadenosine tetraphosphatase) (Nucleoside diphosphate-linked moiety X motif 2) (Nudix motif 2)","Mus musculus (Mouse)","AMP biosynthetic process [GO:0006167]; apoptotic process [GO:0006915]; ATP biosynthetic process [GO:0006754]","GO:0004081; GO:0005525; GO:0005739; GO:0006167; GO:0006754; GO:0006915"
"681",729,250202,"Cluster_589","Peve_00033065",-0.987312673194418,0.101517385806401,0.978262075707395,175,-28.36,"2 20","234 255",18,"77.78%","94.44%","Q9P2P6","StAR-related lipid transfer protein 9 (START domain-containing protein 9) (StARD9)","Homo sapiens (Human)","microtubule-based movement [GO:0007018]; spindle assembly [GO:0051225]","GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005814; GO:0007018; GO:0008017; GO:0008289; GO:0051225"
"682",730,250320,"Cluster_9149","Peve_00023204",-0.200529878714579,0.871467259997656,0.997476741937264,162,-23.26,"2 21","492 512",19,"73.68%","84.21%","Q9SSA4",NA,NA,NA,NA
"683",731,250569,"Cluster_4079","Peve_00000517",-0.915921801943045,0.262922487115284,0.978262075707395,155,-20.07,"2 20","140 161",18,"66.67%","77.78%","Q15746","Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]","Homo sapiens (Human)","aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]","GO:0001725; GO:0003779; GO:0004672; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006939; GO:0014820; GO:0015629; GO:0030027; GO:0030335; GO:0032060; GO:0032154; GO:0046872; GO:0051928; GO:0060414; GO:0071476; GO:0090303"
"684",732,251247,"Cluster_4629","Peve_00037262",-0.510074535031251,0.659235615439238,0.978262075707395,167,-26.19,"2 20","650 671",18,"72.22%","88.89%","Q14642","Inositol polyphosphate-5-phosphatase A (EC 3.1.3.56) (43 kDa inositol polyphosphate 5-phosphatase) (Type I inositol 1,4,5-trisphosphate 5-phosphatase) (5PTase)","Homo sapiens (Human)","inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; inositol phosphate-mediated signaling [GO:0048016]; negative regulation of neuron death [GO:1901215]; phosphatidylinositol dephosphorylation [GO:0046856]","GO:0004445; GO:0005886; GO:0016020; GO:0030425; GO:0042731; GO:0043647; GO:0046855; GO:0046856; GO:0048016; GO:0052658; GO:0052659; GO:1901215"
"685",733,251400,"Cluster_9149","Peve_00037266",-0.637165979311365,0.560213145985724,0.978262075707395,153,-20.24,"2 18","394 415",16,"68.75%","81.25%",NA,NA,NA,NA,NA
"686",734,251400,"Cluster_9149","Peve_00037266",-0.637165979311365,0.560213145985724,0.978262075707395,164,-22.56,"2 21","217 238",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"687",735,251715,"Cluster_9149","Peve_00022361",-0.999345600152943,0.0230324640380137,0.844680676561554,160,-24.22,"2 13","11 32",11,"100.00%","100.00%","P98160","Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]","Homo sapiens (Human)","angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; tissue development [GO:0009888]","GO:0001525; GO:0001540; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007420; GO:0008022; GO:0009887; GO:0009888; GO:0016525; GO:0030021; GO:0030154; GO:0043202; GO:0050750; GO:0060548; GO:0062023; GO:0070062; GO:0072359; GO:0098797; GO:1905907"
"688",737,252690,"Cluster_5882","Peve_00009637",-0.826501224544087,0.380655679042999,0.978262075707395,168,-21.79,"2 21","558 579",19,"68.42%","89.47%",NA,NA,NA,NA,NA
"689",738,252992,"Cluster_589","Peve_00001735",-0.848609188804616,0.354880913369791,0.978262075707395,160,-30.1,"2 20","551 575",22,"77.27%","77.27%","Q9P2E3","NFX1-type zinc finger-containing protein 1","Homo sapiens (Human)","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; RNA-mediated heterochromatin formation [GO:0031048]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607"
"690",739,253043,"Cluster_2882","Peve_00006176",-0.645620135214853,0.553197922075663,0.978262075707395,148,-22.54,"2 15","724 748",16,"81.25%","81.25%",NA,NA,NA,NA,NA
"691",740,253117,"Cluster_11135","Peve_00025752",0.844443877729655,0.359862212804899,0.978262075707395,154,-20.34,"2 17","134 154",15,"80.00%","86.67%","O70277","Tripartite motif-containing protein 3 (Brain-expressed RING finger protein) (RING finger protein 22)","Rattus norvegicus (Rat)","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252]","GO:0000209; GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0030425; GO:0042802; GO:0043161; GO:0061630; GO:0098794; GO:0098978; GO:0140252"
"692",742,253836,"Cluster_11134","Peve_00017317",-0.784948486799808,0.425378731419889,0.978262075707395,160,-25.29,"2 21","8 29",19,"63.16%","84.21%","P17017","Zinc finger protein 14 (Gonadotropin-inducible ovary transcription repressor 4) (GIOT-4) (Zinc finger protein KOX6)","Homo sapiens (Human)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"693",743,254459,"Cluster_8988","Peve_00044174",0.352484775131318,0.770673660193281,0.991161883366906,171,-21.74,"2 20","377 398",18,"77.78%","88.89%","Q1W374","Phosphomannomutase (TaPMM) (EC 5.4.2.8)","Triticum aestivum (Wheat)","GDP-mannose biosynthetic process [GO:0009298]; mannose metabolic process [GO:0006013]; protein N-linked glycosylation [GO:0006487]","GO:0004615; GO:0005829; GO:0006013; GO:0006487; GO:0009298; GO:0046872"
"694",744,254572,"Cluster_2854","Peve_00013545",-0.492476100688937,0.672183790869439,0.978262075707395,192,-30.77,"2 21","785 806",19,"94.74%","94.74%","B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"695",745,254636,"Cluster_8884","Peve_00013542",-0.998136715854457,0.0388688885892676,0.909359886114279,161,-21.36,"2 19","214 238",21,"76.19%","76.19%",NA,NA,NA,NA,NA
"696",746,254637,"Cluster_8887","Peve_00013542",-0.942604884112798,0.216736470862833,0.978262075707395,161,-21.5,"2 19","214 238",21,"76.19%","76.19%",NA,NA,NA,NA,NA
"697",747,254841,"Cluster_2787","Peve_00041522",0.993156421638221,0.0745220394464161,0.978262075707395,158,-21.35,"2 20","409 431",19,"68.42%","84.21%","O75581","Low-density lipoprotein receptor-related protein 6 (LRP-6)","Homo sapiens (Human)","canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244]","GO:0001933; GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006469; GO:0007204; GO:0007268; GO:0009986; GO:0014029; GO:0014033; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0044335; GO:0044340; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0051091; GO:0060070; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090118; GO:0090244; GO:0098609; GO:1904928; GO:1904948; GO:1904953; GO:1990851; GO:1990909"
"698",748,255528,"Cluster_6905","Peve_00004419",-0.986580945066133,0.104410202293151,0.978262075707395,144,-20.11,"2 21","253 278",24,"66.67%","70.83%","P42674","Blastula protease 10 (EC 3.4.24.-)","Paracentrotus lividus (Common sea urchin)","proteolysis [GO:0006508]","GO:0004222; GO:0005615; GO:0005938; GO:0006508; GO:0008270; GO:0048471"
"699",749,256170,"Cluster_9149","Peve_00026474",0.87053325512363,0.327548150800723,0.978262075707395,147,-23.59,"2 21","459 483",22,"63.64%","68.18%",NA,NA,NA,NA,NA
"700",750,256251,"Cluster_7053","Peve_00043969",0.757356542195126,0.452981028424104,0.978262075707395,154,-22.54,"2 21","751 780",27,"66.67%","70.37%","Q9CWR2","Histone-lysine N-methyltransferase SMYD3 (EC 2.1.1.354) (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1)","Mus musculus (Mouse)","cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; histone lysine methylation [GO:0034968]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0000978; GO:0000993; GO:0001162; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0006469; GO:0014904; GO:0018024; GO:0033138; GO:0034968; GO:0042800; GO:0045184; GO:0045944; GO:0046872; GO:0071549"
"701",751,256742,"Cluster_6904","Peve_00042389",-0.945026673829712,0.212070880815512,0.978262075707395,154,-22.52,"2 20","74 97",20,"70.00%","75.00%","Q07496","Ephrin type-A receptor 4 (EC 2.7.10.1) (EPH-like kinase 8) (EK8) (cEK8)","Gallus gallus (Chicken)","axon guidance [GO:0007411]; cell adhesion [GO:0007155]; fasciculation of sensory neuron axon [GO:0097155]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; positive regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001108]; protein autophosphorylation [GO:0046777]; regulation of GTPase activity [GO:0043087]; segmentation [GO:0035282]; somitogenesis [GO:0001756]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0001756; GO:0004672; GO:0004714; GO:0005004; GO:0005005; GO:0005524; GO:0005737; GO:0005886; GO:0007155; GO:0007169; GO:0007411; GO:0018108; GO:0031901; GO:0033674; GO:0035282; GO:0043005; GO:0043087; GO:0043197; GO:0043235; GO:0046777; GO:0097155; GO:0097161; GO:2001108"
"702",752,257540,"Cluster_1167","Peve_00014131",0.953673035831666,0.19453739453975,0.978262075707395,142,-21.64,"2 11","35 56",9,"88.89%","88.89%","Q5XI68","Protein Dr1 (Down-regulator of transcription 1) (Negative cofactor 2-beta) (NC2-beta) (TATA-binding protein-associated phosphoprotein)","Rattus norvegicus (Rat)","chromatin remodeling [GO:0006338]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tubulin deacetylation [GO:0090043]; RNA polymerase II preinitiation complex assembly [GO:0051123]","GO:0000122; GO:0001046; GO:0005634; GO:0006338; GO:0006355; GO:0006357; GO:0016251; GO:0017025; GO:0017054; GO:0031063; GO:0043966; GO:0044154; GO:0045944; GO:0045995; GO:0046982; GO:0051123; GO:0051302; GO:0051726; GO:0090043; GO:0090575; GO:0140672"
"703",753,257673,"Cluster_796","Peve_00014135",-0.319903207175676,0.792699207022354,0.995934364227446,152,-22.58,"2 18","140 166",21,"71.43%","71.43%","A0A2J6RX17",NA,NA,NA,NA
"704",754,257730,"Cluster_5882","Peve_00043380",-0.0642337677838586,0.959079340793284,0.999448381576871,155,-20.07,"2 21","179 202",21,"66.67%","76.19%","Q7ZX22","GATOR complex protein WDR24","Xenopus laevis (African clawed frog)","autophagy [GO:0006914]; positive regulation of TOR signaling [GO:0032008]","GO:0005765; GO:0006914; GO:0032008"
"705",755,257768,"Cluster_2882","Peve_00023902",-0.825810323830606,0.381436312069688,0.978262075707395,169,-20.26,"2 20","283 303",18,"83.33%","88.89%","Q8R151","NFX1-type zinc finger-containing protein 1","Mus musculus (Mouse)","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; RNA-mediated heterochromatin formation [GO:0031048]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607"
"706",756,257947,"Cluster_2854","Peve_00043386",-0.374982329090072,0.755297548095648,0.988219883885475,159,-22.25,"2 20","516 537",18,"61.11%","88.89%","P49442","Inositol polyphosphate 1-phosphatase (IPP) (IPPase) (EC 3.1.3.57)","Mus musculus (Mouse)","inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]","GO:0004441; GO:0046854; GO:0046855; GO:0046872; GO:0052829"
"707",757,258081,"Cluster_2787","Peve_00023908",-0.162677153144436,0.895974199283441,0.999448381576871,153,-21.11,"2 14","365 386",12,"83.33%","91.67%","Q8R3H9","Tetratricopeptide repeat protein 4 (TPR repeat protein 4)","Mus musculus (Mouse)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; protein folding [GO:0006457]","GO:0005634; GO:0005654; GO:0005737; GO:0006457; GO:0030544; GO:0045087; GO:0051607; GO:0051879"
"708",758,258222,"Cluster_4629","Peve_00043038",-0.279024462481097,0.819977886475876,0.995934364227446,164,-25.26,"2 21","61 82",19,"68.42%","84.21%","Q5NVD0","U4/U6 small nuclear ribonucleoprotein Prp4 (U4/U6 snRNP 60 kDa protein) (WD splicing factor Prp4)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","mRNA processing [GO:0006397]; RNA splicing [GO:0008380]","GO:0005681; GO:0006397; GO:0008380; GO:0016607; GO:0071001; GO:0097525"
"709",759,258225,"Cluster_5882","Peve_00043038",0.0231894547036136,0.985235811181174,0.999448381576871,163,-21.04,"2 21","587 609",20,"75.00%","80.00%","Q5NVD0","U4/U6 small nuclear ribonucleoprotein Prp4 (U4/U6 snRNP 60 kDa protein) (WD splicing factor Prp4)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","mRNA processing [GO:0006397]; RNA splicing [GO:0008380]","GO:0005681; GO:0006397; GO:0008380; GO:0016607; GO:0071001; GO:0097525"
"710",760,258935,"Cluster_1167","Peve_00016699",0.977525707446016,0.135224342905782,0.978262075707395,152,-23.21,"2 13","207 228",11,"90.91%","90.91%",NA,NA,NA,NA,NA
"711",761,259281,"Cluster_11134","Peve_00040603",0.60247465608073,0.588362909049178,0.978262075707395,170,-25.2,"2 21","588 608",19,"73.68%","94.74%","Q5R941","Peptidyl-prolyl cis-trans isomerase FKBP14 (PPIase FKBP14) (EC 5.2.1.8) (FK506-binding protein 14) (FKBP-14) (Rotamase)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","","GO:0003755; GO:0005509; GO:0005788"
"712",762,259292,"Cluster_589","Peve_00034862",-0.996949252337422,0.0497403384974724,0.952281411175107,155,-23.55,"2 12","279 300",10,"100.00%","100.00%","Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"713",763,259607,"Cluster_589","Peve_00035409",-0.398153630722668,0.739302181623129,0.986697151420032,155,-25.67,"2 21","862 886",22,"68.18%","72.73%","P0C6F1","Dynein axonemal heavy chain 2 (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2)","Mus musculus (Mouse)","cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]","GO:0003341; GO:0005524; GO:0005858; GO:0005874; GO:0005929; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0031514; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285"
"714",764,259618,"Cluster_4735","Peve_00035409",0.269980760058776,0.825965311484761,0.995934364227446,167,-20.49,"2 16","71 92",14,"92.86%","92.86%","P0C6F1","Dynein axonemal heavy chain 2 (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2)","Mus musculus (Mouse)","cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]","GO:0003341; GO:0005524; GO:0005858; GO:0005874; GO:0005929; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0031514; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285"
"715",765,259697,"Cluster_589","Peve_00035402",-0.934753615028442,0.231240264998328,0.978262075707395,168,-24.25,"2 21","23 44",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"716",766,259701,"Cluster_2787","Peve_00035402",0.867933894665659,0.330895275232091,0.978262075707395,153,-20.45,"2 21","767 790",22,"72.73%","72.73%",NA,NA,NA,NA,NA
"717",767,259745,"Cluster_1167","Peve_00035406",-0.0891915596244717,0.943143335270915,0.999448381576871,152,-22.48,"2 13","618 639",11,"90.91%","90.91%","Q96PM5","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING finger protein 199) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363) (p53-induced RING-H2 protein) (hPirh2)","Homo sapiens (Human)","error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630; GO:0070987"
"718",768,260466,"Cluster_2787","Peve_00041958",-0.773654223740315,0.436853570205638,0.978262075707395,152,-23.05,"2 19","635 655",17,"76.47%","76.47%",NA,NA,NA,NA,NA
"719",769,261415,"Cluster_4080","Peve_00019199",-0.235777127616489,0.848472931070267,0.995934364227446,164,-20.78,"2 21","755 775",20,"80.00%","85.00%",NA,NA,NA,NA,NA
"720",770,261981,"Cluster_11134","Peve_00016214",-0.0195622829453675,0.987545469442176,0.999448381576871,168,-22.18,"2 18","21 44",18,"83.33%","88.89%",NA,NA,NA,NA,NA
"721",771,262985,"Cluster_1167","Peve_00004995",0.999909726776791,0.00855416971793389,0.573710369894872,142,-20.57,"2 11","93 114",9,"88.89%","88.89%",NA,NA,NA,NA,NA
"722",772,263280,"Cluster_9149","Peve_00029462",-0.956206026457172,0.189103747176497,0.978262075707395,155,-20.1,"2 16","178 199",14,"78.57%","85.71%","Q91X43","SH3 domain-containing protein 19 (Kryn)","Mus musculus (Mouse)","cytoskeleton organization [GO:0007010]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of cell morphogenesis [GO:0022604]","GO:0005654; GO:0005829; GO:0005886; GO:0007010; GO:0022604; GO:0051044; GO:0070064"
"723",773,263955,"Cluster_9149","Peve_00031718",-0.535356699146018,0.640354387738876,0.978262075707395,160,-24.98,"2 19","608 628",17,"76.47%","88.24%","Q9ULR3","Protein phosphatase 1H (EC 3.1.3.16)","Homo sapiens (Human)","protein dephosphorylation [GO:0006470]","GO:0004721; GO:0005634; GO:0005654; GO:0005737; GO:0006470; GO:0017018; GO:0042802; GO:0098978"
"724",774,264339,"Cluster_4079","Peve_00015748",-0.999044377811527,0.0278338206502373,0.899469696283718,149,-22.68,"2 20","227 252",22,"68.18%","72.73%","P0CI65","Nephrocystin-3","Danio rerio (Zebrafish) (Brachydanio rerio)","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"725",775,264708,"Cluster_6905","Peve_00005110",-0.875767513773266,0.320711764797665,0.978262075707395,153,-21.83,"2 15","311 333",14,"85.71%","85.71%","F1MDL2","Protein inturned (Inturned planar cell polarity effector homolog) (PDZ domain-containing protein 6)","Bos taurus (Bovine)","cell division [GO:0051301]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; hair follicle morphogenesis [GO:0031069]; keratinocyte differentiation [GO:0030216]; limb development [GO:0060173]; motile cilium assembly [GO:0044458]; negative regulation of cell division [GO:0051782]; negative regulation of keratinocyte proliferation [GO:0010839]; nervous system development [GO:0007399]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to organelle [GO:0033365]; regulation of ossification [GO:0030278]; regulation of smoothened signaling pathway [GO:0008589]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; spinal cord dorsal/ventral patterning [GO:0021513]; tongue morphogenesis [GO:0043587]; vesicle-mediated transport [GO:0016192]","GO:0001736; GO:0005737; GO:0005814; GO:0005929; GO:0007224; GO:0007399; GO:0008589; GO:0009986; GO:0010839; GO:0016192; GO:0021513; GO:0021915; GO:0030216; GO:0030278; GO:0031069; GO:0031514; GO:0033365; GO:0035869; GO:0036064; GO:0042733; GO:0043587; GO:0044458; GO:0045880; GO:0051301; GO:0051782; GO:0060021; GO:0060173; GO:0060271; GO:1905515"
"726",776,264785,"Cluster_1167","Peve_00005119",0.946547515622762,0.209089786937992,0.978262075707395,155,-20.23,"2 21","349 373",22,"68.18%","72.73%",NA,NA,NA,NA,NA
"727",777,264904,"Cluster_10934","Peve_00038734",-0.456234386365879,0.698395722414825,0.978262075707395,164,-23.79,"2 21","77 98",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"728",778,265333,"Cluster_4735","Peve_00023345",-0.638118435070293,0.559426015550302,0.978262075707395,147,-20.12,"2 12","76 97",10,"90.00%","90.00%","Q86V24","Adiponectin receptor protein 2 (Progestin and adipoQ receptor family member 2) (Progestin and adipoQ receptor family member II)","Homo sapiens (Human)","adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of cold-induced thermogenesis [GO:0120162]; vascular wound healing [GO:0061042]","GO:0005886; GO:0009755; GO:0019395; GO:0033211; GO:0038023; GO:0042593; GO:0042802; GO:0046872; GO:0055100; GO:0061042; GO:0097003; GO:0120162"
"729",779,266566,"Cluster_9983","Peve_00022900",0.589766176637386,0.598439809531814,0.978262075707395,158,-20.12,"2 20","788 809",19,"68.42%","84.21%","O15229","Kynurenine 3-monooxygenase (EC 1.14.13.9) (Kynurenine 3-hydroxylase)","Homo sapiens (Human)","'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; aging [GO:0007568]; anthranilate metabolic process [GO:0043420]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; kynurenic acid biosynthetic process [GO:0034276]; kynurenine metabolic process [GO:0070189]; L-kynurenine metabolic process [GO:0097052]; NAD metabolic process [GO:0019674]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; positive regulation of neuron death [GO:1901216]; quinolinate biosynthetic process [GO:0019805]; response to salt stress [GO:0009651]; tryptophan catabolic process [GO:0006569]","GO:0004502; GO:0005615; GO:0005741; GO:0005829; GO:0006569; GO:0007568; GO:0009651; GO:0016174; GO:0019674; GO:0019805; GO:0034276; GO:0034354; GO:0043420; GO:0050660; GO:0070189; GO:0071222; GO:0071347; GO:0071949; GO:0097052; GO:1901216; GO:1903296"
"730",780,266907,"Cluster_4629","Peve_00033826",0.0352593433520309,0.977548551201826,0.999448381576871,171,-27.41,"2 21","26 48",20,"80.00%","85.00%","Q9Z0M5","Lysosomal acid lipase/cholesteryl ester hydrolase (Acid cholesteryl ester hydrolase) (LAL) (EC 3.1.1.13) (Cholesteryl esterase) (Lipase A) (Sterol esterase)","Mus musculus (Mouse)","cell morphogenesis [GO:0000902]; epithelial cell proliferation [GO:0050673]; fatty acid metabolic process [GO:0006631]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; lipid catabolic process [GO:0016042]; lung development [GO:0030324]; macrophage homeostasis [GO:0061519]; sterol metabolic process [GO:0016125]; tissue remodeling [GO:0048771]","GO:0000902; GO:0001650; GO:0004771; GO:0005654; GO:0005764; GO:0005829; GO:0006631; GO:0006954; GO:0016042; GO:0016125; GO:0016298; GO:0030324; GO:0043231; GO:0048771; GO:0048873; GO:0050673; GO:0061519"
"731",781,266925,"Cluster_9149","Peve_00033826",-0.911408141365892,0.269992474080021,0.978262075707395,149,-25.58,"2 16","195 215",14,"71.43%","92.86%","Q9Z0M5","Lysosomal acid lipase/cholesteryl ester hydrolase (Acid cholesteryl ester hydrolase) (LAL) (EC 3.1.1.13) (Cholesteryl esterase) (Lipase A) (Sterol esterase)","Mus musculus (Mouse)","cell morphogenesis [GO:0000902]; epithelial cell proliferation [GO:0050673]; fatty acid metabolic process [GO:0006631]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; lipid catabolic process [GO:0016042]; lung development [GO:0030324]; macrophage homeostasis [GO:0061519]; sterol metabolic process [GO:0016125]; tissue remodeling [GO:0048771]","GO:0000902; GO:0001650; GO:0004771; GO:0005654; GO:0005764; GO:0005829; GO:0006631; GO:0006954; GO:0016042; GO:0016125; GO:0016298; GO:0030324; GO:0043231; GO:0048771; GO:0048873; GO:0050673; GO:0061519"
"732",782,266952,"Cluster_4629","Peve_00033825",-0.554554668634826,0.625777256211528,0.978262075707395,171,-27.41,"2 21","26 48",20,"80.00%","85.00%",NA,NA,NA,NA,NA
"733",783,266970,"Cluster_9149","Peve_00033825",-0.5,0.666666666666667,0.978262075707395,149,-25.58,"2 16","195 215",14,"71.43%","92.86%",NA,NA,NA,NA,NA
"734",786,268113,"Cluster_796","Peve_00041157",0.826767995347781,0.380353884481737,0.978262075707395,153,-21.83,"2 21","768 789",20,"75.00%","75.00%","P09917","Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34)","Homo sapiens (Human)","arachidonic acid metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; hepoxilin biosynthetic process [GO:0051122]; humoral immune response [GO:0006959]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; linoleic acid metabolic process [GO:0043651]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426]","GO:0001937; GO:0002232; GO:0002523; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005576; GO:0005615; GO:0005635; GO:0005641; GO:0005654; GO:0005829; GO:0006691; GO:0006959; GO:0016363; GO:0016525; GO:0016702; GO:0016787; GO:0019369; GO:0019370; GO:0019372; GO:0030501; GO:0031965; GO:0034440; GO:0034774; GO:0036336; GO:0036403; GO:0042593; GO:0042759; GO:0043651; GO:0045598; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0051122; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904813; GO:1904999; GO:2001301"
"735",787,268185,"Cluster_9149","Peve_00026108",-0.5,0.666666666666667,0.978262075707395,167,-26.85,"2 20","552 573",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"736",788,269601,"Cluster_2787","Peve_00011431",0.853541225986864,0.348900583835435,0.978262075707395,157,-21.74,"2 17","489 510",16,"87.50%","87.50%",NA,NA,NA,NA,NA
"737",789,270012,"Cluster_4629","Peve_00017871",-0.402844269576366,0.736043240625227,0.986102778584839,161,-27.09,"2 20","875 898",20,"75.00%","85.00%","P20585","DNA mismatch repair protein Msh3 (hMSH3) (Divergent upstream protein) (DUP) (Mismatch repair protein 1) (MRP1)","Homo sapiens (Human)","DNA repair [GO:0006281]; maintenance of DNA repeat elements [GO:0043570]; mismatch repair [GO:0006298]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; somatic recombination of immunoglobulin gene segments [GO:0016447]","GO:0003690; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006298; GO:0006312; GO:0016020; GO:0016447; GO:0019899; GO:0030983; GO:0032302; GO:0043570; GO:0045910; GO:0051096; GO:0140664"
"738",790,270164,"Cluster_8988","Peve_00013366",0.830482021033426,0.37613016557986,0.978262075707395,180,-28.12,"2 21","554 575",19,"78.95%","94.74%","P63086","Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2)","Rattus norvegicus (Rat)","aging [GO:0007568]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cardiac neural crest cell development involved in heart development [GO:0061308]; caveolin-mediated endocytosis [GO:0072584]; cell cycle [GO:0007049]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to organic substance [GO:0071310]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; cytosine metabolic process [GO:0019858]; decidualization [GO:0046697]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERBB signaling pathway [GO:0038127]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; long-term synaptic potentiation [GO:0060291]; lung morphogenesis [GO:0060425]; mammary gland epithelial cell proliferation [GO:0033598]; MAPK cascade [GO:0000165]; negative regulation of cell differentiation [GO:0045596]; neural crest cell development [GO:0014032]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of translation [GO:0045727]; protein phosphorylation [GO:0006468]; regulation of cellular pH [GO:0030641]; regulation of cytoskeleton organization [GO:0051493]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of ossification [GO:0030278]; regulation of protein stability [GO:0031647]; regulation of stress-activated MAPK cascade [GO:0032872]; response to epidermal growth factor [GO:0070849]; response to estrogen [GO:0043627]; response to exogenous dsRNA [GO:0043330]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to toxic substance [GO:0009636]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]","GO:0000165; GO:0001784; GO:0003690; GO:0004672; GO:0004674; GO:0004707; GO:0004708; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005769; GO:0005770; GO:0005794; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006468; GO:0006915; GO:0006974; GO:0007049; GO:0007165; GO:0007166; GO:0007507; GO:0007568; GO:0008284; GO:0008286; GO:0008353; GO:0009636; GO:0009887; GO:0010628; GO:0010759; GO:0010800; GO:0014032; GO:0014069; GO:0015966; GO:0016301; GO:0018105; GO:0018107; GO:0019233; GO:0019858; GO:0019901; GO:0019902; GO:0030278; GO:0030335; GO:0030424; GO:0030641; GO:0030878; GO:0031143; GO:0031435; GO:0031647; GO:0031663; GO:0032212; GO:0032496; GO:0032839; GO:0032872; GO:0032991; GO:0033598; GO:0034198; GO:0034614; GO:0035094; GO:0035556; GO:0038127; GO:0042307; GO:0042473; GO:0042802; GO:0043204; GO:0043330; GO:0043627; GO:0045596; GO:0045727; GO:0045893; GO:0046697; GO:0048009; GO:0048538; GO:0050852; GO:0050853; GO:0051403; GO:0051493; GO:0051973; GO:0060020; GO:0060045; GO:0060291; GO:0060324; GO:0060425; GO:0060440; GO:0060716; GO:0061308; GO:0070371; GO:0070849; GO:0071276; GO:0071310; GO:0071356; GO:0072584; GO:0072686; GO:0090170; GO:0097011; GO:0106310; GO:0120041; GO:1903351; GO:1904355; GO:2000641"
"739",791,270379,"Cluster_6906","Peve_00013363",0.564615775093787,0.618048729993923,0.978262075707395,162,-21.72,"2 21","377 397",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"740",792,271477,"Cluster_11135","Peve_00017299",0.944688611891262,0.21272806988103,0.978262075707395,155,-21.12,"2 21","875 897",20,"70.00%","75.00%","P82251","b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)","Homo sapiens (Human)","L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804]; protein-containing complex assembly [GO:0065003]","GO:0005886; GO:0015175; GO:0015179; GO:0015184; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0065003"
"741",793,272130,"Cluster_5882","Peve_00012188",-0.981119311652496,0.123905254816442,0.978262075707395,159,-20.77,"2 21","962 985",21,"71.43%","76.19%","Q3UQ28","Peroxidasin homolog (EC 1.11.2.-) [Cleaved into: PXDN active fragment]","Mus musculus (Mouse)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005201; GO:0005604; GO:0005615; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"742",794,272207,"Cluster_589","Peve_00012180",-0.934753615028442,0.231240264998328,0.978262075707395,146,-21.79,"2 11","84 105",9,"88.89%","100.00%","W8W138","Beta-secretase (EC 3.4.23.-)","Strongylocentrotus purpuratus (Purple sea urchin)","amyloid-beta metabolic process [GO:0050435]; membrane protein ectodomain proteolysis [GO:0006509]; proteolysis [GO:0006508]","GO:0004190; GO:0005768; GO:0005802; GO:0005886; GO:0006508; GO:0006509; GO:0050435"
"743",795,272825,"Cluster_10965","Peve_00017129",-0.881493939583369,0.313076612254622,0.978262075707395,158,-20.57,"2 20","223 246",20,"70.00%","80.00%","Q8TF20","Zinc finger protein 721","Homo sapiens (Human)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872"
"744",796,273288,"Cluster_796","Peve_00044702",0.475734142027675,0.684364881012657,0.978262075707395,159,-27.28,"2 21","6 28",20,"70.00%","80.00%","Q9TV36","Fibrillin-1 [Cleaved into: Asprosin]","Sus scrofa (Pig)","activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein kinase A signaling [GO:0010737]","GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0008201; GO:0009653; GO:0010737; GO:0031012; GO:0034199; GO:0042593"
"745",797,273592,"Cluster_11135","Peve_00039923",0.857477742556015,0.344060525911347,0.978262075707395,146,-20.15,"2 20","569 591",19,"57.89%","78.95%",NA,NA,NA,NA,NA
"746",798,273692,"Cluster_589","Peve_00020444",-0.260431871843117,0.832270117472699,0.995934364227446,155,-23.55,"2 12","286 307",10,"100.00%","100.00%","Q9HBH5","Retinol dehydrogenase 14 (EC 1.1.1.300) (Alcohol dehydrogenase PAN2) (Short chain dehydrogenase/reductase family 7C member 4)","Homo sapiens (Human)","osteoblast differentiation [GO:0001649]","GO:0001649; GO:0005634; GO:0005654; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0016020; GO:0052650; GO:0102354"
"747",799,275360,"Cluster_1167","Peve_00041754",0.999909726776791,0.00855416971793389,0.573710369894872,142,-20.26,"2 11","782 803",9,"88.89%","88.89%",NA,NA,NA,NA,NA
"748",800,275392,"Cluster_11135","Peve_00041754",0.844443877729655,0.359862212804899,0.978262075707395,167,-20.59,"2 20","669 690",18,"72.22%","88.89%",NA,NA,NA,NA,NA
"749",801,275673,"Cluster_796","Peve_00042484",-0.829106154727612,0.377699692492649,0.978262075707395,159,-21.34,"2 21","846 868",20,"75.00%","75.00%","Q7TNC8","Glycine receptor subunit alpha-2","Mus musculus (Mouse)","cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]","GO:0004888; GO:0005231; GO:0005886; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0022852; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:1902476; GO:1904315"
"750",802,275797,"Cluster_11135","Peve_00042486",0.473880564649538,0.685705681095932,0.978262075707395,161,-23.31,"2 21","879 898",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"751",803,275910,"Cluster_5882","Peve_00042483",0.996573155106522,0.0527189126684147,0.966552164271111,162,-22.67,"2 19","244 265",17,"70.59%","88.24%",NA,NA,NA,NA,NA
"752",804,276109,"Cluster_10934","Peve_00042488",-0.752048258638315,0.458132030682724,0.978262075707395,158,-23.62,"2 21","981 1000",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"753",805,276672,"Cluster_4629","Peve_00014587",0.997938030915673,0.0408894104551382,0.909359886114279,160,-22.43,"2 21","545 566",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"754",806,277030,"Cluster_4080","Peve_00015180",-0.409738447062385,0.731239938716994,0.984802736331943,157,-20.14,"2 21","79 101",21,"71.43%","80.95%","Q7Z494","Nephrocystin-3","Homo sapiens (Human)","atrial septum development [GO:0003283]; cilium assembly [GO:0060271]; convergent extension [GO:0060026]; convergent extension involved in gastrulation [GO:0060027]; determination of intestine left/right asymmetry [GO:0071908]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; determination of stomach left/right asymmetry [GO:0071909]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment or maintenance of cell polarity [GO:0007163]; extracellular matrix organization [GO:0030198]; heart looping [GO:0001947]; kidney development [GO:0001822]; kidney morphogenesis [GO:0060993]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; maintenance of animal organ identity [GO:0048496]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of protein binding [GO:0032092]; regulation of planar cell polarity pathway involved in neural tube closure [GO:2000167]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; ureter development [GO:0072189]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001947; GO:0003283; GO:0005576; GO:0005829; GO:0005929; GO:0006629; GO:0007163; GO:0007368; GO:0016055; GO:0030198; GO:0030324; GO:0032092; GO:0035469; GO:0045494; GO:0048496; GO:0060026; GO:0060027; GO:0060271; GO:0060287; GO:0060993; GO:0071908; GO:0071909; GO:0071910; GO:0072189; GO:0090090; GO:0097543; GO:0097546; GO:1905515; GO:2000095; GO:2000167"
"755",807,277082,"Cluster_6904","Peve_00019602",-0.987610227653681,0.100317385960486,0.978262075707395,154,-24.07,"2 21","929 949",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"756",808,277084,"Cluster_6906","Peve_00019602",-0.790619918108178,0.419516871177393,0.978262075707395,162,-24.74,"2 21","929 949",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"757",809,277247,"Cluster_589","Peve_00015186",-0.934753615028442,0.231240264998328,0.978262075707395,150,-20.27,"2 20","687 710",20,"65.00%","75.00%",NA,NA,NA,NA,NA
"758",810,278224,"Cluster_10934","Peve_00042220",0.998758250045999,0.0317290557481559,0.903929377050813,155,-22.16,"2 21","131 158",25,"64.00%","72.00%",NA,NA,NA,NA,NA
"759",811,279351,"Cluster_11134","Peve_00044284",0.328226867630311,0.787097901544521,0.995158456348467,155,-21,"2 21","886 908",20,"60.00%","85.00%",NA,NA,NA,NA,NA
"760",812,279352,"Cluster_11135","Peve_00044284",0.977763101014741,0.134505583791596,0.978262075707395,146,-20.26,"2 19","762 787",21,"71.43%","80.95%",NA,NA,NA,NA,NA
"761",813,279396,"Cluster_11134","Peve_00031999",0.87012328820465,0.32807811617807,0.978262075707395,156,-22.22,"2 17","166 187",15,"73.33%","86.67%",NA,NA,NA,NA,NA
"762",814,279455,"Cluster_1167","Peve_00031993",0.999909726776791,0.00855416971793915,0.573710369894872,148,-22.03,"2 20","269 290",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"763",815,279756,"Cluster_11134","Peve_00005452",0.875640822838247,0.320878802775509,0.978262075707395,148,-20.64,"2 21","663 684",19,"57.89%","73.68%","Q9FGB1",NA,NA,NA,NA
"764",816,279862,"Cluster_2854","Peve_00006118",-0.459022672477156,0.696399329916218,0.978262075707395,167,-21.35,"2 21","452 474",20,"75.00%","85.00%","Q01196","Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit)","Homo sapiens (Human)","cardiac muscle tissue regeneration [GO:0061026]; chondrocyte differentiation [GO:0002062]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; myeloid cell differentiation [GO:0030099]; myeloid leukocyte differentiation [GO:0002573]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; ossification [GO:0001503]; peripheral nervous system neuron development [GO:0048935]; positive regulation of angiogenesis [GO:0045766]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cell differentiation [GO:0045595]; regulation of connective tissue replacement [GO:1905203]; regulation of plasminogen activation [GO:0010755]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001222; GO:0001223; GO:0001228; GO:0001503; GO:0002062; GO:0002573; GO:0003677; GO:0003700; GO:0005509; GO:0005524; GO:0005634; GO:0005654; GO:0006357; GO:0010755; GO:0016513; GO:0030097; GO:0030099; GO:0030182; GO:0030853; GO:0030854; GO:0032743; GO:0032967; GO:0042803; GO:0043231; GO:0043371; GO:0043378; GO:0045595; GO:0045766; GO:0045893; GO:0045944; GO:0046982; GO:0048935; GO:0060043; GO:0061026; GO:0071425; GO:0140297; GO:1903055; GO:1905203"
"765",817,280056,"Cluster_7053","Peve_00006113",-0.481812397229847,0.679957338002789,0.978262075707395,164,-20.65,"2 20","931 952",19,"78.95%","89.47%","A6QLI6","5-aminolevulinate synthase, non-specific, mitochondrial (ALAS-H) (EC 2.3.1.37) (5-aminolevulinic acid synthase 1) (Delta-ALA synthase 1) (Delta-aminolevulinate synthase 1)","Bos taurus (Bovine)","erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to bile acid [GO:1903412]","GO:0003870; GO:0005739; GO:0005743; GO:0005759; GO:0006782; GO:0006783; GO:0030170; GO:0042541; GO:0048821; GO:1903412"
"766",819,280311,"Cluster_2787","Peve_00029243",0.797347643552924,0.412471530832369,0.978262075707395,162,-21.65,"2 21","47 67",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"767",821,281580,"Cluster_5882","Peve_00007247",-0.0483211649331207,0.969225807090758,0.999448381576871,168,-28.52,"2 19","702 725",19,"84.21%","89.47%","Q60803","TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3)","Mus musculus (Mouse)","apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of JNK cascade [GO:0046330]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0001817; GO:0002224; GO:0005164; GO:0005739; GO:0005768; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0016740; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032648; GO:0033209; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0045087; GO:0046330; GO:0050688; GO:0070534"
"768",822,281639,"Cluster_8988","Peve_00007240",0.276922823998199,0.821370724996906,0.995934364227446,159,-22.92,"2 21","846 872",24,"66.67%","75.00%",NA,NA,NA,NA,NA
"769",823,282180,"Cluster_9149","Peve_00037038",-0.800836869817248,0.408776755454056,0.978262075707395,163,-27.36,"2 21","243 266",21,"71.43%","80.95%","A0A411L030","Proline hydroxylase buaE (EC 1.14.11.-) (2-oxoglutarate-dependent dioxygenase buaE) (Burnettramic acids biosynthesis cluster protein E)","Aspergillus burnettii","antibiotic biosynthetic process [GO:0017000]; organic acid biosynthetic process [GO:0016053]; organic cyclic compound biosynthetic process [GO:1901362]","GO:0016053; GO:0017000; GO:0046872; GO:0051213; GO:1901362"
"770",824,282800,"Cluster_6914","Peve_00032640",0.870958317374211,0.326997846308427,0.978262075707395,160,-22.01,"2 20","924 944",19,"73.68%","89.47%","Q6NYP0","Transmembrane protein 208","Danio rerio (Zebrafish) (Brachydanio rerio)","autophagy [GO:0006914]; vacuolar protein processing [GO:0006624]","GO:0005773; GO:0005789; GO:0006624; GO:0006914"
"771",825,283309,"Cluster_10934","Peve_00028675",-0.918059889761557,0.259510232656931,0.978262075707395,149,-20.98,"2 19","423 449",22,"63.64%","72.73%","P24386","Rab proteins geranylgeranyltransferase component A 1 (Choroideremia protein) (Rab escort protein 1) (REP-1) (TCD protein)","Homo sapiens (Human)","protein geranylgeranylation [GO:0018344]; protein targeting to membrane [GO:0006612]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601]","GO:0004663; GO:0005092; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005968; GO:0006612; GO:0007264; GO:0007601; GO:0016192; GO:0018344; GO:0031267"
"772",826,283410,"Cluster_16738","Peve_00028670",-0.996857906459909,0.0504798966914922,0.955687500796457,160,-20.56,"2 13","207 228",11,"100.00%","100.00%",NA,NA,NA,NA,NA
"773",827,283620,"Cluster_9149","Peve_00007931",-0.723119839506402,0.485414838400773,0.978262075707395,148,-21.88,"2 20","835 854",18,"61.11%","83.33%","A6QLU6","Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)","Bos taurus (Bovine)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189"
"774",828,283935,"Cluster_9149","Peve_00037697",-0.947218190673067,0.207762065034909,0.978262075707395,154,-21.97,"2 20","42 64",19,"68.42%","78.95%","O62742","Sterol carrier protein 2 (SCP-2) (Acetyl-CoA C-myristoyltransferase) (EC 2.3.1.155) (Non-specific lipid-transfer protein) (NSL-TP) (Propanoyl-CoA C-acyltransferase) (EC 2.3.1.176) (SCP-2/3-oxoacyl-CoA thiolase) (SCP-2/thiolase) (EC 2.3.1.16) (SCP-chi) (SCPX) (Sterol carrier protein X) (SCP-X)","Oryctolagus cuniculus (Rabbit)","bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; regulation of phospholipid biosynthetic process [GO:0071071]","GO:0003988; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0006635; GO:0006869; GO:0008206; GO:0008289; GO:0032367; GO:0033814; GO:0050632; GO:0050633; GO:0071071; GO:0120019; GO:0120020"
"775",831,285321,"Cluster_7053","Peve_00009572",0.72191792776802,0.486521600354106,0.978262075707395,162,-20.38,"2 20","150 175",22,"72.73%","77.27%",NA,NA,NA,NA,NA
"776",832,285514,"Cluster_10934","Peve_00037965",0.651805358594588,0.548023812529939,0.978262075707395,154,-20.23,"2 21","198 223",23,"69.57%","73.91%","Q9CPW0","Contactin-associated protein-like 2 (Cell recognition molecule Caspr2)","Mus musculus (Mouse)","action potential initiation [GO:0099610]; adult behavior [GO:0030534]; associative learning [GO:0008306]; axonogenesis [GO:0007409]; behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; central nervous system myelination [GO:0022010]; cerebellar Purkinje cell layer morphogenesis [GO:0021692]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle [GO:0042745]; clustering of voltage-gated potassium channels [GO:0045163]; dendrite arborization [GO:0140059]; dendritic spine development [GO:0060996]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; embryonic brain development [GO:1990403]; ERK1 and ERK2 cascade [GO:0070371]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; excitatory synapse assembly [GO:1904861]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; glial cell proliferation [GO:0014009]; glutamatergic neuron differentiation [GO:1905962]; grooming behavior [GO:0007625]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; inhibitory chemical synaptic transmission [GO:0098977]; inhibitory synapse assembly [GO:1904862]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; limbic system development [GO:0021761]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; maintenance of synapse structure [GO:0099558]; mitochondrion organization [GO:0007005]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; myelination [GO:0042552]; negative regulation of neuronal action potential [GO:1904456]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neural precursor cell proliferation [GO:0061351]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process [GO:0050905]; neuromuscular process controlling posture [GO:0050884]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuron recognition [GO:0008038]; neuronal action potential [GO:0019228]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of neuronal action potential [GO:1904457]; postsynaptic density organization [GO:0097106]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; protein localization to juxtaparanode region of axon [GO:0071205]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to dietary excess [GO:0002021]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to interleukin-17 [GO:0097396]; response to light intensity [GO:0009642]; response to mechanical stimulus [GO:0009612]; response to metformin [GO:1901558]; response to odorant [GO:1990834]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; rhythmic behavior [GO:0007622]; social behavior [GO:0035176]; TOR signaling [GO:0031929]; transmission of nerve impulse [GO:0019226]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]; walking behavior [GO:0090659]","GO:0000902; GO:0001701; GO:0002021; GO:0005769; GO:0005794; GO:0006954; GO:0007005; GO:0007155; GO:0007268; GO:0007409; GO:0007612; GO:0007622; GO:0007625; GO:0007626; GO:0008038; GO:0008076; GO:0008104; GO:0008283; GO:0008306; GO:0009408; GO:0009410; GO:0009612; GO:0009642; GO:0009725; GO:0009986; GO:0010033; GO:0010467; GO:0014009; GO:0016020; GO:0019226; GO:0019228; GO:0019899; GO:0021549; GO:0021692; GO:0021761; GO:0022010; GO:0030165; GO:0030424; GO:0030425; GO:0030534; GO:0030673; GO:0031175; GO:0031929; GO:0032229; GO:0033010; GO:0035176; GO:0035264; GO:0035556; GO:0042297; GO:0042552; GO:0042734; GO:0042745; GO:0043005; GO:0043025; GO:0043194; GO:0043491; GO:0044224; GO:0044309; GO:0044853; GO:0045163; GO:0045202; GO:0045444; GO:0045475; GO:0048265; GO:0048266; GO:0048787; GO:0048812; GO:0050884; GO:0050905; GO:0060076; GO:0060079; GO:0060996; GO:0061351; GO:0061744; GO:0070371; GO:0071205; GO:0071625; GO:0090659; GO:0097061; GO:0097062; GO:0097106; GO:0097396; GO:0098529; GO:0098793; GO:0098794; GO:0098976; GO:0098977; GO:0098978; GO:0098982; GO:0099072; GO:0099558; GO:0099610; GO:0140059; GO:0150048; GO:1901558; GO:1903598; GO:1904456; GO:1904457; GO:1904861; GO:1904862; GO:1905962; GO:1990403; GO:1990834"
"777",833,285977,"Cluster_589","Peve_00028106",0.380454731606049,0.751534970888455,0.988219883885475,155,-21.76,"2 12","294 315",10,"100.00%","100.00%","Q9D9S1","UPF0193 protein EVG1 homolog","Mus musculus (Mouse)","",""
"778",834,286018,"Cluster_15890","Peve_00028106",0.379387858929204,0.752269217896024,0.988219883885475,200,-36.97,"2 21","687 708",19,"100.00%","100.00%","Q9D9S1","UPF0193 protein EVG1 homolog","Mus musculus (Mouse)","",""
"779",835,286098,"Cluster_10061","Peve_00005981",-0.154351039480072,0.901342659768747,0.999448381576871,168,-22.81,"2 18","571 593",17,"82.35%","94.12%",NA,NA,NA,NA,NA
"780",836,286173,"Cluster_6905","Peve_00005980",-0.934372103334756,0.231922894176892,0.978262075707395,153,-22.73,"2 20","951 975",21,"71.43%","76.19%","A2ATU0","2-oxoadipate dehydrogenase complex component E1 (E1a) (OADC-E1) (OADH-E1) (EC 1.2.4.-) (2-oxoadipate dehydrogenase, mitochondrial) (Alpha-ketoadipate dehydrogenase) (Alpha-KADH-E1) (Dehydrogenase E1 and transketolase domain-containing protein 1) (Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial)","Mus musculus (Mouse)","generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hematopoietic progenitor cell differentiation [GO:0002244]; tricarboxylic acid cycle [GO:0006099]","GO:0002244; GO:0004591; GO:0005739; GO:0006091; GO:0006096; GO:0006099; GO:0030976"
"781",837,286440,"Cluster_5882","Peve_00023064",0.970922741092274,0.153896891887812,0.978262075707395,160,-20.1,"2 21","63 81",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"782",838,286692,"Cluster_15726","Peve_00031696",-0.691620286059443,0.513794380068512,0.978262075707395,163,-20.59,"2 21","909 931",20,"75.00%","80.00%","P28648","CD63 antigen (Mast cell antigen AD1) (CD antigen CD63)","Rattus norvegicus (Rat)","cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; epithelial cell differentiation [GO:0030855]; negative regulation of epithelial cell migration [GO:0010633]; pigment cell differentiation [GO:0050931]; pigment granule maturation [GO:0048757]; pigmentation [GO:0043473]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endocytosis [GO:0045807]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]","GO:0002092; GO:0005615; GO:0005737; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0007160; GO:0008104; GO:0009986; GO:0010008; GO:0010633; GO:0015031; GO:0016020; GO:0016477; GO:0030855; GO:0031902; GO:0031904; GO:0032585; GO:0032991; GO:0035646; GO:0042470; GO:0043473; GO:0044877; GO:0045785; GO:0045807; GO:0048757; GO:0050931; GO:0070062; GO:0097487; GO:1900746; GO:1901379; GO:2001046"
"783",839,286760,"Cluster_6914","Peve_00031695",0.560960213334246,0.62086412296465,0.978262075707395,144,-21.06,"2 18","971 992",17,"70.59%","70.59%",NA,NA,NA,NA,NA
"784",840,286872,"Cluster_15726","Peve_00031693",0.79383033675238,0.416167586736588,0.978262075707395,154,-20.6,"2 21","199 223",22,"72.73%","72.73%",NA,NA,NA,NA,NA
"785",841,287330,"Cluster_1167","Peve_00024388",0.999909726776791,0.00855416971793389,0.573710369894872,151,-23.33,"2 12","579 600",10,"90.00%","100.00%",NA,NA,NA,NA,NA
"786",842,287592,"Cluster_15726","Peve_00024386",-0.525658462286823,0.647637986727327,0.978262075707395,158,-21.98,"2 21","479 499",19,"73.68%","78.95%","P29375","Lysine-specific demethylase 5A (EC 1.14.11.67) (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2) (RBBP-2) ([histone H3]-trimethyl-L-lysine(4) demethylase 5A)","Homo sapiens (Human)","chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; facultative heterochromatin formation [GO:0140718]; histone H3-K4 demethylation [GO:0034720]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]","GO:0000122; GO:0000976; GO:0003677; GO:0003713; GO:0004857; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0008270; GO:0031490; GO:0032452; GO:0032922; GO:0032993; GO:0034647; GO:0034720; GO:0035064; GO:0042393; GO:0045893; GO:0051090; GO:0140718"
"787",843,287788,"Cluster_4735","Peve_00031905",0.619864239900507,0.574375319668645,0.978262075707395,164,-24.58,"2 19","766 786",17,"82.35%","88.24%",NA,NA,NA,NA,NA
"788",844,287880,"Cluster_5882","Peve_00031525",-0.879671420745531,0.315524972466229,0.978262075707395,162,-20.2,"2 15","901 922",13,"84.62%","100.00%","Q5F485","ATP-dependent RNA helicase DDX42 (EC 3.6.4.13) (DEAD box protein 42)","Gallus gallus (Chicken)","protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]","GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0008104; GO:0016887; GO:0042981"
"789",845,288465,"Cluster_5882","Peve_00025388",-0.27814091057559,0.820563558554478,0.995934364227446,160,-24.38,"2 18","173 196",18,"72.22%","88.89%",NA,NA,NA,NA,NA
"790",846,288750,"Cluster_9149","Peve_00005303",-0.5,0.666666666666667,0.978262075707395,147,-21.03,"2 12","183 204",10,"80.00%","100.00%",NA,NA,NA,NA,NA
"791",847,288811,"Cluster_29","Peve_00005300",-0.455197272482487,0.699137468837807,0.978262075707395,162,-21.28,"2 20","30 52",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"792",848,289185,"Cluster_5882","Peve_00025036",0.54740183602677,0.631233888777305,0.978262075707395,161,-20.24,"2 19","275 298",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"793",849,289997,"Cluster_6904","Peve_00026601",-0.966422489004039,0.165440613587419,0.978262075707395,154,-20.26,"2 21","628 653",23,"69.57%","73.91%","B3EWZ5","MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576; GO:0016020"
"794",850,290177,"Cluster_6904","Peve_00026609",0.114387152279019,0.927019131071964,0.999448381576871,149,-20.6,"2 17","843 862",15,"80.00%","80.00%","Q28DL4","TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","intracellular signal transduction [GO:0035556]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]","GO:0004842; GO:0005164; GO:0005634; GO:0005811; GO:0005938; GO:0008270; GO:0035556; GO:0042981; GO:0043122; GO:0070534"
"795",853,292282,"Cluster_2854","Peve_00018824",-0.990510770508141,0.0877717225186119,0.978262075707395,168,-24.41,"2 21","464 485",19,"73.68%","84.21%","Q8VE62","Polyadenylate-binding protein-interacting protein 1 (PABP-interacting protein 1) (PAIP-1) (Poly(A)-binding protein-interacting protein 1)","Mus musculus (Mouse)","CRD-mediated mRNA stabilization [GO:0070934]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; positive regulation by host of viral process [GO:0044794]; positive regulation of cytoplasmic translation [GO:2000767]; regulation of translational initiation [GO:0006446]","GO:0003723; GO:0005829; GO:0006446; GO:0008494; GO:0044794; GO:0070934; GO:0106002; GO:1900152; GO:2000767"
"796",854,293008,"Cluster_4735","Peve_00013284",0.674269544209493,0.528917202472294,0.978262075707395,151,-20.42,"2 16","29 50",14,"71.43%","85.71%",NA,NA,NA,NA,NA
"797",856,293564,"Cluster_8988","Peve_00017626",0.0860148226113438,0.945173514868548,0.999448381576871,167,-20.27,"2 21","590 613",21,"76.19%","80.95%","Q7TQP6","Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (Cardiac ankyrin repeat kinase) (TNNI3-interacting kinase)","Rattus norvegicus (Rat)","bundle of His cell to Purkinje myocyte communication [GO:0086069]; protein phosphorylation [GO:0006468]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0002027; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006357; GO:0006468; GO:0008022; GO:0031013; GO:0046872; GO:0055117; GO:0061629; GO:0086069; GO:0106310; GO:1903779"
"798",857,293700,"Cluster_9149","Peve_00017629",-0.0880155349802657,0.943894972065777,0.999448381576871,158,-21.81,"2 15","120 141",13,"84.62%","92.31%",NA,NA,NA,NA,NA
"799",858,294021,"Cluster_11134","Peve_00039333",0.875640822838247,0.320878802775509,0.978262075707395,152,-21.14,"2 21","223 244",19,"57.89%","78.95%",NA,NA,NA,NA,NA
"800",859,294297,"Cluster_15726","Peve_00034128",-0.5,0.666666666666667,0.978262075707395,168,-22.21,"2 20","455 474",18,"83.33%","88.89%",NA,NA,NA,NA,NA
"801",860,294797,"Cluster_589","Peve_00002308",-0.880804537153031,0.314004810540731,0.978262075707395,163,-25.41,"2 21","867 889",20,"75.00%","80.00%","Q6V0I7","Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)","Homo sapiens (Human)","cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008]","GO:0005509; GO:0005886; GO:0007156; GO:0007157; GO:0021987; GO:0022008; GO:0035329; GO:0070062; GO:0098609"
"802",861,294865,"Cluster_8634","Peve_00026099",0.956227319072805,0.189057429551567,0.978262075707395,170,-20.13,"2 19","20 41",17,"76.47%","94.12%",NA,NA,NA,NA,NA
"803",862,295286,"Cluster_14999","Peve_00000237",-0.503913969445943,0.663785713988346,0.978262075707395,167,-22.6,"2 21","515 538",21,"71.43%","85.71%","Q3TZA2","Cyclin-dependent kinase-like 4 (EC 2.7.11.22)","Mus musculus (Mouse)","protein phosphorylation [GO:0006468]","GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0106310"
"804",863,295302,"Cluster_4629","Peve_00032406",0.251623764805037,0.838070899514893,0.995934364227446,155,-21.23,"2 21","240 262",20,"70.00%","75.00%","O35162","Heat shock 70 kDa protein 13 (Microsomal stress-70 protein ATPase core) (Stress-70 protein chaperone microsome-associated 60 kDa protein)","Rattus norvegicus (Rat)","cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]","GO:0005524; GO:0005737; GO:0005739; GO:0005783; GO:0016887; GO:0031072; GO:0034620; GO:0042026; GO:0044183; GO:0051082; GO:0051085; GO:0051787; GO:0140662"
"805",864,295320,"Cluster_9149","Peve_00032406",0.755926918454867,0.454373023363302,0.978262075707395,153,-24.23,"2 15","153 175",14,"78.57%","92.86%","O35162","Heat shock 70 kDa protein 13 (Microsomal stress-70 protein ATPase core) (Stress-70 protein chaperone microsome-associated 60 kDa protein)","Rattus norvegicus (Rat)","cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]","GO:0005524; GO:0005737; GO:0005739; GO:0005783; GO:0016887; GO:0031072; GO:0034620; GO:0042026; GO:0044183; GO:0051082; GO:0051085; GO:0051787; GO:0140662"
"806",865,296475,"Cluster_5882","Peve_00008020",-0.597634890504111,0.592214485705041,0.978262075707395,168,-23.8,"2 21","399 420",19,"73.68%","84.21%","Q3V050","Multidrug and toxin extrusion protein 2 (MATE-2) (mMATE-2) (H(+)/organic cation antiporter kidney-specific) (Solute carrier family 47 member 2)","Mus musculus (Mouse)","organic cation transport [GO:0015695]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]","GO:0005886; GO:0015101; GO:0015179; GO:0015297; GO:0015299; GO:0015695; GO:0016020; GO:0016323; GO:0016324; GO:0022857; GO:0042910; GO:0061459; GO:1990961"
"807",866,297983,"Cluster_11997","Peve_00019830",-0.858463396062183,0.342839017589914,0.978262075707395,162,-20.67,"2 21","618 641",21,"71.43%","85.71%",NA,NA,NA,NA,NA
"808",867,298740,"Cluster_9149","Peve_00014620",-0.685958049682704,0.518766677991251,0.978262075707395,155,-23.62,"2 18","7 31",19,"78.95%","78.95%","Q5R9J9","Trafficking protein particle complex subunit 4","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","autophagy [GO:0006914]; dendrite development [GO:0016358]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]","GO:0000139; GO:0005783; GO:0005795; GO:0006888; GO:0006914; GO:0008021; GO:0016358; GO:0030008; GO:0030425; GO:0045211"
"809",868,298900,"Cluster_4080","Peve_00014624",-0.822591297596186,0.385055108750895,0.978262075707395,166,-20.01,"2 21","945 965",19,"78.95%","84.21%","A3KNJ3",NA,NA,NA,NA
"810",869,299350,"Cluster_4080","Peve_00031324",0.999992290678624,0.00249978970397961,0.417409525382424,171,-20.17,"2 20","9 30",18,"77.78%","88.89%","Q9CQW0","ER membrane protein complex subunit 6 (Transmembrane protein 93)","Mus musculus (Mouse)","autophagosome assembly [GO:0000045]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]","GO:0000045; GO:0005789; GO:0016020; GO:0032977; GO:0045050; GO:0071816; GO:0072546; GO:1903349"
"811",870,299737,"Cluster_11135","Peve_00034940",-0.960352291084237,0.179866222046799,0.978262075707395,160,-20.02,"2 21","642 663",19,"63.16%","84.21%","Q5RJU3","Coiled-coil domain-containing protein 103","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","axonemal dynein complex assembly [GO:0070286]","GO:0031514; GO:0036157; GO:0070286"
"812",871,300283,"Cluster_15890","Peve_00041682",-0.744174662931319,0.465686026380869,0.978262075707395,167,-20.07,"2 21","624 647",21,"71.43%","85.71%","Q4UMH6","Putative ankyrin repeat protein RF_0381","Rickettsia felis (strain ATCC VR-1525 / URRWXCal2) (Rickettsia azadi)","guanosine tetraphosphate metabolic process [GO:0015969]","GO:0015969"
"813",873,300765,"Cluster_9149","Peve_00014722",-0.5,0.666666666666667,0.978262075707395,153,-26.63,"2 17","313 332",15,"80.00%","86.67%","Q8K4Z5","Splicing factor 3A subunit 1 (SF3a120)","Mus musculus (Mouse)","mRNA cis splicing, via spliceosome [GO:0045292]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]","GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0006397; GO:0016607; GO:0045292; GO:0071004; GO:0071005; GO:0071013; GO:1903241"
"814",874,301332,"Cluster_4629","Peve_00031819",0.229616615979129,0.852505540160184,0.995934364227446,146,-25.05,"2 21","846 871",23,"65.22%","69.57%","Q9Y6D9","Mitotic spindle assembly checkpoint protein MAD1 (Mitotic arrest deficient 1-like protein 1) (MAD1-like protein 1) (Mitotic checkpoint MAD1 protein homolog) (HsMAD1) (hMAD1) (Tax-binding protein 181)","Homo sapiens (Human)","attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cytoplasmic sequestering of protein [GO:0051220]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538]","GO:0000776; GO:0000922; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0007094; GO:0042130; GO:0042802; GO:0043515; GO:0044615; GO:0048538; GO:0051220; GO:0051301; GO:0051315; GO:0072686; GO:0090235; GO:0090267; GO:1902426; GO:1990706; GO:1990728"
"815",875,301341,"Cluster_7053","Peve_00031819",0.175727339627744,0.887544582795028,0.999448381576871,167,-20.16,"2 20","959 980",18,"72.22%","88.89%","Q9Y6D9","Mitotic spindle assembly checkpoint protein MAD1 (Mitotic arrest deficient 1-like protein 1) (MAD1-like protein 1) (Mitotic checkpoint MAD1 protein homolog) (HsMAD1) (hMAD1) (Tax-binding protein 181)","Homo sapiens (Human)","attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cytoplasmic sequestering of protein [GO:0051220]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538]","GO:0000776; GO:0000922; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0007094; GO:0042130; GO:0042802; GO:0043515; GO:0044615; GO:0048538; GO:0051220; GO:0051301; GO:0051315; GO:0072686; GO:0090235; GO:0090267; GO:1902426; GO:1990706; GO:1990728"
"816",876,301462,"Cluster_2854","Peve_00035317",-0.630756184239657,0.565489616690633,0.978262075707395,169,-28.3,"2 21","128 147",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"817",877,301536,"Cluster_11134","Peve_00035315",0.997089150362585,0.0485859177132707,0.947668828184205,163,-24.46,"2 21","718 740",20,"75.00%","80.00%","Q9VW71","Fat-like cadherin-related tumor suppressor homolog (Protein kugelei)","Drosophila melanogaster (Fruit fly)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; centripetally migrating follicle cell migration [GO:0060269]; defense response to Gram-negative bacterium [GO:0050829]; establishment of planar polarity of follicular epithelium [GO:0042247]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; foregut morphogenesis [GO:0007440]; growth of a germarium-derived egg chamber [GO:0007295]; hindgut morphogenesis [GO:0007442]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of innate immune response [GO:0045089]; protein localization to cell leading edge [GO:1902463]; salivary gland development [GO:0007431]","GO:0005509; GO:0005886; GO:0005925; GO:0007156; GO:0007295; GO:0007424; GO:0007431; GO:0007440; GO:0007442; GO:0009925; GO:0016339; GO:0030950; GO:0031254; GO:0042247; GO:0044331; GO:0044877; GO:0045089; GO:0048477; GO:0050829; GO:0050839; GO:0051491; GO:0060269; GO:0098609; GO:0098858; GO:1902463"
"818",878,301597,"Cluster_2854","Peve_00003851",-0.492476100688937,0.672183790869439,0.978262075707395,164,-22.38,"2 20","583 604",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"819",879,302679,"Cluster_4079","Peve_00021823",-0.602524217945433,0.588323376033554,0.978262075707395,153,-20.09,"2 19","182 205",19,"73.68%","73.68%","Q9Y4A5","Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor) (PAF350/400) (STAF40) (Tra1 homolog)","Homo sapiens (Human)","chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair [GO:2000779]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000124; GO:0000786; GO:0000812; GO:0003712; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0006282; GO:0006325; GO:0006355; GO:0006357; GO:0016573; GO:0033276; GO:0035267; GO:0035521; GO:0035522; GO:0042981; GO:0043484; GO:0043966; GO:0043967; GO:0043968; GO:0045893; GO:0051726; GO:1905168; GO:2000779"
"820",880,302715,"Cluster_16738","Peve_00021823",-0.253537410039089,0.836811809988684,0.995934364227446,157,-21.82,"2 19","280 302",18,"77.78%","77.78%","Q9Y4A5","Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor) (PAF350/400) (STAF40) (Tra1 homolog)","Homo sapiens (Human)","chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair [GO:2000779]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000124; GO:0000786; GO:0000812; GO:0003712; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0006282; GO:0006325; GO:0006355; GO:0006357; GO:0016573; GO:0033276; GO:0035267; GO:0035521; GO:0035522; GO:0042981; GO:0043484; GO:0043966; GO:0043967; GO:0043968; GO:0045893; GO:0051726; GO:1905168; GO:2000779"
"821",881,302788,"Cluster_8888","Peve_00021827",-0.734978994113776,0.474383987054699,0.978262075707395,159,-20.12,"2 18","737 760",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"822",882,303077,"Cluster_589","Peve_00035198",0.775072695353894,0.435426401668339,0.978262075707395,151,-20.63,"2 21","856 879",21,"66.67%","71.43%",NA,NA,NA,NA,NA
"823",883,303611,"Cluster_14999","Peve_00012777",0.42953492592166,0.717355011148745,0.980862863934935,164,-20.34,"2 17","790 811",15,"86.67%","86.67%","Q6NZN1","Peroxisome proliferator-activated receptor gamma coactivator-related protein 1 (PGC-1-related coactivator) (PRC)","Mus musculus (Mouse)","positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0003723; GO:0005634; GO:0005654; GO:0030374; GO:0045944; GO:0051091"
"824",884,304020,"Cluster_16738","Peve_00026882",-0.493765079118584,0.671240542455818,0.978262075707395,169,-21.23,"2 21","200 219",19,"78.95%","89.47%","Q0WYX8","MAM domain-containing glycosylphosphatidylinositol anchor protein 1","Gallus gallus (Chicken)","neuron migration [GO:0001764]","GO:0001764; GO:0005886"
"825",885,304197,"Cluster_15726","Peve_00026884",-0.4566496763206,0.698098581797731,0.978262075707395,148,-23.35,"2 21","878 898",20,"65.00%","80.00%","Q2YDN1","G protein-coupled receptor 161","Bos taurus (Bovine)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]","GO:0004930; GO:0005929; GO:0007186; GO:0007189; GO:0055037; GO:0060170; GO:1901621"
"826",886,304904,"Cluster_8988","Peve_00027752",0.971213685246558,0.153121265345213,0.978262075707395,150,-20.84,"2 21","637 660",21,"66.67%","76.19%","Q4PZA2","Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71)","Mus musculus (Mouse)","apoptotic process [GO:0006915]; axonogenesis involved in innervation [GO:0060385]; blood vessel diameter maintenance [GO:0097746]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endothelin maturation [GO:0034959]; gene expression [GO:0010467]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; neuron projection development [GO:0031175]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; regulation of blood pressure [GO:0008217]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to hypoxia [GO:0001666]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; substance P catabolic process [GO:0010814]; sympathetic neuron axon guidance [GO:0097492]","GO:0001666; GO:0001921; GO:0004175; GO:0004222; GO:0005768; GO:0005769; GO:0005794; GO:0005886; GO:0006915; GO:0007507; GO:0008217; GO:0008270; GO:0009897; GO:0009986; GO:0010467; GO:0010613; GO:0010814; GO:0010815; GO:0010816; GO:0016020; GO:0016485; GO:0016486; GO:0030141; GO:0031175; GO:0031410; GO:0031982; GO:0033093; GO:0034959; GO:0035050; GO:0042447; GO:0042733; GO:0042802; GO:0042803; GO:0043583; GO:0043950; GO:0045745; GO:0048471; GO:0060037; GO:0060385; GO:0070372; GO:0097492; GO:0097746; GO:1902287"
"827",887,305561,"Cluster_4115","Peve_00024481",-0.37467466380922,0.755508816604224,0.988219883885475,169,-23.63,"2 20","584 604",18,"83.33%","88.89%","Q6F754","Glycine betaine transporter","Acinetobacter baylyi (strain ATCC 33305 / BD413 / ADP1)","nitrogen compound transport [GO:0071705]","GO:0005886; GO:0022857; GO:0071705"
"828",888,305737,"Cluster_2854","Peve_00045305",-0.590211585280053,0.598088618096309,0.978262075707395,157,-21.26,"2 21","978 1000",21,"71.43%","80.95%","Q5W8I8","Vesicular glutamate transporter 2.1 (Protein blumenkohl) (Solute carrier family 17 member 6-B) (Vesicular glutamate transporter 2-A)","Danio rerio (Zebrafish) (Brachydanio rerio)","anion transport [GO:0006820]; chemical synaptic transmission [GO:0007268]; L-glutamate import [GO:0051938]; L-glutamate transmembrane transport [GO:0015813]; neurotransmitter loading into synaptic vesicle [GO:0098700]; phosphate ion homeostasis [GO:0055062]; phosphate ion transport [GO:0006817]; regulation of synapse structure or activity [GO:0050803]; response to stimulus [GO:0050896]; sodium-dependent phosphate transport [GO:0044341]; synaptic transmission, glutamatergic [GO:0035249]; visual perception [GO:0007601]","GO:0005254; GO:0005313; GO:0005326; GO:0005436; GO:0005886; GO:0006817; GO:0006820; GO:0007268; GO:0007601; GO:0008021; GO:0015386; GO:0015813; GO:0016020; GO:0022857; GO:0030672; GO:0034707; GO:0035249; GO:0043005; GO:0044341; GO:0050803; GO:0050896; GO:0051938; GO:0055062; GO:0060076; GO:0098700; GO:0140788"
"829",889,307479,"Cluster_13502","Peve_00020833",-0.209689531805551,0.865509348425064,0.996660710141104,163,-21,"2 16","885 906",14,"78.57%","100.00%",NA,NA,NA,NA,NA
"830",890,308831,"Cluster_14999","Peve_00013899",0.619279286250752,0.574849742014273,0.978262075707395,162,-20.6,"2 20","24 48",21,"76.19%","76.19%","O75179","Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16)","Homo sapiens (Human)","blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]","GO:0000785; GO:0001673; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246"
"831",891,308838,"Cluster_796","Peve_00018407",0.510465566013227,0.65894615736924,0.978262075707395,156,-21.49,"2 21","444 465",19,"68.42%","73.68%","Q9N126","Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase)","Bos taurus (Bovine)","estrogen biosynthetic process [GO:0006703]; response to stimulus [GO:0050896]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]","GO:0004303; GO:0004745; GO:0005829; GO:0006703; GO:0007601; GO:0016491; GO:0042572; GO:0042622; GO:0050896; GO:0052650"
"832",892,308852,"Cluster_6904","Peve_00018407",0.229454171550025,0.852611792397067,0.995934364227446,168,-27.34,"2 18","88 110",17,"88.24%","88.24%","Q9N126","Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase)","Bos taurus (Bovine)","estrogen biosynthetic process [GO:0006703]; response to stimulus [GO:0050896]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]","GO:0004303; GO:0004745; GO:0005829; GO:0006703; GO:0007601; GO:0016491; GO:0042572; GO:0042622; GO:0050896; GO:0052650"
"833",893,308854,"Cluster_6906","Peve_00018407",0.66903841273607,0.533412307180161,0.978262075707395,164,-25.34,"2 18","88 110",17,"82.35%","88.24%","Q9N126","Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase)","Bos taurus (Bovine)","estrogen biosynthetic process [GO:0006703]; response to stimulus [GO:0050896]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]","GO:0004303; GO:0004745; GO:0005829; GO:0006703; GO:0007601; GO:0016491; GO:0042572; GO:0042622; GO:0050896; GO:0052650"
"834",894,309296,"Cluster_4115","Peve_00043301",-0.999473741771815,0.0206544492090428,0.814021076298899,169,-22.8,"2 19","351 374",19,"78.95%","89.47%","Q8N3X1","Formin-binding protein 4 (Formin-binding protein 30)","Homo sapiens (Human)","","GO:0016607"
"835",895,309411,"Cluster_11134","Peve_00043303",-0.572607101742603,0.611864136485561,0.978262075707395,158,-22.07,"2 20","519 541",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"836",896,310536,"Cluster_11134","Peve_00000805",0.355817293881413,0.768405080625913,0.990527675986719,162,-20.08,"2 20","114 136",19,"68.42%","89.47%","P47990","Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]","Gallus gallus (Chicken)","urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115]","GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0009115; GO:0016491; GO:0030151; GO:0034418; GO:0043546; GO:0050660; GO:0051537; GO:0070674; GO:0071949"
"837",897,310896,"Cluster_11134","Peve_00014865",-0.856078539892879,0.345787863891157,0.978262075707395,160,-20.92,"2 17","582 603",15,"80.00%","86.67%",NA,NA,NA,NA,NA
"838",898,311667,"Cluster_15726","Peve_00029372",0.0343983799184084,0.978096990306825,0.999448381576871,160,-22.98,"2 20","352 371",18,"77.78%","83.33%","O75691","Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73) (NNP73) (Protein Key-1A6)","Homo sapiens (Human)","endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; negative regulation of cell population proliferation [GO:0008285]; rRNA processing [GO:0006364]","GO:0000447; GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0006364; GO:0008285; GO:0030686; GO:0030688; GO:0032040"
"839",899,312253,"Cluster_15890","Peve_00034681",-0.798342573314161,0.411420889239573,0.978262075707395,171,-21.05,"2 21","2 24",20,"80.00%","85.00%","Q8VBT2","L-serine dehydratase/L-threonine deaminase (SDH) (EC 4.3.1.17) (L-serine deaminase) (L-threonine dehydratase) (TDH) (EC 4.3.1.19)","Mus musculus (Mouse)","gluconeogenesis [GO:0006094]; isoleucine biosynthetic process [GO:0009097]; L-serine catabolic process [GO:0006565]; lipid metabolic process [GO:0006629]; protein-containing complex assembly [GO:0065003]; pyruvate biosynthetic process [GO:0042866]; threonine catabolic process [GO:0006567]","GO:0003941; GO:0004794; GO:0005739; GO:0005829; GO:0006094; GO:0006565; GO:0006567; GO:0006629; GO:0009097; GO:0030170; GO:0042803; GO:0042866; GO:0065003"
"840",900,312365,"Cluster_6914","Peve_00013072",0.501091314732273,0.665864143284737,0.978262075707395,153,-21.29,"2 20","497 520",21,"71.43%","76.19%","Q00612","Glucose-6-phosphate 1-dehydrogenase X (G6PD) (EC 1.1.1.49)","Mus musculus (Mouse)","angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002033]; cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte development [GO:0048821]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADP biosynthetic process [GO:0006741]; NADP metabolic process [GO:0006739]; NADPH regeneration [GO:0006740]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of multicellular organism growth [GO:0040014]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to oxidative stress [GO:0006979]; ribose phosphate biosynthetic process [GO:0046390]","GO:0001998; GO:0002033; GO:0004345; GO:0005536; GO:0005634; GO:0005737; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006741; GO:0006749; GO:0006979; GO:0009051; GO:0009898; GO:0010734; GO:0019322; GO:0030246; GO:0034451; GO:0034599; GO:0040014; GO:0042802; GO:0042803; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0048821; GO:0050661; GO:0051156; GO:0061052; GO:1904879; GO:2000378"
"841",901,312436,"Cluster_29","Peve_00013070",0.63451515597209,0.562399624871956,0.978262075707395,158,-20.59,"2 20","159 182",20,"70.00%","80.00%","Q9DAJ5","Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic)","Mus musculus (Mouse)","microtubule-based movement [GO:0007018]","GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0045505"
"842",902,312806,"Cluster_4115","Peve_00016166",-0.930026219102899,0.239567750774005,0.978262075707395,163,-25.01,"2 21","792 814",20,"70.00%","85.00%",NA,NA,NA,NA,NA
"843",903,313271,"Cluster_8884","Peve_00034358",0.784833248844298,0.425497128342257,0.978262075707395,165,-21.72,"2 20","276 298",20,"75.00%","90.00%",NA,NA,NA,NA,NA
"844",904,313272,"Cluster_8887","Peve_00034358",0.583501185226633,0.603364710615822,0.978262075707395,165,-22.07,"2 20","276 298",20,"75.00%","90.00%",NA,NA,NA,NA,NA
"845",905,313273,"Cluster_8888","Peve_00034358",-0.119857162803525,0.923512676513448,0.999448381576871,165,-23.7,"2 20","276 298",20,"75.00%","90.00%",NA,NA,NA,NA,NA
"846",906,313481,"Cluster_4115","Peve_00008644",-0.891083794185289,0.299891628069662,0.978262075707395,151,-21,"2 21","495 518",21,"57.14%","80.95%","Q3YEC7","Rab-like protein 6 (GTP-binding protein Parf) (Partner of ARF) (Rab-like protein 1) (RBEL1)","Homo sapiens (Human)","","GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005829"
"847",907,313489,"Cluster_6906","Peve_00008644",-0.614149405225765,0.578998438572239,0.978262075707395,154,-21.5,"2 21","396 421",23,"69.57%","73.91%","Q3YEC7","Rab-like protein 6 (GTP-binding protein Parf) (Partner of ARF) (Rab-like protein 1) (RBEL1)","Homo sapiens (Human)","","GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005829"
"848",909,314180,"Cluster_10965","Peve_00032218",-0.861501692342472,0.33904874167394,0.978262075707395,151,-22.93,"2 20","463 481",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"849",910,314198,"Cluster_2882","Peve_00002517",0.755776225973772,0.454519544690816,0.978262075707395,157,-22.64,"2 14","364 385",12,"91.67%","91.67%","A0FKG7","Calpain-7 (EC 3.4.22.-)","Sus scrofa (Pig)","proteolysis [GO:0006508]","GO:0004197; GO:0004198; GO:0005634; GO:0006508"
"850",911,314721,"Cluster_11134","Peve_00034310",-0.856078539892879,0.345787863891157,0.978262075707395,166,-22.25,"2 19","678 699",17,"76.47%","88.24%","P29122","Proprotein convertase subtilisin/kexin type 6 (EC 3.4.21.-) (Paired basic amino acid cleaving enzyme 4) (Subtilisin-like proprotein convertase 4) (SPC4) (Subtilisin/kexin-like protease PACE4)","Homo sapiens (Human)","determination of left/right symmetry [GO:0007368]; glycoprotein metabolic process [GO:0009100]; nerve growth factor production [GO:0032902]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; regulation of BMP signaling pathway [GO:0030510]; regulation of lipoprotein lipase activity [GO:0051004]; secretion by cell [GO:0032940]; zygotic determination of anterior/posterior axis, embryo [GO:0007354]","GO:0004175; GO:0004252; GO:0005576; GO:0005615; GO:0005783; GO:0005796; GO:0005886; GO:0007354; GO:0007368; GO:0008201; GO:0009100; GO:0009986; GO:0016020; GO:0016485; GO:0016486; GO:0030510; GO:0032902; GO:0032940; GO:0048406; GO:0051004; GO:0062023"
"851",912,315075,"Cluster_9149","Peve_00003645",0.983234989610239,0.116736227343661,0.978262075707395,153,-20.36,"2 19","853 875",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"852",913,315680,"Cluster_1167","Peve_00019115",0.966845742130488,0.16438872594593,0.978262075707395,148,-21.77,"2 21","565 586",21,"71.43%","71.43%","Q8N945","PRELI domain-containing protein 2","Homo sapiens (Human)","phospholipid transport [GO:0015914]","GO:0005758; GO:0015914; GO:1990050"
"853",914,315750,"Cluster_9149","Peve_00019114",-0.472798086503762,0.686487997568895,0.978262075707395,148,-22.21,"2 21","296 317",19,"57.89%","73.68%",NA,NA,NA,NA,NA
"854",915,316074,"Cluster_13502","Peve_00004916",-0.880252595664254,0.31474612323524,0.978262075707395,166,-23.72,"2 21","212 238",24,"75.00%","79.17%","Q8K375","Leucine-rich repeat-containing protein 56","Mus musculus (Mouse)","cell projection organization [GO:0030030]","GO:0005929; GO:0030030"
"855",916,317242,"Cluster_11135","Peve_00035970",0.976679025969756,0.137757771822993,0.978262075707395,163,-20.38,"2 16","369 390",14,"85.71%","92.86%","A7RKF6","RNA-splicing ligase RtcB homolog (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase)","Nematostella vectensis (Starlet sea anemone)","tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]","GO:0000971; GO:0003972; GO:0005525; GO:0005634; GO:0046872; GO:0072669"
"856",917,317568,"Cluster_796","Peve_00028933",-0.0696341159246928,0.955633640840684,0.999448381576871,146,-21.01,"2 13","86 106",11,"90.91%","90.91%","E7FAM5","E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","Danio rerio (Zebrafish) (Brachydanio rerio)","embryonic body morphogenesis [GO:0010172]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0010172; GO:0010586; GO:0017148; GO:0021915; GO:0030371; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061630; GO:0072089; GO:2000177"
"857",918,317613,"Cluster_796","Peve_00028932",-0.0696341159246929,0.955633640840684,0.999448381576871,146,-21.01,"2 13","86 106",11,"90.91%","90.91%","E7FAM5","E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","Danio rerio (Zebrafish) (Brachydanio rerio)","embryonic body morphogenesis [GO:0010172]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0010172; GO:0010586; GO:0017148; GO:0021915; GO:0030371; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061630; GO:0072089; GO:2000177"
"858",919,318519,"Cluster_4079","Peve_00030841",-0.997945022574284,0.0408200045387614,0.909359886114279,160,-22.37,"2 13","341 362",11,"100.00%","100.00%","A0A481NSZ4",NA,NA,NA,NA
"859",920,319771,"Cluster_29","Peve_00022981",-0.361705048115355,0.764389490613029,0.98947534804317,167,-23.23,"2 20","543 564",18,"77.78%","83.33%","Q9CR50","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630"
"860",921,320225,"Cluster_1167","Peve_00006288",0.555110777311863,0.62535172015887,0.978262075707395,150,-20.6,"2 21","541 561",19,"68.42%","73.68%","Q9UKV8","Protein argonaute-2 (Argonaute2) (hAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (PAZ Piwi domain protein) (PPD) (Protein slicer)","Homo sapiens (Human)","miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; RISC complex assembly [GO:0070922]; RNA secondary structure unwinding [GO:0010501]; RNA-mediated gene silencing [GO:0031047]; RNA-mediated post-transcriptional gene silencing [GO:0035194]; siRNA processing [GO:0030422]; siRNA-mediated gene silencing by mRNA destabilization [GO:0090625]; translation [GO:0006412]","GO:0000340; GO:0000932; GO:0000993; GO:0001046; GO:0003723; GO:0003725; GO:0003727; GO:0003743; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005844; GO:0005845; GO:0006412; GO:0008022; GO:0009791; GO:0010501; GO:0010586; GO:0010628; GO:0016020; GO:0016442; GO:0030422; GO:0030425; GO:0031047; GO:0031054; GO:0035194; GO:0035196; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0036464; GO:0042985; GO:0045766; GO:0045944; GO:0045947; GO:0046872; GO:0060213; GO:0070062; GO:0070551; GO:0070578; GO:0070922; GO:0090624; GO:0090625; GO:0098808; GO:1900153; GO:1901165; GO:1990904"
"861",922,320510,"Cluster_6914","Peve_00006285",0.999973885825882,0.00460080910062486,0.545608313504719,158,-20.29,"2 20","107 128",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"862",923,320595,"Cluster_5882","Peve_00005884",-0.47902401937587,0.681981349264998,0.978262075707395,160,-21.08,"2 21","86 107",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"863",924,321398,"Cluster_2882","Peve_00007482",-0.948138976586998,0.205925761244801,0.978262075707395,159,-21.09,"2 16","368 389",14,"85.71%","85.71%","P20585","DNA mismatch repair protein Msh3 (hMSH3) (Divergent upstream protein) (DUP) (Mismatch repair protein 1) (MRP1)","Homo sapiens (Human)","DNA repair [GO:0006281]; maintenance of DNA repeat elements [GO:0043570]; mismatch repair [GO:0006298]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; somatic recombination of immunoglobulin gene segments [GO:0016447]","GO:0003690; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006298; GO:0006312; GO:0016020; GO:0016447; GO:0019899; GO:0030983; GO:0032302; GO:0043570; GO:0045910; GO:0051096; GO:0140664"
"864",925,322158,"Cluster_796","Peve_00008939",0.898740270652305,0.288966974174018,0.978262075707395,158,-21.93,"2 21","836 856",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"865",926,322337,"Cluster_589","Peve_00037184",-0.105208309949068,0.932898129820433,0.999448381576871,151,-22.37,"2 21","604 629",23,"60.87%","73.91%","Q3SX07","tRNA pseudouridine(38/39) synthase (EC 5.4.99.45) (tRNA pseudouridine synthase 3) (tRNA pseudouridylate synthase 3) (tRNA-uridine isomerase 3)","Bos taurus (Bovine)","mRNA pseudouridine synthesis [GO:1990481]; tRNA pseudouridine synthesis [GO:0031119]","GO:0003723; GO:0005634; GO:0005737; GO:0009982; GO:0031119; GO:0106029; GO:1990481"
"866",927,322832,"Cluster_589","Peve_00037188",-0.957454284605807,0.186369555787961,0.978262075707395,169,-25.46,"2 18","515 536",16,"75.00%","100.00%",NA,NA,NA,NA,NA
"867",928,324145,"Cluster_4080","Peve_00012450",-0.931562206138298,0.236892681665284,0.978262075707395,162,-22.36,"2 21","886 906",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"868",929,324894,"Cluster_13502","Peve_00017214",0.602457722162441,0.588376415962391,0.978262075707395,165,-23.3,"2 21","540 559",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"869",930,325221,"Cluster_2787","Peve_00011900",-0.276822778728964,0.821437006983119,0.995934364227446,146,-20.08,"2 18","206 230",20,"70.00%","75.00%",NA,NA,NA,NA,NA
"870",931,325234,"Cluster_6906","Peve_00011900",0.999023739066517,0.0281328295255526,0.902005420309698,157,-22.41,"2 18","850 871",16,"75.00%","81.25%",NA,NA,NA,NA,NA
"871",932,325400,"Cluster_1167","Peve_00029710",0.979139029800053,0.130262755275379,0.978262075707395,157,-23.35,"2 16","735 755",14,"85.71%","92.86%","Q8NCI6","Beta-galactosidase-1-like protein 3 (EC 3.2.1.-)","Homo sapiens (Human)","carbohydrate metabolic process [GO:0005975]","GO:0004565; GO:0005764; GO:0005773; GO:0005975"
"872",934,325881,"Cluster_11134","Peve_00034507",-0.886757558805676,0.305904564992255,0.978262075707395,161,-21.73,"2 21","898 917",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"873",935,325949,"Cluster_5563","Peve_00013464",0.625839869282362,0.569512686565082,0.978262075707395,168,-20.8,"2 18","819 843",18,"83.33%","88.89%","Q7ZTY6","Integrator complex subunit 15","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0032039"
"874",936,325971,"Cluster_11134","Peve_00013464",0.680995118886432,0.523094953695145,0.978262075707395,152,-20.82,"2 13","353 374",11,"90.91%","90.91%","Q7ZTY6","Integrator complex subunit 15","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0032039"
"875",937,326079,"Cluster_4079","Peve_00013463",0.928877072377217,0.241550641272954,0.978262075707395,163,-22.63,"2 21","156 178",20,"70.00%","85.00%","Q8H1F7","Isopentenyl phosphate kinase (AtIPK) (IPK) (EC 2.7.4.26)","Arabidopsis thaliana (Mouse-ear cress)","phosphorylation [GO:0016310]; terpenoid biosynthetic process [GO:0016114]","GO:0005524; GO:0005829; GO:0016114; GO:0016301; GO:0016310; GO:0102043"
"876",938,326083,"Cluster_4735","Peve_00013463",0.713828651094728,0.493919056241006,0.978262075707395,168,-20.23,"2 21","51 72",19,"68.42%","89.47%","Q8H1F7","Isopentenyl phosphate kinase (AtIPK) (IPK) (EC 2.7.4.26)","Arabidopsis thaliana (Mouse-ear cress)","phosphorylation [GO:0016310]; terpenoid biosynthetic process [GO:0016114]","GO:0005524; GO:0005829; GO:0016114; GO:0016301; GO:0016310; GO:0102043"
"877",939,326872,"Cluster_11135","Peve_00044789",0.881821565207224,0.312634616741919,0.978262075707395,160,-21.12,"2 18","827 849",17,"82.35%","82.35%",NA,NA,NA,NA,NA
"878",940,326954,"Cluster_8988","Peve_00044780",0.575788762440147,0.609390128421735,0.978262075707395,177,-24.9,"2 20","595 615",18,"88.89%","94.44%","P42325","Neurocalcin homolog (DrosNCa)","Drosophila melanogaster (Fruit fly)","negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]","GO:0005509; GO:0045938; GO:1902848"
"879",941,327558,"Cluster_796","Peve_00021796",0.840511273029264,0.36450946409411,0.978262075707395,147,-21.62,"2 12","86 107",10,"90.00%","90.00%","C3YZ51","Ubiquitin-like modifier-activating enzyme 5 (Ubiquitin-activating enzyme 5)","Branchiostoma floridae (Florida lancelet) (Amphioxus)","protein modification by small protein conjugation [GO:0032446]; protein ufmylation [GO:0071569]","GO:0005524; GO:0005737; GO:0005829; GO:0032446; GO:0046872; GO:0071566; GO:0071569"
"880",942,328446,"Cluster_11134","Peve_00026223",0.55949581200006,0.621989589422818,0.978262075707395,167,-23.83,"2 21","813 837",22,"72.73%","81.82%","Q5FVL2","ER membrane protein complex subunit 8 (Neighbor of COX4)","Rattus norvegicus (Rat)","protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]","GO:0005737; GO:0005794; GO:0032977; GO:0045050; GO:0071816; GO:0072546"
"881",943,329032,"Cluster_11135","Peve_00018552",0.454037721326328,0.699966259953284,0.978262075707395,168,-20.92,"2 21","724 743",19,"84.21%","89.47%","Q0VFN8","Cilia- and flagella-associated protein 157","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","sperm axoneme assembly [GO:0007288]","GO:0005737; GO:0007288; GO:0008017; GO:0036064"
"882",944,329442,"Cluster_15726","Peve_00039387",-0.285200383711484,0.81587970163528,0.995934364227446,150,-22.07,"2 21","128 148",19,"63.16%","78.95%","Q5E9H9","Palmitoyl-protein thioesterase ABHD10, mitochondrial (EC 3.1.2.22) (Acyl-protein thioesterase ABHD10) (Alpha/beta hydrolase domain-containing protein 10) (Abhydrolase domain-containing protein 10) (Mycophenolic acid acyl-glucuronide esterase, mitochondrial) (EC 3.1.1.93)","Bos taurus (Bovine)","glucuronoside catabolic process [GO:0019391]; protein depalmitoylation [GO:0002084]","GO:0002084; GO:0004553; GO:0005739; GO:0005829; GO:0008474; GO:0019391; GO:0102390"
"883",945,329677,"Cluster_2854","Peve_00011171",-0.507486347355159,0.661149542463894,0.978262075707395,157,-20.19,"2 21","966 988",21,"71.43%","80.95%",NA,NA,NA,NA,NA
"884",946,329903,"Cluster_2882","Peve_00039726",0.220525388897312,0.858445628039414,0.995934364227446,159,-22.66,"2 21","154 176",20,"70.00%","80.00%","Q80XJ3","Tetratricopeptide repeat protein 28 (TPR repeat protein 28)","Mus musculus (Mouse)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0005737; GO:0005813; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301; GO:0072686; GO:0097431; GO:1990023"
"885",949,331544,"Cluster_8988","Peve_00012059",0.544516361110454,0.633426448470097,0.978262075707395,158,-20.31,"2 21","743 766",21,"71.43%","80.95%","F1NV61","Caspase-7 (CASP-7) (EC 3.4.22.60) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11]","Gallus gallus (Chicken)","apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; execution phase of apoptosis [GO:0097194]; lymphocyte apoptotic process [GO:0070227]; positive regulation of plasma membrane repair [GO:1905686]; proteolysis [GO:0006508]","GO:0003723; GO:0004190; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0042742; GO:0070227; GO:0097153; GO:0097194; GO:0097200; GO:1905686"
"886",950,331707,"Cluster_4629","Peve_00032976",0.801351180379796,0.408229722430887,0.978262075707395,149,-20.61,"2 19","60 83",19,"63.16%","78.95%",NA,NA,NA,NA,NA
"887",954,332271,"Cluster_11134","Peve_00033373",0.932122562459955,0.235909571343465,0.978262075707395,171,-21.87,"2 21","6 28",20,"75.00%","90.00%",NA,NA,NA,NA,NA
"888",955,332760,"Cluster_9149","Peve_00032394",0.0209023133260384,0.98669220488429,0.999448381576871,144,-20.98,"2 13","90 111",11,"72.73%","90.91%","Q9C098","Serine/threonine-protein kinase DCLK3 (EC 2.7.11.1) (Doublecortin domain-containing protein 3C) (Doublecortin-like and CAM kinase-like 3) (Doublecortin-like kinase 3)","Homo sapiens (Human)","peptidyl-serine phosphorylation [GO:0018105]","GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0018105; GO:0106310"
"889",956,333452,"Cluster_589","Peve_00016315",-0.657209318403745,0.543473497407343,0.978262075707395,155,-23.93,"2 12","597 618",10,"100.00%","100.00%","A7S3J7","40S ribosomal protein S3a","Nematostella vectensis (Starlet sea anemone)","translation [GO:0006412]","GO:0003735; GO:0005829; GO:0006412; GO:0022627"
"890",957,333549,"Cluster_4079","Peve_00016317",-0.770183478659426,0.44032924516284,0.978262075707395,159,-24.46,"2 17","364 386",16,"75.00%","93.75%","F8W2M8","Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I)","Danio rerio (Zebrafish) (Brachydanio rerio)","central nervous system development [GO:0007417]; locomotory behavior [GO:0007626]; neurogenesis [GO:0022008]; proteolysis [GO:0006508]","GO:0004175; GO:0004252; GO:0005764; GO:0006508; GO:0007417; GO:0007626; GO:0008240; GO:0022008; GO:0046872"
"891",958,333636,"Cluster_2787","Peve_00016319",0.575077094534184,0.609944096097967,0.978262075707395,165,-22.98,"2 18","377 398",16,"81.25%","87.50%","O89023","Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I)","Mus musculus (Mouse)","bone resorption [GO:0045453]; central nervous system development [GO:0007417]; epithelial cell differentiation [GO:0030855]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; peptide catabolic process [GO:0043171]; protein catabolic process [GO:0030163]; protein localization to chromosome, telomeric region [GO:0070198]; proteolysis [GO:0006508]","GO:0004175; GO:0004252; GO:0005739; GO:0005764; GO:0005794; GO:0006508; GO:0007040; GO:0007399; GO:0007417; GO:0008233; GO:0008236; GO:0008240; GO:0030163; GO:0030855; GO:0035727; GO:0042277; GO:0042470; GO:0043171; GO:0045121; GO:0045453; GO:0046872; GO:0050885; GO:0055037; GO:0070198; GO:0120146; GO:1905146"
"892",959,334347,"Cluster_15726","Peve_00004895",-0.4770981216957,0.683377259407516,0.978262075707395,170,-22.98,"2 21","790 810",19,"84.21%","84.21%",NA,NA,NA,NA,NA
"893",960,334965,"Cluster_9149","Peve_00029547",-0.546351443168337,0.632032611209059,0.978262075707395,158,-31.41,"2 20","11 38",24,"66.67%","75.00%","D8VNT0","Ryncolin-4","Cerberus rynchops (Dog-faced water snake)","","GO:0005576; GO:0090729"
"894",961,335908,"Cluster_8888","Peve_00008404",-0.926055154859667,0.246355500269697,0.978262075707395,154,-20.42,"2 20","806 823",18,"77.78%","83.33%","O75311","Glycine receptor subunit alpha-3","Homo sapiens (Human)","chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]","GO:0004888; GO:0005231; GO:0005886; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030425; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0051260; GO:0060012; GO:1902476; GO:1904315"
"895",962,336162,"Cluster_4629","Peve_00023795",-0.365265234999543,0.761956593035188,0.988787276940888,155,-20.27,"2 12","839 860",10,"100.00%","100.00%","Q6PHZ5","Putative RNA-binding protein 15B (RNA-binding motif protein 15B)","Mus musculus (Mouse)","dosage compensation by inactivation of X chromosome [GO:0009048]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA methylation [GO:0001510]; RNA splicing [GO:0008380]","GO:0000381; GO:0001510; GO:0003723; GO:0003729; GO:0005634; GO:0005635; GO:0005654; GO:0006397; GO:0006406; GO:0008380; GO:0009048; GO:0016607; GO:0036396"
"896",963,336170,"Cluster_6914","Peve_00023795",0.723505958309016,0.48505885924231,0.978262075707395,183,-24.94,"2 20","184 204",18,"88.89%","94.44%","Q6PHZ5","Putative RNA-binding protein 15B (RNA-binding motif protein 15B)","Mus musculus (Mouse)","dosage compensation by inactivation of X chromosome [GO:0009048]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA methylation [GO:0001510]; RNA splicing [GO:0008380]","GO:0000381; GO:0001510; GO:0003723; GO:0003729; GO:0005634; GO:0005635; GO:0005654; GO:0006397; GO:0006406; GO:0008380; GO:0009048; GO:0016607; GO:0036396"
"897",964,337560,"Cluster_5882","Peve_00018755",-0.27814091057559,0.820563558554478,0.995934364227446,159,-24.05,"2 21","178 201",21,"66.67%","80.95%","Q7ZX22","GATOR complex protein WDR24","Xenopus laevis (African clawed frog)","autophagy [GO:0006914]; positive regulation of TOR signaling [GO:0032008]","GO:0005765; GO:0006914; GO:0032008"
"898",965,337979,"Cluster_8988","Peve_00018750",0.508161140306551,0.660650870370508,0.978262075707395,155,-20.15,"2 21","25 50",23,"65.22%","73.91%","Q91YJ5","Translation initiation factor IF-2, mitochondrial (IF-2(Mt)) (IF-2Mt) (IF2(mt))","Mus musculus (Mouse)","mitochondrial translational initiation [GO:0070124]; ribosome disassembly [GO:0032790]; translational initiation [GO:0006413]","GO:0003743; GO:0003924; GO:0005525; GO:0005654; GO:0005737; GO:0005739; GO:0006413; GO:0008135; GO:0032790; GO:0043024; GO:0070124"
"899",966,338007,"Cluster_4629","Peve_00005389",-0.668499081965284,0.5338741259949,0.978262075707395,145,-20.76,"2 16","639 659",14,"78.57%","78.57%","Q3UJK4","GTP-binding protein 2 (GTP-binding-like protein 2)","Mus musculus (Mouse)","nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]","GO:0003746; GO:0003924; GO:0005525; GO:0006414; GO:0042802; GO:0070966; GO:0072344"
"900",968,338625,"Cluster_16738","Peve_00036407",-0.845846441337952,0.358191791246106,0.978262075707395,160,-20.76,"2 13","545 566",11,"100.00%","100.00%",NA,NA,NA,NA,NA
"901",969,339135,"Cluster_5882","Peve_00022829",-0.943423574615029,0.215170147519037,0.978262075707395,170,-21.29,"2 21","401 424",21,"80.95%","85.71%",NA,NA,NA,NA,NA
"902",970,339319,"Cluster_6906","Peve_00022823",0.216311405733033,0.861194711463765,0.996439226369472,143,-20.59,"2 18","96 121",20,"70.00%","70.00%","Q94BV5","Flavin-containing monooxygenase FMO GS-OX-like 4 (EC 1.8.-.-) (Flavin-monooxygenase glucosinolate S-oxygenase-like 4)","Arabidopsis thaliana (Mouse-ear cress)","","GO:0000325; GO:0004499; GO:0050660; GO:0050661"
"903",971,339396,"Cluster_2787","Peve_00002381",0.919484934250533,0.257212237540664,0.978262075707395,170,-28.01,"2 19","181 202",17,"76.47%","94.12%","B3EWZ9","Hephaestin-like protein (EC 1.-.-.-)","Acropora millepora (Staghorn coral) (Heteropora millepora)","copper ion transport [GO:0006825]","GO:0005507; GO:0005576; GO:0006825; GO:0016020; GO:0016491"
"904",972,339627,"Cluster_4629","Peve_00021553",0.997938030915672,0.0408894104551393,0.909359886114279,150,-20.07,"2 20","95 120",22,"63.64%","72.73%",NA,NA,NA,NA,NA
"905",973,340417,"Cluster_11135","Peve_00036217",0.844443877729655,0.359862212804899,0.978262075707395,169,-23.48,"2 18","81 102",16,"81.25%","93.75%",NA,NA,NA,NA,NA
"906",974,341336,"Cluster_4115","Peve_00011377",-0.449040803998016,0.703531560333745,0.978262075707395,152,-20.23,"2 20","65 92",24,"70.83%","75.00%",NA,NA,NA,NA,NA
"907",975,341607,"Cluster_4629","Peve_00016242",-0.33931102186015,0.779612184808739,0.993433959658941,145,-20.4,"2 20","381 401",18,"66.67%","72.22%","Q6QLW4","Cytochrome c","Pectinaria gouldii (Trumpet worm) (Ice-cream cone worm)","","GO:0005758; GO:0009055; GO:0020037; GO:0046872; GO:0070469"
"908",976,341642,"Cluster_589","Peve_00016243",-0.927599765143479,0.243736657231869,0.978262075707395,158,-26.8,"2 20","643 668",22,"63.64%","81.82%","Q9CPW4","Actin-related protein 2/3 complex subunit 5 (Arp2/3 complex 16 kDa subunit) (p16-ARC)","Mus musculus (Mouse)","actin filament network formation [GO:0051639]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cell migration [GO:0016477]; lamellipodium organization [GO:0097581]; maintenance of cell polarity [GO:0030011]; microtubule organizing center localization [GO:0061842]; regulation of actin filament polymerization [GO:0030833]; smooth muscle cell migration [GO:0014909]","GO:0005200; GO:0005634; GO:0005737; GO:0005768; GO:0005885; GO:0014909; GO:0016477; GO:0030011; GO:0030027; GO:0030426; GO:0030833; GO:0034314; GO:0035861; GO:0043005; GO:0051015; GO:0051639; GO:0061842; GO:0097581"
"909",977,341743,"Cluster_4735","Peve_00013205",-0.999762368280092,0.013878928135551,0.720093853779252,158,-24.01,"2 21","196 221",23,"73.91%","73.91%",NA,NA,NA,NA,NA
"910",978,343150,"Cluster_8634","Peve_00024530",-0.0658041221572118,0.958077502184402,0.999448381576871,161,-22.3,"2 21","132 153",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"911",979,345165,"Cluster_5882","Peve_00019415",-0.479523813239683,0.681618820820253,0.978262075707395,155,-21.09,"2 21","847 870",21,"71.43%","71.43%",NA,NA,NA,NA,NA
"912",980,345390,"Cluster_5882","Peve_00044592",-0.701460341253875,0.505063498655057,0.978262075707395,165,-23.1,"2 20","288 308",18,"77.78%","88.89%",NA,NA,NA,NA,NA
"913",982,346057,"Cluster_2854","Peve_00003036",-0.666929978893196,0.535216011119283,0.978262075707395,169,-20.9,"2 21","826 845",19,"84.21%","84.21%",NA,NA,NA,NA,NA
"914",983,346148,"Cluster_2882","Peve_00003033",-0.269974971976875,0.825969138398744,0.995934364227446,164,-20.11,"2 18","705 728",18,"83.33%","83.33%",NA,NA,NA,NA,NA
"915",985,346472,"Cluster_6904","Peve_00041418",0.826849537912348,0.380261594407369,0.978262075707395,155,-21,"2 21","163 185",20,"65.00%","80.00%",NA,NA,NA,NA,NA
"916",986,346474,"Cluster_6906","Peve_00041418",0.995403572861268,0.0610621091904624,0.978262075707395,155,-21,"2 21","163 185",20,"65.00%","80.00%",NA,NA,NA,NA,NA
"917",987,347312,"Cluster_589","Peve_00016665",0.159680919674548,0.897906931664995,0.999448381576871,150,-22.22,"2 20","832 854",19,"68.42%","73.68%","P30975","Tachykinin-like peptides receptor 99D (Tachykinin-like receptor at 99D) (dTKR)","Drosophila melanogaster (Fruit fly)","detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic transmission [GO:0050805]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; positive regulation of sensory perception of pain [GO:1904058]; tachykinin receptor signaling pathway [GO:0007217]","GO:0004995; GO:0005886; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016020; GO:0042048; GO:0050805; GO:0050911; GO:1904058"
"918",989,348492,"Cluster_4629","Peve_00004567",-0.273809878764517,0.823432185953861,0.995934364227446,159,-25.35,"2 21","71 89",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"919",990,348741,"Cluster_11134","Peve_00010845",0.826087819759973,0.381122944340608,0.978262075707395,153,-20.19,"2 21","818 837",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"920",992,349387,"Cluster_2854","Peve_00014066",-0.644258847250901,0.554331898847412,0.978262075707395,163,-22.85,"2 21","546 573",25,"68.00%","76.00%","Q69ZN7","Myoferlin (Fer-1-like protein 3)","Mus musculus (Mouse)","cellular response to heat [GO:0034605]; glycerol metabolic process [GO:0006071]; membrane fusion [GO:0061025]; muscle cell development [GO:0055001]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; T-tubule organization [GO:0033292]","GO:0001778; GO:0005543; GO:0005886; GO:0005901; GO:0006071; GO:0007009; GO:0030659; GO:0030947; GO:0031410; GO:0031965; GO:0033292; GO:0034605; GO:0043231; GO:0046872; GO:0055001; GO:0061025"
"921",993,350072,"Cluster_6904","Peve_00036814",0.256436619546399,0.834903018971818,0.995934364227446,155,-22.13,"2 21","307 329",20,"70.00%","75.00%",NA,NA,NA,NA,NA
"922",994,350430,"Cluster_5882","Peve_00036818",-0.27814091057559,0.820563558554478,0.995934364227446,150,-21.75,"2 21","21 45",22,"63.64%","77.27%",NA,NA,NA,NA,NA
"923",996,352533,"Cluster_796","Peve_00040733",0.189710775269486,0.878489934885364,0.998340606605112,148,-22.6,"2 18","838 856",16,"81.25%","81.25%","Q64731","Forkhead box protein L1 (Forkhead-related protein FKHL11) (Transcription factor FKH-6)","Mus musculus (Mouse)","anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; heart development [GO:0007507]; Peyer's patch morphogenesis [GO:0061146]; proteoglycan biosynthetic process [GO:0030166]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of Wnt signaling pathway [GO:0030111]; visceral mesoderm-endoderm interaction involved in midgut development [GO:0007495]","GO:0000978; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007495; GO:0007507; GO:0009653; GO:0030111; GO:0030154; GO:0030166; GO:0043565; GO:0061146"
"924",997,353320,"Cluster_8634","Peve_00030763",-0.403801111829881,0.735377550730334,0.985967377195944,170,-22.29,"2 15","99 120",13,"100.00%","100.00%","Q9JKK8","Serine/threonine-protein kinase ATR (EC 2.7.11.1) (Ataxia telangiectasia and Rad3-related protein)","Mus musculus (Mouse)","cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; chromosome organization [GO:0051276]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; embryo implantation [GO:0007566]; establishment of RNA localization to telomere [GO:0097694]; negative regulation of DNA replication [GO:0008156]; nucleobase-containing compound metabolic process [GO:0006139]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to chromosome, telomeric region [GO:0070198]; protein phosphorylation [GO:0006468]; regulation of double-strand break repair [GO:2000779]; regulation of protein binding [GO:0043393]; replication fork processing [GO:0031297]; replicative senescence [GO:0090399]; telomere maintenance [GO:0000723]","GO:0000077; GO:0000723; GO:0001673; GO:0001741; GO:0003677; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005794; GO:0006139; GO:0006281; GO:0006468; GO:0006974; GO:0007566; GO:0008156; GO:0016605; GO:0018105; GO:0031297; GO:0032212; GO:0032405; GO:0032407; GO:0034644; GO:0043393; GO:0043517; GO:0046777; GO:0051276; GO:0070198; GO:0070310; GO:0071480; GO:0090399; GO:0097694; GO:0106310; GO:1904884; GO:2000779"
"925",998,354817,"Cluster_11135","Peve_00033236",0.961396534375451,0.17746608502567,0.978262075707395,157,-22.11,"2 21","564 591",25,"72.00%","76.00%","O76031","ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial","Homo sapiens (Human)","ATP metabolic process [GO:0046034]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]","GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006508; GO:0008270; GO:0009368; GO:0009841; GO:0016504; GO:0016887; GO:0042645; GO:0046034; GO:0046983; GO:0051082; GO:0051603; GO:0140662"
"926",999,355185,"Cluster_16738","Peve_00032724",0.999974190676381,0.00457387578916138,0.54328949385489,169,-21.23,"2 18","554 575",16,"87.50%","87.50%",NA,NA,NA,NA,NA
"927",1000,355413,"Cluster_796","Peve_00028537",0.513555769054642,0.656655896090086,0.978262075707395,153,-21.06,"2 21","913 938",23,"73.91%","73.91%",NA,NA,NA,NA,NA
"928",1001,355564,"Cluster_6906","Peve_00032729",-0.581826364675384,0.604676642318764,0.978262075707395,153,-20.83,"2 20","605 628",20,"70.00%","80.00%",NA,NA,NA,NA,NA
"929",1002,355597,"Cluster_2854","Peve_00032728",0.864446365173095,0.335338362258347,0.978262075707395,158,-21.1,"2 20","189 212",20,"70.00%","80.00%",NA,NA,NA,NA,NA
"930",1003,355621,"Cluster_9983","Peve_00032728",-0.859321332858956,0.341772584730946,0.978262075707395,162,-21.53,"2 20","320 344",22,"68.18%","81.82%",NA,NA,NA,NA,NA
"931",1004,356408,"Cluster_2882","Peve_00037809",-0.330762389592554,0.785388267121457,0.994828713796305,155,-21.25,"2 17","147 170",17,"76.47%","82.35%","Q00422","GA-binding protein alpha chain (GABP subunit alpha)","Mus musculus (Mouse)","blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cellular response to dopamine [GO:1903351]; in utero embryonic development [GO:0001701]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001701; GO:0001825; GO:0003682; GO:0005634; GO:0005654; GO:0006357; GO:0010628; GO:0030154; GO:0045653; GO:0045944; GO:1903351; GO:1990837"
"932",1005,356715,"Cluster_16738","Peve_00037803",-0.742916462217786,0.466883893357769,0.978262075707395,167,-20.37,"2 21","875 897",20,"80.00%","80.00%","Q80VY9","ATP-dependent RNA helicase DHX33 (EC 3.6.4.13) (DEAH box protein 33)","Mus musculus (Mouse)","positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413]","GO:0000182; GO:0003723; GO:0003724; GO:0003725; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006413; GO:0016887; GO:0032481; GO:0043023; GO:0043410; GO:0045943; GO:0051092; GO:0072559; GO:0140297; GO:1900227"
"933",1006,357713,"Cluster_2882","Peve_00023189",-0.823226222719061,0.384343695755461,0.978262075707395,164,-21.12,"2 21","722 743",19,"68.42%","84.21%","P31400","V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha)","Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)","","GO:0005524; GO:0033180; GO:0046933; GO:0046961"
"934",1007,358116,"Cluster_2787","Peve_00003045",-0.854313083950712,0.347956334262764,0.978262075707395,153,-20.16,"2 19","711 736",21,"66.67%","76.19%",NA,NA,NA,NA,NA
"935",1008,358953,"Cluster_10061","Peve_00031409",0.999873400436456,0.0101301483856458,0.62545365403098,161,-20.62,"2 18","964 985",16,"75.00%","87.50%",NA,NA,NA,NA,NA
"936",1009,359942,"Cluster_10060","Peve_00020520",-0.110934140073418,0.929231472887504,0.999448381576871,188,-24.34,"2 21","305 326",19,"89.47%","94.74%",NA,NA,NA,NA,NA
"937",1010,360135,"Cluster_16738","Peve_00006598",-0.289651691686775,0.812921061503556,0.995934364227446,174,-24.09,"2 21","175 195",19,"84.21%","89.47%","A0A2J6RX17",NA,NA,NA,NA
"938",1011,360225,"Cluster_16738","Peve_00006597",0.805262494474725,0.404048739350108,0.978262075707395,174,-24.09,"2 21","202 222",19,"84.21%","89.47%","P0CI65","Nephrocystin-3","Danio rerio (Zebrafish) (Brachydanio rerio)","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"939",1012,360936,"Cluster_11134","Peve_00013818",0.480424021751133,0.680965564410332,0.978262075707395,150,-20.18,"2 21","700 723",21,"66.67%","76.19%","Q07536","Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1)","Bos taurus (Bovine)","thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]","GO:0000062; GO:0004491; GO:0005739; GO:0006210; GO:0006573; GO:0006574; GO:0018478; GO:0019859; GO:0102662"
"940",1013,361086,"Cluster_2787","Peve_00013815",-0.00382968334855694,0.997561941898757,0.999448381576871,165,-23.01,"2 21","43 68",23,"78.26%","82.61%",NA,NA,NA,NA,NA
"941",1014,361187,"Cluster_6904","Peve_00044511",-0.968688158256394,0.159730997113641,0.978262075707395,157,-25.02,"2 21","925 946",20,"75.00%","80.00%",NA,NA,NA,NA,NA
"942",1015,361189,"Cluster_6906","Peve_00044511",-0.730117633489696,0.478930482330548,0.978262075707395,153,-22.73,"2 21","925 946",20,"70.00%","80.00%",NA,NA,NA,NA,NA
"943",1016,361431,"Cluster_11134","Peve_00039956",0.87229736245996,0.325258718232456,0.978262075707395,162,-24.26,"2 21","696 716",19,"73.68%","84.21%","Q7SYS9","Histamine N-methyltransferase B (HMT B) (EC 2.1.1.8)","Xenopus laevis (African clawed frog)","histamine catabolic process [GO:0001695]; methylation [GO:0032259]","GO:0001695; GO:0005737; GO:0032259; GO:0046539"
"944",1017,361892,"Cluster_589","Peve_00007316",-0.685119020931263,0.519500353454206,0.978262075707395,161,-24.9,"2 20","590 610",18,"77.78%","83.33%","P20664","DNA primase small subunit (EC 2.7.7.102) (DNA primase 49 kDa subunit) (p49)","Mus musculus (Mouse)","DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]","GO:0000287; GO:0003896; GO:0005658; GO:0006269; GO:0006270; GO:0008270; GO:0032553"
"945",1018,362066,"Cluster_14999","Peve_00007315",0.606565038869219,0.585093942447836,0.978262075707395,175,-23.07,"2 20","765 786",18,"77.78%","94.44%","P97321","Prolyl endopeptidase FAP (EC 3.4.21.26) (Dipeptidyl peptidase FAP) (EC 3.4.14.5) (Fibroblast activation protein alpha) (FAPalpha) (Gelatine degradation protease FAP) (EC 3.4.21.-) (Integral membrane serine protease) (Post-proline cleaving enzyme) (Serine integral membrane protease) (SIMP) (Surface-expressed protease) (Seprase) [Cleaved into: Antiplasmin-cleaving enzyme FAP, soluble form (APCE) (EC 3.4.14.5) (EC 3.4.21.-) (EC 3.4.21.26)]","Mus musculus (Mouse)","angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; melanocyte apoptotic process [GO:1902362]; melanocyte proliferation [GO:0097325]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of extracellular matrix organization [GO:1903054]; positive regulation of execution phase of apoptosis [GO:1900119]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of cell cycle [GO:0051726]; regulation of collagen catabolic process [GO:0010710]","GO:0001525; GO:0002020; GO:0004175; GO:0004252; GO:0005178; GO:0005615; GO:0005886; GO:0006508; GO:0007155; GO:0008233; GO:0008236; GO:0008239; GO:0009986; GO:0010710; GO:0010716; GO:0030027; GO:0031258; GO:0032587; GO:0042802; GO:0042803; GO:0043542; GO:0045177; GO:0045178; GO:0051603; GO:0051726; GO:0060244; GO:0070161; GO:0097325; GO:1900119; GO:1902362; GO:1903054; GO:1905368"
"946",1020,363302,"Cluster_6904","Peve_00017903",-0.840354913686006,0.364693148607936,0.978262075707395,154,-20.37,"2 21","222 246",22,"72.73%","72.73%","Q7SIA2","Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS); Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)]","Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)","cellular response to insulin stimulus [GO:0032869]; cellular response to type II interferon [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433]; regulation of long-chain fatty acid import into cell [GO:0140212]","GO:0004818; GO:0004827; GO:0005524; GO:0005829; GO:0005886; GO:0006424; GO:0006433; GO:0008270; GO:0017101; GO:0017148; GO:0032869; GO:0035613; GO:0042803; GO:0051020; GO:0071346; GO:0097452; GO:0140212; GO:1990904"
"947",1021,363304,"Cluster_6906","Peve_00017903",-0.476386493936202,0.683892633824843,0.978262075707395,154,-21.41,"2 21","222 246",22,"72.73%","72.73%","Q7SIA2","Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS); Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)]","Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)","cellular response to insulin stimulus [GO:0032869]; cellular response to type II interferon [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433]; regulation of long-chain fatty acid import into cell [GO:0140212]","GO:0004818; GO:0004827; GO:0005524; GO:0005829; GO:0005886; GO:0006424; GO:0006433; GO:0008270; GO:0017101; GO:0017148; GO:0032869; GO:0035613; GO:0042803; GO:0051020; GO:0071346; GO:0097452; GO:0140212; GO:1990904"
"948",1022,363314,"Cluster_8988","Peve_00017903",0.338803772638723,0.779955442320287,0.993510726390294,150,-20.19,"2 21","369 395",24,"62.50%","75.00%","Q7SIA2","Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS); Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)]","Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)","cellular response to insulin stimulus [GO:0032869]; cellular response to type II interferon [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433]; regulation of long-chain fatty acid import into cell [GO:0140212]","GO:0004818; GO:0004827; GO:0005524; GO:0005829; GO:0005886; GO:0006424; GO:0006433; GO:0008270; GO:0017101; GO:0017148; GO:0032869; GO:0035613; GO:0042803; GO:0051020; GO:0071346; GO:0097452; GO:0140212; GO:1990904"
"949",1023,363425,"Cluster_1167","Peve_00023746",0.617110798528677,0.576606052398091,0.978262075707395,150,-20.56,"2 17","865 888",17,"76.47%","82.35%",NA,NA,NA,NA,NA
"950",1024,363480,"Cluster_5882","Peve_00034606",0.968541836544288,0.160105752350056,0.978262075707395,165,-23.83,"2 14","650 671",12,"100.00%","100.00%",NA,NA,NA,NA,NA
"951",1025,364632,"Cluster_15726","Peve_00032520",-0.868599123643031,0.330041616870159,0.978262075707395,158,-21.93,"2 19","143 163",18,"83.33%","83.33%",NA,NA,NA,NA,NA
"952",1026,365272,"Cluster_2854","Peve_00015430",-0.878215267357264,0.317468711502223,0.978262075707395,163,-20.34,"2 21","109 131",20,"70.00%","85.00%",NA,NA,NA,NA,NA
"953",1027,365790,"Cluster_9149","Peve_00032294",-0.346604909773926,0.774668930557993,0.992151563864281,154,-23.21,"2 21","873 893",19,"68.42%","78.95%","O42406","Homeobox protein SIX3 (CSIX3) (Sine oculis homeobox homolog 3)","Gallus gallus (Chicken)","apoptotic process involved in development [GO:1902742]; brain development [GO:0007420]; cell proliferation in forebrain [GO:0021846]; epithelial cell maturation [GO:0002070]; eye development [GO:0001654]; forebrain dorsal/ventral pattern formation [GO:0021798]; lens development in camera-type eye [GO:0002088]; lens fiber cell apoptotic process [GO:1990086]; lens fiber cell differentiation [GO:0070306]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Wnt signaling pathway [GO:0030178]; neuroblast differentiation [GO:0014016]; neuroblast migration [GO:0097402]; optic vesicle morphogenesis [GO:0003404]; pituitary gland development [GO:0021983]; proximal/distal axis specification [GO:0009946]; regulation of cell cycle phase transition [GO:1901987]; regulation of cell population proliferation [GO:0042127]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neural retina development [GO:0061074]; regulation of neuroblast proliferation [GO:1902692]; regulation of transcription by RNA polymerase II [GO:0006357]; telencephalon development [GO:0021537]; telencephalon regionalization [GO:0021978]","GO:0000978; GO:0000981; GO:0001228; GO:0001654; GO:0002070; GO:0002088; GO:0003404; GO:0003677; GO:0005634; GO:0005667; GO:0006357; GO:0007420; GO:0009946; GO:0014016; GO:0021537; GO:0021798; GO:0021846; GO:0021978; GO:0021983; GO:0030178; GO:0042127; GO:0045665; GO:0045892; GO:0061074; GO:0070306; GO:0097402; GO:1901987; GO:1902692; GO:1902742; GO:1990086; GO:2000177"
"954",1028,366321,"Cluster_7053","Peve_00013596",0.999599711713374,0.0180134147972475,0.782669382293497,155,-20.38,"2 20","415 434",18,"72.22%","88.89%","Q9JI70","Molecular chaperone MKKS (McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin) (Protein Bbs6 homolog)","Mus musculus (Mouse)","artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; chaperone-mediated protein complex assembly [GO:0051131]; cilium assembly [GO:0060271]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; developmental process [GO:0032502]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of blood pressure [GO:0045776]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of stress fiber assembly [GO:0051492]; response to leptin [GO:0044321]; sensory perception of smell [GO:0007608]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; vasodilation [GO:0042311]","GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006457; GO:0007286; GO:0007608; GO:0010467; GO:0010629; GO:0014824; GO:0021756; GO:0021766; GO:0021987; GO:0030837; GO:0031514; GO:0032502; GO:0033210; GO:0034260; GO:0035176; GO:0036064; GO:0038108; GO:0040018; GO:0042311; GO:0044321; GO:0045444; GO:0045494; GO:0045776; GO:0046907; GO:0048854; GO:0050910; GO:0051082; GO:0051131; GO:0051216; GO:0051492; GO:0060271; GO:0060296; GO:0060324; GO:0061629; GO:1902636; GO:1905515"
"955",1029,366807,"Cluster_4629","Peve_00043994",-0.367866012199436,0.760177013432938,0.988271762439196,149,-21.25,"2 20","374 398",21,"71.43%","71.43%",NA,NA,NA,NA,NA
"956",1030,366960,"Cluster_9149","Peve_00043997",-0.796998016865613,0.412840191451936,0.978262075707395,160,-20.15,"2 21","920 941",19,"73.68%","73.68%",NA,NA,NA,NA,NA
"957",1031,367080,"Cluster_5882","Peve_00043992",-0.499976775845693,0.666683738730963,0.978262075707395,160,-20.16,"2 21","362 383",19,"57.89%","89.47%","P84079","ADP-ribosylation factor 1 (EC 3.6.5.2)","Rattus norvegicus (Rat)","actin filament organization [GO:0007015]; cellular copper ion homeostasis [GO:0006878]; cellular response to virus [GO:0098586]; dendritic spine organization [GO:0097061]; Golgi to transport vesicle transport [GO:0055108]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; lysosomal membrane organization [GO:0097212]; mitotic cleavage furrow ingression [GO:1990386]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of endocytosis [GO:0045807]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of late endosome to lysosome transport [GO:1902824]; positive regulation of protein secretion [GO:0050714]; positive regulation of sodium ion transmembrane transport [GO:1902307]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of phospholipid metabolic process [GO:1903725]; regulation of receptor internalization [GO:0002090]; synaptic vesicle budding [GO:0070142]; very-low-density lipoprotein particle assembly [GO:0034379]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0000287; GO:0002090; GO:0003924; GO:0005525; GO:0005737; GO:0005770; GO:0005794; GO:0005829; GO:0005886; GO:0006878; GO:0006886; GO:0007015; GO:0012505; GO:0014069; GO:0016192; GO:0019003; GO:0019904; GO:0030017; GO:0031252; GO:0032991; GO:0034315; GO:0034379; GO:0043005; GO:0045807; GO:0045956; GO:0050714; GO:0055108; GO:0060292; GO:0060999; GO:0070142; GO:0097061; GO:0097212; GO:0098586; GO:0098974; GO:0098978; GO:1902307; GO:1902824; GO:1902953; GO:1903725; GO:1990386; GO:1990583"
"958",1032,367098,"Cluster_10061","Peve_00043992",-0.647341691061505,0.551761385309713,0.978262075707395,180,-21.44,"2 21","293 314",19,"78.95%","94.74%","P84079","ADP-ribosylation factor 1 (EC 3.6.5.2)","Rattus norvegicus (Rat)","actin filament organization [GO:0007015]; cellular copper ion homeostasis [GO:0006878]; cellular response to virus [GO:0098586]; dendritic spine organization [GO:0097061]; Golgi to transport vesicle transport [GO:0055108]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; lysosomal membrane organization [GO:0097212]; mitotic cleavage furrow ingression [GO:1990386]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of endocytosis [GO:0045807]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of late endosome to lysosome transport [GO:1902824]; positive regulation of protein secretion [GO:0050714]; positive regulation of sodium ion transmembrane transport [GO:1902307]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of phospholipid metabolic process [GO:1903725]; regulation of receptor internalization [GO:0002090]; synaptic vesicle budding [GO:0070142]; very-low-density lipoprotein particle assembly [GO:0034379]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0000287; GO:0002090; GO:0003924; GO:0005525; GO:0005737; GO:0005770; GO:0005794; GO:0005829; GO:0005886; GO:0006878; GO:0006886; GO:0007015; GO:0012505; GO:0014069; GO:0016192; GO:0019003; GO:0019904; GO:0030017; GO:0031252; GO:0032991; GO:0034315; GO:0034379; GO:0043005; GO:0045807; GO:0045956; GO:0050714; GO:0055108; GO:0060292; GO:0060999; GO:0070142; GO:0097061; GO:0097212; GO:0098586; GO:0098974; GO:0098978; GO:1902307; GO:1902824; GO:1902953; GO:1903725; GO:1990386; GO:1990583"
"959",1033,367302,"Cluster_4629","Peve_00015295",0.984592349072389,0.111898055440837,0.978262075707395,156,-21.43,"2 13","345 366",11,"90.91%","100.00%","Q5REV5","Acyl-coenzyme A synthetase ACSM3, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 3) (Butyrate--CoA ligase 3) (Butyryl-coenzyme A synthetase 3) (Middle-chain acyl-CoA synthetase 3) (Propionate--CoA ligase) (EC 6.2.1.17) (Protein SA homolog)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","fatty acid biosynthetic process [GO:0006633]","GO:0005524; GO:0005739; GO:0005759; GO:0006633; GO:0018729; GO:0043759; GO:0046872; GO:0047760; GO:0050218"
"960",1034,369009,"Cluster_4079","Peve_00036992",-0.980601874009695,0.12559708513348,0.978262075707395,162,-22.52,"2 21","428 448",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"961",1035,369183,"Cluster_796","Peve_00036996",0.900663418778519,0.286162131590773,0.978262075707395,160,-20.94,"2 18","123 145",17,"82.35%","82.35%",NA,NA,NA,NA,NA
"962",1036,369276,"Cluster_2787","Peve_00036998",0.826314634207763,0.380866641634401,0.978262075707395,151,-21.64,"2 21","445 470",23,"60.87%","73.91%",NA,NA,NA,NA,NA
"963",1037,369300,"Cluster_9149","Peve_00036998",-0.430551692447647,0.716638033068977,0.980647121511795,161,-22.41,"2 21","340 359",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"964",1038,369692,"Cluster_6904","Peve_00015518",-0.226328022711406,0.854655744837047,0.995934364227446,158,-20.52,"2 21","974 994",19,"68.42%","84.21%","Q8BMF4","Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial (EC 2.3.1.12) (Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex) (Pyruvate dehydrogenase complex component E2) (PDC-E2) (PDCE2)","Mus musculus (Mouse)","acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; tricarboxylic acid cycle [GO:0006099]","GO:0004742; GO:0005739; GO:0005759; GO:0005967; GO:0006006; GO:0006086; GO:0006099; GO:0016407; GO:0034604; GO:0042802; GO:0043209; GO:0043231; GO:0045240; GO:0045254; GO:1902493"
"965",1039,369694,"Cluster_6906","Peve_00015518",0.269709324526725,0.826144769946046,0.995934364227446,158,-20.32,"2 21","974 994",19,"68.42%","84.21%","Q8BMF4","Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial (EC 2.3.1.12) (Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex) (Pyruvate dehydrogenase complex component E2) (PDC-E2) (PDCE2)","Mus musculus (Mouse)","acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; tricarboxylic acid cycle [GO:0006099]","GO:0004742; GO:0005739; GO:0005759; GO:0005967; GO:0006006; GO:0006086; GO:0006099; GO:0016407; GO:0034604; GO:0042802; GO:0043209; GO:0043231; GO:0045240; GO:0045254; GO:1902493"
"966",1040,370533,"Cluster_796","Peve_00000521",-0.818441955581773,0.389676330062044,0.978262075707395,167,-23.6,"2 20","660 681",18,"77.78%","83.33%","Q6AZT7","Nephrocystin-3","Xenopus laevis (African clawed frog)","cilium assembly [GO:0060271]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]","GO:0005929; GO:0016055; GO:0060027; GO:0060271; GO:0090090; GO:2000095"
"967",1041,370920,"Cluster_9149","Peve_00035217",0.859831520858028,0.341136985289496,0.978262075707395,156,-22.6,"2 18","556 578",17,"76.47%","82.35%",NA,NA,NA,NA,NA
"968",1042,371567,"Cluster_589","Peve_00003958",-0.0839757229912827,0.946476360773452,0.999448381576871,161,-27.28,"2 20","947 967",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"969",1043,372354,"Cluster_7855","Peve_00006206",0.15368468138024,0.901771999371963,0.999448381576871,166,-20.41,"2 21","514 534",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"970",1044,372857,"Cluster_10060","Peve_00021903",-0.509953560482644,0.659325150230544,0.978262075707395,162,-20.17,"2 21","476 500",22,"68.18%","86.36%","Q5E9N5","Caseinolytic peptidase B protein homolog (EC 3.6.1.-) (Suppressor of potassium transport defect 3)","Bos taurus (Bovine)","antiviral innate immune response [GO:0140374]; cellular response to heat [GO:0034605]; granulocyte differentiation [GO:0030851]; RIG-I signaling pathway [GO:0039529]","GO:0005524; GO:0005737; GO:0005739; GO:0005758; GO:0016887; GO:0030851; GO:0034605; GO:0039529; GO:0140374; GO:0140545"
"971",1045,373595,"Cluster_1167","Peve_00022288",0.433768525737431,0.714367120936195,0.979921586797081,160,-21.94,"2 21","533 555",21,"80.95%","80.95%",NA,NA,NA,NA,NA
"972",1046,374012,"Cluster_6904","Peve_00037107",-0.951310992493219,0.199475076059675,0.978262075707395,147,-20.21,"2 13","787 809",12,"83.33%","91.67%",NA,NA,NA,NA,NA
"973",1047,374853,"Cluster_796","Peve_00028705",0.898740270652305,0.288966974174018,0.978262075707395,148,-20.55,"2 19","35 55",17,"70.59%","76.47%","Q8WPA2","Allatostatin-A receptor (BAR)","Bombyx mori (Silk moth)","","GO:0004930; GO:0005886; GO:0042562; GO:0042923"
"974",1048,374925,"Cluster_9149","Peve_00016035",0.625144212109638,0.570080299760181,0.978262075707395,145,-21.13,"2 10","923 944",8,"100.00%","100.00%","Q7L5Y6","DET1 homolog (De-etiolated-1 homolog)","Homo sapiens (Human)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]","GO:0005634; GO:0016567; GO:0031461; GO:0031464; GO:0031625; GO:0032436; GO:0044877; GO:0065003; GO:0080008; GO:1990756"
"975",1049,375130,"Cluster_4080","Peve_00023889",0.674673440334274,0.528568932175891,0.978262075707395,160,-21.85,"2 21","511 533",21,"76.19%","85.71%",NA,NA,NA,NA,NA
"976",1050,375195,"Cluster_9149","Peve_00016036",0.388837034524102,0.745753826329117,0.987481572123537,145,-21.13,"2 10","207 228",8,"100.00%","100.00%","P62755","40S ribosomal protein S6","Rattus norvegicus (Rat)","activation-induced cell death of T cells [GO:0006924]; cellular response to ethanol [GO:0071361]; cytoplasmic translation [GO:0002181]; erythrocyte development [GO:0048821]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; glucose homeostasis [GO:0042593]; mammalian oogenesis stage [GO:0022605]; mitotic cell cycle [GO:0000278]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bicellular tight junction assembly [GO:1903347]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; response to insulin [GO:0032868]; ribosomal small subunit assembly [GO:0000028]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; T cell differentiation in thymus [GO:0033077]; T cell proliferation involved in immune response [GO:0002309]; TOR signaling [GO:0031929]","GO:0000028; GO:0000082; GO:0000278; GO:0001890; GO:0002181; GO:0002309; GO:0003729; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005840; GO:0005844; GO:0006364; GO:0006924; GO:0007369; GO:0008284; GO:0015935; GO:0019901; GO:0022605; GO:0022626; GO:0022627; GO:0030425; GO:0031929; GO:0032868; GO:0033077; GO:0036464; GO:0042274; GO:0042593; GO:0043065; GO:0043066; GO:0044297; GO:0048471; GO:0048821; GO:0071361; GO:0098793; GO:0098794; GO:0098982; GO:1903347; GO:1990904"
"977",1051,376112,"Cluster_589","Peve_00024142",-0.762298342062948,0.448141825073086,0.978262075707395,159,-22.23,"2 20","3 24",18,"61.11%","88.89%","O57321","Excitatory amino acid transporter 1 (SEAAT1) (Sodium-dependent glutamate/aspartate transporter) (GLAST)","Ambystoma tigrinum (Eastern tiger salamander)","chloride transmembrane transport [GO:1902476]; D-aspartate import across plasma membrane [GO:0070779]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; potassium ion transmembrane transport [GO:0071805]","GO:0005314; GO:0005886; GO:0015501; GO:0046872; GO:0070779; GO:0071805; GO:0098712; GO:0140009; GO:1902476"
"978",1052,376950,"Cluster_9149","Peve_00031231",-0.5,0.666666666666667,0.978262075707395,162,-24.74,"2 15","818 839",13,"84.62%","100.00%",NA,NA,NA,NA,NA
"979",1053,377020,"Cluster_4080","Peve_00030751",-0.164371176656228,0.894881035560243,0.999448381576871,156,-20.13,"2 18","100 122",17,"70.59%","88.24%",NA,NA,NA,NA,NA
"980",1054,377602,"Cluster_2854","Peve_00021242",-0.492476100688936,0.672183790869439,0.978262075707395,160,-20.7,"2 18","170 192",17,"76.47%","88.24%",NA,NA,NA,NA,NA
"981",1055,377652,"Cluster_4629","Peve_00021243",0.993932333921704,0.0701658511452049,0.978262075707395,142,-20.11,"2 21","626 646",19,"63.16%","68.42%","Q0VD19","Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (aSMase) [Cleaved into: Sphingomyelin phosphodiesterase, processed form]","Bos taurus (Bovine)","cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of viral entry into host cell [GO:0046598]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060]","GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005765; GO:0005811; GO:0005886; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034480; GO:0034612; GO:0034644; GO:0035307; GO:0036019; GO:0042060; GO:0043065; GO:0043407; GO:0045121; GO:0045807; GO:0046513; GO:0046598; GO:0046718; GO:0061750; GO:0070555; GO:0071277"
"982",1056,377923,"Cluster_4735","Peve_00005278",0.0322561884631155,0.979461510007308,0.999448381576871,165,-23.53,"2 18","368 389",16,"81.25%","87.50%",NA,NA,NA,NA,NA
"983",1058,379722,"Cluster_4629","Peve_00003537",-0.989612639465616,0.0918384135101435,0.978262075707395,158,-25.25,"2 21","36 59",21,"76.19%","76.19%","Q8R081","Heterogeneous nuclear ribonucleoprotein L (hnRNP L)","Mus musculus (Mouse)","mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]","GO:0000381; GO:0000785; GO:0000976; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0035770; GO:0043484; GO:0045120; GO:0045202; GO:0045892; GO:0048471; GO:0097157; GO:1990715; GO:1990904"
"984",1059,379805,"Cluster_1167","Peve_00043468",0.999909726776791,0.00855416971793915,0.573710369894872,155,-21.49,"2 21","742 764",20,"70.00%","75.00%","Q9VBW3","Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","Drosophila melanogaster (Fruit fly)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0014068; GO:0016339; GO:0033674; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0090303"
"985",1060,380406,"Cluster_7053","Peve_00024802",0.496350667543253,0.669346062435359,0.978262075707395,173,-20.38,"2 18","324 345",16,"87.50%","93.75%",NA,NA,NA,NA,NA
"986",1061,380660,"Cluster_1167","Peve_00035057",0.0248103733236768,0.984203604908919,0.999448381576871,154,-20.3,"2 21","448 468",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"987",1062,380843,"Cluster_2882","Peve_00044876",-0.898389711968954,0.289475524970989,0.978262075707395,147,-22.19,"2 16","584 605",14,"64.29%","85.71%",NA,NA,NA,NA,NA
"988",1063,380991,"Cluster_7053","Peve_00040347",0.992895983108058,0.0759284530899831,0.978262075707395,169,-20.69,"2 20","477 497",18,"83.33%","88.89%",NA,NA,NA,NA,NA
"989",1064,382186,"Cluster_29","Peve_00033048",-0.368569774287229,0.759695126986102,0.988219883885475,161,-25.02,"2 21","65 89",22,"77.27%","81.82%","Q6PQD5","Serine-protein kinase ATM (EC 2.7.11.1) (Ataxia telangiectasia mutated homolog) (A-T mutated homolog)","Sus scrofa (Pig)","cellular response to DNA damage stimulus [GO:0006974]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; histone mRNA catabolic process [GO:0071044]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of TORC1 signaling [GO:1904262]; peptidyl-serine phosphorylation [GO:0018105]; pexophagy [GO:0000425]; pre-B cell allelic exclusion [GO:0002331]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to ionizing radiation [GO:0010212]; signal transduction in response to DNA damage [GO:0042770]; telomere maintenance [GO:0000723]; translation [GO:0006412]","GO:0000077; GO:0000425; GO:0000723; GO:0002331; GO:0003677; GO:0003735; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005782; GO:0005813; GO:0005840; GO:0006281; GO:0006412; GO:0006468; GO:0006974; GO:0007094; GO:0008630; GO:0010212; GO:0016303; GO:0018105; GO:0031410; GO:0042770; GO:0046777; GO:0047485; GO:0071044; GO:0106310; GO:1904262"
"990",1065,382312,"Cluster_11135","Peve_00029014",0.992681180276387,0.0770692049392397,0.978262075707395,159,-21.82,"2 21","550 572",20,"70.00%","80.00%","A2VE52","Oligoribonuclease, mitochondrial (EC 3.1.15.-) (RNA exonuclease 2 homolog) (Small fragment nuclease)","Bos taurus (Bovine)","","GO:0000175; GO:0000287; GO:0003676; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005925; GO:0008296; GO:0008408"
"991",1066,384558,"Cluster_10061","Peve_00040834",-0.579715070531236,0.606327725401748,0.978262075707395,169,-20.12,"2 18","856 877",16,"81.25%","93.75%","P97499","Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog)","Mus musculus (Mouse)","telomere maintenance via recombination [GO:0000722]","GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904"
"992",1067,384722,"Cluster_6904","Peve_00004817",0.659907128668835,0.541191219096573,0.978262075707395,164,-23.76,"2 18","497 519",17,"82.35%","88.24%",NA,NA,NA,NA,NA
"993",1068,384724,"Cluster_6906","Peve_00004817",0.217544263742227,0.860390704313479,0.996303012730569,164,-24.59,"2 18","497 519",17,"82.35%","88.24%",NA,NA,NA,NA,NA
"994",1069,384981,"Cluster_2787","Peve_00042477",0.952962429313652,0.196035526222913,0.978262075707395,150,-20.33,"2 21","627 653",24,"66.67%","70.83%","Q12888","TP53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1)","Homo sapiens (Human)","cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; DNA damage checkpoint signaling [GO:0000077]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of isotype switching [GO:0045830]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]","GO:0000077; GO:0000776; GO:0000781; GO:0002039; GO:0003684; GO:0003712; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0006303; GO:0006974; GO:0016604; GO:0035064; GO:0035861; GO:0042162; GO:0042393; GO:0045830; GO:0045893; GO:0045944; GO:0051091; GO:0051260; GO:0061629; GO:0061649; GO:0071481; GO:1990391; GO:2000042"
"995",1070,385260,"Cluster_5882","Peve_00016977",0.0604458734571421,0.961495490135897,0.999448381576871,156,-20.39,"2 13","950 971",11,"90.91%","100.00%","Q8CG09","Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)","Rattus norvegicus (Rat)","carboxylic acid transmembrane transport [GO:1905039]; cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene transport [GO:0071716]; long-chain fatty acid import across plasma membrane [GO:0015911]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of inflammatory response [GO:0050729]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962]","GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0006979; GO:0008559; GO:0009235; GO:0009410; GO:0009925; GO:0015420; GO:0015431; GO:0015562; GO:0015889; GO:0015911; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0016491; GO:0016887; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042626; GO:0042887; GO:0042908; GO:0042910; GO:0045332; GO:0046943; GO:0050729; GO:0055085; GO:0060326; GO:0060548; GO:0070633; GO:0071716; GO:0099039; GO:0140115; GO:0140359; GO:1901215; GO:1904646; GO:1905039; GO:1990961; GO:1990962"
"996",1071,385433,"Cluster_2882","Peve_00003455",-0.967963360807899,0.161578998183906,0.978262075707395,167,-20.71,"2 20","390 411",18,"77.78%","83.33%","O54898","Voltage-dependent T-type calcium channel subunit alpha-1G (Voltage-gated calcium channel subunit alpha Cav3.1)","Rattus norvegicus (Rat)","action potential [GO:0001508]; artery smooth muscle contraction [GO:0014824]; AV node cell action potential [GO:0086016]; AV node cell to bundle of His cell signaling [GO:0086027]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular response to dexamethasone stimulus [GO:0071549]; chemical synaptic transmission [GO:0007268]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during SA node cell action potential [GO:0086046]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of calcium ion transport [GO:0051924]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; response to nickel cation [GO:0010045]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell signaling [GO:0086018]","GO:0001508; GO:0001518; GO:0002027; GO:0005245; GO:0005248; GO:0005737; GO:0005886; GO:0005891; GO:0007204; GO:0007268; GO:0008332; GO:0010045; GO:0014824; GO:0016020; GO:0019228; GO:0030425; GO:0034765; GO:0042391; GO:0043005; GO:0043025; GO:0044297; GO:0045202; GO:0045956; GO:0048471; GO:0051924; GO:0060371; GO:0060402; GO:0070509; GO:0070588; GO:0071549; GO:0086002; GO:0086010; GO:0086015; GO:0086016; GO:0086018; GO:0086027; GO:0086045; GO:0086046; GO:0086056; GO:0086059; GO:0086091; GO:0097110"
"997",1072,385482,"Cluster_4629","Peve_00003454",-0.443383362280846,0.707556077121805,0.978262075707395,151,-20.18,"2 20","643 661",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"998",1073,385641,"Cluster_11134","Peve_00016978",0.98920628098729,0.0936207439507944,0.978262075707395,157,-24.23,"2 15","461 483",14,"85.71%","92.86%","Q63120","ATP-binding cassette sub-family C member 2 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Canalicular multidrug resistance protein) (Canalicular multispecific organic anion transporter 1) (Multidrug resistance-associated protein 2)","Rattus norvegicus (Rat)","antibiotic metabolic process [GO:0016999]; benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; bilirubin transport [GO:0015723]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; detoxification of mercury ion [GO:0050787]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; leukotriene transport [GO:0071716]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; organic anion transport [GO:0015711]; prostaglandin transport [GO:0015732]; regulation of bile acid secretion [GO:0120188]; regulation of gene expression [GO:0010468]; response to 17alpha-ethynylestradiol [GO:1904486]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to lipopolysaccharide [GO:0032496]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic catabolic process [GO:0042178]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic export from cell [GO:0046618]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport across blood-brain barrier [GO:1990962]","GO:0005524; GO:0005737; GO:0005886; GO:0006855; GO:0006954; GO:0006979; GO:0007565; GO:0008514; GO:0008559; GO:0009408; GO:0009410; GO:0009986; GO:0010468; GO:0010629; GO:0014070; GO:0015127; GO:0015431; GO:0015694; GO:0015711; GO:0015721; GO:0015722; GO:0015723; GO:0015732; GO:0016020; GO:0016324; GO:0016887; GO:0016999; GO:0019904; GO:0030644; GO:0031526; GO:0032355; GO:0032496; GO:0033762; GO:0038183; GO:0042178; GO:0042626; GO:0042910; GO:0043627; GO:0046581; GO:0046618; GO:0046685; GO:0046691; GO:0048545; GO:0050787; GO:0055085; GO:0070327; GO:0070633; GO:0071222; GO:0071347; GO:0071354; GO:0071356; GO:0071466; GO:0071549; GO:0071716; GO:0097327; GO:0120188; GO:1901086; GO:1904486; GO:1990961; GO:1990962"
"999",1074,387110,"Cluster_6914","Peve_00008487",0.857503374968476,0.344028809467992,0.978262075707395,159,-24.84,"2 17","694 715",16,"81.25%","87.50%","Q922V4","Pleiotropic regulator 1","Mus musculus (Mouse)","mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]","GO:0000398; GO:0000974; GO:0001650; GO:0005634; GO:0005662; GO:0005681; GO:0016607; GO:0031965; GO:0034504; GO:0071007; GO:0071013; GO:1900087"
"1000",1075,388469,"Cluster_8988","Peve_00004104",-0.176644118188749,0.886951668419015,0.999448381576871,171,-25.18,"2 21","787 811",22,"77.27%","81.82%","Q8BLA8","Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor)","Mus musculus (Mouse)","calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular calcium ion homeostasis [GO:0006874]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to organic substance [GO:0071310]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; positive regulation of anion transport [GO:1903793]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of sensory perception of pain [GO:1904058]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832]","GO:0005216; GO:0005245; GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0010033; GO:0014070; GO:0014832; GO:0015267; GO:0015278; GO:0016020; GO:0016324; GO:0019233; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042542; GO:0042802; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0050974; GO:0051289; GO:0070301; GO:0070417; GO:0070588; GO:0071244; GO:0071310; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1904058; GO:1990760"
"1001",1076,388875,"Cluster_9149","Peve_00014532",0.0306231621661092,0.980501641140313,0.999448381576871,162,-21.97,"2 21","346 370",22,"77.27%","77.27%","Q17QA0","Gem-associated protein 7 (Gemin-7)","Bos taurus (Bovine)","spliceosomal snRNP assembly [GO:0000387]","GO:0000387; GO:0005829; GO:0032797; GO:0034719; GO:0097504; GO:0120114"
"1002",1077,389100,"Cluster_9149","Peve_00031039",-0.0718032485127076,0.954249261799908,0.999448381576871,173,-29.43,"2 18","759 780",16,"87.50%","93.75%",NA,NA,NA,NA,NA
"1003",1078,389911,"Cluster_9983","Peve_00000485",0.681888788557642,0.522317594016363,0.978262075707395,174,-21.71,"2 20","590 611",19,"84.21%","89.47%","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1004",1081,392544,"Cluster_4079","Peve_00027215",-0.886171394401763,0.306710889228692,0.978262075707395,151,-21.27,"2 19","496 517",18,"72.22%","83.33%","Q3T112","Proteasome subunit beta type-8 (EC 3.4.25.1) (Proteasome subunit beta-5i)","Bos taurus (Bovine)","antigen processing and presentation [GO:0019882]; fat cell differentiation [GO:0045444]; proteasomal protein catabolic process [GO:0010498]; regulation of endopeptidase activity [GO:0052548]","GO:0004175; GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0010498; GO:0019774; GO:0019882; GO:0045444; GO:0052548; GO:1990111"
"1005",1082,392752,"Cluster_11135","Peve_00027622",0.846390280819749,0.357542218424973,0.978262075707395,156,-20.36,"2 18","81 103",17,"76.47%","82.35%","Q5ZKJ4","FGFR1 oncogene partner 2 homolog","Gallus gallus (Chicken)","response to wounding [GO:0009611]","GO:0005737; GO:0009611"
"1006",1083,392855,"Cluster_1167","Peve_00027217",-0.196890868723889,0.873831065608176,0.997476741937264,152,-20.56,"2 21","465 486",19,"63.16%","73.68%","Q99N95","39S ribosomal protein L3, mitochondrial (L3mt) (MRP-L3)","Mus musculus (Mouse)","mitochondrial translation [GO:0032543]; translation [GO:0006412]","GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0032543"
"1007",1085,394956,"Cluster_11134","Peve_00039881",0.744343263206493,0.465525320150176,0.978262075707395,162,-26.61,"2 21","288 314",24,"70.83%","79.17%","D3YXG0","Hemicentin-1 (Fibulin-6) (FIBL-6)","Mus musculus (Mouse)","actin filament reorganization [GO:0090527]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]","GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711; GO:0090527"
"1008",1086,395331,"Cluster_2787","Peve_00017086",0.325966548218066,0.788620630009186,0.995556400176012,157,-20.78,"2 19","959 981",18,"77.78%","77.78%",NA,NA,NA,NA,NA
"1009",1087,395812,"Cluster_11135","Peve_00013705",0.535499914736697,0.640246436090277,0.978262075707395,157,-21.68,"2 18","232 253",16,"75.00%","81.25%",NA,NA,NA,NA,NA
"1010",1088,395854,"Cluster_10934","Peve_00013706",0.962628300031342,0.17459364744368,0.978262075707395,169,-22.1,"2 20","312 332",18,"83.33%","88.89%","Q9Y4B6","DDB1- and CUL4-associated factor 1 (HIV-1 Vpr-binding protein) (VprBP) (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1) (Vpr-interacting protein)","Homo sapiens (Human)","B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphorylation [GO:0016310]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]","GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006325; GO:0016310; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0043687; GO:0080008; GO:0106310; GO:1990244"
"1011",1089,395916,"Cluster_2787","Peve_00041326",-0.519564188512295,0.652188637062884,0.978262075707395,153,-21.51,"2 21","776 795",19,"73.68%","73.68%","Q3UQ28","Peroxidasin homolog (EC 1.11.2.-) [Cleaved into: PXDN active fragment]","Mus musculus (Mouse)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005201; GO:0005604; GO:0005615; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"1012",1090,397396,"Cluster_29","Peve_00041798",-0.90149143119521,0.284946588709919,0.978262075707395,160,-22.47,"2 20","751 775",21,"76.19%","85.71%",NA,NA,NA,NA,NA
"1013",1091,397533,"Cluster_796","Peve_00041795",0.64693749988835,0.552098905919193,0.978262075707395,167,-23.61,"2 21","930 953",21,"76.19%","80.95%","A5D8V7","Outer dynein arm-docking complex subunit 3 (Coiled-coil domain-containing protein 151)","Homo sapiens (Human)","brain development [GO:0007420]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; flagellated sperm motility [GO:0030317]; multicellular organism growth [GO:0035264]; outer dynein arm assembly [GO:0036158]; regulation of cilium assembly [GO:1902017]; spermatogenesis [GO:0007283]","GO:0003341; GO:0005576; GO:0005814; GO:0005929; GO:0005930; GO:0007283; GO:0007368; GO:0007420; GO:0030317; GO:0035253; GO:0035264; GO:0036064; GO:0036158; GO:0060287; GO:0061371; GO:0090660; GO:0097542; GO:0120228; GO:1902017"
"1014",1092,397949,"Cluster_5563","Peve_00041791",0.953705339843735,0.194469024212578,0.978262075707395,150,-21.87,"2 21","273 300",24,"62.50%","75.00%",NA,NA,NA,NA,NA
"1015",1093,398310,"Cluster_5882","Peve_00026506",0.0402610511311349,0.974362089305134,0.999448381576871,150,-21.39,"2 20","386 411",22,"63.64%","72.73%",NA,NA,NA,NA,NA
"1016",1094,399162,"Cluster_4629","Peve_00015938",-0.61833765580439,0.575612859377394,0.978262075707395,152,-20.39,"2 21","238 259",19,"63.16%","73.68%",NA,NA,NA,NA,NA
"1017",1095,399471,"Cluster_2787","Peve_00039774",-0.788720221725601,0.42148806045497,0.978262075707395,160,-20.16,"2 21","267 288",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"1018",1096,400053,"Cluster_796","Peve_00043237",0.971577670972831,0.152145458355826,0.978262075707395,152,-23.53,"2 13","330 351",11,"90.91%","90.91%","Q5XIG6","N-acetylgalactosamine kinase (EC 2.7.1.157) (GalNAc kinase) (Galactokinase 2)","Rattus norvegicus (Rat)","galactose metabolic process [GO:0006012]","GO:0004335; GO:0005524; GO:0005829; GO:0006012; GO:0033858; GO:0043229"
"1019",1097,400620,"Cluster_9149","Peve_00038061",-0.668782604183555,0.533631388812197,0.978262075707395,156,-22.24,"2 18","60 84",19,"73.68%","78.95%","P29773","Protein C-ets-2","Lytechinus variegatus (Green sea urchin) (Echinus variegatus)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0003700; GO:0005634; GO:0006357; GO:0043565"
"1020",1102,402194,"Cluster_8988","Peve_00012487",-0.905823201447666,0.278506848201881,0.978262075707395,150,-20.6,"2 20","574 597",20,"65.00%","75.00%",NA,NA,NA,NA,NA
"1021",1103,402663,"Cluster_796","Peve_00028244",0.914552419472341,0.265086172849999,0.978262075707395,155,-20.23,"2 20","270 291",18,"72.22%","72.22%","O54852","Potassium voltage-gated channel subfamily H member 7 (Ether-a-go-go-related gene potassium channel 3) (ERG-3) (Eag-related protein 3) (Ether-a-go-go-related protein 3) (Voltage-gated potassium channel subunit Kv11.3)","Rattus norvegicus (Rat)","circadian rhythm [GO:0007623]; membrane repolarization during action potential [GO:0086011]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]","GO:0005242; GO:0005249; GO:0005267; GO:0005886; GO:0006813; GO:0007623; GO:0034765; GO:0042391; GO:0044877; GO:0071805; GO:0086011"
"1022",1104,402915,"Cluster_9149","Peve_00034190",-0.498345080479903,0.667882536987427,0.978262075707395,152,-26.28,"2 21","732 753",19,"57.89%","78.95%","Q9QYS1","Protein Wnt-16","Mus musculus (Mouse)","bone remodeling [GO:0046849]; canonical Wnt signaling pathway [GO:0060070]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell fate commitment [GO:0045165]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; negative regulation of cell death [GO:0060548]; neuron differentiation [GO:0030182]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; replicative senescence [GO:0090399]","GO:0005109; GO:0005125; GO:0005615; GO:0005737; GO:0010628; GO:0014068; GO:0030182; GO:0030216; GO:0043616; GO:0045165; GO:0046330; GO:0046849; GO:0060070; GO:0060317; GO:0060548; GO:0090399; GO:0090403"
"1023",1105,403252,"Cluster_2854","Peve_00035575",-0.32423124356237,0.789788815269255,0.995841163676664,167,-20.54,"2 21","451 473",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"1024",1106,403297,"Cluster_2854","Peve_00035574",-0.525111933052067,0.648046901813849,0.978262075707395,167,-20.54,"2 21","490 512",20,"75.00%","85.00%","Q5ZME8","WD40 repeat-containing protein SMU1 (Smu-1 suppressor of mec-8 and unc-52 protein homolog)","Gallus gallus (Chicken)","mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]","GO:0000381; GO:0000398; GO:0005634; GO:0005737; GO:0008380; GO:0016607; GO:0071005; GO:0071011"
"1025",1107,403473,"Cluster_796","Peve_00035579",-0.818121918319766,0.390030776851777,0.978262075707395,151,-24.46,"2 21","73 97",22,"68.18%","68.18%",NA,NA,NA,NA,NA
"1026",1108,403506,"Cluster_11134","Peve_00035579",0.177370737293809,0.886481666764417,0.999448381576871,160,-23.15,"2 19","3 26",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"1027",1109,403845,"Cluster_5882","Peve_00041861",-0.61492777317909,0.578370307248233,0.978262075707395,161,-24.9,"2 16","533 553",14,"92.86%","92.86%",NA,NA,NA,NA,NA
"1028",1110,404120,"Cluster_6914","Peve_00044307",-0.449774257208956,0.703008872768505,0.978262075707395,150,-22.07,"2 20","38 59",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"1029",1111,404172,"Cluster_8887","Peve_00034221",0.947643204241301,0.206916422778752,0.978262075707395,165,-20.01,"2 19","609 630",18,"83.33%","83.33%",NA,NA,NA,NA,NA
"1030",1112,404326,"Cluster_29","Peve_00044309",-0.995182938890722,0.0625116105373675,0.978262075707395,167,-24.21,"2 21","946 968",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"1031",1113,404525,"Cluster_6914","Peve_00006982",-0.0117248538898032,0.992535555153361,0.999448381576871,157,-20.21,"2 20","142 165",21,"71.43%","80.95%","Q9Z104","SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related (SMARCE1-related protein) (BRCA2-associated factor 35) (HMG box-containing protein 20B) (Structural DNA-binding protein BRAF35)","Mus musculus (Mouse)","cell cycle [GO:0007049]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; negative regulation of protein sumoylation [GO:0033234]; positive regulation of neuron differentiation [GO:0045666]; protein sumoylation [GO:0016925]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; skeletal muscle cell differentiation [GO:0035914]","GO:0000400; GO:0000794; GO:0002111; GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0006338; GO:0006355; GO:0007049; GO:0010468; GO:0016604; GO:0016925; GO:0033234; GO:0035914; GO:0045666"
"1032",1114,406116,"Cluster_11134","Peve_00042887",-0.680183125878477,0.523800502185814,0.978262075707395,152,-20.18,"2 21","330 349",19,"63.16%","89.47%","Q9QZ81","Protein argonaute-2 (Argonaute2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (Golgi ER protein 95 kDa) (GERp95) (Protein slicer)","Rattus norvegicus (Rat)","cell differentiation [GO:0030154]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation, ncRNA-mediated [GO:0045975]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; RISC complex assembly [GO:0070922]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; RNA secondary structure unwinding [GO:0010501]; RNA-mediated gene silencing [GO:0031047]; siRNA processing [GO:0030422]; siRNA-mediated gene silencing by mRNA destabilization [GO:0090625]","GO:0000340; GO:0000932; GO:0000993; GO:0001046; GO:0003723; GO:0003725; GO:0003727; GO:0003729; GO:0004521; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005844; GO:0005845; GO:0008022; GO:0009791; GO:0010501; GO:0010586; GO:0010628; GO:0016442; GO:0030154; GO:0030422; GO:0030425; GO:0031047; GO:0031054; GO:0035196; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0042985; GO:0045766; GO:0045944; GO:0045947; GO:0045975; GO:0046872; GO:0060213; GO:0070062; GO:0070551; GO:0070578; GO:0070922; GO:0090502; GO:0090624; GO:0090625; GO:0098808; GO:1900153; GO:1901165; GO:1990904"
"1033",1116,406316,"Cluster_4115","Peve_00037550",0.938713208041894,0.224038140573558,0.978262075707395,167,-21.08,"2 21","755 777",20,"70.00%","90.00%","Q9BVG8","Kinesin-like protein KIFC3","Homo sapiens (Human)","epithelial cell-cell adhesion [GO:0090136]; Golgi organization [GO:0007030]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; visual perception [GO:0007601]; zonula adherens maintenance [GO:0045218]","GO:0003777; GO:0005524; GO:0005794; GO:0005813; GO:0005871; GO:0005874; GO:0005915; GO:0007017; GO:0007018; GO:0007030; GO:0007601; GO:0008017; GO:0015630; GO:0030659; GO:0042802; GO:0045218; GO:0070062; GO:0090136"
"1034",1118,406752,"Cluster_15726","Peve_00008728",-0.906573455635303,0.277377312240604,0.978262075707395,164,-23.2,"2 21","905 924",19,"84.21%","84.21%","Q99K85","Phosphoserine aminotransferase (PSAT) (EC 2.6.1.52) (Endometrial progesterone-induced protein) (EPIP) (Phosphohydroxythreonine aminotransferase)","Mus musculus (Mouse)","L-serine biosynthetic process [GO:0006564]","GO:0004648; GO:0005737; GO:0005829; GO:0006564; GO:0030170; GO:0042802"
"1035",1119,406851,"Cluster_2787","Peve_00008723",0.990183461160617,0.0892750760694426,0.978262075707395,158,-22.37,"2 21","17 37",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"1036",1120,407061,"Cluster_11134","Peve_00015587",0.660128931495733,0.54100326021175,0.978262075707395,173,-31.45,"2 19","295 317",18,"83.33%","94.44%","Q6YHK3","CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)","Homo sapiens (Human)","hair follicle development [GO:0001942]; keratinocyte proliferation [GO:0043616]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of peptidase activity [GO:0010466]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; protein phosphorylation [GO:0006468]; regulation of keratinocyte differentiation [GO:0045616]; stem cell proliferation [GO:0072089]","GO:0001933; GO:0001942; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0006468; GO:0009986; GO:0010466; GO:0010839; GO:0030512; GO:0031092; GO:0043616; GO:0045616; GO:0050431; GO:0061045; GO:0072089; GO:0072675; GO:2000647"
"1037",1121,407490,"Cluster_5882","Peve_00037887",-0.188470122822619,0.879294269276386,0.998547984197839,162,-22.35,"2 19","540 561",17,"76.47%","82.35%","Q9ZQ31","Serine/threonine-protein kinase STY13 (EC 2.7.11.1) (AtSTYPK) (Serine/threonine/tyrosine-protein kinase 13)","Arabidopsis thaliana (Mouse-ear cress)","protein phosphorylation [GO:0006468]; regulation of embryonic development [GO:0045995]; seed oilbody biogenesis [GO:0010344]; signal transduction [GO:0007165]","GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0010344; GO:0045995; GO:0106310"
"1038",1122,410133,"Cluster_796","Peve_00002955",-0.236662942603704,0.84789257952564,0.995934364227446,147,-20.11,"2 21","918 941",21,"61.90%","71.43%",NA,NA,NA,NA,NA
"1039",1123,410522,"Cluster_10060","Peve_00029973",-0.732992461699907,0.47624607954137,0.978262075707395,167,-21.66,"2 21","359 381",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"1040",1124,410619,"Cluster_13502","Peve_00029971",-0.44209200413486,0.708472937844906,0.978262075707395,156,-21.17,"2 18","358 380",17,"70.59%","88.24%",NA,NA,NA,NA,NA
"1041",1125,410741,"Cluster_8884","Peve_00006518",-0.961321812437412,0.177638878179318,0.978262075707395,165,-20.19,"2 20","238 260",20,"80.00%","85.00%","B1H1W9","Protein kintoun (Dynein assembly factor 2, axonemal)","Xenopus laevis (African clawed frog)","axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]","GO:0005737; GO:0060285; GO:0070286; GO:0120293"
"1042",1126,410742,"Cluster_8887","Peve_00006518",-0.848088960164075,0.355506460452883,0.978262075707395,165,-20.19,"2 20","238 260",20,"80.00%","85.00%","B1H1W9","Protein kintoun (Dynein assembly factor 2, axonemal)","Xenopus laevis (African clawed frog)","axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]","GO:0005737; GO:0060285; GO:0070286; GO:0120293"
"1043",1127,410756,"Cluster_14999","Peve_00006518",0.565054876858794,0.617709976189869,0.978262075707395,179,-25.34,"2 21","955 977",20,"85.00%","90.00%","B1H1W9","Protein kintoun (Dynein assembly factor 2, axonemal)","Xenopus laevis (African clawed frog)","axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]","GO:0005737; GO:0060285; GO:0070286; GO:0120293"
"1044",1128,410949,"Cluster_4079","Peve_00025168",-0.977031478441325,0.136708784729514,0.978262075707395,154,-22.11,"2 18","282 301",16,"81.25%","81.25%","Q92626","Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment]","Homo sapiens (Human)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070062; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"1045",1129,410966,"Cluster_8884","Peve_00025168",-0.858853895308761,0.34235399051756,0.978262075707395,156,-22.9,"2 19","904 923",17,"70.59%","88.24%","Q92626","Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment]","Homo sapiens (Human)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070062; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"1046",1130,410967,"Cluster_8887","Peve_00025168",-0.966806548392751,0.164486408243996,0.978262075707395,156,-27.42,"2 19","904 923",17,"70.59%","88.24%","Q92626","Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment]","Homo sapiens (Human)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070062; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"1047",1131,410968,"Cluster_8888","Peve_00025168",-0.884766021622526,0.308636204626733,0.978262075707395,156,-23.18,"2 19","904 923",17,"70.59%","88.24%","Q92626","Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment]","Homo sapiens (Human)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070062; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"1048",1132,411132,"Cluster_4629","Peve_00021619",0.912101436585674,0.268917897240141,0.978262075707395,162,-21.24,"2 20","51 73",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"1049",1133,411609,"Cluster_13502","Peve_00009982",-0.739236791010994,0.470372862243104,0.978262075707395,167,-21.28,"2 16","130 151",14,"85.71%","100.00%","Q7Z7H5","Transmembrane emp24 domain-containing protein 4 (Endoplasmic reticulum stress-response protein 25) (ERS25) (GMP25iso) (Putative NF-kappa-B-activating protein 156) (p24 family protein alpha-3) (p24alpha3)","Homo sapiens (Human)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]","GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0030134; GO:0043123"
"1050",1134,411936,"Cluster_2787","Peve_00026347",0.625744521850162,0.569590508170833,0.978262075707395,164,-28.16,"2 21","728 747",19,"78.95%","89.47%","O77680","D(1A) dopamine receptor (Dopamine D1 receptor)","Macaca mulatta (Rhesus macaque)","activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of gene expression [GO:0010628]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; vasodilation [GO:0042311]","GO:0001588; GO:0004930; GO:0005789; GO:0005886; GO:0007187; GO:0007190; GO:0007191; GO:0007212; GO:0010628; GO:0035240; GO:0042311; GO:0043197; GO:0051281; GO:0051482; GO:0060158; GO:0060170; GO:0071880; GO:0097730"
"1051",1135,412476,"Cluster_2787","Peve_00026328",0.513547186105516,0.656662264039705,0.978262075707395,158,-20.21,"2 20","70 92",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"1052",1136,412477,"Cluster_2854","Peve_00026328",-0.871413202065014,0.326407996807902,0.978262075707395,162,-20.7,"2 15","492 513",13,"92.31%","92.31%",NA,NA,NA,NA,NA
"1053",1137,412705,"Cluster_4080","Peve_00011236",-0.235777127616489,0.848472931070267,0.995934364227446,162,-22.06,"2 21","449 469",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"1054",1138,412790,"Cluster_1167","Peve_00011235",0.658973053111598,0.541982234013298,0.978262075707395,145,-20.18,"2 10","544 565",8,"100.00%","100.00%",NA,NA,NA,NA,NA
"1055",1139,413143,"Cluster_15890","Peve_00026830",0.234803897014175,0.84911040599833,0.995934364227446,167,-20.69,"2 21","314 336",20,"80.00%","80.00%",NA,NA,NA,NA,NA
"1056",1140,413179,"Cluster_10934","Peve_00026837",-0.546002800702893,0.632297575653459,0.978262075707395,146,-20.91,"2 20","1 16",18,"66.67%","77.78%","Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"1057",1141,413200,"Cluster_4080","Peve_00026838",-0.00361899674555073,0.997696070086482,0.999470707733341,175,-22.05,"2 20","757 778",18,"83.33%","88.89%",NA,NA,NA,NA,NA
"1058",1142,413251,"Cluster_6255","Peve_00026839",-0.311029260722703,0.798652561519489,0.995934364227446,166,-20.04,"2 20","975 997",19,"78.95%","84.21%","Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"1059",1143,413716,"Cluster_9983","Peve_00011588",0.498751907423741,0.667583764936494,0.978262075707395,162,-21.4,"2 20","364 385",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"1060",1144,413913,"Cluster_796","Peve_00011583",0.897160133823092,0.291252728152517,0.978262075707395,156,-23.07,"2 20","281 306",22,"77.27%","77.27%","Q9CR50","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630"
"1061",1145,413992,"Cluster_11135","Peve_00011584",0.844443877729655,0.359862212804899,0.978262075707395,153,-20.52,"2 15","819 841",14,"78.57%","92.86%",NA,NA,NA,NA,NA
"1062",1146,414818,"Cluster_2882","Peve_00039271",-0.977055736325033,0.136636295563783,0.978262075707395,158,-23.22,"2 15","117 138",13,"84.62%","92.31%",NA,NA,NA,NA,NA
"1063",1147,415245,"Cluster_9149","Peve_00008133",-0.999965637301935,0.00527764279292991,0.551398425649056,164,-20.98,"2 20","190 209",18,"83.33%","83.33%","P58027","Amine oxidase [flavin-containing] A (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A)","Canis lupus familiaris (Dog) (Canis familiaris)","catecholamine metabolic process [GO:0006584]; neurotransmitter catabolic process [GO:0042135]","GO:0005739; GO:0005741; GO:0006584; GO:0008131; GO:0042135; GO:0050660; GO:0052595; GO:0052596; GO:0097621"
"1064",1148,415452,"Cluster_4629","Peve_00017324",-0.945504437122742,0.211138755910182,0.978262075707395,153,-20.37,"2 20","417 437",18,"66.67%","83.33%","Q8N972","Zinc finger protein 709","Homo sapiens (Human)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"1065",1149,415671,"Cluster_2787","Peve_00017321",0.384697428481462,0.748611582886512,0.988219883885475,158,-22.37,"2 21","17 37",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"1066",1150,415852,"Cluster_2854","Peve_00034020",-0.838945952848089,0.366344648277057,0.978262075707395,172,-22.26,"2 21","547 568",19,"73.68%","89.47%","Q00537","Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2)","Homo sapiens (Human)","protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]","GO:0000083; GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0106310"
"1067",1151,415897,"Cluster_2854","Peve_00034021",-0.507486347355159,0.661149542463894,0.978262075707395,172,-22.26,"2 21","228 249",19,"73.68%","89.47%","Q9MYM7","Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)","Pongo pygmaeus (Bornean orangutan)","lipid metabolic process [GO:0006629]; protein glycosylation [GO:0006486]","GO:0000139; GO:0006486; GO:0006629; GO:0047275"
"1068",1152,416490,"Cluster_5882","Peve_00020203",-0.779314222306939,0.431135232681729,0.978262075707395,168,-21.79,"2 21","558 579",19,"68.42%","89.47%",NA,NA,NA,NA,NA
"1069",1153,416766,"Cluster_7053","Peve_00044495",-0.00749125846798571,0.995230872132244,0.999448381576871,176,-21.67,"2 21","27 48",19,"78.95%","89.47%","Q9F234","Alpha-glucosidase 2 (EC 3.2.1.20) (Alpha-glucosidase II)","Bacillus thermoamyloliquefaciens","","GO:0030246; GO:0032450"
"1070",1154,417018,"Cluster_796","Peve_00041513",0.898740270652305,0.288966974174018,0.978262075707395,150,-22,"2 21","678 702",22,"68.18%","72.73%",NA,NA,NA,NA,NA
"1071",1155,418734,"Cluster_4079","Peve_00019779",0.585667726732403,0.601664712659408,0.978262075707395,161,-25.22,"2 14","333 354",12,"91.67%","100.00%","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1072",1157,419526,"Cluster_11134","Peve_00036910",-0.0195622829453675,0.987545469442176,0.999448381576871,161,-21.19,"2 20","241 265",21,"76.19%","80.95%",NA,NA,NA,NA,NA
"1073",1162,420347,"Cluster_589","Peve_00035294",-0.884838657147761,0.308536967433249,0.978262075707395,155,-21.82,"2 12","319 340",10,"100.00%","100.00%","Q9UDY8","Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase)","Homo sapiens (Human)","activation of NF-kappaB-inducing kinase activity [GO:0007250]; B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]","GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006952; GO:0007250; GO:0008233; GO:0009620; GO:0031398; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0032991; GO:0036094; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043066; GO:0043123; GO:0043280; GO:0043621; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0051092; GO:0051168; GO:0051603; GO:2000321"
"1074",1163,420564,"Cluster_13502","Peve_00035290",-0.985340161575227,0.109141948173345,0.978262075707395,151,-21.65,"2 17","580 602",16,"75.00%","81.25%","Q9BXB4","Oxysterol-binding protein-related protein 11 (ORP-11) (OSBP-related protein 11)","Homo sapiens (Human)","fat cell differentiation [GO:0045444]; positive regulation of sequestering of triglyceride [GO:0010890]","GO:0005654; GO:0005794; GO:0005829; GO:0010890; GO:0015248; GO:0016020; GO:0031902; GO:0032934; GO:0043231; GO:0045444"
"1075",1164,420933,"Cluster_796","Peve_00043007",-0.0696341159246928,0.955633640840684,0.999448381576871,148,-25.32,"2 21","113 131",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"1076",1165,421332,"Cluster_15726","Peve_00001253",-0.697402908441927,0.50867768240741,0.978262075707395,153,-21.19,"2 21","526 545",19,"73.68%","73.68%","Q3T134","Signal peptidase complex subunit 1 (Microsomal signal peptidase 12 kDa subunit) (SPase 12 kDa subunit)","Bos taurus (Bovine)","protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]","GO:0005787; GO:0005789; GO:0006465; GO:0045047"
"1077",1166,421377,"Cluster_15726","Peve_00001252",-0.12445633266285,0.920562658088606,0.999448381576871,153,-21.19,"2 21","526 545",19,"73.68%","73.68%","Q5BKL9","45 kDa calcium-binding protein (Cab45) (Stromal cell-derived factor 4) (SDF-4)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0005509; GO:0005796"
"1078",1167,421615,"Cluster_4080","Peve_00040674",-0.75768069351644,0.452664918030814,0.978262075707395,180,-21.9,"2 21","798 819",19,"78.95%","94.74%","Q1LZE9","Serine protease 23 (EC 3.4.21.-)","Bos taurus (Bovine)","proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0005634; GO:0006508"
"1079",1168,422283,"Cluster_796","Peve_00038239",0.995912206995874,0.0575821162539123,0.978262075707395,160,-24.25,"2 21","626 647",19,"73.68%","73.68%","P26714","Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor)","Lymnaea stagnalis (Great pond snail) (Helix stagnalis)","","GO:0004890; GO:0005230; GO:0005254; GO:0034707; GO:0045211"
"1080",1169,423054,"Cluster_4079","Peve_00034520",-0.796272454187231,0.413604356922386,0.978262075707395,164,-23.24,"2 21","225 244",19,"78.95%","89.47%","B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"1081",1170,423394,"Cluster_10934","Peve_00001875",-0.507660159725479,0.661021117108037,0.978262075707395,160,-24.98,"2 21","33 54",19,"63.16%","84.21%",NA,NA,NA,NA,NA
"1082",1171,423480,"Cluster_9149","Peve_00001877",-0.456216729911664,0.698408354059349,0.978262075707395,170,-30.76,"2 21","502 522",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"1083",1172,423595,"Cluster_4080","Peve_00001878",-0.997498841901557,0.045035631247519,0.930829896493262,169,-21.99,"2 20","37 57",18,"83.33%","88.89%",NA,NA,NA,NA,NA
"1084",1173,424100,"Cluster_6914","Peve_00033174",-0.712373438882835,0.495240506438969,0.978262075707395,171,-21.12,"2 20","317 337",18,"72.22%","94.44%",NA,NA,NA,NA,NA
"1085",1174,424812,"Cluster_4629","Peve_00038309",0.987883442128574,0.0992028710840325,0.978262075707395,150,-22.43,"2 20","354 379",22,"68.18%","68.18%","A2BIL7","Tyrosine-protein kinase BAZ1B (EC 2.7.10.2) (Bromodomain adjacent to zinc finger domain protein 1B) (Williams syndrome transcription factor homolog)","Danio rerio (Zebrafish) (Brachydanio rerio)","cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; positive regulation of macromolecule metabolic process [GO:0010604]; positive regulation of nucleobase-containing compound metabolic process [GO:0045935]; post-translational protein modification [GO:0043687]","GO:0004713; GO:0005524; GO:0005634; GO:0006338; GO:0006974; GO:0010604; GO:0035173; GO:0042393; GO:0043687; GO:0045935; GO:0046872; GO:0090535; GO:0140801"
"1086",1175,424937,"Cluster_589","Peve_00028789",0.514562079781581,0.65590901909483,0.978262075707395,155,-23.41,"2 12","917 938",10,"100.00%","100.00%",NA,NA,NA,NA,NA
"1087",1176,425061,"Cluster_11134","Peve_00028780",-0.414419113429378,0.727969548698455,0.983918391426732,172,-25.54,"2 21","42 63",19,"78.95%","84.21%","Q03468","DNA excision repair protein ERCC-6 (EC 3.6.4.-) (ATP-dependent helicase ERCC6) (Cockayne syndrome protein CSB)","Homo sapiens (Human)","base-excision repair [GO:0006284]; chromatin remodeling [GO:0006338]; DNA damage checkpoint signaling [GO:0000077]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; JNK cascade [GO:0007254]; multicellular organism growth [GO:0035264]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; pyrimidine dimer repair [GO:0006290]; regulation of DNA-templated transcription elongation [GO:0032784]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription by RNA polymerase II [GO:0006366]; transcription elongation by RNA polymerase I [GO:0006362]; transcription-coupled nucleotide-excision repair [GO:0006283]","GO:0000012; GO:0000077; GO:0000303; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006283; GO:0006284; GO:0006290; GO:0006338; GO:0006362; GO:0006366; GO:0006979; GO:0007254; GO:0008022; GO:0008023; GO:0008094; GO:0008630; GO:0009411; GO:0009636; GO:0010165; GO:0010224; GO:0010332; GO:0016887; GO:0022008; GO:0030182; GO:0030296; GO:0031175; GO:0032784; GO:0032786; GO:0034243; GO:0035066; GO:0035264; GO:0042262; GO:0044877; GO:0045494; GO:0045739; GO:0045943; GO:0045944; GO:0045945; GO:0047485; GO:0060261; GO:0070063; GO:0090734; GO:0097680; GO:0110016; GO:0140658; GO:1905168; GO:2001033"
"1088",1177,425106,"Cluster_11134","Peve_00028781",-0.391062090989065,0.744215533803136,0.987164357498323,172,-25.54,"2 21","42 63",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"1089",1179,425539,"Cluster_6906","Peve_00007846",0.962327621744432,0.175299050668724,0.978262075707395,156,-20.51,"2 19","381 401",17,"76.47%","82.35%","E7F6D7","Palmitoyltransferase ZDHHC6 (EC 2.3.1.225) (DHHC domain-containing protein 6) (Stearoyltransferase ZDHHC6) (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 6)","Danio rerio (Zebrafish) (Brachydanio rerio)","peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]","GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0018230; GO:0019706; GO:0140439"
"1090",1180,425550,"Cluster_9149","Peve_00007846",-0.015773561011863,0.989957822725476,0.999448381576871,151,-22.24,"2 14","851 871",12,"91.67%","91.67%","E7F6D7","Palmitoyltransferase ZDHHC6 (EC 2.3.1.225) (DHHC domain-containing protein 6) (Stearoyltransferase ZDHHC6) (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 6)","Danio rerio (Zebrafish) (Brachydanio rerio)","peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]","GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0018230; GO:0019706; GO:0140439"
"1091",1181,426107,"Cluster_589","Peve_00008392",0.775072695353894,0.435426401668339,0.978262075707395,146,-23.88,"2 21","222 251",27,"62.96%","66.67%",NA,NA,NA,NA,NA
"1092",1182,426144,"Cluster_13502","Peve_00008392",-0.555752552842411,0.624860395488428,0.978262075707395,161,-21.5,"2 20","112 136",21,"76.19%","80.95%",NA,NA,NA,NA,NA
"1093",1183,426266,"Cluster_8884","Peve_00008399",-0.947118896471403,0.20795915113434,0.978262075707395,172,-20.79,"2 19","203 222",17,"88.24%","94.12%","Q9NXG6","Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4)","Homo sapiens (Human)","peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; regulation of erythrocyte differentiation [GO:0045646]","GO:0004656; GO:0005506; GO:0005509; GO:0005783; GO:0005789; GO:0016706; GO:0018401; GO:0031418; GO:0045646"
"1094",1184,426267,"Cluster_8887","Peve_00008399",-0.821901473199095,0.385826733407904,0.978262075707395,172,-21.11,"2 19","203 222",17,"88.24%","94.12%","Q9NXG6","Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4)","Homo sapiens (Human)","peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; regulation of erythrocyte differentiation [GO:0045646]","GO:0004656; GO:0005506; GO:0005509; GO:0005783; GO:0005789; GO:0016706; GO:0018401; GO:0031418; GO:0045646"
"1095",1185,426268,"Cluster_8888","Peve_00008399",-0.219753560508399,0.858949346278634,0.995934364227446,172,-22.74,"2 19","203 222",17,"88.24%","94.12%","Q9NXG6","Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4)","Homo sapiens (Human)","peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; regulation of erythrocyte differentiation [GO:0045646]","GO:0004656; GO:0005506; GO:0005509; GO:0005783; GO:0005789; GO:0016706; GO:0018401; GO:0031418; GO:0045646"
"1096",1186,426360,"Cluster_9149","Peve_00019434",-0.940478525862837,0.220754728136775,0.978262075707395,150,-21.09,"2 15","628 649",13,"69.23%","92.31%",NA,NA,NA,NA,NA
"1097",1187,426408,"Cluster_10061","Peve_00019435",-0.560532485073024,0.621192992940916,0.978262075707395,175,-22.25,"2 20","664 685",18,"83.33%","88.89%",NA,NA,NA,NA,NA
"1098",1188,428081,"Cluster_14999","Peve_00023375",0.908781066492889,0.274028402975986,0.978262075707395,168,-25.32,"2 19","205 229",20,"85.00%","85.00%","Q6PB03","5'-3' exonuclease PLD3 (EC 3.1.16.1) (Choline phosphatase 3) (Phosphatidylcholine-hydrolyzing phospholipase D3) (Phospholipase D3) (PLD 3)","Xenopus laevis (African clawed frog)","immune system process [GO:0002376]; inflammatory response [GO:0006954]; myotube differentiation [GO:0014902]; regulation of cytokine production involved in inflammatory response [GO:1900015]","GO:0000139; GO:0002376; GO:0005789; GO:0006954; GO:0014902; GO:0031901; GO:0031902; GO:0043202; GO:0045145; GO:1900015"
"1099",1189,428225,"Cluster_1167","Peve_00023371",-0.0753907396121126,0.951959182231936,0.999448381576871,147,-20.33,"2 12","235 256",10,"90.00%","90.00%","P25324","Thiosulfate sulfurtransferase (EC 2.8.1.1) (Rhodanese)","Gallus gallus (Chicken)","rRNA import into mitochondrion [GO:0035928]; rRNA transport [GO:0051029]; transsulfuration [GO:0019346]","GO:0004792; GO:0005739; GO:0005759; GO:0008097; GO:0019346; GO:0035928; GO:0051029"
"1100",1190,428460,"Cluster_5882","Peve_00009912",0.988867325958984,0.0950820632559861,0.978262075707395,165,-20.12,"2 19","16 38",18,"83.33%","83.33%",NA,NA,NA,NA,NA
"1101",1191,428725,"Cluster_4080","Peve_00005143",-0.447616338348081,0.704546075139228,0.978262075707395,167,-20.99,"2 18","119 142",18,"88.89%","88.89%","O16374","Beta-1,4-galactosyltransferase galt-1 (EC 2.4.1.-)","Caenorhabditis elegans","N-glycan processing [GO:0006491]; protein galactosylation [GO:0042125]","GO:0003831; GO:0006491; GO:0032580; GO:0035250; GO:0042125; GO:0043229; GO:0046872"
"1102",1192,429677,"Cluster_6904","Peve_00006497",0.968576899631778,0.160016027982964,0.978262075707395,164,-23.39,"2 21","462 483",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"1103",1193,429679,"Cluster_6906","Peve_00006497",0.729811619910124,0.479215513199871,0.978262075707395,160,-20.94,"2 21","462 483",19,"63.16%","84.21%",NA,NA,NA,NA,NA
"1104",1194,430116,"Cluster_2787","Peve_00020773",0.612304391417252,0.580485415267653,0.978262075707395,158,-20.89,"2 21","275 299",22,"68.18%","81.82%","P53111","NADPH-dependent aldehyde reductase ARI1 (EC 1.1.1.-)","Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)","","GO:0004090; GO:0005634; GO:0005737; GO:0016491; GO:0016616"
"1105",1195,430329,"Cluster_13502","Peve_00030683",0.156284588091377,0.90009660282392,0.999448381576871,172,-22.15,"2 17","244 265",15,"93.33%","93.33%",NA,NA,NA,NA,NA
"1106",1196,430397,"Cluster_6904","Peve_00009834",-0.880575899585923,0.314312088282751,0.978262075707395,157,-20.8,"2 19","382 404",18,"72.22%","83.33%","Q04205","Tensin-1 (EC 3.1.3.-)","Gallus gallus (Chicken)","fibroblast migration [GO:0010761]","GO:0003779; GO:0004721; GO:0005737; GO:0005856; GO:0005925; GO:0009986; GO:0010761"
"1107",1197,431738,"Cluster_2882","Peve_00039852",0.0688372031480257,0.956142191637655,0.999448381576871,144,-20.82,"2 16","800 819",14,"78.57%","78.57%",NA,NA,NA,NA,NA
"1108",1198,431906,"Cluster_14999","Peve_00039855",0.525134194156591,0.64803024914489,0.978262075707395,155,-20.21,"2 21","692 717",23,"69.57%","69.57%","Q8CH87","Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3 (EC 2.4.1.102) (EC 2.4.1.148) (EC 2.4.1.150) (C2GnT-mucin type) (C2GnT-M) (dI/C2/C4GnT) (dIGnT)","Rattus norvegicus (Rat)","intestinal absorption [GO:0050892]; kidney morphogenesis [GO:0060993]; protein glycosylation [GO:0006486]; tissue morphogenesis [GO:0048729]","GO:0000139; GO:0003829; GO:0006486; GO:0008109; GO:0008375; GO:0047225; GO:0048729; GO:0050892; GO:0060993; GO:0106325; GO:0106326"
"1109",1199,431951,"Cluster_14999","Peve_00039856",0.624031656518859,0.57098723489234,0.978262075707395,155,-20.21,"2 21","318 343",23,"69.57%","69.57%","P97402","N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase (N-acetylglucosaminyltransferase) (EC 2.4.1.150) (I-branching enzyme) (IGNT) (Large I antigen-forming beta-1,6-N-acetylglucosaminyltransferase)","Mus musculus (Mouse)","maintenance of lens transparency [GO:0036438]; negative regulation of cell-substrate adhesion [GO:0010812]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of protein kinase B signaling [GO:0051897]; post-transcriptional regulation of gene expression [GO:0010608]; protein glycosylation [GO:0006486]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0000139; GO:0005794; GO:0006486; GO:0007179; GO:0008109; GO:0008284; GO:0008375; GO:0010608; GO:0010718; GO:0010812; GO:0030335; GO:0034116; GO:0036438; GO:0051897; GO:0070374"
"1110",1200,432861,"Cluster_2787","Peve_00018393",0.995701423804156,0.0590490790909256,0.978262075707395,156,-20.5,"2 21","856 875",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"1111",1201,433685,"Cluster_6914","Peve_00011793",0.35569410315058,0.768488996117479,0.990527675986719,154,-20.84,"2 20","901 920",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"1112",1202,433851,"Cluster_2787","Peve_00017829",-0.00382968334855694,0.997561941898757,0.999448381576871,153,-21.05,"2 19","779 804",21,"71.43%","71.43%",NA,NA,NA,NA,NA
"1113",1203,434414,"Cluster_8988","Peve_00017790",0.0860148226113438,0.945173514868548,0.999448381576871,169,-22.24,"2 19","72 95",19,"84.21%","84.21%",NA,NA,NA,NA,NA
"1114",1204,434604,"Cluster_13502","Peve_00017794",-0.214395271790397,0.862443870466059,0.996660710141104,159,-21.04,"2 18","294 314",16,"81.25%","87.50%",NA,NA,NA,NA,NA
"1115",1205,435783,"Cluster_796","Peve_00012174",0.927174059423188,0.244461090121344,0.978262075707395,159,-24.54,"2 21","818 844",24,"70.83%","70.83%",NA,NA,NA,NA,NA
"1116",1206,435855,"Cluster_9149","Peve_00012175",-0.571415065283859,0.612789315328059,0.978262075707395,155,-20.52,"2 21","961 983",20,"70.00%","75.00%","Q70E73","Ras-associated and pleckstrin homology domains-containing protein 1 (RAPH1) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 18 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 9 protein) (Lamellipodin) (Proline-rich EVH1 ligand 2) (PREL-2) (Protein RMO1)","Homo sapiens (Human)","axon extension [GO:0048675]; signal transduction [GO:0007165]","GO:0005829; GO:0005856; GO:0005886; GO:0007165; GO:0016604; GO:0030027; GO:0030175; GO:0048675"
"1117",1207,435962,"Cluster_589","Peve_00012178",-0.955928712470642,0.189705983466144,0.978262075707395,146,-21.79,"2 11","84 105",9,"88.89%","100.00%","Q640V9","Deoxyribonuclease TATDN1 (EC 3.1.21.-)","Xenopus laevis (African clawed frog)","","GO:0004518; GO:0005634; GO:0046872"
"1118",1208,436477,"Cluster_7657","Peve_00042967",-0.705673373193628,0.501289216092251,0.978262075707395,169,-21.73,"2 21","148 169",20,"80.00%","90.00%",NA,NA,NA,NA,NA
"1119",1209,436478,"Cluster_7658","Peve_00042967",-0.0149881471432194,0.990457891890958,0.999448381576871,169,-21.73,"2 21","148 169",20,"80.00%","90.00%",NA,NA,NA,NA,NA
"1120",1210,436767,"Cluster_15726","Peve_00012278",-0.990746583814855,0.0866725612400038,0.978262075707395,160,-21.36,"2 13","963 984",11,"100.00%","100.00%","Q8HXP6","Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)","Pongo pygmaeus (Bornean orangutan)","cellular response to oxidative stress [GO:0034599]; regulation of transcription by RNA polymerase II [GO:0006357]; superoxide metabolic process [GO:0006801]","GO:0004784; GO:0005759; GO:0006357; GO:0006801; GO:0030145; GO:0034599"
"1121",1211,436980,"Cluster_9149","Peve_00036519",-0.999042227116386,0.0278651290317038,0.899642249848007,145,-20.73,"2 16","885 905",14,"71.43%","85.71%","O00468","Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]","Homo sapiens (Human)","animal organ morphogenesis [GO:0009887]; clustering of voltage-gated sodium channels [GO:0045162]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; tissue development [GO:0009888]","GO:0002162; GO:0005200; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0005886; GO:0007165; GO:0007213; GO:0007528; GO:0009887; GO:0009888; GO:0033691; GO:0035374; GO:0043113; GO:0043202; GO:0043236; GO:0043395; GO:0043547; GO:0045162; GO:0045202; GO:0045887; GO:0045944; GO:0050808; GO:0051491; GO:0062023; GO:0070062"
"1122",1212,437385,"Cluster_9149","Peve_00016463",-0.481204118727541,0.680399172526422,0.978262075707395,156,-23.46,"2 20","962 983",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"1123",1213,438421,"Cluster_9983","Peve_00018329",0.16363533786779,0.895355915058685,0.999448381576871,175,-21.31,"2 20","171 191",18,"83.33%","88.89%",NA,NA,NA,NA,NA
"1124",1214,438549,"Cluster_7855","Peve_00041700",-0.0682313294056035,0.956528811883472,0.999448381576871,175,-22.54,"2 21","336 359",21,"76.19%","90.48%","P21783","Neurogenic locus notch homolog protein 1 (Notch 1) (xOTCH) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]","Xenopus laevis (African clawed frog)","angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]","GO:0000122; GO:0001525; GO:0005509; GO:0005654; GO:0005886; GO:0030154; GO:0038023; GO:0050793; GO:0060271; GO:0061314"
"1125",1215,439050,"Cluster_9149","Peve_00043701",0.847266825559667,0.356493032547081,0.978262075707395,164,-26.56,"2 19","141 166",21,"80.95%","80.95%",NA,NA,NA,NA,NA
"1126",1216,439512,"Cluster_15726","Peve_00019981",-0.5,0.666666666666667,0.978262075707395,167,-20.84,"2 21","367 389",20,"80.00%","80.00%",NA,NA,NA,NA,NA
"1127",1217,440271,"Cluster_11134","Peve_00002925",-0.0094435636290075,0.993987951309925,0.999448381576871,159,-22.28,"2 21","188 213",23,"60.87%","82.61%",NA,NA,NA,NA,NA
"1128",1218,440652,"Cluster_4629","Peve_00004185",0.359561720751006,0.765852419551555,0.989877496225754,150,-20.11,"2 21","548 572",22,"63.64%","77.27%","Q5SPC5","Otoferlin (Fer-1-like protein 2)","Danio rerio (Zebrafish) (Brachydanio rerio)","neuromuscular process controlling balance [GO:0050885]; plasma membrane organization [GO:0007009]; response to auditory stimulus [GO:0010996]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]","GO:0000139; GO:0001964; GO:0005509; GO:0005789; GO:0007009; GO:0007605; GO:0010996; GO:0016079; GO:0016082; GO:0016323; GO:0030672; GO:0035612; GO:0042995; GO:0048787; GO:0050885"
"1129",1219,440856,"Cluster_11134","Peve_00000400",-0.13781190672846,0.91198610625166,0.999448381576871,161,-25.93,"2 18","539 560",16,"68.75%","93.75%","Q4R6F3","Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase)","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","glycoprotein catabolic process [GO:0006516]","GO:0000224; GO:0005737; GO:0006516; GO:0046872"
"1130",1220,440873,"Cluster_2882","Peve_00000407",-0.925046515380682,0.248051442704063,0.978262075707395,152,-20.3,"2 21","409 430",19,"63.16%","73.68%",NA,NA,NA,NA,NA
"1131",1221,442061,"Cluster_8884","Peve_00006123",-0.746278561957577,0.463677382590393,0.978262075707395,157,-23.46,"2 20","565 584",18,"72.22%","83.33%",NA,NA,NA,NA,NA
"1132",1222,442062,"Cluster_8887","Peve_00006123",-0.533776182890023,0.641544964863958,0.978262075707395,157,-23.78,"2 20","565 584",18,"72.22%","83.33%",NA,NA,NA,NA,NA
"1133",1223,442485,"Cluster_16738","Peve_00038376",0.541995243697498,0.63533814118188,0.978262075707395,183,-27.87,"2 21","399 421",20,"85.00%","95.00%","Q8BU30","Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS)","Mus musculus (Mouse)","isoleucyl-tRNA aminoacylation [GO:0006428]","GO:0000049; GO:0002161; GO:0004822; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006428; GO:0017101; GO:0051020"
"1134",1224,442522,"Cluster_11135","Peve_00038377",0.519489744863891,0.652244102068047,0.978262075707395,172,-27.06,"2 21","178 199",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"1135",1225,442932,"Cluster_15726","Peve_00030612",1,1.34157585525081e-08,8.89340150118664e-06,159,-23.05,"2 21","67 89",20,"70.00%","80.00%",NA,NA,NA,NA,NA
"1136",1226,443601,"Cluster_11134","Peve_00007298",-0.545463592296323,0.632707226660641,0.978262075707395,160,-23.91,"2 19","272 292",17,"76.47%","88.24%","Q61382","TNF receptor-associated factor 4 (EC 2.3.2.27) (Cysteine-rich motif associated to RING and Traf domains protein 1)","Mus musculus (Mouse)","activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323]","GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007250; GO:0007585; GO:0008270; GO:0016740; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0042802; GO:0042981; GO:0043122; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699"
"1137",1227,444200,"Cluster_1167","Peve_00022089",0.99442484020804,0.0672551830116393,0.978262075707395,151,-20.74,"2 16","471 492",14,"78.57%","78.57%","Q95JD5","Sulfotransferase 1B1 (ST1B1) (cSULT1B1) (EC 2.8.2.1) (Sulfotransferase family cytosolic 1B member 1)","Canis lupus familiaris (Dog) (Canis familiaris)","3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]","GO:0004062; GO:0005737; GO:0006068; GO:0006805; GO:0008146; GO:0009812; GO:0030855; GO:0042403; GO:0050427; GO:0051923"
"1138",1228,444232,"Cluster_11135","Peve_00022089",0.890176960186161,0.301161199511197,0.978262075707395,159,-20.54,"2 20","429 448",18,"83.33%","83.33%","Q95JD5","Sulfotransferase 1B1 (ST1B1) (cSULT1B1) (EC 2.8.2.1) (Sulfotransferase family cytosolic 1B member 1)","Canis lupus familiaris (Dog) (Canis familiaris)","3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]","GO:0004062; GO:0005737; GO:0006068; GO:0006805; GO:0008146; GO:0009812; GO:0030855; GO:0042403; GO:0050427; GO:0051923"
"1139",1230,445219,"Cluster_10934","Peve_00037399",0.998758250045998,0.0317290557481601,0.903929377050813,171,-22.4,"2 20","479 500",18,"83.33%","83.33%","Q924H0","Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor)","Mus musculus (Mouse)","G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]","GO:0004930; GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0042277; GO:0043408; GO:0045761; GO:2000479"
"1140",1232,446232,"Cluster_4629","Peve_00027510",0.958394052305861,0.184285098375783,0.978262075707395,170,-25.16,"2 21","407 427",19,"78.95%","89.47%","Q9NRA2","Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular excitatory amino acid transporter) (VEAT)","Homo sapiens (Human)","amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]","GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0022857; GO:0030672; GO:0042880"
"1141",1233,446493,"Cluster_796","Peve_00017772",0.99078664452329,0.0864844527762934,0.978262075707395,154,-20.36,"2 16","743 766",16,"81.25%","81.25%","Q9SZW4","Cadmium/zinc-transporting ATPase HMA2 (EC 7.2.2.12) (EC 7.2.2.21) (Cadmium/zinc-transporting ATPase 3) (Protein HEAVY METAL ATPASE 2)","Arabidopsis thaliana (Mouse-ear cress)","zinc ion homeostasis [GO:0055069]","GO:0005385; GO:0005524; GO:0005886; GO:0008551; GO:0015086; GO:0016463; GO:0016887; GO:0046872; GO:0055069"
"1142",1234,447575,"Cluster_1167","Peve_00024356",0.111041123124564,0.929162941963199,0.999448381576871,142,-20.52,"2 11","948 969",9,"88.89%","88.89%","Q54PH5","Pre-mRNA-splicing factor cwc2","Dictyostelium discoideum (Social amoeba)","mRNA cis splicing, via spliceosome [GO:0045292]; positive regulation of cell cycle [GO:0045787]; positive regulation of RNA splicing [GO:0033120]; spliceosomal snRNP assembly [GO:0000387]","GO:0000387; GO:0000974; GO:0005634; GO:0005681; GO:0017070; GO:0033120; GO:0036002; GO:0045292; GO:0045787; GO:0046872; GO:0071006; GO:0071007"
"1143",1235,447718,"Cluster_4735","Peve_00027569",-0.863109810520267,0.337027042834866,0.978262075707395,161,-20.57,"2 14","768 789",12,"91.67%","100.00%","O08658","Nuclear pore complex protein Nup88 (88 kDa nucleoporin) (Nucleoporin Nup84) (Nucleoporin Nup88)","Rattus norvegicus (Rat)","mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; protein import into nucleus [GO:0006606]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]","GO:0000055; GO:0000056; GO:0000278; GO:0005635; GO:0005643; GO:0005654; GO:0006406; GO:0006606; GO:0017056"
"1144",1236,447846,"Cluster_2787","Peve_00031577",-0.699646228116051,0.506681914223417,0.978262075707395,157,-23.25,"2 17","520 541",16,"87.50%","87.50%","P41413","Proprotein convertase subtilisin/kexin type 5 (EC 3.4.21.-) (Proprotein convertase 5) (PC5) (Proprotein convertase 6) (PC6) (Subtilisin/kexin-like protease PC5) (rPC5)","Rattus norvegicus (Rat)","anterior/posterior pattern specification [GO:0009952]; cardiac septum development [GO:0003279]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; coronary vasculature development [GO:0060976]; cytokine precursor processing [GO:0140447]; determination of left/right symmetry [GO:0007368]; embryo implantation [GO:0007566]; embryonic digestive tract development [GO:0048566]; embryonic skeletal system development [GO:0048706]; heart development [GO:0007507]; kidney development [GO:0001822]; limb morphogenesis [GO:0035108]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; positive regulation of integrin activation [GO:0033625]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of smooth muscle cell-matrix adhesion [GO:1905609]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein processing [GO:0016485]; renin secretion into blood stream [GO:0002001]; respiratory tube development [GO:0030323]; response to gonadotropin [GO:0034698]; response to luteinizing hormone [GO:0034699]; signal peptide processing [GO:0006465]; vascular associated smooth muscle cell proliferation [GO:1990874]; viral life cycle [GO:0019058]","GO:0000139; GO:0001822; GO:0002001; GO:0003279; GO:0004175; GO:0004252; GO:0005615; GO:0005794; GO:0005797; GO:0005802; GO:0005886; GO:0006465; GO:0007368; GO:0007507; GO:0007566; GO:0008233; GO:0009952; GO:0016020; GO:0016485; GO:0016486; GO:0019058; GO:0030323; GO:0033625; GO:0034698; GO:0034699; GO:0035108; GO:0036120; GO:0042277; GO:0043043; GO:0043204; GO:0048566; GO:0048706; GO:0060976; GO:0140447; GO:1904754; GO:1905609; GO:1990635; GO:1990874; GO:2001046"
"1145",1237,448207,"Cluster_2854","Peve_00021329",0.794259828715278,0.415717773262318,0.978262075707395,149,-21.28,"2 21","760 783",22,"68.18%","72.73%","Q6GL69","MKI67 FHA domain-interacting nucleolar phosphoprotein-like","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0003723; GO:0005730"
"1146",1238,448535,"Cluster_6914","Peve_00021322",0.620035766378939,0.574236151431954,0.978262075707395,170,-21.06,"2 20","801 822",19,"84.21%","84.21%","Q9ES87","Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain]","Rattus norvegicus (Rat)","hair follicle development [GO:0001942]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of sodium ion transport [GO:0010765]; proteolysis [GO:0006508]; response to mineralocorticoid [GO:0051385]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410]; transepithelial transport [GO:0070633]","GO:0001942; GO:0004252; GO:0005615; GO:0005886; GO:0006508; GO:0009410; GO:0010765; GO:0017080; GO:0019897; GO:0043434; GO:0045121; GO:0051385; GO:0070633; GO:1902307"
"1147",1239,448580,"Cluster_6914","Peve_00021321",0.634616931222781,0.562315791561056,0.978262075707395,170,-21.06,"2 20","718 739",19,"84.21%","84.21%","Q9ES87","Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain]","Rattus norvegicus (Rat)","hair follicle development [GO:0001942]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of sodium ion transport [GO:0010765]; proteolysis [GO:0006508]; response to mineralocorticoid [GO:0051385]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410]; transepithelial transport [GO:0070633]","GO:0001942; GO:0004252; GO:0005615; GO:0005886; GO:0006508; GO:0009410; GO:0010765; GO:0017080; GO:0019897; GO:0043434; GO:0045121; GO:0051385; GO:0070633; GO:1902307"
"1148",1240,448608,"Cluster_796","Peve_00021320",0.970040772623928,0.156225056685786,0.978262075707395,150,-21.77,"2 21","640 665",23,"69.57%","69.57%","P69526","Transmembrane protease serine 9 (EC 3.4.21.-) (Polyserase-I) (Polyserine protease 1) (Polyserase-1) [Cleaved into: Serase-1; Serase-2; Serase-3]","Rattus norvegicus (Rat)","plasminogen activation [GO:0031639]; proteolysis [GO:0006508]","GO:0004252; GO:0005886; GO:0006508; GO:0008236; GO:0031639"
"1149",1241,448613,"Cluster_2882","Peve_00021320",-0.96984639371003,0.156733607482757,0.978262075707395,149,-22.72,"2 15","58 81",15,"80.00%","80.00%","P69526","Transmembrane protease serine 9 (EC 3.4.21.-) (Polyserase-I) (Polyserine protease 1) (Polyserase-1) [Cleaved into: Serase-1; Serase-2; Serase-3]","Rattus norvegicus (Rat)","plasminogen activation [GO:0031639]; proteolysis [GO:0006508]","GO:0004252; GO:0005886; GO:0006508; GO:0008236; GO:0031639"
"1150",1242,448667,"Cluster_6904","Peve_00027561",0.399658486132452,0.738257438497133,0.986649900030095,154,-26.12,"2 21","334 360",24,"66.67%","75.00%","Q8BHG1","Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase)","Mus musculus (Mouse)","negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of axonogenesis [GO:0050772]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of myelination [GO:0031643]; proteolysis [GO:0006508]; regulation of endopeptidase activity [GO:0052548]","GO:0004222; GO:0005739; GO:0006508; GO:0008233; GO:0030425; GO:0031643; GO:0046872; GO:0050772; GO:0051044; GO:0052548; GO:0120163"
"1151",1243,449812,"Cluster_11135","Peve_00020634",0.0416594069809366,0.973471120528434,0.999448381576871,160,-20.87,"2 18","508 530",17,"82.35%","82.35%",NA,NA,NA,NA,NA
"1152",1244,449848,"Cluster_8888","Peve_00020635",0.167517972931078,0.892849555604977,0.999448381576871,163,-20.23,"2 20","439 459",18,"77.78%","77.78%",NA,NA,NA,NA,NA
"1153",1245,450372,"Cluster_4629","Peve_00020983",0.982886853890834,0.117945492371805,0.978262075707395,164,-23.34,"2 21","304 325",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"1154",1246,450860,"Cluster_1167","Peve_00026583",-0.511591173923624,0.65811249694873,0.978262075707395,151,-23.51,"2 21","655 679",22,"63.64%","72.73%","Q98902","Neural cell adhesion molecule L1 (N-CAM-L1) (NCAM-L1) (L1-CAM)","Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)","cell adhesion [GO:0007155]; positive regulation of axon extension [GO:0045773]","GO:0005886; GO:0007155; GO:0044295; GO:0045773"
"1155",1247,450892,"Cluster_11135","Peve_00026583",0.0416594069809366,0.973471120528434,0.999448381576871,158,-22.97,"2 21","157 180",21,"71.43%","80.95%","Q98902","Neural cell adhesion molecule L1 (N-CAM-L1) (NCAM-L1) (L1-CAM)","Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)","cell adhesion [GO:0007155]; positive regulation of axon extension [GO:0045773]","GO:0005886; GO:0007155; GO:0044295; GO:0045773"
"1156",1248,451292,"Cluster_10060","Peve_00013961",-0.697617831414603,0.508486740390959,0.978262075707395,173,-20.86,"2 20","36 56",18,"88.89%","88.89%",NA,NA,NA,NA,NA
"1157",1249,451308,"Cluster_796","Peve_00043542",0.943324298826115,0.21536066601262,0.978262075707395,153,-22.71,"2 20","248 273",22,"68.18%","77.27%","F1Q4S1","Probable phospholipid-transporting ATPase IIB (EC 7.6.2.1) (ATPase class II type 9B)","Danio rerio (Zebrafish) (Brachydanio rerio)","endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0000287; GO:0005524; GO:0005768; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016887; GO:0045332; GO:0140326"
"1158",1250,451416,"Cluster_7053","Peve_00043540",-0.37670695740192,0.754112749097857,0.988219883885475,171,-21.46,"2 21","487 509",20,"80.00%","85.00%",NA,NA,NA,NA,NA
"1159",1251,451458,"Cluster_6905","Peve_00043547",-0.854769557020615,0.347396824931368,0.978262075707395,144,-20.27,"2 18","23 45",17,"70.59%","70.59%","Q6DMN8","Spermatogenesis-associated protein 4","Pan troglodytes (Chimpanzee)","regulation of cytoskeleton organization [GO:0051493]","GO:0005634; GO:0005930; GO:0008017; GO:0051493"
"1160",1252,451995,"Cluster_5882","Peve_00027981",-0.27814091057559,0.820563558554478,0.995934364227446,147,-20.39,"2 21","637 659",20,"60.00%","75.00%",NA,NA,NA,NA,NA
"1161",1256,454552,"Cluster_2854","Peve_00039199",-0.507486347355159,0.661149542463894,0.978262075707395,149,-22.41,"2 21","76 98",21,"66.67%","76.19%",NA,NA,NA,NA,NA
"1162",1257,455453,"Cluster_2882","Peve_00032455",0.927984805789988,0.243079657550342,0.978262075707395,158,-23.3,"2 21","959 979",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"1163",1258,456216,"Cluster_2787","Peve_00038761",-0.526102864672067,0.64730536363553,0.978262075707395,152,-20.77,"2 18","287 309",17,"70.59%","82.35%",NA,NA,NA,NA,NA
"1164",1259,456532,"Cluster_2854","Peve_00000264",-0.507486347355159,0.661149542463894,0.978262075707395,169,-21.11,"2 20","409 429",18,"83.33%","88.89%",NA,NA,NA,NA,NA
"1165",1260,457005,"Cluster_9149","Peve_00004681",-0.75874566412441,0.451625079488735,0.978262075707395,151,-23.65,"2 17","576 598",16,"75.00%","81.25%",NA,NA,NA,NA,NA
"1166",1261,457203,"Cluster_796","Peve_00000197",0.761376607855457,0.449047696126545,0.978262075707395,152,-22.46,"2 21","635 658",22,"72.73%","77.27%","Q13002","Glutamate receptor ionotropic, kainate 2 (GluK2) (Excitatory amino acid receptor 4) (EAA4) (Glutamate receptor 6) (GluR-6) (GluR6)","Homo sapiens (Human)","behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; detection of cold stimulus involved in thermoception [GO:0120169]; glutamate receptor signaling pathway [GO:0007215]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of synaptic transmission [GO:0050806]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]","GO:0001662; GO:0005234; GO:0005886; GO:0006874; GO:0007215; GO:0007268; GO:0008066; GO:0014069; GO:0015276; GO:0015277; GO:0019228; GO:0032983; GO:0035249; GO:0038023; GO:0042734; GO:0043025; GO:0043524; GO:0045211; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060080; GO:0097471; GO:0098686; GO:0098978; GO:0099171; GO:0099507; GO:0120169; GO:1904315"
"1167",1262,457787,"Cluster_589","Peve_00019286",-0.913928645349857,0.266066269450645,0.978262075707395,155,-21.13,"2 12","398 419",10,"100.00%","100.00%","B0S5D5","Palmitoyltransferase ZDHHC12-A (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 12-A)","Danio rerio (Zebrafish) (Brachydanio rerio)","peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]","GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0018230; GO:0019706"
"1168",1263,458490,"Cluster_9149","Peve_00003557",-0.981618675337444,0.122250605632956,0.978262075707395,140,-20.71,"2 9","737 758",7,"100.00%","100.00%","Q6NVS5","DDB1- and CUL4-associated factor 13 (WD repeat and SOF domain-containing protein 1)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","protein ubiquitination [GO:0016567]; rRNA processing [GO:0006364]","GO:0005730; GO:0006364; GO:0016567; GO:0080008; GO:1990904"
"1169",1264,458811,"Cluster_11134","Peve_00036602",-0.905704938779196,0.278684506292517,0.978262075707395,150,-21.48,"2 21","488 508",19,"68.42%","73.68%","B8UU78","EGF and laminin G domain-containing protein","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0016020"
"1170",1265,458818,"Cluster_15890","Peve_00036602",0.703472103770649,0.503264006274548,0.978262075707395,175,-20.23,"2 21","250 272",20,"80.00%","90.00%","B8UU78","EGF and laminin G domain-containing protein","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0016020"
"1171",1266,459197,"Cluster_6904","Peve_00002021",-0.82350952924593,0.384025887817355,0.978262075707395,164,-26.26,"2 18","71 93",17,"76.47%","94.12%","Q2KJC3","Macrophage-expressed gene 1 protein (Macrophage gene 1 protein) (Mpg-1) (Perforin-2) (P-2)","Bos taurus (Bovine)","antibacterial innate immune response [GO:0140367]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; disruption by host of symbiont membrane [GO:0052337]","GO:0030659; GO:0031410; GO:0042742; GO:0045335; GO:0050829; GO:0050830; GO:0052337; GO:0140367"
"1172",1267,459199,"Cluster_6906","Peve_00002021",-0.449470493327271,0.703225373034262,0.978262075707395,160,-24.24,"2 18","71 93",17,"70.59%","94.12%","Q2KJC3","Macrophage-expressed gene 1 protein (Macrophage gene 1 protein) (Mpg-1) (Perforin-2) (P-2)","Bos taurus (Bovine)","antibacterial innate immune response [GO:0140367]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; disruption by host of symbiont membrane [GO:0052337]","GO:0030659; GO:0031410; GO:0042742; GO:0045335; GO:0050829; GO:0050830; GO:0052337; GO:0140367"
"1173",1268,459279,"Cluster_4079","Peve_00019866",-0.973973223504478,0.145563262088258,0.978262075707395,172,-22.97,"2 18","865 887",17,"88.24%","94.12%","Q4V7T8","Ropporin-1-like protein","Xenopus laevis (African clawed frog)","","GO:0031514"
"1174",1269,459306,"Cluster_11134","Peve_00019866",0.390775964330223,0.744413435723697,0.98719551447292,155,-22.29,"2 21","837 859",20,"65.00%","80.00%","Q4V7T8","Ropporin-1-like protein","Xenopus laevis (African clawed frog)","","GO:0031514"
"1175",1270,459712,"Cluster_11135","Peve_00004026",0.671539463686612,0.531266746462432,0.978262075707395,160,-20.87,"2 18","488 510",17,"82.35%","82.35%","A2TLM1","Ribose-5-phosphate isomerase (EC 5.3.1.6) (Phosphoriboisomerase)","Sus scrofa (Pig)","D-ribose metabolic process [GO:0006014]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]","GO:0004751; GO:0006014; GO:0009052; GO:0043231"
"1176",1271,460050,"Cluster_5882","Peve_00031374",0.203260293586312,0.869692475403864,0.997451465498882,165,-23.1,"2 20","315 335",18,"77.78%","88.89%",NA,NA,NA,NA,NA
"1177",1272,460241,"Cluster_8884","Peve_00014366",-0.987057350387156,0.102535969786636,0.978262075707395,170,-23.5,"2 20","62 83",19,"78.95%","89.47%","Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"1178",1273,460242,"Cluster_8887","Peve_00014366",-0.993007097509771,0.0753316124869303,0.978262075707395,170,-23.5,"2 20","62 83",19,"78.95%","89.47%","Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"1179",1274,460243,"Cluster_8888","Peve_00014366",-0.651292471598752,0.548454225357658,0.978262075707395,170,-23.74,"2 20","62 83",19,"78.95%","89.47%","Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"1180",1275,460812,"Cluster_4629","Peve_00028040",0.754643580906849,0.455619595583604,0.978262075707395,152,-24.79,"2 20","605 631",23,"69.57%","78.26%","P17178","Sterol 26-hydroxylase, mitochondrial (EC 1.14.15.15) (5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol 26-hydroxylase) (Cytochrome P-450C27/25) (Cytochrome P450 27) (Sterol 27-hydroxylase) (Vitamin D(3) 25-hydroxylase)","Rattus norvegicus (Rat)","bile acid biosynthetic process [GO:0006699]; C21-steroid hormone biosynthetic process [GO:0006700]; calcitriol biosynthetic process from calciol [GO:0036378]; cholesterol catabolic process [GO:0006707]; cholesterol metabolic process [GO:0008203]; steroid catabolic process [GO:0006706]","GO:0005506; GO:0005739; GO:0005740; GO:0005743; GO:0006699; GO:0006700; GO:0006706; GO:0006707; GO:0008123; GO:0008203; GO:0008386; GO:0020037; GO:0030343; GO:0030544; GO:0031073; GO:0036378; GO:0047103; GO:0047748; GO:0047749"
"1181",1276,461685,"Cluster_9149","Peve_00030130",0.132144816411437,0.915627214624762,0.999448381576871,152,-24.4,"2 15","262 282",13,"84.62%","92.31%","E1BD59","E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56)","Bos taurus (Bovine)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of interferon-beta production [GO:0032728]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340]","GO:0000785; GO:0004842; GO:0005654; GO:0005737; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0045893; GO:0051607; GO:0061630; GO:0070534"
"1182",1277,462872,"Cluster_589","Peve_00034686",-0.47126837927824,0.687592652006694,0.978262075707395,160,-21.25,"2 21","560 581",19,"68.42%","78.95%","Q8R3P2","Probable E3 ubiquitin-protein ligase DTX2 (EC 2.3.2.27) (Protein deltex-2) (Deltex2) (mDTX2) (RING-type E3 ubiquitin transferase DTX2)","Mus musculus (Mouse)","Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]","GO:0005654; GO:0005737; GO:0007219; GO:0008270; GO:0016567; GO:0031965; GO:0061630"
"1183",1278,463469,"Cluster_5563","Peve_00031387",-0.31345772996763,0.797025183972604,0.995934364227446,172,-22.46,"2 17","737 759",15,"86.67%","100.00%","Q3KNY5","RIIa domain-containing protein 1","Mus musculus (Mouse)","",""
"1184",1279,464132,"Cluster_589","Peve_00009976",0.559332427502488,0.622115075329514,0.978262075707395,167,-28.51,"2 21","617 639",20,"80.00%","80.00%","O93309","Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3)","Xenopus laevis (African clawed frog)","cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275]","GO:0000775; GO:0000785; GO:0005524; GO:0005634; GO:0006275; GO:0006281; GO:0016887; GO:0030893; GO:0051276; GO:0051301; GO:0051321"
"1185",1280,464331,"Cluster_7053","Peve_00010104",-0.875798969480275,0.320670279123378,0.978262075707395,151,-21.08,"2 21","585 609",22,"59.09%","77.27%","Q00535","Cyclin-dependent kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Cyclin-dependent-like kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit)","Homo sapiens (Human)","axon extension [GO:0048675]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell division [GO:0051301]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; central nervous system neuron development [GO:0021954]; cerebellar cortex formation [GO:0021697]; chemical synaptic transmission [GO:0007268]; corpus callosum development [GO:0022038]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; hippocampus development [GO:0021766]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion organization [GO:0007005]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron death [GO:1901215]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; nucleocytoplasmic transport [GO:0006913]; oligodendrocyte differentiation [GO:0048709]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of glial cell apoptotic process [GO:0034352]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of presynaptic cytosolic calcium concentration [GO:0099533]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein autophosphorylation [GO:0046777]; protein localization to synapse [GO:0035418]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of macroautophagy [GO:0016241]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synapse pruning [GO:1905806]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle recycling [GO:1903421]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; response to wounding [GO:0009611]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; serine phosphorylation of STAT protein [GO:0042501]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]; visual learning [GO:0008542]","GO:0000083; GO:0000226; GO:0000307; GO:0001764; GO:0001963; GO:0002039; GO:0004672; GO:0004674; GO:0004693; GO:0005176; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0005886; GO:0006468; GO:0006886; GO:0006913; GO:0007005; GO:0007160; GO:0007268; GO:0007409; GO:0007416; GO:0007519; GO:0008045; GO:0008542; GO:0009611; GO:0014044; GO:0014069; GO:0016020; GO:0016079; GO:0016241; GO:0016301; GO:0016310; GO:0016533; GO:0018105; GO:0018107; GO:0019233; GO:0019901; GO:0021697; GO:0021766; GO:0021819; GO:0021954; GO:0022038; GO:0030027; GO:0030054; GO:0030175; GO:0030182; GO:0030334; GO:0030424; GO:0030425; GO:0030426; GO:0030517; GO:0030549; GO:0030866; GO:0031175; GO:0031397; GO:0031594; GO:0031914; GO:0032092; GO:0032801; GO:0034352; GO:0035173; GO:0035249; GO:0035418; GO:0042501; GO:0042981; GO:0043005; GO:0043025; GO:0043113; GO:0043125; GO:0043204; GO:0043525; GO:0045786; GO:0045860; GO:0045861; GO:0045892; GO:0045956; GO:0046777; GO:0046826; GO:0046875; GO:0048148; GO:0048156; GO:0048167; GO:0048488; GO:0048489; GO:0048511; GO:0048675; GO:0048709; GO:0048813; GO:0050321; GO:0051301; GO:0051402; GO:0051726; GO:0051879; GO:0051966; GO:0060079; GO:0061001; GO:0070509; GO:0090314; GO:0098685; GO:0098793; GO:0098978; GO:0099509; GO:0099533; GO:0106310; GO:1901215; GO:1901387; GO:1903076; GO:1903421; GO:1904646; GO:1905806; GO:2000251"
"1186",1281,464384,"Cluster_8988","Peve_00010103",-0.869686503916913,0.32864189277174,0.978262075707395,170,-22.33,"2 21","315 335",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"1187",1282,464678,"Cluster_2882","Peve_00027702",-0.712973250884265,0.494696166625114,0.978262075707395,150,-20.22,"2 15","112 133",13,"69.23%","92.31%","P56069","Cystathionine gamma-synthase (CGS) (EC 2.5.1.48) (O-succinylhomoserine (thiol)-lyase)","Helicobacter pylori (strain ATCC 700392 / 26695) (Campylobacter pylori)","cysteine biosynthetic process via cystathionine [GO:0019343]; methionine biosynthetic process [GO:0009086]; transsulfuration [GO:0019346]","GO:0003962; GO:0004123; GO:0005737; GO:0009086; GO:0016846; GO:0019343; GO:0019346; GO:0030170; GO:0102028"
"1188",1283,465421,"Cluster_9983","Peve_00009755",0.365268577629603,0.761954307099096,0.988787276940888,174,-20.35,"2 19","563 583",17,"76.47%","100.00%","Q9NUQ9","CYFIP-related Rac1 interactor B (L1)","Homo sapiens (Human)","cellular response to molecule of bacterial origin [GO:0071219]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of type II interferon production [GO:0032729]; regulation of cell migration [GO:0030334]; regulation of chemotaxis [GO:0050920]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitochondrial fission [GO:0090140]","GO:0001916; GO:0005576; GO:0005739; GO:0005929; GO:0016020; GO:0023030; GO:0030334; GO:0030837; GO:0031093; GO:0031267; GO:0032729; GO:0050870; GO:0050920; GO:0051058; GO:0070062; GO:0071219; GO:0090140; GO:2000114; GO:2000568"
"1189",1284,465486,"Cluster_2787","Peve_00025709",0.989000822596314,0.0945092034550463,0.978262075707395,156,-24.18,"2 19","359 384",21,"71.43%","80.95%","Q61768","Kinesin-1 heavy chain (Conventional kinesin heavy chain) (Ubiquitous kinesin heavy chain) (UKHC)","Mus musculus (Mouse)","anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axon guidance [GO:0007411]; cellular response to type II interferon [GO:0071346]; centrosome localization [GO:0051642]; cytoplasm organization [GO:0007028]; cytoskeleton-dependent intracellular transport [GO:0030705]; hippocampus development [GO:0021766]; lysosome localization [GO:0032418]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; mitochondrial transport [GO:0006839]; mitochondrion transport along microtubule [GO:0047497]; mitocytosis [GO:0160040]; natural killer cell mediated cytotoxicity [GO:0042267]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of vesicle fusion [GO:0031340]; positive regulation of voltage-gated sodium channel activity [GO:1905152]; regulation of membrane potential [GO:0042391]; retrograde neuronal dense core vesicle transport [GO:1990049]; stress granule disassembly [GO:0035617]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]","GO:0003777; GO:0005524; GO:0005737; GO:0005739; GO:0005765; GO:0005829; GO:0005871; GO:0005874; GO:0006839; GO:0007017; GO:0007018; GO:0007028; GO:0007411; GO:0008017; GO:0008432; GO:0008574; GO:0015630; GO:0016887; GO:0021766; GO:0030139; GO:0030705; GO:0031340; GO:0031982; GO:0032230; GO:0032418; GO:0032839; GO:0034451; GO:0035253; GO:0035617; GO:0035774; GO:0042267; GO:0042391; GO:0042802; GO:0043005; GO:0043227; GO:0043268; GO:0044295; GO:0044877; GO:0045335; GO:0047496; GO:0047497; GO:0048471; GO:0048489; GO:0051642; GO:0071346; GO:0072383; GO:0090316; GO:0098971; GO:0099609; GO:0099641; GO:0160040; GO:1903078; GO:1904115; GO:1905152; GO:1990049"
"1190",1285,466185,"Cluster_9149","Peve_00017457",-0.983913077966376,0.114344565658969,0.978262075707395,147,-22.14,"2 12","383 404",10,"80.00%","100.00%","Q9BZH6","WD repeat-containing protein 11 (Bromodomain and WD repeat-containing protein 2) (WD repeat-containing protein 15)","Homo sapiens (Human)","cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041]","GO:0005634; GO:0005737; GO:0005765; GO:0005802; GO:0005829; GO:0005930; GO:0006886; GO:0007507; GO:0008589; GO:0015630; GO:0016020; GO:0031410; GO:0035264; GO:0036064; GO:0060271; GO:0060322; GO:0099041"
"1191",1286,467252,"Cluster_6904","Peve_00012246",-0.923648366464242,0.250384280374875,0.978262075707395,155,-20.5,"2 18","980 1000",16,"81.25%","81.25%","A2A4P0","ATP-dependent RNA helicase DHX8 (EC 3.6.4.13) (DEAH box protein 8)","Mus musculus (Mouse)","mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex disassembly [GO:0000390]","GO:0000390; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0016604; GO:0016887; GO:0042802; GO:0071007; GO:0071013"
"1192",1288,467669,"Cluster_8988","Peve_00012249",-0.296703227729277,0.80822557218663,0.995934364227446,161,-20.49,"2 21","584 603",19,"73.68%","84.21%","B1AY10","Transcriptional repressor NF-X1 (m-Nfx.1) (EC 2.3.2.-) (Nuclear transcription factor, X box-binding protein 1)","Mus musculus (Mouse)","negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; regulation of DNA-templated transcription [GO:0006355]","GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006355; GO:0008270; GO:0045347; GO:0051865; GO:0061630"
"1193",1289,468340,"Cluster_8634","Peve_00015288",0.833124299210544,0.373099670972369,0.978262075707395,166,-23.14,"2 17","331 351",15,"93.33%","93.33%",NA,NA,NA,NA,NA
"1194",1290,469200,"Cluster_9149","Peve_00014169",-0.128328535797377,0.918077606043669,0.999448381576871,158,-22.87,"2 21","165 189",22,"72.73%","77.27%",NA,NA,NA,NA,NA
"1195",1291,469717,"Cluster_2854","Peve_00038107",-0.997755955103144,0.042657179825614,0.914411088077857,148,-20.08,"2 15","945 965",13,"84.62%","84.62%",NA,NA,NA,NA,NA
"1196",1292,469802,"Cluster_589","Peve_00038101",-0.986743327562306,0.103775140194514,0.978262075707395,155,-23.41,"2 12","763 784",10,"100.00%","100.00%",NA,NA,NA,NA,NA
"1197",1293,469892,"Cluster_589","Peve_00038102",-0.398077932490683,0.739354715301677,0.986697151420032,157,-21.94,"2 14","109 130",12,"83.33%","100.00%",NA,NA,NA,NA,NA
"1198",1294,471066,"Cluster_2787","Peve_00030489",0.938265178334461,0.224864140932918,0.978262075707395,162,-25.73,"2 21","723 743",19,"68.42%","89.47%","Q6GPI1","Chymotrypsinogen B2 (EC 3.4.21.1) [Cleaved into: Chymotrypsin B2 chain A; Chymotrypsin B2 chain B; Chymotrypsin B2 chain C]","Homo sapiens (Human)","digestion [GO:0007586]; proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0007586"
"1199",1295,471360,"Cluster_9149","Peve_00041906",-0.58414377285509,0.602860838934092,0.978262075707395,168,-29.41,"2 19","637 657",17,"88.24%","88.24%","O88281","Multiple epidermal growth factor-like domains protein 6 (Multiple EGF-like domains protein 6) (Epidermal growth factor-like protein 3) (EGF-like protein 3)","Rattus norvegicus (Rat)","","GO:0005509; GO:0005576"
"1200",1296,471405,"Cluster_9149","Peve_00041900",-0.5,0.666666666666667,0.978262075707395,158,-26.44,"2 21","316 341",23,"69.57%","78.26%","Q64559","Cytosolic acyl coenzyme A thioester hydrolase (EC 3.1.2.2) (ACH1) (ACT) (Acyl-CoA thioesterase 7) (Brain acyl-CoA hydrolase) (BACH) (CTE-IIa) (CTE-IIb) (CTE-II) (LACH1) (Long chain acyl-CoA thioester hydrolase) (MTE-II)","Rattus norvegicus (Rat)","acyl-CoA metabolic process [GO:0006637]; coenzyme A biosynthetic process [GO:0015937]; fatty acid catabolic process [GO:0009062]; fatty acid metabolic process [GO:0006631]; long-chain fatty-acyl-CoA catabolic process [GO:0036116]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; palmitic acid biosynthetic process [GO:1900535]","GO:0000062; GO:0005654; GO:0005737; GO:0005759; GO:0005829; GO:0006631; GO:0006637; GO:0009062; GO:0015937; GO:0016290; GO:0036042; GO:0036114; GO:0036116; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0044297; GO:0047617; GO:0051792; GO:0102991; GO:1900535"
"1201",1297,471716,"Cluster_8884","Peve_00028472",-0.951674994367624,0.198721896093692,0.978262075707395,162,-20.2,"2 19","682 702",17,"76.47%","82.35%","P18321","Profilin","Clypeaster japonicus (Sand dollar)","regulation of cellular component biogenesis [GO:0044087]","GO:0003779; GO:0005737; GO:0005856; GO:0044087"
"1202",1298,471717,"Cluster_8887","Peve_00028472",-0.830079903969688,0.376589478367257,0.978262075707395,162,-20.2,"2 19","682 702",17,"76.47%","82.35%","P18321","Profilin","Clypeaster japonicus (Sand dollar)","regulation of cellular component biogenesis [GO:0044087]","GO:0003779; GO:0005737; GO:0005856; GO:0044087"
"1203",1299,471810,"Cluster_9149","Peve_00028475",0.880386291625999,0.314566703252411,0.978262075707395,161,-21.99,"2 20","556 579",20,"80.00%","80.00%","Q7Z5V6","Protein phosphatase 1 regulatory subunit 32","Homo sapiens (Human)","","GO:0005737; GO:0019902; GO:0036064"
"1204",1300,471900,"Cluster_9149","Peve_00028477",-0.5,0.666666666666667,0.978262075707395,142,-21.9,"2 11","112 133",9,"77.78%","100.00%",NA,NA,NA,NA,NA
"1205",1301,472055,"Cluster_1167","Peve_00034302",-0.123967283328019,0.920876426476334,0.999448381576871,157,-24.78,"2 20","105 125",18,"77.78%","77.78%","Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"1206",1302,472110,"Cluster_5882","Peve_00034300",-0.999810125119312,0.0124061134927224,0.685998477593919,160,-22.36,"2 17","412 433",15,"73.33%","93.33%","O75976","Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180)","Homo sapiens (Human)","peptide metabolic process [GO:0006518]; protein processing [GO:0016485]","GO:0004181; GO:0004185; GO:0005615; GO:0005886; GO:0006518; GO:0008270; GO:0016020; GO:0016485; GO:0070062"
"1207",1303,472254,"Cluster_7855","Peve_00034305",-0.648635812299437,0.55067970266673,0.978262075707395,162,-21.11,"2 21","500 520",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"1208",1304,473430,"Cluster_9149","Peve_00041040",-0.950863514525157,0.200397230214515,0.978262075707395,142,-21.9,"2 11","112 133",9,"77.78%","100.00%",NA,NA,NA,NA,NA
"1209",1305,474139,"Cluster_6906","Peve_00032228",-0.680495255938949,0.523529375318739,0.978262075707395,174,-23.38,"2 19","480 501",17,"82.35%","94.12%","O74549","NEDD8-conjugating enzyme ubc12 (EC 2.3.2.34) (RUB1-conjugating enzyme) (Ubiquitin carrier protein 12)","Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)","protein neddylation [GO:0045116]","GO:0005524; GO:0005634; GO:0005829; GO:0019788; GO:0045116; GO:0061654"
"1210",1308,475028,"Cluster_2882","Peve_00022130",-0.90187704500797,0.284378845264354,0.978262075707395,144,-20.22,"2 19","177 201",20,"70.00%","70.00%",NA,NA,NA,NA,NA
"1211",1309,475166,"Cluster_4115","Peve_00000012",-0.396041832548128,0.740767040644522,0.986697151420032,150,-20.44,"2 18","968 987",16,"75.00%","81.25%","Q6DK98","Nuclear distribution protein nudE-like 1-A","Xenopus laevis (African clawed frog)","lysosome localization [GO:0032418]; positive regulation of ruffle assembly [GO:1900029]","GO:0005737; GO:0005815; GO:0005819; GO:0005874; GO:0008017; GO:0032418; GO:1900029"
"1212",1310,475170,"Cluster_5882","Peve_00000012",0.484178383658989,0.678237151575005,0.978262075707395,166,-22.83,"2 19","950 971",17,"76.47%","88.24%","Q6DK98","Nuclear distribution protein nudE-like 1-A","Xenopus laevis (African clawed frog)","lysosome localization [GO:0032418]; positive regulation of ruffle assembly [GO:1900029]","GO:0005737; GO:0005815; GO:0005819; GO:0005874; GO:0008017; GO:0032418; GO:1900029"
"1213",1311,475702,"Cluster_2854","Peve_00019126",-0.997565388064538,0.0444322335382886,0.926725506280974,174,-25.76,"2 21","237 260",21,"80.95%","90.48%",NA,NA,NA,NA,NA
"1214",1314,476808,"Cluster_10061","Peve_00018294",-0.446077406355246,0.705641205133228,0.978262075707395,172,-22.01,"2 21","83 104",19,"73.68%","89.47%","Q7RTR2","NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","Homo sapiens (Human)","I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223"
"1215",1315,477054,"Cluster_4079","Peve_00015713",-0.620686484770669,0.573707971380865,0.978262075707395,143,-20.58,"2 21","110 139",27,"59.26%","62.96%",NA,NA,NA,NA,NA
"1216",1316,477574,"Cluster_10934","Peve_00018749",-0.00714633304768226,0.995450464357173,0.999448381576871,151,-20.45,"2 21","630 652",20,"65.00%","75.00%","Q8BQH6","CUB domain-containing protein 2","Mus musculus (Mouse)","","GO:0005576"
"1217",1317,477960,"Cluster_5882","Peve_00019076",-0.27814091057559,0.820563558554478,0.995934364227446,179,-22.48,"2 21","410 432",20,"85.00%","90.00%",NA,NA,NA,NA,NA
"1218",1318,479019,"Cluster_13502","Peve_00025545",-0.972497895695992,0.149650604157303,0.978262075707395,156,-23.5,"2 19","13 34",17,"64.71%","82.35%","Q28ET8","Eukaryotic translation initiation factor 4E type 3 (eIF-4E type 3) (eIF-4E3) (eIF4E type 3) (eIF4E-3)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0003723; GO:0003743; GO:0005845"
"1219",1319,479075,"Cluster_1167","Peve_00025549",0.786478229253194,0.423804401804062,0.978262075707395,160,-21.16,"2 21","26 47",19,"68.42%","78.95%","O46385","Supervillin (Archvillin) (p205/p250)","Bos taurus (Bovine)","actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; positive regulation of cytokinesis [GO:0032467]","GO:0002102; GO:0005546; GO:0005737; GO:0008154; GO:0015629; GO:0030496; GO:0032154; GO:0032467; GO:0036449; GO:0042995; GO:0051014; GO:0051015; GO:0051016; GO:0060090; GO:0070161"
"1220",1320,479121,"Cluster_2787","Peve_00006416",0.919483894536361,0.257213921229429,0.978262075707395,165,-26.01,"2 20","293 313",18,"72.22%","94.44%",NA,NA,NA,NA,NA
"1221",1321,479256,"Cluster_2787","Peve_00006415",0.822560111379491,0.385090022258489,0.978262075707395,165,-26.01,"2 20","293 313",18,"72.22%","94.44%","Q9DBF7","Pre-mRNA-splicing factor CWC25 homolog (Coiled-coil domain-containing protein 49) (Spliceosome-associated protein homolog CWC25)","Mus musculus (Mouse)","mRNA splicing, via spliceosome [GO:0000398]","GO:0000398; GO:0005634; GO:0005684; GO:0016607; GO:0071006"
"1222",1322,479380,"Cluster_14500","Peve_00006413",-0.999945819357893,0.0066270333402645,0.573710369894872,162,-21.66,"2 21","758 783",23,"73.91%","78.26%","Q9Y2I7","1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase) (Serine-protein kinase PIKFYVE) (EC 2.7.11.1)","Homo sapiens (Human)","1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0000139; GO:0000285; GO:0004674; GO:0005524; GO:0005829; GO:0005911; GO:0006612; GO:0006661; GO:0008270; GO:0010008; GO:0012506; GO:0016308; GO:0019065; GO:0019886; GO:0030593; GO:0030670; GO:0031410; GO:0031901; GO:0031902; GO:0032288; GO:0032438; GO:0034504; GO:0035556; GO:0036289; GO:0042147; GO:0043813; GO:0045121; GO:0048471; GO:0052810; GO:0090382; GO:0090385; GO:0106310; GO:1903100; GO:1903426; GO:1904562; GO:2000785"
"1223",1323,481010,"Cluster_1167","Peve_00026154",0.897792436731221,0.290340075634798,0.978262075707395,149,-24.49,"2 21","962 989",25,"68.00%","72.00%","Q5SXM8","DNL-type zinc finger protein (Hsp70-escort protein 1) (HEP1) (mtHsp70-escort protein)","Homo sapiens (Human)","protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150]; protein stabilization [GO:0050821]","GO:0005654; GO:0005739; GO:0006457; GO:0008270; GO:0030150; GO:0050821; GO:0051087"
"1224",1324,481187,"Cluster_589","Peve_00026153",-0.852740197851694,0.349878098700568,0.978262075707395,177,-32.71,"2 20","56 76",18,"88.89%","94.44%","Q86Y79","Probable peptidyl-tRNA hydrolase (PTH) (EC 3.1.1.29)","Homo sapiens (Human)","","GO:0003723; GO:0004045"
"1225",1325,482040,"Cluster_16738","Peve_00011466",0.126914596811679,0.918985168838208,0.999448381576871,167,-20.96,"2 16","820 841",14,"85.71%","100.00%","E9Q5F9","Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.359) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2)","Mus musculus (Mouse)","angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic organ development [GO:0048568]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of ossification [GO:0045778]; regulation of cytokinesis [GO:0032465]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of gene expression [GO:0010468]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation by RNA polymerase II promoter [GO:0006368]; vasculogenesis [GO:0001570]","GO:0001525; GO:0001570; GO:0001763; GO:0001843; GO:0005634; GO:0005694; GO:0006298; GO:0006355; GO:0006368; GO:0010468; GO:0010569; GO:0010793; GO:0016279; GO:0018023; GO:0030900; GO:0032465; GO:0032727; GO:0034340; GO:0034728; GO:0035441; GO:0035987; GO:0043014; GO:0045778; GO:0046872; GO:0046975; GO:0048332; GO:0048568; GO:0048701; GO:0048863; GO:0048864; GO:0051607; GO:0060039; GO:0060669; GO:0060977; GO:0097198; GO:0097676; GO:0140955; GO:1902850; GO:1905634"
"1226",1326,483942,"Cluster_4629","Peve_00017175",-0.554554668634826,0.625777256211528,0.978262075707395,140,-20.62,"2 9","255 276",7,"100.00%","100.00%","P25291","Pancreatic secretory granule membrane major glycoprotein GP2 (Pancreatic zymogen granule membrane protein GP-2) (ZAP75)","Canis lupus familiaris (Dog) (Canis familiaris)","antigen transcytosis by M cells in mucosal-associated lymphoid tissue [GO:0002412]; innate immune response [GO:0045087]; neutrophil migration [GO:1990266]","GO:0002412; GO:0005201; GO:0005615; GO:0005768; GO:0009897; GO:0009986; GO:0016324; GO:0042589; GO:0045087; GO:0045121; GO:1990266"
"1227",1327,484962,"Cluster_15726","Peve_00013415",-0.780718486847674,0.429706594098758,0.978262075707395,158,-21.37,"2 21","608 631",21,"71.43%","80.95%","Q7ZYL5","Kinesin-like protein KIF22-B (Chromokinesin kid-B) (Xkid-B)","Xenopus laevis (African clawed frog)","microtubule-based movement [GO:0007018]","GO:0003677; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005874; GO:0007018; GO:0008017"
"1228",1328,485097,"Cluster_15726","Peve_00013411",-0.972793624228977,0.148840132101773,0.978262075707395,150,-23.48,"2 21","358 378",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"1229",1329,485103,"Cluster_796","Peve_00013412",-0.658611823564295,0.54228790770108,0.978262075707395,153,-20.59,"2 21","110 131",20,"75.00%","75.00%",NA,NA,NA,NA,NA
"1230",1330,485117,"Cluster_6904","Peve_00013412",-0.0482517618489931,0.969270042065228,0.999448381576871,155,-20.16,"2 18","811 831",16,"81.25%","81.25%",NA,NA,NA,NA,NA
"1231",1331,485283,"Cluster_796","Peve_00045004",0.688147880853597,0.516848046438364,0.978262075707395,156,-20.05,"2 19","766 786",17,"76.47%","82.35%",NA,NA,NA,NA,NA
"1232",1332,485513,"Cluster_2882","Peve_00021745",0.0688372031480257,0.956142191637655,0.999448381576871,164,-23.01,"2 21","150 171",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"1233",1333,485513,"Cluster_2882","Peve_00021745",0.0688372031480257,0.956142191637655,0.999448381576871,164,-23.01,"2 21","748 769",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"1234",1334,486034,"Cluster_10934","Peve_00000243",-0.373815986322051,0.756098306054521,0.988219883885475,155,-22.45,"2 21","873 895",20,"70.00%","75.00%",NA,NA,NA,NA,NA
"1235",1335,486746,"Cluster_8884","Peve_00036442",-0.431065204340282,0.716275781172058,0.980524072524907,163,-25.41,"2 20","678 698",18,"61.11%","94.44%",NA,NA,NA,NA,NA
"1236",1336,486747,"Cluster_8887","Peve_00036442",-0.663185370327588,0.538408198898494,0.978262075707395,163,-25.04,"2 20","678 698",18,"61.11%","94.44%",NA,NA,NA,NA,NA
"1237",1337,486748,"Cluster_8888","Peve_00036442",-0.994746318613058,0.0652855860277648,0.978262075707395,163,-26.67,"2 20","678 698",18,"61.11%","94.44%",NA,NA,NA,NA,NA
"1238",1338,486812,"Cluster_589","Peve_00001738",-0.993473169943426,0.0727750931896396,0.978262075707395,150,-20.55,"2 11","462 483",9,"100.00%","100.00%","P41180","Extracellular calcium-sensing receptor (CaR) (CaSR) (hCasR) (Parathyroid cell calcium-sensing receptor 1) (PCaR1)","Homo sapiens (Human)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; anatomical structure morphogenesis [GO:0009653]; apoptotic process [GO:0006915]; bile acid secretion [GO:0032782]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to peptide [GO:1901653]; cellular response to vitamin D [GO:0071305]; chemosensory behavior [GO:0007635]; chloride transmembrane transport [GO:1902476]; detection of calcium ion [GO:0005513]; fat pad development [GO:0060613]; G protein-coupled receptor signaling pathway [GO:0007186]; JNK cascade [GO:0007254]; ossification [GO:0001503]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of vasoconstriction [GO:0045907]; regulation of calcium ion transport [GO:0051924]; response to fibroblast growth factor [GO:0071774]; response to ischemia [GO:0002931]; vasodilation [GO:0042311]","GO:0001503; GO:0002931; GO:0004435; GO:0004930; GO:0005178; GO:0005509; GO:0005513; GO:0005634; GO:0005737; GO:0005886; GO:0006874; GO:0006915; GO:0007186; GO:0007193; GO:0007200; GO:0007254; GO:0007635; GO:0008284; GO:0009653; GO:0009986; GO:0010628; GO:0016323; GO:0016324; GO:0016597; GO:0019901; GO:0032024; GO:0032781; GO:0032782; GO:0035729; GO:0042311; GO:0042802; GO:0042803; GO:0043025; GO:0043679; GO:0044325; GO:0045907; GO:0048754; GO:0050927; GO:0051924; GO:0060613; GO:0070374; GO:0070509; GO:0071305; GO:0071333; GO:0071404; GO:0071456; GO:0071774; GO:0090280; GO:1901653; GO:1902476"
"1239",1339,487487,"Cluster_589","Peve_00013947",-0.934753615028442,0.231240264998328,0.978262075707395,156,-20.72,"2 21","436 457",19,"63.16%","78.95%",NA,NA,NA,NA,NA
"1240",1340,487490,"Cluster_1167","Peve_00013947",0.999909726776791,0.00855416971793389,0.573710369894872,141,-21.45,"2 12","681 701",10,"90.00%","90.00%",NA,NA,NA,NA,NA
"1241",1341,488010,"Cluster_9149","Peve_00043123",1,0,0,157,-23.58,"2 21","803 824",20,"75.00%","80.00%",NA,NA,NA,NA,NA
"1242",1342,488477,"Cluster_589","Peve_00030847",0.823262708024696,0.384302780134235,0.978262075707395,155,-23.55,"2 12","246 267",10,"100.00%","100.00%","P84060","Dystrobrevin beta (DTN-B) (Beta-dystrobrevin)","Rattus norvegicus (Rat)","neuron differentiation [GO:0030182]; synaptic signaling [GO:0099536]","GO:0003677; GO:0005634; GO:0005737; GO:0005886; GO:0008270; GO:0009925; GO:0014069; GO:0019902; GO:0030182; GO:0030425; GO:0045202; GO:0060077; GO:0099536"
"1243",1343,488685,"Cluster_9149","Peve_00035773",-0.324650110425316,0.789506906795229,0.99575406345257,156,-21.58,"2 21","892 910",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"1244",1344,488691,"Cluster_11134","Peve_00035773",-0.210924390172484,0.864705229313613,0.996660710141104,146,-21.16,"2 17","120 140",15,"73.33%","80.00%",NA,NA,NA,NA,NA
"1245",1345,489012,"Cluster_15726","Peve_00029298",-0.979852777192469,0.128007252474761,0.978262075707395,155,-22.76,"2 20","387 405",18,"72.22%","83.33%","A7RT29","Ragulator complex protein LAMTOR5 homolog (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 5)","Nematostella vectensis (Starlet sea anemone)","cellular response to amino acid stimulus [GO:0071230]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein localization to lysosome [GO:0061462]; regulation of cell size [GO:0008361]","GO:0005764; GO:0008361; GO:0032008; GO:0043154; GO:0061462; GO:0071230; GO:0071986; GO:1904263"
"1246",1346,489169,"Cluster_6906","Peve_00030693",0.999488224375111,0.0203682371525405,0.810097073649321,155,-20.73,"2 21","558 576",19,"73.68%","84.21%","Q86VD9","GPI mannosyltransferase 4 (EC 2.4.1.-) (GPI mannosyltransferase IV) (GPI-MT-IV) (Phosphatidylinositol-glycan biosynthesis class Z protein) (PIG-Z) (SMP3 homolog) (hSMP3)","Homo sapiens (Human)","GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]","GO:0000026; GO:0000030; GO:0005783; GO:0005789; GO:0006506; GO:0016254"
"1247",1347,489512,"Cluster_589","Peve_00007219",-0.926536103198208,0.245542911110407,0.978262075707395,155,-23.41,"2 21","314 337",21,"61.90%","80.95%","Q7L5D6","Golgi to ER traffic protein 4 homolog (Conserved edge-expressed protein) (Transmembrane domain recognition complex 35 kDa subunit) (TRC35)","Homo sapiens (Human)","cytoplasmic sequestering of protein [GO:0051220]; maintenance of unfolded protein involved in ERAD pathway [GO:1904378]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein insertion into ER membrane [GO:0045048]; regulation of protein stability [GO:0031647]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0006620; GO:0031647; GO:0045048; GO:0051087; GO:0051220; GO:0071816; GO:0071818; GO:1904378"
"1248",1348,489546,"Cluster_11134","Peve_00007219",0.666396859765905,0.53567135444909,0.978262075707395,167,-22.88,"2 21","167 190",21,"71.43%","85.71%","Q7L5D6","Golgi to ER traffic protein 4 homolog (Conserved edge-expressed protein) (Transmembrane domain recognition complex 35 kDa subunit) (TRC35)","Homo sapiens (Human)","cytoplasmic sequestering of protein [GO:0051220]; maintenance of unfolded protein involved in ERAD pathway [GO:1904378]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein insertion into ER membrane [GO:0045048]; regulation of protein stability [GO:0031647]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0006620; GO:0031647; GO:0045048; GO:0051087; GO:0051220; GO:0071816; GO:0071818; GO:1904378"
"1249",1349,490408,"Cluster_15890","Peve_00018795",-0.93187046611915,0.236352341244964,0.978262075707395,164,-20.61,"2 21","742 763",19,"68.42%","84.21%","O94929","Actin-binding LIM protein 3 (abLIM-3) (Actin-binding LIM protein family member 3)","Homo sapiens (Human)","cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]","GO:0001725; GO:0005737; GO:0006366; GO:0007010; GO:0015629; GO:0030027; GO:0030032; GO:0045944; GO:0046872; GO:0051015; GO:0060271; GO:0098978; GO:1903955"
"1250",1350,490427,"Cluster_6904","Peve_00041359",-0.923657420010922,0.250369240673211,0.978262075707395,163,-26.77,"2 18","717 737",16,"87.50%","87.50%",NA,NA,NA,NA,NA
"1251",1351,490429,"Cluster_6906","Peve_00041359",-0.625771210555079,0.569568725890118,0.978262075707395,159,-24.75,"2 18","717 737",16,"81.25%","87.50%",NA,NA,NA,NA,NA
"1252",1352,491704,"Cluster_10934","Peve_00036335",-0.456234386365879,0.698395722414825,0.978262075707395,164,-22.19,"2 19","859 879",17,"82.35%","88.24%",NA,NA,NA,NA,NA
"1253",1353,491704,"Cluster_10934","Peve_00036335",-0.456234386365879,0.698395722414825,0.978262075707395,166,-21.29,"2 21","738 758",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"1254",1354,491826,"Cluster_7053","Peve_00027300",-0.000666049336702279,0.999575979791532,0.999889080685919,150,-20.11,"2 20","709 731",19,"63.16%","78.95%",NA,NA,NA,NA,NA
"1255",1355,492362,"Cluster_6904","Peve_00018244",-0.810156355240736,0.398764327119569,0.978262075707395,159,-23.79,"2 20","633 653",19,"78.95%","84.21%","O35474","EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1)","Mus musculus (Mouse)","cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811]","GO:0005509; GO:0005576; GO:0007155; GO:0010811"
"1256",1356,492364,"Cluster_6906","Peve_00018244",-0.428671140284071,0.717963812336476,0.981002297503938,155,-20.3,"2 20","633 653",19,"73.68%","84.21%","O35474","EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1)","Mus musculus (Mouse)","cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811]","GO:0005509; GO:0005576; GO:0007155; GO:0010811"
"1257",1357,492489,"Cluster_4079","Peve_00003246",-0.353927615137903,0.769691836641235,0.990894405416752,153,-22.83,"2 14","187 208",12,"83.33%","91.67%","A7S7Z9","Zinc finger protein-like 1 homolog","Nematostella vectensis (Starlet sea anemone)","","GO:0005794; GO:0016020; GO:0046872"
"1258",1358,492767,"Cluster_6904","Peve_00018245",-0.756588051406496,0.453729729689094,0.978262075707395,147,-20.28,"2 16","358 379",14,"71.43%","78.57%","P28827","Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48)","Homo sapiens (Human)","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; response to xenobiotic stimulus [GO:0009410]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]","GO:0001937; GO:0004725; GO:0005001; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0006470; GO:0007156; GO:0007165; GO:0009410; GO:0010596; GO:0010842; GO:0016525; GO:0030027; GO:0031175; GO:0031290; GO:0042802; GO:0043232; GO:0045296; GO:0048471"
"1259",1359,494005,"Cluster_14500","Peve_00023035",-0.619997928550321,0.574266853271141,0.978262075707395,164,-21.56,"2 19","499 524",21,"80.95%","80.95%","Q8N0W4","Neuroligin-4, X-linked (Neuroligin X) (HNLX)","Homo sapiens (Human)","adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]","GO:0003360; GO:0005886; GO:0007158; GO:0007268; GO:0007612; GO:0009986; GO:0016020; GO:0021549; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0038023; GO:0042043; GO:0042803; GO:0045202; GO:0045216; GO:0048488; GO:0050804; GO:0050808; GO:0050839; GO:0060076; GO:0071625; GO:0090394; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098839; GO:0098983; GO:0098985; GO:0099054; GO:0099634"
"1260",1360,494055,"Cluster_16738","Peve_00023034",-0.758406275095175,0.451956673846602,0.978262075707395,160,-21.29,"2 13","194 215",11,"100.00%","100.00%",NA,NA,NA,NA,NA
"1261",1361,494678,"Cluster_11997","Peve_00011091",-0.952799520399272,0.196377418347217,0.978262075707395,162,-20.67,"2 21","618 641",21,"71.43%","85.71%",NA,NA,NA,NA,NA
"1262",1362,494769,"Cluster_13502","Peve_00000601",0.997844556977271,0.0418062711782387,0.909359886114279,153,-21.15,"2 19","925 950",21,"66.67%","76.19%",NA,NA,NA,NA,NA
"1263",1363,494794,"Cluster_6906","Peve_00031648",-0.686063329690759,0.518674561276582,0.978262075707395,153,-23.54,"2 21","531 556",24,"70.83%","70.83%",NA,NA,NA,NA,NA
"1264",1364,494901,"Cluster_11134","Peve_00000604",-0.0195622829453675,0.987545469442176,0.999448381576871,147,-22.66,"2 21","196 214",19,"63.16%","84.21%",NA,NA,NA,NA,NA
"1265",1365,495147,"Cluster_4629","Peve_00024023",0.572882589929692,0.611650187457185,0.978262075707395,158,-20.71,"2 19","92 113",17,"76.47%","76.47%",NA,NA,NA,NA,NA
"1266",1366,495818,"Cluster_2882","Peve_00004539",-0.130056712848051,0.916968116155208,0.999448381576871,157,-21.99,"2 14","641 662",12,"91.67%","91.67%","Q8IUH2","Protein CREG2 (Cellular repressor of E1A-stimulated genes 2)","Homo sapiens (Human)","","GO:0005615; GO:0005783; GO:0005794"
"1267",1367,496367,"Cluster_6904","Peve_00024652",0.544248388054089,0.633629821603705,0.978262075707395,166,-22.58,"2 21","946 966",19,"78.95%","84.21%","Q9GV16","Endoglycoceramidase (EGCase) (EC 3.2.1.123) (Glycosphingolipid-specific enzyme) (GSL-specific enzyme)","Cyanea nozakii (Jellyfish)","carbohydrate derivative catabolic process [GO:1901136]; cellulose catabolic process [GO:0030245]; lipid catabolic process [GO:0016042]","GO:0005576; GO:0016042; GO:0030245; GO:0042151; GO:0047876; GO:1901136"
"1268",1368,496791,"Cluster_11134","Peve_00025080",0.920806705417559,0.255063298551679,0.978262075707395,162,-20.6,"2 21","884 907",21,"76.19%","80.95%","Q9D8U2","Transmembrane protein 41A","Mus musculus (Mouse)","","GO:0016020"
"1269",1369,497166,"Cluster_2787","Peve_00029457",0.122129188735372,0.922055554571149,0.999448381576871,153,-20.34,"2 18","509 530",16,"68.75%","81.25%","Q8AV57","Protein sidekick-2","Gallus gallus (Chicken)","camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]","GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202; GO:0060219"
"1270",1370,497336,"Cluster_14999","Peve_00005952",0.844452079263614,0.359852465059544,0.978262075707395,161,-20.89,"2 15","208 230",14,"92.86%","92.86%",NA,NA,NA,NA,NA
"1271",1371,497477,"Cluster_589","Peve_00005955",-0.970542812304101,0.154904008964404,0.978262075707395,155,-23.41,"2 12","655 676",10,"100.00%","100.00%",NA,NA,NA,NA,NA
"1272",1372,497561,"Cluster_14999","Peve_00005958",0.525134194156591,0.64803024914489,0.978262075707395,161,-20.89,"2 15","208 230",14,"92.86%","92.86%",NA,NA,NA,NA,NA
"1273",1373,497667,"Cluster_4629","Peve_00006607",0.518940714572329,0.652653072058428,0.978262075707395,172,-23.4,"2 21","11 32",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"1274",1374,497712,"Cluster_4629","Peve_00006606",0.490739155480984,0.673453603293458,0.978262075707395,172,-23.4,"2 21","528 549",19,"78.95%","84.21%","P13686","Tartrate-resistant acid phosphatase type 5 (TR-AP) (EC 3.1.3.2) (Tartrate-resistant acid ATPase) (TrATPase) (Type 5 acid phosphatase)","Homo sapiens (Human)","bone morphogenesis [GO:0060349]; bone resorption [GO:0045453]; defense response to Gram-positive bacterium [GO:0050830]; dephosphorylation [GO:0016311]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of superoxide anion generation [GO:0032929]; negative regulation of tumor necrosis factor production [GO:0032720]; nitric oxide biosynthetic process [GO:0006809]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; superoxide anion generation [GO:0042554]","GO:0003993; GO:0005764; GO:0005829; GO:0006809; GO:0008198; GO:0008199; GO:0010936; GO:0016020; GO:0016311; GO:0032496; GO:0032691; GO:0032695; GO:0032720; GO:0032929; GO:0034097; GO:0042554; GO:0045019; GO:0045453; GO:0050728; GO:0050830; GO:0060349"
"1275",1375,497752,"Cluster_2854","Peve_00006605",-0.784441472206795,0.425899436210557,0.978262075707395,160,-20.01,"2 19","41 64",19,"78.95%","84.21%","Q15485","Ficolin-2 (37 kDa elastin-binding protein) (Collagen/fibrinogen domain-containing protein 2) (EBP-37) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35)","Homo sapiens (Human)","cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]","GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0042802; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0062023; GO:0070062; GO:0072562; GO:0097367; GO:1903028; GO:1905370; GO:2001065"
"1276",1376,499422,"Cluster_4629","Peve_00004887",-0.501704119674688,0.665413246235045,0.978262075707395,154,-23.59,"2 16","828 850",15,"73.33%","93.33%","Q86UT8","Centrosomal AT-AC splicing factor (Coiled-coil domain-containing protein 84)","Homo sapiens (Human)","negative regulation of centrosome duplication [GO:0010826]; regulation of protein catabolic process [GO:0042176]","GO:0005737; GO:0005813; GO:0010826; GO:0042176"
"1277",1377,499677,"Cluster_15726","Peve_00012596",-0.284511049996623,0.816337512018842,0.995934364227446,149,-22.59,"2 21","342 369",25,"68.00%","72.00%","Q9ULV0","Unconventional myosin-Vb","Homo sapiens (Human)","actin filament organization [GO:0007015]; endosomal transport [GO:0016197]; protein transport [GO:0015031]; renal water homeostasis [GO:0003091]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]","GO:0000146; GO:0003091; GO:0005516; GO:0005524; GO:0005737; GO:0007015; GO:0015031; GO:0015629; GO:0016192; GO:0016197; GO:0016459; GO:0030050; GO:0030659; GO:0031267; GO:0031982; GO:0032991; GO:0045179; GO:0051015; GO:0070062"
"1278",1378,499865,"Cluster_1167","Peve_00027012",0.411796331339113,0.729803026865328,0.984465526978144,150,-21.22,"2 16","127 149",15,"73.33%","86.67%","Q86YH6","All trans-polyprenyl-diphosphate synthase PDSS2 (All-trans-decaprenyl-diphosphate synthase subunit 2) (EC 2.5.1.91) (Candidate tumor suppressor protein) (Decaprenyl pyrophosphate synthase subunit 2) (Decaprenyl-diphosphate synthase subunit 2) (Solanesyl-diphosphate synthase subunit 2)","Homo sapiens (Human)","cerebellum development [GO:0021549]; isoprenoid biosynthetic process [GO:0008299]; regulation of body fluid levels [GO:0050878]; ubiquinone biosynthetic process [GO:0006744]","GO:0000010; GO:0004659; GO:0005759; GO:0005829; GO:0006744; GO:0008299; GO:0021549; GO:0046982; GO:0050878; GO:0052923; GO:0097269; GO:1990234"
"1279",1379,499900,"Cluster_14500","Peve_00027012",0.0303850737953016,0.980653283473206,0.999448381576871,153,-20.24,"2 15","285 307",14,"85.71%","85.71%","Q86YH6","All trans-polyprenyl-diphosphate synthase PDSS2 (All-trans-decaprenyl-diphosphate synthase subunit 2) (EC 2.5.1.91) (Candidate tumor suppressor protein) (Decaprenyl pyrophosphate synthase subunit 2) (Decaprenyl-diphosphate synthase subunit 2) (Solanesyl-diphosphate synthase subunit 2)","Homo sapiens (Human)","cerebellum development [GO:0021549]; isoprenoid biosynthetic process [GO:0008299]; regulation of body fluid levels [GO:0050878]; ubiquinone biosynthetic process [GO:0006744]","GO:0000010; GO:0004659; GO:0005759; GO:0005829; GO:0006744; GO:0008299; GO:0021549; GO:0046982; GO:0050878; GO:0052923; GO:0097269; GO:1990234"
"1280",1380,499962,"Cluster_4629","Peve_00027010",0.862194368760976,0.338179260472469,0.978262075707395,161,-22.18,"2 21","78 97",19,"78.95%","78.95%","P27170","Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (Serum aryldialkylphosphatase 1)","Oryctolagus cuniculus (Rabbit)","response to organophosphorus [GO:0046683]","GO:0004063; GO:0004064; GO:0005509; GO:0016209; GO:0034364; GO:0046683; GO:0102007"
"1281",1382,500841,"Cluster_11134","Peve_00013275",0.950357665045776,0.201434760116386,0.978262075707395,158,-30.92,"2 20","167 193",23,"69.57%","73.91%","Q6DEP7","Small ubiquitin-related modifier 1 (SUMO-1)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","cellular response to cadmium ion [GO:0071276]; cellular response to heat [GO:0034605]; protein sumoylation [GO:0016925]","GO:0005737; GO:0005886; GO:0008134; GO:0016605; GO:0016607; GO:0016925; GO:0031965; GO:0034605; GO:0071276; GO:0097165"
"1282",1383,501136,"Cluster_6255","Peve_00011698",-0.995166883382934,0.0626157849769958,0.978262075707395,182,-25.15,"2 20","687 709",19,"89.47%","94.74%","Q5ZIR1","Endophilin-B1 (SH3 domain-containing GRB2-like protein B1)","Gallus gallus (Chicken)","apoptotic process [GO:0006915]; membrane organization [GO:0061024]","GO:0000139; GO:0005741; GO:0006915; GO:0008289; GO:0016020; GO:0061024"
"1283",1384,502296,"Cluster_2787","Peve_00001160",0.754089155165755,0.456157270171873,0.978262075707395,166,-29.97,"2 21","924 949",23,"78.26%","78.26%","P20482","Segmentation protein cap'n'collar","Drosophila melanogaster (Fruit fly)","blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; head development [GO:0060322]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pharynx development [GO:0060465]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bicoid mRNA localization [GO:0008359]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]","GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005703; GO:0006357; GO:0006979; GO:0007310; GO:0007317; GO:0007350; GO:0008103; GO:0008340; GO:0008359; GO:0034976; GO:0036335; GO:0045944; GO:0046982; GO:0048813; GO:0051663; GO:0060322; GO:0060465; GO:2000378"
"1284",1385,502977,"Cluster_4629","Peve_00012638",0.997938030915672,0.0408894104551393,0.909359886114279,162,-20.05,"2 20","206 228",19,"73.68%","84.21%","Q92626","Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment]","Homo sapiens (Human)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070062; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"1285",1386,503037,"Cluster_8887","Peve_00017031",-0.0823630340017489,0.947506599925429,0.999448381576871,157,-20.24,"2 20","688 713",23,"73.91%","73.91%",NA,NA,NA,NA,NA
"1286",1387,503091,"Cluster_11134","Peve_00017036",-0.0195622829453675,0.987545469442176,0.999448381576871,167,-20.26,"2 21","180 203",21,"76.19%","80.95%",NA,NA,NA,NA,NA
"1287",1388,503245,"Cluster_4080","Peve_00004533",0.994949187886819,0.0640116013615338,0.978262075707395,168,-20.13,"2 21","246 265",19,"84.21%","89.47%",NA,NA,NA,NA,NA
"1288",1389,504048,"Cluster_796","Peve_00044567",0.906410178266634,0.277623498536471,0.978262075707395,149,-21.95,"2 21","31 52",20,"65.00%","80.00%","Q13813","Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) (Spectrin, non-erythroid alpha subunit)","Homo sapiens (Human)","actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]","GO:0003779; GO:0005200; GO:0005509; GO:0005516; GO:0005576; GO:0005829; GO:0005886; GO:0008091; GO:0015630; GO:0016020; GO:0030036; GO:0030054; GO:0030864; GO:0035580; GO:0042995; GO:0043231; GO:0045296; GO:0051015; GO:0051693; GO:0070062; GO:1903561; GO:1904724"
"1289",1390,504356,"Cluster_14999","Peve_00003000",-0.998266557633023,0.0374897530420475,0.909359886114279,161,-21.13,"2 14","905 926",12,"91.67%","100.00%",NA,NA,NA,NA,NA
"1290",1393,504683,"Cluster_2882","Peve_00019571",-0.868931081714065,0.329614878776467,0.978262075707395,149,-20.81,"2 14","690 711",12,"83.33%","83.33%",NA,NA,NA,NA,NA
"1291",1394,504948,"Cluster_796","Peve_00016631",0.814106188114078,0.394454672995439,0.978262075707395,168,-28.33,"2 21","823 841",19,"84.21%","84.21%",NA,NA,NA,NA,NA
"1292",1395,505096,"Cluster_6255","Peve_00041428",-0.146672670236191,0.906287201802721,0.999448381576871,176,-22.78,"2 17","38 59",15,"93.33%","100.00%",NA,NA,NA,NA,NA
"1293",1396,505670,"Cluster_1167","Peve_00045219",0.995497161628435,0.0604367911651442,0.978262075707395,155,-26.85,"2 17","756 778",16,"81.25%","81.25%","Q5SXM8","DNL-type zinc finger protein (Hsp70-escort protein 1) (HEP1) (mtHsp70-escort protein)","Homo sapiens (Human)","protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150]; protein stabilization [GO:0050821]","GO:0005654; GO:0005739; GO:0006457; GO:0008270; GO:0030150; GO:0050821; GO:0051087"
"1294",1397,505814,"Cluster_5563","Peve_00027218",0.750927374361875,0.459213623395546,0.978262075707395,161,-21.22,"2 21","845 871",24,"75.00%","75.00%",NA,NA,NA,NA,NA
"1295",1398,505852,"Cluster_2854","Peve_00009724",-0.715781400952845,0.492141394958667,0.978262075707395,156,-20.02,"2 21","391 412",19,"68.42%","73.68%","P00516","cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI)","Bos taurus (Bovine)","cGMP-mediated signaling [GO:0019934]; collateral sprouting [GO:0048668]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; protein phosphorylation [GO:0006468]; regulation of GTPase activity [GO:0043087]; relaxation of vascular associated smooth muscle [GO:0060087]","GO:0001764; GO:0004692; GO:0005246; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006468; GO:0016358; GO:0019934; GO:0030553; GO:0030900; GO:0042802; GO:0043087; GO:0048668; GO:0060087; GO:0090331; GO:0106310; GO:1904706; GO:1904753"
"1296",1399,506456,"Cluster_8884","Peve_00002840",0.152085585227155,0.902802125922894,0.999448381576871,145,-21.07,"2 20","152 176",22,"63.64%","72.73%","P05375","Phosphatidyl-N-methylethanolamine N-methyltransferase (EC 2.1.1.17) (EC 2.1.1.71) (Overproducer of inositol protein 3) (Phospholipid methyltransferase) (PLMT)","Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)","methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]","GO:0000773; GO:0004608; GO:0005739; GO:0005783; GO:0005789; GO:0006656; GO:0031966; GO:0032259; GO:0071944; GO:0080101"
"1297",1400,506457,"Cluster_8887","Peve_00002840",0.418753109329671,0.72493454364933,0.983034523417378,145,-20.7,"2 20","152 176",22,"63.64%","72.73%","P05375","Phosphatidyl-N-methylethanolamine N-methyltransferase (EC 2.1.1.17) (EC 2.1.1.71) (Overproducer of inositol protein 3) (Phospholipid methyltransferase) (PLMT)","Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)","methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]","GO:0000773; GO:0004608; GO:0005739; GO:0005783; GO:0005789; GO:0006656; GO:0031966; GO:0032259; GO:0071944; GO:0080101"
"1298",1401,506775,"Cluster_9149","Peve_00036867",-0.539842794138798,0.636967357731734,0.978262075707395,148,-22.08,"2 18","412 435",18,"72.22%","72.22%","E7F3F0","Unconventional myosin-IXAb (Myosin IXAb)","Danio rerio (Zebrafish) (Brachydanio rerio)","axon development [GO:0061564]; axon extension [GO:0048675]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; swimming behavior [GO:0036269]","GO:0000146; GO:0005096; GO:0005524; GO:0005737; GO:0005884; GO:0007626; GO:0016020; GO:0016459; GO:0035556; GO:0036269; GO:0044295; GO:0045198; GO:0045202; GO:0046872; GO:0048675; GO:0051015; GO:0061564; GO:0098529"
"1299",1402,507527,"Cluster_6904","Peve_00000728",0.742592842212241,0.467191590606991,0.978262075707395,162,-24.28,"2 21","730 750",19,"78.95%","78.95%","P16092","Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331)","Mus musculus (Mouse)","angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium ion homeostasis [GO:0055074]; cardiac muscle cell proliferation [GO:0060038]; cell maturation [GO:0048469]; cell population proliferation [GO:0008283]; cementum mineralization [GO:0071529]; central nervous system neuron development [GO:0021954]; chondrocyte differentiation [GO:0002062]; diphosphate metabolic process [GO:0071344]; ear development [GO:0043583]; embryonic limb morphogenesis [GO:0030326]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; gene expression [GO:0010467]; generation of neurons [GO:0048699]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung development [GO:0030324]; lung-associated mesenchyme development [GO:0060484]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; motogenic signaling involved in postnatal olfactory bulb interneuron migration [GO:0021837]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection development [GO:0031175]; orbitofrontal cortex development [GO:0021769]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of inflammatory response [GO:0050729]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of gene expression [GO:0010468]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; regulation of sensory perception of pain [GO:0051930]; regulation of stem cell proliferation [GO:0072091]; response to sodium phosphate [GO:1904383]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; stem cell proliferation [GO:0072089]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640]","GO:0000122; GO:0001525; GO:0001657; GO:0001701; GO:0001759; GO:0001837; GO:0002053; GO:0002062; GO:0004713; GO:0004714; GO:0005007; GO:0005102; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007169; GO:0007420; GO:0007435; GO:0007605; GO:0008201; GO:0008283; GO:0008284; GO:0008543; GO:0010463; GO:0010467; GO:0010468; GO:0010629; GO:0010763; GO:0010863; GO:0010966; GO:0010976; GO:0017134; GO:0018108; GO:0019827; GO:0021769; GO:0021837; GO:0021847; GO:0021954; GO:0030324; GO:0030326; GO:0030901; GO:0031175; GO:0031410; GO:0033674; GO:0035607; GO:0042127; GO:0042169; GO:0042472; GO:0042473; GO:0042474; GO:0042802; GO:0042803; GO:0043235; GO:0043406; GO:0043410; GO:0043536; GO:0043583; GO:0044877; GO:0045597; GO:0045666; GO:0045668; GO:0045787; GO:0045944; GO:0046777; GO:0048339; GO:0048378; GO:0048469; GO:0048471; GO:0048514; GO:0048699; GO:0048762; GO:0048863; GO:0050678; GO:0050729; GO:0050839; GO:0051174; GO:0051897; GO:0051930; GO:0055074; GO:0060038; GO:0060045; GO:0060117; GO:0060445; GO:0060484; GO:0060665; GO:0060979; GO:0070640; GO:0071344; GO:0071529; GO:0072089; GO:0072091; GO:0090080; GO:0090272; GO:0090722; GO:1903465; GO:1904383; GO:1905564; GO:2000491; GO:2000546; GO:2000648; GO:2000830; GO:2001239"
"1300",1403,507529,"Cluster_6906","Peve_00000728",0.973101367926095,0.147992105390085,0.978262075707395,158,-22.36,"2 21","730 750",19,"73.68%","78.95%","P16092","Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331)","Mus musculus (Mouse)","angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium ion homeostasis [GO:0055074]; cardiac muscle cell proliferation [GO:0060038]; cell maturation [GO:0048469]; cell population proliferation [GO:0008283]; cementum mineralization [GO:0071529]; central nervous system neuron development [GO:0021954]; chondrocyte differentiation [GO:0002062]; diphosphate metabolic process [GO:0071344]; ear development [GO:0043583]; embryonic limb morphogenesis [GO:0030326]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; gene expression [GO:0010467]; generation of neurons [GO:0048699]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung development [GO:0030324]; lung-associated mesenchyme development [GO:0060484]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; motogenic signaling involved in postnatal olfactory bulb interneuron migration [GO:0021837]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection development [GO:0031175]; orbitofrontal cortex development [GO:0021769]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of inflammatory response [GO:0050729]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of gene expression [GO:0010468]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; regulation of sensory perception of pain [GO:0051930]; regulation of stem cell proliferation [GO:0072091]; response to sodium phosphate [GO:1904383]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; stem cell proliferation [GO:0072089]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640]","GO:0000122; GO:0001525; GO:0001657; GO:0001701; GO:0001759; GO:0001837; GO:0002053; GO:0002062; GO:0004713; GO:0004714; GO:0005007; GO:0005102; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007169; GO:0007420; GO:0007435; GO:0007605; GO:0008201; GO:0008283; GO:0008284; GO:0008543; GO:0010463; GO:0010467; GO:0010468; GO:0010629; GO:0010763; GO:0010863; GO:0010966; GO:0010976; GO:0017134; GO:0018108; GO:0019827; GO:0021769; GO:0021837; GO:0021847; GO:0021954; GO:0030324; GO:0030326; GO:0030901; GO:0031175; GO:0031410; GO:0033674; GO:0035607; GO:0042127; GO:0042169; GO:0042472; GO:0042473; GO:0042474; GO:0042802; GO:0042803; GO:0043235; GO:0043406; GO:0043410; GO:0043536; GO:0043583; GO:0044877; GO:0045597; GO:0045666; GO:0045668; GO:0045787; GO:0045944; GO:0046777; GO:0048339; GO:0048378; GO:0048469; GO:0048471; GO:0048514; GO:0048699; GO:0048762; GO:0048863; GO:0050678; GO:0050729; GO:0050839; GO:0051174; GO:0051897; GO:0051930; GO:0055074; GO:0060038; GO:0060045; GO:0060117; GO:0060445; GO:0060484; GO:0060665; GO:0060979; GO:0070640; GO:0071344; GO:0071529; GO:0072089; GO:0072091; GO:0090080; GO:0090272; GO:0090722; GO:1903465; GO:1904383; GO:1905564; GO:2000491; GO:2000546; GO:2000648; GO:2000830; GO:2001239"
"1301",1405,507966,"Cluster_2787","Peve_00031842",0.57893725826683,0.606935225406069,0.978262075707395,152,-21.21,"2 19","858 882",20,"70.00%","80.00%",NA,NA,NA,NA,NA
"1302",1406,508062,"Cluster_4629","Peve_00031849",0.552478266975,0.62736445417872,0.978262075707395,153,-22.48,"2 21","229 255",24,"70.83%","75.00%","Q9FWW9","Flavin-containing monooxygenase FMO GS-OX-like 2 (EC 1.8.-.-) (Flavin-monooxygenase glucosinolate S-oxygenase-like 2)","Arabidopsis thaliana (Mouse-ear cress)","defense response to fungus [GO:0050832]","GO:0004499; GO:0050660; GO:0050661; GO:0050832"
"1303",1407,508316,"Cluster_14999","Peve_00001091",-0.560582643484465,0.621154433297991,0.978262075707395,174,-21.07,"2 19","810 831",17,"88.24%","88.24%",NA,NA,NA,NA,NA
"1304",1408,508399,"Cluster_10934","Peve_00001099",0.170281029862239,0.89106489863287,0.999448381576871,150,-21.59,"2 21","902 919",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"1305",1409,508671,"Cluster_11134","Peve_00033994",0.693973139305106,0.511717265958415,0.978262075707395,167,-24.68,"2 21","775 798",21,"76.19%","80.95%","Q9NFN6","Glutamate--cysteine ligase (EC 6.3.2.2) (Gamma-ECS) (GCS) (Gamma-glutamylcysteine synthetase)","Onchocerca volvulus","glutathione biosynthetic process [GO:0006750]","GO:0004357; GO:0005524; GO:0006750"
"1306",1410,509090,"Cluster_1167","Peve_00029314",0.622550313087995,0.572193200360734,0.978262075707395,146,-20.06,"2 21","18 41",21,"61.90%","76.19%","O67554","Putative L-lysine 2,3-aminomutase aq_1632 (LAM) (EC 5.4.3.-)","Aquifex aeolicus (strain VF5)","","GO:0016853; GO:0046872; GO:0051539"
"1307",1411,509637,"Cluster_4629","Peve_00034411",0.829359774370803,0.377410806483443,0.978262075707395,146,-20.63,"2 11","799 820",9,"88.89%","100.00%","A6QLU1","Glycerol-3-phosphate dehydrogenase, mitochondrial (GPD-M) (GPDH-M) (EC 1.1.5.3)","Bos taurus (Bovine)","glycerol catabolic process [GO:0019563]; glycerol-3-phosphate metabolic process [GO:0006072]","GO:0004368; GO:0005509; GO:0005739; GO:0006072; GO:0009331; GO:0019563; GO:0052591"
"1308",1412,510141,"Cluster_7053","Peve_00038520",-0.344025875954946,0.776418411563335,0.992694647475491,168,-20.51,"2 20","295 316",19,"84.21%","89.47%","Q9H772","Gremlin-2 (Cysteine knot superfamily 1, BMP antagonist 2) (DAN domain family member 3) (Protein related to DAN and cerberus)","Homo sapiens (Human)","animal organ morphogenesis [GO:0009887]; cytokine-mediated signaling pathway [GO:0019221]; determination of dorsal identity [GO:0048263]; embryonic body morphogenesis [GO:0010172]; regulation of cytokine activity [GO:0060300]; sequestering of BMP from receptor via BMP binding [GO:0038098]","GO:0005125; GO:0005576; GO:0005615; GO:0008201; GO:0009887; GO:0010172; GO:0019221; GO:0036122; GO:0038098; GO:0042802; GO:0048018; GO:0048263; GO:0060300"
"1309",1413,510531,"Cluster_2787","Peve_00006957",0.975013341501996,0.142612528511477,0.978262075707395,155,-21.23,"2 18","634 654",16,"81.25%","81.25%",NA,NA,NA,NA,NA
"1310",1414,512310,"Cluster_9149","Peve_00027250",-0.501126465390336,0.665838284708926,0.978262075707395,152,-25.82,"2 18","72 96",19,"68.42%","78.95%","E9Q236","ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 4)","Mus musculus (Mouse)","bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; fatty acid derivative transport [GO:1901571]; leukotriene transport [GO:0071716]; organic hydroxy compound transport [GO:0015850]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; urate transport [GO:0015747]; xenobiotic transmembrane transport [GO:0006855]","GO:0001409; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006855; GO:0008559; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015665; GO:0015721; GO:0015732; GO:0015747; GO:0015850; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:1901571"
"1311",1415,512506,"Cluster_29","Peve_00001658",0.780138692316065,0.430296936735473,0.978262075707395,166,-22.18,"2 21","880 900",19,"78.95%","84.21%","A2BGU9","Serine hydrolase-like protein (EC 3.1.-.-)","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0016787"
"1312",1416,512535,"Cluster_9149","Peve_00001658",-0.974758411017693,0.143341269611758,0.978262075707395,164,-20.61,"2 21","402 423",19,"73.68%","78.95%","A2BGU9","Serine hydrolase-like protein (EC 3.1.-.-)","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0016787"
"1313",1417,512551,"Cluster_29","Peve_00037874",0.266764185798453,0.828091028903856,0.995934364227446,160,-20.4,"2 21","419 438",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"1314",1418,512645,"Cluster_1167","Peve_00037877",-0.431588491428478,0.715906532126999,0.980430418387298,144,-26.45,"2 21","88 108",20,"65.00%","75.00%",NA,NA,NA,NA,NA
"1315",1419,513992,"Cluster_589","Peve_00024255",-0.964103632174262,0.171091385095854,0.978262075707395,155,-23.55,"2 12","960 981",10,"100.00%","100.00%","Q5VVW2","GTPase-activating Rap/Ran-GAP domain-like protein 3","Homo sapiens (Human)","activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]","GO:0005096; GO:0005737; GO:0051056; GO:0090630"
"1316",1420,514400,"Cluster_1167","Peve_00031438",0.877526217707037,0.318384696474256,0.978262075707395,156,-20.9,"2 21","230 249",19,"78.95%","78.95%","Q9WV92","Band 4.1-like protein 3 (4.1B) (Differentially expressed in adenocarcinoma of the lung protein 1) (DAL-1) (DAL1P) (mDAL-1) (Erythrocyte membrane protein band 4.1-like 3) [Cleaved into: Band 4.1-like protein 3, N-terminally processed]","Mus musculus (Mouse)","actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; axon development [GO:0061564]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]","GO:0002175; GO:0003779; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0006915; GO:0008360; GO:0014069; GO:0030054; GO:0030865; GO:0030866; GO:0030913; GO:0031032; GO:0033270; GO:0043217; GO:0044224; GO:0048812; GO:0061564; GO:0071205; GO:0072659; GO:0106006; GO:1990227"
"1317",1421,515235,"Cluster_9149","Peve_00011060",0.0130465649315108,0.991694063162219,0.999448381576871,147,-22.51,"2 12","288 309",10,"80.00%","100.00%","Q03173","Protein enabled homolog (NPC-derived proline-rich protein 1) (NDPP-1)","Mus musculus (Mouse)","actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin polymerization or depolymerization [GO:0008154]; actin polymerization-dependent cell motility [GO:0070358]; axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; neural tube closure [GO:0001843]","GO:0001725; GO:0001843; GO:0003779; GO:0005522; GO:0005829; GO:0005886; GO:0005925; GO:0007015; GO:0007411; GO:0008154; GO:0015629; GO:0017124; GO:0030027; GO:0030036; GO:0030054; GO:0030175; GO:0043005; GO:0045202; GO:0050699; GO:0070358; GO:1990830"
"1318",1422,515235,"Cluster_9149","Peve_00011060",0.0130465649315108,0.991694063162219,0.999448381576871,163,-22.59,"2 20","369 390",18,"72.22%","83.33%","Q03173","Protein enabled homolog (NPC-derived proline-rich protein 1) (NDPP-1)","Mus musculus (Mouse)","actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin polymerization or depolymerization [GO:0008154]; actin polymerization-dependent cell motility [GO:0070358]; axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; neural tube closure [GO:0001843]","GO:0001725; GO:0001843; GO:0003779; GO:0005522; GO:0005829; GO:0005886; GO:0005925; GO:0007015; GO:0007411; GO:0008154; GO:0015629; GO:0017124; GO:0030027; GO:0030036; GO:0030054; GO:0030175; GO:0043005; GO:0045202; GO:0050699; GO:0070358; GO:1990830"
"1319",1423,515775,"Cluster_9149","Peve_00020572",0.750942856523495,0.459198698185804,0.978262075707395,158,-22.82,"2 15","732 753",13,"84.62%","92.31%","Q9VCZ3","Octopamine receptor beta-1R (DmOA2) (DmOct-beta-1R)","Drosophila melanogaster (Fruit fly)","adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]","GO:0004930; GO:0004935; GO:0004989; GO:0005886; GO:0007186; GO:0007188; GO:0007189; GO:0008227; GO:0016020; GO:0045886; GO:0071880"
"1320",1424,516049,"Cluster_10934","Peve_00005564",0.747621393583581,0.462391626433407,0.978262075707395,162,-23.03,"2 21","48 68",19,"73.68%","84.21%","Q9I928","Fucolectin-4","Anguilla japonica (Japanese eel)","regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]","GO:0001868; GO:0005509; GO:0005615; GO:0010185; GO:0030246; GO:0042806; GO:0045088"
"1321",1425,516468,"Cluster_796","Peve_00033705",0.833341375689936,0.372849734963471,0.978262075707395,147,-21.42,"2 12","319 340",10,"90.00%","90.00%","D3YXG0","Hemicentin-1 (Fibulin-6) (FIBL-6)","Mus musculus (Mouse)","actin filament reorganization [GO:0090527]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]","GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711; GO:0090527"
"1322",1426,516485,"Cluster_6914","Peve_00033705",-0.0168008107520985,0.989303768443862,0.999448381576871,158,-22.51,"2 20","61 82",19,"68.42%","84.21%","D3YXG0","Hemicentin-1 (Fibulin-6) (FIBL-6)","Mus musculus (Mouse)","actin filament reorganization [GO:0090527]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]","GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711; GO:0090527"
"1323",1427,518856,"Cluster_2787","Peve_00029130",0.116270312528897,0.925812220580248,0.999448381576871,163,-22.2,"2 20","701 722",18,"72.22%","83.33%","Q8CEE6","PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (EC 2.7.11.1)","Mus musculus (Mouse)","energy homeostasis [GO:0097009]; intracellular signal transduction [GO:0035556]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of glucagon secretion [GO:0070092]; regulation of respiratory gaseous exchange [GO:0043576]","GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0035091; GO:0035556; GO:0043576; GO:0045719; GO:0046777; GO:0070092; GO:0097009; GO:0106310"
"1324",1428,519282,"Cluster_8887","Peve_00011558",-0.956642706513102,0.188151627726252,0.978262075707395,155,-21.65,"2 20","791 808",18,"72.22%","83.33%",NA,NA,NA,NA,NA
"1325",1429,519283,"Cluster_8888","Peve_00011558",-0.50731755968962,0.661274240596982,0.978262075707395,155,-23.28,"2 20","791 808",18,"72.22%","83.33%",NA,NA,NA,NA,NA
"1326",1430,520242,"Cluster_15726","Peve_00013024",-0.373424591877293,0.756366928683694,0.988219883885475,169,-22.16,"2 18","389 410",16,"81.25%","93.75%","A7S4N4","Probable serine incorporator","Nematostella vectensis (Starlet sea anemone)","phospholipid biosynthetic process [GO:0008654]","GO:0005789; GO:0008654; GO:0016020"
"1327",1432,520464,"Cluster_13502","Peve_00013023",-0.192179011996831,0.876889152946194,0.998019177863956,176,-23.47,"2 21","903 924",19,"78.95%","89.47%","Q90867","Hepatocyte nuclear factor 1-alpha (HNF-1-alpha) (HNF-1A) (Transcription factor 1) (TCF-1)","Gallus gallus (Chicken)","glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; liver development [GO:0001889]; pancreas development [GO:0031016]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000976; GO:0000978; GO:0000981; GO:0001889; GO:0003700; GO:0005634; GO:0006357; GO:0030073; GO:0031016; GO:0032991; GO:0042593; GO:0045893"
"1328",1433,520705,"Cluster_4080","Peve_00033607",-0.830329914463571,0.37630396531547,0.978262075707395,154,-26.15,"2 21","34 60",24,"66.67%","75.00%",NA,NA,NA,NA,NA
"1329",1434,522448,"Cluster_15890","Peve_00038406",-0.989010261210762,0.0944685700265161,0.978262075707395,161,-20.37,"2 21","702 727",23,"73.91%","82.61%","Q16527","Cysteine and glycine-rich protein 2 (Cysteine-rich protein 2) (CRP2) (LIM domain only protein 5) (LMO-5) (Smooth muscle cell LIM protein) (SmLIM)","Homo sapiens (Human)","actin cytoskeleton organization [GO:0030036]; cell differentiation [GO:0030154]; muscle tissue development [GO:0060537]; sarcomere organization [GO:0045214]","GO:0005634; GO:0005737; GO:0005925; GO:0008307; GO:0030018; GO:0030036; GO:0030154; GO:0042805; GO:0045214; GO:0046872; GO:0060537"
"1330",1435,522590,"Cluster_1167","Peve_00004968",0.735863729728454,0.47355277101514,0.978262075707395,155,-21.5,"2 12","428 449",10,"100.00%","100.00%",NA,NA,NA,NA,NA
"1331",1436,523055,"Cluster_6914","Peve_00004963",0.0244174697248888,0.984453810914684,0.999448381576871,173,-23.07,"2 18","624 644",16,"87.50%","93.75%",NA,NA,NA,NA,NA
"1332",1437,524077,"Cluster_2854","Peve_00033913",-0.492476100688937,0.672183790869439,0.978262075707395,163,-23.52,"2 21","48 71",21,"66.67%","85.71%","Q5ZM55","Protein fem-1 homolog B (FEM1b) (FEM1-beta)","Gallus gallus (Chicken)","apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756; GO:2000001"
"1333",1438,524115,"Cluster_16738","Peve_00033913",-0.493765079118584,0.671240542455818,0.978262075707395,157,-20.81,"2 19","88 110",18,"77.78%","77.78%","Q5ZM55","Protein fem-1 homolog B (FEM1b) (FEM1-beta)","Gallus gallus (Chicken)","apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756; GO:2000001"
"1334",1439,526443,"Cluster_10061","Peve_00018216",0.493084568595917,0.671738625037915,0.978262075707395,184,-22.57,"2 21","191 212",19,"89.47%","89.47%","C6FG12","Protein NLRC5","Ictalurus punctatus (Channel catfish) (Silurus punctatus)","innate immune response [GO:0045087]","GO:0005524; GO:0005737; GO:0045087"
"1335",1440,526533,"Cluster_10061","Peve_00018214",0.957102117899548,0.187144870960807,0.978262075707395,184,-22.57,"2 21","50 71",19,"89.47%","89.47%","A6QLE5","NACHT, LRR and PYD domains-containing protein 3 (EC 3.6.4.-)","Bos taurus (Bovine)","detection of biotic stimulus [GO:0009595]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; NLRP3 inflammasome complex assembly [GO:0044546]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type 2 immune response [GO:0002830]; protein homooligomerization [GO:0051260]; regulation of inflammatory response [GO:0050727]","GO:0002674; GO:0002830; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005783; GO:0006954; GO:0009595; GO:0016020; GO:0016887; GO:0031021; GO:0032731; GO:0032753; GO:0035591; GO:0043280; GO:0043531; GO:0043565; GO:0044546; GO:0045087; GO:0045630; GO:0045944; GO:0050727; GO:0050729; GO:0051260; GO:0070273; GO:0072559; GO:0140297; GO:0140299; GO:1901223; GO:1901981; GO:2000553"
"1336",1441,526587,"Cluster_15726","Peve_00018219",-0.94405740083576,0.213949936638121,0.978262075707395,159,-22.63,"2 18","679 702",18,"83.33%","83.33%","Q9H1A4","Anaphase-promoting complex subunit 1 (APC1) (Cyclosome subunit 1) (Mitotic checkpoint regulator) (Testis-specific gene 24 protein)","Homo sapiens (Human)","anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]","GO:0005654; GO:0005680; GO:0005829; GO:0007091; GO:0007346; GO:0031145; GO:0051301; GO:0051445; GO:0060090; GO:0070979"
"1337",1442,526623,"Cluster_10061","Peve_00018218",-0.696265133689105,0.509687578464817,0.978262075707395,184,-22.57,"2 21","39 60",19,"89.47%","89.47%",NA,NA,NA,NA,NA
"1338",1443,526845,"Cluster_9149","Peve_00043637",-0.5,0.666666666666667,0.978262075707395,152,-20.99,"2 18","463 485",17,"70.59%","82.35%","D2IYS2","Tyrosine-protein kinase receptor torso (EC 2.7.10.1)","Bombyx mori (Silk moth)","","GO:0004714; GO:0005524; GO:0005886; GO:0046872"
"1339",1444,526889,"Cluster_8988","Peve_00043638",0.0860148226113438,0.945173514868548,0.999448381576871,167,-23.76,"2 21","343 365",20,"70.00%","90.00%","Q9TST5","Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor)","Felis catus (Cat) (Felis silvestris catus)","activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; bone resorption [GO:0045453]; brown fat cell differentiation [GO:0050873]; cellular response to amyloid-beta [GO:1904646]; desensitization of G protein-coupled receptor signaling pathway by arrestin [GO:0002032]; diet induced thermogenesis [GO:0002024]; heat generation [GO:0031649]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of smooth muscle contraction [GO:0045986]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of lipophagy [GO:1904504]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor-mediated endocytosis [GO:0006898]; regulation of sodium ion transport [GO:0002028]; response to cold [GO:0009409]; smooth muscle contraction [GO:0006939]; transcription by RNA polymerase II [GO:0006366]","GO:0001540; GO:0002024; GO:0002025; GO:0002028; GO:0002032; GO:0004930; GO:0004941; GO:0005634; GO:0005769; GO:0005794; GO:0005886; GO:0006366; GO:0006898; GO:0006939; GO:0007190; GO:0008179; GO:0009409; GO:0010739; GO:0015459; GO:0016324; GO:0030501; GO:0031649; GO:0040015; GO:0042803; GO:0043235; GO:0043410; GO:0044877; GO:0045453; GO:0045944; GO:0045986; GO:0050873; GO:0051380; GO:0061885; GO:0071880; GO:0071902; GO:0098992; GO:0120162; GO:1901098; GO:1904504; GO:1904646; GO:2000969"
"1340",1445,527502,"Cluster_4629","Peve_00031146",-0.937280820070513,0.226668802447259,0.978262075707395,151,-21.2,"2 12","565 586",10,"90.00%","100.00%",NA,NA,NA,NA,NA
"1341",1446,528291,"Cluster_11134","Peve_00007729",-0.883669789338331,0.310130366389591,0.978262075707395,158,-25.82,"2 21","791 814",21,"71.43%","80.95%","Q80ZQ5","Juxtaposed with another zinc finger protein 1","Mus musculus (Mouse)","lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]","GO:0000122; GO:0001650; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006629; GO:0017053; GO:0046872"
"1342",1447,528420,"Cluster_9149","Peve_00007726",-0.967979993322332,0.161536822560152,0.978262075707395,153,-20.34,"2 14","685 706",12,"83.33%","91.67%","Q5XIZ6","Glycerol-3-phosphate dehydrogenase 1-like protein (EC 1.1.1.8)","Danio rerio (Zebrafish) (Brachydanio rerio)","carbohydrate metabolic process [GO:0005975]; glycerol-3-phosphate catabolic process [GO:0046168]","GO:0005829; GO:0005975; GO:0009331; GO:0016616; GO:0042803; GO:0046168; GO:0051287"
"1343",1448,528525,"Cluster_16738","Peve_00007724",-0.403764906687503,0.735402744793728,0.985974261895598,174,-24.09,"2 21","220 240",19,"84.21%","89.47%","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1344",1449,528705,"Cluster_16738","Peve_00007720",-0.688786809403726,0.516287212419881,0.978262075707395,174,-24.09,"2 21","175 195",19,"84.21%","89.47%","P0CI65","Nephrocystin-3","Danio rerio (Zebrafish) (Brachydanio rerio)","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"1345",1450,528966,"Cluster_11134","Peve_00040553",0.873707382873757,0.32341819984338,0.978262075707395,159,-20.02,"2 21","260 283",21,"66.67%","80.95%",NA,NA,NA,NA,NA
"1346",1451,529125,"Cluster_5882","Peve_00040557",-0.367098984086308,0.760702055693628,0.988438822234503,151,-20.22,"2 21","95 118",21,"66.67%","71.43%","O00338","Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.1) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2)","Homo sapiens (Human)","amine metabolic process [GO:0009308]; sulfation [GO:0051923]","GO:0004062; GO:0005737; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051923"
"1347",1452,529260,"Cluster_5882","Peve_00040558",-0.447624980145958,0.704539922830403,0.978262075707395,151,-20.22,"2 21","95 118",21,"66.67%","71.43%","O00338","Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.1) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2)","Homo sapiens (Human)","amine metabolic process [GO:0009308]; sulfation [GO:0051923]","GO:0004062; GO:0005737; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051923"
"1348",1453,529487,"Cluster_6904","Peve_00006230",-0.94063613764244,0.220459296838925,0.978262075707395,147,-21.97,"2 21","66 88",20,"60.00%","75.00%","Q9WVH4","Forkhead box protein O3","Mus musculus (Mouse)","aging [GO:0007568]; antral ovarian follicle growth [GO:0001547]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cellular response to amyloid-beta [GO:1904646]; cellular response to corticosterone stimulus [GO:0071386]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidative stress [GO:0034599]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glucose homeostasis [GO:0042593]; initiation of primordial ovarian follicle growth [GO:0001544]; mitochondrial transcription [GO:0006390]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuronal stem cell population maintenance [GO:0097150]; oocyte maturation [GO:0001556]; ovulation from ovarian follicle [GO:0001542]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of muscle atrophy [GO:0014737]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; response to dexamethasone [GO:0071548]; response to fatty acid [GO:0070542]; response to starvation [GO:0042594]; response to water-immersion restraint stress [GO:1990785]; response to xenobiotic stimulus [GO:0009410]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001221; GO:0001227; GO:0001228; GO:0001542; GO:0001544; GO:0001547; GO:0001556; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005759; GO:0005829; GO:0006355; GO:0006357; GO:0006390; GO:0006417; GO:0007568; GO:0008013; GO:0009410; GO:0010508; GO:0014737; GO:0016020; GO:0019901; GO:0030330; GO:0031490; GO:0032991; GO:0033209; GO:0034246; GO:0034599; GO:0042593; GO:0042594; GO:0043565; GO:0045591; GO:0045648; GO:0045665; GO:0045893; GO:0045944; GO:0048854; GO:0060070; GO:0070542; GO:0071333; GO:0071386; GO:0071456; GO:0071548; GO:0090090; GO:0090571; GO:0097150; GO:0097192; GO:1901300; GO:1902895; GO:1903428; GO:1904646; GO:1990090; GO:1990785; GO:1990837; GO:2000177; GO:2000353; GO:2000377"
"1349",1454,529950,"Cluster_9149","Peve_00021936",-0.137907691124636,0.911924540162949,0.999448381576871,164,-23.79,"2 21","245 266",19,"68.42%","84.21%","O57422","Melanopsin-B (Opsin-4B) (xMOP)","Xenopus laevis (African clawed frog)","phototransduction [GO:0007602]; visual perception [GO:0007601]","GO:0004930; GO:0005886; GO:0007601; GO:0007602; GO:0009881"
"1350",1455,530085,"Cluster_9149","Peve_00021932",0.851193961309844,0.351758115292625,0.978262075707395,155,-22.4,"2 12","121 142",10,"100.00%","100.00%","Q64487","Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)","Mus musculus (Mouse)","heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; protein dephosphorylation [GO:0006470]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling [GO:0099537]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]","GO:0004725; GO:0005102; GO:0006470; GO:0007157; GO:0030182; GO:0042734; GO:0046426; GO:0050775; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099054; GO:0099151; GO:0099537; GO:0099545; GO:0099560"
"1351",1456,531095,"Cluster_1167","Peve_00037489",0.658973053111598,0.541982234013298,0.978262075707395,157,-23.35,"2 16","753 773",14,"85.71%","92.86%","Q8IW92","Beta-galactosidase-1-like protein 2 (EC 3.2.1.-)","Homo sapiens (Human)","carbohydrate metabolic process [GO:0005975]","GO:0004565; GO:0005576; GO:0005764; GO:0005773; GO:0005975"
"1352",1457,531328,"Cluster_4735","Peve_00037482",-0.879398164055854,0.31589056304168,0.978262075707395,147,-20.02,"2 21","399 417",19,"73.68%","73.68%","Q7SZQ0","Lysophospholipid acyltransferase 7 (LPLAT 7) (EC 2.3.1.-) (Leukocyte receptor cluster member 4) (Membrane-bound O-acyltransferase domain-containing protein 7) (O-acyltransferase domain-containing protein 7)","Danio rerio (Zebrafish) (Brachydanio rerio)","lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phosphatidylinositol biosynthetic process [GO:0006661]; regulation of triglyceride metabolic process [GO:0090207]","GO:0005789; GO:0006661; GO:0008374; GO:0016020; GO:0016746; GO:0030258; GO:0036149; GO:0036151; GO:0044233; GO:0071617; GO:0090207"
"1353",1458,531756,"Cluster_11134","Peve_00036285",-0.172781239254178,0.889449269711114,0.999448381576871,150,-20.21,"2 16","219 241",15,"73.33%","86.67%","O08962","Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (RERG) (r-ERG) (Voltage-gated potassium channel subunit Kv11.1)","Rattus norvegicus (Rat)","brain development [GO:0007420]; cardiac muscle contraction [GO:0060048]; cellular response to xenobiotic stimulus [GO:0071466]; membrane depolarization during action potential [GO:0086010]; membrane repolarization [GO:0086009]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of potassium ion export across plasma membrane [GO:1903765]; negative regulation of potassium ion transmembrane transport [GO:1901380]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion export across plasma membrane [GO:0097623]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane potential [GO:0042391]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; spinal cord development [GO:0021510]; ventricular cardiac muscle cell action potential [GO:0086005]","GO:0000976; GO:0005216; GO:0005242; GO:0005249; GO:0005251; GO:0005267; GO:0005635; GO:0005737; GO:0005886; GO:0006813; GO:0007420; GO:0008076; GO:0009986; GO:0021510; GO:0031625; GO:0042391; GO:0042802; GO:0042803; GO:0044877; GO:0045893; GO:0048471; GO:0055075; GO:0055131; GO:0060048; GO:0060306; GO:0060307; GO:0071466; GO:0071805; GO:0086005; GO:0086009; GO:0086010; GO:0086011; GO:0086013; GO:0086091; GO:0097110; GO:0097623; GO:0098915; GO:1901379; GO:1901380; GO:1901381; GO:1902282; GO:1902937; GO:1903765; GO:1990573"
"1354",1459,531926,"Cluster_8884","Peve_00036281",-0.947118896471403,0.20795915113434,0.978262075707395,154,-21.14,"2 20","567 592",23,"69.57%","69.57%","Q9ES07","Solute carrier family 15 member 2 (Kidney H(+)/peptide cotransporter) (Oligopeptide transporter, kidney isoform) (Peptide transporter 2)","Mus musculus (Mouse)","dipeptide import across plasma membrane [GO:0140206]; dipeptide transport [GO:0042938]; innate immune response [GO:0045087]; oligopeptide transport [GO:0006857]; peptidoglycan transport [GO:0015835]; protein transport [GO:0015031]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; renal absorption [GO:0070293]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]","GO:0005886; GO:0006857; GO:0015031; GO:0015333; GO:0015334; GO:0015835; GO:0016020; GO:0016324; GO:0022857; GO:0042908; GO:0042938; GO:0045087; GO:0055085; GO:0070293; GO:0070424; GO:0071916; GO:0140206"
"1355",1460,531927,"Cluster_8887","Peve_00036281",-0.821901473199094,0.385826733407904,0.978262075707395,154,-20.77,"2 20","567 592",23,"69.57%","69.57%","Q9ES07","Solute carrier family 15 member 2 (Kidney H(+)/peptide cotransporter) (Oligopeptide transporter, kidney isoform) (Peptide transporter 2)","Mus musculus (Mouse)","dipeptide import across plasma membrane [GO:0140206]; dipeptide transport [GO:0042938]; innate immune response [GO:0045087]; oligopeptide transport [GO:0006857]; peptidoglycan transport [GO:0015835]; protein transport [GO:0015031]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; renal absorption [GO:0070293]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]","GO:0005886; GO:0006857; GO:0015031; GO:0015333; GO:0015334; GO:0015835; GO:0016020; GO:0016324; GO:0022857; GO:0042908; GO:0042938; GO:0045087; GO:0055085; GO:0070293; GO:0070424; GO:0071916; GO:0140206"
"1356",1461,531942,"Cluster_15726","Peve_00036281",-0.5,0.666666666666667,0.978262075707395,162,-20.63,"2 19","260 281",17,"76.47%","82.35%","Q9ES07","Solute carrier family 15 member 2 (Kidney H(+)/peptide cotransporter) (Oligopeptide transporter, kidney isoform) (Peptide transporter 2)","Mus musculus (Mouse)","dipeptide import across plasma membrane [GO:0140206]; dipeptide transport [GO:0042938]; innate immune response [GO:0045087]; oligopeptide transport [GO:0006857]; peptidoglycan transport [GO:0015835]; protein transport [GO:0015031]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; renal absorption [GO:0070293]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]","GO:0005886; GO:0006857; GO:0015031; GO:0015333; GO:0015334; GO:0015835; GO:0016020; GO:0016324; GO:0022857; GO:0042908; GO:0042938; GO:0045087; GO:0055085; GO:0070293; GO:0070424; GO:0071916; GO:0140206"
"1357",1462,532817,"Cluster_6904","Peve_00036753",-0.0351655396037939,0.977608305579394,0.999448381576871,153,-21.66,"2 20","456 479",20,"70.00%","80.00%",NA,NA,NA,NA,NA
"1358",1463,532819,"Cluster_6906","Peve_00036753",-0.511191178584135,0.658408820362488,0.978262075707395,161,-23.62,"2 20","456 479",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"1359",1464,532858,"Cluster_4735","Peve_00036750",-0.499055763751742,0.667360561442895,0.978262075707395,146,-21.01,"2 21","44 71",25,"60.00%","72.00%",NA,NA,NA,NA,NA
"1360",1465,533640,"Cluster_9149","Peve_00017248",-0.816632592124766,0.391676553232345,0.978262075707395,160,-27.96,"2 21","849 868",19,"73.68%","89.47%","O35474","EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1)","Mus musculus (Mouse)","cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811]","GO:0005509; GO:0005576; GO:0007155; GO:0010811"
"1361",1466,534017,"Cluster_589","Peve_00021211",-0.671197181579835,0.531560764204223,0.978262075707395,157,-21.3,"2 14","969 990",12,"91.67%","91.67%",NA,NA,NA,NA,NA
"1362",1467,534102,"Cluster_15726","Peve_00021210",-0.5,0.666666666666667,0.978262075707395,150,-21.77,"2 19","921 942",17,"70.59%","70.59%",NA,NA,NA,NA,NA
"1363",1468,534112,"Cluster_2854","Peve_00021216",0.999962448044095,0.00551712420276166,0.551398425649056,156,-20.4,"2 20","190 209",18,"72.22%","83.33%",NA,NA,NA,NA,NA
"1364",1469,534180,"Cluster_9149","Peve_00021215",-0.570143501258424,0.613775187349442,0.978262075707395,154,-20.36,"2 20","213 235",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"1365",1470,534245,"Cluster_1167","Peve_00021218",0.877025139482546,0.319049290638912,0.978262075707395,152,-23.21,"2 13","244 265",11,"90.91%","90.91%",NA,NA,NA,NA,NA
"1366",1471,534637,"Cluster_11135","Peve_00023160",0.549528098388524,0.629615060339979,0.978262075707395,158,-21.43,"2 21","544 567",21,"71.43%","80.95%","Q792I0","Protein lin-7 homolog C (Lin-7C) (Mammalian lin-seven protein 3) (MALS-3) (Vertebrate lin-7 homolog 3) (Veli-3)","Rattus norvegicus (Rat)","exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; morphogenesis of an epithelial sheet [GO:0002011]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031]","GO:0002011; GO:0005737; GO:0005886; GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0008092; GO:0015031; GO:0016020; GO:0016323; GO:0019904; GO:0030165; GO:0045199; GO:0045202; GO:0097016; GO:0097025; GO:0098793; GO:0098839; GO:0098978; GO:1903361"
"1367",1472,535863,"Cluster_796","Peve_00045087",0.761545671893146,0.448881655156071,0.978262075707395,161,-26.26,"2 20","458 484",23,"73.91%","78.26%","Q5ZJ75","Sodium/hydrogen exchanger 8 (Na(+)/H(+) exchanger 8) (NHE-8) (Solute carrier family 9 member 8)","Gallus gallus (Chicken)","potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]","GO:0000139; GO:0015385; GO:0015386; GO:0051453; GO:0071805"
"1368",1473,536007,"Cluster_4629","Peve_00015724",-0.926341976985491,0.245871205202795,0.978262075707395,141,-20.87,"2 10","523 544",8,"87.50%","100.00%",NA,NA,NA,NA,NA
"1369",1474,536081,"Cluster_14999","Peve_00015608",-0.309778699814634,0.799490061948509,0.995934364227446,162,-22.37,"2 16","471 494",16,"87.50%","87.50%",NA,NA,NA,NA,NA
"1370",1475,536115,"Cluster_9149","Peve_00030185",-0.908581638502046,0.274332505377023,0.978262075707395,170,-27.29,"2 21","927 947",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"1371",1476,536796,"Cluster_11134","Peve_00012981",0.368939488930982,0.759441914640341,0.988219883885475,146,-22.28,"2 21","479 503",22,"54.55%","81.82%",NA,NA,NA,NA,NA
"1372",1477,537845,"Cluster_1167","Peve_00015043",0.999909726776791,0.00855416971793915,0.573710369894872,155,-29.94,"2 21","395 419",22,"68.18%","72.73%",NA,NA,NA,NA,NA
"1373",1478,538327,"Cluster_11135","Peve_00002637",0.999511573163594,0.019898143482347,0.802868112010331,168,-21.37,"2 21","948 969",19,"68.42%","89.47%","Q8K2J9","BTB/POZ domain-containing protein 6","Mus musculus (Mouse)","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"1374",1479,538431,"Cluster_2787","Peve_00014977",0.867061518767537,0.332011733794598,0.978262075707395,154,-23.53,"2 19","337 358",17,"64.71%","82.35%","Q3USF0","Acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase (EC 2.4.1.147) (Core 3 synthase) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6) (BGnT-6) (Beta-1,3-Gn-T6) (Beta-1,3-N-acetylglucosaminyltransferase 6) (Beta3Gn-T6)","Mus musculus (Mouse)","poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]","GO:0000139; GO:0006486; GO:0008194; GO:0008378; GO:0016757; GO:0030311; GO:0106327; GO:0106328"
"1375",1480,539130,"Cluster_9149","Peve_00010275",-0.5,0.666666666666667,0.978262075707395,152,-21.1,"2 14","604 626",13,"84.62%","92.31%","Q6ZMM2","ADAMTS-like protein 5 (ADAMTSL-5) (Thrombospondin type-1 domain-containing protein 6)","Homo sapiens (Human)","","GO:0001527; GO:0005576; GO:0008201; GO:0031012; GO:0050436"
"1376",1481,539912,"Cluster_589","Peve_00030565",-0.995321885048105,0.0616027383042477,0.978262075707395,156,-24.16,"2 15","397 417",13,"92.31%","92.31%",NA,NA,NA,NA,NA
"1377",1482,540042,"Cluster_15726","Peve_00030563",-0.637256547921221,0.560138332728045,0.978262075707395,152,-20.74,"2 21","480 498",19,"73.68%","73.68%",NA,NA,NA,NA,NA
"1378",1483,541127,"Cluster_589","Peve_00001934",-0.994308920690028,0.0679514333437774,0.978262075707395,158,-27.07,"2 21","212 238",24,"70.83%","75.00%","P70187","Hippocampus abundant transcript 1 protein (Major facilitator superfamily domain-containing 14A)","Mus musculus (Mouse)","acrosome assembly [GO:0001675]; sperm mitochondrion organization [GO:0030382]; spermatid development [GO:0007286]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]","GO:0001675; GO:0007283; GO:0007286; GO:0007289; GO:0016020; GO:0022857; GO:0030382"
"1379",1484,541173,"Cluster_796","Peve_00001935",0.998840928019511,0.030654361989868,0.903929377050813,159,-24.54,"2 21","302 328",24,"70.83%","70.83%","O08726","Galanin receptor type 2 (GAL2-R) (GALR-2)","Rattus norvegicus (Rat)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; galanin-activated signaling pathway [GO:0090663]; inositol phosphate metabolic process [GO:0043647]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; phosphatidylinositol metabolic process [GO:0046488]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of large conductance calcium-activated potassium channel activity [GO:1902608]; positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0004966; GO:0005886; GO:0005929; GO:0007186; GO:0007188; GO:0007189; GO:0007194; GO:0007200; GO:0007204; GO:0007218; GO:0008528; GO:0017046; GO:0031175; GO:0042923; GO:0043647; GO:0045944; GO:0046488; GO:0090663; GO:1902608"
"1380",1485,541369,"Cluster_6906","Peve_00001931",-0.297171816135322,0.807913169198166,0.995934364227446,155,-21.51,"2 21","788 811",21,"71.43%","71.43%","O95477","Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein)","Homo sapiens (Human)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein lipidation [GO:0006497]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; response to laminar fluid shear stress [GO:0034616]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061]","GO:0002790; GO:0005102; GO:0005319; GO:0005524; GO:0005548; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0006497; GO:0006869; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0010745; GO:0010875; GO:0010887; GO:0015485; GO:0016197; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071404; GO:0071806; GO:0090107; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359"
"1381",1486,541715,"Cluster_1167","Peve_00013614",0.527521835099349,0.646242581995431,0.978262075707395,147,-21.49,"2 20","27 45",18,"72.22%","72.22%","Q6UPE1","Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)","Rattus norvegicus (Rat)","electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979]","GO:0004174; GO:0005743; GO:0006979; GO:0009055; GO:0016491; GO:0022900; GO:0031966; GO:0033539; GO:0046872; GO:0048038; GO:0048039; GO:0051536; GO:0051539"
"1382",1487,541854,"Cluster_4079","Peve_00013619",-0.776136859480486,0.434353131480188,0.978262075707395,159,-24.7,"2 21","45 67",20,"65.00%","85.00%",NA,NA,NA,NA,NA
"1383",1488,543356,"Cluster_8884","Peve_00003796",-0.994340539216538,0.0677622290589584,0.978262075707395,168,-22.75,"2 18","329 351",18,"83.33%","88.89%","Q3SZX5","39S ribosomal protein L22, mitochondrial (L22mt) (MRP-L22)","Bos taurus (Bovine)","ribosome assembly [GO:0042255]; translation [GO:0006412]","GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0015934; GO:0042255"
"1384",1489,543357,"Cluster_8887","Peve_00003796",-0.926484741507151,0.245629811332523,0.978262075707395,168,-22.75,"2 18","329 351",18,"83.33%","88.89%","Q3SZX5","39S ribosomal protein L22, mitochondrial (L22mt) (MRP-L22)","Bos taurus (Bovine)","ribosome assembly [GO:0042255]; translation [GO:0006412]","GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0015934; GO:0042255"
"1385",1490,544265,"Cluster_10965","Peve_00002778",-0.237064041297522,0.847629752891304,0.995934364227446,172,-20.13,"2 21","310 331",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"1386",1491,544349,"Cluster_8988","Peve_00009836",0.0860148226113438,0.945173514868548,0.999448381576871,160,-21.15,"2 21","144 163",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"1387",1492,545152,"Cluster_7657","Peve_00000687",-0.86008776112817,0.340817354077294,0.978262075707395,176,-24.98,"2 18","72 94",17,"94.12%","94.12%",NA,NA,NA,NA,NA
"1388",1493,545153,"Cluster_7658","Peve_00000687",0.234865215949685,0.849070246094085,0.995934364227446,176,-24.98,"2 18","72 94",17,"94.12%","94.12%",NA,NA,NA,NA,NA
"1389",1494,545282,"Cluster_6904","Peve_00003425",-0.178225660104942,0.885928593852659,0.999448381576871,154,-21.36,"2 18","489 508",16,"81.25%","81.25%",NA,NA,NA,NA,NA
"1390",1495,545497,"Cluster_2854","Peve_00018399",-0.650512650689624,0.549108170032854,0.978262075707395,157,-23.36,"2 14","813 834",12,"83.33%","100.00%","Q6ZQY2","Leucine-rich repeat-containing protein 74B","Homo sapiens (Human)","",""
"1391",1496,545542,"Cluster_2854","Peve_00018396",-0.600468161653425,0.589961837581351,0.978262075707395,154,-20.53,"2 20","365 389",21,"66.67%","76.19%","O95628","CCR4-NOT transcription complex subunit 4 (EC 2.3.2.27) (CCR4-associated factor 4) (E3 ubiquitin-protein ligase CNOT4) (Potential transcriptional repressor NOT4Hp) (RING-type E3 ubiquitin transferase CNOT4)","Homo sapiens (Human)","nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of megakaryocyte differentiation [GO:0045652]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000289; GO:0003723; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0016567; GO:0030014; GO:0045652; GO:0046872; GO:0051865"
"1392",1497,546437,"Cluster_589","Peve_00044964",-0.999852293886836,0.0109420753621189,0.647820986329688,160,-23.7,"2 17","733 754",15,"80.00%","86.67%",NA,NA,NA,NA,NA
"1393",1498,546808,"Cluster_4735","Peve_00036516",0.999722156026375,0.0150074072356261,0.742836432891574,155,-20.6,"2 16","301 322",14,"78.57%","85.71%",NA,NA,NA,NA,NA
"1394",1499,547025,"Cluster_1167","Peve_00001484",0.951701062536279,0.198667850776575,0.978262075707395,155,-21.98,"2 16","962 983",14,"78.57%","85.71%","B3EWZ3","Coadhesin","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0016020"
"1395",1500,547515,"Cluster_16738","Peve_00030917",-0.290399938539647,0.812423319196466,0.995934364227446,174,-24.09,"2 21","105 125",19,"84.21%","89.47%","P0CI65","Nephrocystin-3","Danio rerio (Zebrafish) (Brachydanio rerio)","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"1396",1501,547567,"Cluster_2854","Peve_00009308",-0.46100701639859,0.694976582894838,0.978262075707395,157,-20.04,"2 15","826 848",14,"85.71%","92.86%","Q9JLC8","Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)","Mus musculus (Mouse)","negative regulation of inclusion body assembly [GO:0090084]","GO:0005634; GO:0005737; GO:0005739; GO:0030544; GO:0042802; GO:0050750; GO:0051087; GO:0070628; GO:0090084"
"1397",1502,548114,"Cluster_5563","Peve_00029919",0.727427811797146,0.481431226182643,0.978262075707395,179,-23,"2 21","363 386",20,"85.00%","90.00%","A7SPE8","Biogenesis of lysosome-related organelles complex 1 subunit 5 (BLOC-1 subunit 5) (Protein Muted homolog)","Nematostella vectensis (Starlet sea anemone)","","GO:0030133; GO:0031083"
"1398",1503,548749,"Cluster_6906","Peve_00025372",0.973101367926095,0.147992105390085,0.978262075707395,149,-20.41,"2 20","137 162",22,"68.18%","72.73%",NA,NA,NA,NA,NA
"1399",1504,548867,"Cluster_589","Peve_00029806",-0.750495218422571,0.459630072641646,0.978262075707395,158,-20.4,"2 21","925 948",21,"71.43%","80.95%",NA,NA,NA,NA,NA
"1400",1505,549367,"Cluster_2854","Peve_00005487",-0.507486347355159,0.661149542463894,0.978262075707395,161,-22.53,"2 18","323 344",16,"75.00%","87.50%",NA,NA,NA,NA,NA
"1401",1506,549643,"Cluster_4735","Peve_00030007",-0.989910537754987,0.0905096650495642,0.978262075707395,160,-22.16,"2 21","957 976",19,"78.95%","84.21%","Q8N3Y7","Epidermal retinol dehydrogenase 2 (EPHD-2) (RDH-E2) (EC 1.1.1.105) (Retinal short-chain dehydrogenase reductase 2) (retSDR2) (Short-chain dehydrogenase/reductase family 16C member 5)","Homo sapiens (Human)","keratinocyte proliferation [GO:0043616]; negative regulation of histone acetylation [GO:0035067]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]","GO:0000122; GO:0003714; GO:0004745; GO:0005634; GO:0005789; GO:0005811; GO:0016616; GO:0017053; GO:0031065; GO:0035067; GO:0042572; GO:0042574; GO:0043616; GO:0061629; GO:0140297"
"1402",1507,550680,"Cluster_5882","Peve_00026053",-0.27814091057559,0.820563558554478,0.995934364227446,171,-24.85,"2 21","207 230",21,"76.19%","85.71%",NA,NA,NA,NA,NA
"1403",1508,551570,"Cluster_1167","Peve_00026942",0.337230783670769,0.781019466952213,0.993822736383039,145,-21.94,"2 10","483 504",8,"100.00%","100.00%",NA,NA,NA,NA,NA
"1404",1509,551844,"Cluster_4079","Peve_00037366",-0.758903206998846,0.451471086482866,0.978262075707395,151,-22.22,"2 20","405 428",21,"71.43%","80.95%","A2AUY4","Bromodomain adjacent to zinc finger domain protein 2B","Mus musculus (Mouse)","","GO:0003677; GO:0005634; GO:0046872"
"1405",1510,552574,"Cluster_6906","Peve_00015003",-0.25109630513093,0.838417829428062,0.995934364227446,154,-20.98,"2 19","286 307",17,"64.71%","82.35%","Q14008","Cytoskeleton-associated protein 5 (Colonic and hepatic tumor overexpressed gene protein) (Ch-TOG)","Homo sapiens (Human)","cell division [GO:0051301]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; microtubule depolymerization [GO:0007019]; microtubule polymerization [GO:0046785]; mitotic spindle organization [GO:0007052]; positive regulation of microtubule nucleation [GO:0090063]; RNA transport [GO:0050658]; spindle organization [GO:0007051]","GO:0000776; GO:0000922; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007019; GO:0007051; GO:0007052; GO:0007098; GO:0008017; GO:0016020; GO:0030951; GO:0032991; GO:0043021; GO:0045296; GO:0046785; GO:0050658; GO:0051010; GO:0051298; GO:0051301; GO:0061863; GO:0090063"
"1406",1511,553453,"Cluster_15890","Peve_00024545",-0.935162775453945,0.230506017990759,0.978262075707395,166,-24.63,"2 21","925 945",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"1407",1512,554232,"Cluster_4629","Peve_00011858",-0.999998482798634,0.00110896231522268,0.278265881456726,162,-22.01,"2 21","146 170",22,"77.27%","77.27%","O43147","Small G protein signaling modulator 2 (RUN and TBC1 domain-containing protein 1)","Homo sapiens (Human)","activation of GTPase activity [GO:0090630]; late endosome to Golgi transport [GO:0034499]; positive regulation of GTPase activity [GO:0043547]","GO:0005096; GO:0005737; GO:0031267; GO:0034499; GO:0042470; GO:0043547; GO:0090630"
"1408",1513,554232,"Cluster_4629","Peve_00011858",-0.999998482798634,0.00110896231522268,0.278265881456726,162,-22.01,"2 21","586 610",22,"77.27%","77.27%","O43147","Small G protein signaling modulator 2 (RUN and TBC1 domain-containing protein 1)","Homo sapiens (Human)","activation of GTPase activity [GO:0090630]; late endosome to Golgi transport [GO:0034499]; positive regulation of GTPase activity [GO:0043547]","GO:0005096; GO:0005737; GO:0031267; GO:0034499; GO:0042470; GO:0043547; GO:0090630"
"1409",1514,555936,"Cluster_2787","Peve_00021027",0.825627488983208,0.38164265852652,0.978262075707395,153,-20.05,"2 14","610 631",12,"75.00%","100.00%","Q6DG32","Solute carrier family 25 member 36-A","Danio rerio (Zebrafish) (Brachydanio rerio)","mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleotide import into mitochondrion [GO:1990519]","GO:0000002; GO:0005739; GO:0005743; GO:0015218; GO:1990519"
"1410",1515,556220,"Cluster_6914","Peve_00014402",0.31428619994269,0.796469691971694,0.995934364227446,149,-20.53,"2 20","236 261",23,"65.22%","73.91%",NA,NA,NA,NA,NA
"1411",1517,556740,"Cluster_16738","Peve_00012086",-0.981197772627443,0.123646721099654,0.978262075707395,154,-20.63,"2 21","958 982",22,"68.18%","77.27%","B3EWY9","Mucin-like protein","Acropora millepora (Staghorn coral) (Heteropora millepora)","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0007160; GO:0016020"
"1412",1518,556793,"Cluster_2882","Peve_00004535",-0.685614318305549,0.519067344761309,0.978262075707395,159,-22.92,"2 21","391 413",20,"75.00%","75.00%","Q8IUH2","Protein CREG2 (Cellular repressor of E1A-stimulated genes 2)","Homo sapiens (Human)","","GO:0005615; GO:0005783; GO:0005794"
"1413",1519,556819,"Cluster_10934","Peve_00004535",0.714771468328116,0.493061407852877,0.978262075707395,152,-25.58,"2 21","145 169",23,"69.57%","78.26%","Q8IUH2","Protein CREG2 (Cellular repressor of E1A-stimulated genes 2)","Homo sapiens (Human)","","GO:0005615; GO:0005783; GO:0005794"
"1414",1520,557082,"Cluster_8887","Peve_00042114",-0.821901473199095,0.385826733407904,0.978262075707395,166,-21.15,"2 19","560 580",17,"76.47%","88.24%",NA,NA,NA,NA,NA
"1415",1521,557083,"Cluster_8888","Peve_00042114",-0.219753560508399,0.858949346278634,0.995934364227446,166,-21.53,"2 19","560 580",17,"76.47%","88.24%",NA,NA,NA,NA,NA
"1416",1522,557439,"Cluster_7855","Peve_00027243",0.898105383830785,0.289887386474843,0.978262075707395,162,-21.34,"2 21","904 924",19,"68.42%","89.47%","O15439","ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B) (Multidrug resistance-associated protein 4)","Homo sapiens (Human)","bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; leukotriene transport [GO:0071716]; platelet degranulation [GO:0002576]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate transport [GO:0015747]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]","GO:0001409; GO:0002576; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006805; GO:0006855; GO:0008559; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0043225; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359; GO:0150104"
"1417",1523,559650,"Cluster_9149","Peve_00014012",-0.248921835469806,0.839847542860223,0.995934364227446,155,-22.15,"2 12","505 526",10,"100.00%","100.00%","Q6NWH1","DDB1- and CUL4-associated factor 10 (WD repeat-containing protein 32)","Danio rerio (Zebrafish) (Brachydanio rerio)","protein ubiquitination [GO:0016567]","GO:0016567; GO:0080008"
"1418",1524,559717,"Cluster_2854","Peve_00014014",-0.454569832986505,0.699586000630607,0.978262075707395,159,-21.15,"2 20","651 672",18,"66.67%","83.33%",NA,NA,NA,NA,NA
"1419",1525,559807,"Cluster_2854","Peve_00014016",-0.0611524423276255,0.9610448407205,0.999448381576871,161,-24.31,"2 20","721 745",21,"76.19%","80.95%",NA,NA,NA,NA,NA
"1420",1526,560018,"Cluster_11997","Peve_00043240",-0.869456764350561,0.328938074919923,0.978262075707395,175,-20.22,"2 20","944 965",18,"77.78%","94.44%","Q9Y3B9","RRP15-like protein (Ribosomal RNA-processing protein 15)","Homo sapiens (Human)","maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]","GO:0000460; GO:0000470; GO:0030687"
"1421",1527,560505,"Cluster_9149","Peve_00038032",-0.5,0.666666666666667,0.978262075707395,159,-20.78,"2 21","538 561",21,"66.67%","80.95%","Q4U0S5","RNA polymerase II-associated factor 1 homolog (PD2-like protein)","Danio rerio (Zebrafish) (Brachydanio rerio)","heart development [GO:0007507]; histone modification [GO:0016570]; negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription elongation by RNA polymerase II promoter [GO:0006368]","GO:0000122; GO:0000993; GO:0003682; GO:0005634; GO:0006368; GO:0007507; GO:0016570; GO:0016593"
"1422",1528,560832,"Cluster_15726","Peve_00030248",-0.556043854292013,0.624637299932436,0.978262075707395,152,-20.67,"2 21","45 66",19,"57.89%","78.95%",NA,NA,NA,NA,NA
"1423",1529,560930,"Cluster_1167","Peve_00029393",0.999909726776791,0.00855416971793389,0.573710369894872,149,-22.43,"2 20","154 174",18,"72.22%","72.22%","P34992","Neuropeptide Y receptor type 1 (NPY1-R)","Xenopus laevis (African clawed frog)","","GO:0004983; GO:0005886"
"1424",1530,561236,"Cluster_14999","Peve_00030241",-0.982369982532868,0.119718596292839,0.978262075707395,159,-21.66,"2 21","131 157",24,"62.50%","79.17%","O05510","Putative fructokinase (EC 2.7.1.4) (Glucomannan utilization protein E)","Bacillus subtilis (strain 168)","negative regulation of DNA-templated transcription [GO:0045892]; polysaccharide catabolic process [GO:0000272]","GO:0000272; GO:0005524; GO:0008865; GO:0045892; GO:0046872"
"1425",1531,561540,"Cluster_9149","Peve_00000943",-0.5,0.666666666666667,0.978262075707395,143,-20.29,"2 14","949 969",12,"75.00%","91.67%",NA,NA,NA,NA,NA
"1426",1532,561557,"Cluster_589","Peve_00000940",0.775072695353894,0.435426401668339,0.978262075707395,142,-22.27,"2 20","232 258",23,"56.52%","69.57%",NA,NA,NA,NA,NA
"1427",1534,563272,"Cluster_2854","Peve_00002092",-0.877319384588678,0.318659178777617,0.978262075707395,154,-22.4,"2 21","219 242",21,"61.90%","85.71%",NA,NA,NA,NA,NA
"1428",1535,564195,"Cluster_9149","Peve_00028276",-0.0492544744085908,0.968630935409314,0.999448381576871,163,-32.68,"2 21","51 74",21,"71.43%","80.95%","Q66JG5","Transcriptional adapter 3 (ADA3 homolog) (Transcriptional adapter 3-like) (ADA3-like protein)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0005634"
"1429",1536,564579,"Cluster_4079","Peve_00033266",-0.464715410312253,0.692313272777237,0.978262075707395,153,-20.09,"2 19","370 393",19,"73.68%","73.68%",NA,NA,NA,NA,NA
"1430",1537,564615,"Cluster_16738","Peve_00033266",-0.766669688817049,0.443824838822106,0.978262075707395,159,-21.43,"2 21","470 492",20,"75.00%","75.00%",NA,NA,NA,NA,NA
"1431",1538,565745,"Cluster_1167","Peve_00006279",0.972064943316456,0.15082944072742,0.978262075707395,150,-20.6,"2 21","217 237",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"1432",1539,566136,"Cluster_11134","Peve_00019237",0.99895412821558,0.0291187147996283,0.903929377050813,157,-25.17,"2 21","142 163",20,"70.00%","85.00%","P56407","Homeobox protein ceh-9","Caenorhabditis elegans","cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030154"
"1433",1540,566286,"Cluster_2787","Peve_00038795",-0.00382968334855694,0.997561941898757,0.999448381576871,153,-20.38,"2 21","823 847",23,"69.57%","73.91%",NA,NA,NA,NA,NA
"1434",1541,566417,"Cluster_589","Peve_00029639",0.434712674662728,0.713699862974353,0.979794481645986,184,-31.65,"2 21","593 614",19,"84.21%","94.74%",NA,NA,NA,NA,NA
"1435",1542,566651,"Cluster_4115","Peve_00037563",0.175661664283555,0.887587053663191,0.999448381576871,169,-22.8,"2 19","878 901",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"1436",1543,566688,"Cluster_796","Peve_00037560",0.868266917323247,0.330468172694952,0.978262075707395,145,-20.61,"2 18","309 330",16,"68.75%","68.75%",NA,NA,NA,NA,NA
"1437",1544,566760,"Cluster_9149","Peve_00029636",0.945542496005761,0.211064331877459,0.978262075707395,146,-23.88,"2 12","499 521",11,"90.91%","90.91%",NA,NA,NA,NA,NA
"1438",1545,566777,"Cluster_589","Peve_00029630",-0.821308974285692,0.386488415870934,0.978262075707395,158,-22.53,"2 21","450 475",23,"69.57%","78.26%",NA,NA,NA,NA,NA
"1439",1546,567124,"Cluster_10934","Peve_00022625",-0.940841365277286,0.220074042813454,0.978262075707395,166,-23.12,"2 21","863 883",19,"78.95%","84.21%","Q8IUH5","Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Acyltransferase ZDHHC17) (EC 2.3.1.-) (DHHC domain-containing cysteine-rich protein 17) (DHHC17) (Huntingtin yeast partner H) (Huntingtin-interacting protein 14) (HIP-14) (Huntingtin-interacting protein 3) (HIP-3) (Huntingtin-interacting protein H) (Putative MAPK-activating protein PM11) (Putative NF-kappa-B-activating protein 205) (Zinc finger DHHC domain-containing protein 17)","Homo sapiens (Human)","axonogenesis [GO:0007409]; lipoprotein transport [GO:0042953]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein palmitoylation [GO:0018345]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neurotrophin TRK receptor signaling pathway [GO:0051386]","GO:0000139; GO:0005102; GO:0005794; GO:0007409; GO:0016235; GO:0016409; GO:0018230; GO:0018345; GO:0019705; GO:0019706; GO:0030660; GO:0042734; GO:0042802; GO:0042953; GO:0042995; GO:0043123; GO:0043231; GO:0051386; GO:0070372; GO:0140439"
"1440",1547,567169,"Cluster_10934","Peve_00022624",-0.344282420287561,0.776244464491046,0.992655147623631,158,-20.28,"2 21","487 507",19,"73.68%","78.95%","Q29RP8","Histone-lysine N-methyltransferase KMT5B (Lysine-specific methyltransferase 5B) (Suppressor of variegation 4-20 homolog 1) (Su(var)4-20 homolog 1) (Suv4-20h1) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.361)","Bos taurus (Bovine)","chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone H4-K20 dimethylation [GO:0034772]; histone H4-K20 trimethylation [GO:0034773]; muscle organ development [GO:0007517]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]","GO:0003682; GO:0005634; GO:0005694; GO:0006281; GO:0006325; GO:0007517; GO:0018024; GO:0034772; GO:0034773; GO:0042799; GO:0045830; GO:0046872; GO:0140941; GO:0140944; GO:1904047; GO:2001034"
"1441",1548,567267,"Cluster_15726","Peve_00022629",-0.508340446263344,0.660518324492283,0.978262075707395,164,-23.2,"2 21","310 331",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"1442",1549,568307,"Cluster_589","Peve_00000164",-0.733238550296243,0.476015725308107,0.978262075707395,172,-28.36,"2 21","333 354",19,"78.95%","84.21%","Q5VWQ0","Lysine-specific demethylase 9 (KDM9) (EC 1.14.11.-) (Round spermatid basic protein 1)","Homo sapiens (Human)","chromatin organization [GO:0006325]","GO:0005634; GO:0006325; GO:0035575; GO:0046872"
"1443",1550,568334,"Cluster_8988","Peve_00000164",-0.293963717857765,0.810051024821673,0.995934364227446,169,-20.68,"2 20","196 216",18,"83.33%","88.89%","Q5VWQ0","Lysine-specific demethylase 9 (KDM9) (EC 1.14.11.-) (Round spermatid basic protein 1)","Homo sapiens (Human)","chromatin organization [GO:0006325]","GO:0005634; GO:0006325; GO:0035575; GO:0046872"
"1444",1551,568622,"Cluster_589","Peve_00034790",0.775072695353894,0.435426401668339,0.978262075707395,160,-25.3,"2 21","686 707",19,"68.42%","78.95%","Q8N539","Fibrinogen C domain-containing protein 1","Homo sapiens (Human)","cell adhesion [GO:0007155]","GO:0005102; GO:0005615; GO:0007155; GO:0008061; GO:0016020; GO:0046872; GO:0062023"
"1445",1552,569163,"Cluster_796","Peve_00015009",-0.964715981874777,0.169617029015854,0.978262075707395,150,-20.02,"2 21","673 697",22,"68.18%","72.73%",NA,NA,NA,NA,NA
"1446",1553,569170,"Cluster_4080","Peve_00015009",0.818250027103012,0.389888927880395,0.978262075707395,149,-20.42,"2 20","809 838",26,"65.38%","69.23%",NA,NA,NA,NA,NA
"1447",1554,569297,"Cluster_589","Peve_00034799",0.159680919674548,0.897906931664995,0.999448381576871,155,-22.7,"2 12","209 230",10,"100.00%","100.00%","P46023","G-protein coupled receptor GRL101","Lymnaea stagnalis (Great pond snail) (Helix stagnalis)","","GO:0004930; GO:0005886"
"1448",1556,570970,"Cluster_4080","Peve_00001451",0.969617798415894,0.157329617310262,0.978262075707395,175,-20.59,"2 20","694 715",18,"83.33%","88.89%","P01027","Complement C3 (HSE-MSF) [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc); Complement C3 alpha chain; C3a anaphylatoxin; Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2]","Mus musculus (Mouse)","amyloid-beta clearance [GO:0097242]; blood coagulation [GO:0007596]; cell surface receptor signaling pathway involved in cell-cell signaling [GO:1905114]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; complement-dependent cytotoxicity [GO:0097278]; complement-mediated synapse pruning [GO:0150062]; fatty acid metabolic process [GO:0006631]; inflammatory response [GO:0006954]; neuron remodeling [GO:0016322]; opsonization [GO:0008228]; oviduct epithelium development [GO:0035846]; positive regulation of activation of membrane attack complex [GO:0001970]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of apoptotic process in another organism [GO:0044533]; positive regulation of developmental growth [GO:0048639]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of immune response [GO:0050778]; positive regulation of lipid storage [GO:0010884]; positive regulation of opsonization [GO:1903028]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of type IIa hypersensitivity [GO:0001798]; positive regulation of vascular endothelial growth factor production [GO:0010575]; proteolysis [GO:0006508]; regulation of complement activation [GO:0030449]; regulation of complement activation, alternative pathway [GO:0030451]; regulation of triglyceride biosynthetic process [GO:0010866]; response to bacterium [GO:0009617]; vertebrate eye-specific patterning [GO:0150064]","GO:0001798; GO:0001934; GO:0001970; GO:0004866; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0006631; GO:0006954; GO:0006956; GO:0006957; GO:0006958; GO:0007596; GO:0008228; GO:0008289; GO:0009617; GO:0009986; GO:0010575; GO:0010828; GO:0010866; GO:0010884; GO:0016322; GO:0030449; GO:0030451; GO:0031715; GO:0032991; GO:0035846; GO:0044533; GO:0045745; GO:0045766; GO:0048260; GO:0048639; GO:0050766; GO:0050778; GO:0060100; GO:0070374; GO:0097242; GO:0097278; GO:0150062; GO:0150064; GO:1903028; GO:1905114; GO:1905370; GO:2000427"
"1449",1557,571281,"Cluster_2787","Peve_00039724",-0.999918519895221,0.0081268802250093,0.573710369894872,161,-22.45,"2 19","175 197",18,"72.22%","88.89%","Q9Z2L6","Multiple inositol polyphosphate phosphatase 1 (EC 3.1.3.62) (2,3-bisphosphoglycerate 3-phosphatase) (2,3-BPG phosphatase) (EC 3.1.3.80) (Inositol (1,3,4,5)-tetrakisphosphate 3-phosphatase) (Ins(1,3,4,5)P(4) 3-phosphatase)","Mus musculus (Mouse)","","GO:0003993; GO:0005788; GO:0005886; GO:0030351; GO:0030352; GO:0034417; GO:0052745; GO:0052826"
"1450",1558,572907,"Cluster_4629","Peve_00023915",-0.554554668634826,0.625777256211528,0.978262075707395,155,-22.51,"2 20","40 61",18,"66.67%","77.78%",NA,NA,NA,NA,NA
"1451",1559,573639,"Cluster_7855","Peve_00011260",-0.17935137656472,0.885200204296234,0.999448381576871,170,-21.5,"2 21","11 34",21,"76.19%","90.48%",NA,NA,NA,NA,NA
"1452",1560,573761,"Cluster_4115","Peve_00011267",0.167612271903061,0.892788662041347,0.999448381576871,172,-22.03,"2 21","963 984",19,"73.68%","89.47%","Q3T178","Vacuolar protein sorting-associated protein 28 homolog (ESCRT-I complex subunit VPS28)","Bos taurus (Bovine)","negative regulation of protein ubiquitination [GO:0031397]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]","GO:0000813; GO:0005737; GO:0005886; GO:0031397; GO:0031902; GO:0043162; GO:0043328; GO:0044877"
"1453",1561,574191,"Cluster_11134","Peve_00029024",-0.327148337029589,0.787824641632019,0.99535616417183,163,-21.53,"2 21","802 824",20,"75.00%","80.00%","Q5U3S7","Nitric oxide synthase-interacting protein (E3 ubiquitin-protein ligase NOSIP) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase NOSIP)","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0005634; GO:0005737; GO:0061630"
"1454",1562,574417,"Cluster_11135","Peve_00004210",0.844443877729655,0.359862212804899,0.978262075707395,176,-24.57,"2 21","317 338",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"1455",1563,574792,"Cluster_2854","Peve_00010605",-0.99449130451154,0.0668527184470704,0.978262075707395,147,-20.22,"2 21","144 168",22,"59.09%","72.73%",NA,NA,NA,NA,NA
"1456",1564,574876,"Cluster_29","Peve_00010608",0.457231063582339,0.697682478650525,0.978262075707395,154,-20.77,"2 21","43 60",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"1457",1565,574876,"Cluster_29","Peve_00010608",0.457231063582339,0.697682478650525,0.978262075707395,154,-20.77,"2 21","881 898",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"1458",1566,574950,"Cluster_9149","Peve_00010609",0.235990375023797,0.848333231408383,0.995934364227446,155,-21.68,"2 21","258 281",21,"71.43%","71.43%",NA,NA,NA,NA,NA
"1459",1567,575112,"Cluster_4629","Peve_00022350",0.997938030915673,0.0408894104551382,0.909359886114279,160,-21.85,"2 21","166 187",19,"63.16%","84.21%",NA,NA,NA,NA,NA
"1460",1568,575141,"Cluster_14999","Peve_00022350",0.47443735243041,0.685303084188443,0.978262075707395,165,-23.2,"2 20","663 688",22,"77.27%","81.82%",NA,NA,NA,NA,NA
"1461",1569,575146,"Cluster_29","Peve_00017371",-0.509818275471839,0.659425267534668,0.978262075707395,168,-21.57,"2 21","961 982",19,"68.42%","89.47%",NA,NA,NA,NA,NA
"1462",1570,575817,"Cluster_15726","Peve_00035724",-0.342095789924016,0.7777265282258,0.993016088612937,153,-22.94,"2 21","589 608",19,"68.42%","78.95%","Q9FT51","ABC transporter G family member 27 (ABC transporter ABCG.27) (AtABCG27) (Probable white-brown complex homolog protein 28) (AtWBC28)","Arabidopsis thaliana (Mouse-ear cress)","transmembrane transport [GO:0055085]","GO:0005524; GO:0016020; GO:0016887; GO:0042626; GO:0055085; GO:0140359"
"1463",1571,575898,"Cluster_10061","Peve_00020238",-0.711884987609404,0.495683435666353,0.978262075707395,162,-22.02,"2 15","800 821",13,"84.62%","100.00%",NA,NA,NA,NA,NA
"1464",1572,576170,"Cluster_10965","Peve_00020232",0.906359513828093,0.277699847825028,0.978262075707395,151,-21.53,"2 17","849 873",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"1465",1573,576282,"Cluster_4629","Peve_00030532",-0.554554668634826,0.625777256211528,0.978262075707395,143,-20.14,"2 20","451 472",18,"55.56%","72.22%",NA,NA,NA,NA,NA
"1466",1574,577533,"Cluster_796","Peve_00003694",0.898740270652305,0.288966974174018,0.978262075707395,153,-23.1,"2 21","309 330",20,"75.00%","75.00%",NA,NA,NA,NA,NA
"1467",1575,577644,"Cluster_7855","Peve_00003692",0.596986629317498,0.592729062802603,0.978262075707395,173,-22.61,"2 20","939 959",18,"83.33%","94.44%","P54357","Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain)","Drosophila melanogaster (Fruit fly)","actin filament-based movement [GO:0030048]","GO:0005509; GO:0005829; GO:0016460; GO:0017022; GO:0030048; GO:0031475; GO:0031476; GO:0031477; GO:0032036"
"1468",1576,577739,"Cluster_8988","Peve_00014739",0.0860148226113438,0.945173514868548,0.999448381576871,172,-20.76,"2 21","493 514",19,"78.95%","84.21%","Q96KE9","BTB/POZ domain-containing protein 6 (Lens BTB domain protein)","Homo sapiens (Human)","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"1469",1577,578211,"Cluster_2787","Peve_00035962",0.69306532584942,0.512519461358625,0.978262075707395,173,-22.58,"2 18","171 192",16,"87.50%","93.75%",NA,NA,NA,NA,NA
"1470",1578,578462,"Cluster_10060","Peve_00004473",-0.977729743372942,0.134606809370256,0.978262075707395,169,-20.35,"2 20","805 825",18,"77.78%","94.44%",NA,NA,NA,NA,NA
"1471",1579,578642,"Cluster_10060","Peve_00004474",0.61303173531583,0.579899539116826,0.978262075707395,169,-20.35,"2 20","805 825",18,"77.78%","94.44%","Q91YL3","Uridine-cytidine kinase-like 1 (EC 2.7.1.48)","Mus musculus (Mouse)","phosphorylation [GO:0016310]; UMP salvage [GO:0044206]","GO:0004849; GO:0005524; GO:0005634; GO:0005737; GO:0016310; GO:0044206"
"1472",1580,578700,"Cluster_16738","Peve_00024988",-0.822712512850281,0.384919379868032,0.978262075707395,161,-20.14,"2 21","443 462",19,"78.95%","78.95%","Q8L7W2","Nudix hydrolase 8 (AtNUDT8) (EC 3.6.1.-)","Arabidopsis thaliana (Mouse-ear cress)","response to wounding [GO:0009611]","GO:0005829; GO:0009611; GO:0035529; GO:0046872; GO:0047631; GO:0051287"
"1473",1581,578736,"Cluster_11134","Peve_00009957",-0.377728676894172,0.753410417142383,0.988219883885475,151,-20.85,"2 21","764 786",20,"60.00%","80.00%","Q9CZL5","Pterin-4-alpha-carbinolamine dehydratase 2 (PHS 2) (EC 4.2.1.96) (4-alpha-hydroxy-tetrahydropterin dehydratase 2) (DcoH-like protein DCoHm) (Dimerization cofactor of hepatocyte nuclear factor 1 from muscle) (HNF-1-alpha dimerization cofactor)","Mus musculus (Mouse)","positive regulation of DNA-templated transcription [GO:0045893]; tetrahydrobiopterin biosynthetic process [GO:0006729]","GO:0004505; GO:0005634; GO:0005739; GO:0006729; GO:0008124; GO:0042802; GO:0045893"
"1474",1582,579000,"Cluster_9149","Peve_00012294",0.760940937954124,0.449475341541513,0.978262075707395,160,-20.26,"2 21","139 160",19,"73.68%","73.68%","Q5SNQ7","Protein SERAC1 (Serine active site-containing protein 1)","Danio rerio (Zebrafish) (Brachydanio rerio)","phospholipid biosynthetic process [GO:0008654]","GO:0005739; GO:0005783; GO:0008654; GO:0016020"
"1475",1583,579481,"Cluster_6255","Peve_00042097",-0.827452811627608,0.379578195585221,0.978262075707395,180,-21.23,"2 21","894 915",19,"84.21%","89.47%","Q8BH60","Golgi-associated PDZ and coiled-coil motif-containing protein (CFTR-associated ligand) (PDZ protein interacting specifically with TC10) (PIST)","Mus musculus (Mouse)","autophagy [GO:0006914]; negative regulation of anion channel activity [GO:0010360]; negative regulation of protein localization to cell surface [GO:2000009]; protein transport [GO:0015031]; spermatid nucleus differentiation [GO:0007289]","GO:0000139; GO:0005109; GO:0005737; GO:0005794; GO:0005886; GO:0006914; GO:0007289; GO:0008022; GO:0010360; GO:0014069; GO:0015031; GO:0016020; GO:0019905; GO:0030140; GO:0030425; GO:0030695; GO:0032991; GO:0042802; GO:0042803; GO:0044325; GO:0045202; GO:0140313; GO:2000009"
"1476",1584,579800,"Cluster_6914","Peve_00014191",-0.292430023830286,0.811072287249909,0.995934364227446,168,-20.79,"2 18","541 562",17,"82.35%","94.12%","O13024","Inner centromere protein A (XL-INCENP) (xINC) (xIncenp) (Mitotic phosphoprotein 130)","Xenopus laevis (African clawed frog)","chromosome segregation [GO:0007059]; mitotic cytokinesis [GO:0000281]; spindle assembly [GO:0051225]","GO:0000281; GO:0000775; GO:0000776; GO:0005634; GO:0005694; GO:0005721; GO:0005737; GO:0005819; GO:0005874; GO:0007059; GO:0019901; GO:0030496; GO:0032133; GO:0051225"
"1477",1585,580186,"Cluster_29","Peve_00036946",-0.302587475348502,0.804299118143317,0.995934364227446,158,-22.96,"2 21","401 421",19,"68.42%","84.21%","Q502W6","von Willebrand factor A domain-containing protein 3B (VWA domain-containing protein 3B)","Homo sapiens (Human)","","GO:0005654; GO:0005829"
"1478",1586,581436,"Cluster_11134","Peve_00003906",-0.275132236060801,0.822556725320958,0.995934364227446,159,-20.58,"2 21","689 712",21,"66.67%","80.95%","Q63164","Dynein axonemal heavy chain 1 (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1)","Rattus norvegicus (Rat)","cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]; sperm axoneme assembly [GO:0007288]","GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0007288; GO:0008569; GO:0030286; GO:0030317; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060294"
"1479",1587,581875,"Cluster_8634","Peve_00001224",0.851823407894495,0.350993882211662,0.978262075707395,169,-20.11,"2 20","697 720",20,"80.00%","90.00%",NA,NA,NA,NA,NA
"1480",1588,583220,"Cluster_6914","Peve_00007105",0.239786192599533,0.845845315276726,0.995934364227446,171,-21.95,"2 20","968 988",18,"77.78%","88.89%","P0CI65","Nephrocystin-3","Danio rerio (Zebrafish) (Brachydanio rerio)","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"1481",1589,583776,"Cluster_11134","Peve_00037150",-0.686208744379369,0.518547307297524,0.978262075707395,166,-26.77,"2 21","208 228",19,"78.95%","84.21%","Q6ZPV2","Chromatin-remodeling ATPase INO80 (EC 3.6.4.-) (DNA helicase-related INO80 complex homolog 1) (DNA helicase-related protein INO80)","Mus musculus (Mouse)","cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; DNA-templated transcription [GO:0006351]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; spindle assembly [GO:0051225]; telomere maintenance [GO:0000723]; UV-damage excision repair [GO:0070914]","GO:0000070; GO:0000723; GO:0000724; GO:0003677; GO:0003779; GO:0005524; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005874; GO:0006275; GO:0006281; GO:0006282; GO:0006302; GO:0006338; GO:0006351; GO:0008094; GO:0010571; GO:0016604; GO:0016887; GO:0030307; GO:0031011; GO:0033044; GO:0034644; GO:0042393; GO:0043014; GO:0043618; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0051225; GO:0051301; GO:0051726; GO:0060382; GO:0070914; GO:0071479; GO:0140658; GO:1904507; GO:2000045"
"1482",1590,583804,"Cluster_6906","Peve_00043673",-0.686063329690759,0.518674561276582,0.978262075707395,159,-20.7,"2 17","627 650",17,"82.35%","82.35%","Q92051","Carbonic anhydrase (EC 4.2.1.1) (Carbonate dehydratase)","Danio rerio (Zebrafish) (Brachydanio rerio)","carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539]; one-carbon metabolic process [GO:0006730]","GO:0004089; GO:0005737; GO:0006730; GO:0008270; GO:0015670; GO:0016836; GO:0042539"
"1483",1591,583910,"Cluster_10965","Peve_00023852",0.870479314169719,0.327617924992727,0.978262075707395,168,-20.19,"2 21","257 278",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"1484",1592,583927,"Cluster_2854","Peve_00023851",-0.729479702784429,0.479524517526292,0.978262075707395,157,-20.72,"2 20","178 198",18,"77.78%","77.78%",NA,NA,NA,NA,NA
"1485",1593,583975,"Cluster_4080","Peve_00029656",-0.804992017350097,0.404339062205255,0.978262075707395,168,-22.75,"2 19","34 54",17,"82.35%","94.12%","Q8TA86","Retinitis pigmentosa 9 protein (Pim-1-associated protein) (PAP-1)","Homo sapiens (Human)","cognition [GO:0050890]; RNA splicing [GO:0008380]","GO:0003723; GO:0005634; GO:0005785; GO:0008380; GO:0046872; GO:0050890"
"1486",1594,584283,"Cluster_796","Peve_00022188",0.971205427859617,0.153143331780713,0.978262075707395,159,-28.15,"2 20","912 933",18,"66.67%","83.33%","Q9D9H8","Mitochondrial protein C2orf69 homolog","Mus musculus (Mouse)","oxidative phosphorylation [GO:0006119]","GO:0005739; GO:0005759; GO:0006119; GO:0070469"
"1487",1595,584310,"Cluster_9149","Peve_00022188",-0.672032489844692,0.530843024273362,0.978262075707395,152,-23.57,"2 15","827 847",13,"84.62%","92.31%","Q9D9H8","Mitochondrial protein C2orf69 homolog","Mus musculus (Mouse)","oxidative phosphorylation [GO:0006119]","GO:0005739; GO:0005759; GO:0006119; GO:0070469"
"1488",1596,584444,"Cluster_8988","Peve_00027356",0.819808378836323,0.388159818464786,0.978262075707395,159,-20.75,"2 21","242 269",25,"68.00%","72.00%",NA,NA,NA,NA,NA
"1489",1597,584778,"Cluster_796","Peve_00028757",0.623386195356995,0.571512930352965,0.978262075707395,153,-20.43,"2 20","751 771",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"1490",1598,584919,"Cluster_4079","Peve_00028750",-0.638080662980875,0.55945724658873,0.978262075707395,155,-20.88,"2 16","37 58",14,"71.43%","92.86%","Q8R3P7","Clusterin-associated protein 1","Mus musculus (Mouse)","axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; floor plate formation [GO:0021508]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; left/right pattern formation [GO:0060972]; neural tube closure [GO:0001843]; smoothened signaling pathway [GO:0007224]","GO:0001843; GO:0001947; GO:0005654; GO:0005813; GO:0005929; GO:0007224; GO:0021508; GO:0030991; GO:0030992; GO:0035082; GO:0035720; GO:0042073; GO:0043231; GO:0060271; GO:0060972; GO:0097542; GO:0097546"
"1491",1599,586290,"Cluster_9149","Peve_00029406",0.317422868579818,0.794365085697009,0.995934364227446,152,-22.15,"2 18","150 175",20,"70.00%","75.00%","P10950","Acetylserotonin O-methyltransferase (EC 2.1.1.4) (Hydroxyindole O-methyltransferase) (HIOMT)","Bos taurus (Bovine)","aromatic compound biosynthetic process [GO:0019438]; lipid metabolic process [GO:0006629]; melatonin biosynthetic process [GO:0030187]; methylation [GO:0032259]","GO:0006629; GO:0008171; GO:0008757; GO:0017096; GO:0019438; GO:0030187; GO:0032259; GO:0042803"
"1492",1600,586656,"Cluster_11134","Peve_00023321",-0.757469794823491,0.452870605850128,0.978262075707395,162,-21.4,"2 16","965 987",15,"86.67%","93.33%",NA,NA,NA,NA,NA
"1493",1601,588180,"Cluster_9149","Peve_00018356",-0.996444419317323,0.0537006020293112,0.970441005149595,141,-21.21,"2 18","235 254",16,"68.75%","81.25%","Q5U4M5","Mitotic-spindle organizing protein 1 (Mitotic-spindle organizing protein associated with a ring of gamma-tubulin 1)","Xenopus laevis (African clawed frog)","gamma-tubulin complex localization [GO:0033566]","GO:0000931; GO:0005737; GO:0005813; GO:0005819; GO:0033566"
"1494",1602,588471,"Cluster_2787","Peve_00020749",-0.00382968334855694,0.997561941898757,0.999448381576871,160,-20.15,"2 21","21 40",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"1495",1603,588567,"Cluster_4629","Peve_00026741",-0.992718615961777,0.0768716077066333,0.978262075707395,152,-21,"2 17","239 260",15,"66.67%","86.67%","Q03936","Zinc finger protein 92 (Zinc finger protein HTF12)","Homo sapiens (Human)","regulation of DNA-templated transcription [GO:0006355]","GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0008270"
"1496",1604,588873,"Cluster_796","Peve_00006779",-0.716025067293665,0.491919219476014,0.978262075707395,166,-20.03,"2 20","597 620",20,"80.00%","80.00%","Q3ULD5","Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)","Mus musculus (Mouse)","coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]","GO:0002169; GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:0015936; GO:1905202"
"1497",1605,589502,"Cluster_589","Peve_00001193",-0.99919278413099,0.0255810981953082,0.875092164569788,154,-23.1,"2 20","676 698",19,"68.42%","78.95%","P22127","Ras-related protein Rab-10 (ORA1)","Diplobatis ommata (Ocellated electric ray) (Discopyge ommata)","axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; endoplasmic reticulum tubular network organization [GO:0071786]; endosomal transport [GO:0016197]; establishment of neuroblast polarity [GO:0045200]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; polarized epithelial cell differentiation [GO:0030859]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192]","GO:0003924; GO:0005525; GO:0005768; GO:0005789; GO:0005794; GO:0005802; GO:0005929; GO:0006893; GO:0007409; GO:0016192; GO:0016197; GO:0019003; GO:0030670; GO:0030859; GO:0032593; GO:0032869; GO:0043001; GO:0045200; GO:0055037; GO:0055038; GO:0071782; GO:0071786; GO:0072659; GO:0097051; GO:1903361"
"1498",1606,589778,"Cluster_2882","Peve_00039807",-0.938969308815557,0.223564672335958,0.978262075707395,150,-23.69,"2 16","663 685",15,"80.00%","80.00%","Q8R5F3","ADP-ribose glycohydrolase OARD1 (O-acetyl-ADP-ribose deacetylase 1) (EC 3.5.1.-) (Terminal ADP-ribose protein glycohydrolase 1) ([Protein ADP-ribosylglutamate] hydrolase OARD1) (EC 3.2.2.-)","Mus musculus (Mouse)","cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]","GO:0001883; GO:0005654; GO:0005730; GO:0006974; GO:0042278; GO:0051725; GO:0061463; GO:0090734; GO:0140291; GO:0140293"
"1499",1607,589980,"Cluster_9149","Peve_00043437",-0.98227205808179,0.120051605384904,0.978262075707395,164,-26.53,"2 21","484 503",19,"78.95%","89.47%","Q63ZU0","Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]","GO:0004000; GO:0005764; GO:0005886; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0046103; GO:0046936; GO:0060205; GO:0070161"
"1500",1608,590425,"Cluster_8634","Peve_00027830",0.693582432626225,0.512062635803609,0.978262075707395,164,-23.96,"2 21","459 480",19,"73.68%","78.95%","Q4JAI4","Methionine synthase (EC 2.1.1.-) (Homocysteine methyltransferase)","Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770)","methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]","GO:0003871; GO:0008270; GO:0009086; GO:0032259"
"1501",1609,590721,"Cluster_2787","Peve_00012909",0.995563781663665,0.0599877067729693,0.978262075707395,166,-26.16,"2 21","92 112",19,"78.95%","84.21%","P54310","Hormone-sensitive lipase (HSL) (EC 3.1.1.79) (Monoacylglycerol lipase LIPE) (EC 3.1.1.23) (Retinyl ester hydrolase) (REH)","Mus musculus (Mouse)","cellular response to cold [GO:0070417]; cholesterol metabolic process [GO:0008203]; diacylglycerol catabolic process [GO:0046340]; ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042]; long-chain fatty acid catabolic process [GO:0042758]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation at RNA polymerase I promoter [GO:0006361]; triglyceride catabolic process [GO:0019433]","GO:0004771; GO:0004806; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0005901; GO:0006361; GO:0006363; GO:0008203; GO:0016020; GO:0016042; GO:0016788; GO:0017171; GO:0019433; GO:0019901; GO:0033878; GO:0042134; GO:0042758; GO:0046340; GO:0046485; GO:0047372; GO:0047376; GO:0050253; GO:0070417; GO:0102258; GO:0102259"
"1502",1610,591033,"Cluster_796","Peve_00012907",-0.999864535075281,0.0104788458953449,0.635656620419967,156,-20.81,"2 21","643 664",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"1503",1611,591081,"Cluster_2787","Peve_00012906",0.609866629578938,0.582445999555564,0.978262075707395,166,-26.16,"2 21","92 112",19,"78.95%","84.21%","Q6DRI7","ATP-dependent RNA helicase DDX51 (EC 3.6.4.13) (DEAD box protein 51)","Danio rerio (Zebrafish) (Brachydanio rerio)","rRNA processing [GO:0006364]","GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0016887"
"1504",1612,591341,"Cluster_14999","Peve_00001336",0.701492901066659,0.50503441427207,0.978262075707395,165,-22.23,"2 20","60 84",21,"80.95%","80.95%","D8VNT0","Ryncolin-4","Cerberus rynchops (Dog-faced water snake)","","GO:0005576; GO:0090729"
"1505",1613,591520,"Cluster_14500","Peve_00014527",0.689583620610672,0.515587134843221,0.978262075707395,150,-20.22,"2 21","622 650",26,"65.38%","69.23%",NA,NA,NA,NA,NA
"1506",1614,592191,"Cluster_11134","Peve_00011760",0.960811616945192,0.178814350292464,0.978262075707395,171,-21.49,"2 21","122 144",20,"70.00%","95.00%","Q9D855","Cytochrome b-c1 complex subunit 7 (Complex III subunit 7) (Complex III subunit VII) (Ubiquinol-cytochrome c reductase complex 14 kDa protein)","Mus musculus (Mouse)","cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]","GO:0005739; GO:0005743; GO:0005750; GO:0006122; GO:0044877; GO:0045333"
"1507",1615,592392,"Cluster_4629","Peve_00011767",0.288711210884523,0.813546513063266,0.995934364227446,147,-20.18,"2 21","960 983",21,"57.14%","76.19%",NA,NA,NA,NA,NA
"1508",1617,594330,"Cluster_5882","Peve_00012125",0.970922741092274,0.153896891887811,0.978262075707395,150,-21.15,"2 20","151 173",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"1509",1618,594362,"Cluster_589","Peve_00012124",0.342276424937025,0.777604144359717,0.992983198155606,155,-22.86,"2 12","629 650",10,"100.00%","100.00%",NA,NA,NA,NA,NA
"1510",1619,594407,"Cluster_589","Peve_00044762",0.775072695353894,0.435426401668339,0.978262075707395,150,-22.46,"2 21","860 880",19,"68.42%","73.68%","P30532","Neuronal acetylcholine receptor subunit alpha-5","Homo sapiens (Human)","behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]","GO:0005231; GO:0005886; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0015276; GO:0015464; GO:0022848; GO:0030594; GO:0034220; GO:0035094; GO:0035095; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051899; GO:0098691; GO:0098793; GO:0099171; GO:1904315"
"1511",1620,594452,"Cluster_589","Peve_00044763",-0.602856624654093,0.588058183939166,0.978262075707395,151,-23.61,"2 21","431 455",22,"63.64%","72.73%","P26152","Neuronal acetylcholine receptor subunit alpha-5","Gallus gallus (Chicken)","chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]","GO:0004888; GO:0005231; GO:0005886; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0022848; GO:0030594; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051899; GO:1904315"
"1512",1621,594458,"Cluster_2882","Peve_00044763",-0.527453960394567,0.646293443911827,0.978262075707395,166,-21.94,"2 15","136 157",13,"92.31%","100.00%","P26152","Neuronal acetylcholine receptor subunit alpha-5","Gallus gallus (Chicken)","chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]","GO:0004888; GO:0005231; GO:0005886; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0022848; GO:0030594; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051899; GO:1904315"
"1513",1622,594467,"Cluster_6904","Peve_00044763",-0.969612716203791,0.157342842881162,0.978262075707395,144,-20.67,"2 21","13 34",19,"63.16%","63.16%","P26152","Neuronal acetylcholine receptor subunit alpha-5","Gallus gallus (Chicken)","chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]","GO:0004888; GO:0005231; GO:0005886; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0022848; GO:0030594; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051899; GO:1904315"
"1514",1623,596440,"Cluster_4080","Peve_00015697",-0.235777127616489,0.848472931070267,0.995934364227446,184,-27.03,"2 21","778 799",19,"84.21%","94.74%","O57525","Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (EC 1.14.14.32) (17-alpha-hydroxyprogesterone aldolase) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Cytochrome P450c17)","Rana dybowskii (Dybovsky's frog) (Korean brown frog)","steroid biosynthetic process [GO:0006694]","GO:0004508; GO:0005506; GO:0006694; GO:0016020; GO:0020037; GO:0047442"
"1515",1624,596632,"Cluster_7657","Peve_00042424",0.920553680709868,0.255475989398071,0.978262075707395,171,-21.71,"2 21","925 947",20,"75.00%","90.00%",NA,NA,NA,NA,NA
"1516",1625,596633,"Cluster_7658","Peve_00042424",-0.922201503279838,0.25277690261872,0.978262075707395,171,-21.71,"2 21","925 947",20,"75.00%","90.00%",NA,NA,NA,NA,NA
"1517",1627,597619,"Cluster_6906","Peve_00009869",-0.416205553358048,0.726719345684983,0.983558025734099,158,-21.66,"2 17","623 643",15,"86.67%","86.67%",NA,NA,NA,NA,NA
"1518",1628,598240,"Cluster_4080","Peve_00016929",-0.723592846810962,0.484978724323871,0.978262075707395,156,-21.1,"2 18","165 189",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"1519",1629,598374,"Cluster_4079","Peve_00037614",-0.997292545957876,0.0468569161220451,0.939542385262084,169,-28.14,"2 21","495 517",21,"80.95%","85.71%","P41250","Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS) (Glycyl-tRNA synthetase 1)","Homo sapiens (Human)","diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418]","GO:0004081; GO:0004820; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006418; GO:0006426; GO:0015966; GO:0016740; GO:0030141; GO:0030424; GO:0042802; GO:0046983; GO:0070062; GO:0070150"
"1520",1630,599151,"Cluster_7053","Peve_00004159",0.972879435695235,0.148604145468088,0.978262075707395,158,-20.91,"2 21","920 940",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"1521",1631,600036,"Cluster_2787","Peve_00037612",0.914747636840208,0.264778738597391,0.978262075707395,163,-24.01,"2 20","220 241",18,"66.67%","88.89%",NA,NA,NA,NA,NA
"1522",1632,600186,"Cluster_7053","Peve_00009382",-0.599492520986274,0.590738213576683,0.978262075707395,163,-20.78,"2 20","636 657",18,"66.67%","88.89%",NA,NA,NA,NA,NA
"1523",1633,600670,"Cluster_4080","Peve_00031060",-0.126213463533593,0.919435142647328,0.999448381576871,152,-23.94,"2 18","903 925",17,"76.47%","76.47%",NA,NA,NA,NA,NA
"1524",1635,602156,"Cluster_4115","Peve_00028174",0.705031953217496,0.501865271557381,0.978262075707395,149,-20.9,"2 16","83 103",14,"78.57%","85.71%","F1NZI4","Protein-glucosylgalactosylhydroxylysine glucosidase (EC 3.2.1.107) (Acid trehalase-like protein 1)","Gallus gallus (Chicken)","carbohydrate metabolic process [GO:0005975]","GO:0004553; GO:0005829; GO:0005975; GO:0047402"
"1525",1636,602247,"Cluster_4629","Peve_00028170",0.198731790437063,0.872635473486945,0.997476741937264,159,-21.95,"2 20","344 365",18,"66.67%","83.33%",NA,NA,NA,NA,NA
"1526",1637,603356,"Cluster_14999","Peve_00030088",0.34540875583054,0.775480558524101,0.992428970739677,158,-23.45,"2 21","977 1000",21,"71.43%","80.95%",NA,NA,NA,NA,NA
"1527",1638,603591,"Cluster_2787","Peve_00015660",-0.0368483757592716,0.976536283517859,0.999448381576871,166,-24,"2 21","24 47",21,"76.19%","85.71%","Q5F336","Acyl-coenzyme A thioesterase MBLAC2 (Acyl-CoA thioesterase MBLAC2) (EC 3.1.2.2) (Beta-lactamase MBLAC2) (EC 3.5.2.6) (Metallo-beta-lactamase domain-containing protein 2) (Palmitoyl-coenzyme A thioesterase MBLAC2)","Gallus gallus (Chicken)","fatty acid metabolic process [GO:0006631]","GO:0005789; GO:0005886; GO:0006631; GO:0008800; GO:0016290; GO:0046872; GO:0102991"
"1528",1639,604055,"Cluster_6914","Peve_00033570",0.0244174697248888,0.984453810914684,0.999448381576871,171,-21.05,"2 20","3 23",18,"83.33%","83.33%","Q00546","Tenascin-R (TN-R) (Restrictin)","Gallus gallus (Chicken)","cell adhesion [GO:0007155]; neuron projection development [GO:0031175]; regulation of cell adhesion [GO:0030155]","GO:0005615; GO:0007155; GO:0030155; GO:0031175; GO:0062023; GO:0098966"
"1529",1640,604137,"Cluster_4629","Peve_00019325",-0.911276495991633,0.270196064966463,0.978262075707395,168,-27.12,"2 21","941 962",19,"73.68%","84.21%","Q4V8V1","Breast cancer metastasis-suppressor 1-like protein-A","Danio rerio (Zebrafish) (Brachydanio rerio)","histone deacetylation [GO:0016575]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]","GO:0000122; GO:0016575; GO:0030336; GO:0030512; GO:0042826; GO:0070822; GO:1902455; GO:1902459"
"1530",1650,605342,"Cluster_589","Peve_00037053",-0.994525139579148,0.0666469052184108,0.978262075707395,174,-29.96,"2 21","89 109",19,"84.21%","89.47%","Q90XE6","Kruppel-like factor 1 (Erythroid krueppel-like transcription factor) (Kruppel-like factor d)","Danio rerio (Zebrafish) (Brachydanio rerio)","animal organ regeneration [GO:0031100]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell proliferation [GO:0060038]; cell dedifferentiation [GO:0043697]; positive regulation of gene expression [GO:0010628]; primitive erythrocyte differentiation [GO:0060319]; regulation of transcription by RNA polymerase II [GO:0006357]; sarcomere organization [GO:0045214]","GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005829; GO:0006357; GO:0010628; GO:0031100; GO:0043565; GO:0043697; GO:0045214; GO:0046872; GO:0055007; GO:0060038; GO:0060319"
"1531",1651,605705,"Cluster_1167","Peve_00008247",0.996606748965606,0.052459723618107,0.964920539748816,157,-22.05,"2 21","157 176",19,"73.68%","78.95%","C9J069","Apical junction component 1 homolog","Homo sapiens (Human)","cell-cell junction organization [GO:0045216]","GO:0005886; GO:0005912; GO:0005929; GO:0016324; GO:0043296; GO:0045216"
"1532",1652,606292,"Cluster_2854","Peve_00027679",-0.47951108465044,0.681628054977415,0.978262075707395,153,-20.14,"2 20","902 922",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"1533",1653,606432,"Cluster_4629","Peve_00036019",-0.0399503448467998,0.974560050340911,0.999448381576871,164,-22.75,"2 21","743 764",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"1534",1654,607799,"Cluster_8988","Peve_00024329",-0.962266888195009,0.175441198401495,0.978262075707395,167,-23.46,"2 21","191 214",21,"76.19%","80.95%","Q55GC7","Sphingomyelinase phosphodiesterase D (EC 3.1.4.-) (ASM-like phosphodiesterase D)","Dictyostelium discoideum (Social amoeba)","ceramide biosynthetic process [GO:0046513]; sphingomyelin catabolic process [GO:0006685]","GO:0004767; GO:0005576; GO:0006685; GO:0016798; GO:0046513; GO:0046872"
"1535",1655,607970,"Cluster_6914","Peve_00031547",-0.964802999137955,0.169406501028916,0.978262075707395,170,-21.02,"2 20","542 563",19,"84.21%","84.21%",NA,NA,NA,NA,NA
"1536",1656,608222,"Cluster_589","Peve_00021317",-0.84857488557902,0.354922191516103,0.978262075707395,150,-22.3,"2 19","276 298",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"1537",1657,608627,"Cluster_589","Peve_00005365",-0.772512951154495,0.437999010003882,0.978262075707395,151,-20.75,"2 21","668 694",24,"62.50%","70.83%",NA,NA,NA,NA,NA
"1538",1658,608672,"Cluster_589","Peve_00005364",-0.842102258871239,0.3626357408091,0.978262075707395,151,-20.75,"2 21","454 480",24,"62.50%","70.83%","Q54PR9","Counting factor 60","Dictyostelium discoideum (Social amoeba)","dephosphorylation [GO:0016311]; negative regulation of aggregate size involved in sorocarp development [GO:0031158]","GO:0005576; GO:0016311; GO:0016791; GO:0031158"
"1539",1659,608721,"Cluster_2787","Peve_00005367",0.448259530572088,0.704088089354263,0.978262075707395,151,-21.75,"2 21","210 235",23,"60.87%","73.91%","Q04742","Homeobox protein EMX1 (Empty spiracles homolog 1) (Empty spiracles-like protein 1)","Mus musculus (Mouse)","brain development [GO:0007420]; brain morphogenesis [GO:0048854]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex neuron differentiation [GO:0021895]; cerebral cortex regionalization [GO:0021796]; homeostasis of number of cells [GO:0048872]; in utero embryonic development [GO:0001701]; neuroepithelial cell differentiation [GO:0060563]; neuron differentiation [GO:0030182]; neuron projection extension [GO:1990138]; post-embryonic development [GO:0009791]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of transcription by RNA polymerase II [GO:0006357]; response to xenobiotic stimulus [GO:0009410]; telencephalon development [GO:0021537]","GO:0000978; GO:0000981; GO:0001701; GO:0005634; GO:0005694; GO:0005730; GO:0006357; GO:0007417; GO:0007420; GO:0009410; GO:0009791; GO:0021537; GO:0021796; GO:0021895; GO:0021987; GO:0030182; GO:0048854; GO:0048872; GO:0060019; GO:0060563; GO:0070445; GO:1990138; GO:1990837"
"1540",1660,609302,"Cluster_589","Peve_00004932",-0.967909129418905,0.161716439779092,0.978262075707395,151,-20.85,"2 21","209 231",20,"65.00%","75.00%",NA,NA,NA,NA,NA
"1541",1661,609470,"Cluster_10965","Peve_00020957",0.94821731988768,0.205768793210166,0.978262075707395,167,-20.47,"2 21","367 389",20,"75.00%","85.00%","O61967","Protein lap1 (Lethal protein 413)","Caenorhabditis elegans","actin filament-based process [GO:0030029]; adherens junction assembly [GO:0034333]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic digestive tract morphogenesis [GO:0048557]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; protein transport [GO:0015031]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of intermediate filament polymerization or depolymerization [GO:0045108]","GO:0005912; GO:0007043; GO:0007163; GO:0009792; GO:0014069; GO:0015031; GO:0016323; GO:0030029; GO:0030054; GO:0034333; GO:0043113; GO:0045108; GO:0045197; GO:0045199; GO:0048557; GO:0097120; GO:0098609; GO:0098887; GO:0098968"
"1542",1662,610056,"Cluster_11134","Peve_00042194",0.847185403979911,0.356590606760613,0.978262075707395,154,-20.57,"2 21","435 455",19,"63.16%","84.21%","O09012","Peroxisomal targeting signal 1 receptor (PTS1 receptor) (PTS1R) (PTS1-BP) (PXR1P) (Peroxin-5) (Peroxisomal C-terminal targeting signal import receptor) (Peroxisome receptor 1)","Mus musculus (Mouse)","cell development [GO:0048468]; cellular lipid metabolic process [GO:0044255]; cerebral cortex cell migration [GO:0021795]; cerebral cortex neuron differentiation [GO:0021895]; endoplasmic reticulum organization [GO:0007029]; fatty acid beta-oxidation [GO:0006635]; mitochondrial membrane organization [GO:0007006]; mitochondrion organization [GO:0007005]; negative regulation of protein-containing complex assembly [GO:0031333]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; pexophagy [GO:0000425]; positive regulation of multicellular organism growth [GO:0040018]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein import into peroxisome matrix, translocation [GO:0016561]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]; protein tetramerization [GO:0051262]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0000268; GO:0000425; GO:0001764; GO:0005052; GO:0005737; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005794; GO:0005829; GO:0006625; GO:0006635; GO:0007005; GO:0007006; GO:0007029; GO:0007031; GO:0008022; GO:0016020; GO:0016558; GO:0016560; GO:0016561; GO:0016562; GO:0019899; GO:0021795; GO:0021895; GO:0031267; GO:0031333; GO:0032991; GO:0033328; GO:0040018; GO:0044183; GO:0044255; GO:0044721; GO:0045046; GO:0047485; GO:0048468; GO:0050905; GO:0051262; GO:0140597"
"1543",1663,611382,"Cluster_4629","Peve_00027533",0.756155774815714,0.454150427217986,0.978262075707395,160,-20.29,"2 21","870 891",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"1544",1664,611781,"Cluster_2787","Peve_00018844",0.888011478776684,0.304173065688165,0.978262075707395,162,-21.52,"2 20","114 136",19,"78.95%","78.95%","Q9UA35","Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (hfCNT)","Eptatretus stoutii (Pacific hagfish)","","GO:0005337; GO:0005886; GO:0015293"
"1545",1665,611805,"Cluster_9149","Peve_00018844",-0.998768459381639,0.031598325746414,0.903929377050813,148,-22.4,"2 17","795 813",15,"80.00%","80.00%","Q9UA35","Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (hfCNT)","Eptatretus stoutii (Pacific hagfish)","","GO:0005337; GO:0005886; GO:0015293"
"1546",1667,613002,"Cluster_4629","Peve_00040123",-0.518182709424052,0.65321744446548,0.978262075707395,143,-20.14,"2 20","60 81",18,"55.56%","72.22%","P70531","Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase)","Rattus norvegicus (Rat)","cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of protein autophosphorylation [GO:0031952]; regulation of translation at postsynapse [GO:0140245]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]","GO:0002931; GO:0004674; GO:0004686; GO:0005509; GO:0005516; GO:0005524; GO:0014069; GO:0031952; GO:0032869; GO:0043066; GO:0043197; GO:0045182; GO:0045807; GO:0046777; GO:0051965; GO:0061003; GO:0071277; GO:0071320; GO:0071454; GO:0098978; GO:0140245; GO:1990416; GO:1990637"
"1547",1668,613020,"Cluster_9149","Peve_00040123",0.996359479470216,0.0543386326563241,0.972738924996157,145,-21.37,"2 10","88 109",8,"100.00%","100.00%","P70531","Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase)","Rattus norvegicus (Rat)","cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of protein autophosphorylation [GO:0031952]; regulation of translation at postsynapse [GO:0140245]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]","GO:0002931; GO:0004674; GO:0004686; GO:0005509; GO:0005516; GO:0005524; GO:0014069; GO:0031952; GO:0032869; GO:0043066; GO:0043197; GO:0045182; GO:0045807; GO:0046777; GO:0051965; GO:0061003; GO:0071277; GO:0071320; GO:0071454; GO:0098978; GO:0140245; GO:1990416; GO:1990637"
"1548",1669,613383,"Cluster_10061","Peve_00017646",0.227985087066449,0.853572507029262,0.995934364227446,167,-22.29,"2 20","825 846",18,"72.22%","88.89%",NA,NA,NA,NA,NA
"1549",1670,613473,"Cluster_10061","Peve_00017648",0.0571509779095003,0.963596722143584,0.999448381576871,164,-20.45,"2 17","93 114",15,"80.00%","93.33%",NA,NA,NA,NA,NA
"1550",1671,613566,"Cluster_11134","Peve_00013152",-0.0195622829453675,0.987545469442176,0.999448381576871,162,-24.88,"2 20","639 661",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"1551",1672,613588,"Cluster_4735","Peve_00013155",-0.63641618430974,0.560832227504274,0.978262075707395,159,-22.96,"2 17","783 805",16,"81.25%","87.50%","Q92116","Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1)","Stenotomus chrysops (Scup) (Sparus chrysops)","","GO:0005506; GO:0005789; GO:0020037; GO:0070330"
"1552",1674,614788,"Cluster_15890","Peve_00044355",0.960033987429349,0.180591649868319,0.978262075707395,191,-33.4,"2 21","479 501",20,"95.00%","95.00%",NA,NA,NA,NA,NA
"1553",1675,615207,"Cluster_4629","Peve_00000256",0.997938030915672,0.0408894104551393,0.909359886114279,150,-20.58,"2 19","641 662",17,"70.59%","70.59%",NA,NA,NA,NA,NA
"1554",1676,615570,"Cluster_5882","Peve_00008089",-0.090451236380318,0.942338145419759,0.999448381576871,159,-21.45,"2 21","486 508",20,"65.00%","85.00%",NA,NA,NA,NA,NA
"1555",1677,615896,"Cluster_8884","Peve_00038717",-0.947118896471404,0.207959151134339,0.978262075707395,162,-20.42,"2 20","186 207",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"1556",1678,615897,"Cluster_8887","Peve_00038717",-0.821901473199095,0.385826733407904,0.978262075707395,162,-20.31,"2 20","186 207",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"1557",1679,615898,"Cluster_8888","Peve_00038717",-0.219753560508399,0.858949346278634,0.995934364227446,162,-21.94,"2 20","186 207",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"1558",1682,617892,"Cluster_15726","Peve_00001619",-0.665532341813047,0.536409131412529,0.978262075707395,163,-24.21,"2 21","698 721",21,"76.19%","76.19%",NA,NA,NA,NA,NA
"1559",1683,618239,"Cluster_8988","Peve_00003699",0.91025229664013,0.271775107041621,0.978262075707395,173,-24.06,"2 20","564 584",18,"83.33%","94.44%","A7YVD7","NADH dehydrogenase (ubiquinone) complex I, assembly factor 6","Bos taurus (Bovine)","biosynthetic process [GO:0009058]; mitochondrial respiratory chain complex I assembly [GO:0032981]","GO:0005739; GO:0005743; GO:0009058; GO:0032981"
"1560",1684,618992,"Cluster_6904","Peve_00045314",0.327303423177517,0.78772015852628,0.995337676310217,155,-20.16,"2 18","21 41",16,"81.25%","81.25%","Q58A42","Protein DD3-3","Dictyostelium discoideum (Social amoeba)","","GO:0016020"
"1561",1685,619122,"Cluster_4629","Peve_00029925",0.967015480533103,0.163965031291723,0.978262075707395,164,-22.16,"2 21","288 309",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"1562",1686,619157,"Cluster_589","Peve_00029921",-0.176758868988998,0.886877447892646,0.999448381576871,160,-21.75,"2 21","858 879",19,"68.42%","78.95%","P29341","Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1)","Mus musculus (Mouse)","CRD-mediated mRNA stabilization [GO:0070934]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; RNA splicing [GO:0008380]; RNA-mediated gene silencing [GO:0031047]","GO:0000184; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0008022; GO:0008143; GO:0008266; GO:0008380; GO:0010494; GO:0030027; GO:0030425; GO:0031047; GO:0031252; GO:0036464; GO:0045202; GO:0060213; GO:0070934; GO:0071013; GO:0106002; GO:1900152; GO:1900153; GO:1990124; GO:1990904; GO:2000623; GO:2000767"
"1563",1687,619212,"Cluster_4629","Peve_00041675",0.15284058718367,0.90231579107666,0.999448381576871,159,-24.52,"2 21","63 85",20,"70.00%","80.00%","P34897","Serine hydroxymethyltransferase, mitochondrial (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)","Homo sapiens (Human)","folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell population proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; purine nucleobase biosynthetic process [GO:0009113]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]","GO:0000900; GO:0002082; GO:0003682; GO:0004372; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0005829; GO:0006544; GO:0006563; GO:0006564; GO:0006565; GO:0006730; GO:0008270; GO:0008284; GO:0008732; GO:0009113; GO:0015630; GO:0019264; GO:0030170; GO:0034340; GO:0035999; GO:0042645; GO:0042803; GO:0046653; GO:0046655; GO:0048027; GO:0051262; GO:0051289; GO:0070062; GO:0070129; GO:0070536; GO:0070552; GO:0070905; GO:1903715"
"1564",1688,619667,"Cluster_6904","Peve_00030160",-0.951310992493219,0.199475076059675,0.978262075707395,149,-22.29,"2 17","365 384",15,"73.33%","86.67%",NA,NA,NA,NA,NA
"1565",1689,619669,"Cluster_6906","Peve_00030160",-0.686063329690759,0.518674561276582,0.978262075707395,145,-20.27,"2 17","365 384",15,"66.67%","86.67%",NA,NA,NA,NA,NA
"1566",1690,620187,"Cluster_15726","Peve_00007613",0.999883443510219,0.00972002918842882,0.612877211000455,157,-20.89,"2 15","292 315",15,"86.67%","86.67%","P28175","Clotting factor C (FC) (EC 3.4.21.84) (Limulus factor C) [Cleaved into: Clotting factor C heavy chain; Clotting factor C light chain; Clotting factor C chain A; Clotting factor C chain B]","Tachypleus tridentatus (Japanese horseshoe crab)","cell adhesion [GO:0007155]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]","GO:0004252; GO:0005576; GO:0007155; GO:0016485; GO:0030246; GO:0042381"
"1567",1691,620287,"Cluster_2854","Peve_00007610",-0.587317698924066,0.60036784304043,0.978262075707395,164,-22.78,"2 17","85 106",15,"86.67%","86.67%",NA,NA,NA,NA,NA
"1568",1692,620681,"Cluster_14999","Peve_00023998",-0.919206911354979,0.257662090986608,0.978262075707395,151,-22.71,"2 21","575 603",26,"61.54%","69.23%","E7FAM5","E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","Danio rerio (Zebrafish) (Brachydanio rerio)","embryonic body morphogenesis [GO:0010172]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0010172; GO:0010586; GO:0017148; GO:0021915; GO:0030371; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061630; GO:0072089; GO:2000177"
"1569",1694,621912,"Cluster_4629","Peve_00026869",-0.695734672392516,0.510157888332157,0.978262075707395,150,-20.69,"2 21","845 870",23,"60.87%","78.26%",NA,NA,NA,NA,NA
"1570",1695,621958,"Cluster_4735","Peve_00026868",-0.743080770610535,0.466727606081079,0.978262075707395,156,-26.3,"2 21","182 202",20,"75.00%","80.00%",NA,NA,NA,NA,NA
"1571",1696,622808,"Cluster_2882","Peve_00022341",-0.76282004474673,0.447628427608456,0.978262075707395,160,-22.51,"2 17","884 905",15,"80.00%","86.67%",NA,NA,NA,NA,NA
"1572",1697,622882,"Cluster_11135","Peve_00022342",0.999706721854346,0.0154186228806241,0.751144232060475,153,-21.16,"2 21","882 905",22,"68.18%","77.27%",NA,NA,NA,NA,NA
"1573",1698,623177,"Cluster_6904","Peve_00022349",0.742592842212241,0.467191590606991,0.978262075707395,156,-25.79,"2 20","757 780",21,"71.43%","80.95%",NA,NA,NA,NA,NA
"1574",1699,623179,"Cluster_6906","Peve_00022349",0.973101367926095,0.147992105390085,0.978262075707395,152,-23.77,"2 20","757 780",21,"66.67%","80.95%",NA,NA,NA,NA,NA
"1575",1700,623331,"Cluster_11134","Peve_00009929",0.872530937901588,0.324954486064203,0.978262075707395,158,-28.46,"2 20","155 178",20,"70.00%","80.00%","P49706","G1/S-specific cyclin-D2","Gallus gallus (Chicken)","cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]","GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0016538; GO:0031965; GO:0044772; GO:0051301; GO:1900087"
"1576",1701,623888,"Cluster_2882","Peve_00027735",0.690475629329983,0.514802546101834,0.978262075707395,164,-20.83,"2 21","193 214",19,"73.68%","78.95%","Q5XJ56","tRNA-uridine aminocarboxypropyltransferase 1 (EC 2.5.1.25) (DTW domain-containing protein 1)","Danio rerio (Zebrafish) (Brachydanio rerio)","tRNA modification [GO:0006400]","GO:0005634; GO:0006400; GO:0016432"
"1577",1702,624155,"Cluster_1167","Peve_00024422",-0.511591173923624,0.65811249694873,0.978262075707395,150,-21.55,"2 20","406 423",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"1578",1703,624495,"Cluster_9149","Peve_00010682",0.977226860205871,0.136123851030647,0.978262075707395,147,-23.75,"2 12","118 139",10,"80.00%","100.00%",NA,NA,NA,NA,NA
"1579",1704,625593,"Cluster_796","Peve_00012296",0.79685941231669,0.412986263772751,0.978262075707395,162,-20.54,"2 21","22 42",19,"78.95%","78.95%","B8V7S0","CUB and peptidase domain-containing protein 1","Acropora millepora (Staghorn coral) (Heteropora millepora)","proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508"
"1580",1705,625935,"Cluster_9149","Peve_00044115",-0.69954493572172,0.506772160856215,0.978262075707395,152,-22.9,"2 18","101 124",18,"72.22%","77.78%","Q95029","Cathepsin L (EC 3.4.22.15) (Cysteine proteinase 1) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain]","Drosophila melanogaster (Fruit fly)","digestion [GO:0007586]; immune response [GO:0006955]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]","GO:0004197; GO:0005615; GO:0005764; GO:0006508; GO:0006955; GO:0007586; GO:0008233; GO:0008234; GO:0045169; GO:0051603"
"1581",1706,626116,"Cluster_9983","Peve_00044110",0.889670545505238,0.301868034010365,0.978262075707395,173,-24.24,"2 20","591 613",20,"85.00%","90.00%","Q95029","Cathepsin L (EC 3.4.22.15) (Cysteine proteinase 1) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain]","Drosophila melanogaster (Fruit fly)","digestion [GO:0007586]; immune response [GO:0006955]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]","GO:0004197; GO:0005615; GO:0005764; GO:0006508; GO:0006955; GO:0007586; GO:0008233; GO:0008234; GO:0045169; GO:0051603"
"1582",1707,626133,"Cluster_796","Peve_00044113",-0.219818869135935,0.858906727400838,0.995934364227446,155,-23.83,"2 21","438 460",20,"65.00%","80.00%","Q95029","Cathepsin L (EC 3.4.22.15) (Cysteine proteinase 1) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain]","Drosophila melanogaster (Fruit fly)","digestion [GO:0007586]; immune response [GO:0006955]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]","GO:0004197; GO:0005615; GO:0005764; GO:0006508; GO:0006955; GO:0007586; GO:0008233; GO:0008234; GO:0045169; GO:0051603"
"1583",1710,626945,"Cluster_1167","Peve_00041549",0.916495796184145,0.262010544197132,0.978262075707395,146,-26.18,"2 20","360 382",19,"57.89%","78.95%",NA,NA,NA,NA,NA
"1584",1711,627407,"Cluster_6904","Peve_00010911",-0.612099324712498,0.580650521211597,0.978262075707395,149,-20.54,"2 18","627 648",16,"68.75%","75.00%","Q2T9Y1","Uncharacterized protein C3orf26 homolog","Bos taurus (Bovine)","",""
"1585",1712,627980,"Cluster_1167","Peve_00026456",0.815084599919971,0.393380802273466,0.978262075707395,163,-20.53,"2 20","520 541",18,"77.78%","77.78%","Q13507","Short transient receptor potential channel 3 (TrpC3) (Transient receptor protein 3) (TRP-3) (hTrp-3) (hTrp3)","Homo sapiens (Human)","calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; phototransduction [GO:0007602]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to ATP [GO:0033198]; response to calcium ion [GO:0051592]; single fertilization [GO:0007338]","GO:0005262; GO:0005886; GO:0006816; GO:0007338; GO:0007602; GO:0010524; GO:0015279; GO:0033198; GO:0034703; GO:0046872; GO:0051480; GO:0051592; GO:0070588; GO:0070679; GO:1903244"
"1586",1713,628091,"Cluster_8884","Peve_00026451",0.477195964324231,0.683306382202059,0.978262075707395,162,-20.04,"2 20","563 585",20,"75.00%","80.00%","A5PMU4","Ankyrin repeat and sterile alpha motif domain-containing protein 1B","Danio rerio (Zebrafish) (Brachydanio rerio)","ephrin receptor signaling pathway [GO:0048013]","GO:0005829; GO:0046875; GO:0048013"
"1587",1714,628521,"Cluster_2787","Peve_00015247",0.87677834615342,0.319376154473195,0.978262075707395,157,-22.14,"2 21","20 39",19,"73.68%","78.95%","P24140","UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase (EC 2.7.8.15) (GlcNAc-1-P transferase) (G1PT) (GPT) (N-acetylglucosamine-1-phosphate transferase)","Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)","dolichol biosynthetic process [GO:0019408]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]","GO:0003975; GO:0003976; GO:0005789; GO:0006488; GO:0016020; GO:0016757; GO:0019408; GO:0042802; GO:0046872"
"1588",1715,629659,"Cluster_6906","Peve_00003981",0.580198122736081,0.60595023618938,0.978262075707395,154,-21.28,"2 18","551 570",16,"81.25%","81.25%","A0JM24","NADP-dependent oxidoreductase domain-containing protein 1 (EC 1.-.-.-) (Pyrroline-5-carboxylate reductase-like protein C14orf148 homolog)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0016491"
"1589",1716,630979,"Cluster_10934","Peve_00014802",-0.54252386368012,0.634937610918508,0.978262075707395,154,-20.55,"2 21","45 62",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"1590",1717,631024,"Cluster_10934","Peve_00014801",-0.903427868199287,0.282084791908959,0.978262075707395,154,-20.55,"2 21","45 62",19,"78.95%","78.95%","M9NDE3","Protein bark beetle (Protein anakonda)","Drosophila melanogaster (Fruit fly)","cell-cell junction maintenance [GO:0045217]; liquid clearance, open tracheal system [GO:0035002]; regulation of tube length, open tracheal system [GO:0035159]; response to endoplasmic reticulum stress [GO:0034976]; tricellular tight junction assembly [GO:1904274]","GO:0005044; GO:0005912; GO:0005918; GO:0005923; GO:0016328; GO:0030246; GO:0034976; GO:0035002; GO:0035159; GO:0045217; GO:0061689; GO:1904274"
"1591",1718,631137,"Cluster_4629","Peve_00014805",0.970736051924438,0.1543925732283,0.978262075707395,167,-26.37,"2 21","523 547",22,"72.73%","81.82%","O34363","Putative L-amino-acid oxidase YobN (EC 1.4.3.2)","Bacillus subtilis (strain 168)","amino acid catabolic process [GO:0009063]","GO:0001716; GO:0009063; GO:0016491; GO:0046592"
"1592",1720,632110,"Cluster_14500","Peve_00040083",0.919760399174369,0.256765788542317,0.978262075707395,168,-20.75,"2 17","28 49",15,"86.67%","93.33%",NA,NA,NA,NA,NA
"1593",1722,633546,"Cluster_11134","Peve_00006851",-0.638888447353719,0.558789070350425,0.978262075707395,156,-20.03,"2 19","864 884",17,"76.47%","82.35%","Q9R1S4","X-box-binding protein 1 (Hepatocarcinogenesis-related transcription factor) (HTF) [Cleaved into: X-box-binding protein 1, cytoplasmic form; X-box-binding protein 1, luminal form]","Rattus norvegicus (Rat)","adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to fluid shear stress [GO:0071498]; cellular response to fructose stimulus [GO:0071332]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-4 [GO:0071353]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nutrient [GO:0031670]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; DNA-templated transcription [GO:0006351]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; epithelial cell maturation [GO:0002070]; epithelial cell maturation involved in salivary gland development [GO:0060691]; exocrine pancreas development [GO:0031017]; fatty acid homeostasis [GO:0055089]; glandular epithelial cell maturation [GO:0002071]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; liver development [GO:0001889]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of myotube differentiation [GO:0010832]; neuron development [GO:0048666]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lactation [GO:1903489]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of plasma cell differentiation [GO:1900100]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response [GO:0006990]; positive regulation of vascular wound healing [GO:0035470]; protein destabilization [GO:0031648]; regulation of autophagy [GO:0010506]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to electrical stimulus [GO:0051602]; response to endoplasmic reticulum stress [GO:0034976]; response to insulin-like growth factor stimulus [GO:1990418]; response to xenobiotic stimulus [GO:0009410]; serotonin secretion, neurotransmission [GO:0060096]; sterol homeostasis [GO:0055092]; transcription by RNA polymerase II [GO:0006366]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001525; GO:0001889; GO:0001935; GO:0002070; GO:0002071; GO:0002639; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0006351; GO:0006355; GO:0006357; GO:0006366; GO:0006511; GO:0006990; GO:0007517; GO:0008284; GO:0009410; GO:0010506; GO:0010832; GO:0030335; GO:0030968; GO:0031017; GO:0031490; GO:0031648; GO:0031670; GO:0032755; GO:0032869; GO:0034976; GO:0035356; GO:0035470; GO:0035924; GO:0036312; GO:0042149; GO:0042632; GO:0042802; GO:0042826; GO:0043066; GO:0043565; GO:0044389; GO:0045348; GO:0045579; GO:0045582; GO:0045600; GO:0045766; GO:0045944; GO:0046982; GO:0048666; GO:0051602; GO:0055089; GO:0055092; GO:0060096; GO:0060612; GO:0060691; GO:0070059; GO:0071222; GO:0071230; GO:0071236; GO:0071332; GO:0071333; GO:0071353; GO:0071375; GO:0071498; GO:0071499; GO:0090575; GO:0098793; GO:1900100; GO:1900103; GO:1902236; GO:1903489; GO:1990418; GO:1990830; GO:1990837; GO:2000347"
"1594",1723,633657,"Cluster_4629","Peve_00006859",-0.562935866415593,0.619343593115557,0.978262075707395,153,-20.4,"2 15","247 269",14,"85.71%","85.71%","P22727","Protein Wnt-6","Mus musculus (Mouse)","animal organ morphogenesis [GO:0009887]; axis specification [GO:0009798]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; epithelial-mesenchymal cell signaling [GO:0060684]; nephron tubule development [GO:0072080]; nephron tubule formation [GO:0072079]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of tooth mineralization [GO:0070172]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]","GO:0001658; GO:0005102; GO:0005109; GO:0005125; GO:0005615; GO:0005788; GO:0007165; GO:0007267; GO:0009798; GO:0009887; GO:0009986; GO:0010628; GO:0016055; GO:0030182; GO:0031012; GO:0042475; GO:0045165; GO:0045893; GO:0060070; GO:0060684; GO:0070172; GO:0072079; GO:0072080"
"1595",1724,633849,"Cluster_7855","Peve_00032856",0.899618889669603,0.287688698711506,0.978262075707395,179,-22.95,"2 21","473 495",20,"85.00%","90.00%","O15254","Peroxisomal acyl-coenzyme A oxidase 3 (EC 1.3.3.6) (Branched-chain acyl-CoA oxidase) (BRCACox) (Pristanoyl-CoA oxidase)","Homo sapiens (Human)","fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]","GO:0003997; GO:0005504; GO:0005777; GO:0005782; GO:0005829; GO:0016020; GO:0016402; GO:0033540; GO:0050660; GO:0055088; GO:0071949"
"1596",1725,634640,"Cluster_1167","Peve_00008656",0.641393154644361,0.556713531700172,0.978262075707395,156,-25.18,"2 21","545 566",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"1597",1726,634710,"Cluster_9149","Peve_00032273",0.0510142342399207,0.967509226791935,0.999448381576871,153,-20.27,"2 14","859 880",12,"75.00%","100.00%",NA,NA,NA,NA,NA
"1598",1727,635105,"Cluster_6914","Peve_00007893",-0.723872236352323,0.484720979190408,0.978262075707395,157,-20.3,"2 20","120 139",18,"77.78%","77.78%","Q8TEB9","Rhomboid-related protein 4 (RRP4) (EC 3.4.21.105) (Rhomboid domain-containing protein 1) (Rhomboid-like protein 4)","Homo sapiens (Human)","apoptotic process [GO:0006915]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; ERAD pathway [GO:0036503]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein processing [GO:0010954]; positive regulation of secretion [GO:0051047]; post-translational protein modification [GO:0043687]; spermatid differentiation [GO:0048515]","GO:0004175; GO:0004252; GO:0005783; GO:0005789; GO:0006915; GO:0010954; GO:0031293; GO:0031966; GO:0033619; GO:0034620; GO:0034644; GO:0036503; GO:0043066; GO:0043687; GO:0044322; GO:0045732; GO:0048515; GO:0051047; GO:1904211"
"1599",1728,635997,"Cluster_4629","Peve_00037733",0.828788088522562,0.378061711961277,0.978262075707395,157,-22.26,"2 21","65 86",20,"70.00%","85.00%",NA,NA,NA,NA,NA
"1600",1729,636027,"Cluster_15726","Peve_00037733",-0.869024758141174,0.329494365160528,0.978262075707395,149,-25.55,"2 19","450 478",24,"66.67%","66.67%",NA,NA,NA,NA,NA
"1601",1730,636078,"Cluster_796","Peve_00000048",0.841139757993062,0.363770314781968,0.978262075707395,146,-20.07,"2 19","375 396",17,"64.71%","70.59%","P16065","Speract receptor (EC 4.6.1.2) (Guanylate cyclase)","Strongylocentrotus purpuratus (Purple sea urchin)","cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]","GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0006468; GO:0007165; GO:0007168; GO:0035556"
"1602",1731,636696,"Cluster_11134","Peve_00008548",0.865857273297574,0.333547341418641,0.978262075707395,154,-20.88,"2 20","869 892",20,"70.00%","75.00%",NA,NA,NA,NA,NA
"1603",1732,636697,"Cluster_11135","Peve_00008548",0.0217700524956066,0.986139659171566,0.999448381576871,157,-21.55,"2 18","229 250",16,"75.00%","81.25%",NA,NA,NA,NA,NA
"1604",1733,636742,"Cluster_11135","Peve_00031772",0.844443877729655,0.359862212804899,0.978262075707395,163,-22.29,"2 21","872 894",20,"75.00%","80.00%","A2VE52","Oligoribonuclease, mitochondrial (EC 3.1.15.-) (RNA exonuclease 2 homolog) (Small fragment nuclease)","Bos taurus (Bovine)","","GO:0000175; GO:0000287; GO:0003676; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005925; GO:0008296; GO:0008408"
"1605",1734,636894,"Cluster_4079","Peve_00031779",-0.208019844359599,0.866596274946242,0.996724421549243,179,-31.42,"2 20","470 491",18,"77.78%","100.00%","Q4V8X0","Transmembrane protein adipocyte-associated 1 homolog (Integral membrane protein GPR175)","Danio rerio (Zebrafish) (Brachydanio rerio)","G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007186"
"1606",1735,637731,"Cluster_11134","Peve_00019468",0.281389499027548,0.818409423735157,0.995934364227446,159,-21.94,"2 21","576 598",20,"65.00%","85.00%","B3EWZ6","MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576; GO:0016020"
"1607",1736,638261,"Cluster_8884","Peve_00033554",-0.670557741692071,0.532109709137357,0.978262075707395,149,-21.67,"2 19","691 717",23,"65.22%","69.57%","Q8VDR5","Transmembrane protein 267","Mus musculus (Mouse)","","GO:0016020"
"1608",1737,638262,"Cluster_8887","Peve_00033554",-0.849139582305531,0.354242126863792,0.978262075707395,149,-21.67,"2 19","691 717",23,"65.22%","69.57%","Q8VDR5","Transmembrane protein 267","Mus musculus (Mouse)","","GO:0016020"
"1609",1738,638456,"Cluster_14999","Peve_00025579",-0.85361578313536,0.348809474788265,0.978262075707395,159,-21.74,"2 21","745 768",21,"71.43%","76.19%","Q6DDT4",NA,NA,NA,NA
"1610",1739,638739,"Cluster_4079","Peve_00025574",-0.787702800207363,0.422540557088504,0.978262075707395,153,-20.67,"2 19","797 820",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"1611",1740,639531,"Cluster_11134","Peve_00030827",-0.298926150269215,0.806743148428903,0.995934364227446,164,-24.46,"2 21","485 506",19,"73.68%","78.95%","P56695","Wolframin","Mus musculus (Mouse)","calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; nervous system process [GO:0050877]; olfactory behavior [GO:0042048]; pancreas development [GO:0031016]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; ubiquitin-dependent ERAD pathway [GO:0030433]; visual perception [GO:0007601]","GO:0000122; GO:0001822; GO:0003091; GO:0005516; GO:0005783; GO:0005789; GO:0007601; GO:0007605; GO:0017148; GO:0030141; GO:0030425; GO:0030433; GO:0030672; GO:0030968; GO:0031016; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042048; GO:0042593; GO:0043066; GO:0043069; GO:0043433; GO:0043524; GO:0045182; GO:0045927; GO:0048306; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:0070628; GO:0140297; GO:1902236; GO:1903573; GO:1903892; GO:1904294; GO:2000675"
"1612",1741,640721,"Cluster_4115","Peve_00018206",0.596872408715347,0.592819696813187,0.978262075707395,172,-22.56,"2 21","902 921",19,"89.47%","89.47%",NA,NA,NA,NA,NA
"1613",1742,640785,"Cluster_9149","Peve_00018207",-0.969838725227652,0.156753637279836,0.978262075707395,158,-21.37,"2 21","266 286",19,"73.68%","78.95%","Q5PPZ9","Rap1 GTPase-GDP dissociation stimulator 1-B (Rap1gds1-B protein) (RalB-binding protein B) (XsmgGDS-B) (smgGDS-B)","Xenopus laevis (African clawed frog)","positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]","GO:0005085; GO:0005096; GO:0005739; GO:0005783; GO:0005829; GO:0007264; GO:0031267; GO:0043547"
"1614",1743,641368,"Cluster_8888","Peve_00021474",-0.910689512519935,0.27110209311329,0.978262075707395,165,-21.03,"2 19","78 102",21,"76.19%","80.95%",NA,NA,NA,NA,NA
"1615",1744,641720,"Cluster_6914","Peve_00007426",0.173815298717639,0.888780853429927,0.999448381576871,153,-20.31,"2 20","219 244",23,"69.57%","73.91%","Q9US04","Glutathione hydrolase proenzyme 1 (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (EC 2.3.2.2) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]","Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)","cellular detoxification [GO:1990748]; glutathione catabolic process [GO:0006751]; proteolysis [GO:0006508]","GO:0000324; GO:0005783; GO:0005789; GO:0005886; GO:0006508; GO:0006751; GO:0036374; GO:0102953; GO:0103068; GO:1990748"
"1616",1745,642371,"Cluster_14999","Peve_00008950",0.525134194156591,0.64803024914489,0.978262075707395,166,-21.97,"2 20","859 881",19,"73.68%","89.47%","P97292","Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I)","Mus musculus (Mouse)","chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonic acid secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; toxin transport [GO:1901998]; visual learning [GO:0008542]","GO:0001696; GO:0001697; GO:0001698; GO:0003382; GO:0004969; GO:0004993; GO:0005886; GO:0007187; GO:0007268; GO:0007613; GO:0008542; GO:0016020; GO:0030425; GO:0030594; GO:0045202; GO:0045907; GO:0048167; GO:0048565; GO:0048732; GO:1900139; GO:1901363; GO:1901998"
"1617",1746,642376,"Cluster_29","Peve_00008953",-0.62077240343352,0.573638206347232,0.978262075707395,157,-21.51,"2 20","932 955",20,"75.00%","80.00%","Q1T7B7","Centromere protein P (CENP-P)","Gallus gallus (Chicken)","CENP-A containing chromatin assembly [GO:0034080]","GO:0000775; GO:0005634; GO:0034080"
"1618",1747,642494,"Cluster_8988","Peve_00008955",0.81013240015686,0.398790341259968,0.978262075707395,167,-22.02,"2 21","235 257",20,"70.00%","90.00%","Q66KC4","Hydroxysteroid dehydrogenase-like protein 2 (EC 1.-.-.-)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0005777; GO:0016491"
"1619",1748,643232,"Cluster_589","Peve_00011452",-0.94978418877363,0.202604785764173,0.978262075707395,160,-25.85,"2 21","691 712",19,"68.42%","78.95%","Q9IA76","60S ribosomal protein L31","Paralichthys olivaceus (Bastard halibut) (Hippoglossus olivaceus)","translation [GO:0006412]","GO:0003735; GO:0005737; GO:0005840; GO:0006412; GO:1990904"
"1620",1749,643759,"Cluster_10934","Peve_00017855",-0.918124484311509,0.259406484926531,0.978262075707395,158,-22.72,"2 21","402 422",19,"68.42%","84.21%","Q6DED0","Translocating chain-associated membrane protein 1-like 1","Xenopus laevis (African clawed frog)","SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]","GO:0005789; GO:0006616"
"1621",1750,643845,"Cluster_9149","Peve_00017857",-0.473691628001625,0.685842264503463,0.978262075707395,158,-22.36,"2 19","843 864",17,"76.47%","76.47%",NA,NA,NA,NA,NA
"1622",1751,643968,"Cluster_6905","Peve_00013342",-0.929945104908788,0.239708228175045,0.978262075707395,159,-26.62,"2 21","7 30",21,"66.67%","80.95%",NA,NA,NA,NA,NA
"1623",1752,644141,"Cluster_4115","Peve_00013347",0.783271532591398,0.427098915892661,0.978262075707395,165,-23.21,"2 18","280 301",16,"81.25%","87.50%",NA,NA,NA,NA,NA
"1624",1753,644417,"Cluster_6904","Peve_00014436",-0.999185657644639,0.0256937863850763,0.876505990190277,167,-27.12,"2 21","703 725",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"1625",1754,644419,"Cluster_6906","Peve_00014436",-0.856803977596318,0.344893271601986,0.978262075707395,167,-25.6,"2 21","703 725",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"1626",1755,644855,"Cluster_1167","Peve_00010496",0.731638242442794,0.477512110187888,0.978262075707395,152,-23.72,"2 13","322 343",11,"90.91%","90.91%","Q9EQS5","Lathosterol oxidase (EC 1.14.19.20) (C-5 sterol desaturase) (Delta(7)-sterol 5-desaturase) (Delta(7)-sterol C5(6)-desaturase) (Lathosterol 5-desaturase) (Sterol-C5-desaturase)","Rattus norvegicus (Rat)","cholesterol biosynthetic process via lathosterol [GO:0033490]; fatty acid metabolic process [GO:0006631]; sterol biosynthetic process [GO:0016126]","GO:0000248; GO:0005506; GO:0005789; GO:0006631; GO:0016020; GO:0016126; GO:0016491; GO:0033490; GO:0043231; GO:0050046"
"1627",1756,644884,"Cluster_10934","Peve_00010496",-0.944893788313833,0.212329442509,0.978262075707395,143,-23.11,"2 21","906 930",22,"54.55%","72.73%","Q9EQS5","Lathosterol oxidase (EC 1.14.19.20) (C-5 sterol desaturase) (Delta(7)-sterol 5-desaturase) (Delta(7)-sterol C5(6)-desaturase) (Lathosterol 5-desaturase) (Sterol-C5-desaturase)","Rattus norvegicus (Rat)","cholesterol biosynthetic process via lathosterol [GO:0033490]; fatty acid metabolic process [GO:0006631]; sterol biosynthetic process [GO:0016126]","GO:0000248; GO:0005506; GO:0005789; GO:0006631; GO:0016020; GO:0016126; GO:0016491; GO:0033490; GO:0043231; GO:0050046"
"1628",1757,645696,"Cluster_11134","Peve_00044836",0.131862100783307,0.91580878586775,0.999448381576871,160,-27.92,"2 17","89 110",15,"73.33%","93.33%",NA,NA,NA,NA,NA
"1629",1758,645787,"Cluster_11135","Peve_00020464",-0.973319480959132,0.14738816647481,0.978262075707395,148,-20.01,"2 18","10 34",19,"63.16%","78.95%","Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"1630",1759,645978,"Cluster_796","Peve_00044834",0.141583939925119,0.909560973352036,0.999448381576871,150,-20.61,"2 17","831 854",17,"76.47%","82.35%","Q8IXF0","Neuronal PAS domain-containing protein 3 (Neuronal PAS3) (Basic-helix-loop-helix-PAS protein MOP6) (Class E basic helix-loop-helix protein 12) (bHLHe12) (Member of PAS protein 6) (PAS domain-containing protein 6)","Homo sapiens (Human)","positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000785; GO:0000977; GO:0000981; GO:0005654; GO:0006357; GO:0045893; GO:0046982"
"1631",1760,646070,"Cluster_1167","Peve_00020468",0.93313433565581,0.234124507187096,0.978262075707395,155,-21.86,"2 16","752 773",14,"78.57%","85.71%","Q9Y5X5","Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor)","Homo sapiens (Human)","detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]","GO:0004930; GO:0005886; GO:0007186; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0042277; GO:0043408; GO:0045761; GO:2000479"
"1632",1761,646596,"Cluster_11134","Peve_00042932",0.558654140522389,0.622635848867722,0.978262075707395,156,-23.16,"2 17","965 986",15,"80.00%","80.00%","O65201","Acyl-coenzyme A oxidase 2, peroxisomal (AOX 2) (EC 1.3.3.6) (Long-chain acyl-CoA oxidase) (AtCX2)","Arabidopsis thaliana (Mouse-ear cress)","fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]; long-chain fatty acid metabolic process [GO:0001676]","GO:0001676; GO:0003997; GO:0005504; GO:0005777; GO:0006635; GO:0033540; GO:0050660; GO:0055088; GO:0071949"
"1633",1762,646776,"Cluster_11134","Peve_00016437",0.300468550150938,0.805713916700262,0.995934364227446,150,-20.6,"2 16","683 705",15,"66.67%","93.33%","Q03426","Mevalonate kinase (MK) (EC 2.7.1.36)","Homo sapiens (Human)","cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; negative regulation of inflammatory response [GO:0050728]; phosphorylation [GO:0016310]","GO:0000287; GO:0004496; GO:0005524; GO:0005777; GO:0005829; GO:0006695; GO:0008299; GO:0016310; GO:0019287; GO:0042802; GO:0043231; GO:0050728"
"1634",1763,646776,"Cluster_11134","Peve_00016437",0.300468550150938,0.805713916700262,0.995934364227446,154,-20.71,"2 16","665 687",15,"73.33%","93.33%","Q03426","Mevalonate kinase (MK) (EC 2.7.1.36)","Homo sapiens (Human)","cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; negative regulation of inflammatory response [GO:0050728]; phosphorylation [GO:0016310]","GO:0000287; GO:0004496; GO:0005524; GO:0005777; GO:0005829; GO:0006695; GO:0008299; GO:0016310; GO:0019287; GO:0042802; GO:0043231; GO:0050728"
"1635",1764,647113,"Cluster_4735","Peve_00045059",-0.500943642233887,0.665972771890438,0.978262075707395,159,-20.61,"2 21","244 266",20,"70.00%","80.00%",NA,NA,NA,NA,NA
"1636",1765,647199,"Cluster_4079","Peve_00045053",-0.125755588100116,0.919728976410948,0.999448381576871,162,-21.2,"2 21","758 781",21,"76.19%","80.95%",NA,NA,NA,NA,NA
"1637",1767,647765,"Cluster_10965","Peve_00006845",0.0552332766441666,0.964819500898049,0.999448381576871,171,-22.89,"2 21","542 564",20,"75.00%","90.00%",NA,NA,NA,NA,NA
"1638",1768,647769,"Cluster_13502","Peve_00006845",-0.50123790122962,0.665756302930985,0.978262075707395,171,-23.56,"2 16","755 776",14,"92.86%","100.00%",NA,NA,NA,NA,NA
"1639",1770,649392,"Cluster_15726","Peve_00038931",-0.655405804919495,0.544995251133748,0.978262075707395,155,-20.47,"2 17","81 103",16,"81.25%","81.25%","Q9NPF2","Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)","Homo sapiens (Human)","apoptotic process [GO:0006915]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0006915; GO:0007179; GO:0007585; GO:0008146; GO:0009791; GO:0016020; GO:0016051; GO:0030166; GO:0030206; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050659"
"1640",1771,649447,"Cluster_2854","Peve_00037742",-0.712750034571058,0.494898794557776,0.978262075707395,167,-22.65,"2 21","244 267",21,"76.19%","80.95%","E7FAM5","E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","Danio rerio (Zebrafish) (Brachydanio rerio)","embryonic body morphogenesis [GO:0010172]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0010172; GO:0010586; GO:0017148; GO:0021915; GO:0030371; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061630; GO:0072089; GO:2000177"
"1641",1772,649674,"Cluster_4079","Peve_00038939",-0.664301648120274,0.537458088616076,0.978262075707395,158,-23.35,"2 15","574 595",13,"76.92%","100.00%","O19071","Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143) (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II) (GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)","Sus scrofa (Pig)","oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0000139; GO:0005795; GO:0006487; GO:0008455; GO:0009312; GO:0018279; GO:0030145; GO:0042803"
"1642",1773,650034,"Cluster_4079","Peve_00001302",-0.279106222718297,0.819923682898776,0.995934364227446,162,-20.6,"2 15","393 414",13,"84.62%","100.00%",NA,NA,NA,NA,NA
"1643",1774,650132,"Cluster_6904","Peve_00001300",-0.995176395982436,0.0625540843722557,0.978262075707395,153,-20.83,"2 21","754 773",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"1644",1776,651377,"Cluster_589","Peve_00007222",-0.818912996747632,0.389154131885704,0.978262075707395,161,-23.37,"2 20","795 815",18,"72.22%","88.89%","P28606","Uncharacterized protein SYNPCC7002_A1628","Synechococcus sp. (strain ATCC 27264 / PCC 7002 / PR-6) (Agmenellum quadruplicatum)","histone deacetylation [GO:0016575]","GO:0004407; GO:0016575"
"1645",1777,651653,"Cluster_2882","Peve_00005771",0.0688372031480257,0.956142191637655,0.999448381576871,155,-20.65,"2 21","60 83",21,"66.67%","76.19%",NA,NA,NA,NA,NA
"1646",1778,651692,"Cluster_589","Peve_00019498",-0.934753615028442,0.231240264998328,0.978262075707395,155,-23.41,"2 12","5 26",10,"100.00%","100.00%",NA,NA,NA,NA,NA
"1647",1779,652137,"Cluster_15726","Peve_00028381",-0.994711374949671,0.0655025334015686,0.978262075707395,170,-24.11,"2 21","226 246",19,"84.21%","84.21%",NA,NA,NA,NA,NA
"1648",1782,652389,"Cluster_7855","Peve_00033313",0.779682130534951,0.430761324651428,0.978262075707395,179,-26.34,"2 21","482 504",20,"85.00%","90.00%","Q8JFV8","Synaptic vesicle membrane protein VAT-1 homolog (EC 1.-.-.-)","Danio rerio (Zebrafish) (Brachydanio rerio)","negative regulation of mitochondrial fusion [GO:0010637]","GO:0005741; GO:0008270; GO:0010637; GO:0016491"
"1649",1783,652878,"Cluster_6905","Peve_00028652",-0.807123412314029,0.402046381730305,0.978262075707395,148,-21.3,"2 13","53 74",11,"81.82%","90.91%","Q14623","Indian hedgehog protein (IHH) (EC 3.1.-.-) (HHG-2) [Cleaved into: Indian hedgehog protein N-product]","Homo sapiens (Human)","bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; camera-type eye photoreceptor cell fate commitment [GO:0060220]; cartilage development [GO:0051216]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell-cell signaling [GO:0007267]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; chondrocyte proliferation [GO:0035988]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic digit morphogenesis [GO:0042733]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint development [GO:0072498]; epithelial cell morphogenesis [GO:0003382]; epithelial cell-cell adhesion [GO:0090136]; head morphogenesis [GO:0060323]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; intein-mediated protein splicing [GO:0016539]; liver regeneration [GO:0097421]; maternal process involved in female pregnancy [GO:0060135]; multicellular organism growth [GO:0035264]; negative regulation of alpha-beta T cell differentiation [GO:0046639]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of eye pigmentation [GO:0048074]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; negative regulation of T cell differentiation in thymus [GO:0033085]; neuron development [GO:0048666]; osteoblast differentiation [GO:0001649]; pancreas development [GO:0031016]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoprocessing [GO:0016540]; proteoglycan metabolic process [GO:0006029]; regulation of gene expression [GO:0010468]; regulation of growth [GO:0040008]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; retinal pigment epithelium development [GO:0003406]; self proteolysis [GO:0097264]; skeletal system development [GO:0001501]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; somite development [GO:0061053]; vitelline membrane formation [GO:0030704]","GO:0000139; GO:0001501; GO:0001569; GO:0001649; GO:0001701; GO:0001708; GO:0001947; GO:0002053; GO:0003382; GO:0003406; GO:0003413; GO:0005113; GO:0005509; GO:0005576; GO:0005615; GO:0005789; GO:0005886; GO:0006029; GO:0007224; GO:0007267; GO:0008233; GO:0009612; GO:0009880; GO:0010468; GO:0016539; GO:0016540; GO:0030704; GO:0031012; GO:0031016; GO:0032331; GO:0032355; GO:0032967; GO:0033085; GO:0033088; GO:0033089; GO:0034189; GO:0035264; GO:0035988; GO:0040008; GO:0042733; GO:0043066; GO:0045453; GO:0045880; GO:0045944; GO:0046638; GO:0046639; GO:0048074; GO:0048469; GO:0048557; GO:0048596; GO:0048666; GO:0048745; GO:0050679; GO:0051216; GO:0060135; GO:0060220; GO:0060323; GO:0061053; GO:0072498; GO:0090136; GO:0097264; GO:0097421; GO:0140853"
"1650",1785,655700,"Cluster_1167","Peve_00023048",0.990904249230271,0.0859298657413908,0.978262075707395,155,-23.27,"2 20","518 536",18,"77.78%","77.78%","Q32KP1","Tetraspanin-31 (Tspan-31)","Bos taurus (Bovine)","","GO:0005886"
"1651",1786,655743,"Cluster_796","Peve_00023049",0.9999733342158,0.00464914686852433,0.548889669521695,151,-21.71,"2 21","271 297",24,"62.50%","70.83%","P54357","Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain)","Drosophila melanogaster (Fruit fly)","actin filament-based movement [GO:0030048]","GO:0005509; GO:0005829; GO:0016460; GO:0017022; GO:0030048; GO:0031475; GO:0031476; GO:0031477; GO:0032036"
"1652",1787,656121,"Cluster_7053","Peve_00037949",-0.709997911466898,0.497391717776167,0.978262075707395,167,-20.69,"2 21","521 543",20,"70.00%","90.00%","Q6V4S5","Protein sidekick-2","Mus musculus (Mouse)","camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]","GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0045202; GO:0060219"
"1653",1788,656452,"Cluster_11135","Peve_00025943",0.892904069265496,0.297328106833842,0.978262075707395,171,-26.02,"2 20","842 863",18,"77.78%","88.89%","Q6GNG3","Protein disulfide-isomerase TMX3 (EC 5.3.4.1) (Thioredoxin domain-containing protein 10) (Thioredoxin-related transmembrane protein 3)","Xenopus laevis (African clawed frog)","","GO:0003756; GO:0005789"
"1654",1789,656551,"Cluster_29","Peve_00025940",-0.502796685179005,0.664608885166892,0.978262075707395,162,-23.92,"2 19","350 371",17,"70.59%","88.24%","F1MM41","E3 ubiquitin-protein ligase ZNRF1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase ZNRF1) (Zinc/RING finger protein 1)","Bos taurus (Bovine)","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]","GO:0004842; GO:0005737; GO:0005764; GO:0005768; GO:0016020; GO:0030672; GO:0043161; GO:0043231; GO:0046872; GO:0061630; GO:0070936"
"1655",1790,656742,"Cluster_4629","Peve_00018721",0.0474283083018248,0.96979486981244,0.999448381576871,145,-23.41,"2 19","170 194",20,"65.00%","70.00%","Q9PVW8","Rhamnose-binding lectin (RBL) (Roe lectin) (SAL)","Silurus asotus (Amur catfish) (Parasilurus asotus)","","GO:0005576; GO:0030246"
"1656",1792,656912,"Cluster_589","Peve_00014403",-0.981918579778579,0.121246150565083,0.978262075707395,154,-24.22,"2 20","311 333",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"1657",1793,657647,"Cluster_6904","Peve_00026629",-0.991636693392021,0.0823924227570073,0.978262075707395,145,-21.19,"2 21","733 759",24,"66.67%","70.83%","P0DXC0",NA,NA,NA,NA
"1658",1794,657970,"Cluster_8634","Peve_00006638",0.897252695236691,0.291119293136327,0.978262075707395,168,-20.46,"2 21","77 96",19,"84.21%","89.47%",NA,NA,NA,NA,NA
"1659",1795,658362,"Cluster_4629","Peve_00013938",-0.554554668634826,0.625777256211528,0.978262075707395,151,-22.44,"2 12","473 494",10,"90.00%","100.00%","Q8AV58","Protein sidekick-1","Gallus gallus (Chicken)","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]","GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202"
"1660",1796,660607,"Cluster_2854","Peve_00035669",-0.507486347355159,0.661149542463894,0.978262075707395,166,-26.11,"2 15","352 373",13,"92.31%","100.00%",NA,NA,NA,NA,NA
"1661",1797,660639,"Cluster_13502","Peve_00035669",-0.44209200413486,0.708472937844906,0.978262075707395,180,-21.69,"2 21","135 156",19,"84.21%","89.47%",NA,NA,NA,NA,NA
"1662",1798,660729,"Cluster_13502","Peve_00035667",-0.754353846049414,0.455900641626428,0.978262075707395,180,-21.69,"2 21","826 847",19,"84.21%","89.47%","Q9Y256","CAAX prenyl protease 2 (EC 3.4.-.-) (Farnesylated proteins-converting enzyme 2) (FACE-2) (Prenyl protein-specific endoprotease 2) (RCE1 homolog) (hRCE1)","Homo sapiens (Human)","CAAX-box protein processing [GO:0071586]; MAPK cascade [GO:0000165]; protein prenylation [GO:0018342]","GO:0000165; GO:0004175; GO:0004197; GO:0004222; GO:0005789; GO:0005829; GO:0005886; GO:0008238; GO:0016020; GO:0018342; GO:0071586"
"1663",1799,661646,"Cluster_4115","Peve_00034141",-0.930026219102899,0.239567750774005,0.978262075707395,161,-21.52,"2 18","143 164",16,"81.25%","81.25%","Q60928","Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]","Mus musculus (Mouse)","aging [GO:0007568]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638]","GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005783; GO:0005886; GO:0006536; GO:0006749; GO:0006750; GO:0006751; GO:0007283; GO:0007568; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0048471; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0102953; GO:0103068"
"1664",1800,662150,"Cluster_6914","Peve_00012607",0.997809832643678,0.0421417987017475,0.911075865480802,166,-23.44,"2 20","358 379",19,"78.95%","84.21%","Q8CG08","Collagen triple helix repeat-containing protein 1","Rattus norvegicus (Rat)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005581; GO:0005615; GO:0005737; GO:0016477; GO:0016528; GO:0017147; GO:0031012; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0090090; GO:0090103; GO:0090177"
"1665",1801,662370,"Cluster_5882","Peve_00002326",-0.27814091057559,0.820563558554478,0.995934364227446,155,-20.39,"2 21","5 27",20,"65.00%","80.00%",NA,NA,NA,NA,NA
"1666",1802,662548,"Cluster_4735","Peve_00044685",-0.218255066174751,0.859927052409095,0.996170159552649,154,-20.03,"2 21","767 793",24,"66.67%","75.00%","Q25532","V-type proton ATPase subunit G (V-ATPase subunit G) (V-ATPase 13 kDa subunit) (Vacuolar proton pump subunit G)","Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)","","GO:0016324; GO:0016471; GO:0046961"
"1667",1803,662550,"Cluster_5882","Peve_00044685",-0.553466631388407,0.626609278035821,0.978262075707395,174,-23.17,"2 21","7 31",22,"81.82%","86.36%","Q25532","V-type proton ATPase subunit G (V-ATPase subunit G) (V-ATPase 13 kDa subunit) (Vacuolar proton pump subunit G)","Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)","","GO:0016324; GO:0016471; GO:0046961"
"1668",1804,662614,"Cluster_10934","Peve_00044686",-0.456234386365879,0.698395722414825,0.978262075707395,162,-22.84,"2 19","897 918",17,"76.47%","82.35%",NA,NA,NA,NA,NA
"1669",1805,662730,"Cluster_5882","Peve_00013788",-0.93923842140847,0.223066110531933,0.978262075707395,158,-25.87,"2 21","902 926",22,"63.64%","86.36%",NA,NA,NA,NA,NA
"1670",1806,664416,"Cluster_11134","Peve_00016609",0.388477416643715,0.746002300633379,0.987555889713218,154,-21.98,"2 16","216 238",15,"73.33%","93.33%","Q3UQ28","Peroxidasin homolog (EC 1.11.2.-) [Cleaved into: PXDN active fragment]","Mus musculus (Mouse)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005201; GO:0005604; GO:0005615; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"1671",1807,664667,"Cluster_6904","Peve_00003582",-0.0180048925195245,0.988537110033224,0.999448381576871,147,-20.9,"2 21","739 765",24,"62.50%","66.67%","Q6P1S4","Arginine--tRNA ligase, cytoplasmic (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","arginyl-tRNA aminoacylation [GO:0006420]","GO:0004814; GO:0005524; GO:0005829; GO:0006420; GO:0017101"
"1672",1808,664878,"Cluster_796","Peve_00003585",0.890790675751809,0.300302537908043,0.978262075707395,144,-21.64,"2 13","522 543",11,"81.82%","81.82%","Q8IY21","Probable ATP-dependent RNA helicase DDX60 (EC 3.6.4.13) (DEAD box protein 60)","Homo sapiens (Human)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; response to virus [GO:0009615]","GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005737; GO:0005829; GO:0009615; GO:0016887; GO:0045087; GO:0045111; GO:0051607; GO:1900245; GO:1900246"
"1673",1809,665371,"Cluster_29","Peve_00001696",-0.822655594754449,0.384983118229214,0.978262075707395,176,-22.13,"2 21","244 265",19,"84.21%","84.21%","O43399","Tumor protein D54 (hD54) (Tumor protein D52-like 2)","Homo sapiens (Human)","carbohydrate metabolic process [GO:0005975]; regulation of cell population proliferation [GO:0042127]","GO:0003723; GO:0005737; GO:0005975; GO:0042127; GO:0042803; GO:0048471"
"1674",1811,666323,"Cluster_2882","Peve_00034964",-0.92702799553486,0.244709180595301,0.978262075707395,173,-22.4,"2 18","138 159",16,"81.25%","100.00%",NA,NA,NA,NA,NA
"1675",1813,666815,"Cluster_1167","Peve_00004057",-0.623443399920909,0.571466354112859,0.978262075707395,150,-27.15,"2 21","386 410",22,"68.18%","72.73%",NA,NA,NA,NA,NA
"1676",1814,667083,"Cluster_796","Peve_00031304",0.971126338755501,0.153354525971163,0.978262075707395,170,-25.93,"2 19","881 902",17,"82.35%","88.24%","Q9CXE6","DNA repair protein XRCC3 (X-ray repair cross-complementing protein 3)","Mus musculus (Mouse)","DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; interstrand cross-link repair [GO:0036297]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of centrosome duplication [GO:0010824]; resolution of mitotic recombination intermediates [GO:0071140]; response to organic substance [GO:0010033]; t-circle formation [GO:0090656]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere trimming [GO:0090737]","GO:0000400; GO:0000722; GO:0000724; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006281; GO:0008821; GO:0010033; GO:0010824; GO:0033065; GO:0036297; GO:0045003; GO:0048471; GO:0071140; GO:0090267; GO:0090656; GO:0090737; GO:0140664"
"1677",1815,667128,"Cluster_796","Peve_00031305",0.34877321916608,0.773196688131686,0.991778614034704,170,-25.93,"2 19","881 902",17,"82.35%","88.24%",NA,NA,NA,NA,NA
"1678",1816,667172,"Cluster_589","Peve_00000779",-0.925431682172391,0.247405119556688,0.978262075707395,157,-20.74,"2 19","197 219",18,"72.22%","83.33%","O60519","cAMP-responsive element-binding protein-like 2","Homo sapiens (Human)","cell cycle [GO:0007049]; cell differentiation [GO:0030154]; DNA-templated transcription [GO:0006351]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of glucose import [GO:0046326]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein stabilization [GO:0050821]; regulation of DNA-templated transcription [GO:0006355]; signal transduction [GO:0007165]","GO:0000785; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006351; GO:0006355; GO:0007049; GO:0007165; GO:0030154; GO:0033138; GO:0045600; GO:0045893; GO:0046326; GO:0046889; GO:0050821"
"1679",1817,667519,"Cluster_10934","Peve_00000777",-0.494858144159221,0.670440037347684,0.978262075707395,148,-23.54,"2 19","672 692",17,"70.59%","76.47%",NA,NA,NA,NA,NA
"1680",1818,667536,"Cluster_2787","Peve_00000776",0.889444519128064,0.302183019966681,0.978262075707395,163,-26.08,"2 21","913 935",20,"75.00%","80.00%",NA,NA,NA,NA,NA
"1681",1819,667926,"Cluster_11134","Peve_00028037",0.51130025766007,0.658328020849251,0.978262075707395,156,-20.02,"2 21","892 913",19,"63.16%","78.95%","P17178","Sterol 26-hydroxylase, mitochondrial (EC 1.14.15.15) (5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol 26-hydroxylase) (Cytochrome P-450C27/25) (Cytochrome P450 27) (Sterol 27-hydroxylase) (Vitamin D(3) 25-hydroxylase)","Rattus norvegicus (Rat)","bile acid biosynthetic process [GO:0006699]; C21-steroid hormone biosynthetic process [GO:0006700]; calcitriol biosynthetic process from calciol [GO:0036378]; cholesterol catabolic process [GO:0006707]; cholesterol metabolic process [GO:0008203]; steroid catabolic process [GO:0006706]","GO:0005506; GO:0005739; GO:0005740; GO:0005743; GO:0006699; GO:0006700; GO:0006706; GO:0006707; GO:0008123; GO:0008203; GO:0008386; GO:0020037; GO:0030343; GO:0030544; GO:0031073; GO:0036378; GO:0047103; GO:0047748; GO:0047749"
"1682",1820,668071,"Cluster_29","Peve_00024116",-0.561297207366245,0.620604935257934,0.978262075707395,160,-26.32,"2 21","255 274",19,"73.68%","89.47%","Q7Z020","Transient receptor potential cation channel subfamily A member 1 (dTRPA1) (Ankyrin-like with transmembrane domains protein 1) (dANKTM1)","Drosophila melanogaster (Fruit fly)","calcium ion transport [GO:0006816]; cation transport [GO:0006812]; cellular response to heat [GO:0034605]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; mechanosensory behavior [GO:0007638]; negative phototaxis [GO:0046957]; neuronal signal transduction [GO:0023041]; phototransduction [GO:0007602]; positive regulation of calcium-mediated signaling [GO:0050850]; response to heat [GO:0009408]; response to light stimulus [GO:0009416]; temperature compensation of the circadian clock [GO:0010378]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]","GO:0001580; GO:0005261; GO:0005262; GO:0005886; GO:0006812; GO:0006816; GO:0007602; GO:0007638; GO:0009408; GO:0009416; GO:0010378; GO:0015276; GO:0016020; GO:0023041; GO:0034605; GO:0034703; GO:0040040; GO:0043052; GO:0046957; GO:0050850; GO:0050960; GO:0050965; GO:0050968; GO:0097604"
"1683",1821,668800,"Cluster_4080","Peve_00040799",-0.645050636290516,0.553672532107486,0.978262075707395,152,-20.13,"2 21","209 233",23,"69.57%","78.26%","O75970","Multiple PDZ domain protein (Multi-PDZ domain protein 1)","Homo sapiens (Human)","","GO:0005737; GO:0005923; GO:0008022; GO:0014069; GO:0016324; GO:0016327; GO:0030425"
"1684",1822,668883,"Cluster_796","Peve_00040793",0.299468094244464,0.806381572875205,0.995934364227446,166,-24.58,"2 21","867 890",21,"80.95%","80.95%","O09173","Homogentisate 1,2-dioxygenase (EC 1.13.11.5) (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase)","Mus musculus (Mouse)","amino acid metabolic process [GO:0006520]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]","GO:0004411; GO:0006520; GO:0006559; GO:0006572; GO:0042802; GO:0046872"
"1685",1823,669428,"Cluster_2882","Peve_00035370",0.688935540608687,0.516156592882085,0.978262075707395,156,-21.95,"2 21","242 263",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"1686",1824,669564,"Cluster_4079","Peve_00003879",-0.937416100346746,0.226421604465405,0.978262075707395,154,-21.59,"2 20","562 584",19,"57.89%","89.47%","P11498","Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB)","Homo sapiens (Human)","gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; NADH metabolic process [GO:0006734]; NADP metabolic process [GO:0006739]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral process [GO:0044794]; pyruvate metabolic process [GO:0006090]; viral release from host cell [GO:0019076]; viral RNA genome packaging [GO:0019074]","GO:0004736; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006090; GO:0006094; GO:0006629; GO:0006734; GO:0006739; GO:0009374; GO:0010629; GO:0019074; GO:0019076; GO:0042802; GO:0044794; GO:0046872"
"1687",1825,669831,"Cluster_2787","Peve_00006347",0.997397732644906,0.0459372826693576,0.934604794067411,163,-22.73,"2 21","273 297",22,"72.73%","77.27%","Q86WI1","Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1)","Homo sapiens (Human)","immune response [GO:0006955]; sensory perception of sound [GO:0007605]","GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0120234"
"1688",1826,671586,"Cluster_2787","Peve_00031964",-0.376625825958598,0.754168505494443,0.988219883885475,160,-22.17,"2 21","855 876",19,"63.16%","84.21%","Q6PF45","Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter) (xVIAAT)","Xenopus laevis (African clawed frog)","beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836]","GO:0001762; GO:0006836; GO:0008021; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800"
"1689",1827,672215,"Cluster_1167","Peve_00004562",-0.457707957563407,0.697341057706077,0.978262075707395,140,-20.45,"2 9","669 690",7,"100.00%","100.00%","Q9D1D6","Collagen triple helix repeat-containing protein 1","Mus musculus (Mouse)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0031012; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0090090; GO:0090103; GO:0090177"
"1690",1828,672240,"Cluster_9149","Peve_00004562",-0.552381830947265,0.62743810590932,0.978262075707395,167,-27.97,"2 20","674 695",18,"77.78%","83.33%","Q9D1D6","Collagen triple helix repeat-containing protein 1","Mus musculus (Mouse)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0031012; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0090090; GO:0090103; GO:0090177"
"1691",1829,672721,"Cluster_6255","Peve_00024930",-0.780368577918257,0.430062950603287,0.978262075707395,175,-21.28,"2 21","219 241",20,"80.00%","90.00%","Q8NB14","Ubiquitin carboxyl-terminal hydrolase 38 (EC 3.4.19.12) (Deubiquitinating enzyme 38) (HP43.8KD) (Ubiquitin thioesterase 38) (Ubiquitin-specific-processing protease 38)","Homo sapiens (Human)","protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016579"
"1692",1830,673932,"Cluster_4629","Peve_00024209",0.719450661300249,0.488787281946321,0.978262075707395,143,-20.01,"2 21","101 127",24,"54.17%","70.83%","Q6P4Z9","COP9 signalosome complex subunit 8 (SGN8) (Signalosome subunit 8) (COP9 homolog) (JAB1-containing signalosome subunit 8)","Rattus norvegicus (Rat)","activation of NF-kappaB-inducing kinase activity [GO:0007250]; COP9 signalosome assembly [GO:0010387]; negative regulation of cell population proliferation [GO:0008285]; protein deneddylation [GO:0000338]; protein phosphorylation [GO:0006468]","GO:0000338; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0007250; GO:0008180; GO:0008285; GO:0010387; GO:0048471"
"1693",1831,673953,"Cluster_10061","Peve_00024209",0.800698959771548,0.408923333024622,0.978262075707395,184,-23.34,"2 21","712 733",19,"84.21%","94.74%","Q6P4Z9","COP9 signalosome complex subunit 8 (SGN8) (Signalosome subunit 8) (COP9 homolog) (JAB1-containing signalosome subunit 8)","Rattus norvegicus (Rat)","activation of NF-kappaB-inducing kinase activity [GO:0007250]; COP9 signalosome assembly [GO:0010387]; negative regulation of cell population proliferation [GO:0008285]; protein deneddylation [GO:0000338]; protein phosphorylation [GO:0006468]","GO:0000338; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0007250; GO:0008180; GO:0008285; GO:0010387; GO:0048471"
"1694",1832,674088,"Cluster_10061","Peve_00024200",-0.711650941590777,0.495895558694091,0.978262075707395,172,-21.32,"2 17","819 840",15,"93.33%","93.33%",NA,NA,NA,NA,NA
"1695",1833,674361,"Cluster_11134","Peve_00031465",0.54085700899364,0.636200019604716,0.978262075707395,154,-20.57,"2 21","567 587",19,"63.16%","84.21%","Q9HAR2","Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3)","Homo sapiens (Human)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; synapse assembly [GO:0007416]","GO:0001764; GO:0004930; GO:0005509; GO:0005886; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0007420; GO:0016020; GO:0030246; GO:0030424; GO:0098742; GO:0098978"
"1696",1834,674430,"Cluster_5882","Peve_00031466",-0.27814091057559,0.820563558554478,0.995934364227446,170,-23.16,"2 21","291 311",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"1697",1835,675723,"Cluster_796","Peve_00020588",0.971959619121991,0.151114851197767,0.978262075707395,161,-22.23,"2 19","660 682",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"1698",1836,675750,"Cluster_9149","Peve_00020588",-0.674388620660253,0.528814543690416,0.978262075707395,150,-22.26,"2 19","71 92",17,"70.59%","70.59%",NA,NA,NA,NA,NA
"1699",1837,676982,"Cluster_589","Peve_00027226",0.779914400976911,0.430525125503704,0.978262075707395,149,-23.98,"2 20","333 353",18,"66.67%","77.78%","Q5BKQ4","Inactive pancreatic lipase-related protein 1 (PL-RP1)","Mus musculus (Mouse)","lipid metabolic process [GO:0006629]","GO:0004806; GO:0005509; GO:0005615; GO:0006629; GO:0016298"
"1700",1838,677286,"Cluster_11134","Peve_00043325",0.999679946581222,0.0161071216942691,0.766206870688277,154,-20.57,"2 21","535 555",19,"63.16%","84.21%","Q7TPS5","C2 domain-containing protein 5 (138 kDa C2 domain-containing phosphoprotein)","Mus musculus (Mouse)","cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein localization to plasma membrane [GO:0072659]; vesicle fusion [GO:0006906]","GO:0005509; GO:0005544; GO:0005829; GO:0005886; GO:0005938; GO:0006906; GO:0010828; GO:0030659; GO:0031340; GO:0032587; GO:0032869; GO:0034451; GO:0038028; GO:0046326; GO:0065002; GO:0072659; GO:0090314"
"1701",1839,677325,"Cluster_9149","Peve_00043324",-0.850685712885948,0.3523741133843,0.978262075707395,163,-22.2,"2 21","743 765",20,"75.00%","80.00%",NA,NA,NA,NA,NA
"1702",1840,677595,"Cluster_9149","Peve_00012830",-0.990728198330697,0.0867587561451818,0.978262075707395,157,-22.54,"2 14","276 297",12,"91.67%","91.67%",NA,NA,NA,NA,NA
"1703",1841,677706,"Cluster_2787","Peve_00044504",0.857906199462388,0.343530025366473,0.978262075707395,157,-21.53,"2 14","505 526",12,"91.67%","91.67%","P35443","Thrombospondin-4","Homo sapiens (Human)","behavioral response to pain [GO:0048266]; endothelial cell-cell adhesion [GO:0071603]; myoblast migration [GO:0051451]; negative regulation of angiogenesis [GO:0016525]; positive regulation of cell division [GO:0051781]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of tissue remodeling [GO:0034103]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; tissue remodeling [GO:0048771]","GO:0001938; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006986; GO:0008083; GO:0008201; GO:0016525; GO:0016529; GO:0034103; GO:0034976; GO:0048266; GO:0048771; GO:0050731; GO:0051451; GO:0051781; GO:0062023; GO:0070062; GO:0071603; GO:0090023"
"1704",1844,678594,"Cluster_13502","Peve_00011563",0.172614238707227,0.889557207338519,0.999448381576871,162,-23.98,"2 19","517 538",17,"76.47%","82.35%","Q96PM5","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING finger protein 199) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363) (p53-induced RING-H2 protein) (hPirh2)","Homo sapiens (Human)","error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630; GO:0070987"
"1705",1846,678980,"Cluster_6914","Peve_00014883",-0.536892832700827,0.639195889461172,0.978262075707395,165,-21.98,"2 20","808 831",21,"76.19%","85.71%","O18806","Coagulation factor VIII (Procoagulant component)","Canis lupus familiaris (Dog) (Canis familiaris)","acute-phase response [GO:0006953]; blood coagulation [GO:0007596]","GO:0005507; GO:0005615; GO:0006953; GO:0007596; GO:0016491"
"1706",1847,679337,"Cluster_6904","Peve_00035171",0.373819991307953,0.756095557108439,0.988219883885475,154,-21.02,"2 21","173 193",19,"73.68%","73.68%","U3JAG9","Centrosomal protein of 131 kDa (5-azacytidine-induced protein 1)","Danio rerio (Zebrafish) (Brachydanio rerio)","cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; negative regulation of intracellular protein transport [GO:0090317]; regulation of centrosome duplication [GO:0010824]; sensory perception of light stimulus [GO:0050953]","GO:0000775; GO:0001669; GO:0005576; GO:0005929; GO:0010824; GO:0030154; GO:0032402; GO:0034451; GO:0035721; GO:0035735; GO:0050953; GO:0060271; GO:0060287; GO:0070121; GO:0090317"
"1707",1848,679339,"Cluster_6906","Peve_00035171",-0.117997623786165,0.924704957674655,0.999448381576871,154,-21,"2 21","173 193",19,"73.68%","73.68%","U3JAG9","Centrosomal protein of 131 kDa (5-azacytidine-induced protein 1)","Danio rerio (Zebrafish) (Brachydanio rerio)","cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; negative regulation of intracellular protein transport [GO:0090317]; regulation of centrosome duplication [GO:0010824]; sensory perception of light stimulus [GO:0050953]","GO:0000775; GO:0001669; GO:0005576; GO:0005929; GO:0010824; GO:0030154; GO:0032402; GO:0034451; GO:0035721; GO:0035735; GO:0050953; GO:0060271; GO:0060287; GO:0070121; GO:0090317"
"1708",1849,679382,"Cluster_6904","Peve_00035170",-0.743881135154467,0.465965703098651,0.978262075707395,154,-21.02,"2 21","173 193",19,"73.68%","73.68%","U3JAG9","Centrosomal protein of 131 kDa (5-azacytidine-induced protein 1)","Danio rerio (Zebrafish) (Brachydanio rerio)","cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; negative regulation of intracellular protein transport [GO:0090317]; regulation of centrosome duplication [GO:0010824]; sensory perception of light stimulus [GO:0050953]","GO:0000775; GO:0001669; GO:0005576; GO:0005929; GO:0010824; GO:0030154; GO:0032402; GO:0034451; GO:0035721; GO:0035735; GO:0050953; GO:0060271; GO:0060287; GO:0070121; GO:0090317"
"1709",1850,679383,"Cluster_6905","Peve_00035170",-0.784604026903208,0.425732550983281,0.978262075707395,159,-20.15,"2 16","845 866",14,"85.71%","85.71%","U3JAG9","Centrosomal protein of 131 kDa (5-azacytidine-induced protein 1)","Danio rerio (Zebrafish) (Brachydanio rerio)","cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; negative regulation of intracellular protein transport [GO:0090317]; regulation of centrosome duplication [GO:0010824]; sensory perception of light stimulus [GO:0050953]","GO:0000775; GO:0001669; GO:0005576; GO:0005929; GO:0010824; GO:0030154; GO:0032402; GO:0034451; GO:0035721; GO:0035735; GO:0050953; GO:0060271; GO:0060287; GO:0070121; GO:0090317"
"1710",1851,679384,"Cluster_6906","Peve_00035170",-0.973543182674903,0.146766217881744,0.978262075707395,154,-21,"2 21","173 193",19,"73.68%","73.68%","U3JAG9","Centrosomal protein of 131 kDa (5-azacytidine-induced protein 1)","Danio rerio (Zebrafish) (Brachydanio rerio)","cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; negative regulation of intracellular protein transport [GO:0090317]; regulation of centrosome duplication [GO:0010824]; sensory perception of light stimulus [GO:0050953]","GO:0000775; GO:0001669; GO:0005576; GO:0005929; GO:0010824; GO:0030154; GO:0032402; GO:0034451; GO:0035721; GO:0035735; GO:0050953; GO:0060271; GO:0060287; GO:0070121; GO:0090317"
"1711",1852,679762,"Cluster_11135","Peve_00013057",0.428832493648184,0.717850110537834,0.980968929949629,152,-20.97,"2 15","768 788",13,"84.62%","92.31%","Q3SYU1","Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor)","Bos taurus (Bovine)","apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]; transcription initiation-coupled chromatin remodeling [GO:0045815]","GO:0000122; GO:0002903; GO:0003714; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0006915; GO:0030690; GO:0030691; GO:0031491; GO:0034644; GO:0035067; GO:0042273; GO:0042393; GO:0045815; GO:0140297; GO:2001243"
"1712",1853,679772,"Cluster_589","Peve_00013050",0.467659886263981,0.690194426671515,0.978262075707395,173,-27.44,"2 18","846 867",16,"81.25%","100.00%","Q23915","Probable serine/threonine-protein kinase kinX (EC 2.7.11.1)","Dictyostelium discoideum (Social amoeba)","protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]","GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0106310"
"1713",1854,679915,"Cluster_4080","Peve_00013059",-0.783097934215443,0.427276654875697,0.978262075707395,165,-20.27,"2 21","600 622",21,"76.19%","85.71%","Q8TAQ5","Zinc finger protein 420","Homo sapiens (Human)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0046872"
"1714",1856,682653,"Cluster_796","Peve_00004935",0.981329299401889,0.123212130810769,0.978262075707395,167,-21.69,"2 21","764 786",20,"80.00%","80.00%","Q8MPM1","Gelsolin-like protein 2 (Actin-modulator) (EWAM-P2)","Lumbricus terrestris (Common earthworm)","actin filament capping [GO:0051693]","GO:0005737; GO:0005856; GO:0051015; GO:0051693"
"1715",1857,682810,"Cluster_8634","Peve_00004938",0.937344672712495,0.226552156536451,0.978262075707395,162,-21.85,"2 17","270 290",15,"86.67%","93.33%",NA,NA,NA,NA,NA
"1716",1858,683202,"Cluster_4629","Peve_00008637",0.228690933381189,0.853110958059531,0.995934364227446,157,-22.5,"2 20","243 263",18,"66.67%","88.89%","P35486","Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial (EC 1.2.4.1) (PDHE1-A type I)","Mus musculus (Mouse)","acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; tricarboxylic acid cycle [GO:0006099]","GO:0004738; GO:0004739; GO:0005730; GO:0005739; GO:0005967; GO:0006006; GO:0006086; GO:0006099; GO:0034604; GO:0043209; GO:0045254; GO:1902494"
"1717",1859,683553,"Cluster_796","Peve_00040914",0.898740270652305,0.288966974174018,0.978262075707395,176,-22.4,"2 21","917 938",19,"84.21%","84.21%",NA,NA,NA,NA,NA
"1718",1860,683862,"Cluster_15726","Peve_00042518",-0.759321062673981,0.451062435787596,0.978262075707395,154,-20.64,"2 21","432 456",22,"68.18%","77.27%","A5PJY4","Transmembrane protein 138","Bos taurus (Bovine)","cilium assembly [GO:0060271]","GO:0005774; GO:0005929; GO:0060271"
"1719",1861,684105,"Cluster_5882","Peve_00042515",-0.798989405387636,0.410736602747584,0.978262075707395,145,-20.63,"2 19","736 758",18,"61.11%","77.78%","O77633","Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c)","Sus scrofa (Pig)","adherens junction organization [GO:0034332]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; epidermal growth factor receptor ligand maturation [GO:0038004]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; negative regulation of gene expression [GO:0010629]; Notch signaling pathway [GO:0007219]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein catabolic process at postsynapse [GO:0140249]; protein phosphorylation [GO:0006468]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of postsynapse organization [GO:0099175]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612]; toxin transport [GO:1901998]","GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005634; GO:0005798; GO:0005886; GO:0005912; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0008284; GO:0008593; GO:0009986; GO:0010629; GO:0010820; GO:0014069; GO:0017124; GO:0019901; GO:0030136; GO:0030307; GO:0030424; GO:0030425; GO:0034332; GO:0034612; GO:0038004; GO:0042117; GO:0042803; GO:0046872; GO:0046930; GO:0046931; GO:0051089; GO:0070573; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0098696; GO:0098978; GO:0099173; GO:0099175; GO:0140249; GO:1901342; GO:1901998; GO:1902945"
"1720",1862,684418,"Cluster_4735","Peve_00016810",-0.993079954561733,0.0749376995639775,0.978262075707395,160,-21.38,"2 21","609 632",22,"77.27%","81.82%","Q5I597","Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5)","Bos taurus (Bovine)","amino-acid betaine catabolic process [GO:0006579]; L-methionine salvage [GO:0071267]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]","GO:0005634; GO:0005829; GO:0006579; GO:0008270; GO:0009086; GO:0032259; GO:0047150; GO:0071267"
"1721",1863,684486,"Cluster_11134","Peve_00016816",0.919239967997566,0.257608642745253,0.978262075707395,159,-23.7,"2 21","648 672",22,"68.18%","77.27%","Q9YHY6","Condensin complex subunit 1 (Chromosome assembly protein XCAP-D2) (Chromosome condensation-related SMC-associated protein 1) (Chromosome-associated protein D2) (Eg7) (Non-SMC condensin I complex subunit D2)","Xenopus laevis (African clawed frog)","cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]","GO:0005634; GO:0005694; GO:0005829; GO:0007076; GO:0051301"
"1722",1864,684647,"Cluster_6904","Peve_00044318",-0.951310992493219,0.199475076059675,0.978262075707395,151,-22.3,"2 21","829 854",23,"60.87%","73.91%",NA,NA,NA,NA,NA
"1723",1865,684649,"Cluster_6906","Peve_00044318",-0.686063329690759,0.518674561276582,0.978262075707395,147,-20.28,"2 21","831 854",21,"61.90%","71.43%",NA,NA,NA,NA,NA
"1724",1866,684913,"Cluster_4735","Peve_00035917",-0.826260080189807,0.380928302071133,0.978262075707395,170,-23.02,"2 19","620 641",17,"76.47%","94.12%",NA,NA,NA,NA,NA
"1725",1867,685874,"Cluster_8988","Peve_00036461",0.0860148226113438,0.945173514868548,0.999448381576871,162,-21.8,"2 21","783 803",19,"68.42%","89.47%",NA,NA,NA,NA,NA
"1726",1868,686317,"Cluster_7657","Peve_00009271",-0.705673373193628,0.501289216092251,0.978262075707395,171,-20.96,"2 21","94 116",20,"80.00%","85.00%",NA,NA,NA,NA,NA
"1727",1869,686318,"Cluster_7658","Peve_00009271",-0.0149881471432194,0.990457891890958,0.999448381576871,171,-20.96,"2 21","94 116",20,"80.00%","85.00%",NA,NA,NA,NA,NA
"1728",1870,686837,"Cluster_589","Peve_00014412",0.775072695353894,0.435426401668339,0.978262075707395,154,-22.94,"2 16","121 143",15,"80.00%","86.67%",NA,NA,NA,NA,NA
"1729",1871,687251,"Cluster_4115","Peve_00012803",-0.930026219102899,0.239567750774005,0.978262075707395,153,-20.44,"2 19","883 905",18,"72.22%","77.78%","E7FAM5","E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","Danio rerio (Zebrafish) (Brachydanio rerio)","embryonic body morphogenesis [GO:0010172]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0010172; GO:0010586; GO:0017148; GO:0021915; GO:0030371; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061630; GO:0072089; GO:2000177"
"1730",1872,687281,"Cluster_14999","Peve_00012803",0.525134194156591,0.64803024914489,0.978262075707395,166,-23.49,"2 17","347 367",15,"93.33%","93.33%","E7FAM5","E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","Danio rerio (Zebrafish) (Brachydanio rerio)","embryonic body morphogenesis [GO:0010172]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0010172; GO:0010586; GO:0017148; GO:0021915; GO:0030371; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061630; GO:0072089; GO:2000177"
"1731",1873,687743,"Cluster_2882","Peve_00007715",-0.744970149630445,0.464927388085887,0.978262075707395,157,-21.99,"2 14","158 179",12,"91.67%","91.67%",NA,NA,NA,NA,NA
"1732",1874,689685,"Cluster_5882","Peve_00027476",-0.333799769480929,0.783338121442994,0.99435281692613,171,-22.89,"2 21","164 187",21,"76.19%","85.71%","Q92556","Engulfment and cell motility protein 1 (Protein ced-12 homolog)","Homo sapiens (Human)","actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell motility [GO:0048870]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]","GO:0005737; GO:0005829; GO:0005886; GO:0006911; GO:0006915; GO:0007015; GO:0016020; GO:0016601; GO:0017124; GO:0030036; GO:0032045; GO:0048870"
"1733",1875,690042,"Cluster_4629","Peve_00023576",-0.443383362280846,0.707556077121805,0.978262075707395,158,-22.36,"2 21","565 590",23,"73.91%","73.91%","Q90Z00","Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)","Danio rerio (Zebrafish) (Brachydanio rerio)","anatomical structure homeostasis [GO:0060249]; cardiac muscle tissue development [GO:0048738]; dorsal/ventral pattern formation [GO:0009953]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; liver development [GO:0001889]; negative regulation of endodermal cell fate specification [GO:0042664]; olfactory nerve formation [GO:0021628]; olfactory placode morphogenesis [GO:0071699]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phospholipase C activity [GO:0010863]; post-anal tail morphogenesis [GO:0036342]; posterior lateral line development [GO:0048916]; response to ethanol [GO:0045471]; skin morphogenesis [GO:0043589]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0001889; GO:0004714; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007169; GO:0008201; GO:0008284; GO:0008543; GO:0009953; GO:0010863; GO:0017134; GO:0018108; GO:0021628; GO:0031101; GO:0031410; GO:0033674; GO:0036342; GO:0042664; GO:0043235; GO:0043406; GO:0043589; GO:0045471; GO:0045597; GO:0048738; GO:0048916; GO:0060249; GO:0071699"
"1734",1876,690167,"Cluster_589","Peve_00023572",-0.934753615028442,0.231240264998328,0.978262075707395,145,-20.66,"2 10","51 72",8,"100.00%","100.00%",NA,NA,NA,NA,NA
"1735",1877,690465,"Cluster_9149","Peve_00010767",-0.52519859343157,0.647982073031168,0.978262075707395,149,-22.96,"2 21","436 455",19,"57.89%","84.21%","Q5SV77","Gametogenetin-binding protein 2 (Dioxin-inducible factor 3) (DIF-3) (Protein ZNF403)","Mus musculus (Mouse)","cell differentiation [GO:0030154]; labyrinthine layer blood vessel development [GO:0060716]; labyrinthine layer development [GO:0060711]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033140]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; spermatogenesis [GO:0007283]","GO:0005634; GO:0005737; GO:0007283; GO:0008285; GO:0010629; GO:0030154; GO:0031410; GO:0033140; GO:0042532; GO:0060711; GO:0060716; GO:0061099"
"1736",1878,690590,"Cluster_6914","Peve_00010763",0.970675542301765,0.154552898832575,0.978262075707395,171,-24.1,"2 16","965 985",14,"92.86%","100.00%","Q8K2J9","BTB/POZ domain-containing protein 6","Mus musculus (Mouse)","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"1737",1879,690635,"Cluster_6914","Peve_00010762",0.925872677592222,0.246663140537056,0.978262075707395,171,-24.1,"2 16","965 985",14,"92.86%","100.00%","Q8K2J9","BTB/POZ domain-containing protein 6","Mus musculus (Mouse)","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"1738",1880,690662,"Cluster_589","Peve_00010761",0.519096153648329,0.65253730244261,0.978262075707395,153,-20.39,"2 20","879 899",18,"66.67%","83.33%","Q96KE9","BTB/POZ domain-containing protein 6 (Lens BTB domain protein)","Homo sapiens (Human)","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"1739",1881,690852,"Cluster_4629","Peve_00036703",-0.554554668634826,0.625777256211528,0.978262075707395,151,-21.65,"2 16","4 25",14,"71.43%","85.71%",NA,NA,NA,NA,NA
"1740",1882,691459,"Cluster_10934","Peve_00020178",-0.608729755545326,0.583358749050634,0.978262075707395,162,-27.04,"2 21","123 143",19,"68.42%","89.47%","Q8C5H1","Anoctamin-4 (Transmembrane protein 16D)","Mus musculus (Mouse)","calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; establishment of localization in cell [GO:0051649]; transmembrane transport [GO:0055085]","GO:0005254; GO:0005886; GO:0006821; GO:0017128; GO:0046983; GO:0051649; GO:0055085; GO:0061589; GO:0061590; GO:0061591; GO:1902476"
"1741",1883,691611,"Cluster_2787","Peve_00024623",0.27411200914503,0.823232192180661,0.995934364227446,161,-25.93,"2 20","286 306",18,"72.22%","88.89%","Q6NRQ1","UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2 (Beta-1,3-GalNAc-T2) (EC 2.4.1.313) (Beta-1,3-N-acetylgalactosaminyltransferase II)","Xenopus laevis (African clawed frog)","protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]","GO:0000139; GO:0005783; GO:0006486; GO:0006493; GO:0008376"
"1742",1884,692092,"Cluster_11135","Peve_00011966",0.844443877729655,0.359862212804899,0.978262075707395,160,-20.87,"2 18","880 902",17,"82.35%","82.35%",NA,NA,NA,NA,NA
"1743",1885,692462,"Cluster_589","Peve_00011969",-0.93107279301354,0.237748155088271,0.978262075707395,156,-23.55,"2 18","953 975",17,"70.59%","88.24%",NA,NA,NA,NA,NA
"1744",1886,692755,"Cluster_8634","Peve_00013447",0.956227319072805,0.189057429551567,0.978262075707395,149,-20.09,"2 15","539 561",14,"78.57%","85.71%",NA,NA,NA,NA,NA
"1745",1887,692967,"Cluster_4629","Peve_00013441",0.861349605188276,0.339239379202118,0.978262075707395,149,-20.93,"2 20","486 510",21,"71.43%","71.43%","Q5SV80","Unconventional myosin-XIX (Myosin head domain-containing protein 1)","Mus musculus (Mouse)","actin filament organization [GO:0007015]; mitochondrion migration along actin filament [GO:0034642]; mitocytosis [GO:0160040]; regulation of cytokinesis [GO:0032465]; regulation of mitochondrial fission [GO:0090140]; vesicle transport along actin filament [GO:0030050]","GO:0000146; GO:0003779; GO:0005524; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0007015; GO:0015629; GO:0016459; GO:0016887; GO:0030050; GO:0031982; GO:0032027; GO:0032465; GO:0034642; GO:0051015; GO:0060002; GO:0090140; GO:0160040"
"1746",1888,693452,"Cluster_589","Peve_00041222",-0.761431121945908,0.448994162370026,0.978262075707395,157,-22.99,"2 14","303 324",12,"91.67%","91.67%",NA,NA,NA,NA,NA
"1747",1889,693735,"Cluster_5882","Peve_00021228",-0.826423843312443,0.38074318019153,0.978262075707395,167,-22.92,"2 21","882 904",20,"70.00%","90.00%",NA,NA,NA,NA,NA
"1748",1890,693975,"Cluster_9149","Peve_00021224",1,0,0,144,-21.08,"2 18","333 357",19,"68.42%","68.42%",NA,NA,NA,NA,NA
"1749",1891,694449,"Cluster_4079","Peve_00042759",0.86399550892611,0.335908859125034,0.978262075707395,151,-21.06,"2 21","355 373",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"1750",1892,695526,"Cluster_2787","Peve_00042280",0.867933894665659,0.330895275232091,0.978262075707395,161,-24.48,"2 20","467 490",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"1751",1893,696297,"Cluster_4629","Peve_00014252",-0.0409474527784848,0.973924751766937,0.999448381576871,143,-20.3,"2 16","588 609",14,"71.43%","71.43%","Q9P000","COMM domain-containing protein 9","Homo sapiens (Human)","cholesterol homeostasis [GO:0042632]; sodium ion transport [GO:0006814]","GO:0005576; GO:0005654; GO:0005794; GO:0005829; GO:0006814; GO:0034774; GO:0042632; GO:1904813"
"1752",1894,696387,"Cluster_4629","Peve_00014257",-0.443383362280846,0.707556077121805,0.978262075707395,150,-23.04,"2 21","249 269",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"1753",1895,696552,"Cluster_15726","Peve_00043486",-0.627634217792298,0.568046730078473,0.978262075707395,168,-21.62,"2 21","258 279",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"1754",1896,696692,"Cluster_589","Peve_00043152",-0.922999301496277,0.251460281782511,0.978262075707395,145,-22.22,"2 10","371 392",8,"100.00%","100.00%",NA,NA,NA,NA,NA
"1755",1897,696961,"Cluster_29","Peve_00043159",-0.097067722000589,0.938107314564243,0.999448381576871,155,-20.64,"2 20","190 209",18,"72.22%","88.89%","F1MKX4","Proteasome activator complex subunit 4 (Proteasome activator PA200)","Bos taurus (Bovine)","cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; sperm DNA condensation [GO:0035092]","GO:0005634; GO:0005829; GO:0006281; GO:0006974; GO:0010499; GO:0016504; GO:0016607; GO:0035092; GO:0070577; GO:0070628; GO:1990111"
"1756",1898,697252,"Cluster_7657","Peve_00011152",-0.705673373193628,0.501289216092251,0.978262075707395,169,-20.07,"2 20","299 319",18,"83.33%","88.89%",NA,NA,NA,NA,NA
"1757",1899,697253,"Cluster_7658","Peve_00011152",-0.0149881471432194,0.990457891890958,0.999448381576871,169,-20.07,"2 20","299 319",18,"83.33%","88.89%",NA,NA,NA,NA,NA
"1758",1900,697309,"Cluster_10934","Peve_00011151",0.65013377733782,0.549425679217164,0.978262075707395,170,-23.88,"2 20","598 621",20,"80.00%","85.00%",NA,NA,NA,NA,NA
"1759",1901,697700,"Cluster_6914","Peve_00014920",-0.256623003420621,0.834780255183766,0.995934364227446,153,-20.08,"2 19","231 256",22,"68.18%","72.73%","P13804","Electron transfer flavoprotein subunit alpha, mitochondrial (Alpha-ETF)","Homo sapiens (Human)","amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]","GO:0005739; GO:0005759; GO:0009055; GO:0009063; GO:0016491; GO:0022904; GO:0033539; GO:0045251; GO:0050660"
"1760",1902,697771,"Cluster_29","Peve_00014922",-0.378606944117116,0.752806441851507,0.988219883885475,159,-20.53,"2 21","552 574",20,"70.00%","80.00%","Q9TXQ1","Poly [ADP-ribose] polymerase tankyrase (EC 2.4.2.30) (Poly ADP-ribose metabolism enzyme 5) (Protein poly-ADP-ribosyltransferase tankyrase) (EC 2.4.2.-)","Caenorhabditis elegans","cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of programmed cell death [GO:0043069]; protein poly-ADP-ribosylation [GO:0070212]; response to gamma radiation [GO:0010332]","GO:0003950; GO:0005634; GO:0005694; GO:0005730; GO:0006302; GO:0006974; GO:0008630; GO:0010332; GO:0016779; GO:0043069; GO:0070212; GO:1990404"
"1761",1903,697790,"Cluster_6914","Peve_00014922",0.859145946579751,0.341990837284054,0.978262075707395,153,-20.08,"2 19","899 924",22,"68.18%","72.73%","Q9TXQ1","Poly [ADP-ribose] polymerase tankyrase (EC 2.4.2.30) (Poly ADP-ribose metabolism enzyme 5) (Protein poly-ADP-ribosyltransferase tankyrase) (EC 2.4.2.-)","Caenorhabditis elegans","cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of programmed cell death [GO:0043069]; protein poly-ADP-ribosylation [GO:0070212]; response to gamma radiation [GO:0010332]","GO:0003950; GO:0005634; GO:0005694; GO:0005730; GO:0006302; GO:0006974; GO:0008630; GO:0010332; GO:0016779; GO:0043069; GO:0070212; GO:1990404"
"1762",1904,699915,"Cluster_9149","Peve_00033391",0.932849199462805,0.234628882273968,0.978262075707395,147,-24.82,"2 21","395 412",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"1763",1905,699993,"Cluster_6905","Peve_00033393",-0.498791238000385,0.667554876444875,0.978262075707395,148,-23.33,"2 14","42 64",13,"84.62%","84.62%",NA,NA,NA,NA,NA
"1764",1906,701237,"Cluster_589","Peve_00028060",-0.0749404317077906,0.952246670435131,0.999448381576871,165,-30.37,"2 21","392 418",24,"79.17%","79.17%","Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"1765",1907,701367,"Cluster_15726","Peve_00015045",-0.5,0.666666666666667,0.978262075707395,154,-21.29,"2 20","757 779",19,"73.68%","73.68%","Q9EQD2","Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor)","Rattus norvegicus (Rat)","G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]","GO:0004930; GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0042277; GO:0043408; GO:0045761; GO:2000479"
"1766",1908,702346,"Cluster_9983","Peve_00037676",0.747802720967195,0.462217782181404,0.978262075707395,142,-20.42,"2 20","101 131",28,"57.14%","64.29%",NA,NA,NA,NA,NA
"1767",1909,702641,"Cluster_4115","Peve_00037678",0.783271532591398,0.427098915892661,0.978262075707395,150,-20.43,"2 21","912 932",19,"63.16%","78.95%",NA,NA,NA,NA,NA
"1768",1910,703860,"Cluster_5882","Peve_00009593",-0.692781830516684,0.512769774778856,0.978262075707395,162,-20.96,"2 21","713 737",22,"72.73%","81.82%",NA,NA,NA,NA,NA
"1769",1911,704466,"Cluster_11134","Peve_00028893",-0.0195622829453675,0.987545469442176,0.999448381576871,152,-21.29,"2 19","509 533",20,"70.00%","80.00%",NA,NA,NA,NA,NA
"1770",1912,704477,"Cluster_589","Peve_00028890",-0.934753615028442,0.231240264998328,0.978262075707395,144,-20.49,"2 18","662 688",21,"61.90%","71.43%",NA,NA,NA,NA,NA
"1771",1913,704511,"Cluster_11134","Peve_00028890",-0.0195622829453675,0.987545469442176,0.999448381576871,163,-20.67,"2 21","886 908",20,"75.00%","80.00%",NA,NA,NA,NA,NA
"1772",1914,704800,"Cluster_4080","Peve_00018075",-0.395512734992648,0.741133823730297,0.986697151420032,161,-20.21,"2 21","109 128",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"1773",1915,705883,"Cluster_4735","Peve_00030941",-0.500943642233887,0.665972771890438,0.978262075707395,158,-21.39,"2 21","913 938",23,"73.91%","73.91%",NA,NA,NA,NA,NA
"1774",1916,706131,"Cluster_11134","Peve_00025322",-0.0195622829453675,0.987545469442176,0.999448381576871,169,-25.81,"2 21","507 528",20,"80.00%","90.00%",NA,NA,NA,NA,NA
"1775",1917,706258,"Cluster_8888","Peve_00025327",-0.682281632738944,0.521975597954868,0.978262075707395,162,-20.3,"2 20","682 703",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"1776",1918,706317,"Cluster_15726","Peve_00025326",-0.643762941820264,0.554744573991684,0.978262075707395,151,-20.15,"2 21","223 245",20,"60.00%","80.00%","Q8IX03","Protein KIBRA (HBeAg-binding protein 3) (Kidney and brain protein) (KIBRA) (WW domain-containing protein 1)","Homo sapiens (Human)","cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of MAPK cascade [GO:0043410]; regulation of DNA-templated transcription [GO:0006355]; regulation of hippo signaling [GO:0035330]; regulation of intracellular transport [GO:0032386]","GO:0000122; GO:0003713; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0016477; GO:0019900; GO:0030010; GO:0032386; GO:0032587; GO:0032991; GO:0035330; GO:0035331; GO:0043410; GO:0046621; GO:0048471; GO:0060090"
"1777",1919,706481,"Cluster_8884","Peve_00025328",0.528334649118419,0.645633303492171,0.978262075707395,154,-20.09,"2 20","922 939",18,"77.78%","83.33%","Q6GL87","Growth hormone-regulated TBC protein 1","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0005096"
"1778",1920,706482,"Cluster_8887","Peve_00025328",0.741988537649272,0.467765721218606,0.978262075707395,154,-20.45,"2 20","922 939",18,"77.78%","83.33%","Q6GL87","Growth hormone-regulated TBC protein 1","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0005096"
"1779",1921,706483,"Cluster_8888","Peve_00025328",0.999964597582385,0.00535689165213977,0.551398425649056,154,-22.08,"2 20","922 939",18,"77.78%","83.33%","Q6GL87","Growth hormone-regulated TBC protein 1","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0005096"
"1780",1922,706517,"Cluster_6904","Peve_00003847",-0.787945553377521,0.422289637423629,0.978262075707395,155,-20.6,"2 21","31 53",20,"70.00%","75.00%","G5E8K5","Ankyrin-3 (ANK-3) (Ankyrin-G)","Mus musculus (Mouse)","anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; signal transduction [GO:0007165]; synapse organization [GO:0050808]","GO:0000281; GO:0005200; GO:0005737; GO:0005764; GO:0005886; GO:0005923; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1904115; GO:2000651; GO:2001259"
"1781",1923,706519,"Cluster_6906","Peve_00003847",-0.986917375130573,0.103090152206722,0.978262075707395,163,-24.17,"2 21","31 53",20,"75.00%","80.00%","G5E8K5","Ankyrin-3 (ANK-3) (Ankyrin-G)","Mus musculus (Mouse)","anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; signal transduction [GO:0007165]; synapse organization [GO:0050808]","GO:0000281; GO:0005200; GO:0005737; GO:0005764; GO:0005886; GO:0005923; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1904115; GO:2000651; GO:2001259"
"1782",1924,706626,"Cluster_11134","Peve_00029853",-0.310938196627617,0.798713559282707,0.995934364227446,159,-20.33,"2 17","979 1000",16,"81.25%","87.50%","Q08DG6","Cytochrome c oxidase assembly protein COX15 homolog","Bos taurus (Bovine)","heme A biosynthetic process [GO:0006784]","GO:0005743; GO:0006784; GO:0016653"
"1783",1925,707025,"Cluster_9149","Peve_00005904",0.634757315797126,0.562200140478262,0.978262075707395,146,-21.28,"2 11","617 638",9,"88.89%","100.00%",NA,NA,NA,NA,NA
"1784",1926,707076,"Cluster_11134","Peve_00005906",-0.723097950700821,0.485435012368537,0.978262075707395,164,-21.76,"2 21","92 113",19,"57.89%","94.74%","Q54H45","Probable serine/threonine-protein kinase drkB (EC 2.7.11.1) (Receptor-like kinase 2) (Receptor-like kinase B) (Vesicle-associated receptor tyrosine kinase-like protein 2)","Dictyostelium discoideum (Social amoeba)","protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]","GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0016020; GO:0106310"
"1785",1927,707516,"Cluster_8884","Peve_00007506",-0.86961150659234,0.328738606623903,0.978262075707395,172,-23.36,"2 19","67 86",17,"88.24%","94.12%","Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"1786",1928,707517,"Cluster_8887","Peve_00007506",-0.699731211015895,0.506606188897468,0.978262075707395,172,-22.99,"2 19","67 86",17,"88.24%","94.12%","Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"1787",1929,707518,"Cluster_8888","Peve_00007506",-0.0318365431975917,0.979728801768197,0.999448381576871,172,-23.23,"2 19","67 86",17,"88.24%","94.12%","Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"1788",1930,707642,"Cluster_6904","Peve_00007503",-0.901413806969744,0.285060748224555,0.978262075707395,154,-21.66,"2 15","970 991",13,"76.92%","92.31%",NA,NA,NA,NA,NA
"1789",1931,707644,"Cluster_6906","Peve_00007503",-0.582358222967054,0.604260233441462,0.978262075707395,160,-22.67,"2 19","971 991",17,"76.47%","88.24%",NA,NA,NA,NA,NA
"1790",1932,707943,"Cluster_796","Peve_00026003",0.520348984049068,0.65160373812843,0.978262075707395,157,-21.11,"2 20","766 786",18,"77.78%","77.78%","P50430","Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)","Rattus norvegicus (Rat)","anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; dermatan sulfate catabolic process [GO:0030209]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]","GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030209; GO:0043627; GO:0043890; GO:0046872; GO:0051597; GO:0061580; GO:0097065"
"1791",1933,707982,"Cluster_15726","Peve_00026003",-0.908862559334589,0.273904045635781,0.978262075707395,166,-22.46,"2 21","535 558",21,"80.95%","80.95%","P50430","Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)","Rattus norvegicus (Rat)","anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; dermatan sulfate catabolic process [GO:0030209]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]","GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030209; GO:0043627; GO:0043890; GO:0046872; GO:0051597; GO:0061580; GO:0097065"
"1792",1934,708041,"Cluster_4115","Peve_00026001",0.783271532591398,0.427098915892661,0.978262075707395,161,-20.13,"2 20","223 243",18,"72.22%","88.89%","Q8WU66","Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR)","Homo sapiens (Human)","hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505]","GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170"
"1793",1935,708218,"Cluster_2882","Peve_00026009",-0.775678773701944,0.43481540968864,0.978262075707395,163,-25.65,"2 17","948 970",16,"87.50%","87.50%","Q00655","Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) [Cleaved into: 72 kDa tyrosine-protein kinase SYK; 40 kDa tyrosine-protein kinase SYK]","Sus scrofa (Pig)","adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; B cell receptor signaling pathway [GO:0050853]; blood vessel morphogenesis [GO:0048514]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to molecule of fungal origin [GO:0071226]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-3-mediated signaling pathway [GO:0038156]; intracellular signal transduction [GO:0035556]; leukocyte activation involved in immune response [GO:0002366]; leukocyte cell-cell adhesion [GO:0007159]; lymph vessel development [GO:0001945]; macrophage activation involved in immune response [GO:0002281]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of interleukin-4 production [GO:0032753]; receptor internalization [GO:0031623]; regulation of arachidonic acid secretion [GO:0090237]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neutrophil degranulation [GO:0043313]; regulation of phagocytosis [GO:0050764]; regulation of platelet activation [GO:0010543]; regulation of platelet aggregation [GO:0090330]; regulation of superoxide anion generation [GO:0032928]; serotonin secretion by platelet [GO:0002554]","GO:0001525; GO:0001945; GO:0002250; GO:0002281; GO:0002283; GO:0002366; GO:0002554; GO:0004715; GO:0005524; GO:0005829; GO:0005886; GO:0007159; GO:0007229; GO:0010543; GO:0018108; GO:0030593; GO:0031623; GO:0032009; GO:0032753; GO:0032928; GO:0033630; GO:0035556; GO:0038156; GO:0042742; GO:0043313; GO:0045087; GO:0045780; GO:0048514; GO:0050764; GO:0050853; GO:0070372; GO:0071226; GO:0071404; GO:0090237; GO:0090330"
"1794",1936,708780,"Cluster_9149","Peve_00026910",1,0,0,165,-22,"2 19","663 685",18,"83.33%","83.33%",NA,NA,NA,NA,NA
"1795",1937,709005,"Cluster_9149","Peve_00026917",-0.970284421669783,0.155585300947346,0.978262075707395,147,-22.18,"2 21","914 936",20,"60.00%","75.00%","Q8HXQ3","Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)","Hylobates lar (Common gibbon) (White-handed gibbon)","auditory receptor cell stereocilium organization [GO:0060088]; cellular iron ion homeostasis [GO:0006879]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of MAPK cascade [GO:0043410]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular associated smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to axon injury [GO:0048678]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to organic substance [GO:0010033]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]","GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0002262; GO:0004784; GO:0005507; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006749; GO:0006801; GO:0006879; GO:0007283; GO:0007566; GO:0007605; GO:0007626; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031410; GO:0032287; GO:0032839; GO:0032991; GO:0040014; GO:0042542; GO:0043025; GO:0043085; GO:0043410; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046716; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0072593"
"1796",1938,709617,"Cluster_4629","Peve_00013220",0.728200220909821,0.480714181470686,0.978262075707395,163,-22.04,"2 20","401 422",18,"77.78%","77.78%",NA,NA,NA,NA,NA
"1797",1940,710200,"Cluster_4080","Peve_00024512",0.391306517112257,0.744046453705608,0.987083654200536,169,-22.52,"2 21","523 544",20,"85.00%","85.00%",NA,NA,NA,NA,NA
"1798",1941,710422,"Cluster_2854","Peve_00024514",0.90559827179948,0.278844654148129,0.978262075707395,162,-23.5,"2 20","869 891",19,"68.42%","89.47%","P0CM16","ADP-ribosylation factor","Cryptococcus neoformans var. neoformans serotype D (strain JEC21 / ATCC MYA-565) (Filobasidiella neoformans)","intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]","GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005886; GO:0006886; GO:0016192"
"1799",1942,710513,"Cluster_2882","Peve_00010048",-0.916277610520719,0.262357542360023,0.978262075707395,150,-22.28,"2 16","1 16",15,"80.00%","80.00%","Q5R5M0","Mitochondrial carrier homolog 2","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","lipid homeostasis [GO:0055088]; positive regulation of apoptotic process [GO:0043065]; positive regulation of stem cell differentiation [GO:2000738]; protein insertion into mitochondrial outer membrane [GO:0045040]; regulation of mitochondrial fusion [GO:0010635]","GO:0005741; GO:0010635; GO:0032977; GO:0043065; GO:0045040; GO:0055088; GO:2000738"
"1800",1943,710817,"Cluster_15726","Peve_00010046",-0.769062752224002,0.441446674826415,0.978262075707395,151,-30.15,"2 21","595 624",27,"59.26%","70.37%","Q14191","Bifunctional 3'-5' exonuclease/ATP-dependent helicase WRN (DNA helicase, RecQ-like type 3) (RecQ protein-like 2) (Werner syndrome protein) [Includes: 3'-5' exonuclease (EC 3.1.-.-); ATP-dependent helicase (EC 3.6.4.12)]","Homo sapiens (Human)","aging [GO:0007568]; base-excision repair [GO:0006284]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to starvation [GO:0009267]; cellular senescence [GO:0090398]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; multicellular organism aging [GO:0010259]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of strand invasion [GO:0098530]; protein localization to nucleolus [GO:1902570]; regulation of growth rate [GO:0040009]; replication fork processing [GO:0031297]; replicative senescence [GO:0090399]; response to oxidative stress [GO:0006979]; response to UV-C [GO:0010225]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomeric D-loop disassembly [GO:0061820]","GO:0000287; GO:0000400; GO:0000403; GO:0000405; GO:0000723; GO:0000724; GO:0000731; GO:0000781; GO:0003677; GO:0003678; GO:0003682; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005730; GO:0005737; GO:0005813; GO:0006259; GO:0006260; GO:0006268; GO:0006281; GO:0006284; GO:0006302; GO:0006310; GO:0006974; GO:0006979; GO:0007420; GO:0007568; GO:0008408; GO:0009267; GO:0009378; GO:0010225; GO:0010259; GO:0016607; GO:0016887; GO:0030145; GO:0031297; GO:0032201; GO:0032405; GO:0032508; GO:0040009; GO:0042803; GO:0043005; GO:0043138; GO:0044806; GO:0044877; GO:0051345; GO:0051880; GO:0061749; GO:0061820; GO:0061821; GO:0061849; GO:0070337; GO:0071480; GO:0090398; GO:0090399; GO:0090656; GO:0098530; GO:1902570; GO:1905773"
"1801",1944,710956,"Cluster_29","Peve_00040163",-0.368569774287229,0.759695126986102,0.988219883885475,168,-22.22,"2 21","682 701",19,"84.21%","89.47%",NA,NA,NA,NA,NA
"1802",1945,711768,"Cluster_796","Peve_00010596",0.869326171700025,0.329106327979496,0.978262075707395,160,-23.99,"2 13","420 441",11,"100.00%","100.00%","B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"1803",1946,711950,"Cluster_1167","Peve_00010592",0.915094935384515,0.264230969680779,0.978262075707395,153,-23.18,"2 21","137 156",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"1804",1947,711951,"Cluster_2787","Peve_00010592",0.583098381564746,0.603680414630807,0.978262075707395,166,-28.96,"2 21","645 670",23,"73.91%","82.61%",NA,NA,NA,NA,NA
"1805",1948,712674,"Cluster_4079","Peve_00014235",-0.416635790853662,0.72641808510458,0.983490692580993,161,-23.71,"2 21","462 487",23,"73.91%","82.61%","Q9M9E8","Lysine-specific demethylase JMJ21 (EC 1.14.11.-) (F-box protein JMJ21) (Jumonji domain-containing protein 21) (AtJMJ21) (Protein JUMONJI 21) (Lysine-specific histone demethylase JMJ21) ([histone H3]-trimethyl-L-lysine monodemethylase JMJ21)","Arabidopsis thaliana (Mouse-ear cress)","","GO:0005634; GO:0005737; GO:0016491; GO:0046872"
"1806",1949,712722,"Cluster_4629","Peve_00014237",-0.437741460684252,0.711557044407697,0.979284521934012,150,-20.53,"2 17","238 258",15,"73.33%","86.67%","P31266","Recombining binding protein suppressor of hairless (J kappa-recombination signal-binding protein) (RBP-J kappa)","Mus musculus (Mouse)","angiogenesis [GO:0001525]; aortic valve development [GO:0003176]; arterial endothelial cell fate commitment [GO:0060844]; artery morphogenesis [GO:0048844]; atrioventricular canal development [GO:0036302]; auditory receptor cell fate commitment [GO:0009912]; B cell differentiation [GO:0030183]; blood vessel endothelial cell fate specification [GO:0097101]; blood vessel lumenization [GO:0072554]; blood vessel remodeling [GO:0001974]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cell population proliferation [GO:0008283]; club cell differentiation [GO:0060486]; defense response to bacterium [GO:0042742]; determination of heart left/right asymmetry [GO:0061371]; dorsal aorta morphogenesis [GO:0035912]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; epidermal cell fate specification [GO:0009957]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; humoral immune response [GO:0006959]; inflammatory response to antigenic stimulus [GO:0002437]; keratinocyte differentiation [GO:0030216]; labyrinthine layer blood vessel development [GO:0060716]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of ossification [GO:0030279]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in arterial endothelial cell fate commitment [GO:0060853]; outflow tract morphogenesis [GO:0003151]; pituitary gland development [GO:0021983]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment [GO:1901297]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell proliferation involved in heart morphogenesis [GO:2000138]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERBB signaling pathway [GO:1901186]; positive regulation of gene expression [GO:0010628]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; pulmonary valve development [GO:0003177]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of epithelial cell proliferation [GO:0050678]; regulation of gene expression [GO:0010468]; regulation of reproductive process [GO:2000241]; regulation of timing of cell differentiation [GO:0048505]; regulation of transcription by RNA polymerase II [GO:0006357]; sebaceous gland development [GO:0048733]; secondary heart field specification [GO:0003139]; somatic stem cell population maintenance [GO:0035019]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]","GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0001756; GO:0001837; GO:0001947; GO:0001974; GO:0002193; GO:0002437; GO:0003139; GO:0003151; GO:0003157; GO:0003160; GO:0003176; GO:0003177; GO:0003198; GO:0003214; GO:0003222; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0006357; GO:0006959; GO:0007219; GO:0007221; GO:0007507; GO:0008283; GO:0009912; GO:0009957; GO:0010468; GO:0010628; GO:0017053; GO:0021983; GO:0030097; GO:0030154; GO:0030182; GO:0030183; GO:0030216; GO:0030279; GO:0030513; GO:0032991; GO:0032993; GO:0035019; GO:0035481; GO:0035912; GO:0036302; GO:0042742; GO:0043011; GO:0043565; GO:0044877; GO:0045165; GO:0045596; GO:0045892; GO:0045893; GO:0045944; GO:0047485; GO:0048505; GO:0048733; GO:0048820; GO:0048844; GO:0050673; GO:0050678; GO:0050679; GO:0060045; GO:0060379; GO:0060412; GO:0060486; GO:0060716; GO:0060844; GO:0060853; GO:0061314; GO:0061344; GO:0061371; GO:0061419; GO:0061629; GO:0072089; GO:0072554; GO:0097101; GO:0120163; GO:0140297; GO:1901186; GO:1901189; GO:1901297; GO:2000138; GO:2000241; GO:2000647"
"1807",1950,712722,"Cluster_4629","Peve_00014237",-0.437741460684252,0.711557044407697,0.979284521934012,150,-20.53,"2 17","556 576",15,"73.33%","86.67%","P31266","Recombining binding protein suppressor of hairless (J kappa-recombination signal-binding protein) (RBP-J kappa)","Mus musculus (Mouse)","angiogenesis [GO:0001525]; aortic valve development [GO:0003176]; arterial endothelial cell fate commitment [GO:0060844]; artery morphogenesis [GO:0048844]; atrioventricular canal development [GO:0036302]; auditory receptor cell fate commitment [GO:0009912]; B cell differentiation [GO:0030183]; blood vessel endothelial cell fate specification [GO:0097101]; blood vessel lumenization [GO:0072554]; blood vessel remodeling [GO:0001974]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cell population proliferation [GO:0008283]; club cell differentiation [GO:0060486]; defense response to bacterium [GO:0042742]; determination of heart left/right asymmetry [GO:0061371]; dorsal aorta morphogenesis [GO:0035912]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; epidermal cell fate specification [GO:0009957]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; humoral immune response [GO:0006959]; inflammatory response to antigenic stimulus [GO:0002437]; keratinocyte differentiation [GO:0030216]; labyrinthine layer blood vessel development [GO:0060716]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of ossification [GO:0030279]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in arterial endothelial cell fate commitment [GO:0060853]; outflow tract morphogenesis [GO:0003151]; pituitary gland development [GO:0021983]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment [GO:1901297]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell proliferation involved in heart morphogenesis [GO:2000138]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERBB signaling pathway [GO:1901186]; positive regulation of gene expression [GO:0010628]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; pulmonary valve development [GO:0003177]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of epithelial cell proliferation [GO:0050678]; regulation of gene expression [GO:0010468]; regulation of reproductive process [GO:2000241]; regulation of timing of cell differentiation [GO:0048505]; regulation of transcription by RNA polymerase II [GO:0006357]; sebaceous gland development [GO:0048733]; secondary heart field specification [GO:0003139]; somatic stem cell population maintenance [GO:0035019]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]","GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0001756; GO:0001837; GO:0001947; GO:0001974; GO:0002193; GO:0002437; GO:0003139; GO:0003151; GO:0003157; GO:0003160; GO:0003176; GO:0003177; GO:0003198; GO:0003214; GO:0003222; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0006357; GO:0006959; GO:0007219; GO:0007221; GO:0007507; GO:0008283; GO:0009912; GO:0009957; GO:0010468; GO:0010628; GO:0017053; GO:0021983; GO:0030097; GO:0030154; GO:0030182; GO:0030183; GO:0030216; GO:0030279; GO:0030513; GO:0032991; GO:0032993; GO:0035019; GO:0035481; GO:0035912; GO:0036302; GO:0042742; GO:0043011; GO:0043565; GO:0044877; GO:0045165; GO:0045596; GO:0045892; GO:0045893; GO:0045944; GO:0047485; GO:0048505; GO:0048733; GO:0048820; GO:0048844; GO:0050673; GO:0050678; GO:0050679; GO:0060045; GO:0060379; GO:0060412; GO:0060486; GO:0060716; GO:0060844; GO:0060853; GO:0061314; GO:0061344; GO:0061371; GO:0061419; GO:0061629; GO:0072089; GO:0072554; GO:0097101; GO:0120163; GO:0140297; GO:1901186; GO:1901189; GO:1901297; GO:2000138; GO:2000241; GO:2000647"
"1808",1951,713127,"Cluster_4629","Peve_00044602",-0.937277878737284,0.226674174285796,0.978262075707395,151,-20.84,"2 12","29 50",10,"90.00%","100.00%","Q28FE4","MORN repeat-containing protein 5","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","",""
"1809",1952,713692,"Cluster_11135","Peve_00011883",0.70520700419677,0.501708110760817,0.978262075707395,147,-21.68,"2 17","255 281",20,"65.00%","75.00%",NA,NA,NA,NA,NA
"1810",1954,714338,"Cluster_2882","Peve_00013432",-0.436706448193914,0.712289693016804,0.979496192350513,162,-20.19,"2 21","784 808",22,"72.73%","81.82%",NA,NA,NA,NA,NA
"1811",1955,714572,"Cluster_6904","Peve_00012678",-0.81859045406599,0.389511769925826,0.978262075707395,146,-20.21,"2 17","873 896",17,"76.47%","76.47%",NA,NA,NA,NA,NA
"1812",1956,715113,"Cluster_6905","Peve_00039583",0.891832586576559,0.298839556542654,0.978262075707395,150,-21.03,"2 16","586 608",15,"80.00%","80.00%","P19804","Nucleoside diphosphate kinase B (NDK B) (NDP kinase B) (EC 2.7.4.6) (Histidine protein kinase NDKB) (EC 2.7.13.3) (P18)","Rattus norvegicus (Rat)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of epidermis development [GO:0045682]; response to growth hormone [GO:0060416]; UTP biosynthetic process [GO:0006228]","GO:0001726; GO:0002762; GO:0003677; GO:0003713; GO:0004550; GO:0004673; GO:0004674; GO:0005504; GO:0005524; GO:0005634; GO:0005737; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0007189; GO:0007229; GO:0009142; GO:0010976; GO:0019003; GO:0019215; GO:0019899; GO:0030027; GO:0031966; GO:0034599; GO:0042802; GO:0042981; GO:0043066; GO:0045618; GO:0045682; GO:0045893; GO:0045944; GO:0046777; GO:0046872; GO:0048471; GO:0050679; GO:0051880; GO:0060416; GO:0071333; GO:0071398; GO:0071944; GO:1901363"
"1813",1957,715249,"Cluster_6906","Peve_00045262",-0.724953865374852,0.48372210987314,0.978262075707395,142,-20.99,"2 17","803 829",20,"65.00%","75.00%","O60841","Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2)","Homo sapiens (Human)","regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]","GO:0003723; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005829; GO:0006413; GO:0006446; GO:0045202; GO:0046872"
"1814",1958,715755,"Cluster_9149","Peve_00019501",-0.450726568124074,0.702329895919414,0.978262075707395,141,-21.04,"2 10","764 785",8,"87.50%","100.00%","Q8NBS3","Solute carrier family 4 member 11 (Sodium borate cotransporter 1) (NaBC1)","Homo sapiens (Human)","bicarbonate transport [GO:0015701]; borate transport [GO:0046713]; cellular cation homeostasis [GO:0030003]; cellular hypotonic response [GO:0071476]; cellular response to oxidative stress [GO:0034599]; fluid transport [GO:0042044]; ion homeostasis [GO:0050801]; proton transmembrane transport [GO:1902600]; regulation of mesenchymal stem cell differentiation [GO:2000739]; regulation of mitochondrial membrane potential [GO:0051881]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]","GO:0005272; GO:0005372; GO:0005452; GO:0005886; GO:0006814; GO:0012506; GO:0015078; GO:0015106; GO:0015252; GO:0015293; GO:0015701; GO:0016323; GO:0016324; GO:0022857; GO:0030003; GO:0034599; GO:0042044; GO:0046713; GO:0046715; GO:0046983; GO:0050801; GO:0051881; GO:0055085; GO:0071476; GO:1902600; GO:2000739"
"1815",1959,716452,"Cluster_2854","Peve_00004509",0.482104738253558,0.679744930618126,0.978262075707395,166,-26.08,"2 15","353 374",13,"92.31%","100.00%",NA,NA,NA,NA,NA
"1816",1960,716585,"Cluster_1167","Peve_00002830",-0.450568413619538,0.702442681917752,0.978262075707395,152,-21.9,"2 20","810 829",18,"66.67%","83.33%","Q5RAK8","Circadian locomoter output cycles protein kaput (EC 2.3.1.48)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","cellular response to DNA damage stimulus [GO:0006974]; circadian regulation of gene expression [GO:0032922]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein acetylation [GO:0006473]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription [GO:0006355]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283]","GO:0000978; GO:0003677; GO:0003700; GO:0004402; GO:0005634; GO:0005667; GO:0005829; GO:0006355; GO:0006473; GO:0006974; GO:0007283; GO:0031490; GO:0032922; GO:0033391; GO:0042634; GO:0042752; GO:0043161; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046983; GO:0050796; GO:0051092; GO:0051775; GO:0070888; GO:2000074; GO:2000323"
"1817",1961,716694,"Cluster_7855","Peve_00002832",-0.075674557486116,0.951777980527359,0.999448381576871,188,-23.29,"2 21","399 420",19,"89.47%","94.74%",NA,NA,NA,NA,NA
"1818",1962,716868,"Cluster_6905","Peve_00002837",-0.929945104908788,0.239708228175045,0.978262075707395,155,-22.47,"2 18","731 751",16,"81.25%","81.25%",NA,NA,NA,NA,NA
"1819",1963,717087,"Cluster_4629","Peve_00043837",-0.448355559535223,0.704019697647163,0.978262075707395,146,-21.6,"2 21","61 81",19,"63.16%","73.68%","Q8VDJ3","Vigilin (High density lipoprotein-binding protein) (HDL-binding protein)","Mus musculus (Mouse)","cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]","GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006869; GO:0008203; GO:0034364"
"1820",1964,717290,"Cluster_10965","Peve_00043838",-0.861501692342471,0.33904874167394,0.978262075707395,162,-20.42,"2 20","785 809",21,"76.19%","76.19%","Q8NFZ3","Neuroligin-4, Y-linked (Neuroligin Y)","Homo sapiens (Human)","chemical synaptic transmission [GO:0007268]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]","GO:0005886; GO:0007158; GO:0007268; GO:0007612; GO:0009986; GO:0016020; GO:0035176; GO:0038023; GO:0042043; GO:0045202; GO:0048488; GO:0050804; GO:0050839; GO:0071625; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098839; GO:0098983; GO:0098985; GO:0099054; GO:0099634"
"1821",1965,717393,"Cluster_796","Peve_00015331",0.490834294769647,0.673384087672509,0.978262075707395,163,-23.44,"2 20","88 109",18,"77.78%","77.78%",NA,NA,NA,NA,NA
"1822",1966,717731,"Cluster_8884","Peve_00042123",0.51337602643252,0.656789244620732,0.978262075707395,165,-23.62,"2 18","744 764",16,"81.25%","87.50%","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1823",1967,717732,"Cluster_8887","Peve_00042123",0.730127100426989,0.478921662347167,0.978262075707395,165,-23.62,"2 18","744 764",16,"81.25%","87.50%","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1824",1968,718985,"Cluster_6914","Peve_00000998",0.958454729110168,0.184149725973742,0.978262075707395,159,-20.12,"2 19","771 789",17,"82.35%","82.35%",NA,NA,NA,NA,NA
"1825",1969,719046,"Cluster_11134","Peve_00000995",0.850223079221909,0.352933988879336,0.978262075707395,152,-21.46,"2 21","9 30",19,"57.89%","78.95%","Q6GPE5","Protein fem-1 homolog B (FEM1b) (FEM1-beta)","Xenopus laevis (African clawed frog)","apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756; GO:2000001"
"1826",1970,719157,"Cluster_4629","Peve_00030299",0.951162899474742,0.199780719005777,0.978262075707395,168,-27.12,"2 21","880 901",19,"73.68%","84.21%","Q4V8V1","Breast cancer metastasis-suppressor 1-like protein-A","Danio rerio (Zebrafish) (Brachydanio rerio)","histone deacetylation [GO:0016575]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]","GO:0000122; GO:0016575; GO:0030336; GO:0030512; GO:0042826; GO:0070822; GO:1902455; GO:1902459"
"1827",1971,720780,"Cluster_5882","Peve_00007075",0.193724048589327,0.875886714454834,0.997736388472058,172,-21.26,"2 21","337 358",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"1828",1972,722942,"Cluster_6904","Peve_00019263",-0.951310992493219,0.199475076059675,0.978262075707395,151,-20.53,"2 21","120 143",21,"61.90%","76.19%",NA,NA,NA,NA,NA
"1829",1973,722944,"Cluster_6906","Peve_00019263",-0.686063329690759,0.518674561276582,0.978262075707395,151,-21.27,"2 21","120 143",21,"61.90%","76.19%",NA,NA,NA,NA,NA
"1830",1974,723144,"Cluster_13502","Peve_00019267",0.919004795220497,0.257988658647054,0.978262075707395,196,-37.19,"2 21","409 430",19,"94.74%","100.00%","Q5ZJT0","ATP-dependent RNA helicase SUPV3L1, mitochondrial (EC 3.6.4.13) (Suppressor of var1 3-like protein 1) (SUV3-like protein 1)","Gallus gallus (Chicken)","DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion morphogenesis [GO:0070584]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401]","GO:0000958; GO:0000962; GO:0000965; GO:0003677; GO:0003678; GO:0003724; GO:0003725; GO:0005524; GO:0005634; GO:0005739; GO:0005759; GO:0006310; GO:0006401; GO:0016887; GO:0030307; GO:0032508; GO:0034458; GO:0035945; GO:0035946; GO:0042645; GO:0043066; GO:0045025; GO:0070584; GO:2000827"
"1831",1975,723225,"Cluster_9149","Peve_00019269",-0.637745444128505,0.559734359468861,0.978262075707395,148,-21.68,"2 18","331 354",18,"72.22%","72.22%",NA,NA,NA,NA,NA
"1832",1976,723337,"Cluster_2854","Peve_00029644",-0.656218036723363,0.544310304449957,0.978262075707395,169,-28.3,"2 21","924 943",19,"78.95%","89.47%","Q9NSN8","Gamma-1-syntrophin (G1SYN) (Syntrophin-4) (SYN4)","Homo sapiens (Human)","cell communication [GO:0007154]","GO:0003779; GO:0005198; GO:0005634; GO:0005737; GO:0005856; GO:0007154; GO:0008022; GO:0016010; GO:0016013; GO:0032587"
"1833",1977,723822,"Cluster_15726","Peve_00022611",-0.9269079096159,0.244912968432719,0.978262075707395,171,-21.41,"2 20","205 226",18,"77.78%","88.89%","Q7T312","Coiled-coil domain-containing protein 25","Danio rerio (Zebrafish) (Brachydanio rerio)","positive regulation of cell motility [GO:2000147]","GO:0003677; GO:0005886; GO:0012505; GO:2000147"
"1834",1978,724012,"Cluster_2854","Peve_00024755",-0.995463600609732,0.0606617698463826,0.978262075707395,147,-20.22,"2 21","392 416",22,"59.09%","72.73%",NA,NA,NA,NA,NA
"1835",1979,724056,"Cluster_2787","Peve_00024757",0.867933894665659,0.330895275232091,0.978262075707395,158,-22.77,"2 15","167 188",13,"84.62%","92.31%",NA,NA,NA,NA,NA
"1836",1980,724292,"Cluster_6904","Peve_00038835",0.820047249746893,0.387894178746288,0.978262075707395,158,-21.95,"2 19","393 414",17,"70.59%","82.35%","B3EWZ5","MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576; GO:0016020"
"1837",1981,724316,"Cluster_14999","Peve_00038835",0.361396023080245,0.764600496049147,0.989508063027969,162,-23.07,"2 21","323 346",21,"76.19%","80.95%","B3EWZ5","MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576; GO:0016020"
"1838",1982,725007,"Cluster_4629","Peve_00025489",0.997938030915672,0.0408894104551393,0.909359886114279,143,-20.34,"2 12","908 929",10,"80.00%","90.00%",NA,NA,NA,NA,NA
"1839",1983,726230,"Cluster_6914","Peve_00025156",0.785903576337605,0.424396384214392,0.978262075707395,153,-20.29,"2 20","824 846",20,"70.00%","80.00%",NA,NA,NA,NA,NA
"1840",1984,726767,"Cluster_6904","Peve_00020500",0.397520956849851,0.739741192011838,0.986697151420032,147,-20.12,"2 17","303 327",18,"72.22%","72.22%",NA,NA,NA,NA,NA
"1841",1985,727302,"Cluster_4629","Peve_00021670",-0.254728945523392,0.836027505567368,0.995934364227446,159,-22.01,"2 17","427 449",16,"81.25%","87.50%","Q6ZSS7","Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2 homolog)","Homo sapiens (Human)","antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]","GO:0005886; GO:0016020; GO:0042590"
"1842",1986,727511,"Cluster_14999","Peve_00021676",0.999075146741859,0.0273819903750951,0.894692732264905,167,-25.85,"2 16","820 841",14,"85.71%","100.00%",NA,NA,NA,NA,NA
"1843",1987,727667,"Cluster_6904","Peve_00006062",0.740109681533494,0.469547115649012,0.978262075707395,142,-24.37,"2 21","218 247",27,"59.26%","66.67%",NA,NA,NA,NA,NA
"1844",1988,728290,"Cluster_4080","Peve_00039973",0.959498247432244,0.1818062644036,0.978262075707395,179,-24.5,"2 20","472 493",18,"88.89%","88.89%",NA,NA,NA,NA,NA
"1845",1989,728763,"Cluster_10061","Peve_00007333",-0.635883330703932,0.561271885724667,0.978262075707395,166,-20.22,"2 15","776 797",13,"92.31%","100.00%",NA,NA,NA,NA,NA
"1846",1990,728777,"Cluster_589","Peve_00007338",0.775072695353894,0.435426401668339,0.978262075707395,154,-20.71,"2 19","380 401",17,"64.71%","82.35%",NA,NA,NA,NA,NA
"1847",1991,728849,"Cluster_8988","Peve_00044956",0.917258131990139,0.260794722933018,0.978262075707395,154,-21.83,"2 21","267 291",22,"63.64%","81.82%","Q8C206","G-protein coupled receptor 157","Mus musculus (Mouse)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; circadian behavior [GO:0048512]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; radial glial cell differentiation [GO:0060019]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0048512; GO:0051482; GO:0060019; GO:0060170"
"1848",1992,729296,"Cluster_8884","Peve_00027146",0.195666758587174,0.874625817801006,0.997476741937264,153,-21.41,"2 20","84 103",18,"66.67%","83.33%",NA,NA,NA,NA,NA
"1849",1993,729297,"Cluster_8887","Peve_00027146",-0.0823630340017489,0.947506599925429,0.999448381576871,153,-21.04,"2 20","84 103",18,"66.67%","83.33%",NA,NA,NA,NA,NA
"1850",1994,729625,"Cluster_14500","Peve_00011297",0.409296274095264,0.731548494390394,0.984904317662596,168,-20.39,"2 19","636 656",17,"82.35%","94.12%",NA,NA,NA,NA,NA
"1851",1995,730054,"Cluster_6906","Peve_00017925",-0.506766881859655,0.661680974297832,0.978262075707395,165,-23.64,"2 20","976 996",18,"83.33%","83.33%",NA,NA,NA,NA,NA
"1852",1996,730680,"Cluster_5882","Peve_00034621",-0.286613124287243,0.814941145203436,0.995934364227446,160,-20.09,"2 21","222 241",19,"73.68%","89.47%","Q26422","Limulus clotting factor C (FC) (EC 3.4.21.84) [Cleaved into: Limulus clotting factor C heavy chain; Limulus clotting factor C light chain; Limulus clotting factor C chain A; Limulus clotting factor C chain B]","Carcinoscorpius rotundicauda (Mangrove horseshoe crab) (Limulus rotundicauda)","cell adhesion [GO:0007155]; hemolymph coagulation [GO:0042381]; proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508; GO:0007155; GO:0030246; GO:0042381"
"1853",1997,730725,"Cluster_5882","Peve_00034622",-0.216717506974581,0.860929897846958,0.996382113043354,160,-20.09,"2 21","228 247",19,"73.68%","89.47%","O00339","Matrilin-2","Homo sapiens (Human)","extracellular matrix organization [GO:0030198]","GO:0005201; GO:0005509; GO:0005576; GO:0030198; GO:0031012; GO:0062023; GO:0120216"
"1854",1999,731567,"Cluster_589","Peve_00002201",0.692749046994668,0.512798715030707,0.978262075707395,159,-24.18,"2 16","748 769",14,"85.71%","85.71%","A0A1D5NSM8",NA,NA,NA,NA
"1855",2000,731599,"Cluster_10934","Peve_00002201",-0.640366088556982,0.557565297556141,0.978262075707395,174,-21.26,"2 20","174 196",19,"84.21%","89.47%","A0A1D5NSM8",NA,NA,NA,NA
"1856",2001,731640,"Cluster_9149","Peve_00012722",1,0,0,152,-25.13,"2 15","768 788",13,"84.62%","92.31%",NA,NA,NA,NA,NA
"1857",2002,731977,"Cluster_2854","Peve_00020269",-0.56332494844659,0.619043850983386,0.978262075707395,160,-22.29,"2 21","194 215",19,"73.68%","73.68%","P42290","D(1B) dopamine receptor (D(5) dopamine receptor) (Dopamine D5 receptor)","Xenopus laevis (African clawed frog)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; regulation of biological quality [GO:0065008]","GO:0004930; GO:0004952; GO:0005886; GO:0007189; GO:0045202; GO:0065008"
"1858",2003,731977,"Cluster_2854","Peve_00020269",-0.56332494844659,0.619043850983386,0.978262075707395,192,-30.77,"2 21","354 375",19,"94.74%","94.74%","P42290","D(1B) dopamine receptor (D(5) dopamine receptor) (Dopamine D5 receptor)","Xenopus laevis (African clawed frog)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; regulation of biological quality [GO:0065008]","GO:0004930; GO:0004952; GO:0005886; GO:0007189; GO:0045202; GO:0065008"
"1859",2004,732922,"Cluster_2854","Peve_00003154",-0.481797400454618,0.67996823321869,0.978262075707395,154,-21.28,"2 21","433 459",24,"66.67%","75.00%","P98133","Fibrillin-1 (MP340) [Cleaved into: Asprosin]","Bos taurus (Bovine)","activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein kinase A signaling [GO:0010737]","GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0008201; GO:0009653; GO:0010737; GO:0031012; GO:0034199; GO:0042593"
"1860",2006,733534,"Cluster_10934","Peve_00035998",-0.784404677989838,0.425937202962567,0.978262075707395,151,-20.73,"2 19","415 434",17,"64.71%","88.24%","Q7K556","TRPL translocation defect protein 14","Drosophila melanogaster (Fruit fly)","photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]","GO:0005525; GO:0005829; GO:0015031; GO:0035091; GO:0045494; GO:0070300"
"1861",2007,733862,"Cluster_589","Peve_00016724",-0.966514079005266,0.165213545069559,0.978262075707395,170,-31.44,"2 15","623 644",13,"100.00%","100.00%",NA,NA,NA,NA,NA
"1862",2008,734041,"Cluster_29","Peve_00014766",-0.876818282166452,0.319323282234185,0.978262075707395,152,-20.57,"2 20","299 323",21,"71.43%","80.95%","Q23915","Probable serine/threonine-protein kinase kinX (EC 2.7.11.1)","Dictyostelium discoideum (Social amoeba)","protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]","GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0106310"
"1863",2009,734394,"Cluster_13502","Peve_00001793",-0.44209200413486,0.708472937844906,0.978262075707395,151,-20.06,"2 21","822 844",20,"60.00%","80.00%",NA,NA,NA,NA,NA
"1864",2010,735083,"Cluster_2882","Peve_00016896",0.0688372031480257,0.956142191637655,0.999448381576871,172,-23.67,"2 21","952 973",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"1865",2011,735126,"Cluster_2787","Peve_00016898",0.8341545900412,0.37191210348585,0.978262075707395,154,-20.83,"2 21","648 671",21,"71.43%","76.19%","Q92870","Amyloid beta precursor protein binding family B member 2 (Amyloid-beta (A4) precursor protein-binding family B member 2) (Protein Fe65-like 1)","Homo sapiens (Human)","intracellular signal transduction [GO:0035556]; maintenance of lens transparency [GO:0036438]; negative regulation of cell cycle phase transition [GO:1901988]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; smooth muscle contraction [GO:0006939]; synapse organization [GO:0050808]","GO:0000122; GO:0001540; GO:0005634; GO:0005737; GO:0005769; GO:0005783; GO:0005794; GO:0006355; GO:0006939; GO:0016020; GO:0030027; GO:0030426; GO:0035556; GO:0036438; GO:0045202; GO:0045944; GO:0050808; GO:1901988"
"1866",2012,735446,"Cluster_4115","Peve_00014496",-0.757284035040816,0.45305171204491,0.978262075707395,169,-22.8,"2 19","696 719",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"1867",2013,735502,"Cluster_7657","Peve_00014491",0.67975039820707,0.524176207143376,0.978262075707395,167,-22.5,"2 21","16 38",20,"75.00%","85.00%","Q8L7S6","Beta-hexosaminidase 3 (EC 3.2.1.52) (Beta-GlcNAcase 3) (Beta-N-acetylhexosaminidase 3) (Beta-hexosaminidase 1) (AtHEX1) (N-acetyl-beta-glucosaminidase 3)","Arabidopsis thaliana (Mouse-ear cress)","carbohydrate metabolic process [GO:0005975]; glycosaminoglycan metabolic process [GO:0030203]","GO:0004563; GO:0005634; GO:0005886; GO:0005975; GO:0015929; GO:0016020; GO:0030203; GO:0102148"
"1868",2014,735503,"Cluster_7658","Peve_00014491",-0.999687209109476,0.0159233151265928,0.762215157405503,167,-22.5,"2 21","16 38",20,"75.00%","85.00%","Q8L7S6","Beta-hexosaminidase 3 (EC 3.2.1.52) (Beta-GlcNAcase 3) (Beta-N-acetylhexosaminidase 3) (Beta-hexosaminidase 1) (AtHEX1) (N-acetyl-beta-glucosaminidase 3)","Arabidopsis thaliana (Mouse-ear cress)","carbohydrate metabolic process [GO:0005975]; glycosaminoglycan metabolic process [GO:0030203]","GO:0004563; GO:0005634; GO:0005886; GO:0005975; GO:0015929; GO:0016020; GO:0030203; GO:0102148"
"1869",2015,735696,"Cluster_11134","Peve_00038359",0.875640822838247,0.320878802775509,0.978262075707395,148,-20.05,"2 13","932 953",11,"72.73%","100.00%","Q8K3X2","GDP-L-fucose synthase (EC 1.1.1.271) (GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase) (Protein FX) (Red cell NADP(H)-binding protein)","Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)","'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]","GO:0010595; GO:0016853; GO:0042351; GO:0050577; GO:1904906"
"1870",2016,736116,"Cluster_2787","Peve_00004317",0.884315829541892,0.309250618976593,0.978262075707395,146,-20.67,"2 21","254 270",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"1871",2017,736146,"Cluster_11134","Peve_00004317",0.014435314307299,0.990809874302326,0.999448381576871,159,-21.34,"2 21","596 619",21,"66.67%","80.95%",NA,NA,NA,NA,NA
"1872",2018,736196,"Cluster_14999","Peve_00004315",0.47443735243041,0.685303084188443,0.978262075707395,179,-24.56,"2 21","399 422",21,"80.95%","90.48%",NA,NA,NA,NA,NA
"1873",2019,736605,"Cluster_16738","Peve_00019660",-0.506209111557797,0.662092790877516,0.978262075707395,152,-20.61,"2 15","447 467",13,"84.62%","92.31%",NA,NA,NA,NA,NA
"1874",2020,736731,"Cluster_11134","Peve_00018313",-0.990883040211503,0.086030143460633,0.978262075707395,159,-22.58,"2 21","256 278",20,"65.00%","85.00%",NA,NA,NA,NA,NA
"1875",2021,736804,"Cluster_6906","Peve_00000545",-0.686063329690759,0.518674561276582,0.978262075707395,154,-20.22,"2 19","55 76",17,"64.71%","82.35%","Q99999","Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase)","Homo sapiens (Human)","galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; myelination [GO:0042552]; protein N-linked glycosylation [GO:0006487]; spermatogenesis [GO:0007283]; sphingolipid metabolic process [GO:0006665]","GO:0000139; GO:0001733; GO:0005886; GO:0006487; GO:0006665; GO:0006681; GO:0006682; GO:0007283; GO:0008146; GO:0016020; GO:0042552; GO:0046486; GO:0050694"
"1876",2022,737331,"Cluster_2787","Peve_00040693",-0.0375566256566296,0.976085085276776,0.999448381576871,149,-20.39,"2 21","210 231",20,"70.00%","75.00%",NA,NA,NA,NA,NA
"1877",2023,737991,"Cluster_11134","Peve_00006266",-0.954326300947892,0.193150224940171,0.978262075707395,164,-20.39,"2 17","779 800",15,"80.00%","93.33%",NA,NA,NA,NA,NA
"1878",2024,738276,"Cluster_2787","Peve_00030462",-0.995128589607497,0.0628635553841154,0.978262075707395,158,-20.92,"2 21","95 120",23,"73.91%","73.91%","Q15542","Transcription initiation factor TFIID subunit 5 (Transcription initiation factor TFIID 100 kDa subunit) (TAF(II)100) (TAFII-100) (TAFII100)","Homo sapiens (Human)","DNA-templated transcription initiation [GO:0006352]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation at RNA polymerase II promoter [GO:0006367]","GO:0000785; GO:0005634; GO:0005654; GO:0005669; GO:0006282; GO:0006352; GO:0006357; GO:0006367; GO:0006468; GO:0015629; GO:0016251; GO:0033276; GO:0035521; GO:0035522; GO:0042789; GO:0042802; GO:0043966; GO:0045893; GO:0051123; GO:0060261"
"1879",2025,738463,"Cluster_4735","Peve_00030466",0.0768299115485453,0.951040311566434,0.999448381576871,159,-22.58,"2 21","104 126",20,"70.00%","80.00%","B3S3D5","DDRGK domain-containing protein 1","Trichoplax adhaerens (Trichoplax reptans)","",""
"1880",2026,739041,"Cluster_2787","Peve_00044869",0.867933894665659,0.330895275232091,0.978262075707395,161,-20.62,"2 21","180 201",20,"75.00%","85.00%","Q5PR73","GTP-binding protein Di-Ras2 (Distinct subgroup of the Ras family member 2)","Mus musculus (Mouse)","signal transduction [GO:0007165]","GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0019003"
"1881",2027,739397,"Cluster_589","Peve_00004152",-0.879398090270499,0.315890661706851,0.978262075707395,155,-22.2,"2 12","39 60",10,"100.00%","100.00%",NA,NA,NA,NA,NA
"1882",2028,739827,"Cluster_8887","Peve_00006889",-0.653594358869095,0.546520527333501,0.978262075707395,168,-20.7,"2 17","180 200",15,"86.67%","93.33%",NA,NA,NA,NA,NA
"1883",2029,739828,"Cluster_8888","Peve_00006889",-0.993361100827683,0.0733979144627711,0.978262075707395,168,-20.94,"2 17","180 200",15,"86.67%","93.33%",NA,NA,NA,NA,NA
"1884",2031,740531,"Cluster_4115","Peve_00037164",-0.991571656890649,0.0827126106499989,0.978262075707395,161,-21.76,"2 20","721 744",20,"75.00%","85.00%","P19137","Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha)","Mus musculus (Mouse)","animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; branching involved in salivary gland morphogenesis [GO:0060445]; camera-type eye development [GO:0043010]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; morphogenesis of an epithelial sheet [GO:0002011]; neuron projection development [GO:0031175]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein phosphorylation [GO:0006468]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; retina development in camera-type eye [GO:0060041]; retinal blood vessel morphogenesis [GO:0061304]; tissue development [GO:0009888]","GO:0002011; GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005608; GO:0005615; GO:0005911; GO:0006468; GO:0007155; GO:0007166; GO:0007411; GO:0008022; GO:0009887; GO:0009888; GO:0016020; GO:0030334; GO:0031012; GO:0031175; GO:0043010; GO:0043208; GO:0043256; GO:0045198; GO:0045785; GO:0045995; GO:0048514; GO:0051149; GO:0060041; GO:0060441; GO:0060445; GO:0061304; GO:0062023; GO:0098637; GO:0110011; GO:2001046"
"1885",2033,742204,"Cluster_6906","Peve_00037782",-0.98544865254169,0.108736354237794,0.978262075707395,158,-20.37,"2 20","654 676",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"1886",2034,742332,"Cluster_4629","Peve_00037787",-0.443383362280846,0.707556077121805,0.978262075707395,161,-21.31,"2 20","162 182",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"1887",2035,742547,"Cluster_589","Peve_00022401",0.961347172070704,0.177580252835034,0.978262075707395,155,-23.55,"2 12","326 347",10,"100.00%","100.00%",NA,NA,NA,NA,NA
"1888",2036,742708,"Cluster_8888","Peve_00023326",-0.651292471598752,0.548454225357659,0.978262075707395,144,-20.8,"2 20","869 890",20,"65.00%","75.00%",NA,NA,NA,NA,NA
"1889",2037,742715,"Cluster_10965","Peve_00023326",-0.523109346337314,0.649543862594915,0.978262075707395,149,-22.06,"2 18","271 292",16,"68.75%","75.00%",NA,NA,NA,NA,NA
"1890",2040,743592,"Cluster_4629","Peve_00024129",-0.99650927856604,0.0532082691278197,0.968387579406125,151,-20.04,"2 20","37 58",18,"66.67%","72.22%",NA,NA,NA,NA,NA
"1891",2041,743633,"Cluster_2882","Peve_00024122",-0.565821683003127,0.617118112037854,0.978262075707395,160,-22.85,"2 17","91 112",15,"80.00%","86.67%","A0JMR6","Histone H2A deubiquitinase MYSM1 (2A-DUB) (EC 3.4.19.-) (Myb-like, SWIRM and MPN domain-containing protein 1)","Xenopus laevis (African clawed frog)","chromatin remodeling [GO:0006338]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0003677; GO:0003713; GO:0005634; GO:0006338; GO:0035522; GO:0042393; GO:0045944; GO:0046872; GO:0140492"
"1892",2042,744841,"Cluster_29","Peve_00031250",-0.786495899421841,0.42378618765931,0.978262075707395,145,-20.04,"2 21","178 205",25,"64.00%","72.00%",NA,NA,NA,NA,NA
"1893",2043,744846,"Cluster_2787","Peve_00031250",-0.722893503614552,0.485623410122497,0.978262075707395,164,-24.27,"2 21","952 973",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"1894",2044,744921,"Cluster_11134","Peve_00029184",0.875640822838247,0.320878802775509,0.978262075707395,165,-24.58,"2 21","554 576",21,"76.19%","85.71%",NA,NA,NA,NA,NA
"1895",2045,746082,"Cluster_8887","Peve_00006743",-0.821901473199095,0.385826733407904,0.978262075707395,168,-20.39,"2 20","925 945",19,"84.21%","89.47%",NA,NA,NA,NA,NA
"1896",2046,746083,"Cluster_8888","Peve_00006743",-0.219753560508399,0.858949346278634,0.995934364227446,168,-20.63,"2 20","925 945",19,"84.21%","89.47%",NA,NA,NA,NA,NA
"1897",2047,746085,"Cluster_9149","Peve_00006743",-0.5,0.666666666666667,0.978262075707395,145,-20.86,"2 14","796 817",12,"66.67%","91.67%",NA,NA,NA,NA,NA
"1898",2048,746466,"Cluster_2787","Peve_00009821",0.979726400401929,0.128409460636302,0.978262075707395,160,-21.32,"2 17","508 529",15,"80.00%","86.67%","E7FAM5","E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","Danio rerio (Zebrafish) (Brachydanio rerio)","embryonic body morphogenesis [GO:0010172]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0010172; GO:0010586; GO:0017148; GO:0021915; GO:0030371; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061630; GO:0072089; GO:2000177"
"1899",2049,746868,"Cluster_796","Peve_00039839",0.612151483134259,0.580608529895556,0.978262075707395,141,-22.22,"2 20","76 103",24,"58.33%","70.83%",NA,NA,NA,NA,NA
"1900",2050,747132,"Cluster_15726","Peve_00039834",-0.129531312799106,0.917305449730477,0.999448381576871,153,-23.79,"2 21","225 244",19,"73.68%","73.68%","A0A0R3K2G2","Glycerol 3-phosphate dehydrogenase (EC 1.1.99.-)","Caloramator mitchellensis","glycerol catabolic process [GO:0019563]","GO:0003973; GO:0019563; GO:0046872; GO:0051537"
"1901",2051,747517,"Cluster_7657","Peve_00043408",-0.446225285623867,0.705536012580961,0.978262075707395,169,-21.84,"2 21","182 203",20,"80.00%","90.00%",NA,NA,NA,NA,NA
"1902",2052,747518,"Cluster_7658","Peve_00043408",0.952366632304808,0.19728312056417,0.978262075707395,169,-21.84,"2 21","182 203",20,"80.00%","90.00%",NA,NA,NA,NA,NA
"1903",2053,747865,"Cluster_4080","Peve_00039783",0.0835681848874033,0.946736722775132,0.999448381576871,168,-23.1,"2 19","190 210",17,"88.24%","88.24%",NA,NA,NA,NA,NA
"1904",2054,748619,"Cluster_16498","Peve_00011733",0.99999477106698,0.00205874164373314,0.362847063101065,169,-20.57,"2 21","10 31",20,"80.00%","90.00%","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1905",2055,748799,"Cluster_16498","Peve_00011735",0.987103861089021,0.102351168762727,0.978262075707395,169,-20.57,"2 21","469 490",20,"80.00%","90.00%","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1906",2056,748809,"Cluster_4079","Peve_00011734",-0.961235306403477,0.177838717616369,0.978262075707395,162,-21.4,"2 17","803 826",17,"88.24%","88.24%","Q6GQB9","ER degradation-enhancing alpha-mannosidase-like protein 3 (EC 3.2.1.113) (Alpha-1,2-mannosidase EDEM3)","Xenopus laevis (African clawed frog)","carbohydrate metabolic process [GO:0005975]; endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]","GO:0004571; GO:0005509; GO:0005788; GO:0005975; GO:0006486; GO:0006986; GO:0016020; GO:0044322; GO:1904380; GO:1904382"
"1907",2057,749070,"Cluster_16738","Peve_00024820",-0.71948210764391,0.488758457499588,0.978262075707395,164,-24.22,"2 21","919 937",19,"78.95%","84.21%","P81274","G-protein-signaling modulator 2 (Mosaic protein LGN)","Homo sapiens (Human)","cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]","GO:0000132; GO:0000166; GO:0001965; GO:0005092; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007052; GO:0007186; GO:0008022; GO:0016328; GO:0019904; GO:0031291; GO:0032991; GO:0042802; GO:0043621; GO:0051301; GO:0051661; GO:0060236; GO:0070840; GO:0097431; GO:0097575; GO:0099738; GO:1904778; GO:1905832"
"1908",2058,749154,"Cluster_13502","Peve_00024826",0.973203144541087,0.147710595198457,0.978262075707395,196,-37.19,"2 21","161 182",19,"94.74%","100.00%","B0JZV4","Cytosolic carboxypeptidase-like protein 5 (EC 3.4.17.-) (EC 3.4.17.24) (ATP/GTP-binding protein-like 5) (Protein deglutamylase CCP5)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508]","GO:0004181; GO:0005634; GO:0005829; GO:0006508; GO:0008270; GO:0015631; GO:0030496; GO:0035608; GO:0035609; GO:0035610; GO:0035611; GO:0051607; GO:0072686"
"1909",2059,749568,"Cluster_796","Peve_00023753",0.840512020202321,0.364508586148618,0.978262075707395,146,-20.78,"2 12","80 102",11,"90.91%","90.91%","A0A2J6RX17",NA,NA,NA,NA
"1910",2060,749865,"Cluster_9149","Peve_00017884",-0.888304861204295,0.303766628917056,0.978262075707395,155,-20.64,"2 12","651 672",10,"100.00%","100.00%","P15431","Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1)","Rattus norvegicus (Rat)","cellular response to histamine [GO:0071420]; central nervous system neuron development [GO:0021954]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; ovulation cycle [GO:0042698]; regulation of membrane potential [GO:0042391]; regulation of presynaptic membrane potential [GO:0099505]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165]","GO:0004890; GO:0005231; GO:0005253; GO:0005634; GO:0005635; GO:0005737; GO:0005886; GO:0006811; GO:0006821; GO:0007165; GO:0007186; GO:0007214; GO:0007268; GO:0009636; GO:0015276; GO:0016020; GO:0021954; GO:0022851; GO:0030425; GO:0030594; GO:0032570; GO:0034220; GO:0034707; GO:0042391; GO:0042698; GO:0043005; GO:0043235; GO:0045202; GO:0048787; GO:0050811; GO:0050877; GO:0071420; GO:0098685; GO:0098982; GO:0099505; GO:0099507; GO:0099634; GO:0150047; GO:1902476; GO:1902711; GO:1904315"
"1911",2061,750356,"Cluster_8884","Peve_00035787",-0.279365177958851,0.819751997678577,0.995934364227446,158,-20.24,"2 19","451 471",17,"70.59%","82.35%","Q9C0G6","Dynein axonemal heavy chain 6 (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)","Homo sapiens (Human)","microtubule-based movement [GO:0007018]","GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959"
"1912",2062,750612,"Cluster_4629","Peve_00034782",-0.653234227815997,0.54682338916145,0.978262075707395,157,-20.11,"2 19","228 251",19,"73.68%","78.95%","P07314","Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]","Rattus norvegicus (Rat)","aging [GO:0007568]; amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638]","GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006691; GO:0006750; GO:0006751; GO:0007283; GO:0007568; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0102953; GO:0103068; GO:1901750"
"1913",2063,751110,"Cluster_5882","Peve_00001967",0.424250967726828,0.72107487422675,0.981802834997821,157,-23.33,"2 14","242 263",12,"83.33%","100.00%","P59895","Serine/threonine-protein kinase Nek6 (EC 2.7.11.1) (Never in mitosis A-related kinase 6) (NimA-related protein kinase 6)","Rattus norvegicus (Rat)","apoptotic process [GO:0006915]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic metaphase/anaphase transition [GO:0030071]","GO:0000287; GO:0000922; GO:0001222; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0006915; GO:0007059; GO:0016607; GO:0018105; GO:0019894; GO:0019901; GO:0030071; GO:0031625; GO:0032991; GO:0034451; GO:0046777; GO:0051301; GO:0106310; GO:0140297"
"1914",2064,752841,"Cluster_11134","Peve_00032333",0.700781286811111,0.50566977324547,0.978262075707395,174,-23.81,"2 20","362 384",19,"84.21%","89.47%","Q9BQS2","Synaptotagmin-15 (Chr10Syt) (Synaptotagmin XV) (SytXV)","Homo sapiens (Human)","calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]","GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0030276; GO:0070382; GO:0071277"
"1915",2065,753018,"Cluster_10061","Peve_00002435",-0.142655809088433,0.908871602725513,0.999448381576871,170,-20.23,"2 21","409 434",23,"78.26%","82.61%","Q8IYN6","UBA-like domain-containing protein 2","Homo sapiens (Human)","",""
"1916",2066,753362,"Cluster_6904","Peve_00012111",-0.950273700713649,0.201606476953246,0.978262075707395,159,-21,"2 21","401 423",20,"70.00%","80.00%","P27590","Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","Rattus norvegicus (Rat)","antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; calcium ion homeostasis [GO:0055074]; cellular calcium ion homeostasis [GO:0006874]; cellular chloride ion homeostasis [GO:0030644]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to unfolded protein [GO:0034620]; cellular sodium ion homeostasis [GO:0006883]; chaperone-mediated protein folding [GO:0061077]; chemical homeostasis [GO:0048878]; chloride ion homeostasis [GO:0055064]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; creatinine homeostasis [GO:0097273]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; gene expression [GO:0010467]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; ion homeostasis [GO:0050801]; juxtaglomerular apparatus development [GO:0072051]; kidney development [GO:0001822]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; loop of Henle development [GO:0072070]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; multicellular organismal homeostasis [GO:0048871]; multicellular organismal response to stress [GO:0033555]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; peptidyl-threonine phosphorylation [GO:0018107]; phosphate ion homeostasis [GO:0055062]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein phosphorylation [GO:0006468]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; response to organic substance [GO:0010033]; response to unfolded protein [GO:0006986]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; sodium ion homeostasis [GO:0055078]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent ERAD pathway [GO:0030433]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918]; water homeostasis [GO:0030104]","GO:0000922; GO:0001822; GO:0002251; GO:0003091; GO:0003094; GO:0005201; GO:0005509; GO:0005615; GO:0005783; GO:0005794; GO:0005886; GO:0005929; GO:0006468; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006915; GO:0006954; GO:0006986; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008380; GO:0009410; GO:0009414; GO:0009986; GO:0010033; GO:0010467; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0018107; GO:0019864; GO:0030104; GO:0030433; GO:0030643; GO:0030644; GO:0031410; GO:0032496; GO:0033209; GO:0033555; GO:0034620; GO:0034976; GO:0035809; GO:0044861; GO:0045121; GO:0045177; GO:0046720; GO:0048871; GO:0048878; GO:0050801; GO:0050829; GO:0051223; GO:0055062; GO:0055064; GO:0055074; GO:0055075; GO:0055078; GO:0060073; GO:0060170; GO:0061077; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072070; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097273; GO:0097709; GO:0097744; GO:0140367; GO:1990266"
"1917",2067,753362,"Cluster_6904","Peve_00012111",-0.950273700713649,0.201606476953246,0.978262075707395,159,-21,"2 21","701 723",20,"70.00%","80.00%","P27590","Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","Rattus norvegicus (Rat)","antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; calcium ion homeostasis [GO:0055074]; cellular calcium ion homeostasis [GO:0006874]; cellular chloride ion homeostasis [GO:0030644]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to unfolded protein [GO:0034620]; cellular sodium ion homeostasis [GO:0006883]; chaperone-mediated protein folding [GO:0061077]; chemical homeostasis [GO:0048878]; chloride ion homeostasis [GO:0055064]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; creatinine homeostasis [GO:0097273]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; gene expression [GO:0010467]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; ion homeostasis [GO:0050801]; juxtaglomerular apparatus development [GO:0072051]; kidney development [GO:0001822]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; loop of Henle development [GO:0072070]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; multicellular organismal homeostasis [GO:0048871]; multicellular organismal response to stress [GO:0033555]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; peptidyl-threonine phosphorylation [GO:0018107]; phosphate ion homeostasis [GO:0055062]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein phosphorylation [GO:0006468]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; response to organic substance [GO:0010033]; response to unfolded protein [GO:0006986]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; sodium ion homeostasis [GO:0055078]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent ERAD pathway [GO:0030433]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918]; water homeostasis [GO:0030104]","GO:0000922; GO:0001822; GO:0002251; GO:0003091; GO:0003094; GO:0005201; GO:0005509; GO:0005615; GO:0005783; GO:0005794; GO:0005886; GO:0005929; GO:0006468; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006915; GO:0006954; GO:0006986; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008380; GO:0009410; GO:0009414; GO:0009986; GO:0010033; GO:0010467; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0018107; GO:0019864; GO:0030104; GO:0030433; GO:0030643; GO:0030644; GO:0031410; GO:0032496; GO:0033209; GO:0033555; GO:0034620; GO:0034976; GO:0035809; GO:0044861; GO:0045121; GO:0045177; GO:0046720; GO:0048871; GO:0048878; GO:0050801; GO:0050829; GO:0051223; GO:0055062; GO:0055064; GO:0055074; GO:0055075; GO:0055078; GO:0060073; GO:0060170; GO:0061077; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072070; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097273; GO:0097709; GO:0097744; GO:0140367; GO:1990266"
"1918",2068,753364,"Cluster_6906","Peve_00012111",-0.683623681548398,0.520805962170153,0.978262075707395,159,-20.6,"2 21","401 423",20,"70.00%","80.00%","P27590","Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","Rattus norvegicus (Rat)","antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; calcium ion homeostasis [GO:0055074]; cellular calcium ion homeostasis [GO:0006874]; cellular chloride ion homeostasis [GO:0030644]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to unfolded protein [GO:0034620]; cellular sodium ion homeostasis [GO:0006883]; chaperone-mediated protein folding [GO:0061077]; chemical homeostasis [GO:0048878]; chloride ion homeostasis [GO:0055064]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; creatinine homeostasis [GO:0097273]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; gene expression [GO:0010467]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; ion homeostasis [GO:0050801]; juxtaglomerular apparatus development [GO:0072051]; kidney development [GO:0001822]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; loop of Henle development [GO:0072070]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; multicellular organismal homeostasis [GO:0048871]; multicellular organismal response to stress [GO:0033555]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; peptidyl-threonine phosphorylation [GO:0018107]; phosphate ion homeostasis [GO:0055062]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein phosphorylation [GO:0006468]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; response to organic substance [GO:0010033]; response to unfolded protein [GO:0006986]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; sodium ion homeostasis [GO:0055078]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent ERAD pathway [GO:0030433]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918]; water homeostasis [GO:0030104]","GO:0000922; GO:0001822; GO:0002251; GO:0003091; GO:0003094; GO:0005201; GO:0005509; GO:0005615; GO:0005783; GO:0005794; GO:0005886; GO:0005929; GO:0006468; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006915; GO:0006954; GO:0006986; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008380; GO:0009410; GO:0009414; GO:0009986; GO:0010033; GO:0010467; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0018107; GO:0019864; GO:0030104; GO:0030433; GO:0030643; GO:0030644; GO:0031410; GO:0032496; GO:0033209; GO:0033555; GO:0034620; GO:0034976; GO:0035809; GO:0044861; GO:0045121; GO:0045177; GO:0046720; GO:0048871; GO:0048878; GO:0050801; GO:0050829; GO:0051223; GO:0055062; GO:0055064; GO:0055074; GO:0055075; GO:0055078; GO:0060073; GO:0060170; GO:0061077; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072070; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097273; GO:0097709; GO:0097744; GO:0140367; GO:1990266"
"1919",2069,753364,"Cluster_6906","Peve_00012111",-0.683623681548398,0.520805962170153,0.978262075707395,159,-20.6,"2 21","701 723",20,"70.00%","80.00%","P27590","Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","Rattus norvegicus (Rat)","antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; calcium ion homeostasis [GO:0055074]; cellular calcium ion homeostasis [GO:0006874]; cellular chloride ion homeostasis [GO:0030644]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to unfolded protein [GO:0034620]; cellular sodium ion homeostasis [GO:0006883]; chaperone-mediated protein folding [GO:0061077]; chemical homeostasis [GO:0048878]; chloride ion homeostasis [GO:0055064]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; creatinine homeostasis [GO:0097273]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; gene expression [GO:0010467]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; ion homeostasis [GO:0050801]; juxtaglomerular apparatus development [GO:0072051]; kidney development [GO:0001822]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; loop of Henle development [GO:0072070]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; multicellular organismal homeostasis [GO:0048871]; multicellular organismal response to stress [GO:0033555]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; peptidyl-threonine phosphorylation [GO:0018107]; phosphate ion homeostasis [GO:0055062]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein phosphorylation [GO:0006468]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; response to organic substance [GO:0010033]; response to unfolded protein [GO:0006986]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; sodium ion homeostasis [GO:0055078]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent ERAD pathway [GO:0030433]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918]; water homeostasis [GO:0030104]","GO:0000922; GO:0001822; GO:0002251; GO:0003091; GO:0003094; GO:0005201; GO:0005509; GO:0005615; GO:0005783; GO:0005794; GO:0005886; GO:0005929; GO:0006468; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006915; GO:0006954; GO:0006986; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008380; GO:0009410; GO:0009414; GO:0009986; GO:0010033; GO:0010467; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0018107; GO:0019864; GO:0030104; GO:0030433; GO:0030643; GO:0030644; GO:0031410; GO:0032496; GO:0033209; GO:0033555; GO:0034620; GO:0034976; GO:0035809; GO:0044861; GO:0045121; GO:0045177; GO:0046720; GO:0048871; GO:0048878; GO:0050801; GO:0050829; GO:0051223; GO:0055062; GO:0055064; GO:0055074; GO:0055075; GO:0055078; GO:0060073; GO:0060170; GO:0061077; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072070; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097273; GO:0097709; GO:0097744; GO:0140367; GO:1990266"
"1920",2070,753825,"Cluster_9149","Peve_00004871",1,0,0,147,-21.53,"2 12","622 643",10,"80.00%","100.00%",NA,NA,NA,NA,NA
"1921",2071,754146,"Cluster_11134","Peve_00038667",-0.981287815343826,0.123349365516123,0.978262075707395,148,-26.58,"2 18","248 277",24,"66.67%","66.67%",NA,NA,NA,NA,NA
"1922",2072,754167,"Cluster_4629","Peve_00000367",0.13620361632204,0.913019722874695,0.999448381576871,148,-21.02,"2 18","275 298",18,"66.67%","77.78%","Q4KM86","Gamma-glutamylaminecyclotransferase (GGACT) (EC 4.3.2.8) (AIG2-like domain-containing protein 1) (Gamma-glutamylamine cyclotransferase)","Rattus norvegicus (Rat)","cellular modified amino acid catabolic process [GO:0042219]","GO:0005829; GO:0042219; GO:0061929"
"1923",2073,754506,"Cluster_11134","Peve_00040816",0.993029415393417,0.0752111655705937,0.978262075707395,147,-20.09,"2 21","206 231",23,"56.52%","73.91%","B3EWZ3","Coadhesin","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0016020"
"1924",2074,755629,"Cluster_10934","Peve_00042411",0.715782576200444,0.492140323556193,0.978262075707395,164,-21.53,"2 19","682 705",19,"84.21%","84.21%",NA,NA,NA,NA,NA
"1925",2075,755742,"Cluster_4629","Peve_00016916",-0.454418896320921,0.699693875239276,0.978262075707395,145,-21.27,"2 20","457 481",21,"61.90%","76.19%","P35738","2-oxoisovalerate dehydrogenase subunit beta, mitochondrial (EC 1.2.4.4) (Branched-chain alpha-keto acid dehydrogenase E1 component beta chain) (BCKDE1B) (BCKDH E1-beta)","Rattus norvegicus (Rat)","branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]","GO:0003863; GO:0005654; GO:0005730; GO:0005739; GO:0005947; GO:0006629; GO:0007584; GO:0009083; GO:0044877; GO:0051384; GO:0051591"
"1926",2076,755787,"Cluster_4629","Peve_00016917",-0.652201715493459,0.547691019930977,0.978262075707395,145,-21.27,"2 20","457 481",21,"61.90%","76.19%","P35738","2-oxoisovalerate dehydrogenase subunit beta, mitochondrial (EC 1.2.4.4) (Branched-chain alpha-keto acid dehydrogenase E1 component beta chain) (BCKDE1B) (BCKDH E1-beta)","Rattus norvegicus (Rat)","branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]","GO:0003863; GO:0005654; GO:0005730; GO:0005739; GO:0005947; GO:0006629; GO:0007584; GO:0009083; GO:0044877; GO:0051384; GO:0051591"
"1927",2077,755830,"Cluster_4080","Peve_00016914",-0.0413839109778582,0.973646658114663,0.999448381576871,161,-20.6,"2 21","476 500",23,"73.91%","78.26%","A7T167","Protein GDAP2 homolog","Nematostella vectensis (Starlet sea anemone)","",""
"1928",2078,756017,"Cluster_6904","Peve_00019694",0.492370837277007,0.672260785557662,0.978262075707395,160,-22.48,"2 19","114 134",17,"70.59%","94.12%",NA,NA,NA,NA,NA
"1929",2079,756019,"Cluster_6906","Peve_00019694",0.850117788039287,0.353061300340755,0.978262075707395,160,-22.48,"2 19","114 134",17,"70.59%","94.12%",NA,NA,NA,NA,NA
"1930",2080,756042,"Cluster_15726","Peve_00019694",-0.748449278146849,0.461597471715996,0.978262075707395,159,-22.12,"2 16","769 790",14,"85.71%","85.71%",NA,NA,NA,NA,NA
"1931",2081,756087,"Cluster_15726","Peve_00019695",-0.837783732540583,0.367701978378439,0.978262075707395,163,-22.81,"2 21","318 342",22,"72.73%","77.27%","Q91YK2","Ribosomal RNA processing protein 1 homolog B (RRP1-like protein B)","Mus musculus (Mouse)","apoptotic process [GO:0006915]; cellular response to virus [GO:0098586]; mRNA processing [GO:0006397]; negative regulation of GTPase activity [GO:0034260]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]","GO:0000791; GO:0000792; GO:0001652; GO:0003713; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006364; GO:0006397; GO:0006915; GO:0008380; GO:0030687; GO:0030688; GO:0034260; GO:0043065; GO:0043484; GO:0043923; GO:0045944; GO:0098586"
"1932",2082,757232,"Cluster_6904","Peve_00036548",0.299593633561026,0.806297806044947,0.995934364227446,168,-22.64,"2 21","231 252",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"1933",2083,757234,"Cluster_6906","Peve_00036548",-0.195856396255873,0.874502708738146,0.997476741937264,164,-20.59,"2 21","231 252",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"1934",2084,757277,"Cluster_6904","Peve_00036547",-0.804786783920383,0.404559234420025,0.978262075707395,159,-22.21,"2 18","960 980",16,"81.25%","87.50%","P15105","Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate--ammonia ligase) (Palmitoyltransferase GLUL) (EC 2.3.1.225)","Mus musculus (Mouse)","ammonia assimilation cycle [GO:0019676]; angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cellular response to starvation [GO:0009267]; glutamate metabolic process [GO:0006536]; glutamine biosynthetic process [GO:0006542]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of insulin secretion [GO:0032024]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of protein localization to nucleolus [GO:1904749]; regulation of sprouting angiogenesis [GO:1903670]; response to glucose [GO:0009749]; ribosome biogenesis [GO:0042254]","GO:0000287; GO:0001525; GO:0004356; GO:0005524; GO:0005737; GO:0005739; GO:0005791; GO:0005829; GO:0005886; GO:0006536; GO:0006542; GO:0008283; GO:0009267; GO:0009749; GO:0010594; GO:0016595; GO:0018345; GO:0019676; GO:0019706; GO:0030145; GO:0032024; GO:0032991; GO:0042254; GO:0042802; GO:0042995; GO:0043005; GO:0043204; GO:0043209; GO:0043231; GO:0043679; GO:0044297; GO:0045503; GO:0050679; GO:0051968; GO:0097386; GO:1903670; GO:1904749"
"1935",2085,757279,"Cluster_6906","Peve_00036547",-0.420429636923846,0.723758719636932,0.982650334327478,155,-20.77,"2 18","960 980",16,"75.00%","87.50%","P15105","Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate--ammonia ligase) (Palmitoyltransferase GLUL) (EC 2.3.1.225)","Mus musculus (Mouse)","ammonia assimilation cycle [GO:0019676]; angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cellular response to starvation [GO:0009267]; glutamate metabolic process [GO:0006536]; glutamine biosynthetic process [GO:0006542]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of insulin secretion [GO:0032024]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of protein localization to nucleolus [GO:1904749]; regulation of sprouting angiogenesis [GO:1903670]; response to glucose [GO:0009749]; ribosome biogenesis [GO:0042254]","GO:0000287; GO:0001525; GO:0004356; GO:0005524; GO:0005737; GO:0005739; GO:0005791; GO:0005829; GO:0005886; GO:0006536; GO:0006542; GO:0008283; GO:0009267; GO:0009749; GO:0010594; GO:0016595; GO:0018345; GO:0019676; GO:0019706; GO:0030145; GO:0032024; GO:0032991; GO:0042254; GO:0042802; GO:0042995; GO:0043005; GO:0043204; GO:0043209; GO:0043231; GO:0043679; GO:0044297; GO:0045503; GO:0050679; GO:0051968; GO:0097386; GO:1903670; GO:1904749"
"1936",2086,757549,"Cluster_6906","Peve_00001188",0.973101367926095,0.147992105390085,0.978262075707395,169,-20.49,"2 18","722 743",16,"87.50%","87.50%",NA,NA,NA,NA,NA
"1937",2087,757630,"Cluster_4080","Peve_00019969",0.717187776142076,0.490857961563753,0.978262075707395,169,-23.58,"2 20","698 722",21,"80.95%","85.71%","Q13114","TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (LMP1-associated protein 1) (LAP1) (RING-type E3 ubiquitin transferase TRAF3)","Homo sapiens (Human)","apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of JNK cascade [GO:0046330]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; signal transduction [GO:0007165]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; type I interferon-mediated signaling pathway [GO:0060337]","GO:0000151; GO:0001817; GO:0002224; GO:0004842; GO:0005164; GO:0005739; GO:0005768; GO:0005829; GO:0006915; GO:0007165; GO:0008063; GO:0008270; GO:0009898; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032648; GO:0033209; GO:0035631; GO:0035666; GO:0042802; GO:0042981; GO:0043122; GO:0046330; GO:0050688; GO:0051607; GO:0060337; GO:0070534; GO:1902554"
"1938",2088,758165,"Cluster_1167","Peve_00028817",0.580406959884863,0.60578698754176,0.978262075707395,158,-22.63,"2 21","921 941",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"1939",2089,758387,"Cluster_589","Peve_00028810",-0.999776252592975,0.0134673523968407,0.710997774681485,155,-22.76,"2 12","405 426",10,"100.00%","100.00%",NA,NA,NA,NA,NA
"1940",2090,758658,"Cluster_796","Peve_00014512",-0.250041052875115,0.839111761155604,0.995934364227446,154,-21.86,"2 21","522 542",19,"73.68%","73.68%","P23818","Glutamate receptor 1 (GluR-1) (AMPA-selective glutamate receptor 1) (GluR-A) (GluR-K1) (Glutamate receptor ionotropic, AMPA 1) (GluA1)","Mus musculus (Mouse)","cellular response to ammonium ion [GO:0071242]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; chemical synaptic transmission [GO:0007268]; long-term memory [GO:0007616]; long-term synaptic depression [GO:0060292]; modulation of chemical synaptic transmission [GO:0050804]; neuronal action potential [GO:0019228]; positive regulation of gene expression [GO:0010628]; positive regulation of membrane potential [GO:0045838]; positive regulation of synaptic transmission [GO:0050806]; receptor internalization [GO:0031623]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of receptor recycling [GO:0001919]; regulation of synaptic plasticity [GO:0048167]; response to toxic substance [GO:0009636]","GO:0001540; GO:0001919; GO:0001965; GO:0004970; GO:0004971; GO:0005737; GO:0005769; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0005911; GO:0007268; GO:0007616; GO:0008021; GO:0008022; GO:0008179; GO:0008328; GO:0009636; GO:0009986; GO:0010628; GO:0014069; GO:0015276; GO:0016020; GO:0019228; GO:0019865; GO:0019901; GO:0019904; GO:0030165; GO:0030425; GO:0030672; GO:0031267; GO:0031489; GO:0031594; GO:0031623; GO:0031681; GO:0031698; GO:0031901; GO:0032279; GO:0032281; GO:0032590; GO:0032591; GO:0032809; GO:0032991; GO:0035254; GO:0035255; GO:0036477; GO:0038023; GO:0042734; GO:0042802; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0044297; GO:0044308; GO:0044309; GO:0045202; GO:0045211; GO:0045838; GO:0048167; GO:0048787; GO:0050804; GO:0050806; GO:0051018; GO:0055037; GO:0055038; GO:0060076; GO:0060078; GO:0060292; GO:0071242; GO:0097060; GO:0097110; GO:0098793; GO:0098794; GO:0098839; GO:0098978; GO:0099507; GO:0099544; GO:0099583; GO:1904315; GO:1990416"
"1941",2091,759142,"Cluster_11135","Peve_00031012",0.462137181880512,0.694165531613618,0.978262075707395,159,-21.09,"2 17","117 140",17,"82.35%","82.35%",NA,NA,NA,NA,NA
"1942",2092,760050,"Cluster_16738","Peve_00005457",0.996766620824908,0.0512083200549036,0.958916893458089,152,-21.35,"2 20","627 654",24,"70.83%","75.00%",NA,NA,NA,NA,NA
"1943",2093,760638,"Cluster_796","Peve_00005986",0.638713399452029,0.558933914386987,0.978262075707395,163,-25.76,"2 21","198 221",21,"71.43%","80.95%","P70191","TNF receptor-associated factor 5","Mus musculus (Mouse)","apoptotic process [GO:0006915]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA stabilization [GO:0048255]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0005164; GO:0005813; GO:0005829; GO:0006915; GO:0007165; GO:0008270; GO:0008284; GO:0009898; GO:0023019; GO:0031625; GO:0031996; GO:0033209; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0043123; GO:0046330; GO:0048255; GO:0051091; GO:0051092; GO:0070534; GO:0097400"
"1944",2094,761194,"Cluster_6906","Peve_00007588",-0.617605065120396,0.576206068994977,0.978262075707395,158,-22.5,"2 17","413 433",15,"80.00%","93.33%","Q5E9H5","Mitochondrial chaperone BCS1 (BCS1-like protein)","Bos taurus (Bovine)","mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex III assembly [GO:0034551]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]","GO:0005524; GO:0005743; GO:0016887; GO:0032979; GO:0032981; GO:0033617; GO:0034551"
"1945",2095,761237,"Cluster_6904","Peve_00007585",-0.951310992493219,0.199475076059675,0.978262075707395,160,-20.39,"2 21","106 127",19,"68.42%","78.95%","G5EG78","Peroxidasin homolog pxn-2 (EC 1.11.2.-)","Caenorhabditis elegans","axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; embryonic body morphogenesis [GO:0010172]; muscle attachment [GO:0016203]; negative regulation of axon regeneration [GO:0048681]; regulation of basement membrane organization [GO:0110011]; response to oxidative stress [GO:0006979]","GO:0004601; GO:0005604; GO:0005615; GO:0006979; GO:0007411; GO:0010172; GO:0016203; GO:0020037; GO:0046872; GO:0048681; GO:0071711; GO:0110011; GO:0140825"
"1946",2096,761239,"Cluster_6906","Peve_00007585",-0.686063329690759,0.518674561276582,0.978262075707395,168,-23.85,"2 21","106 127",19,"73.68%","84.21%","G5EG78","Peroxidasin homolog pxn-2 (EC 1.11.2.-)","Caenorhabditis elegans","axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; embryonic body morphogenesis [GO:0010172]; muscle attachment [GO:0016203]; negative regulation of axon regeneration [GO:0048681]; regulation of basement membrane organization [GO:0110011]; response to oxidative stress [GO:0006979]","GO:0004601; GO:0005604; GO:0005615; GO:0006979; GO:0007411; GO:0010172; GO:0016203; GO:0020037; GO:0046872; GO:0048681; GO:0071711; GO:0110011; GO:0140825"
"1947",2097,761457,"Cluster_4629","Peve_00006183",-0.25713343631052,0.83444402075251,0.995934364227446,154,-25.21,"2 21","234 259",23,"65.22%","78.26%","Q9VN12","Probable sodium/potassium/calcium exchanger CG1090 (Na(+)/K(+)/Ca(2+)-exchange protein CG1090)","Drosophila melanogaster (Fruit fly)","calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; sodium ion transport [GO:0006814]","GO:0005262; GO:0005886; GO:0006814; GO:0006816; GO:0006874; GO:0008273; GO:0015293; GO:0016020; GO:0070588"
"1948",2100,762741,"Cluster_11134","Peve_00037082",0.895657756527525,0.293410645313133,0.978262075707395,173,-26.2,"2 18","772 793",16,"87.50%","93.75%","Q6DIV6","Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836]","GO:0001762; GO:0006836; GO:0008021; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800"
"1949",2101,762832,"Cluster_11135","Peve_00026998",-0.314507608292154,0.796321209745628,0.995934364227446,153,-20.98,"2 21","384 403",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"1950",2102,763292,"Cluster_589","Peve_00037339",-0.93126344607766,0.23741525097946,0.978262075707395,159,-28.97,"2 21","136 163",25,"68.00%","72.00%","Q13951","Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit)","Homo sapiens (Human)","cell maturation [GO:0048469]; definitive hemopoiesis [GO:0060216]; lymphocyte differentiation [GO:0030098]; myeloid cell differentiation [GO:0030099]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein polyubiquitination [GO:0000209]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]","GO:0000122; GO:0000209; GO:0001649; GO:0003713; GO:0005654; GO:0006357; GO:0006366; GO:0016020; GO:0016513; GO:0030098; GO:0030099; GO:0043371; GO:0043378; GO:0043565; GO:0045944; GO:0048469; GO:0060216"
"1951",2103,764119,"Cluster_6906","Peve_00024596",-0.288511176668282,0.813679518670254,0.995934364227446,160,-21.36,"2 18","41 63",17,"76.47%","88.24%","Q96RW7","Hemicentin-1 (Fibulin-6) (FIBL-6)","Homo sapiens (Human)","actin filament reorganization [GO:0090527]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711; GO:0090527"
"1952",2104,765804,"Cluster_13502","Peve_00025643",-0.258468637896986,0.833564267545269,0.995934364227446,175,-25.11,"2 21","573 595",20,"85.00%","85.00%","Q9Z138","Tyrosine-protein kinase transmembrane receptor ROR2 (mROR2) (EC 2.7.10.1) (Neurotrophic tyrosine kinase, receptor-related 2)","Mus musculus (Mouse)","astrocyte development [GO:0014002]; BMP signaling pathway [GO:0030509]; cartilage condensation [GO:0001502]; cell fate commitment [GO:0045165]; chondrocyte differentiation [GO:0002062]; embryonic digit morphogenesis [GO:0042733]; embryonic genitalia morphogenesis [GO:0030538]; inner ear morphogenesis [GO:0042472]; JNK cascade [GO:0007254]; macrophage migration [GO:1905517]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of kinase activity [GO:0033674]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of postsynapse organization [GO:0099175]; regulation of synaptic signaling by nitric oxide [GO:0150045]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; smoothened signaling pathway [GO:0007224]; somitogenesis [GO:0001756]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001501; GO:0001502; GO:0001756; GO:0002062; GO:0004714; GO:0005109; GO:0005524; GO:0005737; GO:0005874; GO:0005886; GO:0007165; GO:0007169; GO:0007223; GO:0007224; GO:0007254; GO:0009986; GO:0010976; GO:0014002; GO:0014068; GO:0017147; GO:0030335; GO:0030425; GO:0030509; GO:0030538; GO:0031435; GO:0033674; GO:0042472; GO:0042733; GO:0043025; GO:0043235; GO:0043507; GO:0045165; GO:0045651; GO:0045893; GO:0046872; GO:0050804; GO:0051968; GO:0060071; GO:0060395; GO:0060828; GO:0090090; GO:0090263; GO:0098794; GO:0098978; GO:0099175; GO:0150045; GO:1900020; GO:1905517"
"1953",2105,766994,"Cluster_5563","Peve_00029875",0.732207585173565,0.476980173636768,0.978262075707395,159,-20.49,"2 22","78 103",23,"69.57%","78.26%","B0JZG0","Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","sodium ion transport [GO:0006814]","GO:0006814; GO:0015229; GO:0015293; GO:0098590"
"1954",2106,767331,"Cluster_11134","Peve_00018991",-0.996414691696678,0.0539247594263064,0.971515329401449,163,-20.69,"2 20","689 710",18,"72.22%","83.33%",NA,NA,NA,NA,NA
"1955",2107,767443,"Cluster_4735","Peve_00042656",-0.500943642233887,0.665972771890438,0.978262075707395,156,-25.48,"2 21","74 95",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"1956",2108,767469,"Cluster_13502","Peve_00042656",-0.44209200413486,0.708472937844906,0.978262075707395,172,-22.15,"2 17","418 439",15,"93.33%","93.33%",NA,NA,NA,NA,NA
"1957",2109,767531,"Cluster_4115","Peve_00042651",-0.840735564077921,0.364245832555248,0.978262075707395,168,-24.07,"2 21","712 733",19,"68.42%","89.47%","P51687","Sulfite oxidase, mitochondrial (EC 1.8.3.1)","Homo sapiens (Human)","sulfur compound metabolic process [GO:0006790]","GO:0005739; GO:0005758; GO:0005759; GO:0006790; GO:0008482; GO:0020037; GO:0030151; GO:0043546"
"1958",2110,767676,"Cluster_7053","Peve_00013987",0.992895983108058,0.0759284530899831,0.978262075707395,152,-20.61,"2 21","303 324",19,"57.89%","78.95%","Q460N3","Protein mono-ADP-ribosyltransferase PARP15 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 7) (ARTD7) (B-aggressive lymphoma protein 3) (Poly [ADP-ribose] polymerase 15) (PARP-15)","Homo sapiens (Human)","negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein poly-ADP-ribosylation [GO:0070212]","GO:0000122; GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0010629; GO:0016779; GO:0070212; GO:0070403; GO:1990404"
"1959",2111,767999,"Cluster_8988","Peve_00045155",-0.938249571468832,0.224892861800015,0.978262075707395,164,-21.32,"2 17","775 796",15,"73.33%","100.00%","P54802","Alpha-N-acetylglucosaminidase (EC 3.2.1.50) (N-acetyl-alpha-glucosaminidase) (NAG) [Cleaved into: Alpha-N-acetylglucosaminidase 82 kDa form; Alpha-N-acetylglucosaminidase 77 kDa form]","Homo sapiens (Human)","cerebellar Purkinje cell layer development [GO:0021680]; heparan sulfate proteoglycan catabolic process [GO:0030200]; inner ear receptor cell development [GO:0060119]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; middle ear morphogenesis [GO:0042474]; nervous system development [GO:0007399]; retinal rod cell development [GO:0046548]","GO:0004561; GO:0005764; GO:0007040; GO:0007399; GO:0021680; GO:0030200; GO:0042474; GO:0043202; GO:0045475; GO:0046548; GO:0060119; GO:0070062"
"1960",2112,768062,"Cluster_589","Peve_00045153",0.735459033097804,0.473933132849018,0.978262075707395,150,-21.08,"2 11","630 651",9,"100.00%","100.00%",NA,NA,NA,NA,NA
"1961",2113,768474,"Cluster_4079","Peve_00026520",0.114286207468651,0.927083818752212,0.999448381576871,153,-24.04,"2 15","887 909",14,"85.71%","85.71%","Q8NBN7","Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3)","Homo sapiens (Human)","eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]","GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650"
"1962",2114,768477,"Cluster_4629","Peve_00026520",0.984482355521989,0.112297794381702,0.978262075707395,146,-20.24,"2 21","618 645",25,"64.00%","68.00%","Q8NBN7","Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3)","Homo sapiens (Human)","eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]","GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650"
"1963",2115,769407,"Cluster_15726","Peve_00014068",-0.5,0.666666666666667,0.978262075707395,154,-23.14,"2 20","321 348",24,"66.67%","70.83%",NA,NA,NA,NA,NA
"1964",2116,769452,"Cluster_15726","Peve_00014069",1,9.48637384723993e-09,6.86838308108347e-06,154,-23.14,"2 20","861 888",24,"66.67%","70.83%",NA,NA,NA,NA,NA
"1965",2117,769706,"Cluster_8884","Peve_00014063",-0.444404269730391,0.706830773165912,0.978262075707395,158,-22.05,"2 20","457 480",21,"71.43%","76.19%","B3DLH6","Myoferlin (Fer-1-like protein 3)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","plasma membrane repair [GO:0001778]","GO:0001778; GO:0005543; GO:0005901; GO:0030659; GO:0031965; GO:0046872"
"1966",2118,769707,"Cluster_8887","Peve_00014063",-0.674216195421122,0.528963190892348,0.978262075707395,158,-22.41,"2 20","457 480",21,"71.43%","76.19%","B3DLH6","Myoferlin (Fer-1-like protein 3)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","plasma membrane repair [GO:0001778]","GO:0001778; GO:0005543; GO:0005901; GO:0030659; GO:0031965; GO:0046872"
"1967",2119,770712,"Cluster_15726","Peve_00010367",-0.404756912692515,0.734712278463461,0.985790467738525,160,-21.8,"2 21","570 591",21,"76.19%","80.95%",NA,NA,NA,NA,NA
"1968",2120,770772,"Cluster_4629","Peve_00010364",-0.331709373097701,0.784749329334719,0.994686890083175,142,-21.25,"2 21","419 448",27,"59.26%","66.67%","A6QLU6","Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)","Bos taurus (Bovine)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189"
"1969",2121,770897,"Cluster_589","Peve_00000919",-0.934753615028442,0.231240264998328,0.978262075707395,172,-25.5,"2 21","71 92",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"1970",2123,772359,"Cluster_7855","Peve_00041841",-0.109443892976159,0.930186006234899,0.999448381576871,168,-24.04,"2 17","746 767",15,"86.67%","93.33%","Q5ZMH6","Protein-L-histidine N-pros-methyltransferase (EC 2.1.1.-) (Methyltransferase-like protein 9)","Gallus gallus (Chicken)","","GO:0005739; GO:0005783; GO:0106370"
"1971",2124,772404,"Cluster_7855","Peve_00041842",-0.964200894011073,0.170858037010867,0.978262075707395,168,-24.04,"2 17","629 650",15,"86.67%","93.33%","Q91WV7","Neutral and basic amino acid transport protein rBAT (Solute carrier family 3 member 1) (b(0,+)-type amino acid transport protein) (NBAT)","Mus musculus (Mouse)","amino acid transport [GO:0006865]; aspartate transmembrane transport [GO:0015810]; carbohydrate metabolic process [GO:0005975]; gene expression [GO:0010467]; L-cystine transport [GO:0015811]; L-glutamate transmembrane transport [GO:0015813]","GO:0005743; GO:0005774; GO:0005886; GO:0005975; GO:0006865; GO:0010467; GO:0015810; GO:0015811; GO:0015813; GO:0016324; GO:0031526; GO:0044877; GO:0046982"
"1972",2125,773915,"Cluster_1167","Peve_00002665",0.761250837005636,0.449171185059158,0.978262075707395,152,-21.14,"2 13","8 29",11,"90.91%","90.91%",NA,NA,NA,NA,NA
"1973",2126,773915,"Cluster_1167","Peve_00002665",0.761250837005636,0.449171185059158,0.978262075707395,158,-21.76,"2 21","330 353",21,"76.19%","76.19%",NA,NA,NA,NA,NA
"1974",2127,774075,"Cluster_9149","Peve_00002661",-0.998403640393818,0.0359764475202205,0.909359886114279,149,-25.07,"2 18","337 356",16,"75.00%","87.50%","E7FAM5","E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","Danio rerio (Zebrafish) (Brachydanio rerio)","embryonic body morphogenesis [GO:0010172]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0010172; GO:0010586; GO:0017148; GO:0021915; GO:0030371; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061630; GO:0072089; GO:2000177"
"1975",2128,774525,"Cluster_9149","Peve_00016033",-0.965190386071459,0.168466147234797,0.978262075707395,160,-23.44,"2 18","936 958",17,"82.35%","82.35%","Q0IH10","E3 ubiquitin-protein ligase MARCHF3 (EC 2.3.2.27) (Membrane-associated RING finger protein 3) (Membrane-associated RING-CH protein III) (MARCH-III) (RING-type E3 ubiquitin transferase MARCHF3)","Xenopus laevis (African clawed frog)","endocytosis [GO:0006897]; protein ubiquitination [GO:0016567]","GO:0005764; GO:0005768; GO:0006897; GO:0008270; GO:0016567; GO:0016740; GO:0031901"
"1976",2129,774973,"Cluster_8888","Peve_00000285",-0.526156989791448,0.647264845113537,0.978262075707395,165,-20.12,"2 20","554 573",18,"83.33%","83.33%",NA,NA,NA,NA,NA
"1977",2130,775546,"Cluster_6255","Peve_00003533",0.386261149092905,0.747532708005932,0.98800640813601,171,-20.16,"2 21","916 938",20,"80.00%","85.00%","Q92051","Carbonic anhydrase (EC 4.2.1.1) (Carbonate dehydratase)","Danio rerio (Zebrafish) (Brachydanio rerio)","carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539]; one-carbon metabolic process [GO:0006730]","GO:0004089; GO:0005737; GO:0006730; GO:0008270; GO:0015670; GO:0016836; GO:0042539"
"1978",2131,775573,"Cluster_15890","Peve_00003533",0.760646111066547,0.449764547041249,0.978262075707395,151,-21.13,"2 17","823 849",20,"70.00%","75.00%","Q92051","Carbonic anhydrase (EC 4.2.1.1) (Carbonate dehydratase)","Danio rerio (Zebrafish) (Brachydanio rerio)","carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539]; one-carbon metabolic process [GO:0006730]","GO:0004089; GO:0005737; GO:0006730; GO:0008270; GO:0015670; GO:0016836; GO:0042539"
"1979",2132,775846,"Cluster_29","Peve_00004627",-0.62077240343352,0.573638206347232,0.978262075707395,157,-20.28,"2 19","149 173",20,"75.00%","75.00%",NA,NA,NA,NA,NA
"1980",2133,775937,"Cluster_589","Peve_00004624",-0.782003710334288,0.42839554331706,0.978262075707395,175,-29.11,"2 20","574 595",18,"77.78%","94.44%","B0CQN7","NADH-cytochrome b5 reductase 1 (EC 1.6.2.2) (Microsomal cytochrome b reductase)","Laccaria bicolor (strain S238N-H82 / ATCC MYA-4686) (Bicoloured deceiver) (Laccaria laccata var. bicolor)","peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]; tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation [GO:0002926]","GO:0002926; GO:0003954; GO:0004128; GO:0005741; GO:0016740; GO:0017183"
"1981",2134,776106,"Cluster_11134","Peve_00004621",-0.486166661370526,0.676789586704249,0.978262075707395,151,-22.66,"2 20","142 163",18,"66.67%","72.22%","P0CI65","Nephrocystin-3","Danio rerio (Zebrafish) (Brachydanio rerio)","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"1982",2135,776206,"Cluster_29","Peve_00004628",-0.602533862437288,0.588315682890332,0.978262075707395,157,-20.28,"2 19","149 173",20,"75.00%","75.00%",NA,NA,NA,NA,NA
"1983",2136,776570,"Cluster_1167","Peve_00004388",0.983185909213826,0.116907459120533,0.978262075707395,170,-25.99,"2 20","717 740",20,"80.00%","85.00%","Q9H0A0","RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10) (N-acetyltransferase-like protein) (hALP)","Homo sapiens (Human)","negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391]","GO:0000049; GO:0000154; GO:0000781; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006473; GO:0008080; GO:0010824; GO:0016020; GO:0030496; GO:0032211; GO:0045727; GO:0051391; GO:0070182; GO:0106162; GO:1904812; GO:1990883"
"1984",2137,776574,"Cluster_4079","Peve_00004388",-0.662411675743584,0.539065985760856,0.978262075707395,162,-20.6,"2 15","320 341",13,"84.62%","100.00%","Q9H0A0","RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10) (N-acetyltransferase-like protein) (hALP)","Homo sapiens (Human)","negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391]","GO:0000049; GO:0000154; GO:0000781; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006473; GO:0008080; GO:0010824; GO:0016020; GO:0030496; GO:0032211; GO:0045727; GO:0051391; GO:0070182; GO:0106162; GO:1904812; GO:1990883"
"1985",2138,776952,"Cluster_8887","Peve_00036667",-0.0823630340017489,0.947506599925429,0.999448381576871,143,-20.97,"2 16","473 493",14,"64.29%","78.57%","O70528","5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)","Cavia porcellus (Guinea pig)","chemical synaptic transmission [GO:0007268]; regulation of appetite [GO:0032098]","GO:0004993; GO:0005768; GO:0005886; GO:0007268; GO:0032098; GO:0045202"
"1986",2139,777021,"Cluster_2787","Peve_00036665",0.272232800316385,0.824475835784285,0.995934364227446,153,-24.24,"2 20","946 969",20,"65.00%","85.00%",NA,NA,NA,NA,NA
"1987",2140,777296,"Cluster_4115","Peve_00023126",0.368901218438833,0.75946812741494,0.988219883885475,165,-22.69,"2 21","532 554",21,"76.19%","85.71%",NA,NA,NA,NA,NA
"1988",2141,777647,"Cluster_589","Peve_00009072",-0.969111037908922,0.158643057953386,0.978262075707395,146,-20.33,"2 21","598 625",25,"56.00%","76.00%",NA,NA,NA,NA,NA
"1989",2142,777737,"Cluster_589","Peve_00009076",-0.681862814506405,0.522340200056908,0.978262075707395,156,-22.41,"2 17","622 643",15,"66.67%","93.33%","Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"1990",2143,778170,"Cluster_9149","Peve_00001662",-0.222738942289824,0.857000495890254,0.995934364227446,155,-23.13,"2 21","836 858",20,"70.00%","75.00%","Q5E9Q3","Mitochondrial potassium channel (MITOK) (Coiled-coil domain-containing protein 51)","Bos taurus (Bovine)","cell volume homeostasis [GO:0006884]; mitochondrial potassium ion transmembrane transport [GO:0140141]; potassium ion transmembrane transport [GO:0071805]","GO:0005743; GO:0006884; GO:0062156; GO:0062157; GO:0071805; GO:0140141"
"1991",2144,779136,"Cluster_2787","Peve_00040976",0.745477980393459,0.464442552621193,0.978262075707395,158,-26.79,"2 16","758 780",15,"80.00%","93.33%",NA,NA,NA,NA,NA
"1992",2145,780919,"Cluster_10934","Peve_00026324",0.993744582381753,0.0712442676400804,0.978262075707395,154,-21.32,"2 21","184 201",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"1993",2146,781054,"Cluster_10934","Peve_00026323",0.99130377652417,0.0840186494959752,0.978262075707395,154,-21.32,"2 21","771 788",19,"78.95%","78.95%","Q9YGN6","Single-strand selective monofunctional uracil DNA glycosylase (EC 3.2.2.-)","Xenopus laevis (African clawed frog)","base-excision repair [GO:0006284]","GO:0003677; GO:0005634; GO:0006284; GO:0017065"
"1994",2147,782517,"Cluster_4629","Peve_00026819",0.923842023199118,0.250062391896704,0.978262075707395,150,-23.99,"2 21","566 592",24,"66.67%","70.83%",NA,NA,NA,NA,NA
"1995",2148,782828,"Cluster_2882","Peve_00037274",-0.804943160621314,0.404391484546158,0.978262075707395,165,-23.64,"2 20","35 55",18,"77.78%","88.89%",NA,NA,NA,NA,NA
"1996",2149,784100,"Cluster_6914","Peve_00010167",-0.551079542108337,0.628432159650593,0.978262075707395,154,-24.17,"2 20","277 302",23,"65.22%","73.91%",NA,NA,NA,NA,NA
"1997",2150,784324,"Cluster_6906","Peve_00044162",0.26194719911604,0.831270739164479,0.995934364227446,160,-21.35,"2 17","328 349",15,"73.33%","93.33%","F1R777","N6-adenosine-methyltransferase subunit METTL3 (EC 2.1.1.348) (N6-adenosine-methyltransferase 70 kDa subunit) (MT-A70)","Danio rerio (Zebrafish) (Brachydanio rerio)","adenosine to inosine editing [GO:0006382]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; endothelial to hematopoietic transition [GO:0098508]; flagellated sperm motility [GO:0030317]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; hematopoietic stem cell proliferation [GO:0071425]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; Notch signaling pathway involved in arterial endothelial cell fate commitment [GO:0060853]; oocyte maturation [GO:0001556]; oogenesis [GO:0048477]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translation [GO:0045727]; primary miRNA processing [GO:0031053]; regulation of apoptotic process [GO:0042981]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of mRNA modification [GO:0090365]; regulation of T cell differentiation [GO:0045580]; sex determination [GO:0007530]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]","GO:0000398; GO:0001556; GO:0001734; GO:0003729; GO:0005634; GO:0005737; GO:0006382; GO:0006402; GO:0006974; GO:0007283; GO:0007530; GO:0008168; GO:0008173; GO:0016422; GO:0016607; GO:0019827; GO:0021861; GO:0030317; GO:0031053; GO:0034644; GO:0036396; GO:0042063; GO:0042981; GO:0045580; GO:0045727; GO:0045746; GO:0046982; GO:0048477; GO:0051445; GO:0060339; GO:0060853; GO:0061157; GO:0071425; GO:0080009; GO:0090365; GO:0098508; GO:1902036; GO:1903679; GO:1904047"
"1998",2151,784344,"Cluster_13502","Peve_00044162",-0.0330892483976051,0.978930884267197,0.999448381576871,154,-22.96,"2 21","595 621",24,"62.50%","79.17%","F1R777","N6-adenosine-methyltransferase subunit METTL3 (EC 2.1.1.348) (N6-adenosine-methyltransferase 70 kDa subunit) (MT-A70)","Danio rerio (Zebrafish) (Brachydanio rerio)","adenosine to inosine editing [GO:0006382]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; endothelial to hematopoietic transition [GO:0098508]; flagellated sperm motility [GO:0030317]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; hematopoietic stem cell proliferation [GO:0071425]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; Notch signaling pathway involved in arterial endothelial cell fate commitment [GO:0060853]; oocyte maturation [GO:0001556]; oogenesis [GO:0048477]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translation [GO:0045727]; primary miRNA processing [GO:0031053]; regulation of apoptotic process [GO:0042981]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of mRNA modification [GO:0090365]; regulation of T cell differentiation [GO:0045580]; sex determination [GO:0007530]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]","GO:0000398; GO:0001556; GO:0001734; GO:0003729; GO:0005634; GO:0005737; GO:0006382; GO:0006402; GO:0006974; GO:0007283; GO:0007530; GO:0008168; GO:0008173; GO:0016422; GO:0016607; GO:0019827; GO:0021861; GO:0030317; GO:0031053; GO:0034644; GO:0036396; GO:0042063; GO:0042981; GO:0045580; GO:0045727; GO:0045746; GO:0046982; GO:0048477; GO:0051445; GO:0060339; GO:0060853; GO:0061157; GO:0071425; GO:0080009; GO:0090365; GO:0098508; GO:1902036; GO:1903679; GO:1904047"
"1999",2152,784355,"Cluster_1167","Peve_00017300",0.847341820790966,0.356403138448671,0.978262075707395,156,-24.01,"2 21","94 115",19,"63.16%","78.95%",NA,NA,NA,NA,NA
"2000",2153,784715,"Cluster_1167","Peve_00034369",0.472995396070564,0.686345438691592,0.978262075707395,146,-22.9,"2 16","515 538",16,"75.00%","75.00%","P24752","Acetyl-CoA acetyltransferase, mitochondrial (EC 2.3.1.9) (Acetoacetyl-CoA thiolase) (T2)","Homo sapiens (Human)","acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body catabolic process [GO:0046952]; ketone body metabolic process [GO:1902224]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]","GO:0001889; GO:0003985; GO:0005739; GO:0005759; GO:0006085; GO:0006550; GO:0006635; GO:0007420; GO:0009725; GO:0014070; GO:0015936; GO:0015937; GO:0016453; GO:0019899; GO:0030955; GO:0042594; GO:0042802; GO:0046356; GO:0046952; GO:0060612; GO:0070062; GO:0072229; GO:0120225; GO:1902224; GO:1902860"
"2001",2154,784816,"Cluster_6255","Peve_00044204",-0.708556755141542,0.498693222674594,0.978262075707395,168,-21.38,"2 20","822 841",18,"83.33%","88.89%",NA,NA,NA,NA,NA
"2002",2155,785246,"Cluster_14999","Peve_00013532",0.298347646860978,0.807129044829066,0.995934364227446,175,-22,"2 20","399 420",18,"77.78%","94.44%","Q2KIG2","WD repeat-containing protein 5","Bos taurus (Bovine)","transcription initiation-coupled chromatin remodeling [GO:0045815]","GO:0000123; GO:0005634; GO:0035064; GO:0035097; GO:0045815; GO:0048188; GO:0071339"
"2003",2156,785257,"Cluster_2854","Peve_00013531",-0.999994747981342,0.00206328129499564,0.363213043883873,176,-25.43,"2 21","596 617",19,"84.21%","84.21%","O00116","Alkyldihydroxyacetonephosphate synthase, peroxisomal (Alkyl-DHAP synthase) (EC 2.5.1.26) (Aging-associated gene 5 protein) (Alkylglycerone-phosphate synthase)","Homo sapiens (Human)","ether lipid biosynthetic process [GO:0008611]; lipid biosynthetic process [GO:0008610]","GO:0005730; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0008609; GO:0008610; GO:0008611; GO:0016020; GO:0071949"
"2004",2157,785336,"Cluster_14999","Peve_00013530",0.114565243754939,0.926905004246194,0.999448381576871,175,-22,"2 20","673 694",18,"77.78%","94.44%","Q9EP80","PRKCA-binding protein (Protein interacting with C kinase 1) (Protein kinase C-alpha-binding protein)","Rattus norvegicus (Rat)","cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; dopamine transport [GO:0015872]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; monoamine transport [GO:0015844]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; positive regulation of receptor internalization [GO:0002092]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; protein targeting [GO:0006605]; receptor clustering [GO:0043113]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of insulin secretion [GO:0050796]; regulation of kainate selective glutamate receptor activity [GO:2000312]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]","GO:0001664; GO:0002092; GO:0005080; GO:0005102; GO:0005484; GO:0005543; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006605; GO:0006886; GO:0007205; GO:0008021; GO:0008022; GO:0008092; GO:0010629; GO:0014069; GO:0015844; GO:0015872; GO:0016020; GO:0019899; GO:0019904; GO:0021782; GO:0030425; GO:0030971; GO:0032588; GO:0032991; GO:0034315; GO:0034316; GO:0035255; GO:0035256; GO:0036294; GO:0042149; GO:0042734; GO:0042802; GO:0043005; GO:0043113; GO:0043197; GO:0045202; GO:0046872; GO:0046875; GO:0048471; GO:0050796; GO:0051015; GO:0051020; GO:0060292; GO:0060548; GO:0071933; GO:0097061; GO:0097062; GO:0098842; GO:0098843; GO:0098978; GO:0099149; GO:0099572; GO:0140090; GO:2000312"
"2005",2158,785752,"Cluster_2854","Peve_00021139",-0.953728939872859,0.194419060842132,0.978262075707395,160,-20.08,"2 18","602 624",17,"76.47%","88.24%","B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"2006",2159,785932,"Cluster_2854","Peve_00021132",-0.728874176677885,0.480087831492968,0.978262075707395,160,-20.22,"2 18","597 619",17,"76.47%","88.24%","B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"2007",2160,786276,"Cluster_11134","Peve_00043993",-0.988543560238512,0.0964573785382989,0.978262075707395,167,-20.11,"2 21","978 1000",21,"71.43%","85.71%","Q8VCK5","Kelch-like protein 20 (Kelch-like ECT2-interacting protein)","Mus musculus (Mouse)","Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]","GO:0003779; GO:0004842; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390"
"2008",2161,787173,"Cluster_10061","Peve_00043970",-0.0803653366068362,0.94878260447532,0.999448381576871,158,-20.26,"2 21","680 708",26,"69.23%","73.08%","P56213","FAD-linked sulfhydryl oxidase ALR (EC 1.8.3.2) (Augmenter of liver regeneration)","Mus musculus (Mouse)","cellular response to actinomycin D [GO:0072717]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to toxic substance [GO:0097237]; cellular response to tumor necrosis factor [GO:0071356]; liver development [GO:0001889]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; positive regulation of DNA biosynthetic process [GO:2000573]","GO:0001889; GO:0005615; GO:0005739; GO:0005758; GO:0005829; GO:0008083; GO:0015035; GO:0016971; GO:0043066; GO:0045953; GO:0050660; GO:0071222; GO:0071356; GO:0072717; GO:0097237; GO:0097421; GO:1903204; GO:2000573"
"2009",2162,787717,"Cluster_11135","Peve_00042377",0.844443877729655,0.359862212804899,0.978262075707395,160,-20.86,"2 21","837 858",19,"68.42%","78.95%","Q99542","Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI) (Matrix metalloproteinase-18) (MMP-18)","Homo sapiens (Human)","angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; luteolysis [GO:0001554]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to hormone [GO:0009725]","GO:0001525; GO:0001541; GO:0001542; GO:0001554; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0009725; GO:0022617; GO:0030154; GO:0030198; GO:0030574; GO:0031012; GO:0051591"
"2010",2163,788405,"Cluster_1167","Peve_00018443",0.829183811035474,0.377611258561576,0.978262075707395,145,-24.97,"2 10","364 385",8,"100.00%","100.00%","O08983","BLOC-3 complex member HPS1 (Hermansky-Pudlak syndrome 1 protein homolog)","Mus musculus (Mouse)","blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; cellular zinc ion homeostasis [GO:0006882]; eye pigmentation [GO:0048069]; gene expression [GO:0010467]; inflammatory response [GO:0006954]; intracellular transport [GO:0046907]; lung development [GO:0030324]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; organelle organization [GO:0006996]; pigmentation [GO:0043473]; platelet dense granule organization [GO:0060155]; positive regulation of natural killer cell activation [GO:0032816]; respiratory system process [GO:0003016]; retina development in camera-type eye [GO:0060041]; secretion of lysosomal enzymes [GO:0033299]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192]","GO:0000902; GO:0003016; GO:0005085; GO:0005737; GO:0006882; GO:0006954; GO:0006996; GO:0007040; GO:0007283; GO:0007338; GO:0007596; GO:0010467; GO:0016192; GO:0030318; GO:0030324; GO:0031085; GO:0031410; GO:0032816; GO:0033299; GO:0043473; GO:0046907; GO:0046983; GO:0048069; GO:0060041; GO:0060155; GO:0060425; GO:1903232"
"2011",2164,788571,"Cluster_11134","Peve_00018449",-0.0195622829453675,0.987545469442176,0.999448381576871,165,-20.07,"2 20","377 397",18,"77.78%","88.89%",NA,NA,NA,NA,NA
"2012",2165,788711,"Cluster_14999","Peve_00043391",0.168352989757453,0.892310308978981,0.999448381576871,166,-21.65,"2 21","307 332",23,"78.26%","78.26%","Q91ZY6","Homologous-pairing protein 2 homolog (Nuclear receptor coactivator GT198) (PSMC3-interacting protein) (Proteasome 26S ATPase subunit 3-interacting protein)","Rattus norvegicus (Rat)","homologous chromosome pairing at meiosis [GO:0007129]; meiotic joint molecule formation [GO:0000709]; meiotic strand invasion involved in reciprocal meiotic recombination [GO:0010774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; reciprocal meiotic recombination [GO:0007131]","GO:0000709; GO:0000794; GO:0003690; GO:0005634; GO:0007129; GO:0007131; GO:0010774; GO:0030331; GO:0030374; GO:0035259; GO:0044877; GO:0045944; GO:0046966; GO:0050681; GO:0050692; GO:0065003; GO:0120230; GO:0120231"
"2013",2166,788711,"Cluster_14999","Peve_00043391",0.168352989757453,0.892310308978981,0.999448381576871,166,-21.65,"2 21","566 591",23,"78.26%","78.26%","Q91ZY6","Homologous-pairing protein 2 homolog (Nuclear receptor coactivator GT198) (PSMC3-interacting protein) (Proteasome 26S ATPase subunit 3-interacting protein)","Rattus norvegicus (Rat)","homologous chromosome pairing at meiosis [GO:0007129]; meiotic joint molecule formation [GO:0000709]; meiotic strand invasion involved in reciprocal meiotic recombination [GO:0010774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; reciprocal meiotic recombination [GO:0007131]","GO:0000709; GO:0000794; GO:0003690; GO:0005634; GO:0007129; GO:0007131; GO:0010774; GO:0030331; GO:0030374; GO:0035259; GO:0044877; GO:0045944; GO:0046966; GO:0050681; GO:0050692; GO:0065003; GO:0120230; GO:0120231"
"2014",2167,788816,"Cluster_4115","Peve_00043394",0.0656966239757251,0.958146086060708,0.999448381576871,154,-22.43,"2 20","295 322",24,"66.67%","70.83%",NA,NA,NA,NA,NA
"2015",2168,788902,"Cluster_2854","Peve_00043399",-0.535973730849427,0.639889204840856,0.978262075707395,158,-20.93,"2 15","502 523",13,"84.62%","92.31%","Q27245","Putative aminopeptidase W07G4.4 (EC 3.4.11.-)","Caenorhabditis elegans","proteolysis [GO:0006508]","GO:0005737; GO:0006508; GO:0008233; GO:0030145; GO:0070006"
"2016",2169,789285,"Cluster_9149","Peve_00043020",-0.96038979742484,0.179780555872127,0.978262075707395,168,-23.03,"2 21","321 342",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"2017",2170,790078,"Cluster_4735","Peve_00030399",-0.906968400973129,0.276780974343036,0.978262075707395,153,-20.18,"2 21","611 632",20,"75.00%","75.00%","O43719","HIV Tat-specific factor 1 (Tat-SF1)","Homo sapiens (Human)","mRNA splicing, via spliceosome [GO:0000398]; regulation of DNA-templated transcription elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; U2-type prespliceosome assembly [GO:1903241]; viral genome replication [GO:0019079]","GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0006357; GO:0019079; GO:0032784; GO:1903241"
"2018",2171,790130,"Cluster_6914","Peve_00018242",0.881432431194037,0.313159528569569,0.978262075707395,157,-20.35,"2 20","725 744",18,"72.22%","83.33%",NA,NA,NA,NA,NA
"2019",2172,790236,"Cluster_11134","Peve_00000891",-0.999479069517375,0.0205496231198021,0.812495585628734,156,-25.76,"2 21","699 718",19,"73.68%","84.21%","Q3KR37","Protein Aster-B (GRAM domain-containing protein 1B)","Homo sapiens (Human)","cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]; intracellular sterol transport [GO:0032366]","GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016020; GO:0032366; GO:0032934; GO:0042632; GO:0070300; GO:0071397; GO:0120015; GO:0120020; GO:0140268"
"2020",2173,790708,"Cluster_4735","Peve_00034898",-0.550236396234039,0.629075197231697,0.978262075707395,150,-22.91,"2 19","692 711",17,"76.47%","82.35%","P20749","B-cell lymphoma 3 protein (BCL-3) (Proto-oncogene BCL3)","Homo sapiens (Human)","antimicrobial humoral response [GO:0019730]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of T cell apoptotic process [GO:0070233]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of type II interferon production [GO:0032729]; protein import into nucleus [GO:0006606]; regulation of apoptotic process [GO:0042981]; regulation of DNA binding [GO:0051101]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T cell apoptotic process [GO:0070231]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064]","GO:0002268; GO:0002315; GO:0002455; GO:0002467; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006606; GO:0006974; GO:0007249; GO:0009615; GO:0010225; GO:0019730; GO:0030198; GO:0030330; GO:0030496; GO:0030674; GO:0032088; GO:0032717; GO:0032720; GO:0032729; GO:0032733; GO:0032991; GO:0032996; GO:0033257; GO:0042088; GO:0042742; GO:0042771; GO:0042826; GO:0042832; GO:0042981; GO:0043066; GO:0043231; GO:0045064; GO:0045727; GO:0045892; GO:0045893; GO:0045944; GO:0046426; GO:0048471; GO:0048536; GO:0051101; GO:0070231; GO:0070233; GO:0140297; GO:1901222"
"2021",2175,791244,"Cluster_4079","Peve_00037553",0.922028042287347,0.253062309744281,0.978262075707395,159,-21.99,"2 21","542 567",23,"65.22%","78.26%",NA,NA,NA,NA,NA
"2022",2176,791338,"Cluster_4735","Peve_00006808",0.911179607420358,0.270345812114251,0.978262075707395,164,-20.67,"2 21","504 525",19,"73.68%","78.95%","Q5RB75","NudC domain-containing protein 3","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","cilium assembly [GO:0060271]; protein localization to pericentriolar material [GO:1905793]","GO:0005868; GO:0060271; GO:1905793"
"2023",2177,791418,"Cluster_796","Peve_00001852",0.177682874319348,0.886279746858571,0.999448381576871,156,-22.57,"2 21","771 790",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"2024",2178,791969,"Cluster_5563","Peve_00029721",0.999970783906393,0.00486639381889994,0.551398425649056,168,-22.23,"2 21","925 945",19,"84.21%","89.47%",NA,NA,NA,NA,NA
"2025",2179,792172,"Cluster_11135","Peve_00041079",0.980989959106427,0.124330320478117,0.978262075707395,158,-20.49,"2 16","799 821",15,"86.67%","86.67%",NA,NA,NA,NA,NA
"2026",2180,792313,"Cluster_15890","Peve_00032829",-0.999967287119389,0.00514938897746555,0.551398425649056,162,-22.12,"2 21","284 304",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"2027",2181,792502,"Cluster_2854","Peve_00032822",-0.979998098297893,0.127543205375138,0.978262075707395,156,-20.51,"2 18","393 415",17,"70.59%","88.24%",NA,NA,NA,NA,NA
"2028",2182,792685,"Cluster_4080","Peve_00028410",0.313076027793828,0.797281062750317,0.995934364227446,166,-20.55,"2 20","43 66",20,"80.00%","80.00%","Q9CQQ4","Gem-associated protein 2 (Gemin-2) (Component of gems 2) (Survival of motor neuron protein-interacting protein 1) (SMN-interacting protein 1)","Mus musculus (Mouse)","negative regulation of RNA binding [GO:1905215]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]","GO:0000245; GO:0000387; GO:0005634; GO:0005654; GO:0005681; GO:0005730; GO:0005737; GO:0005829; GO:0016604; GO:0032797; GO:0034719; GO:0097504; GO:1905215"
"2029",2183,792739,"Cluster_6906","Peve_00028411",-0.287038038235336,0.814658772056752,0.995934364227446,172,-23.33,"2 21","510 531",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"2030",2184,793727,"Cluster_6904","Peve_00036250",0.742592842212241,0.467191590606991,0.978262075707395,155,-22.9,"2 17","917 940",17,"70.59%","88.24%",NA,NA,NA,NA,NA
"2031",2185,793729,"Cluster_6906","Peve_00036250",0.973101367926095,0.147992105390085,0.978262075707395,152,-21.18,"2 21","916 940",23,"69.57%","78.26%",NA,NA,NA,NA,NA
"2032",2186,794004,"Cluster_7855","Peve_00007866",-0.94898368474513,0.204227171462966,0.978262075707395,173,-22.43,"2 20","333 353",18,"83.33%","94.44%","Q5I0R4","Cilia- and flagella-associated protein 300","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0005737; GO:0005856; GO:0031514"
"2033",2187,794295,"Cluster_16738","Peve_00022158",-0.981200960665208,0.123636205034929,0.978262075707395,155,-21.83,"2 21","67 91",22,"68.18%","72.73%","Q95M12","Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1)","Bos taurus (Bovine)","negative regulation of ERBB signaling pathway [GO:1901185]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]","GO:0003014; GO:0004197; GO:0005764; GO:0006508; GO:0032801; GO:0051603; GO:1901185"
"2034",2188,794835,"Cluster_16738","Peve_00023689",-0.339954682488226,0.779176521029078,0.993291512285701,170,-20.99,"2 21","270 290",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"2035",2189,795557,"Cluster_589","Peve_00004989",-0.97795721412483,0.133915041543952,0.978262075707395,153,-20.49,"2 14","91 112",12,"83.33%","91.67%","Q9UQQ1","Aminopeptidase NAALADL1 (EC 3.4.11.-) (100 kDa ileum brush border membrane protein) (I100) (Ileal dipeptidylpeptidase) (N-acetylated-alpha-linked acidic dipeptidase-like protein) (NAALADase L)","Homo sapiens (Human)","peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]","GO:0004177; GO:0004180; GO:0005509; GO:0006508; GO:0008233; GO:0008237; GO:0008270; GO:0016020; GO:0016324; GO:0042803; GO:0043171"
"2036",2190,795561,"Cluster_2787","Peve_00004989",0.933447107689976,0.233570051777715,0.978262075707395,158,-20.68,"2 18","61 82",17,"82.35%","88.24%","Q9UQQ1","Aminopeptidase NAALADL1 (EC 3.4.11.-) (100 kDa ileum brush border membrane protein) (I100) (Ileal dipeptidylpeptidase) (N-acetylated-alpha-linked acidic dipeptidase-like protein) (NAALADase L)","Homo sapiens (Human)","peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]","GO:0004177; GO:0004180; GO:0005509; GO:0006508; GO:0008233; GO:0008237; GO:0008270; GO:0016020; GO:0016324; GO:0042803; GO:0043171"
"2037",2191,795923,"Cluster_2882","Peve_00000077",-0.9297673087207,0.24001587012427,0.978262075707395,161,-25.29,"2 20","85 105",18,"77.78%","83.33%","Q17R89","Rho GTPase-activating protein 44 (NPC-A-10) (Rho-type GTPase-activating protein RICH2) (RhoGAP interacting with CIP4 homologs protein 2) (RICH-2)","Homo sapiens (Human)","exocytosis [GO:0006887]; modification of dendritic spine [GO:0098886]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of Rac protein signal transduction [GO:0035021]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of Rac protein signal transduction [GO:0035020]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]","GO:0005096; GO:0005543; GO:0005829; GO:0006887; GO:0007165; GO:0014069; GO:0030425; GO:0031256; GO:0031267; GO:0032956; GO:0035020; GO:0035021; GO:0043087; GO:0043197; GO:0048786; GO:0050804; GO:0051056; GO:0051490; GO:0055037; GO:0061001; GO:0098886; GO:0098887; GO:0098978; GO:0099152"
"2038",2192,795932,"Cluster_6904","Peve_00000077",-0.924518590919554,0.248934730906394,0.978262075707395,155,-21.81,"2 17","290 313",17,"76.47%","82.35%","Q17R89","Rho GTPase-activating protein 44 (NPC-A-10) (Rho-type GTPase-activating protein RICH2) (RhoGAP interacting with CIP4 homologs protein 2) (RICH-2)","Homo sapiens (Human)","exocytosis [GO:0006887]; modification of dendritic spine [GO:0098886]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of Rac protein signal transduction [GO:0035021]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of Rac protein signal transduction [GO:0035020]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]","GO:0005096; GO:0005543; GO:0005829; GO:0006887; GO:0007165; GO:0014069; GO:0030425; GO:0031256; GO:0031267; GO:0032956; GO:0035020; GO:0035021; GO:0043087; GO:0043197; GO:0048786; GO:0050804; GO:0051056; GO:0051490; GO:0055037; GO:0061001; GO:0098886; GO:0098887; GO:0098978; GO:0099152"
"2039",2193,795934,"Cluster_6906","Peve_00000077",-0.627527227098398,0.568134216123301,0.978262075707395,152,-21.33,"2 14","290 313",14,"85.71%","85.71%","Q17R89","Rho GTPase-activating protein 44 (NPC-A-10) (Rho-type GTPase-activating protein RICH2) (RhoGAP interacting with CIP4 homologs protein 2) (RICH-2)","Homo sapiens (Human)","exocytosis [GO:0006887]; modification of dendritic spine [GO:0098886]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of Rac protein signal transduction [GO:0035021]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of Rac protein signal transduction [GO:0035020]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]","GO:0005096; GO:0005543; GO:0005829; GO:0006887; GO:0007165; GO:0014069; GO:0030425; GO:0031256; GO:0031267; GO:0032956; GO:0035020; GO:0035021; GO:0043087; GO:0043197; GO:0048786; GO:0050804; GO:0051056; GO:0051490; GO:0055037; GO:0061001; GO:0098886; GO:0098887; GO:0098978; GO:0099152"
"2040",2194,796402,"Cluster_11135","Peve_00008516",0.891918083543542,0.298719213165561,0.978262075707395,163,-22.11,"2 21","130 153",21,"66.67%","85.71%","Q6NUB7","Ubiquitin thioesterase zranb1-B (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1B)","Xenopus laevis (African clawed frog)","cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; positive regulation of Wnt signaling pathway [GO:0030177]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K63-linked deubiquitination [GO:0070536]; regulation of cell morphogenesis [GO:0022604]; Wnt signaling pathway [GO:0016055]","GO:0004843; GO:0005634; GO:0005737; GO:0007010; GO:0016055; GO:0016477; GO:0022604; GO:0030177; GO:0035523; GO:0046872; GO:0070536; GO:1990168"
"2041",2195,796603,"Cluster_4735","Peve_00031704",-0.989721916659334,0.0913532215794848,0.978262075707395,161,-24.76,"2 19","255 279",20,"70.00%","85.00%",NA,NA,NA,NA,NA
"2042",2196,796648,"Cluster_4735","Peve_00031705",-0.0843054139194434,0.94626572607607,0.999448381576871,161,-24.76,"2 19","6 30",20,"70.00%","85.00%","F1MMV1","EF-hand domain-containing family member B (Cilia- and flagella-associated protein 21)","Bos taurus (Bovine)","calcium ion transport [GO:0006816]; negative regulation of protein binding [GO:0032091]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of store-operated calcium entry [GO:2001256]","GO:0005879; GO:0006816; GO:0032091; GO:0061891; GO:0070884; GO:2001256"
"2043",2197,796721,"Cluster_14999","Peve_00031706",-0.538678865199837,0.63784723680649,0.978262075707395,163,-22.89,"2 21","366 388",20,"75.00%","80.00%",NA,NA,NA,NA,NA
"2044",2199,797896,"Cluster_29","Peve_00005298",-0.195101620544982,0.874992666208138,0.997550215314002,162,-21.28,"2 20","879 901",19,"73.68%","84.21%","Q5GFD9","Protein IMPACT (Imprinted and ancient gene protein homolog)","Rattus norvegicus (Rat)","cellular response to acidic pH [GO:0071468]; cellular response to amino acid starvation [GO:0034198]; cellular response to benomyl [GO:0072755]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to leucine starvation [GO:1990253]; cellular response to UV-C [GO:0071494]; GCN2-mediated signaling [GO:0140469]; negative regulation of cell death [GO:0060548]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; neuron projection extension [GO:1990138]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of translational initiation in response to starvation [GO:0071264]; regulation of translational initiation [GO:0006446]","GO:0000122; GO:0001933; GO:0003779; GO:0005737; GO:0005844; GO:0006446; GO:0031333; GO:0031953; GO:0034198; GO:0042149; GO:0043022; GO:0045666; GO:0060548; GO:0070301; GO:0071264; GO:0071468; GO:0071494; GO:0072755; GO:0097201; GO:0140469; GO:1990138; GO:1990253"
"2045",2200,797925,"Cluster_9149","Peve_00005298",-0.647811203136041,0.551369127444631,0.978262075707395,157,-25.85,"2 14","542 563",12,"83.33%","100.00%","Q5GFD9","Protein IMPACT (Imprinted and ancient gene protein homolog)","Rattus norvegicus (Rat)","cellular response to acidic pH [GO:0071468]; cellular response to amino acid starvation [GO:0034198]; cellular response to benomyl [GO:0072755]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to leucine starvation [GO:1990253]; cellular response to UV-C [GO:0071494]; GCN2-mediated signaling [GO:0140469]; negative regulation of cell death [GO:0060548]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; neuron projection extension [GO:1990138]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of translational initiation in response to starvation [GO:0071264]; regulation of translational initiation [GO:0006446]","GO:0000122; GO:0001933; GO:0003779; GO:0005737; GO:0005844; GO:0006446; GO:0031333; GO:0031953; GO:0034198; GO:0042149; GO:0043022; GO:0045666; GO:0060548; GO:0070301; GO:0071264; GO:0071468; GO:0071494; GO:0072755; GO:0097201; GO:0140469; GO:1990138; GO:1990253"
"2046",2201,798220,"Cluster_4080","Peve_00005832",0.921617076861498,0.253737285863812,0.978262075707395,171,-24.53,"2 16","968 989",14,"92.86%","100.00%",NA,NA,NA,NA,NA
"2047",2202,798607,"Cluster_11135","Peve_00022973",-0.886103284710592,0.306804453861767,0.978262075707395,170,-22.46,"2 21","855 878",21,"80.95%","85.71%",NA,NA,NA,NA,NA
"2048",2204,799164,"Cluster_4079","Peve_00033832",-0.934480251243925,0.231729583004234,0.978262075707395,150,-21.16,"2 16","735 757",15,"80.00%","80.00%","Q91WC3","Long-chain-fatty-acid--CoA ligase 6 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 6) (LACS 6)","Mus musculus (Mouse)","fatty acid transport [GO:0015908]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; neuroblast proliferation [GO:0007405]; phospholipid biosynthetic process [GO:0008654]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; positive regulation of neuron projection development [GO:0010976]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0001676; GO:0004467; GO:0005524; GO:0005634; GO:0005739; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0007405; GO:0008654; GO:0010747; GO:0010976; GO:0015908; GO:0016020; GO:0019432; GO:0019899; GO:0035338; GO:0042803; GO:0047676"
"2049",2205,799866,"Cluster_11134","Peve_00027843",0.262140774229727,0.831143043202861,0.995934364227446,156,-20.31,"2 18","582 606",19,"73.68%","78.95%","A6QLP7","Translocon-associated protein subunit alpha (TRAP-alpha) (Signal sequence receptor subunit alpha) (SSR-alpha)","Bos taurus (Bovine)","","GO:0005783; GO:0005789"
"2050",2206,800162,"Cluster_6904","Peve_00007473",-0.879939119315978,0.315166441150215,0.978262075707395,154,-22.39,"2 21","411 436",23,"69.57%","73.91%","Q54H55","FAD-linked oxidoreductase DDB_G0289697 (EC 1.-.-.-)","Dictyostelium discoideum (Social amoeba)","","GO:0016491; GO:0071949"
"2051",2207,800164,"Cluster_6906","Peve_00007473",-0.543278001096993,0.634365926367122,0.978262075707395,154,-23.42,"2 21","411 436",23,"69.57%","73.91%","Q54H55","FAD-linked oxidoreductase DDB_G0289697 (EC 1.-.-.-)","Dictyostelium discoideum (Social amoeba)","","GO:0016491; GO:0071949"
"2052",2208,800202,"Cluster_4629","Peve_00007471",-0.387841518480853,0.746441567963719,0.987685209841204,158,-23.25,"2 20","74 96",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"2053",2209,800247,"Cluster_4629","Peve_00007470",0.711051655707265,0.496438383687806,0.978262075707395,158,-23.25,"2 20","551 573",19,"68.42%","84.21%","Q90744","Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B)","Gallus gallus (Chicken)","glycoside catabolic process [GO:0016139]; lipid metabolic process [GO:0006629]; oligosaccharide metabolic process [GO:0009311]","GO:0004557; GO:0005737; GO:0005764; GO:0006629; GO:0008456; GO:0009311; GO:0016139"
"2054",2210,800787,"Cluster_4629","Peve_00037847",0.99263568381324,0.0773086729116669,0.978262075707395,152,-23.73,"2 21","535 556",19,"63.16%","73.68%",NA,NA,NA,NA,NA
"2055",2211,801322,"Cluster_2854","Peve_00017809",-0.874296882154139,0.322645880255724,0.978262075707395,148,-21.68,"2 18","731 756",20,"60.00%","80.00%","Q66I12","PAT complex subunit CCDC47 (Coiled-coil domain-containing protein 47)","Danio rerio (Zebrafish) (Brachydanio rerio)","endoplasmic reticulum calcium ion homeostasis [GO:0032469]; protein insertion into ER membrane [GO:0045048]","GO:0005509; GO:0005783; GO:0005789; GO:0030867; GO:0032469; GO:0043022; GO:0044183; GO:0045048"
"2056",2214,802920,"Cluster_9149","Peve_00012190",-0.370014638056316,0.7587053327477,0.988219883885475,157,-20.7,"2 19","303 327",20,"75.00%","75.00%","P97846","Contactin-associated protein 1 (Caspr) (Caspr1) (Neurexin IV) (Neurexin-4) (Paranodin) (p190)","Rattus norvegicus (Rat)","axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128]","GO:0002175; GO:0007005; GO:0007010; GO:0007155; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030424; GO:0030913; GO:0031175; GO:0033010; GO:0033270; GO:0042552; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0050905; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227"
"2057",2215,802941,"Cluster_2787","Peve_00012191",0.9521249215577,0.197787088943309,0.978262075707395,161,-23.42,"2 20","354 377",20,"80.00%","80.00%","O54991","Contactin-associated protein 1 (Caspr) (Caspr1) (MHDNIV) (NCP1) (Neurexin IV) (Neurexin-4) (Paranodin)","Mus musculus (Mouse)","axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128]","GO:0002175; GO:0005886; GO:0005918; GO:0007005; GO:0007010; GO:0007155; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030424; GO:0030913; GO:0031175; GO:0033010; GO:0033270; GO:0042552; GO:0043209; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0050905; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227"
"2058",2216,803060,"Cluster_10965","Peve_00012195",-0.861501692342471,0.33904874167394,0.978262075707395,158,-21.35,"2 20","312 335",20,"70.00%","80.00%","B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"2059",2218,804090,"Cluster_9149","Peve_00044730",-0.127917855536093,0.918341225906392,0.999448381576871,150,-20.6,"2 15","462 483",13,"76.92%","84.62%",NA,NA,NA,NA,NA
"2060",2219,804270,"Cluster_9149","Peve_00042946",-0.641985814638166,0.556221593572825,0.978262075707395,162,-25.67,"2 21","371 396",23,"73.91%","78.26%","Q9UMX0","Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1) (hPLIC-1)","Homo sapiens (Human)","aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of macroautophagy [GO:0016241]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000045; GO:0000502; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005829; GO:0005886; GO:0006511; GO:0016235; GO:0016236; GO:0016241; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0032991; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0048471; GO:0071456; GO:0097352; GO:1901340; GO:1902175; GO:1903071"
"2061",2221,807747,"Cluster_15726","Peve_00043724",-0.998403640393818,0.0359764475202192,0.909359886114279,165,-27.25,"2 20","949 973",21,"80.95%","80.95%","Q9MYM7","Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)","Pongo pygmaeus (Bornean orangutan)","lipid metabolic process [GO:0006629]; protein glycosylation [GO:0006486]","GO:0000139; GO:0006486; GO:0006629; GO:0047275"
"2062",2222,807997,"Cluster_7657","Peve_00009628",-0.420273437088026,0.723868312034918,0.982695822316307,160,-20.62,"2 20","869 890",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"2063",2223,807998,"Cluster_7658","Peve_00009628",0.943191419045912,0.215615420018127,0.978262075707395,160,-20.62,"2 20","869 890",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"2064",2224,808202,"Cluster_589","Peve_00002908",-0.934753615028442,0.231240264998328,0.978262075707395,158,-22.83,"2 16","959 981",15,"80.00%","93.33%","Q80XJ3","Tetratricopeptide repeat protein 28 (TPR repeat protein 28)","Mus musculus (Mouse)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0005737; GO:0005813; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301; GO:0072686; GO:0097431; GO:1990023"
"2065",2225,808400,"Cluster_6914","Peve_00002900",-0.229322040662165,0.852698213960576,0.995934364227446,159,-21.88,"2 20","463 481",18,"77.78%","88.89%","A0A2B4RP11",NA,NA,NA,NA
"2066",2226,808445,"Cluster_6914","Peve_00002901",0.865718268435541,0.333724182418612,0.978262075707395,159,-21.88,"2 20","129 147",18,"77.78%","88.89%",NA,NA,NA,NA,NA
"2067",2227,809715,"Cluster_9149","Peve_00028186",-0.579456433342001,0.606529776298629,0.978262075707395,143,-20.89,"2 21","314 332",19,"63.16%","78.95%","F1QNV4","Nuclear pore complex protein Nup133 (Nucleoporin 133)","Danio rerio (Zebrafish) (Brachydanio rerio)","poly(A)+ mRNA export from nucleus [GO:0016973]; protein import into nucleus [GO:0006606]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]","GO:0000776; GO:0000972; GO:0006606; GO:0016973; GO:0017056; GO:0031080"
"2068",2228,809742,"Cluster_4629","Peve_00028187",-0.349469736842154,0.77272349679925,0.991668984508097,146,-21.38,"2 11","598 619",9,"88.89%","100.00%","Q5U2N4","MAP kinase-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 2) (MAPK signal-integrating kinase 2) (Mnk2)","Rattus norvegicus (Rat)","cellular response to arsenic-containing substance [GO:0071243]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]","GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006417; GO:0006468; GO:0009931; GO:0016605; GO:0018105; GO:0030097; GO:0035556; GO:0046777; GO:0046872; GO:0071243; GO:0097192; GO:0106310"
"2069",2229,809940,"Cluster_9149","Peve_00002026",0.917506259758502,0.26039783815488,0.978262075707395,152,-20.4,"2 15","689 709",13,"84.62%","92.31%",NA,NA,NA,NA,NA
"2070",2230,810463,"Cluster_4735","Peve_00006101",-0.583321352304893,0.603505671527791,0.978262075707395,164,-23.87,"2 19","47 67",17,"82.35%","88.24%","O75581","Low-density lipoprotein receptor-related protein 6 (LRP-6)","Homo sapiens (Human)","canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244]","GO:0001933; GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006469; GO:0007204; GO:0007268; GO:0009986; GO:0014029; GO:0014033; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0044335; GO:0044340; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0051091; GO:0060070; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090118; GO:0090244; GO:0098609; GO:1904928; GO:1904948; GO:1904953; GO:1990851; GO:1990909"
"2071",2231,810812,"Cluster_589","Peve_00030588",-0.983817674668046,0.114684041181378,0.978262075707395,158,-22.72,"2 17","397 417",15,"80.00%","93.33%","Q96DX5","Ankyrin repeat and SOCS box protein 9 (ASB-9)","Homo sapiens (Human)","intracellular signal transduction [GO:0035556]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567]","GO:0005739; GO:0005829; GO:0016567; GO:0035556; GO:0045732"
"2072",2232,810868,"Cluster_4735","Peve_00040406",-0.0597216067120709,0.961957407203555,0.999448381576871,162,-23.2,"2 21","911 934",21,"76.19%","80.95%",NA,NA,NA,NA,NA
"2073",2233,810909,"Cluster_4079","Peve_00040405",0.924545907016503,0.248889100380961,0.978262075707395,148,-20.11,"2 20","484 508",22,"63.64%","77.27%","Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"2074",2234,811138,"Cluster_4735","Peve_00040409",-0.271767820914284,0.824783448750317,0.995934364227446,161,-20.99,"2 20","919 942",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"2075",2235,811446,"Cluster_2787","Peve_00007854",-0.864104211317102,0.335771391434576,0.978262075707395,143,-20.6,"2 21","393 415",20,"60.00%","70.00%",NA,NA,NA,NA,NA
"2076",2236,812145,"Cluster_9149","Peve_00023643",-0.5,0.666666666666667,0.978262075707395,154,-28.58,"2 20","939 964",22,"68.18%","72.73%",NA,NA,NA,NA,NA
"2077",2239,813108,"Cluster_796","Peve_00033582",-0.00685316165830792,0.995637107633496,0.999448381576871,157,-24.62,"2 20","339 359",18,"77.78%","77.78%",NA,NA,NA,NA,NA
"2078",2240,814451,"Cluster_14999","Peve_00028602",-0.385628098915349,0.747969567283086,0.988162023688381,175,-22,"2 20","375 396",18,"77.78%","94.44%","A2ARA8","Integrin alpha-8 [Cleaved into: Integrin alpha-8 heavy chain; Integrin alpha-8 light chain]","Mus musculus (Mouse)","brain development [GO:0007420]; cell adhesion mediated by integrin [GO:0033627]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; establishment of protein localization [GO:0045184]; extracellular matrix organization [GO:0030198]; inner ear morphogenesis [GO:0042472]; integrin-mediated signaling pathway [GO:0007229]; kidney development [GO:0001822]; memory [GO:0007613]; mesodermal cell differentiation [GO:0048333]; metanephros development [GO:0001656]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; smooth muscle cell differentiation [GO:0051145]; smooth muscle tissue development [GO:0048745]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0001656; GO:0001822; GO:0005178; GO:0005783; GO:0005886; GO:0007160; GO:0007179; GO:0007229; GO:0007420; GO:0007613; GO:0008305; GO:0009897; GO:0009986; GO:0014069; GO:0030030; GO:0030198; GO:0030511; GO:0032591; GO:0033627; GO:0034446; GO:0042472; GO:0043204; GO:0045177; GO:0045184; GO:0045944; GO:0046872; GO:0048333; GO:0048745; GO:0051145; GO:0098609; GO:0098839; GO:0098978"
"2079",2241,815322,"Cluster_4629","Peve_00003222",-0.554554668634826,0.625777256211528,0.978262075707395,159,-20.38,"2 20","416 437",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"2080",2242,815360,"Cluster_1167","Peve_00008231",0.800653099556457,0.408972065520488,0.978262075707395,144,-20.58,"2 21","69 90",19,"63.16%","63.16%","Q9D994","WD repeat-containing protein 38","Mus musculus (Mouse)","hematopoietic progenitor cell differentiation [GO:0002244]","GO:0002244"
"2081",2243,815540,"Cluster_1167","Peve_00008236",-0.827973482085711,0.378987500863212,0.978262075707395,159,-26.34,"2 21","581 603",20,"70.00%","80.00%","Q96J01","THO complex subunit 3 (Tho3) (TEX1 homolog) (hTREX45)","Homo sapiens (Human)","mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784]","GO:0000346; GO:0000445; GO:0003723; GO:0005654; GO:0006397; GO:0006406; GO:0008380; GO:0016607; GO:0046784"
"2082",2245,815910,"Cluster_5882","Peve_00036353",-0.592652657272051,0.596161381763121,0.978262075707395,155,-20.39,"2 21","156 178",20,"65.00%","80.00%",NA,NA,NA,NA,NA
"2083",2246,816021,"Cluster_11134","Peve_00036357",0.94097110908022,0.219830152972574,0.978262075707395,149,-21.79,"2 14","435 456",12,"75.00%","91.67%",NA,NA,NA,NA,NA
"2084",2247,816573,"Cluster_796","Peve_00037916",0.801251947507498,0.408335317891974,0.978262075707395,166,-22.36,"2 19","138 159",17,"82.35%","82.35%","Q2KIK0","Protein SGT1 homolog (Suppressor of G2 allele of SKP1 homolog)","Bos taurus (Bovine)","protein stabilization [GO:0050821]","GO:0005634; GO:0005737; GO:0050821; GO:0051087"
"2085",2248,816881,"Cluster_14999","Peve_00025970",-0.999571546587002,0.0186364175217764,0.782669382293497,178,-27.37,"2 20","596 618",19,"84.21%","94.74%",NA,NA,NA,NA,NA
"2086",2249,817013,"Cluster_11997","Peve_00024377",-0.972884261006854,0.148590864647564,0.978262075707395,172,-21.35,"2 21","244 265",19,"73.68%","89.47%","Q8VDU0","G-protein-signaling modulator 2 (Pins homolog)","Mus musculus (Mouse)","cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]","GO:0000132; GO:0000166; GO:0001965; GO:0005092; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007052; GO:0008022; GO:0016328; GO:0019904; GO:0031291; GO:0032991; GO:0042802; GO:0043621; GO:0051301; GO:0051661; GO:0060236; GO:0070840; GO:0097431; GO:0097575; GO:0099738; GO:1904778; GO:1905832"
"2087",2251,818633,"Cluster_11997","Peve_00025028",-0.647017877151962,0.55203179882939,0.978262075707395,183,-22.19,"2 20","781 802",18,"88.89%","94.44%",NA,NA,NA,NA,NA
"2088",2252,818640,"Cluster_16738","Peve_00025028",-0.9981690675047,0.0385298725994388,0.909359886114279,176,-25.72,"2 21","741 762",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"2089",2253,818676,"Cluster_11134","Peve_00020618",0.355755499774518,0.768447174277424,0.990527675986719,146,-20.43,"2 17","858 878",15,"66.67%","86.67%","P33268","Cytochrome P450 3A8 (EC 1.14.14.1) (CYPIIIA8) (Cytochrome P-450-MK2) (Cytochrome P450-MKNF2)","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","","GO:0004497; GO:0005506; GO:0005789; GO:0020037; GO:0070330"
"2090",2254,819490,"Cluster_14500","Peve_00006663",0.81245691296176,0.396259136068087,0.978262075707395,172,-22.55,"2 21","454 475",19,"78.95%","84.21%","C3ZQF9","QRFP-like peptide receptor","Branchiostoma floridae (Florida lancelet) (Amphioxus)","cellular response to peptide [GO:1901653]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:1901653"
"2091",2256,819723,"Cluster_796","Peve_00006668",0.896936513602078,0.291574861250422,0.978262075707395,166,-25,"2 21","412 435",21,"80.95%","80.95%",NA,NA,NA,NA,NA
"2092",2258,820355,"Cluster_1167","Peve_00043521",0.999909606796706,0.00855985249202504,0.574004478614831,146,-23.91,"2 21","190 214",22,"63.64%","72.73%",NA,NA,NA,NA,NA
"2093",2259,820400,"Cluster_1167","Peve_00043520",0.520782178468325,0.651280743125403,0.978262075707395,146,-23.91,"2 21","190 214",22,"63.64%","72.73%",NA,NA,NA,NA,NA
"2094",2260,820745,"Cluster_10965","Peve_00043294",-0.321790233327782,0.791430830991505,0.995934364227446,162,-20.02,"2 21","637 657",19,"78.95%","78.95%","E2JA28","Dapdiamide synthesis protein DdaC (EC 1.-.-.-)","Enterobacter agglomerans (Erwinia herbicola) (Pantoea agglomerans)","antibiotic biosynthetic process [GO:0017000]","GO:0016491; GO:0017000"
"2095",2262,821259,"Cluster_4079","Peve_00015999",-0.796272454187231,0.413604356922385,0.978262075707395,151,-20.3,"2 16","360 381",14,"71.43%","85.71%","Q5R5C5","NADPH oxidase 4 (EC 1.6.3.-)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","reactive oxygen species metabolic process [GO:0072593]","GO:0005789; GO:0005886; GO:0005925; GO:0050664; GO:0072593"
"2096",2263,821937,"Cluster_4629","Peve_00020781",-0.61999434978747,0.574269757040039,0.978262075707395,150,-20.53,"2 20","852 876",21,"57.14%","80.95%","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"2097",2264,821955,"Cluster_9149","Peve_00020781",-0.428372593171845,0.718174165838156,0.981094945209539,144,-20.23,"2 21","725 743",19,"63.16%","73.68%","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"2098",2265,822557,"Cluster_589","Peve_00013125",0.775072695353894,0.435426401668339,0.978262075707395,153,-21,"2 19","558 580",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"2099",2266,823677,"Cluster_15726","Peve_00040173",-0.63341680528182,0.563303771839087,0.978262075707395,148,-20.17,"2 17","792 810",15,"80.00%","80.00%","Q6P4S6","Serine/threonine-protein kinase SIK3 (EC 2.7.11.1) (Salt-inducible kinase 3) (SIK-3) (Serine/threonine-protein kinase QSK)","Mus musculus (Mouse)","cartilage development involved in endochondral bone morphogenesis [GO:0060351]; endochondral ossification [GO:0001958]; intracellular signal transduction [GO:0035556]; limb morphogenesis [GO:0035108]; microtubule cytoskeleton organization [GO:0000226]; multicellular organism growth [GO:0035264]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein phosphorylation [GO:0006468]; regulation of protein localization [GO:0032880]; skeletal system morphogenesis [GO:0048705]","GO:0000226; GO:0000287; GO:0001958; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0006468; GO:0032880; GO:0035108; GO:0035264; GO:0035556; GO:0048705; GO:0050321; GO:0060351; GO:0106310; GO:1904263; GO:1904515"
"2100",2267,823755,"Cluster_9149","Peve_00039320",-0.99707405830425,0.048711769379337,0.94828359635183,153,-25.57,"2 14","871 892",12,"75.00%","100.00%",NA,NA,NA,NA,NA
"2101",2268,824006,"Cluster_4115","Peve_00012650",-0.708436710670535,0.498801513957222,0.978262075707395,180,-27.36,"2 21","192 213",19,"84.21%","89.47%","Q8BX37","Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form)","Mus musculus (Mouse)","","GO:0003993; GO:0005576; GO:0046872"
"2102",2269,824049,"Cluster_4079","Peve_00002371",-0.796272454187231,0.413604356922385,0.978262075707395,161,-20.02,"2 14","603 624",12,"91.67%","100.00%","G3V9H8","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Rattus norvegicus (Rat)","cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797"
"2103",2270,825330,"Cluster_9149","Peve_00032474",0.971409767459622,0.15259635021536,0.978262075707395,159,-23.87,"2 20","281 302",18,"66.67%","83.33%","Q23915","Probable serine/threonine-protein kinase kinX (EC 2.7.11.1)","Dictyostelium discoideum (Social amoeba)","protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]","GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0106310"
"2104",2272,826752,"Cluster_4629","Peve_00009783",-0.859098285345735,0.342050125726125,0.978262075707395,162,-26.91,"2 20","741 763",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"2105",2273,827312,"Cluster_10060","Peve_00008786",-0.222606084812048,0.857087253791963,0.995934364227446,176,-20.31,"2 21","532 553",19,"78.95%","89.47%","B8V7S0","CUB and peptidase domain-containing protein 1","Acropora millepora (Staghorn coral) (Heteropora millepora)","proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508"
"2106",2274,827497,"Cluster_11135","Peve_00043886",0.844443877729655,0.359862212804899,0.978262075707395,158,-22.4,"2 21","316 336",19,"68.42%","84.21%","F1NV61","Caspase-7 (CASP-7) (EC 3.4.22.60) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11]","Gallus gallus (Chicken)","apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; execution phase of apoptosis [GO:0097194]; lymphocyte apoptotic process [GO:0070227]; positive regulation of plasma membrane repair [GO:1905686]; proteolysis [GO:0006508]","GO:0003723; GO:0004190; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0042742; GO:0070227; GO:0097153; GO:0097194; GO:0097200; GO:1905686"
"2107",2275,828046,"Cluster_29","Peve_00004003",-0.807819139853771,0.401295561413051,0.978262075707395,166,-21.22,"2 20","495 517",19,"73.68%","89.47%","Q1RMP7","Probable inactive peptidyl-prolyl cis-trans isomerase-like 6 (PPIase) (Cyclophilin-like protein PPIL6)","Bos taurus (Bovine)","protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]","GO:0000413; GO:0003755; GO:0005737; GO:0006457"
"2108",2276,828363,"Cluster_796","Peve_00043850",0.161838997492345,0.896514951618963,0.999448381576871,162,-21.16,"2 21","565 585",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"2109",2277,829223,"Cluster_2882","Peve_00034956",-0.988077292924717,0.0984045095788651,0.978262075707395,174,-20.97,"2 20","308 330",19,"84.21%","89.47%","O89110","Caspase-8 (CASP-8) (EC 3.4.22.61) [Cleaved into: Caspase-8 subunit p18; Caspase-8 subunit p10]","Mus musculus (Mouse)","activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cardiac muscle tissue development [GO:0048738]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; heart development [GO:0007507]; hepatocyte apoptotic process [GO:0097284]; macrophage differentiation [GO:0030225]; necroptotic process [GO:0070266]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of necroptotic process [GO:0060546]; neural tube formation [GO:0001841]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of neuron death [GO:1901216]; positive regulation of proteolysis [GO:0045862]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; pyroptosis [GO:0070269]; regulation of apoptotic signaling pathway [GO:2001233]; regulation of cytokine production [GO:0001817]; regulation of innate immune response [GO:0045088]; regulation of thymocyte apoptotic process [GO:0070243]; response to ethanol [GO:0045471]; response to tumor necrosis factor [GO:0034612]; self proteolysis [GO:0097264]; TRAIL-activated apoptotic signaling pathway [GO:0036462]","GO:0001525; GO:0001817; GO:0001841; GO:0004175; GO:0004197; GO:0005123; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006508; GO:0006915; GO:0006919; GO:0007507; GO:0008233; GO:0008303; GO:0008625; GO:0016485; GO:0030225; GO:0030690; GO:0031264; GO:0031265; GO:0031625; GO:0032731; GO:0032991; GO:0034612; GO:0035877; GO:0036462; GO:0042802; GO:0043005; GO:0043065; GO:0043123; GO:0043124; GO:0044297; GO:0044877; GO:0045088; GO:0045121; GO:0045471; GO:0045651; GO:0045862; GO:0048738; GO:0051603; GO:0060546; GO:0070243; GO:0070266; GO:0070269; GO:0097110; GO:0097153; GO:0097190; GO:0097191; GO:0097194; GO:0097199; GO:0097200; GO:0097202; GO:0097264; GO:0097284; GO:0097342; GO:1901216; GO:2001233; GO:2001238"
"2110",2278,829262,"Cluster_589","Peve_00034957",-0.459482434956865,0.696069833125748,0.978262075707395,154,-21.7,"2 16","960 982",15,"73.33%","93.33%","P46777","60S ribosomal protein L5 (Large ribosomal subunit protein uL18)","Homo sapiens (Human)","cytoplasmic translation [GO:0002181]; negative regulation of protein neddylation [GO:2000435]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of gene expression [GO:0010628]; positive regulation of translation [GO:0045727]; protein stabilization [GO:0050821]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412]","GO:0000027; GO:0002181; GO:0003723; GO:0003730; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005829; GO:0005925; GO:0006364; GO:0006412; GO:0008097; GO:0010628; GO:0016020; GO:0022625; GO:0022626; GO:0031625; GO:0032991; GO:0042273; GO:0045727; GO:0048027; GO:0050821; GO:0070062; GO:1901796; GO:1904667; GO:1990904; GO:1990948; GO:2000059; GO:2000435"
"2111",2279,829812,"Cluster_4629","Peve_00000786",0.997938030915673,0.0408894104551371,0.909359886114279,162,-24.67,"2 21","469 493",22,"72.73%","81.82%",NA,NA,NA,NA,NA
"2112",2280,829847,"Cluster_589","Peve_00000787",0.165142682092847,0.894383074900482,0.999448381576871,157,-20.74,"2 19","197 219",18,"72.22%","83.33%",NA,NA,NA,NA,NA
"2113",2281,830405,"Cluster_6914","Peve_00031820",0.681370036207874,0.522768938995673,0.978262075707395,170,-20.06,"2 19","12 32",17,"82.35%","88.24%",NA,NA,NA,NA,NA
"2114",2282,830796,"Cluster_2787","Peve_00035306",0.712814925666201,0.494839895457948,0.978262075707395,160,-26.33,"2 21","233 254",19,"63.16%","84.21%",NA,NA,NA,NA,NA
"2115",2283,830931,"Cluster_2787","Peve_00035302",0.996824647103056,0.0507465014605484,0.95773079106992,158,-21.35,"2 20","759 781",19,"68.42%","84.21%","A7SFP1","Leucine-rich repeat protein soc-2 homolog","Nematostella vectensis (Starlet sea anemone)","positive regulation of Ras protein signal transduction [GO:0046579]; signal transduction [GO:0007165]","GO:0007165; GO:0046579"
"2116",2284,831792,"Cluster_4629","Peve_00040238",-0.0860013818294061,0.945182103361281,0.999448381576871,151,-21.65,"2 16","725 746",14,"71.43%","85.71%",NA,NA,NA,NA,NA
"2117",2285,832785,"Cluster_5882","Peve_00022396",-0.462462340800209,0.693932085052799,0.978262075707395,162,-22.07,"2 19","895 916",17,"76.47%","82.35%","Q06124","Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3)","Homo sapiens (Human)","abortive mitotic cell cycle [GO:0033277]; atrioventricular canal development [GO:0036302]; axonogenesis [GO:0007409]; Bergmann glial cell differentiation [GO:0060020]; brain development [GO:0007420]; cellular response to epidermal growth factor stimulus [GO:0071364]; cerebellar cortex formation [GO:0021697]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage checkpoint signaling [GO:0000077]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB signaling pathway [GO:0038127]; face morphogenesis [GO:0060325]; fibroblast growth factor receptor signaling pathway [GO:0008543]; genitalia development [GO:0048806]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; homeostasis of number of cells within a tissue [GO:0048873]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; intestinal epithelial cell migration [GO:0061582]; megakaryocyte development [GO:0035855]; microvillus organization [GO:0032528]; multicellular organism growth [GO:0035264]; multicellular organismal reproductive process [GO:0048609]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of cortisol secretion [GO:0051463]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of insulin secretion [GO:0046676]; neurotrophin TRK receptor signaling pathway [GO:0048011]; organ growth [GO:0035265]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet formation [GO:0030220]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose import [GO:0046326]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of tumor necrosis factor production [GO:0032760]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of protein export from nucleus [GO:0046825]; regulation of protein-containing complex assembly [GO:0043254]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; T cell costimulation [GO:0031295]; triglyceride metabolic process [GO:0006641]","GO:0000077; GO:0001784; GO:0004721; GO:0004725; GO:0004726; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006470; GO:0006641; GO:0007173; GO:0007229; GO:0007409; GO:0007420; GO:0007507; GO:0008543; GO:0009755; GO:0019221; GO:0019901; GO:0021697; GO:0030159; GO:0030220; GO:0030971; GO:0031295; GO:0032331; GO:0032528; GO:0032728; GO:0032755; GO:0032760; GO:0032991; GO:0033277; GO:0033628; GO:0033629; GO:0035264; GO:0035265; GO:0035335; GO:0035855; GO:0036302; GO:0038127; GO:0042445; GO:0042593; GO:0043254; GO:0045296; GO:0045778; GO:0045931; GO:0046326; GO:0046628; GO:0046676; GO:0046825; GO:0046887; GO:0048008; GO:0048011; GO:0048013; GO:0048609; GO:0048806; GO:0048839; GO:0048873; GO:0050731; GO:0050839; GO:0051428; GO:0051463; GO:0060020; GO:0060125; GO:0060325; GO:0060338; GO:0061582; GO:0070374; GO:0071364; GO:1990782"
"2118",2286,832986,"Cluster_11134","Peve_00022398",0.18162312041101,0.883729819235175,0.999448381576871,149,-20.92,"2 21","957 979",21,"66.67%","76.19%","Q9HB96","Fanconi anemia group E protein (Protein FACE)","Homo sapiens (Human)","interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]","GO:0000785; GO:0005634; GO:0005654; GO:0006513; GO:0036297; GO:0043240"
"2119",2287,833515,"Cluster_8634","Peve_00024942",-0.224693088757062,0.855724096218234,0.995934364227446,160,-21.51,"2 18","895 919",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"2120",2288,834040,"Cluster_4080","Peve_00027767",0.720867886602447,0.487486874194194,0.978262075707395,157,-20.46,"2 21","742 761",19,"68.42%","84.21%","B6MFW3","Protein Hook homolog","Branchiostoma floridae (Florida lancelet) (Amphioxus)","cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; protein transport [GO:0015031]","GO:0005737; GO:0005813; GO:0005874; GO:0008017; GO:0015031; GO:0030705; GO:0031122; GO:0051959"
"2121",2289,834185,"Cluster_6914","Peve_00027763",0.116449519009393,0.925697353915029,0.999448381576871,156,-24.77,"2 20","134 157",21,"76.19%","80.95%","Q6ZMY6","WD repeat-containing protein 88 (PQQ repeat and WD repeat-containing protein)","Homo sapiens (Human)","",""
"2122",2290,835196,"Cluster_14999","Peve_00024237",0.903054687563958,0.282638406378003,0.978262075707395,166,-20.43,"2 21","738 758",19,"78.95%","84.21%","Q923I7","Sodium/glucose cotransporter 2 (Na(+)/glucose cotransporter 2) (Low affinity sodium-glucose cotransporter) (Solute carrier family 5 member 2)","Mus musculus (Mouse)","alpha-glucoside transport [GO:0000017]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; negative regulation of urine volume [GO:0035811]; renal glucose absorption [GO:0035623]; renal potassium excretion [GO:0036359]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]","GO:0000017; GO:0005412; GO:0005886; GO:0006814; GO:0015151; GO:0016020; GO:0016324; GO:0031526; GO:0035623; GO:0035811; GO:0036359; GO:0055056; GO:0098708; GO:0098719; GO:1904659"
"2123",2291,835272,"Cluster_8887","Peve_00000291",0.845209764903643,0.358950917561005,0.978262075707395,150,-21.17,"2 19","886 906",17,"64.71%","76.47%","P30883","Tubulin beta-4 chain","Xenopus laevis (African clawed frog)","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0046872"
"2124",2292,837075,"Cluster_9149","Peve_00040609",-0.633566032068382,0.563180992183839,0.978262075707395,160,-24.02,"2 19","63 83",17,"82.35%","82.35%","Q91ZS8","Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase)","Mus musculus (Mouse)","adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of mRNA processing [GO:0050685]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965]","GO:0003723; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006382; GO:0006396; GO:0006397; GO:0007274; GO:0008251; GO:0008285; GO:0016553; GO:0016556; GO:0021610; GO:0021618; GO:0021965; GO:0030336; GO:0035264; GO:0042802; GO:0044387; GO:0045070; GO:0045202; GO:0046872; GO:0050685; GO:0050884; GO:0051726; GO:0060384; GO:0060415; GO:0061744; GO:0097049"
"2125",2293,837282,"Cluster_4629","Peve_00001507",0.887022251960252,0.305539811934712,0.978262075707395,163,-23.88,"2 21","299 322",21,"71.43%","80.95%",NA,NA,NA,NA,NA
"2126",2294,837680,"Cluster_1167","Peve_00042049",-0.281467208308385,0.818357868732929,0.995934364227446,157,-26.37,"2 21","362 389",25,"72.00%","76.00%","C3YWU0","Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase)","Branchiostoma floridae (Florida lancelet) (Amphioxus)","fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]","GO:0004560; GO:0005576; GO:0005764; GO:0006004; GO:0016139"
"2127",2295,838390,"Cluster_14500","Peve_00043313",-0.836237066495949,0.369501437886685,0.978262075707395,162,-21.31,"2 19","739 758",17,"88.24%","88.24%","Q96KE9","BTB/POZ domain-containing protein 6 (Lens BTB domain protein)","Homo sapiens (Human)","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"2128",2296,838605,"Cluster_9149","Peve_00043314",0.628504255483548,0.567334941899341,0.978262075707395,152,-26.19,"2 18","321 345",19,"68.42%","78.95%","Q8K2J9","BTB/POZ domain-containing protein 6","Mus musculus (Mouse)","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"2129",2297,839727,"Cluster_8887","Peve_00018992",0.2355777435687,0.848603542033948,0.995934364227446,154,-21.69,"2 20","868 889",19,"68.42%","78.95%","Q9FJ70","Fimbrin-3 (AtFIM3) (Fimbrin3)","Arabidopsis thaliana (Mouse-ear cress)","actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]","GO:0000325; GO:0005737; GO:0005884; GO:0032432; GO:0046872; GO:0051015; GO:0051017; GO:0051639"
"2130",2298,839728,"Cluster_8888","Peve_00018992",0.831049674129521,0.375480929163219,0.978262075707395,154,-21.93,"2 20","868 889",19,"68.42%","78.95%","Q9FJ70","Fimbrin-3 (AtFIM3) (Fimbrin3)","Arabidopsis thaliana (Mouse-ear cress)","actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]","GO:0000325; GO:0005737; GO:0005884; GO:0032432; GO:0046872; GO:0051015; GO:0051017; GO:0051639"
"2131",2299,839893,"Cluster_4735","Peve_00016067",-0.92100689146644,0.254736341061413,0.978262075707395,151,-21.11,"2 12","160 181",10,"90.00%","100.00%",NA,NA,NA,NA,NA
"2132",2300,840469,"Cluster_1140","Peve_00038129",-0.965158492987321,0.168543758907255,0.978262075707395,178,-20.86,"2 20","332 354",19,"84.21%","94.74%",NA,NA,NA,NA,NA
"2133",2301,840514,"Cluster_1140","Peve_00038128",-0.914915026563122,0.264514860239055,0.978262075707395,178,-20.86,"2 20","601 623",19,"84.21%","94.74%",NA,NA,NA,NA,NA
"2134",2302,840557,"Cluster_589","Peve_00038127",0.578940071761952,0.606933028704916,0.978262075707395,167,-22.3,"2 20","374 395",18,"61.11%","100.00%","Q4LDE5","Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)","Homo sapiens (Human)","cell adhesion [GO:0007155]; epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193]","GO:0003017; GO:0003682; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0007155; GO:0008544; GO:0010467; GO:0016020; GO:0036303; GO:0048014; GO:0120193"
"2135",2303,840928,"Cluster_4735","Peve_00000818",-0.500943642233887,0.665972771890438,0.978262075707395,151,-20.23,"2 14","869 889",12,"91.67%","91.67%","Q8N0W4","Neuroligin-4, X-linked (Neuroligin X) (HNLX)","Homo sapiens (Human)","adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]","GO:0003360; GO:0005886; GO:0007158; GO:0007268; GO:0007612; GO:0009986; GO:0016020; GO:0021549; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0038023; GO:0042043; GO:0042803; GO:0045202; GO:0045216; GO:0048488; GO:0050804; GO:0050808; GO:0050839; GO:0060076; GO:0071625; GO:0090394; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098839; GO:0098983; GO:0098985; GO:0099054; GO:0099634"
"2136",2304,841193,"Cluster_2882","Peve_00014855",0.829552508820929,0.377191141695678,0.978262075707395,145,-20.82,"2 10","875 896",8,"100.00%","100.00%",NA,NA,NA,NA,NA
"2137",2305,841596,"Cluster_2787","Peve_00030311",0.867933894665659,0.330895275232091,0.978262075707395,162,-23.36,"2 20","670 692",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"2138",2306,841623,"Cluster_10061","Peve_00030311",-0.446077406355246,0.705641205133228,0.978262075707395,163,-20.17,"2 19","302 321",17,"82.35%","88.24%",NA,NA,NA,NA,NA
"2139",2307,842012,"Cluster_6904","Peve_00033660",-0.81564969006928,0.392759416578221,0.978262075707395,143,-20.18,"2 21","522 545",21,"57.14%","71.43%",NA,NA,NA,NA,NA
"2140",2308,842014,"Cluster_6906","Peve_00033660",-0.437173828563236,0.711958901795128,0.979387676091274,143,-20.89,"2 21","522 545",21,"57.14%","71.43%",NA,NA,NA,NA,NA
"2141",2309,842377,"Cluster_7657","Peve_00035492",-0.952048434917628,0.197946305435425,0.978262075707395,158,-20.67,"2 21","870 894",22,"68.18%","81.82%","Q06725","Nuclear receptor subfamily 2 group F member 1-A (COUP transcription factor 1-A) (COUP-TFalpha-A) (zCOUP-TFI) (Seven-up related 44) (Svp[44]) (zSvp[44]) (Steroid receptor homolog SVP 44)","Danio rerio (Zebrafish) (Brachydanio rerio)","anatomical structure development [GO:0048856]; atrial cardiac muscle cell differentiation [GO:0055011]; cardiac atrium morphogenesis [GO:0003209]; cardiac muscle tissue development [GO:0048738]; cell differentiation [GO:0030154]; endothelial cell proliferation [GO:0001935]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; vasculature development [GO:0001944]","GO:0000122; GO:0000978; GO:0001935; GO:0001944; GO:0003209; GO:0004879; GO:0005634; GO:0006357; GO:0008270; GO:0030154; GO:0045944; GO:0048738; GO:0048856; GO:0055011"
"2142",2310,842378,"Cluster_7658","Peve_00035492",0.883540179598999,0.310306586581365,0.978262075707395,158,-20.67,"2 21","870 894",22,"68.18%","81.82%","Q06725","Nuclear receptor subfamily 2 group F member 1-A (COUP transcription factor 1-A) (COUP-TFalpha-A) (zCOUP-TFI) (Seven-up related 44) (Svp[44]) (zSvp[44]) (Steroid receptor homolog SVP 44)","Danio rerio (Zebrafish) (Brachydanio rerio)","anatomical structure development [GO:0048856]; atrial cardiac muscle cell differentiation [GO:0055011]; cardiac atrium morphogenesis [GO:0003209]; cardiac muscle tissue development [GO:0048738]; cell differentiation [GO:0030154]; endothelial cell proliferation [GO:0001935]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; vasculature development [GO:0001944]","GO:0000122; GO:0000978; GO:0001935; GO:0001944; GO:0003209; GO:0004879; GO:0005634; GO:0006357; GO:0008270; GO:0030154; GO:0045944; GO:0048738; GO:0048856; GO:0055011"
"2143",2311,842384,"Cluster_8988","Peve_00035492",-0.848018621354167,0.355590963603776,0.978262075707395,159,-20.84,"2 21","112 134",20,"60.00%","90.00%","Q06725","Nuclear receptor subfamily 2 group F member 1-A (COUP transcription factor 1-A) (COUP-TFalpha-A) (zCOUP-TFI) (Seven-up related 44) (Svp[44]) (zSvp[44]) (Steroid receptor homolog SVP 44)","Danio rerio (Zebrafish) (Brachydanio rerio)","anatomical structure development [GO:0048856]; atrial cardiac muscle cell differentiation [GO:0055011]; cardiac atrium morphogenesis [GO:0003209]; cardiac muscle tissue development [GO:0048738]; cell differentiation [GO:0030154]; endothelial cell proliferation [GO:0001935]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; vasculature development [GO:0001944]","GO:0000122; GO:0000978; GO:0001935; GO:0001944; GO:0003209; GO:0004879; GO:0005634; GO:0006357; GO:0008270; GO:0030154; GO:0045944; GO:0048738; GO:0048856; GO:0055011"
"2144",2312,842687,"Cluster_6904","Peve_00044209",-0.0755268827315017,0.95187226301652,0.999448381576871,146,-24.26,"2 21","264 291",25,"64.00%","68.00%","P97292","Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I)","Mus musculus (Mouse)","chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonic acid secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; toxin transport [GO:1901998]; visual learning [GO:0008542]","GO:0001696; GO:0001697; GO:0001698; GO:0003382; GO:0004969; GO:0004993; GO:0005886; GO:0007187; GO:0007268; GO:0007613; GO:0008542; GO:0016020; GO:0030425; GO:0030594; GO:0045202; GO:0045907; GO:0048167; GO:0048565; GO:0048732; GO:1900139; GO:1901363; GO:1901998"
"2145",2313,842689,"Cluster_6906","Peve_00044209",-0.545508944753718,0.632672777799613,0.978262075707395,154,-26.6,"2 21","264 291",25,"68.00%","72.00%","P97292","Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I)","Mus musculus (Mouse)","chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonic acid secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; toxin transport [GO:1901998]; visual learning [GO:0008542]","GO:0001696; GO:0001697; GO:0001698; GO:0003382; GO:0004969; GO:0004993; GO:0005886; GO:0007187; GO:0007268; GO:0007613; GO:0008542; GO:0016020; GO:0030425; GO:0030594; GO:0045202; GO:0045907; GO:0048167; GO:0048565; GO:0048732; GO:1900139; GO:1901363; GO:1901998"
"2146",2314,843397,"Cluster_2854","Peve_00016177",-0.711928142031852,0.495644315677516,0.978262075707395,168,-20.99,"2 21","802 823",19,"78.95%","78.95%","Q96EH3","Mitochondrial assembly of ribosomal large subunit protein 1","Homo sapiens (Human)","negative regulation of mitochondrial translation [GO:0070130]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of translation [GO:0017148]; ribosomal large subunit biogenesis [GO:0042273]","GO:0005739; GO:0005759; GO:0005829; GO:0017148; GO:0042273; GO:0043023; GO:0070130; GO:0090071"
"2147",2315,843604,"Cluster_10934","Peve_00016286",0.83107749175497,0.375449088153859,0.978262075707395,156,-23.81,"2 21","837 858",19,"63.16%","78.95%","Q0VA42","Probable ubiquitin carboxyl-terminal hydrolase MINDY-4 (EC 3.4.19.12) (Probable deubiquitinating enzyme MINDY-4)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","protein K48-linked deubiquitination [GO:0071108]","GO:0004843; GO:0071108; GO:1990380"
"2148",2316,845377,"Cluster_2854","Peve_00003677",-0.507486347355159,0.661149542463894,0.978262075707395,159,-21.6,"2 20","753 774",18,"66.67%","83.33%",NA,NA,NA,NA,NA
"2149",2317,845502,"Cluster_15726","Peve_00003679",-0.0867980951013845,0.944672996145068,0.999448381576871,155,-20.41,"2 21","748 774",24,"62.50%","75.00%",NA,NA,NA,NA,NA
"2150",2318,845624,"Cluster_8988","Peve_00040282",-0.999041633391172,0.0278737658962114,0.899642249848007,162,-21.05,"2 21","329 354",23,"69.57%","82.61%",NA,NA,NA,NA,NA
"2151",2319,846267,"Cluster_15726","Peve_00004907",-0.840913680828153,0.364036353430722,0.978262075707395,148,-20.13,"2 21","405 423",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"2152",2320,846273,"Cluster_796","Peve_00004904",-0.481506989985522,0.680179197353503,0.978262075707395,155,-24.44,"2 21","939 961",20,"70.00%","75.00%",NA,NA,NA,NA,NA
"2153",2321,846489,"Cluster_13502","Peve_00042520",-0.254539786976536,0.836152032365248,0.995934364227446,165,-20.88,"2 18","656 677",16,"81.25%","87.50%","Q66HA2","Cyclic AMP-responsive element-binding protein 3-like protein 1 (cAMP-responsive element-binding protein 3-like protein 1) (Old astrocyte specifically-induced substance) (OASIS) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 1]","Rattus norvegicus (Rat)","DNA-templated transcription [GO:0006351]; DNA-templated transcription elongation [GO:0006354]; endoplasmic reticulum unfolded protein response [GO:0030968]; extracellular matrix constituent secretion [GO:0070278]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression [GO:0010629]; negative regulation of sprouting angiogenesis [GO:1903671]; osteoblast differentiation [GO:0001649]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; regulation of ossification [GO:0030278]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000785; GO:0000976; GO:0000981; GO:0001227; GO:0001228; GO:0001649; GO:0003682; GO:0005634; GO:0005783; GO:0005789; GO:0006351; GO:0006354; GO:0006357; GO:0010629; GO:0016020; GO:0030278; GO:0030968; GO:0032967; GO:0035497; GO:0040037; GO:0045892; GO:0045944; GO:0046332; GO:0070278; GO:1902236; GO:1903671; GO:1990440; GO:1990837"
"2154",2322,846795,"Cluster_9149","Peve_00016822",-0.988862378411062,0.0951032283160556,0.978262075707395,164,-20.28,"2 21","364 385",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"2155",2323,846858,"Cluster_796","Peve_00016820",0.822287023022644,0.385395631168823,0.978262075707395,162,-20.95,"2 19","302 323",17,"76.47%","82.35%","Q6DCE8","Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2)","Xenopus laevis (African clawed frog)","L-arginine transmembrane transport [GO:1903826]","GO:0005886; GO:0061459; GO:1903826"
"2156",2324,847485,"Cluster_16738","Peve_00015736",-0.877776516983749,0.318052241578191,0.978262075707395,171,-22.22,"2 21","476 498",20,"80.00%","85.00%","Q6IP18","Replication protein A 32 kDa subunit-A (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34)","Xenopus laevis (African clawed frog)","base-excision repair [GO:0006284]; DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; double-strand break repair via homologous recombination [GO:0000724]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; telomere maintenance [GO:0000723]","GO:0000076; GO:0000723; GO:0000724; GO:0000785; GO:0003684; GO:0003697; GO:0005634; GO:0005662; GO:0006260; GO:0006284; GO:0006289; GO:0006298; GO:0016605; GO:0034502"
"2157",2326,849849,"Cluster_7855","Peve_00025291",-0.800332648857473,0.409312447429449,0.978262075707395,170,-21.52,"2 19","419 440",17,"82.35%","88.24%",NA,NA,NA,NA,NA
"2158",2327,849969,"Cluster_4079","Peve_00000593",0.922028042287347,0.253062309744281,0.978262075707395,165,-20.04,"2 21","794 813",19,"73.68%","89.47%",NA,NA,NA,NA,NA
"2159",2328,850575,"Cluster_9149","Peve_00027237",-0.5,0.666666666666667,0.978262075707395,149,-24.54,"2 15","3 26",15,"73.33%","86.67%","D3YXG0","Hemicentin-1 (Fibulin-6) (FIBL-6)","Mus musculus (Mouse)","actin filament reorganization [GO:0090527]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]","GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711; GO:0090527"
"2160",2329,850620,"Cluster_9149","Peve_00007749",-0.5,0.666666666666667,0.978262075707395,145,-20.62,"2 15","283 305",14,"71.43%","85.71%",NA,NA,NA,NA,NA
"2161",2330,851667,"Cluster_15726","Peve_00026174",0.380692286681764,0.751371432473679,0.988219883885475,164,-20.22,"2 21","301 322",19,"73.68%","78.95%","Q09470","Potassium voltage-gated channel subfamily A member 1 (Voltage-gated K(+) channel HuKI) (Voltage-gated potassium channel HBK1) (Voltage-gated potassium channel subunit Kv1.1)","Homo sapiens (Human)","axon development [GO:0061564]; cell communication by electrical coupling [GO:0010644]; cellular response to magnesium ion [GO:0071286]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; corpus callosum development [GO:0022038]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; hippocampus development [GO:0021766]; magnesium ion homeostasis [GO:0010960]; neuroblast proliferation [GO:0007405]; neuromuscular process [GO:0050905]; neuronal action potential [GO:0019228]; neuronal signal transduction [GO:0023041]; optic nerve development [GO:0021554]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; startle response [GO:0001964]","GO:0001964; GO:0005249; GO:0005251; GO:0005267; GO:0005783; GO:0005829; GO:0005886; GO:0006813; GO:0006937; GO:0007268; GO:0007405; GO:0008076; GO:0008104; GO:0009986; GO:0010644; GO:0010960; GO:0015079; GO:0016020; GO:0016324; GO:0019228; GO:0021554; GO:0021766; GO:0021987; GO:0022038; GO:0023041; GO:0030054; GO:0030425; GO:0031410; GO:0033270; GO:0042391; GO:0042734; GO:0043025; GO:0043194; GO:0043204; GO:0043679; GO:0044224; GO:0044305; GO:0045202; GO:0045211; GO:0050905; GO:0050966; GO:0050976; GO:0051260; GO:0061564; GO:0070161; GO:0071286; GO:0071805; GO:0097718; GO:0098978; GO:0099508; GO:1903818; GO:1905030"
"2162",2331,852533,"Cluster_2882","Peve_00022217",-0.898389711968954,0.289475524970989,0.978262075707395,148,-20.93,"2 17","211 232",15,"73.33%","73.33%",NA,NA,NA,NA,NA
"2163",2332,854317,"Cluster_11135","Peve_00020109",0.660188234683025,0.540952997580709,0.978262075707395,160,-20.87,"2 18","470 492",17,"82.35%","82.35%",NA,NA,NA,NA,NA
"2164",2333,855195,"Cluster_5882","Peve_00017190",-0.600709532689659,0.589769654436723,0.978262075707395,156,-20.42,"2 18","698 720",17,"70.59%","88.24%",NA,NA,NA,NA,NA
"2165",2334,856272,"Cluster_4629","Peve_00023176",-0.675355605883078,0.527980320741203,0.978262075707395,160,-20.92,"2 13","741 762",11,"100.00%","100.00%",NA,NA,NA,NA,NA
"2166",2335,857955,"Cluster_9149","Peve_00018104",-0.5,0.666666666666667,0.978262075707395,167,-29.75,"2 21","568 590",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"2167",2336,858426,"Cluster_2787","Peve_00014261",0.255772746747013,0.835340235104456,0.995934364227446,164,-23.91,"2 21","799 820",19,"63.16%","89.47%","P46023","G-protein coupled receptor GRL101","Lymnaea stagnalis (Great pond snail) (Helix stagnalis)","","GO:0004930; GO:0005886"
"2168",2337,858436,"Cluster_6255","Peve_00014261",0.0513724797521885,0.967280861172193,0.999448381576871,163,-20.87,"2 20","696 717",18,"72.22%","83.33%","P46023","G-protein coupled receptor GRL101","Lymnaea stagnalis (Great pond snail) (Helix stagnalis)","","GO:0004930; GO:0005886"
"2169",2338,858721,"Cluster_9983","Peve_00011169",0.996265776670817,0.0550339269945434,0.975735777266924,157,-20.58,"2 18","28 48",16,"75.00%","81.25%",NA,NA,NA,NA,NA
"2170",2339,858740,"Cluster_1167","Peve_00011166",-0.996891806540242,0.0502067021364352,0.954794982852557,158,-25.42,"2 21","204 228",22,"72.73%","77.27%",NA,NA,NA,NA,NA
"2171",2340,860149,"Cluster_6906","Peve_00032907",0.973101367926096,0.147992105390084,0.978262075707395,148,-20.7,"2 21","273 294",19,"63.16%","68.42%","Q9DAM2","EF-hand calcium-binding domain-containing protein 9","Mus musculus (Mouse)","flagellated sperm motility [GO:0030317]; sperm capacitation [GO:0048240]; spermatogenesis [GO:0007283]","GO:0005509; GO:0005516; GO:0005737; GO:0007283; GO:0030317; GO:0036128; GO:0048240; GO:0061891; GO:0097228"
"2172",2341,860282,"Cluster_6904","Peve_00032904",0.996618084583096,0.0523719763535238,0.964368691435288,163,-26.56,"2 19","260 279",17,"82.35%","88.24%","P97364","Selenide, water dikinase 2 (EC 2.7.9.3) (Selenium donor protein 2) (Selenophosphate synthase 2)","Mus musculus (Mouse)","phosphorylation [GO:0016310]; selenium compound metabolic process [GO:0001887]; selenocysteine biosynthetic process [GO:0016260]","GO:0001887; GO:0004756; GO:0005524; GO:0005737; GO:0016260; GO:0016310; GO:0046872"
"2173",2342,860284,"Cluster_6906","Peve_00032904",0.913442666339064,0.266827508863383,0.978262075707395,159,-24.92,"2 19","260 279",17,"76.47%","88.24%","P97364","Selenide, water dikinase 2 (EC 2.7.9.3) (Selenium donor protein 2) (Selenophosphate synthase 2)","Mus musculus (Mouse)","phosphorylation [GO:0016310]; selenium compound metabolic process [GO:0001887]; selenocysteine biosynthetic process [GO:0016260]","GO:0001887; GO:0004756; GO:0005524; GO:0005737; GO:0016260; GO:0016310; GO:0046872"
"2174",2343,861150,"Cluster_9149","Peve_00033363",-0.5,0.666666666666667,0.978262075707395,149,-20.98,"2 14","353 374",12,"75.00%","91.67%",NA,NA,NA,NA,NA
"2175",2344,861168,"Cluster_796","Peve_00033364",0.999260034938896,0.0244921839031936,0.862029780817471,145,-20.01,"2 10","259 280",8,"100.00%","100.00%","P22045","9,11-endoperoxide prostaglandin H2 reductase (EC 1.1.1.-) (Prostaglandin F2-alpha synthase)","Leishmania major","prostaglandin biosynthetic process [GO:0001516]","GO:0000166; GO:0001516; GO:0005737; GO:0036130"
"2176",2345,861260,"Cluster_1167","Peve_00033367",0.876503724120225,0.31973951655349,0.978262075707395,149,-22.24,"2 21","159 178",19,"68.42%","73.68%","A0A1L8H0H2",NA,NA,NA,NA
"2177",2346,862066,"Cluster_29","Peve_00022058",-0.997453781157211,0.0454396710191659,0.933005102504876,162,-20.17,"2 19","370 391",17,"70.59%","88.24%",NA,NA,NA,NA,NA
"2178",2347,862146,"Cluster_11134","Peve_00022054",0.949832294412878,0.202506889984634,0.978262075707395,155,-20.46,"2 21","846 868",20,"65.00%","80.00%","Q147X3","N-alpha-acetyltransferase 30 (EC 2.3.1.256) (N-acetyltransferase 12) (N-acetyltransferase MAK3 homolog) (NatC catalytic subunit)","Homo sapiens (Human)","N-terminal peptidyl-methionine acetylation [GO:0017196]","GO:0004596; GO:0005634; GO:0005737; GO:0005829; GO:0017196; GO:0031417"
"2179",2348,862409,"Cluster_8988","Peve_00029081",0.446997781696602,0.704986363617402,0.978262075707395,165,-21.91,"2 18","857 878",16,"81.25%","87.50%",NA,NA,NA,NA,NA
"2180",2349,862641,"Cluster_11134","Peve_00032015",0.875640822838247,0.320878802775509,0.978262075707395,153,-20.55,"2 20","71 94",20,"60.00%","90.00%","A4IHD2","Helicase ARIP4 (EC 3.6.4.12) (Androgen receptor-interacting protein 4) (RAD54-like protein 2)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0016887; GO:0140658"
"2181",2350,862652,"Cluster_589","Peve_00032017",0.159680919674548,0.897906931664995,0.999448381576871,170,-24.15,"2 19","71 92",17,"82.35%","88.24%","B3DM66","G-protein coupled receptor 161","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]","GO:0004930; GO:0005929; GO:0007189; GO:0055037; GO:0060170; GO:1901621"
"2182",2351,862845,"Cluster_5882","Peve_00019319",-0.982072085247855,0.120728828394661,0.978262075707395,160,-21.04,"2 21","509 530",19,"68.42%","78.95%","A8K2U0","Alpha-2-macroglobulin-like protein 1 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 9)","Homo sapiens (Human)","negative regulation of peptidase activity [GO:0010466]; regulation of endopeptidase activity [GO:0052548]","GO:0002020; GO:0004866; GO:0004867; GO:0005615; GO:0010466; GO:0030414; GO:0052548; GO:0070062"
"2183",2352,862971,"Cluster_2787","Peve_00019317",0.88717494676407,0.305329212382125,0.978262075707395,159,-23.08,"2 20","40 61",18,"66.67%","83.33%","Q9NRA2","Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular excitatory amino acid transporter) (VEAT)","Homo sapiens (Human)","amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]","GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0022857; GO:0030672; GO:0042880"
"2184",2353,864495,"Cluster_16738","Peve_00016540",-0.506209111557797,0.662092790877516,0.978262075707395,146,-21.24,"2 21","497 522",23,"65.22%","69.57%",NA,NA,NA,NA,NA
"2185",2354,864942,"Cluster_15726","Peve_00004717",-0.991399718008417,0.0835532241339909,0.978262075707395,157,-20.49,"2 21","327 346",19,"68.42%","84.21%","Q3SZE2","Prefoldin subunit 1","Bos taurus (Bovine)","negative regulation of amyloid fibril formation [GO:1905907]","GO:0001540; GO:0005829; GO:0016272; GO:0044183; GO:0051082; GO:1905907"
"2186",2355,865380,"Cluster_9149","Peve_00000627",-0.569224746881938,0.614486859189336,0.978262075707395,159,-21.02,"2 21","420 442",20,"70.00%","80.00%","O75400","Pre-mRNA-processing factor 40 homolog A (Fas ligand-associated factor 1) (Formin-binding protein 11) (Formin-binding protein 3) (Huntingtin yeast partner A) (Huntingtin-interacting protein 10) (HIP-10) (Huntingtin-interacting protein A) (Renal carcinoma antigen NY-REN-6)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]","GO:0000398; GO:0003723; GO:0005654; GO:0005685; GO:0007010; GO:0007049; GO:0008360; GO:0016020; GO:0016363; GO:0016477; GO:0016607; GO:0032465; GO:0045292; GO:0051301; GO:0071004"
"2187",2356,865896,"Cluster_2787","Peve_00034433",0.876858344281507,0.319270234998944,0.978262075707395,155,-20.06,"2 21","771 793",20,"65.00%","80.00%","Q9H269","Vacuolar protein sorting-associated protein 16 homolog (hVPS16)","Homo sapiens (Human)","autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; vacuole fusion, non-autophagic [GO:0042144]","GO:0003779; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0008333; GO:0010008; GO:0016197; GO:0030136; GO:0030424; GO:0030897; GO:0031902; GO:0033263; GO:0034058; GO:0035542; GO:0042144; GO:0043025; GO:0051015; GO:0055037; GO:0097352; GO:0098793"
"2188",2357,866325,"Cluster_9149","Peve_00034435",-0.32406758685332,0.789898948934806,0.995887336046396,158,-26.15,"2 18","469 488",16,"81.25%","87.50%",NA,NA,NA,NA,NA
"2189",2358,866374,"Cluster_10934","Peve_00018048",-0.54330846070572,0.634342829052333,0.978262075707395,174,-31.72,"2 21","73 97",22,"81.82%","86.36%",NA,NA,NA,NA,NA
"2190",2359,866455,"Cluster_8634","Peve_00034434",0.5854978022779,0.601798163909577,0.978262075707395,173,-21.35,"2 20","162 182",18,"83.33%","94.44%",NA,NA,NA,NA,NA
"2191",2360,866747,"Cluster_589","Peve_00024043",-0.978940738046958,0.130882569967432,0.978262075707395,150,-22.17,"2 20","106 130",21,"66.67%","71.43%","Q7T105","Mesoderm induction early response protein 1 (Early response 1) (Er1) (Mi-er1) (Xmi-er1)","Xenopus laevis (African clawed frog)","chromatin remodeling [GO:0006338]; regulation of DNA-templated transcription [GO:0006355]","GO:0003677; GO:0005634; GO:0006338; GO:0006355; GO:0017053"
"2192",2361,866774,"Cluster_8988","Peve_00024043",0.24135582750454,0.844815819837651,0.995934364227446,159,-22.83,"2 21","65 88",21,"61.90%","85.71%","Q7T105","Mesoderm induction early response protein 1 (Early response 1) (Er1) (Mi-er1) (Xmi-er1)","Xenopus laevis (African clawed frog)","chromatin remodeling [GO:0006338]; regulation of DNA-templated transcription [GO:0006355]","GO:0003677; GO:0005634; GO:0006338; GO:0006355; GO:0017053"
"2193",2362,866835,"Cluster_16738","Peve_00023010",-0.0433865159022793,0.972370613282404,0.999448381576871,170,-20.28,"2 20","31 54",20,"80.00%","85.00%","Q0VCH3","Cysteine-rich DPF motif domain-containing protein 1","Bos taurus (Bovine)","",""
"2194",2363,866910,"Cluster_9149","Peve_00024049",0.999779696086058,0.0133633148443657,0.708804190981816,168,-24.07,"2 21","603 624",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"2195",2364,867765,"Cluster_9149","Peve_00034549",-0.529607056556125,0.644678788144279,0.978262075707395,159,-20.01,"2 21","217 240",21,"71.43%","76.19%","P49285","Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor) (CKA)","Gallus gallus (Chicken)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of glucose import [GO:0046325]; negative regulation of glycolytic process [GO:0045820]","GO:0004930; GO:0005886; GO:0007186; GO:0007193; GO:0007623; GO:0008502; GO:0042562; GO:0043235; GO:0045820; GO:0046325; GO:1904408"
"2196",2365,868169,"Cluster_8988","Peve_00022836",0.0860148226113438,0.945173514868548,0.999448381576871,159,-21.06,"2 21","434 458",22,"68.18%","77.27%",NA,NA,NA,NA,NA
"2197",2366,868502,"Cluster_589","Peve_00034715",-0.934753615028442,0.231240264998328,0.978262075707395,151,-20.92,"2 21","937 959",20,"60.00%","80.00%",NA,NA,NA,NA,NA
"2198",2367,869097,"Cluster_4629","Peve_00007535",0.997938030915672,0.0408894104551393,0.909359886114279,159,-21.98,"2 21","431 453",20,"70.00%","80.00%",NA,NA,NA,NA,NA
"2199",2368,870150,"Cluster_9149","Peve_00011363",-0.5,0.666666666666667,0.978262075707395,164,-22.31,"2 21","577 598",19,"73.68%","78.95%","Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"2200",2369,870342,"Cluster_15726","Peve_00013214",-0.630497338973844,0.565701946201337,0.978262075707395,151,-21.59,"2 19","868 887",17,"76.47%","76.47%","Q5SPP5","Protein EFR3 homolog B","Danio rerio (Zebrafish) (Brachydanio rerio)","phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659]","GO:0005886; GO:0046854; GO:0072659"
"2201",2370,870620,"Cluster_1167","Peve_00010097",0.780337086779239,0.430095009800917,0.978262075707395,154,-21.63,"2 21","871 895",22,"68.18%","77.27%","Q07973","1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial (24-OHase) (Vitamin D(3) 24-hydroxylase) (EC 1.14.15.16) (Cytochrome P450 24A1) (Cytochrome P450-CC24)","Homo sapiens (Human)","fatty acid omega-oxidation [GO:0010430]; osteoblast differentiation [GO:0001649]; response to vitamin D [GO:0033280]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; vitamin D receptor signaling pathway [GO:0070561]; vitamin metabolic process [GO:0006766]","GO:0001649; GO:0005506; GO:0005743; GO:0006766; GO:0008403; GO:0010430; GO:0020037; GO:0030342; GO:0033280; GO:0042359; GO:0042369; GO:0062180; GO:0062181; GO:0070561; GO:0070643"
"2202",2371,871225,"Cluster_8634","Peve_00024529",0.984378276793714,0.112674745364351,0.978262075707395,161,-22.3,"2 21","132 153",20,"75.00%","85.00%","Q9C0H5","Rho GTPase-activating protein 39","Homo sapiens (Human)","postsynapse organization [GO:0099173]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]","GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007165; GO:0051056; GO:0098978; GO:0099173"
"2203",2372,871724,"Cluster_8988","Peve_00010547",0.235365935705644,0.848742284379972,0.995934364227446,165,-24.95,"2 21","288 311",22,"77.27%","81.82%","Q9ULL1","Pleckstrin homology domain-containing family G member 1","Homo sapiens (Human)","regulation of small GTPase mediated signal transduction [GO:0051056]","GO:0005085; GO:0005654; GO:0005829; GO:0051056"
"2204",2373,872600,"Cluster_1167","Peve_00020319",-0.196376305128019,0.874165169670799,0.997476741937264,152,-20.28,"2 21","205 226",19,"68.42%","68.42%",NA,NA,NA,NA,NA
"2205",2374,872733,"Cluster_796","Peve_00020316",0.139952283453436,0.910610165479874,0.999448381576871,158,-22.83,"2 21","741 761",19,"73.68%","78.95%","Q6BZW3","Protein BTN1","Yarrowia lipolytica (strain CLIB 122 / E 150) (Yeast) (Candida lipolytica)","L-arginine transmembrane transport [GO:1903826]; lysine transport [GO:0015819]; regulation of intracellular pH [GO:0051453]","GO:0000324; GO:0005773; GO:0005774; GO:0015819; GO:0022857; GO:0051453; GO:1903826"
"2206",2375,872939,"Cluster_8988","Peve_00015131",-0.691604798463752,0.513808031095463,0.978262075707395,162,-21.38,"2 21","76 96",19,"68.42%","89.47%",NA,NA,NA,NA,NA
"2207",2376,872947,"Cluster_11135","Peve_00015131",-0.993699065391385,0.0715032709681847,0.978262075707395,171,-22.19,"2 21","21 44",21,"76.19%","85.71%",NA,NA,NA,NA,NA
"2208",2377,873214,"Cluster_10934","Peve_00044580",0.998038064060883,0.0398849050546989,0.909359886114279,161,-21.63,"2 20","74 94",18,"77.78%","83.33%","A2RV01","Diphthine--ammonia ligase (EC 6.3.1.14) (ATP-binding domain-containing protein 4) (Diphthamide synthase) (Diphthamide synthetase) (Protein DPH6 homolog)","Danio rerio (Zebrafish) (Brachydanio rerio)","peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]","GO:0005524; GO:0017178; GO:0017183"
"2209",2378,873261,"Cluster_11134","Peve_00044581",0.999774208746349,0.0135287244184117,0.712341789037769,162,-21.68,"2 20","878 900",19,"78.95%","78.95%","Q28DS0","SUMO-activating enzyme subunit 1 (Ubiquitin-like 1-activating enzyme E1A)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","definitive hemopoiesis [GO:0060216]; hematopoietic stem cell homeostasis [GO:0061484]; protein sumoylation [GO:0016925]","GO:0008022; GO:0008641; GO:0016925; GO:0031510; GO:0060216; GO:0061484"
"2210",2379,873460,"Cluster_4080","Peve_00014947",-0.0611492506749984,0.961046876399369,0.999448381576871,162,-22.55,"2 21","353 377",22,"72.73%","81.82%",NA,NA,NA,NA,NA
"2211",2380,874536,"Cluster_2787","Peve_00021049",0.843642971509924,0.360812981147348,0.978262075707395,160,-21.66,"2 18","67 89",17,"76.47%","88.24%",NA,NA,NA,NA,NA
"2212",2381,874560,"Cluster_9149","Peve_00021049",-0.999226469305183,0.0250415897127703,0.869034288843014,162,-20.26,"2 19","468 489",17,"76.47%","82.35%",NA,NA,NA,NA,NA
"2213",2383,876472,"Cluster_2854","Peve_00024808",-0.994783537731913,0.0650537186179004,0.978262075707395,162,-21,"2 20","613 636",20,"75.00%","80.00%","Q9Y5P8","Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta (PP2A subunit B isoform PR48) (Protein phosphatase 2A 48 kDa regulatory subunit)","Homo sapiens (Human)","protein dephosphorylation [GO:0006470]; regulation of cell cycle [GO:0051726]","GO:0000159; GO:0005509; GO:0005634; GO:0005654; GO:0005829; GO:0006470; GO:0019888; GO:0051726"
"2214",2384,876691,"Cluster_29","Peve_00018685",-0.388361545821212,0.746082351685144,0.987577839897734,160,-20.26,"2 17","301 322",15,"80.00%","86.67%","Q14AX6","Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12)","Mus musculus (Mouse)","mRNA processing [GO:0006397]; negative regulation of stem cell differentiation [GO:2000737]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of MAP kinase activity [GO:0043405]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366]; transcription elongation by RNA polymerase II promoter [GO:0006368]","GO:0000307; GO:0002944; GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0006366; GO:0006368; GO:0006397; GO:0006468; GO:0008024; GO:0008353; GO:0008380; GO:0016607; GO:0019901; GO:0019908; GO:0030332; GO:0032968; GO:0043405; GO:0043484; GO:0046777; GO:0070816; GO:0106310; GO:2000737"
"2215",2385,876723,"Cluster_10061","Peve_00018685",-0.465111545417519,0.69202842983227,0.978262075707395,170,-20.74,"2 20","450 472",19,"78.95%","89.47%","Q14AX6","Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12)","Mus musculus (Mouse)","mRNA processing [GO:0006397]; negative regulation of stem cell differentiation [GO:2000737]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of MAP kinase activity [GO:0043405]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366]; transcription elongation by RNA polymerase II promoter [GO:0006368]","GO:0000307; GO:0002944; GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0006366; GO:0006368; GO:0006397; GO:0006468; GO:0008024; GO:0008353; GO:0008380; GO:0016607; GO:0019901; GO:0019908; GO:0030332; GO:0032968; GO:0043405; GO:0043484; GO:0046777; GO:0070816; GO:0106310; GO:2000737"
"2216",2386,876850,"Cluster_8634","Peve_00018688",-0.164652808327468,0.894699266683281,0.999448381576871,167,-22.88,"2 21","619 643",22,"72.73%","81.82%","Q9NVA4","Transmembrane protein 184C (Transmembrane protein 34)","Homo sapiens (Human)","","GO:0016020"
"2217",2387,877948,"Cluster_15890","Peve_00042175",0.634774795523382,0.56218573918887,0.978262075707395,163,-20.77,"2 21","781 803",20,"75.00%","80.00%","Q8C033","Rho guanine nucleotide exchange factor 10","Mus musculus (Mouse)","actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]","GO:0005085; GO:0005813; GO:0019894; GO:0022011; GO:0030036; GO:0051298; GO:0051496; GO:0090307; GO:0090630"
"2218",2388,878090,"Cluster_1167","Peve_00042179",-0.488318552853167,0.675220836384603,0.978262075707395,145,-20.8,"2 21","337 356",19,"68.42%","68.42%",NA,NA,NA,NA,NA
"2219",2389,878166,"Cluster_11134","Peve_00004089",0.0652133433392006,0.958454413273132,0.999448381576871,157,-22.38,"2 21","749 768",19,"73.68%","78.95%","Q8BLA8","Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor)","Mus musculus (Mouse)","calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular calcium ion homeostasis [GO:0006874]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to organic substance [GO:0071310]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; positive regulation of anion transport [GO:1903793]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of sensory perception of pain [GO:1904058]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832]","GO:0005216; GO:0005245; GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0010033; GO:0014070; GO:0014832; GO:0015267; GO:0015278; GO:0016020; GO:0016324; GO:0019233; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042542; GO:0042802; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0050974; GO:0051289; GO:0070301; GO:0070417; GO:0070588; GO:0071244; GO:0071310; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1904058; GO:1990760"
"2220",2390,878205,"Cluster_9149","Peve_00004088",-0.671987513358182,0.530881689086303,0.978262075707395,159,-29.96,"2 21","603 629",24,"66.67%","75.00%","E7EZG2","Unconventional myosin-IXAa (Myosin IXAa)","Danio rerio (Zebrafish) (Brachydanio rerio)","axon development [GO:0061564]; axon extension [GO:0048675]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; positive regulation of GTPase activity [GO:0043547]; swimming behavior [GO:0036269]","GO:0000146; GO:0005096; GO:0005524; GO:0005737; GO:0005884; GO:0007626; GO:0016020; GO:0016459; GO:0035556; GO:0036269; GO:0043547; GO:0044295; GO:0045198; GO:0045202; GO:0046872; GO:0048675; GO:0051015; GO:0061564; GO:0098529"
"2221",2391,878537,"Cluster_589","Peve_00000705",-0.69663979531241,0.509355198261447,0.978262075707395,159,-20.41,"2 21","239 262",21,"71.43%","76.19%",NA,NA,NA,NA,NA
"2222",2392,878830,"Cluster_8634","Peve_00036804",0.999713854690073,0.0152299610722912,0.747042277261995,165,-22.16,"2 18","575 596",16,"81.25%","87.50%",NA,NA,NA,NA,NA
"2223",2393,879022,"Cluster_11135","Peve_00036800",0.0416594069809366,0.973471120528434,0.999448381576871,158,-22.09,"2 19","182 203",17,"70.59%","82.35%","Q9CL21","ATP-dependent DNA helicase RecQ (EC 3.6.4.12)","Pasteurella multocida (strain Pm70)","DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; SOS response [GO:0009432]","GO:0003677; GO:0005524; GO:0006260; GO:0006281; GO:0006310; GO:0009432; GO:0016887; GO:0043138"
"2224",2394,879067,"Cluster_11135","Peve_00036801",0.0416594069809366,0.973471120528434,0.999448381576871,158,-22.09,"2 19","182 203",17,"70.59%","82.35%",NA,NA,NA,NA,NA
"2225",2395,879260,"Cluster_1167","Peve_00035388",0.660371086747753,0.54079799868758,0.978262075707395,147,-23.44,"2 21","469 491",20,"65.00%","70.00%","Q6L8S8","Beta-1,4-N-acetylgalactosaminyltransferase 3 (Beta4GalNAc-T3) (Beta4GalNAcT3) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase III) (N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2) (NGalNAc-T2)","Mus musculus (Mouse)","chondroitin sulfate biosynthetic process [GO:0030206]","GO:0005794; GO:0008376; GO:0030206; GO:0032580; GO:0033842; GO:0043231; GO:0047238"
"2226",2396,879305,"Cluster_1167","Peve_00035389",0.971261692268827,0.15299291307888,0.978262075707395,147,-23.44,"2 21","80 102",20,"65.00%","70.00%","Q8IXZ2","Zinc finger CCCH domain-containing protein 3 (Smad-interacting CPSF-like factor)","Homo sapiens (Human)","mRNA 3'-end processing [GO:0031124]; mRNA transport [GO:0051028]; positive regulation of activin receptor signaling pathway [GO:0032927]; regulation of mRNA polyadenylation [GO:1900363]","GO:0003677; GO:0005634; GO:0005847; GO:0031124; GO:0032927; GO:0046872; GO:0051028; GO:0070412; GO:1900363"
"2227",2397,879369,"Cluster_7855","Peve_00001071",-0.756522056575724,0.45379397756573,0.978262075707395,173,-22.53,"2 20","413 436",20,"85.00%","90.00%","Q5VU97","VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1)","Homo sapiens (Human)","","GO:0005245; GO:0005891"
"2228",2398,879846,"Cluster_2787","Peve_00029336",0.811371354934307,0.397442958881225,0.978262075707395,146,-23.62,"2 11","51 72",9,"88.89%","100.00%","Q0P4P2","Fibrinogen C domain-containing protein 1","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0008061; GO:0016020; GO:0046872"
"2229",2399,881120,"Cluster_6914","Peve_00030773",0.00965476607576375,0.993853489525405,0.999448381576871,157,-22.05,"2 20","360 379",18,"72.22%","83.33%","G8HTB6","ZP domain-containing protein","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0016020"
"2230",2400,882306,"Cluster_11134","Peve_00038542",0.965919755153475,0.166681599245511,0.978262075707395,158,-21.14,"2 16","187 209",15,"80.00%","93.33%",NA,NA,NA,NA,NA
"2231",2401,882850,"Cluster_14500","Peve_00007042",-0.66332724967567,0.538287509260039,0.978262075707395,165,-21.29,"2 19","23 45",18,"72.22%","94.44%",NA,NA,NA,NA,NA
"2232",2402,882940,"Cluster_14500","Peve_00007040",-0.713164843330814,0.49452219341486,0.978262075707395,165,-21.29,"2 19","23 45",18,"72.22%","94.44%",NA,NA,NA,NA,NA
"2233",2403,883296,"Cluster_11134","Peve_00032732",0.899366698658025,0.288056143747285,0.978262075707395,160,-24.98,"2 13","350 371",11,"100.00%","100.00%",NA,NA,NA,NA,NA
"2234",2404,883386,"Cluster_11134","Peve_00032734",0.428228784325412,0.718275480446294,0.98111914123614,160,-24.98,"2 13","350 371",11,"100.00%","100.00%","Q9C091","GREB1-like protein (Growth regulation by estrogen in breast cancer 1-like protein)","Homo sapiens (Human)","branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac ventricle development [GO:0003231]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; paramesonephric duct development [GO:0061205]; uterus development [GO:0060065]","GO:0001656; GO:0001658; GO:0001822; GO:0003231; GO:0016020; GO:0030539; GO:0060065; GO:0061205; GO:0072177"
"2235",2405,883728,"Cluster_6905","Peve_00028523",-0.201187625087429,0.871039814392261,0.997476741937264,165,-21.11,"2 20","612 632",18,"83.33%","83.33%",NA,NA,NA,NA,NA
"2236",2408,884658,"Cluster_796","Peve_00037815",0.988245526601005,0.0977064058240041,0.978262075707395,161,-20.69,"2 18","941 962",16,"81.25%","81.25%",NA,NA,NA,NA,NA
"2237",2409,884748,"Cluster_796","Peve_00037813",0.898740270652305,0.288966974174018,0.978262075707395,147,-21.64,"2 21","189 207",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"2238",2410,885242,"Cluster_589","Peve_00013480",0.0519996220707287,0.966881075605242,0.999448381576871,151,-21.95,"2 18","711 731",16,"75.00%","81.25%","Q4V7Q8","Transmembrane protein 220","Xenopus laevis (African clawed frog)","","GO:0016020"
"2239",2411,885260,"Cluster_6914","Peve_00013480",0.757337967356909,0.45299913697778,0.978262075707395,167,-20.46,"2 20","585 605",18,"77.78%","83.33%","Q4V7Q8","Transmembrane protein 220","Xenopus laevis (African clawed frog)","","GO:0016020"
"2240",2412,885579,"Cluster_7855","Peve_00022575",-0.663593554081334,0.538060922691432,0.978262075707395,159,-20.52,"2 21","917 939",20,"70.00%","80.00%","E2JA28","Dapdiamide synthesis protein DdaC (EC 1.-.-.-)","Enterobacter agglomerans (Erwinia herbicola) (Pantoea agglomerans)","antibiotic biosynthetic process [GO:0017000]","GO:0016491; GO:0017000"
"2241",2413,886010,"Cluster_1167","Peve_00023227",0.999689275367834,0.0158706315126451,0.761370369638947,145,-20.39,"2 10","656 677",8,"100.00%","100.00%","O54988","STE20-like serine/threonine-protein kinase (STE20-like kinase) (mSLK) (EC 2.7.11.1) (Etk4) (STE20-related kinase SMAK) (STE20-related serine/threonine-protein kinase) (STE20-related kinase) (Serine/threonine-protein kinase 2)","Mus musculus (Mouse)","apoptotic process [GO:0006915]; cellular response to type II interferon [GO:0071346]; cytoplasmic microtubule organization [GO:0031122]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893]","GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0006915; GO:0030334; GO:0031122; GO:0031252; GO:0035173; GO:0042802; GO:0042803; GO:0042981; GO:0043065; GO:0046777; GO:0048471; GO:0051893; GO:0071346; GO:0106310"
"2242",2414,886540,"Cluster_14500","Peve_00031415",-0.84425801444626,0.360083053305185,0.978262075707395,167,-20.73,"2 18","14 34",16,"87.50%","93.75%",NA,NA,NA,NA,NA
"2243",2415,887095,"Cluster_4080","Peve_00001448",0.659477270685321,0.541555348216336,0.978262075707395,163,-20.51,"2 21","413 435",20,"75.00%","80.00%","Q62746","Synaptotagmin-6 (Synaptotagmin VI) (SytVI)","Rattus norvegicus (Rat)","acrosomal vesicle exocytosis [GO:0060478]; acrosome reaction [GO:0007340]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; postsynaptic dense core vesicle exocytosis [GO:0150038]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]","GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005829; GO:0005886; GO:0007340; GO:0014059; GO:0016020; GO:0016192; GO:0017156; GO:0017158; GO:0019898; GO:0019905; GO:0030276; GO:0030672; GO:0042802; GO:0042803; GO:0046982; GO:0048306; GO:0060478; GO:0070382; GO:0071277; GO:0097038; GO:0097060; GO:0098794; GO:0098978; GO:0150038"
"2244",2416,887111,"Cluster_8884","Peve_00001448",0.987942959679974,0.0989584317195915,0.978262075707395,170,-20.83,"2 20","797 818",19,"78.95%","89.47%","Q62746","Synaptotagmin-6 (Synaptotagmin VI) (SytVI)","Rattus norvegicus (Rat)","acrosomal vesicle exocytosis [GO:0060478]; acrosome reaction [GO:0007340]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; postsynaptic dense core vesicle exocytosis [GO:0150038]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]","GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005829; GO:0005886; GO:0007340; GO:0014059; GO:0016020; GO:0016192; GO:0017156; GO:0017158; GO:0019898; GO:0019905; GO:0030276; GO:0030672; GO:0042802; GO:0042803; GO:0046982; GO:0048306; GO:0060478; GO:0070382; GO:0071277; GO:0097038; GO:0097060; GO:0098794; GO:0098978; GO:0150038"
"2245",2417,887112,"Cluster_8887","Peve_00001448",0.992328003524988,0.0789091505539726,0.978262075707395,170,-23.7,"2 20","797 818",19,"78.95%","89.47%","Q62746","Synaptotagmin-6 (Synaptotagmin VI) (SytVI)","Rattus norvegicus (Rat)","acrosomal vesicle exocytosis [GO:0060478]; acrosome reaction [GO:0007340]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; postsynaptic dense core vesicle exocytosis [GO:0150038]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]","GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005829; GO:0005886; GO:0007340; GO:0014059; GO:0016020; GO:0016192; GO:0017156; GO:0017158; GO:0019898; GO:0019905; GO:0030276; GO:0030672; GO:0042802; GO:0042803; GO:0046982; GO:0048306; GO:0060478; GO:0070382; GO:0071277; GO:0097038; GO:0097060; GO:0098794; GO:0098978; GO:0150038"
"2246",2418,887113,"Cluster_8888","Peve_00001448",0.647017919555896,0.552031763424703,0.978262075707395,170,-24.08,"2 20","797 818",19,"78.95%","89.47%","Q62746","Synaptotagmin-6 (Synaptotagmin VI) (SytVI)","Rattus norvegicus (Rat)","acrosomal vesicle exocytosis [GO:0060478]; acrosome reaction [GO:0007340]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; postsynaptic dense core vesicle exocytosis [GO:0150038]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]","GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005829; GO:0005886; GO:0007340; GO:0014059; GO:0016020; GO:0016192; GO:0017156; GO:0017158; GO:0019898; GO:0019905; GO:0030276; GO:0030672; GO:0042802; GO:0042803; GO:0046982; GO:0048306; GO:0060478; GO:0070382; GO:0071277; GO:0097038; GO:0097060; GO:0098794; GO:0098978; GO:0150038"
"2247",2419,887316,"Cluster_2787","Peve_00020556",0.997105325686941,0.0484506705316052,0.946735628940312,168,-25.54,"2 21","856 877",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"2248",2420,887720,"Cluster_1167","Peve_00025535",-0.511591173923624,0.65811249694873,0.978262075707395,160,-21.16,"2 21","283 304",19,"68.42%","78.95%","Q8K4L3","Supervillin (Archvillin) (p205/p250)","Mus musculus (Mouse)","actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; positive regulation of cytokinesis [GO:0032467]; skeletal muscle tissue development [GO:0007519]","GO:0002102; GO:0005546; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007519; GO:0008154; GO:0015629; GO:0030496; GO:0032154; GO:0032467; GO:0036449; GO:0042995; GO:0043034; GO:0051014; GO:0051015; GO:0051016; GO:0070161"
"2249",2421,887945,"Cluster_1167","Peve_00006583",0.993649349061238,0.071785106306824,0.978262075707395,153,-21.53,"2 19","141 163",18,"72.22%","77.78%","Q63HN8","E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (ALK lymphoma oligomerization partner on chromosome 17) (E3 ubiquitin-lipopolysaccharide ligase RNF213) (EC 2.3.2.-) (Mysterin) (RING finger protein 213)","Homo sapiens (Human)","angiogenesis [GO:0001525]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]","GO:0001525; GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005737; GO:0005811; GO:0005829; GO:0006511; GO:0016020; GO:0016567; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0051865; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051"
"2250",2422,887992,"Cluster_2854","Peve_00001444",0.999962776498024,0.00549294287464855,0.551398425649056,158,-21.78,"2 21","203 228",23,"69.57%","78.26%","Q0ZZJ6","A.superbus venom factor 1 (AVF-1) (CVF-like) (Complement C3 homolog) [Cleaved into: AVF-1 alpha chain; AVF-1 gamma chain; AVF-1 beta chain]","Austrelaps superbus (Lowland copperhead snake) (Hoplocephalus superbus)","complement activation [GO:0006956]; inflammatory response [GO:0006954]","GO:0004866; GO:0005615; GO:0006954; GO:0006956; GO:0046872; GO:0090729"
"2251",2423,888137,"Cluster_6904","Peve_00020886",-0.492589885356482,0.672100557401011,0.978262075707395,149,-23.07,"2 21","526 551",23,"69.57%","73.91%","P21447","ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1A) (MDR1A) (Multidrug resistance protein 1A) (EC 7.6.2.2) (Multidrug resistance protein 3) (P-glycoprotein 3) (Phospholipid transporter ABCB1) (EC 7.6.2.1)","Mus musculus (Mouse)","brain development [GO:0007420]; carboxylic acid transmembrane transport [GO:1905039]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to alkaloid [GO:0071312]; cellular response to antibiotic [GO:0071236]; cellular response to borneol [GO:1905231]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to external biotic stimulus [GO:0071217]; cellular response to L-glutamate [GO:1905232]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mycotoxin [GO:0036146]; cellular response to tumor necrosis factor [GO:0071356]; ceramide translocation [GO:0099040]; circadian rhythm [GO:0007623]; daunorubicin transport [GO:0043215]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; hormone transport [GO:0009914]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of cell death [GO:0060548]; phospholipid translocation [GO:0045332]; placenta development [GO:0001890]; positive regulation of anion channel activity [GO:1901529]; positive regulation of establishment of Sertoli cell barrier [GO:1904446]; positive regulation of response to drug [GO:2001025]; protein localization to bicellular tight junction [GO:1902396]; regulation of chloride transport [GO:2001225]; regulation of intestinal absorption [GO:1904478]; regulation of response to osmotic stress [GO:0047484]; response to antineoplastic agent [GO:0097327]; response to cadmium ion [GO:0046686]; response to codeine [GO:1905233]; response to cyclosporin A [GO:1905237]; response to glucagon [GO:0033762]; response to glycoside [GO:1903416]; response to hypoxia [GO:0001666]; response to morphine [GO:0043278]; response to quercetin [GO:1905235]; response to thyroxine [GO:0097068]; response to vitamin A [GO:0033189]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]","GO:0000086; GO:0001666; GO:0001890; GO:0005524; GO:0005654; GO:0005737; GO:0005886; GO:0007420; GO:0007595; GO:0007623; GO:0008559; GO:0009410; GO:0009914; GO:0009986; GO:0015562; GO:0016020; GO:0016324; GO:0016887; GO:0022857; GO:0031526; GO:0031625; GO:0033189; GO:0033280; GO:0033762; GO:0035633; GO:0036146; GO:0042626; GO:0042910; GO:0043215; GO:0043278; GO:0045332; GO:0046581; GO:0046686; GO:0046865; GO:0046943; GO:0047484; GO:0050892; GO:0060548; GO:0060856; GO:0070633; GO:0071217; GO:0071222; GO:0071236; GO:0071312; GO:0071356; GO:0071392; GO:0071475; GO:0071549; GO:0072089; GO:0090554; GO:0090555; GO:0097068; GO:0097327; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:1901529; GO:1902396; GO:1903416; GO:1904446; GO:1904478; GO:1905039; GO:1905231; GO:1905232; GO:1905233; GO:1905235; GO:1905237; GO:1990961; GO:1990962; GO:1990963; GO:2001025; GO:2001225"
"2252",2424,888137,"Cluster_6904","Peve_00020886",-0.492589885356482,0.672100557401011,0.978262075707395,164,-25.12,"2 19","557 577",17,"82.35%","88.24%","P21447","ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1A) (MDR1A) (Multidrug resistance protein 1A) (EC 7.6.2.2) (Multidrug resistance protein 3) (P-glycoprotein 3) (Phospholipid transporter ABCB1) (EC 7.6.2.1)","Mus musculus (Mouse)","brain development [GO:0007420]; carboxylic acid transmembrane transport [GO:1905039]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to alkaloid [GO:0071312]; cellular response to antibiotic [GO:0071236]; cellular response to borneol [GO:1905231]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to external biotic stimulus [GO:0071217]; cellular response to L-glutamate [GO:1905232]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mycotoxin [GO:0036146]; cellular response to tumor necrosis factor [GO:0071356]; ceramide translocation [GO:0099040]; circadian rhythm [GO:0007623]; daunorubicin transport [GO:0043215]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; hormone transport [GO:0009914]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of cell death [GO:0060548]; phospholipid translocation [GO:0045332]; placenta development [GO:0001890]; positive regulation of anion channel activity [GO:1901529]; positive regulation of establishment of Sertoli cell barrier [GO:1904446]; positive regulation of response to drug [GO:2001025]; protein localization to bicellular tight junction [GO:1902396]; regulation of chloride transport [GO:2001225]; regulation of intestinal absorption [GO:1904478]; regulation of response to osmotic stress [GO:0047484]; response to antineoplastic agent [GO:0097327]; response to cadmium ion [GO:0046686]; response to codeine [GO:1905233]; response to cyclosporin A [GO:1905237]; response to glucagon [GO:0033762]; response to glycoside [GO:1903416]; response to hypoxia [GO:0001666]; response to morphine [GO:0043278]; response to quercetin [GO:1905235]; response to thyroxine [GO:0097068]; response to vitamin A [GO:0033189]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]","GO:0000086; GO:0001666; GO:0001890; GO:0005524; GO:0005654; GO:0005737; GO:0005886; GO:0007420; GO:0007595; GO:0007623; GO:0008559; GO:0009410; GO:0009914; GO:0009986; GO:0015562; GO:0016020; GO:0016324; GO:0016887; GO:0022857; GO:0031526; GO:0031625; GO:0033189; GO:0033280; GO:0033762; GO:0035633; GO:0036146; GO:0042626; GO:0042910; GO:0043215; GO:0043278; GO:0045332; GO:0046581; GO:0046686; GO:0046865; GO:0046943; GO:0047484; GO:0050892; GO:0060548; GO:0060856; GO:0070633; GO:0071217; GO:0071222; GO:0071236; GO:0071312; GO:0071356; GO:0071392; GO:0071475; GO:0071549; GO:0072089; GO:0090554; GO:0090555; GO:0097068; GO:0097327; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:1901529; GO:1902396; GO:1903416; GO:1904446; GO:1904478; GO:1905039; GO:1905231; GO:1905232; GO:1905233; GO:1905235; GO:1905237; GO:1990961; GO:1990962; GO:1990963; GO:2001025; GO:2001225"
"2253",2425,888139,"Cluster_6906","Peve_00020886",-0.0136654357399745,0.991300042617917,0.999448381576871,150,-24.1,"2 21","526 551",23,"65.22%","73.91%","P21447","ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1A) (MDR1A) (Multidrug resistance protein 1A) (EC 7.6.2.2) (Multidrug resistance protein 3) (P-glycoprotein 3) (Phospholipid transporter ABCB1) (EC 7.6.2.1)","Mus musculus (Mouse)","brain development [GO:0007420]; carboxylic acid transmembrane transport [GO:1905039]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to alkaloid [GO:0071312]; cellular response to antibiotic [GO:0071236]; cellular response to borneol [GO:1905231]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to external biotic stimulus [GO:0071217]; cellular response to L-glutamate [GO:1905232]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mycotoxin [GO:0036146]; cellular response to tumor necrosis factor [GO:0071356]; ceramide translocation [GO:0099040]; circadian rhythm [GO:0007623]; daunorubicin transport [GO:0043215]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; hormone transport [GO:0009914]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of cell death [GO:0060548]; phospholipid translocation [GO:0045332]; placenta development [GO:0001890]; positive regulation of anion channel activity [GO:1901529]; positive regulation of establishment of Sertoli cell barrier [GO:1904446]; positive regulation of response to drug [GO:2001025]; protein localization to bicellular tight junction [GO:1902396]; regulation of chloride transport [GO:2001225]; regulation of intestinal absorption [GO:1904478]; regulation of response to osmotic stress [GO:0047484]; response to antineoplastic agent [GO:0097327]; response to cadmium ion [GO:0046686]; response to codeine [GO:1905233]; response to cyclosporin A [GO:1905237]; response to glucagon [GO:0033762]; response to glycoside [GO:1903416]; response to hypoxia [GO:0001666]; response to morphine [GO:0043278]; response to quercetin [GO:1905235]; response to thyroxine [GO:0097068]; response to vitamin A [GO:0033189]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]","GO:0000086; GO:0001666; GO:0001890; GO:0005524; GO:0005654; GO:0005737; GO:0005886; GO:0007420; GO:0007595; GO:0007623; GO:0008559; GO:0009410; GO:0009914; GO:0009986; GO:0015562; GO:0016020; GO:0016324; GO:0016887; GO:0022857; GO:0031526; GO:0031625; GO:0033189; GO:0033280; GO:0033762; GO:0035633; GO:0036146; GO:0042626; GO:0042910; GO:0043215; GO:0043278; GO:0045332; GO:0046581; GO:0046686; GO:0046865; GO:0046943; GO:0047484; GO:0050892; GO:0060548; GO:0060856; GO:0070633; GO:0071217; GO:0071222; GO:0071236; GO:0071312; GO:0071356; GO:0071392; GO:0071475; GO:0071549; GO:0072089; GO:0090554; GO:0090555; GO:0097068; GO:0097327; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:1901529; GO:1902396; GO:1903416; GO:1904446; GO:1904478; GO:1905039; GO:1905231; GO:1905232; GO:1905233; GO:1905235; GO:1905237; GO:1990961; GO:1990962; GO:1990963; GO:2001025; GO:2001225"
"2254",2426,888139,"Cluster_6906","Peve_00020886",-0.0136654357399745,0.991300042617917,0.999448381576871,160,-23.1,"2 19","557 577",17,"76.47%","88.24%","P21447","ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1A) (MDR1A) (Multidrug resistance protein 1A) (EC 7.6.2.2) (Multidrug resistance protein 3) (P-glycoprotein 3) (Phospholipid transporter ABCB1) (EC 7.6.2.1)","Mus musculus (Mouse)","brain development [GO:0007420]; carboxylic acid transmembrane transport [GO:1905039]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to alkaloid [GO:0071312]; cellular response to antibiotic [GO:0071236]; cellular response to borneol [GO:1905231]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to external biotic stimulus [GO:0071217]; cellular response to L-glutamate [GO:1905232]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mycotoxin [GO:0036146]; cellular response to tumor necrosis factor [GO:0071356]; ceramide translocation [GO:0099040]; circadian rhythm [GO:0007623]; daunorubicin transport [GO:0043215]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; hormone transport [GO:0009914]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of cell death [GO:0060548]; phospholipid translocation [GO:0045332]; placenta development [GO:0001890]; positive regulation of anion channel activity [GO:1901529]; positive regulation of establishment of Sertoli cell barrier [GO:1904446]; positive regulation of response to drug [GO:2001025]; protein localization to bicellular tight junction [GO:1902396]; regulation of chloride transport [GO:2001225]; regulation of intestinal absorption [GO:1904478]; regulation of response to osmotic stress [GO:0047484]; response to antineoplastic agent [GO:0097327]; response to cadmium ion [GO:0046686]; response to codeine [GO:1905233]; response to cyclosporin A [GO:1905237]; response to glucagon [GO:0033762]; response to glycoside [GO:1903416]; response to hypoxia [GO:0001666]; response to morphine [GO:0043278]; response to quercetin [GO:1905235]; response to thyroxine [GO:0097068]; response to vitamin A [GO:0033189]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]","GO:0000086; GO:0001666; GO:0001890; GO:0005524; GO:0005654; GO:0005737; GO:0005886; GO:0007420; GO:0007595; GO:0007623; GO:0008559; GO:0009410; GO:0009914; GO:0009986; GO:0015562; GO:0016020; GO:0016324; GO:0016887; GO:0022857; GO:0031526; GO:0031625; GO:0033189; GO:0033280; GO:0033762; GO:0035633; GO:0036146; GO:0042626; GO:0042910; GO:0043215; GO:0043278; GO:0045332; GO:0046581; GO:0046686; GO:0046865; GO:0046943; GO:0047484; GO:0050892; GO:0060548; GO:0060856; GO:0070633; GO:0071217; GO:0071222; GO:0071236; GO:0071312; GO:0071356; GO:0071392; GO:0071475; GO:0071549; GO:0072089; GO:0090554; GO:0090555; GO:0097068; GO:0097327; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:1901529; GO:1902396; GO:1903416; GO:1904446; GO:1904478; GO:1905039; GO:1905231; GO:1905232; GO:1905233; GO:1905235; GO:1905237; GO:1990961; GO:1990962; GO:1990963; GO:2001025; GO:2001225"
"2255",2427,888146,"Cluster_8884","Peve_00020886",-0.914818961674334,0.264666330206996,0.978262075707395,155,-20.09,"2 20","971 991",18,"66.67%","77.78%","P21447","ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1A) (MDR1A) (Multidrug resistance protein 1A) (EC 7.6.2.2) (Multidrug resistance protein 3) (P-glycoprotein 3) (Phospholipid transporter ABCB1) (EC 7.6.2.1)","Mus musculus (Mouse)","brain development [GO:0007420]; carboxylic acid transmembrane transport [GO:1905039]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to alkaloid [GO:0071312]; cellular response to antibiotic [GO:0071236]; cellular response to borneol [GO:1905231]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to external biotic stimulus [GO:0071217]; cellular response to L-glutamate [GO:1905232]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mycotoxin [GO:0036146]; cellular response to tumor necrosis factor [GO:0071356]; ceramide translocation [GO:0099040]; circadian rhythm [GO:0007623]; daunorubicin transport [GO:0043215]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; hormone transport [GO:0009914]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of cell death [GO:0060548]; phospholipid translocation [GO:0045332]; placenta development [GO:0001890]; positive regulation of anion channel activity [GO:1901529]; positive regulation of establishment of Sertoli cell barrier [GO:1904446]; positive regulation of response to drug [GO:2001025]; protein localization to bicellular tight junction [GO:1902396]; regulation of chloride transport [GO:2001225]; regulation of intestinal absorption [GO:1904478]; regulation of response to osmotic stress [GO:0047484]; response to antineoplastic agent [GO:0097327]; response to cadmium ion [GO:0046686]; response to codeine [GO:1905233]; response to cyclosporin A [GO:1905237]; response to glucagon [GO:0033762]; response to glycoside [GO:1903416]; response to hypoxia [GO:0001666]; response to morphine [GO:0043278]; response to quercetin [GO:1905235]; response to thyroxine [GO:0097068]; response to vitamin A [GO:0033189]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]","GO:0000086; GO:0001666; GO:0001890; GO:0005524; GO:0005654; GO:0005737; GO:0005886; GO:0007420; GO:0007595; GO:0007623; GO:0008559; GO:0009410; GO:0009914; GO:0009986; GO:0015562; GO:0016020; GO:0016324; GO:0016887; GO:0022857; GO:0031526; GO:0031625; GO:0033189; GO:0033280; GO:0033762; GO:0035633; GO:0036146; GO:0042626; GO:0042910; GO:0043215; GO:0043278; GO:0045332; GO:0046581; GO:0046686; GO:0046865; GO:0046943; GO:0047484; GO:0050892; GO:0060548; GO:0060856; GO:0070633; GO:0071217; GO:0071222; GO:0071236; GO:0071312; GO:0071356; GO:0071392; GO:0071475; GO:0071549; GO:0072089; GO:0090554; GO:0090555; GO:0097068; GO:0097327; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:1901529; GO:1902396; GO:1903416; GO:1904446; GO:1904478; GO:1905039; GO:1905231; GO:1905232; GO:1905233; GO:1905235; GO:1905237; GO:1990961; GO:1990962; GO:1990963; GO:2001025; GO:2001225"
"2256",2428,888147,"Cluster_8887","Peve_00020886",-0.990719661862735,0.0867987479334319,0.978262075707395,155,-20.44,"2 20","971 991",18,"66.67%","77.78%","P21447","ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1A) (MDR1A) (Multidrug resistance protein 1A) (EC 7.6.2.2) (Multidrug resistance protein 3) (P-glycoprotein 3) (Phospholipid transporter ABCB1) (EC 7.6.2.1)","Mus musculus (Mouse)","brain development [GO:0007420]; carboxylic acid transmembrane transport [GO:1905039]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to alkaloid [GO:0071312]; cellular response to antibiotic [GO:0071236]; cellular response to borneol [GO:1905231]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to external biotic stimulus [GO:0071217]; cellular response to L-glutamate [GO:1905232]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mycotoxin [GO:0036146]; cellular response to tumor necrosis factor [GO:0071356]; ceramide translocation [GO:0099040]; circadian rhythm [GO:0007623]; daunorubicin transport [GO:0043215]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; hormone transport [GO:0009914]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of cell death [GO:0060548]; phospholipid translocation [GO:0045332]; placenta development [GO:0001890]; positive regulation of anion channel activity [GO:1901529]; positive regulation of establishment of Sertoli cell barrier [GO:1904446]; positive regulation of response to drug [GO:2001025]; protein localization to bicellular tight junction [GO:1902396]; regulation of chloride transport [GO:2001225]; regulation of intestinal absorption [GO:1904478]; regulation of response to osmotic stress [GO:0047484]; response to antineoplastic agent [GO:0097327]; response to cadmium ion [GO:0046686]; response to codeine [GO:1905233]; response to cyclosporin A [GO:1905237]; response to glucagon [GO:0033762]; response to glycoside [GO:1903416]; response to hypoxia [GO:0001666]; response to morphine [GO:0043278]; response to quercetin [GO:1905235]; response to thyroxine [GO:0097068]; response to vitamin A [GO:0033189]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]","GO:0000086; GO:0001666; GO:0001890; GO:0005524; GO:0005654; GO:0005737; GO:0005886; GO:0007420; GO:0007595; GO:0007623; GO:0008559; GO:0009410; GO:0009914; GO:0009986; GO:0015562; GO:0016020; GO:0016324; GO:0016887; GO:0022857; GO:0031526; GO:0031625; GO:0033189; GO:0033280; GO:0033762; GO:0035633; GO:0036146; GO:0042626; GO:0042910; GO:0043215; GO:0043278; GO:0045332; GO:0046581; GO:0046686; GO:0046865; GO:0046943; GO:0047484; GO:0050892; GO:0060548; GO:0060856; GO:0070633; GO:0071217; GO:0071222; GO:0071236; GO:0071312; GO:0071356; GO:0071392; GO:0071475; GO:0071549; GO:0072089; GO:0090554; GO:0090555; GO:0097068; GO:0097327; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:1901529; GO:1902396; GO:1903416; GO:1904446; GO:1904478; GO:1905039; GO:1905231; GO:1905232; GO:1905233; GO:1905235; GO:1905237; GO:1990961; GO:1990962; GO:1990963; GO:2001025; GO:2001225"
"2257",2429,888148,"Cluster_8888","Peve_00020886",-0.821456403175493,0.386323864937298,0.978262075707395,155,-22.07,"2 20","971 991",18,"66.67%","77.78%","P21447","ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1A) (MDR1A) (Multidrug resistance protein 1A) (EC 7.6.2.2) (Multidrug resistance protein 3) (P-glycoprotein 3) (Phospholipid transporter ABCB1) (EC 7.6.2.1)","Mus musculus (Mouse)","brain development [GO:0007420]; carboxylic acid transmembrane transport [GO:1905039]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to alkaloid [GO:0071312]; cellular response to antibiotic [GO:0071236]; cellular response to borneol [GO:1905231]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to external biotic stimulus [GO:0071217]; cellular response to L-glutamate [GO:1905232]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mycotoxin [GO:0036146]; cellular response to tumor necrosis factor [GO:0071356]; ceramide translocation [GO:0099040]; circadian rhythm [GO:0007623]; daunorubicin transport [GO:0043215]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; hormone transport [GO:0009914]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of cell death [GO:0060548]; phospholipid translocation [GO:0045332]; placenta development [GO:0001890]; positive regulation of anion channel activity [GO:1901529]; positive regulation of establishment of Sertoli cell barrier [GO:1904446]; positive regulation of response to drug [GO:2001025]; protein localization to bicellular tight junction [GO:1902396]; regulation of chloride transport [GO:2001225]; regulation of intestinal absorption [GO:1904478]; regulation of response to osmotic stress [GO:0047484]; response to antineoplastic agent [GO:0097327]; response to cadmium ion [GO:0046686]; response to codeine [GO:1905233]; response to cyclosporin A [GO:1905237]; response to glucagon [GO:0033762]; response to glycoside [GO:1903416]; response to hypoxia [GO:0001666]; response to morphine [GO:0043278]; response to quercetin [GO:1905235]; response to thyroxine [GO:0097068]; response to vitamin A [GO:0033189]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]","GO:0000086; GO:0001666; GO:0001890; GO:0005524; GO:0005654; GO:0005737; GO:0005886; GO:0007420; GO:0007595; GO:0007623; GO:0008559; GO:0009410; GO:0009914; GO:0009986; GO:0015562; GO:0016020; GO:0016324; GO:0016887; GO:0022857; GO:0031526; GO:0031625; GO:0033189; GO:0033280; GO:0033762; GO:0035633; GO:0036146; GO:0042626; GO:0042910; GO:0043215; GO:0043278; GO:0045332; GO:0046581; GO:0046686; GO:0046865; GO:0046943; GO:0047484; GO:0050892; GO:0060548; GO:0060856; GO:0070633; GO:0071217; GO:0071222; GO:0071236; GO:0071312; GO:0071356; GO:0071392; GO:0071475; GO:0071549; GO:0072089; GO:0090554; GO:0090555; GO:0097068; GO:0097327; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:1901529; GO:1902396; GO:1903416; GO:1904446; GO:1904478; GO:1905039; GO:1905231; GO:1905232; GO:1905233; GO:1905235; GO:1905237; GO:1990961; GO:1990962; GO:1990963; GO:2001025; GO:2001225"
"2258",2430,889005,"Cluster_9149","Peve_00021687",-0.723109590804819,0.485424284270186,0.978262075707395,160,-22,"2 17","189 210",15,"80.00%","86.67%","Q8N983","39S ribosomal protein L43, mitochondrial (L43mt) (MRP-L43) (Mitochondrial large ribosomal subunit protein mL43) (Mitochondrial ribosomal protein bMRP36a)","Homo sapiens (Human)","mitochondrial translation [GO:0032543]; translation [GO:0006412]","GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0006412; GO:0032543"
"2259",2431,889271,"Cluster_8884","Peve_00013825",-0.993392480885587,0.0732240522373289,0.978262075707395,166,-23.86,"2 20","697 719",20,"80.00%","80.00%",NA,NA,NA,NA,NA
"2260",2432,889272,"Cluster_8887","Peve_00013825",-0.923221973724439,0.251091634510894,0.978262075707395,166,-23.49,"2 20","697 719",20,"80.00%","80.00%",NA,NA,NA,NA,NA
"2261",2433,889273,"Cluster_8888","Peve_00013825",-0.419780300727609,0.724214247381624,0.982826646000572,166,-25.12,"2 20","697 719",20,"80.00%","80.00%",NA,NA,NA,NA,NA
"2262",2434,889527,"Cluster_4629","Peve_00013823",-0.996949447613843,0.0497387457379489,0.952281411175107,154,-20.35,"2 15","722 743",13,"84.62%","84.62%","A0A2J6RX17",NA,NA,NA,NA
"2263",2435,889685,"Cluster_10965","Peve_00000028",0.870479314169719,0.327617924992727,0.978262075707395,160,-20.09,"2 13","262 283",11,"100.00%","100.00%",NA,NA,NA,NA,NA
"2264",2436,890494,"Cluster_10934","Peve_00033042",-0.456234386365879,0.698395722414825,0.978262075707395,166,-23.03,"2 21","408 432",22,"72.73%","86.36%",NA,NA,NA,NA,NA
"2265",2437,890940,"Cluster_9149","Peve_00021652",0.988154915096967,0.098083020518496,0.978262075707395,147,-20.39,"2 20","634 653",18,"72.22%","77.78%","Q5PPI9","Polyglutamylase complex subunit TTLL1 (EC 6.3.2.-) (Tubulin polyglutamylase TTLL1) (Tubulin polyglutamylase complex subunit 3) (PGs3) (Tubulin--tyrosine ligase-like protein 1)","Rattus norvegicus (Rat)","axoneme assembly [GO:0035082]; cerebellar Purkinje cell differentiation [GO:0021702]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; immune response in nasopharyngeal-associated lymphoid tissue [GO:0002395]; microtubule cytoskeleton organization [GO:0000226]; mucociliary clearance [GO:0120197]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222]; sperm axoneme assembly [GO:0007288]","GO:0000226; GO:0002395; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005929; GO:0007288; GO:0015631; GO:0018095; GO:0021702; GO:0030317; GO:0031514; GO:0035082; GO:0036064; GO:0046872; GO:0070740; GO:0120197; GO:0120222"
"2266",2438,891276,"Cluster_2787","Peve_00011530",0.867933894665659,0.330895275232091,0.978262075707395,155,-21.97,"2 18","735 759",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"2267",2439,891306,"Cluster_11134","Peve_00011530",-0.0195622829453675,0.987545469442176,0.999448381576871,160,-20.03,"2 21","743 764",19,"63.16%","84.21%",NA,NA,NA,NA,NA
"2268",2440,892310,"Cluster_1167","Peve_00041125",0.436994933326685,0.712085525820843,0.97942580414729,157,-25.87,"2 14","852 873",12,"91.67%","91.67%","Q55E31","Ras-related protein Rab-32B","Dictyostelium discoideum (Social amoeba)","intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; vesicle-mediated transport [GO:0016192]","GO:0003924; GO:0005525; GO:0005802; GO:0006886; GO:0012505; GO:0016192; GO:0031982; GO:0032438"
"2269",2441,892515,"Cluster_9149","Peve_00027196",-0.771875019283279,0.438638179881664,0.978262075707395,168,-22.79,"2 21","262 283",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"2270",2442,892581,"Cluster_2787","Peve_00027194",0.484970958303372,0.677660336736146,0.978262075707395,151,-21.63,"2 21","49 72",21,"61.90%","76.19%","Q9CWL8","Beta-catenin-like protein 1 (Nuclear-associated protein) (NAP)","Mus musculus (Mouse)","adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; somatic diversification of immunoglobulins [GO:0016445]","GO:0000398; GO:0000974; GO:0002250; GO:0005634; GO:0005654; GO:0005681; GO:0005813; GO:0005829; GO:0006915; GO:0016445; GO:0019899; GO:0043065"
"2271",2443,892645,"Cluster_8634","Peve_00034673",-0.841515191257027,0.363328137362649,0.978262075707395,159,-23.29,"2 21","680 702",20,"70.00%","80.00%",NA,NA,NA,NA,NA
"2272",2444,892851,"Cluster_2787","Peve_00032314",0.904554863124497,0.280406697996142,0.978262075707395,156,-21,"2 21","691 712",19,"63.16%","78.95%",NA,NA,NA,NA,NA
"2273",2445,894036,"Cluster_7053","Peve_00032535",0.984821909487227,0.111059199387113,0.978262075707395,159,-20.82,"2 18","294 314",16,"81.25%","87.50%",NA,NA,NA,NA,NA
"2274",2446,895362,"Cluster_15726","Peve_00032283",0.365124406986344,0.762052898654682,0.988823817186575,151,-26.86,"2 21","123 151",26,"65.38%","65.38%",NA,NA,NA,NA,NA
"2275",2447,897104,"Cluster_8988","Peve_00014751",0.0860148226113438,0.945173514868548,0.999448381576871,157,-20.41,"2 20","797 820",20,"70.00%","85.00%","C6FG12","Protein NLRC5","Ictalurus punctatus (Channel catfish) (Silurus punctatus)","innate immune response [GO:0045087]","GO:0005524; GO:0005737; GO:0045087"
"2276",2449,897485,"Cluster_1167","Peve_00043614",-0.488318552853167,0.675220836384604,0.978262075707395,160,-23.13,"2 21","806 824",19,"78.95%","78.95%","P55006","Retinol dehydrogenase 7 (EC 1.1.1.105) (Retinol dehydrogenase 3) (Retinol dehydrogenase type III) (RODH III)","Rattus norvegicus (Rat)","retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]","GO:0004745; GO:0005783; GO:0008202; GO:0016491; GO:0042572; GO:0043231"
"2277",2450,897582,"Cluster_4629","Peve_00011789",-0.84596051437857,0.358055627266678,0.978262075707395,167,-22.62,"2 20","153 174",18,"77.78%","83.33%","Q8IYT8","Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2)","Homo sapiens (Human)","autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; axon extension [GO:0048675]; collateral sprouting [GO:0048668]; late nucleophagy [GO:0044805]; negative regulation of collateral sprouting [GO:0048671]; peptidyl-serine phosphorylation [GO:0018105]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; response to starvation [GO:0042594]; reticulophagy [GO:0061709]; signal transduction [GO:0007165]","GO:0000045; GO:0000422; GO:0004674; GO:0005524; GO:0005737; GO:0006914; GO:0007165; GO:0010508; GO:0018105; GO:0030659; GO:0034045; GO:0034727; GO:0042594; GO:0044805; GO:0046777; GO:0048668; GO:0048671; GO:0048675; GO:0061709; GO:0106310"
"2278",2451,897693,"Cluster_10061","Peve_00018491",0.638515638637407,0.559097519404817,0.978262075707395,159,-20.36,"2 21","521 546",23,"65.22%","78.26%","Q00342","Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase 2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Tyrosine-protein kinase receptor flk-2) (CD antigen CD135)","Mus musculus (Mouse)","antigen processing and presentation [GO:0019882]; B cell differentiation [GO:0030183]; cell population proliferation [GO:0008283]; cellular response to cytokine stimulus [GO:0071345]; cellular response to virus [GO:0098586]; common myeloid progenitor cell proliferation [GO:0035726]; cytokine-mediated signaling pathway [GO:0019221]; dendritic cell differentiation [GO:0097028]; dendritic cell homeostasis [GO:0036145]; hemopoiesis [GO:0030097]; homeostasis of number of cells within a tissue [GO:0048873]; leukocyte homeostasis [GO:0001776]; lymph node development [GO:0048535]; lymphocyte differentiation [GO:0030098]; lymphocyte proliferation [GO:0046651]; lymphoid progenitor cell differentiation [GO:0002320]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of kinase activity [GO:0033674]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of type II interferon production [GO:0032729]; post-embryonic development [GO:0009791]; pro-B cell differentiation [GO:0002328]; pro-T cell differentiation [GO:0002572]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; spleen development [GO:0048536]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0001776; GO:0001934; GO:0002318; GO:0002320; GO:0002328; GO:0002572; GO:0004713; GO:0004714; GO:0004896; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0005829; GO:0005886; GO:0006468; GO:0007169; GO:0008283; GO:0008285; GO:0009791; GO:0009897; GO:0009986; GO:0019221; GO:0019838; GO:0019882; GO:0030097; GO:0030098; GO:0030183; GO:0031625; GO:0032715; GO:0032720; GO:0032727; GO:0032729; GO:0032735; GO:0032991; GO:0033674; GO:0035259; GO:0035726; GO:0036145; GO:0040018; GO:0043235; GO:0043548; GO:0043621; GO:0044877; GO:0045578; GO:0046651; GO:0046777; GO:0048535; GO:0048536; GO:0048873; GO:0071345; GO:0097028; GO:0098586"
"2279",2452,897693,"Cluster_10061","Peve_00018491",0.638515638637407,0.559097519404817,0.978262075707395,163,-21.27,"2 17","57 81",18,"83.33%","83.33%","Q00342","Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase 2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Tyrosine-protein kinase receptor flk-2) (CD antigen CD135)","Mus musculus (Mouse)","antigen processing and presentation [GO:0019882]; B cell differentiation [GO:0030183]; cell population proliferation [GO:0008283]; cellular response to cytokine stimulus [GO:0071345]; cellular response to virus [GO:0098586]; common myeloid progenitor cell proliferation [GO:0035726]; cytokine-mediated signaling pathway [GO:0019221]; dendritic cell differentiation [GO:0097028]; dendritic cell homeostasis [GO:0036145]; hemopoiesis [GO:0030097]; homeostasis of number of cells within a tissue [GO:0048873]; leukocyte homeostasis [GO:0001776]; lymph node development [GO:0048535]; lymphocyte differentiation [GO:0030098]; lymphocyte proliferation [GO:0046651]; lymphoid progenitor cell differentiation [GO:0002320]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of kinase activity [GO:0033674]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of type II interferon production [GO:0032729]; post-embryonic development [GO:0009791]; pro-B cell differentiation [GO:0002328]; pro-T cell differentiation [GO:0002572]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; spleen development [GO:0048536]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0001776; GO:0001934; GO:0002318; GO:0002320; GO:0002328; GO:0002572; GO:0004713; GO:0004714; GO:0004896; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0005829; GO:0005886; GO:0006468; GO:0007169; GO:0008283; GO:0008285; GO:0009791; GO:0009897; GO:0009986; GO:0019221; GO:0019838; GO:0019882; GO:0030097; GO:0030098; GO:0030183; GO:0031625; GO:0032715; GO:0032720; GO:0032727; GO:0032729; GO:0032735; GO:0032991; GO:0033674; GO:0035259; GO:0035726; GO:0036145; GO:0040018; GO:0043235; GO:0043548; GO:0043621; GO:0044877; GO:0045578; GO:0046651; GO:0046777; GO:0048535; GO:0048536; GO:0048873; GO:0071345; GO:0097028; GO:0098586"
"2280",2455,898939,"Cluster_6906","Peve_00035260",-0.366886910211959,0.760847193275647,0.988485636521802,158,-23.63,"2 17","4 24",15,"86.67%","86.67%","P17017","Zinc finger protein 14 (Gonadotropin-inducible ovary transcription repressor 4) (GIOT-4) (Zinc finger protein KOX6)","Homo sapiens (Human)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"2281",2456,899001,"Cluster_11134","Peve_00035265",0.106078093288227,0.932341292524937,0.999448381576871,147,-21.02,"2 16","726 747",14,"71.43%","78.57%",NA,NA,NA,NA,NA
"2282",2457,899666,"Cluster_8884","Peve_00040574",-0.855754978378798,0.34618620127458,0.978262075707395,154,-20.09,"2 20","93 110",18,"77.78%","83.33%","Q76IC6","Palmitoyltransferase ZDHHC23 (EC 2.3.1.225) (NNOS-interacting DHHC domain-containing protein with dendritic mRNA) (Zinc finger DHHC domain-containing protein 23) (DHHC-23) (zDHHC23)","Rattus norvegicus (Rat)","peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]","GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0018230; GO:0018345; GO:0019706; GO:0072659"
"2283",2458,899667,"Cluster_8887","Peve_00040574",-0.965250970525115,0.168318619001016,0.978262075707395,154,-20.45,"2 20","93 110",18,"77.78%","83.33%","Q76IC6","Palmitoyltransferase ZDHHC23 (EC 2.3.1.225) (NNOS-interacting DHHC domain-containing protein with dendritic mRNA) (Zinc finger DHHC domain-containing protein 23) (DHHC-23) (zDHHC23)","Rattus norvegicus (Rat)","peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]","GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0018230; GO:0018345; GO:0019706; GO:0072659"
"2284",2459,899668,"Cluster_8888","Peve_00040574",-0.887555332418837,0.304803993869713,0.978262075707395,154,-22.08,"2 20","93 110",18,"77.78%","83.33%","Q76IC6","Palmitoyltransferase ZDHHC23 (EC 2.3.1.225) (NNOS-interacting DHHC domain-containing protein with dendritic mRNA) (Zinc finger DHHC domain-containing protein 23) (DHHC-23) (zDHHC23)","Rattus norvegicus (Rat)","peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]","GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0018230; GO:0018345; GO:0019706; GO:0072659"
"2285",2460,900647,"Cluster_6904","Peve_00021915",-0.92096006808876,0.254812851748422,0.978262075707395,154,-22.31,"2 21","357 381",22,"68.18%","77.27%","P62262","14-3-3 protein epsilon (14-3-3E) (Protein kinase C inhibitor protein 1) (KCIP-1)","Ovis aries (Sheep)","cellular response to heat [GO:0034605]; MAPK cascade [GO:0000165]; positive regulation of protein export from nucleus [GO:0046827]; protein localization to nucleus [GO:0034504]","GO:0000165; GO:0005634; GO:0005737; GO:0034504; GO:0034605; GO:0042470; GO:0046827"
"2286",2461,900649,"Cluster_6906","Peve_00021915",-0.620311558177496,0.574012336965329,0.978262075707395,154,-20.76,"2 21","357 381",22,"68.18%","77.27%","P62262","14-3-3 protein epsilon (14-3-3E) (Protein kinase C inhibitor protein 1) (KCIP-1)","Ovis aries (Sheep)","cellular response to heat [GO:0034605]; MAPK cascade [GO:0000165]; positive regulation of protein export from nucleus [GO:0046827]; protein localization to nucleus [GO:0034504]","GO:0000165; GO:0005634; GO:0005737; GO:0034504; GO:0034605; GO:0042470; GO:0046827"
"2287",2462,900954,"Cluster_4079","Peve_00022296",0.221595926679637,0.857746813860101,0.995934364227446,153,-22.83,"2 14","643 664",12,"83.33%","91.67%","A7S7Z9","Zinc finger protein-like 1 homolog","Nematostella vectensis (Starlet sea anemone)","","GO:0005794; GO:0016020; GO:0046872"
"2288",2463,901314,"Cluster_4079","Peve_00022298",0.952212145179277,0.197605370595572,0.978262075707395,153,-22.83,"2 14","643 664",12,"83.33%","91.67%",NA,NA,NA,NA,NA
"2289",2464,901356,"Cluster_2787","Peve_00014348",0.791029295043501,0.419091055430078,0.978262075707395,158,-22.16,"2 21","807 827",19,"68.42%","84.21%","Q32P28","Prolyl 3-hydroxylase 1 (EC 1.14.11.7) (Growth suppressor 1) (Leucine- and proline-enriched proteoglycan 1) (Leprecan-1)","Homo sapiens (Human)","bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; collagen metabolic process [GO:0032963]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of post-translational protein modification [GO:1901874]; positive regulation of neuron projection development [GO:0010976]; protein folding [GO:0006457]; protein hydroxylation [GO:0018126]; protein stabilization [GO:0050821]; regulation of protein secretion [GO:0050708]","GO:0005506; GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0006457; GO:0008285; GO:0010976; GO:0016020; GO:0018126; GO:0019797; GO:0031418; GO:0032963; GO:0032991; GO:0050708; GO:0050821; GO:0060348; GO:0061077; GO:0070062; GO:1901874"
"2290",2465,901618,"Cluster_15890","Peve_00037132",-0.318404794998924,0.793705766130216,0.995934364227446,155,-20.5,"2 16","710 731",14,"78.57%","85.71%","Q3TZA2","Cyclin-dependent kinase-like 4 (EC 2.7.11.22)","Mus musculus (Mouse)","protein phosphorylation [GO:0006468]","GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0106310"
"2291",2466,901986,"Cluster_2787","Peve_00022433",0.965752000964295,0.167093692077659,0.978262075707395,159,-21.3,"2 16","78 99",14,"85.71%","85.71%","P97739","Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71)","Cavia porcellus (Guinea pig)","proteolysis [GO:0006508]","GO:0004222; GO:0005886; GO:0006508; GO:0046872"
"2292",2467,901986,"Cluster_2787","Peve_00022433",0.965752000964295,0.167093692077659,0.978262075707395,166,-21.3,"2 20","434 457",20,"80.00%","80.00%","P97739","Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71)","Cavia porcellus (Guinea pig)","proteolysis [GO:0006508]","GO:0004222; GO:0005886; GO:0006508; GO:0046872"
"2293",2471,902286,"Cluster_11134","Peve_00027408",-0.0195622829453675,0.987545469442176,0.999448381576871,163,-22.1,"2 17","25 47",16,"81.25%","93.75%","P51637","Caveolin-3 (M-caveolin)","Mus musculus (Mouse)","actin filament organization [GO:0007015]; calcium ion transport [GO:0006816]; cardiac muscle cell development [GO:0055013]; cardiac muscle hypertrophy [GO:0003300]; caveola assembly [GO:0070836]; cell differentiation [GO:0030154]; cellular response to organonitrogen compound [GO:0071417]; cholesterol homeostasis [GO:0042632]; cytoplasmic microtubule organization [GO:0031122]; detection of muscle stretch [GO:0035995]; endocytosis [GO:0006897]; establishment of localization in cell [GO:0051649]; glucose homeostasis [GO:0042593]; heart trabecula formation [GO:0060347]; MAPK cascade [GO:0000165]; membrane raft organization [GO:0031579]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of cell size [GO:0045792]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900826]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of sarcomere organization [GO:0060299]; nucleus localization [GO:0051647]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of myotube differentiation [GO:0010831]; protein localization [GO:0008104]; protein localization to plasma membrane [GO:0072659]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of calcium ion import [GO:0090279]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart contraction [GO:0008016]; regulation of heart rate [GO:0002027]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of membrane potential [GO:0042391]; regulation of nerve growth factor receptor activity [GO:0051394]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein kinase B signaling [GO:0051896]; regulation of signal transduction by receptor internalization [GO:0038009]; regulation of skeletal muscle contraction [GO:0014819]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ventricular cardiac muscle cell membrane depolarization [GO:0060373]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; triglyceride metabolic process [GO:0006641]; ventricular cardiac muscle cell action potential [GO:0086005]","GO:0000139; GO:0000165; GO:0001666; GO:0001778; GO:0002027; GO:0002931; GO:0003300; GO:0005246; GO:0005737; GO:0005783; GO:0005886; GO:0005901; GO:0006469; GO:0006641; GO:0006816; GO:0006897; GO:0007009; GO:0007015; GO:0007204; GO:0007520; GO:0008016; GO:0008022; GO:0008104; GO:0008284; GO:0009986; GO:0010614; GO:0010831; GO:0014704; GO:0014819; GO:0014902; GO:0016010; GO:0016020; GO:0017015; GO:0017080; GO:0019870; GO:0019899; GO:0030018; GO:0030154; GO:0030315; GO:0031116; GO:0031122; GO:0031579; GO:0031594; GO:0031982; GO:0032991; GO:0035995; GO:0038009; GO:0042383; GO:0042391; GO:0042593; GO:0042632; GO:0043014; GO:0043231; GO:0043407; GO:0043409; GO:0044325; GO:0044877; GO:0045121; GO:0045792; GO:0050998; GO:0051001; GO:0051394; GO:0051480; GO:0051647; GO:0051649; GO:0051896; GO:0051924; GO:0051926; GO:0055013; GO:0055117; GO:0060090; GO:0060299; GO:0060307; GO:0060347; GO:0060373; GO:0060762; GO:0061052; GO:0070836; GO:0071253; GO:0071417; GO:0072659; GO:0086005; GO:0090279; GO:0098909; GO:1900744; GO:1900825; GO:1900826; GO:1901017; GO:1901019; GO:1901380; GO:2000649; GO:2001288"
"2294",2472,902999,"Cluster_8988","Peve_00028358",-0.782962213133935,0.427415569617076,0.978262075707395,159,-20.04,"2 21","566 589",21,"71.43%","76.19%",NA,NA,NA,NA,NA
"2295",2473,903204,"Cluster_4079","Peve_00036774",-0.14646165014503,0.906423007974049,0.999448381576871,146,-24.1,"2 17","461 487",20,"70.00%","75.00%","Q5ZLL7","WD repeat-containing protein 91","Gallus gallus (Chicken)","early endosome to late endosome transport [GO:0045022]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]","GO:0005829; GO:0031313; GO:0031901; GO:0031902; GO:0035014; GO:0043551; GO:0045022"
"2296",2474,903270,"Cluster_9149","Peve_00036775",0.963853364394573,0.171690398360261,0.978262075707395,148,-21.35,"2 21","726 747",19,"63.16%","68.42%",NA,NA,NA,NA,NA
"2297",2475,903322,"Cluster_11135","Peve_00036776",0.978434218794299,0.132452852036927,0.978262075707395,166,-23.87,"2 21","936 956",19,"78.95%","84.21%","Q7Z5Y7","BTB/POZ domain-containing protein KCTD20 (Potassium channel tetramerization domain containing 20)","Homo sapiens (Human)","positive regulation of phosphorylation [GO:0042327]","GO:0005737; GO:0042327"
"2298",2476,904012,"Cluster_2854","Peve_00025800",-0.473440387313138,0.686023863456803,0.978262075707395,160,-24.59,"2 21","750 770",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"2299",2477,904941,"Cluster_11134","Peve_00031206",0.98776630572658,0.0996822152657132,0.978262075707395,157,-20.45,"2 19","969 992",19,"63.16%","89.47%",NA,NA,NA,NA,NA
"2300",2478,905100,"Cluster_5882","Peve_00021275",0.970922741092274,0.153896891887811,0.978262075707395,163,-26.73,"2 21","421 444",21,"61.90%","90.48%",NA,NA,NA,NA,NA
"2301",2479,905803,"Cluster_15890","Peve_00005263",0.982191771993529,0.120323952734822,0.978262075707395,167,-22.55,"2 21","312 337",23,"69.57%","82.61%",NA,NA,NA,NA,NA
"2302",2480,905835,"Cluster_9149","Peve_00005268",0.84497262329765,0.359233302115625,0.978262075707395,150,-25.21,"2 21","197 220",21,"61.90%","80.95%","Q9UPY3","Endoribonuclease Dicer (EC 3.1.26.3) (Helicase with RNase motif) (Helicase MOI)","Homo sapiens (Human)","apoptotic DNA fragmentation [GO:0006309]; global gene silencing by mRNA cleavage [GO:0098795]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; negative regulation of gene expression [GO:0010629]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; nerve development [GO:0021675]; neuron projection morphogenesis [GO:0048812]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system myelin formation [GO:0032290]; positive regulation of myelination [GO:0031643]; positive regulation of Schwann cell differentiation [GO:0014040]; pre-miRNA processing [GO:0031054]; RISC complex assembly [GO:0070922]; RNA phosphodiester bond hydrolysis [GO:0090501]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; siRNA processing [GO:0030422]; tRNA catabolic process [GO:0016078]","GO:0000122; GO:0003677; GO:0003723; GO:0003725; GO:0004386; GO:0004521; GO:0004525; GO:0004530; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006309; GO:0010586; GO:0010626; GO:0010629; GO:0014040; GO:0016078; GO:0016442; GO:0019904; GO:0021675; GO:0030422; GO:0031054; GO:0031643; GO:0032290; GO:0032720; GO:0035196; GO:0035197; GO:0038061; GO:0046872; GO:0048471; GO:0048812; GO:0070062; GO:0070578; GO:0070883; GO:0070922; GO:0090501; GO:0090502; GO:0098795"
"2303",2481,906254,"Cluster_16498","Peve_00042729",-0.258482251529253,0.833555295963977,0.995934364227446,178,-21.66,"2 19","829 850",17,"88.24%","94.12%",NA,NA,NA,NA,NA
"2304",2482,907437,"Cluster_4629","Peve_00001169",0.499667946109423,0.666910734200727,0.978262075707395,150,-22.08,"2 20","709 726",18,"72.22%","77.78%","Q9UBQ0","Vacuolar protein sorting-associated protein 29 (hVPS29) (PEP11 homolog) (Vesicle protein sorting 29)","Homo sapiens (Human)","endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0006886; GO:0010008; GO:0030904; GO:0030906; GO:0032456; GO:0042147; GO:0043231; GO:0046872"
"2305",2483,907550,"Cluster_10965","Peve_00004103",-0.951287754177397,0.199523066589912,0.978262075707395,172,-20.68,"2 21","72 93",19,"78.95%","84.21%","Q6RI86","Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor)","Rattus norvegicus (Rat)","calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular calcium ion homeostasis [GO:0006874]; cellular response to caffeine [GO:0071313]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to organic substance [GO:0071310]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; ion transmembrane transport [GO:0034220]; positive regulation of anion transport [GO:1903793]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of sensory perception of pain [GO:1904058]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]; transmembrane transport [GO:0055085]; urinary bladder smooth muscle contraction [GO:0014832]","GO:0005216; GO:0005245; GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0010033; GO:0014070; GO:0014832; GO:0015267; GO:0015278; GO:0016324; GO:0019233; GO:0030424; GO:0032421; GO:0034220; GO:0034605; GO:0035774; GO:0042542; GO:0042802; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0050974; GO:0051289; GO:0055085; GO:0070301; GO:0070417; GO:0070588; GO:0071244; GO:0071310; GO:0071313; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1904058; GO:1990760"
"2306",2484,907577,"Cluster_6904","Peve_00027894",-0.991619158506875,0.0824788722546303,0.978262075707395,155,-21.54,"2 19","694 713",17,"76.47%","82.35%","Q92734","Protein TFG (TRK-fused gene protein)","Homo sapiens (Human)","COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]","GO:0005737; GO:0005829; GO:0006888; GO:0042802; GO:0043123; GO:0043231; GO:0048208; GO:0070971"
"2307",2485,908316,"Cluster_11134","Peve_00043188",-0.0195622829453675,0.987545469442176,0.999448381576871,148,-20.33,"2 21","630 651",19,"63.16%","68.42%",NA,NA,NA,NA,NA
"2308",2486,908546,"Cluster_14999","Peve_00014951",0.34847801794077,0.773397198687932,0.991814309783566,158,-22.82,"2 16","647 671",17,"82.35%","82.35%","Q6ZPJ3","(E3-independent) E2 ubiquitin-conjugating enzyme UBE2O (EC 2.3.2.24) (E2/E3 hybrid ubiquitin-protein ligase UBE2O) (Ubiquitin carrier protein O) (Ubiquitin-conjugating enzyme E2 O) (Ubiquitin-conjugating enzyme E2 of 230 kDa) (Ubiquitin-conjugating enzyme E2-230K) (Ubiquitin-protein ligase O)","Mus musculus (Mouse)","negative regulation of apoptotic process [GO:0043066]; positive regulation of BMP signaling pathway [GO:0030513]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0004842; GO:0004869; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006513; GO:0016604; GO:0030513; GO:0042147; GO:0043066; GO:0061630; GO:0061631; GO:0070534"
"2309",2487,909156,"Cluster_7053","Peve_00035067",0.940063218440175,0.221531379646518,0.978262075707395,160,-20.49,"2 21","208 232",23,"78.26%","78.26%","A0A2J6RX17",NA,NA,NA,NA
"2310",2488,909635,"Cluster_1167","Peve_00040379",0.903698303448267,0.281682965723866,0.978262075707395,146,-22.51,"2 13","229 249",11,"90.91%","90.91%",NA,NA,NA,NA,NA
"2311",2489,909642,"Cluster_4629","Peve_00040379",-0.864286997370448,0.335540120769726,0.978262075707395,158,-26.87,"2 20","717 741",21,"66.67%","80.95%",NA,NA,NA,NA,NA
"2312",2490,909731,"Cluster_4115","Peve_00040371",-0.998463578089383,0.0352944149574942,0.909359886114279,166,-23.07,"2 19","609 630",17,"70.59%","94.12%","P35658","Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN)","Homo sapiens (Human)","mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of nucleocytoplasmic transport [GO:0046822]; RNA export from nucleus [GO:0006405]","GO:0000278; GO:0005049; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006405; GO:0006406; GO:0006606; GO:0006611; GO:0006913; GO:0008139; GO:0017056; GO:0046822; GO:0051726; GO:1990876"
"2313",2491,909733,"Cluster_4735","Peve_00040371",-0.202408727282249,0.87024610770695,0.997476741937264,146,-20.42,"2 21","810 830",19,"63.16%","73.68%","P35658","Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN)","Homo sapiens (Human)","mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of nucleocytoplasmic transport [GO:0046822]; RNA export from nucleus [GO:0006405]","GO:0000278; GO:0005049; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006405; GO:0006406; GO:0006606; GO:0006611; GO:0006913; GO:0008139; GO:0017056; GO:0046822; GO:0051726; GO:1990876"
"2314",2492,909756,"Cluster_11134","Peve_00040371",-0.333897475963207,0.783272133625663,0.994335155944768,148,-21.34,"2 13","48 69",11,"81.82%","90.91%","P35658","Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN)","Homo sapiens (Human)","mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of nucleocytoplasmic transport [GO:0046822]; RNA export from nucleus [GO:0006405]","GO:0000278; GO:0005049; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006405; GO:0006406; GO:0006606; GO:0006611; GO:0006913; GO:0008139; GO:0017056; GO:0046822; GO:0051726; GO:1990876"
"2315",2493,909795,"Cluster_9149","Peve_00040370",1,0,0,161,-25.16,"2 19","356 380",20,"75.00%","80.00%",NA,NA,NA,NA,NA
"2316",2494,910497,"Cluster_4629","Peve_00017706",0.341127496800719,0.778382420502544,0.993087421081785,156,-20.5,"2 20","893 912",18,"72.22%","83.33%",NA,NA,NA,NA,NA
"2317",2496,910848,"Cluster_796","Peve_00013638",0.853410924912889,0.349059760853643,0.978262075707395,150,-22,"2 21","678 702",22,"68.18%","72.73%",NA,NA,NA,NA,NA
"2318",2497,911795,"Cluster_1167","Peve_00041130",-0.0804884743790503,0.948703957759447,0.999448381576871,157,-25.87,"2 14","78 99",12,"91.67%","91.67%","Q9WV98","Mitochondrial import inner membrane translocase subunit Tim9","Mus musculus (Mouse)","protein insertion into mitochondrial inner membrane [GO:0045039]","GO:0005739; GO:0005743; GO:0005758; GO:0032977; GO:0042719; GO:0042721; GO:0042803; GO:0045039; GO:0046872; GO:0051087"
"2319",2498,911826,"Cluster_11134","Peve_00041130",0.998868511449619,0.0302873419647936,0.903929377050813,162,-24.53,"2 19","497 518",17,"64.71%","94.12%","Q9WV98","Mitochondrial import inner membrane translocase subunit Tim9","Mus musculus (Mouse)","protein insertion into mitochondrial inner membrane [GO:0045039]","GO:0005739; GO:0005743; GO:0005758; GO:0032977; GO:0042719; GO:0042721; GO:0042803; GO:0045039; GO:0046872; GO:0051087"
"2320",2499,912225,"Cluster_9149","Peve_00038364",-0.324855301111235,0.789368792404015,0.995742627848044,170,-27.28,"2 19","355 376",17,"82.35%","88.24%","P53621","Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin]","Homo sapiens (Human)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0000139; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0016020; GO:0030126; GO:0030133; GO:0030157; GO:0030426; GO:0070062"
"2321",2500,912630,"Cluster_9149","Peve_00000334",1,0,0,162,-28.39,"2 21","482 502",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"2322",2501,912717,"Cluster_8887","Peve_00029266",-0.529656860789869,0.644641408599486,0.978262075707395,161,-20.08,"2 19","663 684",18,"72.22%","88.89%",NA,NA,NA,NA,NA
"2323",2502,912718,"Cluster_8888","Peve_00029266",0.183930110951461,0.882235978529785,0.999358290797298,161,-21.71,"2 19","663 684",18,"72.22%","88.89%",NA,NA,NA,NA,NA
"2324",2503,913143,"Cluster_796","Peve_00002791",0.896487397355407,0.292220832840911,0.978262075707395,151,-21.01,"2 20","666 687",18,"66.67%","72.22%","Q9N1Q0","Small nuclear ribonucleoprotein-associated protein B' (snRNP-B') (snRPB') (Sm protein B') (Sm-B') (SmB')","Notamacropus eugenii (Tammar wallaby) (Macropus eugenii)","mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]","GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005683; GO:0005685; GO:0005687; GO:0005829; GO:0034709; GO:0034719; GO:0046540; GO:0071005; GO:0071007"
"2325",2504,913176,"Cluster_11134","Peve_00002791",0.779184777474804,0.431266723542896,0.978262075707395,146,-22.29,"2 21","35 60",23,"60.87%","73.91%","Q9N1Q0","Small nuclear ribonucleoprotein-associated protein B' (snRNP-B') (snRPB') (Sm protein B') (Sm-B') (SmB')","Notamacropus eugenii (Tammar wallaby) (Macropus eugenii)","mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]","GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005683; GO:0005685; GO:0005687; GO:0005829; GO:0034709; GO:0034719; GO:0046540; GO:0071005; GO:0071007"
"2326",2505,913197,"Cluster_4629","Peve_00002790",-0.474347520400346,0.685368048372371,0.978262075707395,164,-20.61,"2 21","398 419",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"2327",2506,913197,"Cluster_4629","Peve_00002790",-0.474347520400346,0.685368048372371,0.978262075707395,164,-20.61,"2 21","452 473",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"2328",2507,914008,"Cluster_4735","Peve_00004797",0.876467365213336,0.319787595997474,0.978262075707395,175,-28.22,"2 21","874 896",20,"80.00%","90.00%","Q174D3","Mediator of RNA polymerase II transcription subunit 19 (Mediator complex subunit 19)","Aedes aegypti (Yellowfever mosquito) (Culex aegypti)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0003712; GO:0006357; GO:0016592"
"2329",2508,914271,"Cluster_2787","Peve_00004798",-0.64540507295234,0.553377186178611,0.978262075707395,167,-23.94,"2 21","675 697",20,"80.00%","80.00%","Q5ZMH1","Septin-2","Gallus gallus (Chicken)","cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of exocytosis [GO:0017157]; smoothened signaling pathway [GO:0007224]","GO:0003924; GO:0005525; GO:0005737; GO:0005819; GO:0005940; GO:0007224; GO:0008021; GO:0015630; GO:0017157; GO:0030496; GO:0031105; GO:0032153; GO:0032154; GO:0060090; GO:0060170; GO:0060271; GO:0061640"
"2330",2509,914340,"Cluster_9149","Peve_00016941",-0.818859734327873,0.389213209460729,0.978262075707395,145,-20.34,"2 10","239 260",8,"100.00%","100.00%","O55173","3-phosphoinositide-dependent protein kinase 1 (EC 2.7.11.1) (Protein kinase B kinase) (PkB kinase)","Rattus norvegicus (Rat)","activation of protein kinase B activity [GO:0032148]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; hyperosmotic response [GO:0006972]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein phosphorylation [GO:0006468]; regulation of endothelial cell migration [GO:0010594]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mast cell degranulation [GO:0043304]; type B pancreatic cell development [GO:0003323]","GO:0003323; GO:0004672; GO:0004674; GO:0004676; GO:0005158; GO:0005524; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0006468; GO:0006469; GO:0006972; GO:0007173; GO:0008286; GO:0010518; GO:0010594; GO:0010667; GO:0014069; GO:0016004; GO:0016477; GO:0018105; GO:0018107; GO:0019209; GO:0019722; GO:0019901; GO:0030295; GO:0030512; GO:0031410; GO:0032148; GO:0032869; GO:0034122; GO:0035556; GO:0042995; GO:0043122; GO:0043204; GO:0043274; GO:0043304; GO:0043524; GO:0043536; GO:0043539; GO:0045766; GO:0048009; GO:0048041; GO:0051281; GO:0071364; GO:0097191; GO:0106310; GO:1903078; GO:1903672; GO:1905564; GO:1990416; GO:2000352"
"2331",2510,914450,"Cluster_1167","Peve_00008498",0.999909726776791,0.00855416971793915,0.573710369894872,149,-22.35,"2 21","811 830",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"2332",2511,914508,"Cluster_6905","Peve_00008499",-0.849308336666004,0.354038669122123,0.978262075707395,150,-23.3,"2 20","212 234",19,"68.42%","73.68%","O14924","Regulator of G-protein signaling 12 (RGS12)","Homo sapiens (Human)","G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]","GO:0000794; GO:0003924; GO:0005096; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0008277; GO:0009968; GO:0016363; GO:0030425; GO:0030695; GO:0045202"
"2333",2512,914632,"Cluster_2854","Peve_00008496",0.826948275717696,0.380149816381862,0.978262075707395,157,-20.25,"2 19","714 738",20,"75.00%","75.00%","Q86WZ0","HEAT repeat-containing protein 4","Homo sapiens (Human)","","GO:0016491"
"2334",2513,915450,"Cluster_5882","Peve_00028841",0.970922741092274,0.153896891887811,0.978262075707395,177,-21.48,"2 18","50 71",16,"93.75%","93.75%","F6RRD7","Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2 (EC 3.1.3.16) (RNA polymerase II-associated protein 2)","Bos taurus (Bovine)","dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; snRNA transcription [GO:0009301]","GO:0005634; GO:0005737; GO:0008420; GO:0009301; GO:0016591; GO:0017018; GO:0043175; GO:0046872; GO:0070940"
"2335",2514,915591,"Cluster_7053","Peve_00028845",0.0896524410690472,0.94284874886415,0.999448381576871,162,-22.16,"2 21","627 650",21,"71.43%","85.71%","O95490","Adhesion G protein-coupled receptor L2 (Calcium-independent alpha-latrotoxin receptor 2) (CIRL-2) (Latrophilin homolog 1) (Latrophilin-2) (Lectomedin-1)","Homo sapiens (Human)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0007420; GO:0016020; GO:0016524; GO:0030246; GO:0043005"
"2336",2515,916102,"Cluster_11135","Peve_00036571",0.821201778261388,0.386608022951135,0.978262075707395,162,-23.67,"2 21","571 591",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"2337",2517,916428,"Cluster_796","Peve_00019932",0.898740270652305,0.288966974174018,0.978262075707395,150,-23.05,"2 19","639 660",17,"70.59%","70.59%",NA,NA,NA,NA,NA
"2338",2518,916752,"Cluster_4629","Peve_00041542",0.994352593808093,0.06768995603507,0.978262075707395,157,-23.55,"2 20","646 670",21,"71.43%","80.95%","Q96RS0","Trimethylguanosine synthase (EC 2.1.1.-) (CLL-associated antigen KW-2) (Cap-specific guanine-N2 methyltransferase) (Hepatocellular carcinoma-associated antigen 137) (Nuclear receptor coactivator 6-interacting protein) (PRIP-interacting protein with methyltransferase motif) (PIMT) (PIPMT)","Homo sapiens (Human)","7-methylguanosine cap hypermethylation [GO:0036261]; 7-methylguanosine RNA capping [GO:0009452]; ribonucleoprotein complex biogenesis [GO:0022613]; spliceosomal snRNP assembly [GO:0000387]","GO:0000387; GO:0005615; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0008173; GO:0009452; GO:0015030; GO:0022613; GO:0030532; GO:0036261; GO:0071164"
"2339",2519,917268,"Cluster_10061","Peve_00014547",-0.994674815384296,0.0657287492865934,0.978262075707395,167,-20.12,"2 21","581 603",20,"75.00%","85.00%","Q90XB6","Extracellular sulfatase Sulf-1 (qSulf1) (EC 3.1.6.-)","Coturnix coturnix (Common quail) (Tetrao coturnix)","bone development [GO:0060348]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell adhesion [GO:0007155]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; limb joint morphogenesis [GO:0036022]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of prostatic bud formation [GO:0060686]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of Wnt signaling pathway [GO:0030177]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","GO:0001502; GO:0001822; GO:0001937; GO:0002063; GO:0004065; GO:0005509; GO:0005615; GO:0005783; GO:0005794; GO:0005795; GO:0007155; GO:0008449; GO:0009986; GO:0014846; GO:0016525; GO:0030177; GO:0030201; GO:0030336; GO:0030513; GO:0035860; GO:0036022; GO:0040037; GO:0045121; GO:0048010; GO:0048661; GO:0048706; GO:0051216; GO:0060348; GO:0060384; GO:0060686; GO:0090263"
"2340",2520,917593,"Cluster_15890","Peve_00029820",-0.998956013089957,0.02909245946257,0.903929377050813,152,-21.12,"2 21","158 178",20,"70.00%","80.00%","Q504H8","Homeobox protein HMX3 (Homeobox protein H6 family member 3) (Homeobox protein Nkx-5.1)","Danio rerio (Zebrafish) (Brachydanio rerio)","cell differentiation [GO:0030154]; inner ear morphogenesis [GO:0042472]; nervous system development [GO:0007399]; posterior lateral line development [GO:0048916]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007399; GO:0030154; GO:0042472; GO:0048916"
"2341",2521,917607,"Cluster_4629","Peve_00029821",-0.315858849589622,0.795414782905609,0.995934364227446,154,-22.47,"2 21","833 853",19,"68.42%","78.95%","P15858","Homeobox protein H40","Apis mellifera (Honeybee)","","GO:0000981; GO:0003677; GO:0005634"
"2342",2522,917804,"Cluster_8988","Peve_00029826",0.0860148226113438,0.945173514868548,0.999448381576871,174,-25.04,"2 21","709 729",19,"84.21%","89.47%",NA,NA,NA,NA,NA
"2343",2523,918281,"Cluster_4115","Peve_00030068",-0.676329328783869,0.527139272390332,0.978262075707395,170,-20.09,"2 20","565 588",20,"80.00%","85.00%","Q17R14","Unconventional myosin-Id","Bos taurus (Bovine)","cellular localization [GO:0051641]; early endosome to recycling endosome transport [GO:0061502]; protein transport [GO:0015031]","GO:0000146; GO:0005516; GO:0005524; GO:0005768; GO:0005769; GO:0005790; GO:0005829; GO:0005903; GO:0005938; GO:0015031; GO:0016323; GO:0016459; GO:0030424; GO:0030673; GO:0031410; GO:0043005; GO:0043025; GO:0043204; GO:0043209; GO:0048306; GO:0051015; GO:0051641; GO:0061502; GO:0097440"
"2344",2524,918317,"Cluster_589","Peve_00030066",-0.934753615028442,0.231240264998328,0.978262075707395,155,-24.09,"2 12","316 337",10,"100.00%","100.00%","Q64604","Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR)","Rattus norvegicus (Rat)","cell migration [GO:0016477]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell projection organization [GO:0031345]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of neurotrophin TRK receptor signaling pathway [GO:0051387]; negative regulation of receptor binding [GO:1900121]; nervous system development [GO:0007399]; neuron projection regeneration [GO:0031102]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron apoptotic process [GO:0043525]; protein dephosphorylation [GO:0006470]; regulation of axon regeneration [GO:0048679]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of synapse structure or activity [GO:0050803]; synaptic membrane adhesion [GO:0099560]","GO:0001960; GO:0004725; GO:0005001; GO:0005158; GO:0005768; GO:0005886; GO:0006470; GO:0007156; GO:0007399; GO:0008201; GO:0008285; GO:0010975; GO:0016020; GO:0016477; GO:0030426; GO:0030971; GO:0031102; GO:0031345; GO:0035335; GO:0035373; GO:0042059; GO:0042301; GO:0043005; GO:0043025; GO:0043065; GO:0043231; GO:0043525; GO:0044877; GO:0046627; GO:0048679; GO:0050775; GO:0050803; GO:0050839; GO:0051387; GO:0060076; GO:0098839; GO:0099175; GO:0099560; GO:1900121"
"2345",2525,918351,"Cluster_11134","Peve_00030066",-0.0195622829453675,0.987545469442176,0.999448381576871,154,-20.4,"2 21","720 740",19,"63.16%","84.21%","Q64604","Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR)","Rattus norvegicus (Rat)","cell migration [GO:0016477]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell projection organization [GO:0031345]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of neurotrophin TRK receptor signaling pathway [GO:0051387]; negative regulation of receptor binding [GO:1900121]; nervous system development [GO:0007399]; neuron projection regeneration [GO:0031102]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron apoptotic process [GO:0043525]; protein dephosphorylation [GO:0006470]; regulation of axon regeneration [GO:0048679]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of synapse structure or activity [GO:0050803]; synaptic membrane adhesion [GO:0099560]","GO:0001960; GO:0004725; GO:0005001; GO:0005158; GO:0005768; GO:0005886; GO:0006470; GO:0007156; GO:0007399; GO:0008201; GO:0008285; GO:0010975; GO:0016020; GO:0016477; GO:0030426; GO:0030971; GO:0031102; GO:0031345; GO:0035335; GO:0035373; GO:0042059; GO:0042301; GO:0043005; GO:0043025; GO:0043065; GO:0043231; GO:0043525; GO:0044877; GO:0046627; GO:0048679; GO:0050775; GO:0050803; GO:0050839; GO:0051387; GO:0060076; GO:0098839; GO:0099175; GO:0099560; GO:1900121"
"2346",2526,920173,"Cluster_4735","Peve_00037304",0.99999940598563,0.000693894776259953,0.239778920002343,151,-24.43,"2 18","62 87",20,"70.00%","80.00%",NA,NA,NA,NA,NA
"2347",2527,920308,"Cluster_4735","Peve_00037303",-0.99111605670398,0.084921969033786,0.978262075707395,151,-24.43,"2 18","774 799",20,"70.00%","80.00%","J3S9D9","Reticulocalbin-2 (Taipoxin-associated calcium-binding protein 49 homolog)","Crotalus adamanteus (Eastern diamondback rattlesnake)","","GO:0005509; GO:0005576"
"2348",2528,921158,"Cluster_2882","Peve_00027617",-0.997171486654887,0.0478935089731376,0.945312205299076,162,-20.21,"2 21","400 420",19,"73.68%","84.21%","Q6PHG8","DNA-directed RNA polymerase I subunit RPA43 (DNA-directed RNA polymerase I subunit F) (Twist neighbor protein)","Danio rerio (Zebrafish) (Brachydanio rerio)","DNA-templated transcription initiation [GO:0006352]","GO:0005736; GO:0006352"
"2349",2529,921266,"Cluster_8884","Peve_00027619",-0.963365008288413,0.172853441300553,0.978262075707395,165,-21.02,"2 19","375 396",18,"77.78%","88.89%",NA,NA,NA,NA,NA
"2350",2530,921267,"Cluster_8887","Peve_00027619",-0.852047845580894,0.350721023574118,0.978262075707395,165,-20.65,"2 19","375 396",18,"77.78%","88.89%",NA,NA,NA,NA,NA
"2351",2531,921268,"Cluster_8888","Peve_00027619",-0.273188215995098,0.823843636444847,0.995934364227446,165,-22.28,"2 19","375 396",18,"77.78%","88.89%",NA,NA,NA,NA,NA
"2352",2532,921311,"Cluster_8884","Peve_00027618",-0.974045981944195,0.14535876717191,0.978262075707395,165,-21.02,"2 19","886 907",18,"77.78%","88.89%","B3EWY8","Skeletal aspartic acid-rich protein 2","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0016020"
"2353",2533,921312,"Cluster_8887","Peve_00027618",-0.873853939308191,0.323226349445475,0.978262075707395,165,-20.65,"2 19","886 907",18,"77.78%","88.89%","B3EWY8","Skeletal aspartic acid-rich protein 2","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0016020"
"2354",2534,921313,"Cluster_8888","Peve_00027618",-0.314466226518539,0.796348962316205,0.995934364227446,165,-22.28,"2 19","886 907",18,"77.78%","88.89%","B3EWY8","Skeletal aspartic acid-rich protein 2","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0016020"
"2355",2535,921574,"Cluster_6906","Peve_00012524",-0.334520562462088,0.782851263998728,0.994195537596228,144,-20.12,"2 19","148 177",25,"64.00%","68.00%",NA,NA,NA,NA,NA
"2356",2536,921912,"Cluster_15726","Peve_00020061",-0.926515403541974,0.245577936927607,0.978262075707395,165,-24.24,"2 14","776 797",12,"100.00%","100.00%","A3KPN8","Tetratricopeptide repeat protein 38 (TPR repeat protein 38)","Danio rerio (Zebrafish) (Brachydanio rerio)","",""
"2357",2537,922174,"Cluster_10934","Peve_00025611",-0.487021151584927,0.67616691294172,0.978262075707395,152,-23.53,"2 21","80 104",23,"73.91%","73.91%",NA,NA,NA,NA,NA
"2358",2538,922288,"Cluster_4735","Peve_00025616",-0.93874658933218,0.223976481031751,0.978262075707395,154,-22.98,"2 21","629 652",21,"71.43%","76.19%",NA,NA,NA,NA,NA
"2359",2539,922458,"Cluster_796","Peve_00017540",0.997011731357393,0.0492281083654383,0.950396228648067,156,-25.69,"2 19","770 790",17,"76.47%","82.35%","P51693","Amyloid beta precursor like protein 1 (Amyloid beta (A4) precursor-like protein 1) (Amyloid-like protein 1) (APLP) (APLP-1) [Cleaved into: C30]","Homo sapiens (Human)","animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cellular response to norepinephrine stimulus [GO:0071874]; central nervous system development [GO:0007417]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; forebrain development [GO:0030900]; mRNA polyadenylation [GO:0006378]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; nervous system development [GO:0007399]; regulation of translation [GO:0006417]","GO:0005604; GO:0005654; GO:0005794; GO:0005886; GO:0006378; GO:0006417; GO:0006897; GO:0006915; GO:0007155; GO:0007399; GO:0007409; GO:0007417; GO:0008201; GO:0009887; GO:0030198; GO:0030900; GO:0031694; GO:0031695; GO:0031696; GO:0042802; GO:0046914; GO:0048471; GO:0071874; GO:0106072"
"2360",2540,923167,"Cluster_11135","Peve_00011870",-0.81891351195299,0.389153560392372,0.978262075707395,155,-20.35,"2 21","382 400",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"2361",2541,923678,"Cluster_2882","Peve_00013737",-0.983262542679321,0.11663999121516,0.978262075707395,157,-22.58,"2 15","453 475",14,"85.71%","92.86%",NA,NA,NA,NA,NA
"2362",2542,924240,"Cluster_9149","Peve_00041332",0.930577196733696,0.23861145716465,0.978262075707395,164,-21.3,"2 21","831 852",19,"73.68%","78.95%","Q3UQ28","Peroxidasin homolog (EC 1.11.2.-) [Cleaved into: PXDN active fragment]","Mus musculus (Mouse)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005201; GO:0005604; GO:0005615; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"2363",2543,925301,"Cluster_4115","Peve_00041481",0.0885895429072347,0.943528114208398,0.999448381576871,154,-22.19,"2 21","853 878",23,"60.87%","82.61%","Q92113","Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (EC 1.14.14.32) (17-alpha-hydroxyprogesterone aldolase) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Cytochrome P450c17)","Squalus acanthias (Spiny dogfish)","steroid biosynthetic process [GO:0006694]","GO:0004508; GO:0005506; GO:0006694; GO:0016020; GO:0020037; GO:0047442"
"2364",2544,925527,"Cluster_4629","Peve_00041486",-0.242964498285417,0.843760291635181,0.995934364227446,154,-20.51,"2 15","839 860",13,"84.62%","84.62%","Q99JW4","LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1)","Mus musculus (Mouse)","cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cell-matrix adhesion [GO:0007160]; cholangiocyte proliferation [GO:1990705]; chordate embryonic development [GO:0043009]; establishment of protein localization [GO:0045184]; establishment or maintenance of cell polarity [GO:0007163]; hepatocyte apoptotic process [GO:0097284]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of cholangiocyte proliferation [GO:1904055]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of neural precursor cell proliferation [GO:2000178]; neural precursor cell proliferation [GO:0061351]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0005737; GO:0005886; GO:0005911; GO:0005925; GO:0007160; GO:0007163; GO:0007229; GO:0008270; GO:0010628; GO:0010811; GO:0019901; GO:0032991; GO:0033209; GO:0043009; GO:0043547; GO:0044877; GO:0045184; GO:0045216; GO:0045892; GO:0048471; GO:0051894; GO:0061351; GO:0097284; GO:0098609; GO:1900026; GO:1901224; GO:1903944; GO:1904055; GO:1990705; GO:2000178; GO:2000346; GO:2001046"
"2365",2545,926057,"Cluster_589","Peve_00015245",0.198089917319516,0.873052391383585,0.997476741937264,165,-22.75,"2 20","826 846",18,"77.78%","88.89%","Q96JB1","Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8)","Homo sapiens (Human)","cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]","GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060285"
"2366",2546,927227,"Cluster_589","Peve_00018602",0.159680919674548,0.897906931664995,0.999448381576871,146,-22.05,"2 21","556 581",23,"60.87%","73.91%",NA,NA,NA,NA,NA
"2367",2547,927467,"Cluster_6904","Peve_00005757",-0.859545519297175,0.341493421544832,0.978262075707395,149,-21.15,"2 18","423 444",16,"62.50%","81.25%","O35474","EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1)","Mus musculus (Mouse)","cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811]","GO:0005509; GO:0005576; GO:0007155; GO:0010811"
"2368",2548,927469,"Cluster_6906","Peve_00005757",-0.508104269543602,0.660692906761739,0.978262075707395,157,-22.24,"2 21","425 444",19,"73.68%","78.95%","O35474","EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1)","Mus musculus (Mouse)","cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811]","GO:0005509; GO:0005576; GO:0007155; GO:0010811"
"2369",2549,927682,"Cluster_2854","Peve_00015923",-0.507486347355159,0.661149542463894,0.978262075707395,158,-20.17,"2 21","474 498",22,"72.73%","77.27%",NA,NA,NA,NA,NA
"2370",2550,929078,"Cluster_2882","Peve_00030269",-0.249331888237711,0.839577996596235,0.995934364227446,155,-23.13,"2 21","671 693",20,"65.00%","80.00%","P58854","Gamma-tubulin complex component 3 (GCP-3)","Mus musculus (Mouse)","cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]","GO:0000278; GO:0000923; GO:0000930; GO:0005737; GO:0005813; GO:0005814; GO:0005827; GO:0005829; GO:0007020; GO:0008275; GO:0031122; GO:0043015; GO:0051225; GO:0051321"
"2371",2551,930312,"Cluster_8887","Peve_00043659",-0.396096865224243,0.740728885445503,0.986697151420032,150,-22.6,"2 20","41 62",19,"63.16%","78.95%",NA,NA,NA,NA,NA
"2372",2552,930313,"Cluster_8888","Peve_00043659",0.329635195538111,0.786148501683768,0.994992167375969,150,-22.98,"2 20","41 62",19,"63.16%","78.95%",NA,NA,NA,NA,NA
"2373",2553,933352,"Cluster_2854","Peve_00029618",-0.999816725191885,0.0121885808006402,0.68064733699131,177,-23.34,"2 18","870 891",16,"93.75%","93.75%","Q8K2X2","RNA-binding protein 48","Mus musculus (Mouse)","","GO:0003723; GO:0005654"
"2374",2554,933440,"Cluster_1167","Peve_00018474",0.882645111148157,0.311521038646834,0.978262075707395,140,-25.01,"2 9","948 969",7,"100.00%","100.00%","O95198","Kelch-like protein 2 (Actin-binding protein Mayven)","Homo sapiens (Human)","protein ubiquitination [GO:0016567]","GO:0001726; GO:0003779; GO:0005737; GO:0005829; GO:0015629; GO:0016567; GO:0030027; GO:0031463; GO:0042802"
"2375",2555,933919,"Cluster_10934","Peve_00019214",-0.142419664411289,0.909023487940492,0.999448381576871,159,-22.01,"2 21","307 330",21,"71.43%","76.19%","P49256","Vesicular integral-membrane protein VIP36 (Lectin mannose-binding 2) (Vesicular integral-membrane protein 36) (VIP36)","Canis lupus familiaris (Dog) (Canis familiaris)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of phagocytosis [GO:0050766]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0000139; GO:0005537; GO:0005615; GO:0005789; GO:0005793; GO:0005794; GO:0005886; GO:0006888; GO:0006890; GO:0009986; GO:0015031; GO:0030134; GO:0030137; GO:0031072; GO:0031410; GO:0046872; GO:0048471; GO:0050766; GO:0070382"
"2376",2556,934505,"Cluster_10965","Peve_00038842",-0.523109346337314,0.649543862594915,0.978262075707395,160,-20.07,"2 21","774 795",19,"63.16%","84.21%","Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"2377",2557,935175,"Cluster_9149","Peve_00031495",-0.102106738499693,0.934883346621819,0.999448381576871,148,-20.42,"2 18","214 236",17,"64.71%","82.35%","Q27802","Cytoplasmic dynein 2 heavy chain 1 (Dynein heavy chain isotype 1B)","Tripneustes gratilla (Hawaian sea urchin) (Echinus gratilla)","cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]","GO:0005524; GO:0005737; GO:0005874; GO:0005886; GO:0005929; GO:0007018; GO:0008569; GO:0030030; GO:0030286; GO:0045505; GO:0051959"
"2378",2558,935320,"Cluster_14500","Peve_00018161",-0.892359012078568,0.298097859379402,0.978262075707395,174,-21.82,"2 19","486 507",17,"82.35%","94.12%","Q61555","Fibrillin-2 [Cleaved into: Placensin]","Mus musculus (Mouse)","anatomical structure morphogenesis [GO:0009653]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583]","GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0009653; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023; GO:1901163"
"2379",2559,935427,"Cluster_4629","Peve_00018165",0.928114371110003,0.24285819862046,0.978262075707395,150,-21.94,"2 15","111 132",13,"76.92%","84.62%","H3BPM6","MKRN2 opposite strand protein (MKRN2 antisense RNA 1) (MKRN2 antisense gene protein 1)","Homo sapiens (Human)","",""
"2380",2560,935472,"Cluster_4629","Peve_00018164",-0.660098986551336,0.541028638832691,0.978262075707395,150,-21.94,"2 15","118 139",13,"76.92%","84.62%","H3BPM6","MKRN2 opposite strand protein (MKRN2 antisense RNA 1) (MKRN2 antisense gene protein 1)","Homo sapiens (Human)","",""
"2381",2561,935778,"Cluster_796","Peve_00015023",-0.829106154727612,0.377699692492649,0.978262075707395,160,-25.6,"2 18","128 150",17,"82.35%","82.35%",NA,NA,NA,NA,NA
"2382",2562,935894,"Cluster_8988","Peve_00015021",0.0860148226113438,0.945173514868548,0.999448381576871,169,-20.58,"2 19","574 597",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"2383",2563,936245,"Cluster_6914","Peve_00005057",-0.852004437281909,0.35077381177203,0.978262075707395,159,-21.26,"2 20","963 983",18,"72.22%","77.78%","F8J2D3","Phospholipase-B 81 (PLB) (EC 3.1.1.-)","Drysdalia coronoides (White-lipped snake) (Hoplocephalus coronoides)","hemolysis in another organism [GO:0044179]; lipid catabolic process [GO:0016042]","GO:0004620; GO:0005576; GO:0016042; GO:0044179; GO:0090729"
"2384",2564,936588,"Cluster_796","Peve_00003688",0.971280009023234,0.152943913300331,0.978262075707395,159,-21.14,"2 20","372 393",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"2385",2565,936680,"Cluster_1167","Peve_00040077",-0.372713851609382,0.756854608799618,0.988219883885475,141,-20.26,"2 20","534 554",18,"61.11%","72.22%",NA,NA,NA,NA,NA
"2386",2566,936987,"Cluster_15726","Peve_00003683",-0.546864820179747,0.631642319300291,0.978262075707395,155,-20.41,"2 21","510 536",24,"62.50%","75.00%",NA,NA,NA,NA,NA
"2387",2567,937322,"Cluster_6904","Peve_00025183",0.590801194046884,0.597623511170353,0.978262075707395,163,-25.71,"2 21","918 941",21,"76.19%","76.19%","Q5RCU5","Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196, EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (Alcohol dehydrogenase [NAD(P)+] CBR1) (EC 1.1.1.71) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","lipid metabolic process [GO:0006629]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805]","GO:0004090; GO:0005737; GO:0006629; GO:0006805; GO:0008106; GO:0042373; GO:0047020; GO:0047021; GO:0050221"
"2388",2568,937324,"Cluster_6906","Peve_00025183",0.905878310095148,0.278424025953445,0.978262075707395,163,-26,"2 21","918 941",21,"76.19%","76.19%","Q5RCU5","Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196, EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (Alcohol dehydrogenase [NAD(P)+] CBR1) (EC 1.1.1.71) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","lipid metabolic process [GO:0006629]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805]","GO:0004090; GO:0005737; GO:0006629; GO:0006805; GO:0008106; GO:0042373; GO:0047020; GO:0047021; GO:0050221"
"2389",2569,937470,"Cluster_9149","Peve_00025187",-0.643242855867786,0.555177129686483,0.978262075707395,156,-21.75,"2 19","41 66",21,"71.43%","80.95%","P42325","Neurocalcin homolog (DrosNCa)","Drosophila melanogaster (Fruit fly)","negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]","GO:0005509; GO:0045938; GO:1902848"
"2390",2570,938639,"Cluster_8988","Peve_00026376",0.985956009470065,0.106819358987891,0.978262075707395,167,-20.22,"2 21","706 728",20,"75.00%","85.00%","Q4R630","Kinetochore protein NDC80 homolog (Kinetochore protein Hec1) (Kinetochore-associated protein 2)","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; metaphase plate congression [GO:0051310]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]","GO:0000776; GO:0005634; GO:0007052; GO:0007059; GO:0031262; GO:0051301; GO:0051310; GO:0051315; GO:0090267; GO:0140483"
"2391",2571,938826,"Cluster_11134","Peve_00023937",0.830944292274776,0.375601531277926,0.978262075707395,149,-21.09,"2 19","360 382",18,"61.11%","83.33%","P31646","Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Solute carrier family 6 member 13)","Rattus norvegicus (Rat)","amino acid import across plasma membrane [GO:0089718]; creatine transmembrane transport [GO:0015881]; gamma-aminobutyric acid import [GO:0051939]; monocarboxylic acid transport [GO:0015718]; neurotransmitter transport [GO:0006836]; nitrogen compound transport [GO:0071705]; positive regulation of necrotic cell death [GO:0010940]; sodium ion transmembrane transport [GO:0035725]; taurine transport [GO:0015734]","GO:0005283; GO:0005308; GO:0005332; GO:0005368; GO:0005369; GO:0005886; GO:0006836; GO:0008028; GO:0010940; GO:0015171; GO:0015185; GO:0015718; GO:0015734; GO:0015881; GO:0016323; GO:0035725; GO:0042165; GO:0043005; GO:0051939; GO:0071705; GO:0089718"
"2392",2572,940485,"Cluster_9149","Peve_00017973",-0.847993445992382,0.355621204243706,0.978262075707395,163,-22.9,"2 20","812 833",18,"72.22%","83.33%","O75581","Low-density lipoprotein receptor-related protein 6 (LRP-6)","Homo sapiens (Human)","canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244]","GO:0001933; GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006469; GO:0007204; GO:0007268; GO:0009986; GO:0014029; GO:0014033; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0044335; GO:0044340; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0051091; GO:0060070; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090118; GO:0090244; GO:0098609; GO:1904928; GO:1904948; GO:1904953; GO:1990851; GO:1990909"
"2393",2573,941101,"Cluster_6255","Peve_00013085",-0.675015113868665,0.528274178955442,0.978262075707395,164,-20.85,"2 20","458 481",21,"80.95%","80.95%","Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"2394",2574,941966,"Cluster_8884","Peve_00039240",-0.365684280896904,0.761669993533083,0.988687818896508,168,-22.56,"2 17","711 731",15,"86.67%","93.33%","Q29611","Battenin (Protein CLN3)","Canis lupus familiaris (Dog) (Canis familiaris)","amyloid precursor protein catabolic process [GO:0042987]; autophagosome-lysosome fusion [GO:0061909]; cellular water homeostasis [GO:0009992]; glycerophospholipid biosynthetic process [GO:0046474]; glycolipid transport [GO:0046836]; Golgi to lysosome transport [GO:0090160]; L-arginine transmembrane transport [GO:1903826]; learning or memory [GO:0007611]; lysosomal lumen acidification [GO:0007042]; lysosomal lumen pH elevation [GO:0035752]; lysosomal protein catabolic process [GO:1905146]; negative regulation of apoptotic process [GO:0043066]; phagosome-lysosome docking [GO:0090384]; phagosome-lysosome fusion [GO:0090385]; plasma membrane raft organization [GO:0044857]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of pinocytosis [GO:0048549]; receptor-mediated endocytosis [GO:0006898]; regulation of arginine biosynthetic process [GO:1900079]; regulation of autophagosome maturation [GO:1901096]; regulation of cellular response to osmotic stress [GO:0106049]; regulation of cytoskeleton organization [GO:0051493]; regulation of fibroblast migration [GO:0010762]; regulation of modification of synaptic structure [GO:1905244]; regulation of phagosome maturation [GO:1905162]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of protein processing [GO:0070613]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic transmission, glutamatergic [GO:0051966]; renal potassium excretion [GO:0036359]; vesicle transport along microtubule [GO:0047496]","GO:0000139; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0005794; GO:0005795; GO:0005802; GO:0005829; GO:0005886; GO:0005901; GO:0006898; GO:0007042; GO:0007611; GO:0008021; GO:0009992; GO:0010762; GO:0016020; GO:0031901; GO:0032228; GO:0035752; GO:0036359; GO:0042987; GO:0042998; GO:0043005; GO:0043066; GO:0044754; GO:0044857; GO:0045121; GO:0046474; GO:0046836; GO:0047496; GO:0048172; GO:0048549; GO:0051493; GO:0051861; GO:0051966; GO:0055037; GO:0061909; GO:0070613; GO:0090160; GO:0090384; GO:0090385; GO:0106049; GO:0120146; GO:1900079; GO:1901096; GO:1903076; GO:1903826; GO:1905146; GO:1905162; GO:1905244; GO:2001288"
"2395",2575,941967,"Cluster_8887","Peve_00039240",-0.0948314389780528,0.939537575806648,0.999448381576871,168,-22.56,"2 17","711 731",15,"86.67%","93.33%","Q29611","Battenin (Protein CLN3)","Canis lupus familiaris (Dog) (Canis familiaris)","amyloid precursor protein catabolic process [GO:0042987]; autophagosome-lysosome fusion [GO:0061909]; cellular water homeostasis [GO:0009992]; glycerophospholipid biosynthetic process [GO:0046474]; glycolipid transport [GO:0046836]; Golgi to lysosome transport [GO:0090160]; L-arginine transmembrane transport [GO:1903826]; learning or memory [GO:0007611]; lysosomal lumen acidification [GO:0007042]; lysosomal lumen pH elevation [GO:0035752]; lysosomal protein catabolic process [GO:1905146]; negative regulation of apoptotic process [GO:0043066]; phagosome-lysosome docking [GO:0090384]; phagosome-lysosome fusion [GO:0090385]; plasma membrane raft organization [GO:0044857]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of pinocytosis [GO:0048549]; receptor-mediated endocytosis [GO:0006898]; regulation of arginine biosynthetic process [GO:1900079]; regulation of autophagosome maturation [GO:1901096]; regulation of cellular response to osmotic stress [GO:0106049]; regulation of cytoskeleton organization [GO:0051493]; regulation of fibroblast migration [GO:0010762]; regulation of modification of synaptic structure [GO:1905244]; regulation of phagosome maturation [GO:1905162]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of protein processing [GO:0070613]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic transmission, glutamatergic [GO:0051966]; renal potassium excretion [GO:0036359]; vesicle transport along microtubule [GO:0047496]","GO:0000139; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0005794; GO:0005795; GO:0005802; GO:0005829; GO:0005886; GO:0005901; GO:0006898; GO:0007042; GO:0007611; GO:0008021; GO:0009992; GO:0010762; GO:0016020; GO:0031901; GO:0032228; GO:0035752; GO:0036359; GO:0042987; GO:0042998; GO:0043005; GO:0043066; GO:0044754; GO:0044857; GO:0045121; GO:0046474; GO:0046836; GO:0047496; GO:0048172; GO:0048549; GO:0051493; GO:0051861; GO:0051966; GO:0055037; GO:0061909; GO:0070613; GO:0090160; GO:0090384; GO:0090385; GO:0106049; GO:0120146; GO:1900079; GO:1901096; GO:1903076; GO:1903826; GO:1905146; GO:1905162; GO:1905244; GO:2001288"
"2396",2576,942032,"Cluster_589","Peve_00039242",-0.406618080432288,0.733415953351982,0.985471879812644,165,-24.16,"2 20","59 79",18,"83.33%","83.33%","P20420","Neuronal acetylcholine receptor subunit alpha-5","Rattus norvegicus (Rat)","behavioral response to nicotine [GO:0035095]; cellular response to nicotine [GO:0071316]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; hippocampus development [GO:0021766]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of membrane potential [GO:0042391]; regulation of neuronal action potential [GO:0098908]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]","GO:0005231; GO:0005886; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0015464; GO:0021766; GO:0022848; GO:0030425; GO:0030594; GO:0034220; GO:0035094; GO:0035095; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0044877; GO:0045202; GO:0045211; GO:0050877; GO:0050966; GO:0051899; GO:0071316; GO:0098691; GO:0098793; GO:0098908; GO:0099171; GO:1904315; GO:2000300"
"2397",2577,942457,"Cluster_7657","Peve_00017359",-0.260774605488123,0.832044117241082,0.995934364227446,169,-21.84,"2 21","384 405",20,"80.00%","90.00%",NA,NA,NA,NA,NA
"2398",2578,942458,"Cluster_7658","Peve_00017359",0.873422197946786,0.323791225224291,0.978262075707395,169,-21.84,"2 21","384 405",20,"80.00%","90.00%",NA,NA,NA,NA,NA
"2399",2579,942893,"Cluster_2882","Peve_00012284",-0.630568919404957,0.565643234878137,0.978262075707395,171,-24.86,"2 21","452 475",21,"80.95%","80.95%",NA,NA,NA,NA,NA
"2400",2580,943347,"Cluster_4629","Peve_00034592",0.47346947953462,0.686002836771947,0.978262075707395,155,-20.17,"2 16","350 371",14,"78.57%","85.71%",NA,NA,NA,NA,NA
"2401",2581,943528,"Cluster_4735","Peve_00020211",-0.868136693131895,0.330635245275392,0.978262075707395,159,-23.43,"2 21","228 250",20,"65.00%","85.00%","P49253","Amine oxidase [flavin-containing] (EC 1.4.3.4) (Monoamine oxidase) (MAO)","Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri)","","GO:0005741; GO:0008131; GO:0097621"
"2402",2582,943684,"Cluster_10934","Peve_00020214",-0.528568717374908,0.6454577806311,0.978262075707395,149,-20.98,"2 19","425 451",22,"63.64%","72.73%","Q9QZD5","Rab proteins geranylgeranyltransferase component A 2 (Choroideremia-like protein) (Rab escort protein 2) (REP-2)","Mus musculus (Mouse)","intracellular protein transport [GO:0006886]; protein geranylgeranylation [GO:0018344]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]","GO:0005092; GO:0005096; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005968; GO:0006886; GO:0007264; GO:0016192; GO:0018344; GO:0031267"
"2403",2583,944084,"Cluster_8988","Peve_00037731",-0.701832374281184,0.504731098427676,0.978262075707395,162,-23.7,"2 21","785 811",24,"70.83%","79.17%",NA,NA,NA,NA,NA
"2404",2584,944156,"Cluster_4115","Peve_00021164",-0.886708149833677,0.305972607256823,0.978262075707395,154,-22.43,"2 20","271 298",24,"66.67%","70.83%",NA,NA,NA,NA,NA
"2405",2585,944567,"Cluster_6904","Peve_00013502",-0.788370163560434,0.421850438292581,0.978262075707395,150,-21.17,"2 17","213 233",15,"73.33%","86.67%",NA,NA,NA,NA,NA
"2406",2586,944698,"Cluster_4735","Peve_00013501",-0.0332509025413194,0.978827915381361,0.999448381576871,161,-25.05,"2 20","848 868",18,"66.67%","94.44%",NA,NA,NA,NA,NA
"2407",2587,946518,"Cluster_10061","Peve_00019763",0.998126576037554,0.0389745384665604,0.909359886114279,171,-20.53,"2 21","470 492",20,"75.00%","90.00%","B8V7S0","CUB and peptidase domain-containing protein 1","Acropora millepora (Staghorn coral) (Heteropora millepora)","proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508"
"2408",2588,946882,"Cluster_11135","Peve_00018417",0.844443877729655,0.359862212804899,0.978262075707395,149,-23.66,"2 20","391 418",24,"62.50%","75.00%",NA,NA,NA,NA,NA
"2409",2589,947246,"Cluster_14999","Peve_00044235",0.492460876133319,0.672194927162647,0.978262075707395,159,-22.97,"2 21","362 384",20,"70.00%","80.00%","P09759","Ephrin type-B receptor 1 (EC 2.7.10.1) (ELK) (Tyrosine-protein kinase receptor EPH-2)","Rattus norvegicus (Rat)","angiogenesis [GO:0001525]; axon guidance [GO:0007411]; camera-type eye morphogenesis [GO:0048593]; cell chemotaxis [GO:0060326]; cell-substrate adhesion [GO:0031589]; central nervous system projection neuron axonogenesis [GO:0021952]; cranial nerve development [GO:0021545]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; hindbrain tangential cell migration [GO:0021934]; immunological synapse formation [GO:0001771]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; optic nerve morphogenesis [GO:0021631]; positive regulation of kinase activity [GO:0033674]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of neuron death [GO:1901214]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle satellite cell activation [GO:0014719]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0001525; GO:0001771; GO:0004713; GO:0004714; GO:0005005; GO:0005524; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0007169; GO:0007411; GO:0008046; GO:0014719; GO:0016020; GO:0021545; GO:0021631; GO:0021934; GO:0021952; GO:0022008; GO:0030010; GO:0030424; GO:0030425; GO:0031290; GO:0031589; GO:0031901; GO:0032433; GO:0033674; GO:0043005; GO:0043235; GO:0044877; GO:0045121; GO:0046328; GO:0046777; GO:0048013; GO:0048593; GO:0050804; GO:0050965; GO:0051965; GO:0060326; GO:0060996; GO:0060997; GO:0061351; GO:0070372; GO:0098978; GO:1901214; GO:1902723; GO:1902725"
"2410",2590,947280,"Cluster_9149","Peve_00043699",0.133352890905718,0.914851263066461,0.999448381576871,164,-26.56,"2 19","141 166",21,"80.95%","80.95%","Q5F3K0","Tetratricopeptide repeat protein 27 (TPR repeat protein 27)","Gallus gallus (Chicken)","",""
"2411",2591,947297,"Cluster_589","Peve_00043698",0.0151069552798743,0.990382247717507,0.999448381576871,163,-23.78,"2 21","828 851",21,"71.43%","80.95%",NA,NA,NA,NA,NA
"2412",2592,947488,"Cluster_4735","Peve_00042342",-0.989599567939083,0.0918962808756769,0.978262075707395,172,-20.82,"2 21","441 462",19,"78.95%","84.21%","Q58A42","Protein DD3-3","Dictyostelium discoideum (Social amoeba)","","GO:0016020"
"2413",2593,947792,"Cluster_589","Peve_00003630",0.587215829997522,0.600447966957186,0.978262075707395,147,-20.14,"2 14","929 949",12,"83.33%","91.67%",NA,NA,NA,NA,NA
"2414",2594,947922,"Cluster_15726","Peve_00014038",-0.5,0.666666666666667,0.978262075707395,168,-22.98,"2 21","627 648",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"2415",2595,948153,"Cluster_796","Peve_00027625",0.898740270652305,0.288966974174018,0.978262075707395,153,-20.57,"2 21","214 238",22,"72.73%","77.27%",NA,NA,NA,NA,NA
"2416",2596,948276,"Cluster_11134","Peve_00001249",0.201646584458236,0.87074151837035,0.997476741937264,168,-21.35,"2 21","789 810",19,"68.42%","89.47%","Q8TB52","F-box only protein 30","Homo sapiens (Human)","","GO:0005829; GO:0008270; GO:0061630"
"2417",2597,948506,"Cluster_14999","Peve_00040641",0.525134194156591,0.64803024914489,0.978262075707395,165,-22.64,"2 20","617 642",22,"77.27%","81.82%",NA,NA,NA,NA,NA
"2418",2598,948516,"Cluster_2787","Peve_00040640",0.867933894665659,0.330895275232091,0.978262075707395,162,-20.6,"2 21","268 292",22,"72.73%","81.82%",NA,NA,NA,NA,NA
"2419",2600,949338,"Cluster_6905","Peve_00030436",-0.628831108914747,0.567067373039967,0.978262075707395,154,-22.93,"2 19","5 26",17,"64.71%","82.35%",NA,NA,NA,NA,NA
"2420",2601,951271,"Cluster_6255","Peve_00023837",-0.763077129047589,0.44737525623554,0.978262075707395,169,-20.47,"2 18","256 277",16,"81.25%","93.75%",NA,NA,NA,NA,NA
"2421",2602,951316,"Cluster_6255","Peve_00023836",-0.763077129047589,0.44737525623554,0.978262075707395,169,-20.47,"2 18","103 124",16,"81.25%","93.75%","Q42371","LRR receptor-like serine/threonine-protein kinase ERECTA (EC 2.7.11.1) (Protein QUANTITATIVE RESISTANCE TO PLECTOSPHAERELLA 1) (Protein QUANTITATIVE RESISTANCE TO RALSTONIA SOLANACEARUM 1) (Protein TRANSPIRATION EFFICIENCY 1)","Arabidopsis thaliana (Mouse-ear cress)","cellular heat acclimation [GO:0070370]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; inflorescence morphogenesis [GO:0048281]; leaf morphogenesis [GO:0009965]; phloem or xylem histogenesis [GO:0010087]; plant-type cell wall organization [GO:0009664]; polarity specification of adaxial/abaxial axis [GO:0009944]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell division [GO:0051302]; regulation of cell growth [GO:0001558]; regulation of plant organ morphogenesis [GO:1905421]; stomatal complex morphogenesis [GO:0010103]; transpiration [GO:0010148]","GO:0001558; GO:0004674; GO:0005102; GO:0005524; GO:0005739; GO:0005886; GO:0006468; GO:0009664; GO:0009944; GO:0009965; GO:0010087; GO:0010103; GO:0010148; GO:0019199; GO:0030155; GO:0033612; GO:0042277; GO:0042742; GO:0048281; GO:0050832; GO:0051302; GO:0070370; GO:0106310; GO:1905421"
"2422",2603,952084,"Cluster_6906","Peve_00036260",-0.822817650985949,0.384801619160967,0.978262075707395,162,-20.9,"2 21","724 744",19,"73.68%","84.21%","Q5RA50","Protein FAM124A","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","",""
"2423",2604,952175,"Cluster_6914","Peve_00007833",-0.625769282019826,0.569570299905465,0.978262075707395,165,-25.93,"2 20","623 645",20,"80.00%","85.00%","Q5U4X7","Limb region 1 protein homolog","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0016020"
"2424",2605,952220,"Cluster_6914","Peve_00007832",-0.999985569263183,0.00342010859677409,0.509766725418101,165,-25.93,"2 20","603 625",20,"80.00%","85.00%","Q8WVP7","Limb region 1 protein homolog (Differentiation-related gene 14 protein)","Homo sapiens (Human)","embryonic digit morphogenesis [GO:0042733]; signal transduction [GO:0007165]","GO:0004888; GO:0005886; GO:0007165; GO:0042733"
"2425",2606,953040,"Cluster_9149","Peve_00033105",0.949516760596056,0.203148175704504,0.978262075707395,153,-20.77,"2 20","669 692",20,"70.00%","80.00%","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"2426",2607,953359,"Cluster_10934","Peve_00019405",0.799413491069175,0.410287429786378,0.978262075707395,162,-20.28,"2 21","42 65",21,"76.19%","80.95%",NA,NA,NA,NA,NA
"2427",2608,953382,"Cluster_4629","Peve_00019406",0.778010025405824,0.432458504698814,0.978262075707395,166,-22.85,"2 21","660 680",19,"73.68%","89.47%",NA,NA,NA,NA,NA
"2428",2609,953506,"Cluster_29","Peve_00009477",-0.62077240343352,0.573638206347232,0.978262075707395,166,-22.14,"2 20","975 997",19,"73.68%","89.47%",NA,NA,NA,NA,NA
"2429",2610,953705,"Cluster_6914","Peve_00009473",0.853558462702337,0.348879522418649,0.978262075707395,154,-23.54,"2 20","923 950",25,"64.00%","72.00%","P62972","Polyubiquitin [Cleaved into: Ubiquitin]","Xenopus laevis (African clawed frog)","","GO:0005634; GO:0005737"
"2430",2612,954472,"Cluster_7657","Peve_00006856",-0.652344977732298,0.547570696025476,0.978262075707395,166,-21.79,"2 21","873 896",21,"76.19%","85.71%","Q7TQH0","Ataxin-2-like protein","Mus musculus (Mouse)","mRNA metabolic process [GO:0016071]; stress granule assembly [GO:0034063]","GO:0003723; GO:0005829; GO:0010494; GO:0016020; GO:0016071; GO:0016607; GO:0034063"
"2431",2613,954473,"Cluster_7658","Peve_00006856",-0.087575157331046,0.944176411957733,0.999448381576871,166,-21.79,"2 21","873 896",21,"76.19%","85.71%","Q7TQH0","Ataxin-2-like protein","Mus musculus (Mouse)","mRNA metabolic process [GO:0016071]; stress granule assembly [GO:0034063]","GO:0003723; GO:0005829; GO:0010494; GO:0016020; GO:0016071; GO:0016607; GO:0034063"
"2432",2614,954570,"Cluster_9149","Peve_00006854",-0.990695081905981,0.0869137983885691,0.978262075707395,168,-26.53,"2 17","340 361",15,"86.67%","93.33%","Q5I0K3","Citramalyl-CoA lyase, mitochondrial (EC 4.1.3.25) ((3S)-malyl-CoA thioesterase) (EC 3.1.2.30) (Beta-methylmalate synthase) (EC 2.3.3.-) (Citrate lyase subunit beta-like protein, mitochondrial) (Citrate lyase beta-like) (Malate synthase) (EC 2.3.3.9)","Rattus norvegicus (Rat)","positive regulation of cobalamin metabolic process [GO:0106121]; protein homotrimerization [GO:0070207]; regulation of cobalamin metabolic process [GO:0106064]","GO:0000287; GO:0004474; GO:0005739; GO:0016787; GO:0047777; GO:0070207; GO:0106064; GO:0106121"
"2433",2615,954600,"Cluster_5882","Peve_00036482",-0.827329851387817,0.379717574715268,0.978262075707395,159,-20.01,"2 19","665 686",18,"83.33%","83.33%",NA,NA,NA,NA,NA
"2434",2616,955076,"Cluster_14999","Peve_00023307",0.986888731292914,0.103203193735213,0.978262075707395,167,-24.84,"2 16","134 155",14,"85.71%","100.00%","Q4G0X4","BTB/POZ domain-containing protein KCTD21 (KCASH2 protein) (Potassium channel tetramerization domain-containing protein 21)","Homo sapiens (Human)","negative regulation of smoothened signaling pathway [GO:0045879]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0006511; GO:0016567; GO:0042802; GO:0042826; GO:0045879; GO:0051260; GO:0097602"
"2435",2617,955128,"Cluster_796","Peve_00006853",0.729300419163387,0.479691358375832,0.978262075707395,156,-21.33,"2 21","48 67",19,"78.95%","78.95%","Q5I0K3","Citramalyl-CoA lyase, mitochondrial (EC 4.1.3.25) ((3S)-malyl-CoA thioesterase) (EC 3.1.2.30) (Beta-methylmalate synthase) (EC 2.3.3.-) (Citrate lyase subunit beta-like protein, mitochondrial) (Citrate lyase beta-like) (Malate synthase) (EC 2.3.3.9)","Rattus norvegicus (Rat)","positive regulation of cobalamin metabolic process [GO:0106121]; protein homotrimerization [GO:0070207]; regulation of cobalamin metabolic process [GO:0106064]","GO:0000287; GO:0004474; GO:0005739; GO:0016787; GO:0047777; GO:0070207; GO:0106064; GO:0106121"
"2436",2618,955327,"Cluster_7657","Peve_00031289",0.972237474858324,0.150360761327457,0.978262075707395,171,-21.82,"2 21","809 833",22,"77.27%","81.82%",NA,NA,NA,NA,NA
"2437",2619,955328,"Cluster_7658","Peve_00031289",-0.846097434504597,0.357892130689333,0.978262075707395,171,-21.82,"2 21","809 833",22,"77.27%","81.82%",NA,NA,NA,NA,NA
"2438",2620,955632,"Cluster_4629","Peve_00005156",0.507628930708832,0.661044192525938,0.978262075707395,151,-20.73,"2 21","236 258",20,"65.00%","75.00%",NA,NA,NA,NA,NA
"2439",2621,956083,"Cluster_4735","Peve_00025222",-0.382825832302647,0.749901873018013,0.988219883885475,159,-22.82,"2 21","937 961",22,"68.18%","77.27%",NA,NA,NA,NA,NA
"2440",2622,956601,"Cluster_11134","Peve_00020764",0.782812194726559,0.427569073736769,0.978262075707395,160,-26.7,"2 21","77 99",21,"76.19%","85.71%","Q14839","Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta)","Homo sapiens (Human)","chromatin remodeling [GO:0006338]; double-strand break repair via homologous recombination [GO:0000724]; histone deacetylation [GO:0016575]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; regulation of synapse assembly [GO:0051963]; terminal button organization [GO:0072553]","GO:0000122; GO:0000724; GO:0000781; GO:0000785; GO:0001221; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006338; GO:0008270; GO:0010629; GO:0016020; GO:0016575; GO:0016581; GO:0016887; GO:0032991; GO:0042393; GO:0042659; GO:0042826; GO:0045892; GO:0045893; GO:0051963; GO:0061629; GO:0072553; GO:0090575; GO:0090734; GO:0140658; GO:0150048; GO:2000736"
"2441",2623,957495,"Cluster_9149","Peve_00022948",-0.497850550954399,0.668245608966349,0.978262075707395,147,-21.42,"2 19","819 840",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"2442",2624,958382,"Cluster_6904","Peve_00039866",-0.882746841103408,0.311383228106958,0.978262075707395,152,-25.3,"2 19","198 223",21,"71.43%","76.19%","O42412","Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase)","Gallus gallus (Chicken)","hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403]","GO:0004800; GO:0005886; GO:0010008; GO:0033798; GO:0042403; GO:0042446"
"2443",2625,958384,"Cluster_6906","Peve_00039866",-0.548257553620033,0.630582713323865,0.978262075707395,152,-22.47,"2 21","202 223",19,"63.16%","73.68%","O42412","Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase)","Gallus gallus (Chicken)","hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403]","GO:0004800; GO:0005886; GO:0010008; GO:0033798; GO:0042403; GO:0042446"
"2444",2626,958461,"Cluster_2787","Peve_00039863",-0.719536138840511,0.488708928096164,0.978262075707395,166,-24.11,"2 21","491 514",21,"76.19%","85.71%","P49895","Type I iodothyronine deiodinase (EC 1.21.99.4) (5DI) (DIOI) (Type 1 DI) (Type-I 5'-deiodinase)","Homo sapiens (Human)","amino acid metabolic process [GO:0006520]; hormone biosynthetic process [GO:0042446]; thyroid hormone generation [GO:0006590]; thyroid hormone metabolic process [GO:0042403]","GO:0004800; GO:0005789; GO:0005886; GO:0006520; GO:0006590; GO:0008430; GO:0042403; GO:0042446"
"2445",2628,960251,"Cluster_14999","Peve_00013329",0.525134194156591,0.64803024914489,0.978262075707395,168,-20.44,"2 21","40 61",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"2446",2629,961067,"Cluster_589","Peve_00011782",0.611509837293649,0.581124952470517,0.978262075707395,158,-23.77,"2 20","382 404",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"2447",2630,961206,"Cluster_2787","Peve_00017838",0.488220337230869,0.675292483587265,0.978262075707395,159,-20.88,"2 16","256 277",14,"78.57%","92.86%",NA,NA,NA,NA,NA
"2448",2631,961508,"Cluster_11997","Peve_00017834",0.201698507964387,0.870707769399663,0.997476741937264,159,-20.47,"2 21","625 647",20,"70.00%","80.00%","F1NWE3","Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha)","Gallus gallus (Chicken)","negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; synaptic membrane adhesion [GO:0099560]","GO:0004725; GO:0005886; GO:0006470; GO:0008201; GO:0030424; GO:0030426; GO:0030517; GO:0030672; GO:0035335; GO:0042803; GO:0043204; GO:0043395; GO:0048671; GO:0048681; GO:0061000; GO:0098839; GO:0099560"
"2449",2632,961641,"Cluster_11134","Peve_00010438",-0.278005308096232,0.820653430324568,0.995934364227446,155,-20.62,"2 18","95 115",16,"75.00%","87.50%","Q5ZIE6","NEDD8-activating enzyme E1 regulatory subunit (APP-BP1) (Amyloid protein-binding protein 1)","Gallus gallus (Chicken)","protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]","GO:0005737; GO:0019781; GO:0032446; GO:0045116"
"2450",2633,961776,"Cluster_11134","Peve_00010430",-0.0195622829453675,0.987545469442176,0.999448381576871,148,-21.39,"2 14","52 75",14,"78.57%","85.71%",NA,NA,NA,NA,NA
"2451",2634,962236,"Cluster_29","Peve_00017781",-0.679988783950028,0.523969260131965,0.978262075707395,159,-21.01,"2 20","916 937",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"2452",2635,962381,"Cluster_4115","Peve_00034089",-0.930026219102899,0.239567750774005,0.978262075707395,170,-21.97,"2 21","75 95",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"2453",2636,962556,"Cluster_2787","Peve_00012491",0.589657419573059,0.598525539741698,0.978262075707395,151,-21.58,"2 18","439 462",18,"77.78%","77.78%",NA,NA,NA,NA,NA
"2454",2637,962715,"Cluster_9149","Peve_00034085",-0.696197450258139,0.509747605713303,0.978262075707395,150,-23.13,"2 19","953 972",17,"76.47%","82.35%",NA,NA,NA,NA,NA
"2455",2638,962760,"Cluster_9149","Peve_00012495",-0.19299026550697,0.87636284052907,0.99789907223726,150,-21.09,"2 21","401 421",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"2456",2639,964176,"Cluster_2787","Peve_00042993",-0.489068877828086,0.674673333630133,0.978262075707395,174,-26.79,"2 21","574 594",19,"84.21%","89.47%","Q92664","Transcription factor IIIA (TFIIIA)","Homo sapiens (Human)","ribosomal large subunit biogenesis [GO:0042273]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]","GO:0003677; GO:0005634; GO:0005654; GO:0006383; GO:0008097; GO:0009303; GO:0042273; GO:0046872"
"2457",2640,964577,"Cluster_589","Peve_00032368",0.527587288366341,0.646193532193725,0.978262075707395,161,-24.84,"2 20","708 728",18,"66.67%","94.44%","Q92752","Tenascin-R (TN-R) (Janusin) (Restrictin)","Homo sapiens (Human)","associative learning [GO:0008306]; axon extension involved in regeneration [GO:0048677]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; locomotory exploration behavior [GO:0035641]; long-term synaptic potentiation [GO:0060291]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic transmission [GO:0050805]; neuroblast migration [GO:0097402]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of cell migration [GO:0030334]; synapse organization [GO:0050808]; synaptic transmission, glutamatergic [GO:0035249]; telencephalon cell migration [GO:0022029]","GO:0005102; GO:0005576; GO:0005615; GO:0007155; GO:0007158; GO:0007411; GO:0008306; GO:0009986; GO:0010977; GO:0022029; GO:0022408; GO:0030155; GO:0030198; GO:0030334; GO:0035249; GO:0035641; GO:0045121; GO:0045595; GO:0048677; GO:0048692; GO:0050805; GO:0050808; GO:0050885; GO:0051968; GO:0051971; GO:0060291; GO:0062023; GO:0072534; GO:0090733; GO:0097402; GO:0098685; GO:0098978"
"2458",2641,964830,"Cluster_9149","Peve_00016238",-0.5,0.666666666666667,0.978262075707395,160,-22.14,"2 21","966 987",19,"63.16%","84.21%","Q8TDB6","E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2) (Rhysin2)","Homo sapiens (Human)","cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; DNA damage checkpoint signaling [GO:0000077]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000077; GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006325; GO:0006511; GO:0006974; GO:0007219; GO:0008333; GO:0010390; GO:0015031; GO:0016567; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0033522; GO:0033523; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0046872; GO:0051444; GO:0051607; GO:0051865; GO:0061630; GO:0070936; GO:0097677; GO:0140768; GO:1900182; GO:1902966; GO:2000646"
"2459",2642,965145,"Cluster_9149","Peve_00016494",-0.811993478684942,0.396764895059051,0.978262075707395,155,-21.62,"2 21","316 338",20,"70.00%","75.00%","Q9R1K5","Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog)","Mus musculus (Mouse)","anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; DNA repair [GO:0006281]; lens fiber cell differentiation [GO:0070306]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cellular senescence [GO:2000773]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of meiotic nuclear division [GO:0040020]","GO:0005654; GO:0005680; GO:0006281; GO:0007095; GO:0008284; GO:0010997; GO:0016567; GO:0031145; GO:0031965; GO:0040020; GO:0051301; GO:0051603; GO:0070306; GO:1904668; GO:1905786; GO:1990757; GO:2000773"
"2460",2643,965179,"Cluster_6906","Peve_00016493",-0.64023566713254,0.557673390567536,0.978262075707395,146,-21.33,"2 21","404 429",23,"60.87%","73.91%","Q8BRK8","5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31)","Mus musculus (Mouse)","autophagy [GO:0006914]; cellular response to calcium ion [GO:0071277]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol biosynthetic process [GO:0006695]; chromatin organization [GO:0006325]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; lipid droplet disassembly [GO:1905691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of TOR signaling [GO:0032007]; negative regulation of tubulin deacetylation [GO:1904428]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; positive regulation of protein localization [GO:1903829]; protein localization to lipid droplet [GO:1990044]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of lipid metabolic process [GO:0019216]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stress granule assembly [GO:0062028]; response to activity [GO:0014823]; response to caffeine [GO:0031000]; response to muscle activity [GO:0014850]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]","GO:0003682; GO:0004672; GO:0004674; GO:0004679; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006325; GO:0006468; GO:0006633; GO:0006695; GO:0006914; GO:0008610; GO:0010468; GO:0010494; GO:0010508; GO:0010629; GO:0014823; GO:0014850; GO:0016055; GO:0016241; GO:0016324; GO:0016607; GO:0019216; GO:0030424; GO:0030425; GO:0030674; GO:0031000; GO:0031588; GO:0031669; GO:0032007; GO:0032991; GO:0034599; GO:0035174; GO:0035556; GO:0042149; GO:0042593; GO:0042752; GO:0043025; GO:0043066; GO:0044877; GO:0045821; GO:0046872; GO:0047322; GO:0048511; GO:0050405; GO:0055089; GO:0062028; GO:0070507; GO:0071277; GO:0071333; GO:0071380; GO:0071466; GO:0097009; GO:0106310; GO:1903829; GO:1904428; GO:1905691; GO:1990044; GO:2000758"
"2461",2644,965207,"Cluster_589","Peve_00016492",-0.393728333916376,0.742370143559619,0.986697151420032,164,-24.2,"2 20","137 158",19,"84.21%","84.21%","P52888","Thimet oligopeptidase (EC 3.4.24.15) (Endopeptidase 24.15) (MP78)","Homo sapiens (Human)","peptide metabolic process [GO:0006518]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]","GO:0000209; GO:0004222; GO:0005758; GO:0005829; GO:0006508; GO:0006518; GO:0046872"
"2462",2645,965213,"Cluster_2882","Peve_00016492",-0.476051888150708,0.684134883586959,0.978262075707395,165,-26.39,"2 20","1 21",18,"77.78%","88.89%","P52888","Thimet oligopeptidase (EC 3.4.24.15) (Endopeptidase 24.15) (MP78)","Homo sapiens (Human)","peptide metabolic process [GO:0006518]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]","GO:0000209; GO:0004222; GO:0005758; GO:0005829; GO:0006508; GO:0006518; GO:0046872"
"2463",2646,965336,"Cluster_14999","Peve_00003734",0.966623866728312,0.164940958412028,0.978262075707395,154,-23.66,"2 20","565 593",25,"68.00%","68.00%","Q9JHI9","Solute carrier family 40 member 1 (Ferroportin-1) (Iron-regulated transporter 1) (Metal transporter protein 1) (MTP1)","Mus musculus (Mouse)","apoptotic process [GO:0006915]; cellular iron ion homeostasis [GO:0006879]; endothelium development [GO:0003158]; establishment of localization in cell [GO:0051649]; iron ion export across plasma membrane [GO:1903988]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; lymphocyte homeostasis [GO:0002260]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; spleen development [GO:0048536]; spleen trabecula formation [GO:0060345]; transcription by RNA polymerase II [GO:0006366]","GO:0002260; GO:0003158; GO:0005381; GO:0005654; GO:0005829; GO:0005886; GO:0006366; GO:0006826; GO:0006879; GO:0006915; GO:0008021; GO:0015093; GO:0016323; GO:0017046; GO:0034395; GO:0034755; GO:0042802; GO:0043066; GO:0045944; GO:0046872; GO:0048536; GO:0051649; GO:0055072; GO:0060345; GO:0060586; GO:1903988"
"2464",2647,965488,"Cluster_4735","Peve_00001466",0.840443823203419,0.364588711451301,0.978262075707395,167,-23.74,"2 16","173 194",14,"85.71%","100.00%",NA,NA,NA,NA,NA
"2465",2648,965991,"Cluster_7053","Peve_00041715",0.928819221641637,0.241650055122415,0.978262075707395,156,-23.23,"2 21","629 650",19,"63.16%","78.95%",NA,NA,NA,NA,NA
"2466",2649,966243,"Cluster_796","Peve_00018331",0.898740270652305,0.288966974174018,0.978262075707395,160,-24.85,"2 21","400 418",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"2467",2650,966288,"Cluster_796","Peve_00018332",0.898740270652305,0.288966974174018,0.978262075707395,160,-24.85,"2 21","400 418",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"2468",2651,966962,"Cluster_589","Peve_00009677",0.159680919674548,0.897906931664995,0.999448381576871,159,-24.58,"2 21","154 176",20,"70.00%","80.00%",NA,NA,NA,NA,NA
"2469",2652,967980,"Cluster_9149","Peve_00031048",-0.575644427812778,0.609502507012712,0.978262075707395,151,-23.64,"2 18","81 101",16,"75.00%","81.25%",NA,NA,NA,NA,NA
"2470",2653,968137,"Cluster_2854","Peve_00031043",-0.587023404583084,0.600599297155793,0.978262075707395,157,-20.35,"2 21","968 987",19,"73.68%","78.95%","Q8TD57","Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b)","Homo sapiens (Human)","cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]","GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959; GO:0060285; GO:0097729"
"2471",2654,968222,"Cluster_589","Peve_00031040",-0.935807343137816,0.229344770164185,0.978262075707395,152,-26.85,"2 18","745 771",21,"66.67%","76.19%",NA,NA,NA,NA,NA
"2472",2655,968762,"Cluster_589","Peve_00000416",-0.990312001114105,0.088687702757617,0.978262075707395,156,-21.9,"2 21","667 687",20,"70.00%","85.00%","Q66JG2","Ceramide-1-phosphate transfer protein (Glycolipid transfer protein domain-containing protein 1) (CPTP)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","ceramide 1-phosphate transport [GO:1902389]; negative regulation of autophagy [GO:0010507]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]","GO:0005543; GO:0005640; GO:0005794; GO:0005829; GO:0005886; GO:0010008; GO:0010507; GO:0032691; GO:1900226; GO:1902387; GO:1902388; GO:1902389"
"2473",2656,969195,"Cluster_9149","Peve_00028158",-0.740204823815997,0.469457040675494,0.978262075707395,141,-21.71,"2 10","261 282",8,"87.50%","100.00%","Q5EA70","Transmembrane protein 229B","Bos taurus (Bovine)","macrophage activation [GO:0042116]; response to bacterium [GO:0009617]","GO:0009617; GO:0016020; GO:0042116"
"2474",2657,969275,"Cluster_6914","Peve_00000041",0.926691392010196,0.245279995927151,0.978262075707395,166,-21.09,"2 20","146 170",22,"72.73%","81.82%","P48545","G protein-activated inward rectifier potassium channel 4 (GIRK-4) (Cardiac inward rectifier) (CIR) (Heart KATP channel) (Inward rectifier K(+) channel Kir3.4) (KATP-1) (Potassium channel, inwardly rectifying subfamily J member 5)","Mus musculus (Mouse)","membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion import across plasma membrane [GO:1990573]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]","GO:0005242; GO:0005886; GO:0008076; GO:0009897; GO:0015467; GO:0030315; GO:0034765; GO:0086089; GO:0086091; GO:0098914; GO:1990573"
"2475",2658,969353,"Cluster_2882","Peve_00000046",-0.581376674835243,0.605028566919554,0.978262075707395,166,-22.1,"2 15","411 432",13,"92.31%","100.00%","Q9HCN4","GPN-loop GTPase 1 (EC 3.6.5.-) (MBD2-interacting protein) (MBDin) (RNAPII-associated protein 4) (XPA-binding protein 1)","Homo sapiens (Human)","","GO:0003924; GO:0005525; GO:0005654; GO:0005739; GO:0005829"
"2476",2659,969427,"Cluster_11135","Peve_00029484",0.979707949357328,0.128468079216384,0.978262075707395,159,-23.48,"2 21","232 257",23,"65.22%","78.26%",NA,NA,NA,NA,NA
"2477",2660,970068,"Cluster_796","Peve_00008549",-0.0696341159246929,0.955633640840684,0.999448381576871,171,-22.28,"2 21","826 849",21,"80.95%","80.95%",NA,NA,NA,NA,NA
"2478",2661,970302,"Cluster_4629","Peve_00006156",-0.913061714782319,0.267422807327362,0.978262075707395,146,-21.71,"2 11","681 702",9,"88.89%","100.00%","A0A0G2JDV3","Guanylate-binding protein 6 (EC 3.6.5.-) (GTP-binding protein 6) (GBP-6) (Guanine nucleotide-binding protein 6) (Macrophage activation 2 like protein)","Mus musculus (Mouse)","adhesion of symbiont to host [GO:0044406]; cellular response to interferon-beta [GO:0035458]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; response to bacterium [GO:0009617]","GO:0003924; GO:0005525; GO:0009617; GO:0020005; GO:0031410; GO:0035458; GO:0042832; GO:0044406; GO:0050830; GO:0071222; GO:0071346"
"2479",2662,970347,"Cluster_4629","Peve_00006154",-0.554554668634826,0.625777256211528,0.978262075707395,160,-21.29,"2 21","564 585",19,"68.42%","78.95%","Q55GU0","Probable serine/threonine-protein kinase DDB_G0267514 (EC 2.7.11.1)","Dictyostelium discoideum (Social amoeba)","protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]","GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0106310"
"2480",2663,970788,"Cluster_796","Peve_00030606",-0.205897946703506,0.86797701067677,0.997023462651288,148,-21.47,"2 20","446 465",18,"66.67%","77.78%","Q9VCA2","Organic cation transporter protein","Drosophila melanogaster (Fruit fly)","apoptotic process [GO:0006915]; ion transport [GO:0006811]","GO:0006811; GO:0006915; GO:0016020; GO:0022857"
"2481",2664,970911,"Cluster_11134","Peve_00030604",-0.801630473638078,0.407932395475838,0.978262075707395,162,-21.4,"2 16","965 987",15,"86.67%","93.33%",NA,NA,NA,NA,NA
"2482",2665,971010,"Cluster_16738","Peve_00030608",-0.978063193850342,0.133591538506967,0.978262075707395,155,-20.98,"2 19","578 599",18,"77.78%","83.33%","Q9VCA2","Organic cation transporter protein","Drosophila melanogaster (Fruit fly)","apoptotic process [GO:0006915]; ion transport [GO:0006811]","GO:0006811; GO:0006915; GO:0016020; GO:0022857"
"2483",2666,971187,"Cluster_15726","Peve_00008881",0.985063221633845,0.110170585059387,0.978262075707395,176,-24.19,"2 21","117 138",19,"78.95%","89.47%","Q91175","Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (MAR1)","Oryzias latipes (Japanese rice fish) (Japanese killifish)","adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; cell-cell signaling [GO:0007267]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vasoconstriction [GO:0045907]","GO:0001996; GO:0004930; GO:0004937; GO:0005886; GO:0007200; GO:0007204; GO:0007267; GO:0043410; GO:0045907; GO:0071880"
"2484",2667,971502,"Cluster_15726","Peve_00033551",-0.995373618784485,0.0612609045746037,0.978262075707395,159,-21.54,"2 21","766 788",20,"70.00%","80.00%","G5EBQ8","Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)","Caenorhabditis elegans","cell wall chitin biosynthetic process [GO:0006038]; chitin biosynthetic process [GO:0006031]; positive regulation of nematode larval development [GO:0061063]","GO:0004100; GO:0005886; GO:0006031; GO:0006038; GO:0030428; GO:0061063; GO:0071944"
"2485",2668,972171,"Cluster_11134","Peve_00002105",0.999968584764073,0.00504622278903583,0.551398425649056,148,-20.4,"2 19","607 630",19,"68.42%","78.95%","Q9JID6","Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Palmitoyl-CoA ligase) (Phytanate--CoA ligase) (EC 6.2.1.24)","Cavia porcellus (Guinea pig)","long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0001676; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0047676; GO:0050197; GO:0070251"
"2486",2669,972228,"Cluster_796","Peve_00002100",0.881006662797646,0.31373293357875,0.978262075707395,144,-20.39,"2 20","708 729",19,"68.42%","73.68%","Q5I0X7","Tetratricopeptide repeat protein 32 (TPR repeat protein 32)","Homo sapiens (Human)","",""
"2487",2670,972487,"Cluster_11135","Peve_00002108",0.0416594069809366,0.973471120528434,0.999448381576871,154,-20.39,"2 21","756 776",19,"63.16%","84.21%",NA,NA,NA,NA,NA
"2488",2671,972750,"Cluster_9149","Peve_00037076",-0.5,0.666666666666667,0.978262075707395,151,-23.75,"2 21","816 839",21,"66.67%","71.43%","Q2S1V4","Tryptophanase (EC 4.1.99.1) (L-tryptophan indole-lyase) (TNase)","Salinibacter ruber (strain DSM 13855 / M31)","","GO:0009034"
"2489",2672,973352,"Cluster_589","Peve_00008261",0.914821567905879,0.264662221918157,0.978262075707395,146,-20.53,"2 20","770 797",24,"62.50%","66.67%","Q96PM5","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING finger protein 199) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363) (p53-induced RING-H2 protein) (hPirh2)","Homo sapiens (Human)","error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630; GO:0070987"
"2490",2673,974852,"Cluster_6904","Peve_00037921",-0.0588603239076974,0.962506683201127,0.999448381576871,160,-23.43,"2 17","59 80",15,"80.00%","86.67%","C9S5C6","Extracellular metalloprotease VDBG_01143 (EC 3.4.24.-)","Verticillium alfalfae (strain VaMs.102 / ATCC MYA-4576 / FGSC 10136) (Verticillium wilt of alfalfa) (Verticillium albo-atrum)","proteolysis [GO:0006508]","GO:0005576; GO:0006508; GO:0008237; GO:0046872"
"2491",2674,974854,"Cluster_6906","Peve_00037921",0.428202735039407,0.718293831581966,0.981132032970022,156,-21.41,"2 17","59 80",15,"73.33%","86.67%","C9S5C6","Extracellular metalloprotease VDBG_01143 (EC 3.4.24.-)","Verticillium alfalfae (strain VaMs.102 / ATCC MYA-4576 / FGSC 10136) (Verticillium wilt of alfalfa) (Verticillium albo-atrum)","proteolysis [GO:0006508]","GO:0005576; GO:0006508; GO:0008237; GO:0046872"
"2492",2675,975420,"Cluster_16738","Peve_00036031",-0.506209111557797,0.662092790877516,0.978262075707395,154,-20.47,"2 21","483 503",19,"68.42%","78.95%","O43435","T-box transcription factor TBX1 (T-box protein 1) (Testis-specific T-box protein)","Homo sapiens (Human)","angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; aorta morphogenesis [GO:0035909]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; cell fate specification [GO:0001708]; cell population proliferation [GO:0008283]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to retinoic acid [GO:0071300]; cochlea morphogenesis [GO:0090103]; coronary artery morphogenesis [GO:0060982]; determination of left/right symmetry [GO:0007368]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic viscerocranium morphogenesis [GO:0048703]; enamel mineralization [GO:0070166]; epithelial cell differentiation [GO:0030855]; face morphogenesis [GO:0060325]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; lymph vessel development [GO:0001945]; mesenchymal cell apoptotic process [GO:0097152]; mesoderm development [GO:0007498]; middle ear morphogenesis [GO:0042474]; muscle cell fate commitment [GO:0042693]; muscle organ development [GO:0007517]; muscle organ morphogenesis [GO:0048644]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell differentiation [GO:0045596]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; neural crest cell migration [GO:0001755]; odontogenesis of dentin-containing tooth [GO:0042475]; outer ear morphogenesis [GO:0042473]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; parathyroid gland development [GO:0060017]; pattern specification process [GO:0007389]; pharyngeal system development [GO:0060037]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of tongue muscle cell differentiation [GO:2001037]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of animal organ morphogenesis [GO:2000027]; regulation of transcription by RNA polymerase II [GO:0006357]; retinoic acid receptor signaling pathway [GO:0048384]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; social behavior [GO:0035176]; soft palate development [GO:0060023]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tongue morphogenesis [GO:0043587]; vagus nerve morphogenesis [GO:0021644]","GO:0000785; GO:0000978; GO:0000981; GO:0001525; GO:0001568; GO:0001708; GO:0001755; GO:0001934; GO:0001945; GO:0002053; GO:0003007; GO:0003148; GO:0003151; GO:0003677; GO:0005634; GO:0006357; GO:0007368; GO:0007389; GO:0007498; GO:0007507; GO:0007517; GO:0007605; GO:0008283; GO:0008284; GO:0009952; GO:0021644; GO:0030855; GO:0030878; GO:0035176; GO:0035909; GO:0042471; GO:0042472; GO:0042473; GO:0042474; GO:0042475; GO:0042693; GO:0042803; GO:0043410; GO:0043565; GO:0043587; GO:0044344; GO:0045596; GO:0045893; GO:0045944; GO:0046983; GO:0048384; GO:0048514; GO:0048538; GO:0048644; GO:0048701; GO:0048703; GO:0048752; GO:0048844; GO:0050679; GO:0060017; GO:0060023; GO:0060037; GO:0060325; GO:0060415; GO:0060982; GO:0070166; GO:0071300; GO:0090103; GO:0097152; GO:1990837; GO:2000027; GO:2001037; GO:2001054"
"2493",2676,975603,"Cluster_796","Peve_00028990",0.999428282268221,0.0215281467469576,0.825175158091499,165,-26.57,"2 21","452 471",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"2494",2677,976542,"Cluster_15726","Peve_00031563",-0.734213002475459,0.475102693190399,0.978262075707395,153,-21.16,"2 21","556 579",22,"72.73%","72.73%","Q8N6S4","Ankyrin repeat domain-containing protein 13C","Homo sapiens (Human)","protein retention in ER lumen [GO:0006621]; regulation of anoikis [GO:2000209]; regulation of signaling receptor activity [GO:0010469]","GO:0005102; GO:0005737; GO:0005783; GO:0005789; GO:0006621; GO:0010469; GO:0048471; GO:2000209"
"2495",2678,977047,"Cluster_2854","Peve_00021332",-0.220103977311049,0.858720664963601,0.995934364227446,162,-23.62,"2 15","110 131",13,"84.62%","100.00%","Q62283","Tetraspanin-7 (Tspan-7) (Cell surface glycoprotein A15) (PE31) (TALLA homolog) (Transmembrane 4 superfamily member 2) (CD antigen CD231)","Mus musculus (Mouse)","regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]","GO:0005886; GO:0099149"
"2496",2679,977079,"Cluster_13502","Peve_00021332",-0.694894823800783,0.5109018153452,0.978262075707395,200,-40.02,"2 21","244 265",19,"100.00%","100.00%","Q62283","Tetraspanin-7 (Tspan-7) (Cell surface glycoprotein A15) (PE31) (TALLA homolog) (Transmembrane 4 superfamily member 2) (CD antigen CD231)","Mus musculus (Mouse)","regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]","GO:0005886; GO:0099149"
"2497",2680,977312,"Cluster_589","Peve_00005349",0.119277017872402,0.92388467693814,0.999448381576871,149,-22.88,"2 20","966 993",24,"66.67%","70.83%","Q91WQ5","TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5L (TAF5L) (PCAF-associated factor 65 beta) (PAF65-beta)","Mus musculus (Mouse)","histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; regulation of somatic stem cell population maintenance [GO:1904672]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000123; GO:0000124; GO:0003713; GO:0005634; GO:0006282; GO:0006355; GO:0006357; GO:0016573; GO:0016607; GO:0033276; GO:0035521; GO:0035522; GO:0036464; GO:0043484; GO:0043966; GO:0045893; GO:1904672"
"2498",2682,978544,"Cluster_6906","Peve_00013954",-0.394295805235056,0.741977083608606,0.986697151420032,148,-20.97,"2 18","917 940",18,"66.67%","77.78%",NA,NA,NA,NA,NA
"2499",2683,978589,"Cluster_6906","Peve_00013957",-0.618833351033174,0.575211227235472,0.978262075707395,148,-20.97,"2 18","265 288",18,"66.67%","77.78%",NA,NA,NA,NA,NA
"2500",2684,978672,"Cluster_4629","Peve_00043558",-0.598156992204998,0.591799826055463,0.978262075707395,154,-22.95,"2 16","382 404",15,"80.00%","86.67%","Q99P75","Ras-related protein Rab-9A","Rattus norvegicus (Rat)","negative regulation by host of symbiont catalytic activity [GO:0052403]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0000139; GO:0003924; GO:0005525; GO:0005764; GO:0005770; GO:0005789; GO:0005829; GO:0005886; GO:0015031; GO:0019003; GO:0030659; GO:0030670; GO:0032482; GO:0032880; GO:0042147; GO:0042470; GO:0042802; GO:0045335; GO:0045921; GO:0052403"
"2501",2687,979527,"Cluster_4629","Peve_00011088",-0.510722259275643,0.658756099416281,0.978262075707395,164,-20.94,"2 21","335 356",19,"68.42%","84.21%","Q9M9E8","Lysine-specific demethylase JMJ21 (EC 1.14.11.-) (F-box protein JMJ21) (Jumonji domain-containing protein 21) (AtJMJ21) (Protein JUMONJI 21) (Lysine-specific histone demethylase JMJ21) ([histone H3]-trimethyl-L-lysine monodemethylase JMJ21)","Arabidopsis thaliana (Mouse-ear cress)","","GO:0005634; GO:0005737; GO:0016491; GO:0046872"
"2502",2688,979590,"Cluster_9149","Peve_00023595",-0.994233635161714,0.0683998409502182,0.978262075707395,155,-23.76,"2 20","735 756",18,"66.67%","77.78%","Q24046","Sodium/potassium-transporting ATPase subunit beta-1 (Protein nervana 1) (Sodium/potassium-dependent ATPase subunit beta-1)","Drosophila melanogaster (Fruit fly)","cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; positive regulation of P-type sodium:potassium-exchanging transporter activity [GO:1903408]; potassium ion import across plasma membrane [GO:1990573]; sodium ion export across plasma membrane [GO:0036376]","GO:0001671; GO:0005886; GO:0005890; GO:0006812; GO:0006883; GO:0030007; GO:0036376; GO:1903408; GO:1990573"
"2503",2689,979597,"Cluster_11135","Peve_00023595",0.930696095845784,0.238404612911549,0.978262075707395,149,-20.23,"2 17","42 61",15,"73.33%","86.67%","Q24046","Sodium/potassium-transporting ATPase subunit beta-1 (Protein nervana 1) (Sodium/potassium-dependent ATPase subunit beta-1)","Drosophila melanogaster (Fruit fly)","cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; positive regulation of P-type sodium:potassium-exchanging transporter activity [GO:1903408]; potassium ion import across plasma membrane [GO:1990573]; sodium ion export across plasma membrane [GO:0036376]","GO:0001671; GO:0005886; GO:0005890; GO:0006812; GO:0006883; GO:0030007; GO:0036376; GO:1903408; GO:1990573"
"2504",2690,981708,"Cluster_10061","Peve_00033719",-0.923962174269532,0.249862483987803,0.978262075707395,166,-20.04,"2 19","908 929",17,"70.59%","94.12%",NA,NA,NA,NA,NA
"2505",2691,982380,"Cluster_9149","Peve_00002348",-0.195494468372728,0.874737661118014,0.997476741937264,154,-23.59,"2 21","715 735",19,"63.16%","84.21%","Q2EMV9","Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14)","Mus musculus (Mouse)","innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein poly-ADP-ribosylation [GO:0070212]","GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016779; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:1902216; GO:1990404"
"2506",2692,982740,"Cluster_9149","Peve_00002344",-0.37778579074028,0.753371147653212,0.988219883885475,150,-20.79,"2 21","834 858",22,"63.64%","77.27%",NA,NA,NA,NA,NA
"2507",2693,982746,"Cluster_11134","Peve_00002344",0.801958187572174,0.407583283762054,0.978262075707395,163,-21.76,"2 21","102 124",20,"65.00%","90.00%",NA,NA,NA,NA,NA
"2508",2694,982911,"Cluster_7053","Peve_00038775",-0.769872686300932,0.44063936032239,0.978262075707395,155,-21.09,"2 21","182 199",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"2509",2696,983471,"Cluster_14999","Peve_00032196",0.47443735243041,0.685303084188443,0.978262075707395,175,-20.29,"2 20","421 442",18,"77.78%","94.44%","Q0P8I7","GDP-D-glycero-alpha-D-manno-heptose dehydrogenase (EC 1.1.98.-)","Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168)","capsule polysaccharide biosynthetic process [GO:0045227]; protein homotetramerization [GO:0051289]","GO:0003978; GO:0016491; GO:0019003; GO:0042802; GO:0045227; GO:0051289; GO:0070404"
"2510",2697,984231,"Cluster_11134","Peve_00004699",-0.0195622829453675,0.987545469442176,0.999448381576871,163,-25.85,"2 21","916 942",24,"70.83%","75.00%","P48733","Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","Bos taurus (Bovine)","antibacterial innate immune response [GO:0140367]; defense response to Gram-negative bacterium [GO:0050829]","GO:0000922; GO:0005201; GO:0005509; GO:0005576; GO:0005929; GO:0016020; GO:0016323; GO:0016324; GO:0031012; GO:0050829; GO:0060170; GO:0140367"
"2511",2698,984247,"Cluster_2854","Peve_00000186",-0.992941691939373,0.0756834995507792,0.978262075707395,168,-21,"2 21","978 999",19,"73.68%","84.21%","Q01062","cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE)","Rattus norvegicus (Rat)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; cAMP-mediated signaling [GO:0019933]; cardiac septum development [GO:0003279]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; coronary vasculature development [GO:0060976]; establishment of endothelial barrier [GO:0061028]; heart development [GO:0007507]; heart valve development [GO:0003170]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cell death [GO:0060548]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of cGMP-mediated signaling [GO:0010752]; regulation of mitochondrion organization [GO:0010821]; regulation of nitric oxide mediated signal transduction [GO:0010749]; response to hydrogen sulfide [GO:1904880]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]","GO:0000122; GO:0000287; GO:0003170; GO:0003279; GO:0003281; GO:0004114; GO:0004115; GO:0004118; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0007193; GO:0007507; GO:0008270; GO:0010628; GO:0010749; GO:0010752; GO:0010754; GO:0010821; GO:0019933; GO:0019934; GO:0030424; GO:0030425; GO:0030552; GO:0030553; GO:0030911; GO:0035904; GO:0036004; GO:0036006; GO:0042301; GO:0042734; GO:0042802; GO:0042803; GO:0043116; GO:0043117; GO:0043949; GO:0043951; GO:0045121; GO:0046069; GO:0047555; GO:0048471; GO:0050729; GO:0060548; GO:0060976; GO:0061028; GO:0071222; GO:0071260; GO:0071320; GO:0071321; GO:0071560; GO:0090324; GO:0097011; GO:0097060; GO:0097457; GO:1904613; GO:1904880"
"2512",2699,984501,"Cluster_11134","Peve_00000180",0.592321343585993,0.596423206590434,0.978262075707395,150,-23.3,"2 21","563 589",24,"62.50%","75.00%",NA,NA,NA,NA,NA
"2513",2700,984528,"Cluster_6905","Peve_00000181",-0.929945104908788,0.239708228175045,0.978262075707395,160,-20.11,"2 21","981 1000",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"2514",2701,984669,"Cluster_7855","Peve_00003561",0.998823748059417,0.0308807526265784,0.903929377050813,165,-20.1,"2 19","121 145",20,"80.00%","80.00%","O62714","Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1)","Sus scrofa (Pig)","cellular calcium ion homeostasis [GO:0006874]; detection of calcium ion [GO:0005513]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of calcium ion transport [GO:0051924]","GO:0004930; GO:0005509; GO:0005513; GO:0005886; GO:0006874; GO:0007186; GO:0016597; GO:0042803; GO:0051924"
"2515",2702,984714,"Cluster_7855","Peve_00003560",0.0452650825714128,0.971173503815397,0.999448381576871,165,-20.1,"2 19","121 145",20,"80.00%","80.00%","O62714","Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1)","Sus scrofa (Pig)","cellular calcium ion homeostasis [GO:0006874]; detection of calcium ion [GO:0005513]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of calcium ion transport [GO:0051924]","GO:0004930; GO:0005509; GO:0005513; GO:0005886; GO:0006874; GO:0007186; GO:0016597; GO:0042803; GO:0051924"
"2516",2703,985069,"Cluster_6906","Peve_00015532",-0.30764818907637,0.800916039316073,0.995934364227446,164,-20.45,"2 21","31 52",19,"68.42%","84.21%","Q9W6I0","Ubiquinol-cytochrome-c reductase complex assembly factor 1 (Basic FGF-repressed Zic-binding protein homolog) (Ubiquinol-cytochrome c reductase complex chaperone CBP3 homolog) (Zic3-binding protein)","Xenopus laevis (African clawed frog)","mitochondrial respiratory chain complex III assembly [GO:0034551]","GO:0005743; GO:0034551"
"2517",2704,985581,"Cluster_11134","Peve_00036632",-0.889351981067467,0.302311891730314,0.978262075707395,163,-21.97,"2 17","287 309",16,"81.25%","93.75%",NA,NA,NA,NA,NA
"2518",2705,985728,"Cluster_796","Peve_00001586",0.0719918644370647,0.954128873610897,0.999448381576871,153,-22.69,"2 20","899 925",23,"69.57%","73.91%","O42097","Hepatocyte nuclear factor 3-beta (HNF-3-beta) (HNF-3B) (Forkhead box protein A2) (Me-HNF3B)","Oryzias latipes (Japanese rice fish) (Japanese killifish)","anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]; system development [GO:0048731]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0009653; GO:0019904; GO:0030154; GO:0048731"
"2519",2706,985761,"Cluster_11134","Peve_00001586",-0.874496806716282,0.322383570005296,0.978262075707395,162,-20.26,"2 16","719 741",15,"86.67%","93.33%","O42097","Hepatocyte nuclear factor 3-beta (HNF-3-beta) (HNF-3B) (Forkhead box protein A2) (Me-HNF3B)","Oryzias latipes (Japanese rice fish) (Japanese killifish)","anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]; system development [GO:0048731]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0009653; GO:0019904; GO:0030154; GO:0048731"
"2520",2707,986087,"Cluster_589","Peve_00001633",-0.262919688684922,0.830629145238912,0.995934364227446,155,-21.93,"2 16","246 267",14,"71.43%","92.86%","D9IQ16","Galaxin","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"2521",2708,986119,"Cluster_10934","Peve_00001633",-0.987931183980523,0.0990068421742399,0.978262075707395,162,-23.81,"2 21","368 394",24,"75.00%","75.00%","D9IQ16","Galaxin","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"2522",2709,986575,"Cluster_14500","Peve_00009006",0.269304459567403,0.826412418391116,0.995934364227446,174,-23.92,"2 19","512 533",17,"82.35%","94.12%","Q7RTR2","NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","Homo sapiens (Human)","I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223"
"2523",2710,986575,"Cluster_14500","Peve_00009006",0.269304459567403,0.826412418391116,0.995934364227446,174,-23.92,"2 19","58 79",17,"82.35%","94.12%","Q7RTR2","NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","Homo sapiens (Human)","I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223"
"2524",2711,987447,"Cluster_4629","Peve_00034900",0.500455522693572,0.666331758692784,0.978262075707395,156,-21.67,"2 21","561 582",19,"57.89%","84.21%",NA,NA,NA,NA,NA
"2525",2712,987531,"Cluster_2787","Peve_00034905",0.748223277074272,0.461814375855689,0.978262075707395,165,-23.63,"2 21","235 254",19,"78.95%","84.21%","Q9ULL1","Pleckstrin homology domain-containing family G member 1","Homo sapiens (Human)","regulation of small GTPase mediated signal transduction [GO:0051056]","GO:0005085; GO:0005654; GO:0005829; GO:0051056"
"2526",2713,987671,"Cluster_4115","Peve_00014377",-0.264989402648826,0.829263076637826,0.995934364227446,149,-21.11,"2 21","122 148",24,"66.67%","75.00%",NA,NA,NA,NA,NA
"2527",2715,988427,"Cluster_589","Peve_00030108",0.159680919674548,0.897906931664995,0.999448381576871,155,-23.55,"2 12","630 651",10,"100.00%","100.00%",NA,NA,NA,NA,NA
"2528",2717,989471,"Cluster_4115","Peve_00024107",-0.869959270126944,0.328289924759087,0.978262075707395,173,-26.69,"2 20","540 560",18,"83.33%","94.44%",NA,NA,NA,NA,NA
"2529",2718,989733,"Cluster_796","Peve_00045236",0.808421038787446,0.400645019274627,0.978262075707395,152,-20.34,"2 19","598 622",20,"75.00%","75.00%","Q7TMK9","Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) (pp68)","Mus musculus (Mouse)","cellular response to type II interferon [GO:0071346]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; negative regulation of mRNA modification [GO:0090367]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; negative regulation of translation [GO:0017148]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA demethylation [GO:1901537]; positive regulation of translation [GO:0045727]; RNA splicing [GO:0008380]","GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006397; GO:0008143; GO:0008380; GO:0016020; GO:0016556; GO:0017148; GO:0043025; GO:0045293; GO:0045727; GO:0048027; GO:0070934; GO:0070937; GO:0071013; GO:0071204; GO:0071346; GO:0090367; GO:0097452; GO:0106002; GO:1900152; GO:1901537; GO:1990635; GO:1990904; GO:2000623; GO:2000767"
"2530",2719,989743,"Cluster_4735","Peve_00045236",-0.999310671556481,0.023639221558204,0.851916223620059,166,-20.89,"2 21","859 883",22,"77.27%","81.82%","Q7TMK9","Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) (pp68)","Mus musculus (Mouse)","cellular response to type II interferon [GO:0071346]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; negative regulation of mRNA modification [GO:0090367]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; negative regulation of translation [GO:0017148]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA demethylation [GO:1901537]; positive regulation of translation [GO:0045727]; RNA splicing [GO:0008380]","GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006397; GO:0008143; GO:0008380; GO:0016020; GO:0016556; GO:0017148; GO:0043025; GO:0045293; GO:0045727; GO:0048027; GO:0070934; GO:0070937; GO:0071013; GO:0071204; GO:0071346; GO:0090367; GO:0097452; GO:0106002; GO:1900152; GO:1901537; GO:1990635; GO:1990904; GO:2000623; GO:2000767"
"2531",2720,989778,"Cluster_796","Peve_00033452",-0.88294434928873,0.311115509476569,0.978262075707395,162,-24.61,"2 20","347 370",20,"75.00%","80.00%","Q92626","Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment]","Homo sapiens (Human)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070062; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"2532",2721,989779,"Cluster_1140","Peve_00033452",0.778916903183029,0.431538724743331,0.978262075707395,187,-23.23,"2 20","813 834",18,"94.44%","94.44%","Q92626","Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment]","Homo sapiens (Human)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070062; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"2533",2722,990106,"Cluster_6255","Peve_00021864",0.901327242988241,0.285188004912926,0.978262075707395,172,-21.21,"2 21","161 182",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"2534",2723,990657,"Cluster_8887","Peve_00007096",-0.966777537948718,0.164558674276183,0.978262075707395,153,-20.33,"2 19","59 80",18,"61.11%","88.89%","Q9D6J6","NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial (EC 7.1.1.2) (NADH-ubiquinone oxidoreductase 24 kDa subunit)","Mus musculus (Mouse)","aerobic respiration [GO:0009060]; cardiac muscle tissue development [GO:0048738]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; nervous system development [GO:0007399]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]","GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0007399; GO:0008137; GO:0009060; GO:0042776; GO:0043209; GO:0046872; GO:0048738; GO:0051537"
"2535",2724,990908,"Cluster_2882","Peve_00019554",0.494202708512986,0.670920113696109,0.978262075707395,143,-20.98,"2 21","678 706",26,"57.69%","65.38%","P35555","Fibrillin-1 [Cleaved into: Asprosin]","Homo sapiens (Human)","activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of appetite [GO:0032100]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]","GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0009653; GO:0010737; GO:0030023; GO:0031012; GO:0032100; GO:0033627; GO:0034199; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0062023; GO:0071560; GO:1990314; GO:2001205"
"2536",2725,991763,"Cluster_2882","Peve_00026499",-0.898389711968954,0.289475524970989,0.978262075707395,157,-21.21,"2 19","521 545",20,"75.00%","75.00%","Q90632","Monocarboxylate transporter 3 (MCT 3) (Retinal epithelial membrane protein) (Solute carrier family 16 member 8)","Gallus gallus (Chicken)","monocarboxylic acid transport [GO:0015718]","GO:0005886; GO:0008028; GO:0015293; GO:0015718; GO:0016020; GO:0016323"
"2537",2726,992751,"Cluster_2787","Peve_00027712",-0.51955741801335,0.652193681614155,0.978262075707395,148,-21.24,"2 21","286 305",19,"73.68%","73.68%","Q4PM47","40S ribosomal protein S29","Ixodes scapularis (Black-legged tick) (Deer tick)","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003735; GO:0005791; GO:0008270; GO:0022627; GO:0042788"
"2538",2727,992890,"Cluster_4080","Peve_00007792",-0.1915941526639,0.877268536002156,0.998126838995118,167,-20.91,"2 21","219 241",20,"70.00%","90.00%",NA,NA,NA,NA,NA
"2539",2728,993180,"Cluster_9149","Peve_00036176",-0.121615713409301,0.922384898122721,0.999448381576871,148,-22.01,"2 21","217 238",19,"57.89%","73.68%","P08582","Melanotransferrin (Melanoma-associated antigen p97) (CD antigen CD228)","Homo sapiens (Human)","iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of plasminogen activation [GO:0010756]","GO:0005506; GO:0005576; GO:0005615; GO:0005769; GO:0005788; GO:0005886; GO:0006826; GO:0009986; GO:0010756; GO:0055037; GO:0055072; GO:0070062; GO:0090091; GO:1900025"
"2540",2729,993225,"Cluster_9149","Peve_00036177",-0.89562550745119,0.293456804233891,0.978262075707395,148,-22.01,"2 21","217 238",19,"57.89%","73.68%","Q9R0R1","Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228)","Mus musculus (Mouse)","iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of plasminogen activation [GO:0010756]","GO:0005506; GO:0005615; GO:0005769; GO:0005886; GO:0006826; GO:0009986; GO:0010756; GO:0055037; GO:0055072; GO:0090091; GO:1900025"
"2541",2730,993772,"Cluster_11135","Peve_00025719",0.906800688861426,0.277034353862668,0.978262075707395,167,-21.9,"2 20","744 765",18,"77.78%","83.33%","A0A1D5NSM8",NA,NA,NA,NA
"2542",2731,994349,"Cluster_8988","Peve_00017463",0.0860148226113438,0.945173514868548,0.999448381576871,175,-22.26,"2 21","68 90",20,"80.00%","90.00%","Q6DHN0","Transmembrane protein 53","Danio rerio (Zebrafish) (Brachydanio rerio)","negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; regulation of nucleocytoplasmic transport [GO:0046822]","GO:0005640; GO:0030279; GO:0030514; GO:0031965; GO:0045668; GO:0046822"
"2543",2732,994386,"Cluster_7053","Peve_00017462",-0.589604972383979,0.598566879409498,0.978262075707395,174,-25.49,"2 20","311 333",19,"78.95%","94.74%","Q5RFI2","Ras-related protein Rab-28","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","","GO:0003924; GO:0005525; GO:0005737; GO:0005886; GO:0019003; GO:0035253; GO:0036064"
"2544",2733,995091,"Cluster_2787","Peve_00044139",-0.864104211317102,0.335771391434576,0.978262075707395,154,-20.09,"2 20","562 584",19,"73.68%","73.68%","Q04861","Nuclear factor NF-kappa-B p105 subunit (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit]","Gallus gallus (Chicken)","regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]","GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0007165; GO:0051059"
"2545",2734,995405,"Cluster_1167","Peve_00000213",0.999909726776791,0.00855416971793915,0.573710369894872,143,-21.79,"2 21","370 395",23,"60.87%","65.22%",NA,NA,NA,NA,NA
"2546",2735,995994,"Cluster_4079","Peve_00041563",-0.125755588100116,0.919728976410948,0.999448381576871,142,-20.57,"2 20","649 673",21,"57.14%","71.43%",NA,NA,NA,NA,NA
"2547",2736,996267,"Cluster_4629","Peve_00004087",0.987572382845184,0.100470798184491,0.978262075707395,151,-22.92,"2 21","135 157",20,"65.00%","75.00%","Q13114","TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (LMP1-associated protein 1) (LAP1) (RING-type E3 ubiquitin transferase TRAF3)","Homo sapiens (Human)","apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of JNK cascade [GO:0046330]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; signal transduction [GO:0007165]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; type I interferon-mediated signaling pathway [GO:0060337]","GO:0000151; GO:0001817; GO:0002224; GO:0004842; GO:0005164; GO:0005739; GO:0005768; GO:0005829; GO:0006915; GO:0007165; GO:0008063; GO:0008270; GO:0009898; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032648; GO:0033209; GO:0035631; GO:0035666; GO:0042802; GO:0042981; GO:0043122; GO:0046330; GO:0050688; GO:0051607; GO:0060337; GO:0070534; GO:1902554"
"2548",2737,997167,"Cluster_4629","Peve_00030270",0.74753454980242,0.462474867366879,0.978262075707395,168,-27.12,"2 21","360 381",19,"73.68%","84.21%","Q0V9J5","Probable RNA-binding protein EIF1AD (Eukaryotic translation initiation factor 1A domain-containing protein)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0003723; GO:0003743; GO:0005634"
"2549",2738,998659,"Cluster_6906","Peve_00038118",-0.642407126459058,0.555871689564893,0.978262075707395,166,-21.59,"2 19","977 998",17,"82.35%","82.35%",NA,NA,NA,NA,NA
"2550",2739,998822,"Cluster_589","Peve_00000846",0.160914574626549,0.897111273587349,0.999448381576871,155,-23.41,"2 12","426 447",10,"100.00%","100.00%",NA,NA,NA,NA,NA
"2551",2740,999027,"Cluster_8887","Peve_00014826",-0.821901473199095,0.385826733407904,0.978262075707395,163,-20.21,"2 20","675 695",18,"66.67%","88.89%",NA,NA,NA,NA,NA
"2552",2741,999028,"Cluster_8888","Peve_00014826",-0.219753560508399,0.858949346278634,0.995934364227446,163,-21.84,"2 20","675 695",18,"66.67%","88.89%",NA,NA,NA,NA,NA
"2553",2742,999171,"Cluster_11134","Peve_00044890",0.244801408829726,0.842554467604457,0.995934364227446,154,-20.71,"2 21","61 81",19,"63.16%","84.21%","Q3SYU7","Transportin-1 (Importin beta-2) (Karyopherin beta-2)","Bos taurus (Bovine)","protein import into nucleus [GO:0006606]","GO:0005634; GO:0005737; GO:0006606; GO:0008139; GO:0031267; GO:0061608"
"2554",2745,999892,"Cluster_11135","Peve_00035444",0.860018598157594,0.340903653832921,0.978262075707395,164,-22.82,"2 20","842 861",18,"83.33%","83.33%",NA,NA,NA,NA,NA
"2555",2746,999894,"Cluster_13502","Peve_00035444",-0.415188142762432,0.727431496816884,0.983768379871108,164,-20.55,"2 21","406 427",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"2556",2747,1000075,"Cluster_14500","Peve_00035440",-0.416779360707035,0.72631754019116,0.983452944477044,165,-20.23,"2 20","240 260",18,"77.78%","88.89%","P78357","Contactin-associated protein 1 (Caspr) (Caspr1) (Neurexin IV) (Neurexin-4) (p190)","Homo sapiens (Human)","axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128]; signal transduction [GO:0007165]","GO:0002175; GO:0005886; GO:0007005; GO:0007010; GO:0007155; GO:0007165; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030913; GO:0033010; GO:0033270; GO:0038023; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227"
"2557",2748,1000384,"Cluster_10934","Peve_00028440",-0.552312516014842,0.627491040777302,0.978262075707395,168,-27.52,"2 21","239 260",19,"73.68%","84.21%","B9FAF3","Kinesin-like protein KIN-14E","Oryza sativa subsp. japonica (Rice)","microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]","GO:0003777; GO:0005524; GO:0005874; GO:0007017; GO:0007018; GO:0008017; GO:0015630"
"2558",2749,1000452,"Cluster_4629","Peve_00028448",0.431400026241126,0.716039531328064,0.980490679985025,160,-21.7,"2 13","646 667",11,"100.00%","100.00%",NA,NA,NA,NA,NA
"2559",2750,1000830,"Cluster_9149","Peve_00006879",-0.5,0.666666666666667,0.978262075707395,154,-23.41,"2 18","769 788",16,"81.25%","81.25%",NA,NA,NA,NA,NA
"2560",2751,1001656,"Cluster_29","Peve_00002554",0.335451817489302,0.782222054806124,0.99406009966819,163,-21.53,"2 18","227 247",16,"87.50%","87.50%","P41413","Proprotein convertase subtilisin/kexin type 5 (EC 3.4.21.-) (Proprotein convertase 5) (PC5) (Proprotein convertase 6) (PC6) (Subtilisin/kexin-like protease PC5) (rPC5)","Rattus norvegicus (Rat)","anterior/posterior pattern specification [GO:0009952]; cardiac septum development [GO:0003279]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; coronary vasculature development [GO:0060976]; cytokine precursor processing [GO:0140447]; determination of left/right symmetry [GO:0007368]; embryo implantation [GO:0007566]; embryonic digestive tract development [GO:0048566]; embryonic skeletal system development [GO:0048706]; heart development [GO:0007507]; kidney development [GO:0001822]; limb morphogenesis [GO:0035108]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; positive regulation of integrin activation [GO:0033625]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of smooth muscle cell-matrix adhesion [GO:1905609]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein processing [GO:0016485]; renin secretion into blood stream [GO:0002001]; respiratory tube development [GO:0030323]; response to gonadotropin [GO:0034698]; response to luteinizing hormone [GO:0034699]; signal peptide processing [GO:0006465]; vascular associated smooth muscle cell proliferation [GO:1990874]; viral life cycle [GO:0019058]","GO:0000139; GO:0001822; GO:0002001; GO:0003279; GO:0004175; GO:0004252; GO:0005615; GO:0005794; GO:0005797; GO:0005802; GO:0005886; GO:0006465; GO:0007368; GO:0007507; GO:0007566; GO:0008233; GO:0009952; GO:0016020; GO:0016485; GO:0016486; GO:0019058; GO:0030323; GO:0033625; GO:0034698; GO:0034699; GO:0035108; GO:0036120; GO:0042277; GO:0043043; GO:0043204; GO:0048566; GO:0048706; GO:0060976; GO:0140447; GO:1904754; GO:1905609; GO:1990635; GO:1990874; GO:2001046"
"2561",2752,1002828,"Cluster_796","Peve_00038927",0.999994129428633,0.00218140105711895,0.379078774249685,164,-21.21,"2 20","939 958",18,"83.33%","83.33%","Q14832","Metabotropic glutamate receptor 3 (mGluR3)","Homo sapiens (Human)","chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; negative regulation of adenylate cyclase activity [GO:0007194]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966]","GO:0001640; GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0010467; GO:0014069; GO:0030424; GO:0042734; GO:0043197; GO:0045211; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170"
"2562",2753,1003600,"Cluster_4080","Peve_00008562",-0.723721119815755,0.484860402263066,0.978262075707395,169,-21.63,"2 20","879 899",18,"83.33%","88.89%",NA,NA,NA,NA,NA
"2563",2754,1004366,"Cluster_4115","Peve_00024602",0.240688212880193,0.845253746757828,0.995934364227446,168,-21.61,"2 21","825 846",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"2564",2755,1004609,"Cluster_8988","Peve_00044301",0.025913135396118,0.983501338842099,0.999448381576871,175,-22.63,"2 21","339 361",20,"80.00%","90.00%","Q6TCG8","Progestin and adipoQ receptor family member 3 (Progestin and adipoQ receptor family member III) (Raf kinase trapping to Golgi) (RKTG)","Mus musculus (Mouse)","negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein phosphorylation [GO:0001933]; protein localization to Golgi apparatus [GO:0034067]; protein phosphorylation [GO:0006468]","GO:0000139; GO:0001933; GO:0005794; GO:0006468; GO:0010977; GO:0033137; GO:0034067; GO:0038023; GO:0043407"
"2565",2756,1005249,"Cluster_13502","Peve_00038970",0.685790333501808,0.518913398458082,0.978262075707395,151,-20.14,"2 21","590 614",22,"63.64%","72.73%","Q4R4V2","Protein phosphatase 1G (EC 3.1.3.16)","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","protein dephosphorylation [GO:0006470]","GO:0005737; GO:0006470; GO:0016020; GO:0017018; GO:0046872"
"2566",2757,1005392,"Cluster_589","Peve_00001773",0.159680919674548,0.897906931664995,0.999448381576871,150,-22.13,"2 16","933 955",15,"73.33%","86.67%",NA,NA,NA,NA,NA
"2567",2758,1006040,"Cluster_6914","Peve_00030809",0.853558462702337,0.34887952241865,0.978262075707395,151,-20.48,"2 17","546 567",16,"75.00%","81.25%","A3RL54",NA,NA,NA,NA
"2568",2759,1006247,"Cluster_589","Peve_00030803",-0.606844068214229,0.584870481036492,0.978262075707395,159,-20.98,"2 21","216 238",20,"65.00%","85.00%","Q13356","RING-type E3 ubiquitin-protein ligase PPIL2 (EC 2.3.2.27) (CYC4) (Cyclophilin-60) (Cyclophilin-like protein Cyp-60) (Cyp60) (hCyP-60) (Probable inactive peptidyl-prolyl cis-trans isomerase-like 2) (PPIase) (Rotamase PPIL2)","Homo sapiens (Human)","protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209]","GO:0000209; GO:0000413; GO:0005634; GO:0005654; GO:0005737; GO:0005796; GO:0005886; GO:0006457; GO:0034450; GO:0061630; GO:0071013; GO:0072659"
"2569",2760,1006412,"Cluster_10060","Peve_00006461",0.0491490494065278,0.968698132435174,0.999448381576871,162,-21.19,"2 20","239 264",22,"68.18%","81.82%","Q2TAW0","Condensin-2 complex subunit G2 (Chromosome-associated protein G2) (Non-SMC condensin II complex subunit G2) (XCAP-G2)","Xenopus laevis (African clawed frog)","cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome condensation [GO:0030261]","GO:0005634; GO:0007049; GO:0030261; GO:0051301"
"2570",2761,1006458,"Cluster_10061","Peve_00006460",0.622432948644678,0.57228866930997,0.978262075707395,173,-20.35,"2 20","648 671",20,"85.00%","90.00%","P97496","SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) (SWI3-related protein) (BAF155)","Mus musculus (Mouse)","animal organ morphogenesis [GO:0009887]; chromatin remodeling [GO:0006338]; chromosome organization [GO:0051276]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell differentiation [GO:0045596]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000776; GO:0000785; GO:0001673; GO:0001741; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0008284; GO:0008286; GO:0009887; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0032435; GO:0035060; GO:0042393; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0045893; GO:0045944; GO:0047485; GO:0051276; GO:0070316; GO:0071564; GO:0071565; GO:0140288; GO:1902459; GO:2000045; GO:2000781; GO:2000819"
"2571",2762,1006593,"Cluster_10061","Peve_00006794",-0.561180259581926,0.620694889846714,0.978262075707395,175,-22.25,"2 20","660 681",18,"83.33%","88.89%",NA,NA,NA,NA,NA
"2572",2763,1007547,"Cluster_15726","Peve_00033869",-0.762018103745519,0.448417400910784,0.978262075707395,155,-22.57,"2 21","462 479",19,"73.68%","78.95%","Q5RBR8","Eukaryotic translation initiation factor 4H (eIF-4H)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","","GO:0003723; GO:0003743; GO:0048471"
"2573",2764,1008011,"Cluster_4115","Peve_00026147",-0.959506471385922,0.181787678956089,0.978262075707395,169,-24.91,"2 21","32 51",19,"78.95%","89.47%","Q5R570","ORM1-like protein 3","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","ceramide metabolic process [GO:0006672]; regulation of ceramide biosynthetic process [GO:2000303]","GO:0005783; GO:0005789; GO:0006672; GO:0035339; GO:2000303"
"2574",2765,1008071,"Cluster_8884","Peve_00026145",0.997253647308052,0.047192471195222,0.941791888778827,158,-20.56,"2 20","712 734",20,"65.00%","85.00%",NA,NA,NA,NA,NA
"2575",2766,1008072,"Cluster_8887","Peve_00026145",0.979007211833875,0.130675111078343,0.978262075707395,158,-20.19,"2 20","712 734",20,"65.00%","85.00%",NA,NA,NA,NA,NA
"2576",2767,1008073,"Cluster_8888","Peve_00026145",0.58294867120736,0.603797723949071,0.978262075707395,158,-21.82,"2 20","712 734",20,"65.00%","85.00%",NA,NA,NA,NA,NA
"2577",2768,1008340,"Cluster_8634","Peve_00026149",0.985940856217488,0.106877107345272,0.978262075707395,177,-22.69,"2 20","164 184",18,"88.89%","94.44%",NA,NA,NA,NA,NA
"2578",2769,1009977,"Cluster_15726","Peve_00033973",-0.602041293011923,0.588708502158014,0.978262075707395,165,-21.46,"2 21","364 388",22,"81.82%","81.82%",NA,NA,NA,NA,NA
"2579",2770,1010075,"Cluster_1167","Peve_00039520",0.952666087889224,0.196657020528373,0.978262075707395,155,-21.15,"2 20","158 176",18,"77.78%","77.78%","P50429","Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)","Mus musculus (Mouse)","anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; chondroitin sulfate catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; dermatan sulfate catabolic process [GO:0030209]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]","GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030207; GO:0030209; GO:0043627; GO:0043890; GO:0046872; GO:0051597; GO:0061580; GO:0097065"
"2580",2772,1011800,"Cluster_6914","Peve_00014394",-0.403542540954352,0.735557472732638,0.986002072796199,163,-21.51,"2 20","698 718",18,"72.22%","83.33%","Q86SS6","Synaptotagmin-9 (Synaptotagmin IX) (SytIX)","Homo sapiens (Human)","calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of insulin secretion [GO:0050796]; vesicle-mediated transport [GO:0016192]","GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030667; GO:0030669; GO:0030672; GO:0031045; GO:0042802; GO:0045956; GO:0050796; GO:0070382; GO:0071277; GO:0098686; GO:0099502"
"2581",2773,1012068,"Cluster_6905","Peve_00041242",-0.798057830568379,0.411721810888039,0.978262075707395,148,-23.55,"2 18","825 847",17,"70.59%","76.47%","Q9DB41","Mitochondrial glutamate carrier 2 (GC-2) (Glutamate/H(+) symporter 2) (Solute carrier family 25 member 18)","Mus musculus (Mouse)","aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]","GO:0005280; GO:0005313; GO:0005743; GO:0015183; GO:0015810; GO:0015813; GO:0022857; GO:0043490"
"2582",2774,1012190,"Cluster_1167","Peve_00041247",0.597284501936973,0.59249265578759,0.978262075707395,148,-27.17,"2 21","108 128",20,"70.00%","75.00%",NA,NA,NA,NA,NA
"2583",2775,1012693,"Cluster_4735","Peve_00042916",0.999824590062268,0.011924181187447,0.672885963152335,173,-22.62,"2 18","311 332",16,"87.50%","93.75%","Q9DBL7","Bifunctional coenzyme A synthase (CoA synthase) [Includes: Phosphopantetheine adenylyltransferase (EC 2.7.7.3) (Dephospho-CoA pyrophosphorylase) (Pantetheine-phosphate adenylyltransferase) (PPAT); Dephospho-CoA kinase (DPCK) (EC 2.7.1.24) (Dephosphocoenzyme A kinase) (DPCOAK)]","Mus musculus (Mouse)","coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]","GO:0004140; GO:0004595; GO:0005524; GO:0005759; GO:0015937; GO:0016310"
"2584",2776,1012732,"Cluster_2854","Peve_00042915",-0.852955432581214,0.349615683331301,0.978262075707395,161,-22.23,"2 20","800 823",20,"80.00%","80.00%","Q5ZMA6","Glutamine-dependent NAD(+) synthetase (EC 6.3.5.1) (NAD(+) synthase [glutamine-hydrolyzing]) (NAD(+) synthetase)","Gallus gallus (Chicken)","'de novo' NAD biosynthetic process [GO:0034627]; NAD biosynthetic process [GO:0009435]","GO:0003952; GO:0004359; GO:0005524; GO:0005737; GO:0009435; GO:0034627"
"2585",2777,1014426,"Cluster_11134","Peve_00034471",-0.0716319571777775,0.954358590775284,0.999448381576871,159,-20.83,"2 21","662 688",24,"66.67%","75.00%","P79110","Tricarboxylate transport protein, mitochondrial (Citrate transport protein) (CTP) (Solute carrier family 25 member 1) (Tricarboxylate carrier protein)","Bos taurus (Bovine)","mitochondrial citrate transmembrane transport [GO:0006843]","GO:0005739; GO:0005743; GO:0006843; GO:0015297; GO:0071913"
"2586",2778,1015500,"Cluster_9149","Peve_00002951",-0.904855182222742,0.279957937793146,0.978262075707395,167,-27.05,"2 20","681 702",18,"77.78%","83.33%","Q9H720","PGAP2-interacting protein (Cell wall biogenesis protein 43 C-terminal homolog)","Homo sapiens (Human)","GPI anchor biosynthetic process [GO:0006506]","GO:0005783; GO:0006506; GO:0016020"
"2587",2779,1015859,"Cluster_8988","Peve_00043791",-0.125589055174954,0.919835841813668,0.999448381576871,160,-21.05,"2 21","445 466",19,"63.16%","84.21%",NA,NA,NA,NA,NA
"2588",2780,1016107,"Cluster_2854","Peve_00019206",-0.216566546463356,0.861028340189602,0.996400654148624,165,-21.15,"2 18","499 520",16,"75.00%","93.75%",NA,NA,NA,NA,NA
"2589",2781,1016946,"Cluster_11134","Peve_00001366",0.645197959929445,0.55354978392455,0.978262075707395,158,-23.43,"2 20","71 96",22,"68.18%","77.27%","P37193","Adrenodoxin-like protein 1, mitochondrial (Ferredoxin-1)","Drosophila melanogaster (Fruit fly)","electron transport chain [GO:0022900]; P450-containing electron transport chain [GO:0140647]; positive regulation of ecdysteroid biosynthetic process [GO:0045998]; positive regulation of oxidoreductase activity [GO:0051353]; steroid biosynthetic process [GO:0006694]","GO:0005739; GO:0005759; GO:0006694; GO:0009055; GO:0022900; GO:0045998; GO:0046872; GO:0051353; GO:0051537; GO:0140647"
"2590",2782,1017905,"Cluster_1167","Peve_00029281",0.970600655730398,0.154751091980289,0.978262075707395,156,-22.04,"2 18","727 749",17,"76.47%","82.35%","Q9H3E2","Sorting nexin-25","Homo sapiens (Human)","negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801]","GO:0005768; GO:0010008; GO:0015031; GO:0030512; GO:0032801; GO:0035091; GO:0043231; GO:0060394"
"2591",2783,1018065,"Cluster_9149","Peve_00035762",-0.76728809532661,0.44321130154854,0.978262075707395,164,-28.29,"2 21","415 436",19,"73.68%","78.95%","P50430","Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)","Rattus norvegicus (Rat)","anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; dermatan sulfate catabolic process [GO:0030209]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]","GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030209; GO:0043627; GO:0043890; GO:0046872; GO:0051597; GO:0061580; GO:0097065"
"2592",2784,1018110,"Cluster_9149","Peve_00035763",-0.5,0.666666666666667,0.978262075707395,164,-28.29,"2 21","188 209",19,"73.68%","78.95%","Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"2593",2785,1018582,"Cluster_2854","Peve_00001984",-0.807742438045016,0.401378396522767,0.978262075707395,167,-23.99,"2 21","279 301",20,"70.00%","90.00%","P0DTE5","UDP-glucuronosyltransferase 2A2 (UDPGT 2A2) (EC 2.4.1.17)","Homo sapiens (Human)","bile acid metabolic process [GO:0008206]; cellular glucuronidation [GO:0052695]","GO:0005789; GO:0008206; GO:0015020; GO:0052695"
"2594",2786,1019042,"Cluster_6904","Peve_00002033",-0.997924541017077,0.0410229927440064,0.909359886114279,164,-24.82,"2 21","320 341",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"2595",2787,1019044,"Cluster_6906","Peve_00002033",-0.844140619863306,0.360222477960914,0.978262075707395,160,-22.46,"2 21","320 341",19,"63.16%","84.21%",NA,NA,NA,NA,NA
"2596",2788,1019173,"Cluster_4735","Peve_00007202",0.732830422318799,0.476397709451312,0.978262075707395,158,-20.41,"2 17","840 860",15,"86.67%","86.67%",NA,NA,NA,NA,NA
"2597",2789,1019955,"Cluster_9149","Peve_00032933",0.950528845267819,0.201084237679873,0.978262075707395,147,-20.05,"2 12","271 292",10,"90.00%","90.00%","Q92626","Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment]","Homo sapiens (Human)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070062; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"2598",2790,1020316,"Cluster_9983","Peve_00002187",0.740205602628361,0.469456303285039,0.978262075707395,145,-20.08,"2 19","466 488",19,"63.16%","73.68%",NA,NA,NA,NA,NA
"2599",2791,1020423,"Cluster_796","Peve_00033332",-0.720647874098624,0.487688932704904,0.978262075707395,162,-21.48,"2 15","230 251",13,"92.31%","92.31%","O95831","Apoptosis-inducing factor 1, mitochondrial (EC 1.6.99.-) (Programmed cell death protein 8)","Homo sapiens (Human)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitric oxide [GO:0071732]; cellular response to oxygen-glucose deprivation [GO:0090650]; chromosome condensation [GO:0030261]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mitochondrial respiratory chain complex assembly [GO:0033108]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of necroptotic process [GO:0060545]; positive regulation of neuron apoptotic process [GO:0043525]; programmed cell death [GO:0012501]; protein import into mitochondrial intermembrane space [GO:0045041]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to ischemia [GO:0002931]; response to L-glutamate [GO:1902065]; response to toxic substance [GO:0009636]","GO:0002931; GO:0003677; GO:0003954; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005829; GO:0006915; GO:0006919; GO:0009636; GO:0012501; GO:0016174; GO:0016651; GO:0030182; GO:0030261; GO:0032981; GO:0033108; GO:0043065; GO:0043525; GO:0045041; GO:0046983; GO:0048471; GO:0051402; GO:0060545; GO:0070059; GO:0070301; GO:0071392; GO:0071732; GO:0071949; GO:0072572; GO:0090650; GO:1902065; GO:1902510; GO:1904045"
"2600",2792,1020450,"Cluster_9149","Peve_00033332",0.209874943750482,0.865388625197554,0.996660710141104,151,-22.68,"2 21","383 400",19,"73.68%","73.68%","O95831","Apoptosis-inducing factor 1, mitochondrial (EC 1.6.99.-) (Programmed cell death protein 8)","Homo sapiens (Human)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitric oxide [GO:0071732]; cellular response to oxygen-glucose deprivation [GO:0090650]; chromosome condensation [GO:0030261]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mitochondrial respiratory chain complex assembly [GO:0033108]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of necroptotic process [GO:0060545]; positive regulation of neuron apoptotic process [GO:0043525]; programmed cell death [GO:0012501]; protein import into mitochondrial intermembrane space [GO:0045041]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to ischemia [GO:0002931]; response to L-glutamate [GO:1902065]; response to toxic substance [GO:0009636]","GO:0002931; GO:0003677; GO:0003954; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005829; GO:0006915; GO:0006919; GO:0009636; GO:0012501; GO:0016174; GO:0016651; GO:0030182; GO:0030261; GO:0032981; GO:0033108; GO:0043065; GO:0043525; GO:0045041; GO:0046983; GO:0048471; GO:0051402; GO:0060545; GO:0070059; GO:0070301; GO:0071392; GO:0071732; GO:0071949; GO:0072572; GO:0090650; GO:1902065; GO:1902510; GO:1904045"
"2601",2793,1020842,"Cluster_6904","Peve_00032684",-0.601084130519322,0.589471307811124,0.978262075707395,155,-20.94,"2 18","193 213",16,"81.25%","81.25%","Q3U1C6","Putative deoxyribonuclease TATDN3 (EC 3.1.21.-)","Mus musculus (Mouse)","","GO:0004518; GO:0005634; GO:0005739; GO:0046872"
"2602",2794,1020917,"Cluster_589","Peve_00032686",-0.934753615028442,0.231240264998328,0.978262075707395,162,-25.97,"2 16","191 213",15,"86.67%","93.33%",NA,NA,NA,NA,NA
"2603",2795,1022385,"Cluster_9149","Peve_00015053",-0.5,0.666666666666667,0.978262075707395,150,-20.15,"2 15","557 578",13,"76.92%","84.62%",NA,NA,NA,NA,NA
"2604",2796,1022434,"Cluster_10934","Peve_00019364",0.998758250045998,0.0317290557481573,0.903929377050813,162,-21.28,"2 20","488 511",20,"75.00%","80.00%",NA,NA,NA,NA,NA
"2605",2797,1022805,"Cluster_16738","Peve_00007658",-0.770108032096346,0.440404544093171,0.978262075707395,166,-22.23,"2 21","718 738",19,"78.95%","84.21%","B2IF94","30S ribosomal protein S11","Beijerinckia indica subsp. indica (strain ATCC 9039 / DSM 1715 / NCIMB 8712)","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412; GO:0019843; GO:1990904"
"2606",2798,1023846,"Cluster_2787","Peve_00004722",0.98990205519205,0.0905477686169604,0.978262075707395,156,-24.84,"2 18","169 192",18,"72.22%","83.33%","Q6UXZ4","Netrin receptor UNC5D (Protein unc-5 homolog 4) (Protein unc-5 homolog D)","Homo sapiens (Human)","apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; pyramidal neuron differentiation [GO:0021859]; regulation of neuron migration [GO:2001222]","GO:0005042; GO:0005886; GO:0006915; GO:0007411; GO:0009986; GO:0021859; GO:0098742; GO:2001222"
"2607",2799,1024061,"Cluster_14999","Peve_00004726",0.87340991852095,0.32380727805984,0.978262075707395,147,-20.17,"2 21","720 745",23,"56.52%","73.91%","Q8WV92","MIT domain-containing protein 1","Homo sapiens (Human)","midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; negative regulation of protein binding [GO:0032091]","GO:0000281; GO:0019898; GO:0019904; GO:0030496; GO:0031902; GO:0032091; GO:0035091; GO:0042802; GO:0043231; GO:0061952; GO:0070062"
"2608",2800,1024303,"Cluster_4735","Peve_00004728",0.0916138408411661,0.941594922467234,0.999448381576871,160,-20.66,"2 21","710 730",20,"80.00%","80.00%",NA,NA,NA,NA,NA
"2609",2801,1024635,"Cluster_9149","Peve_00000614",-0.5,0.666666666666667,0.978262075707395,151,-20.05,"2 20","528 547",18,"77.78%","77.78%","Q6ZHE5","Putative D-cysteine desulfhydrase 1, mitochondrial (EC 4.4.1.15) (OsD-CDes1) (D-CDes1)","Oryza sativa subsp. japonica (Rice)","","GO:0005739; GO:0019148"
"2610",2802,1024766,"Cluster_8884","Peve_00031653",-0.696478136864263,0.509498633842755,0.978262075707395,169,-20.42,"2 20","672 691",18,"83.33%","88.89%","Q5F364","Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)","Gallus gallus (Chicken)","glutathione transmembrane transport [GO:0034775]; lipid transport [GO:0006869]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]","GO:0005524; GO:0006869; GO:0008559; GO:0016020; GO:0016323; GO:0016887; GO:0034634; GO:0034775; GO:0042626; GO:0042908; GO:0055085"
"2611",2803,1024767,"Cluster_8887","Peve_00031653",-0.867359275147596,0.33163105156919,0.978262075707395,169,-20.42,"2 20","672 691",18,"83.33%","88.89%","Q5F364","Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)","Gallus gallus (Chicken)","glutathione transmembrane transport [GO:0034775]; lipid transport [GO:0006869]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]","GO:0005524; GO:0006869; GO:0008559; GO:0016020; GO:0016323; GO:0016887; GO:0034634; GO:0034775; GO:0042626; GO:0042908; GO:0055085"
"2612",2804,1025247,"Cluster_4629","Peve_00035335",-0.554554668634826,0.625777256211528,0.978262075707395,162,-28.71,"2 20","215 238",20,"70.00%","85.00%",NA,NA,NA,NA,NA
"2613",2805,1025918,"Cluster_2882","Peve_00020646",0.817074707277304,0.391188624390771,0.978262075707395,165,-23.91,"2 14","282 303",12,"100.00%","100.00%",NA,NA,NA,NA,NA
"2614",2808,1026784,"Cluster_6906","Peve_00021511",-0.995420541588835,0.0609492064994862,0.978262075707395,158,-21.29,"2 21","343 367",22,"72.73%","77.27%",NA,NA,NA,NA,NA
"2615",2809,1027005,"Cluster_5882","Peve_00027917",0.969295672413953,0.15816575240095,0.978262075707395,160,-20.16,"2 21","364 385",19,"57.89%","89.47%","P61210","ADP-ribosylation factor 1 (EC 3.6.5.2) (lARF1)","Locusta migratoria (Migratory locust)","establishment of localization in cell [GO:0051649]; protein transport [GO:0015031]; system development [GO:0048731]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0003924; GO:0005525; GO:0015031; GO:0016192; GO:0048731; GO:0051649"
"2616",2810,1027085,"Cluster_1167","Peve_00027915",0.750175226897167,0.459938234841611,0.978262075707395,156,-21.4,"2 21","36 57",19,"68.42%","73.68%","Q61LA8","ADP-ribosylation factor 1-like 2 (EC 3.6.5.2) (ADP-ribosylation factor-related protein 1.2)","Caenorhabditis briggsae","embryo development ending in birth or egg hatching [GO:0009792]; intracellular protein transport [GO:0006886]; mitochondrion organization [GO:0007005]; oocyte development [GO:0048599]; regulation of apoptotic process involved in development [GO:1904748]; regulation of receptor-mediated endocytosis [GO:0048259]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0003924; GO:0005525; GO:0005737; GO:0005783; GO:0005886; GO:0006886; GO:0007005; GO:0009792; GO:0016192; GO:0048259; GO:0048599; GO:1904748"
"2617",2811,1027206,"Cluster_11134","Peve_00027913",0.050815540700495,0.967635883301984,0.999448381576871,151,-22.33,"2 21","755 773",19,"68.42%","84.21%","Q8IN35","Neuropeptide SIFamide receptor","Drosophila melanogaster (Fruit fly)","determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]","GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016020; GO:0042277; GO:0048047"
"2618",2812,1027510,"Cluster_8634","Peve_00040200",0.848406009530525,0.355125342806138,0.978262075707395,177,-24.15,"2 20","160 180",18,"88.89%","94.44%",NA,NA,NA,NA,NA
"2619",2813,1027536,"Cluster_2787","Peve_00007569",0.876289213907536,0.320023080096134,0.978262075707395,158,-22.37,"2 21","126 146",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"2620",2814,1028130,"Cluster_5882","Peve_00027003",0.697457323899407,0.508629343858705,0.978262075707395,158,-20.99,"2 20","424 446",19,"68.42%","84.21%","Q5DU56","Protein NLRC3","Mus musculus (Mouse)","I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; regulation of protein ubiquitination [GO:0031396]; response to lipopolysaccharide [GO:0032496]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0031396; GO:0032088; GO:0032496; GO:0032687; GO:0032688; GO:0032691; GO:0032695; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223"
"2621",2815,1028454,"Cluster_7855","Peve_00013243",-0.268316022947477,0.827065722794966,0.995934364227446,170,-22.02,"2 21","688 708",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"2622",2816,1028852,"Cluster_6904","Peve_00010574",-0.492637163231668,0.672065971830569,0.978262075707395,154,-21.67,"2 21","787 807",19,"73.68%","73.68%","Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"2623",2817,1028853,"Cluster_6905","Peve_00010574",-0.546614267928475,0.631832819715199,0.978262075707395,143,-21.15,"2 17","11 33",16,"62.50%","81.25%","Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"2624",2818,1028854,"Cluster_6906","Peve_00010574",-0.850278892243313,0.352866486613662,0.978262075707395,154,-21.67,"2 21","787 807",19,"73.68%","73.68%","Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"2625",2819,1030134,"Cluster_13502","Peve_00029972",0.76692706628941,0.44356957375252,0.978262075707395,156,-21.17,"2 18","358 380",17,"70.59%","88.24%",NA,NA,NA,NA,NA
"2626",2820,1030465,"Cluster_4080","Peve_00006510",-0.232457991936053,0.850646363057685,0.995934364227446,157,-20.22,"2 21","292 313",20,"75.00%","80.00%","Q49LS8","XK-related protein 6","Tetraodon nigroviridis (Spotted green pufferfish) (Chelonodon nigroviridis)","","GO:0005886"
"2627",2821,1030755,"Cluster_9149","Peve_00020364",1,0,0,148,-20.73,"2 14","333 355",13,"76.92%","92.31%","Q0IH72","Nuclease EXOG, mitochondrial (EC 3.1.30.-) (Endonuclease G-like 1) (Endo G-like 1)","Xenopus laevis (African clawed frog)","","GO:0003676; GO:0004519; GO:0005743; GO:0046872"
"2628",2822,1031245,"Cluster_8634","Peve_00044555",0.956227319072805,0.189057429551567,0.978262075707395,157,-21.18,"2 18","103 124",16,"68.75%","87.50%",NA,NA,NA,NA,NA
"2629",2823,1032245,"Cluster_10965","Peve_00001503",-0.769569037816927,0.440942171274941,0.978262075707395,173,-20.6,"2 18","218 239",16,"87.50%","93.75%",NA,NA,NA,NA,NA
"2630",2824,1033305,"Cluster_5882","Peve_00045207",0.656820186055015,0.543802104222494,0.978262075707395,170,-22.06,"2 21","930 950",19,"84.21%","84.21%","Q6DGW9","Calcium load-activated calcium channel (CLAC channel) (GEL complex subunit TMCO1) (Transmembrane and coiled-coil domain-containing protein 1)","Danio rerio (Zebrafish) (Brachydanio rerio)","calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983]","GO:0000139; GO:0005262; GO:0005737; GO:0005783; GO:0005789; GO:0006874; GO:0006983; GO:0032469; GO:0043022; GO:0070588"
"2631",2825,1033365,"Cluster_9149","Peve_00014661",-0.946427677322497,0.209326173498252,0.978262075707395,160,-22.05,"2 20","579 598",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"2632",2826,1033459,"Cluster_10934","Peve_00045208",-0.0662071353055353,0.957820375314635,0.999448381576871,162,-24.02,"2 21","733 753",19,"78.95%","78.95%","Q5ZJV4","Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein)","Gallus gallus (Chicken)","cell division [GO:0051301]; DNA-templated DNA replication [GO:0006261]; sister chromatid cohesion [GO:0007062]","GO:0003682; GO:0005634; GO:0006261; GO:0007062; GO:0051301"
"2633",2827,1033821,"Cluster_11134","Peve_00009730",0.0761716570112392,0.951460601077401,0.999448381576871,148,-21.26,"2 16","3 24",15,"80.00%","86.67%","Q5ZL33","Serine-threonine kinase receptor-associated protein","Gallus gallus (Chicken)","alternative mRNA splicing, via spliceosome [GO:0000380]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron differentiation [GO:0030182]; spliceosomal snRNP assembly [GO:0000387]","GO:0000122; GO:0000380; GO:0000387; GO:0003729; GO:0004857; GO:0005102; GO:0005634; GO:0005829; GO:0030182; GO:0030277; GO:0030512; GO:0032797; GO:0034719; GO:0140416; GO:1990447"
"2634",2828,1033912,"Cluster_11135","Peve_00009739",0.89649825490251,0.292205231891891,0.978262075707395,166,-20.05,"2 21","798 821",21,"76.19%","85.71%",NA,NA,NA,NA,NA
"2635",2829,1034091,"Cluster_11134","Peve_00002858",0.990571538184786,0.0874897877327833,0.978262075707395,154,-23.07,"2 21","554 577",21,"66.67%","80.95%",NA,NA,NA,NA,NA
"2636",2830,1034811,"Cluster_11134","Peve_00036854",0.875640822838247,0.320878802775509,0.978262075707395,151,-21.35,"2 21","511 535",22,"59.09%","77.27%","O75897","Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1) (Sulfotransferase 1C2) (SULT1C#2)","Homo sapiens (Human)","3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; doxorubicin metabolic process [GO:0044598]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805]","GO:0004062; GO:0005737; GO:0005829; GO:0006068; GO:0006805; GO:0008146; GO:0009812; GO:0044598; GO:0050427; GO:0051923"
"2637",2831,1035507,"Cluster_4629","Peve_00014081",-0.0883289875350388,0.943694641732619,0.999448381576871,161,-21.04,"2 20","49 69",18,"77.78%","83.33%","Q7ZUX6","Deoxyhypusine hydroxylase (DOHH) (EC 1.14.99.29) (Deoxyhypusine dioxygenase) (Deoxyhypusine monooxygenase)","Danio rerio (Zebrafish) (Brachydanio rerio)","peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]","GO:0005506; GO:0008612; GO:0016491; GO:0019135"
"2638",2832,1035770,"Cluster_1167","Peve_00034570",-0.778743197056642,0.431715029884993,0.978262075707395,151,-22.1,"2 13","575 597",12,"91.67%","91.67%","Q59H18","Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (Cardiac ankyrin repeat kinase) (Cardiac troponin I-interacting kinase) (TNNI3-interacting kinase)","Homo sapiens (Human)","bundle of His cell to Purkinje myocyte communication [GO:0086069]; protein phosphorylation [GO:0006468]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]; regulation of postsynapse organization [GO:0099175]","GO:0002027; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0008022; GO:0031013; GO:0046872; GO:0055117; GO:0086069; GO:0098978; GO:0099175; GO:0106310; GO:1903779"
"2639",2835,1036317,"Cluster_4629","Peve_00031853",-0.443383362280846,0.707556077121805,0.978262075707395,151,-22.04,"2 20","44 65",18,"55.56%","83.33%",NA,NA,NA,NA,NA
"2640",2836,1036408,"Cluster_4735","Peve_00031858",-0.577821855796711,0.607805678264871,0.978262075707395,151,-20.87,"2 14","538 558",12,"91.67%","91.67%",NA,NA,NA,NA,NA
"2641",2837,1036705,"Cluster_14500","Peve_00001083",-0.30323093845746,0.803869282884913,0.995934364227446,163,-20.34,"2 18","893 916",18,"83.33%","88.89%","Q9Y2K7","Lysine-specific demethylase 2A (EC 1.14.11.27) (CXXC-type zinc finger protein 8) (F-box and leucine-rich repeat protein 11) (F-box protein FBL7) (F-box protein Lilina) (F-box/LRR-repeat protein 11) (JmjC domain-containing histone demethylation protein 1A) ([Histone-H3]-lysine-36 demethylase 1A)","Homo sapiens (Human)","chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone H3-K36 demethylation [GO:0070544]; negative regulation of transcription by competitive promoter binding [GO:0010944]; protein demethylation [GO:0006482]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0003712; GO:0005654; GO:0005694; GO:0006303; GO:0006325; GO:0006357; GO:0006482; GO:0008270; GO:0010944; GO:0032452; GO:0032922; GO:0042752; GO:0045322; GO:0051864; GO:0070544; GO:0140680"
"2642",2838,1037601,"Cluster_11134","Peve_00029368",0.0980501920907844,0.937478856750349,0.999448381576871,160,-20.11,"2 18","872 894",17,"82.35%","82.35%",NA,NA,NA,NA,NA
"2643",2839,1037615,"Cluster_1167","Peve_00029363",0.630219533865033,0.565929764398688,0.978262075707395,153,-23.4,"2 21","17 36",19,"68.42%","78.95%","Q7ZUG0","Small nuclear ribonucleoprotein E (snRNP-E) (Sm protein E) (Sm-E) (SmE)","Danio rerio (Zebrafish) (Brachydanio rerio)","mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]","GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005829; GO:0034709; GO:0034715; GO:0034719; GO:0046540; GO:0071005; GO:0071007; GO:0071011"
"2644",2840,1037689,"Cluster_10934","Peve_00029362",0.810644702211671,0.398233683665601,0.978262075707395,163,-23.3,"2 21","461 483",20,"75.00%","80.00%",NA,NA,NA,NA,NA
"2645",2841,1037689,"Cluster_10934","Peve_00029362",0.810644702211671,0.398233683665601,0.978262075707395,171,-27.75,"2 21","359 381",20,"80.00%","85.00%",NA,NA,NA,NA,NA
"2646",2842,1037725,"Cluster_8634","Peve_00029361",0.652952438201255,0.547060281002961,0.978262075707395,165,-22.16,"2 18","119 140",16,"81.25%","87.50%","P56597","Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)","Homo sapiens (Human)","cilium assembly [GO:0060271]; cilium movement [GO:0003341]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]","GO:0003341; GO:0003351; GO:0004550; GO:0005576; GO:0005929; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0051649; GO:0060271; GO:1902176"
"2647",2843,1037865,"Cluster_9149","Peve_00029366",-0.358790204995241,0.766378700563255,0.989988902482261,146,-21.08,"2 11","511 532",9,"88.89%","100.00%","Q9D864","Actin-related protein 6 (mArp6)","Mus musculus (Mouse)","negative regulation of transcription by RNA polymerase I [GO:0016479]; nucleolus organization [GO:0007000]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of DNA-templated transcription [GO:0006355]","GO:0000786; GO:0000812; GO:0005634; GO:0005730; GO:0005737; GO:0005856; GO:0006355; GO:0007000; GO:0016479; GO:0031491; GO:0045943"
"2648",2844,1038431,"Cluster_4115","Peve_00040261",0.312447215804995,0.797702520756969,0.995934364227446,156,-20.25,"2 20","727 748",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"2649",2845,1038440,"Cluster_6914","Peve_00040261",-0.145542815417232,0.907014292401613,0.999448381576871,183,-24.38,"2 20","541 561",18,"88.89%","94.44%",NA,NA,NA,NA,NA
"2650",2846,1038476,"Cluster_4115","Peve_00040260",0.146754686511502,0.906234417440672,0.999448381576871,156,-20.25,"2 20","727 748",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"2651",2847,1038485,"Cluster_6914","Peve_00040260",0.0244174697248888,0.984453810914684,0.999448381576871,183,-24.38,"2 20","541 561",18,"88.89%","94.44%",NA,NA,NA,NA,NA
"2652",2848,1038837,"Cluster_4629","Peve_00038533",0.205878531233604,0.867989641558981,0.997026753038255,171,-26.77,"2 21","38 61",21,"76.19%","85.71%","Q8TE57","A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-)","Homo sapiens (Human)","branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073]","GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0031012; GO:0046872; GO:0048232; GO:1902017"
"2653",2849,1039055,"Cluster_1167","Peve_00006941",0.999909726776791,0.00855416971793915,0.573710369894872,153,-20.61,"2 21","29 48",19,"63.16%","84.21%",NA,NA,NA,NA,NA
"2654",2850,1039278,"Cluster_796","Peve_00032762",0.655773560890289,0.544685205630072,0.978262075707395,150,-21.72,"2 17","670 694",18,"77.78%","77.78%",NA,NA,NA,NA,NA
"2655",2851,1039452,"Cluster_15726","Peve_00002068",-0.390321225152807,0.744727906197477,0.987243983169561,168,-21.72,"2 18","718 740",17,"88.24%","88.24%","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"2656",2852,1040751,"Cluster_11134","Peve_00024912",-0.638651684568222,0.558984974074488,0.978262075707395,159,-22.42,"2 21","548 572",22,"68.18%","77.27%",NA,NA,NA,NA,NA
"2657",2853,1041083,"Cluster_2882","Peve_00012399",-0.713564133961506,0.49415946682836,0.978262075707395,158,-20.89,"2 15","950 971",13,"84.62%","92.31%",NA,NA,NA,NA,NA
"2658",2854,1041429,"Cluster_13502","Peve_00027797",-0.2511347040922,0.838392574654626,0.995934364227446,172,-21.11,"2 21","924 945",19,"78.95%","84.21%","Q07076","Annexin A7 (Annexin VII) (Annexin-7) (Synexin)","Mus musculus (Mouse)","autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; establishment of localization in cell [GO:0051649]; glial cell proliferation [GO:0014009]; hemostasis [GO:0007599]; insulin secretion [GO:0030073]; ion channel modulating, G protein-coupled receptor signaling pathway [GO:0099105]; ligand-gated ion channel signaling pathway [GO:1990806]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; positive regulation of insulin secretion [GO:0032024]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]","GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007207; GO:0007599; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014009; GO:0014070; GO:0030073; GO:0031982; GO:0032024; GO:0042584; GO:0045202; GO:0048306; GO:0051592; GO:0051649; GO:0061025; GO:0062023; GO:0099105; GO:1990806"
"2659",2855,1041617,"Cluster_589","Peve_00014913",-0.944712403116236,0.212681883919165,0.978262075707395,151,-22.09,"2 20","589 610",18,"66.67%","72.22%","Q0V8L6","Phospholipase D2 (PLD 2) (EC 3.1.4.4) (Choline phosphatase 2) (Phosphatidylcholine-hydrolyzing phospholipase D2)","Bos taurus (Bovine)","inositol lipid-mediated signaling [GO:0048017]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid catabolic process [GO:0009395]; regulation of vesicle-mediated transport [GO:0060627]","GO:0004630; GO:0005737; GO:0005886; GO:0006654; GO:0009395; GO:0035091; GO:0043231; GO:0048017; GO:0060627; GO:0070290"
"2660",2856,1042035,"Cluster_5882","Peve_00024262",0.22872894826713,0.853086098108901,0.995934364227446,175,-21.53,"2 20","739 760",18,"83.33%","88.89%","Q32P51","Heterogeneous nuclear ribonucleoprotein A1-like 2 (hnRNP A1-like 2) (hnRNP core protein A1-like 2)","Homo sapiens (Human)","mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]","GO:0000398; GO:0003730; GO:0005737; GO:0051028; GO:0071013"
"2661",2857,1042410,"Cluster_9149","Peve_00031440",-0.5,0.666666666666667,0.978262075707395,152,-21.89,"2 21","704 722",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"2662",2858,1042596,"Cluster_11134","Peve_00031444",0.999598010096097,0.0180516640819476,0.782669382293497,147,-25.38,"2 21","93 117",22,"63.64%","68.18%","Q99JY0","Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.155) (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)]","Mus musculus (Mouse)","cellular response to lipopolysaccharide [GO:0071222]; fatty acid beta-oxidation [GO:0006635]; gene expression [GO:0010467]","GO:0003985; GO:0003988; GO:0005739; GO:0005741; GO:0005743; GO:0005783; GO:0006635; GO:0010467; GO:0016507; GO:0042645; GO:0044877; GO:0050633; GO:0071222; GO:0106222"
"2663",2859,1042951,"Cluster_9983","Peve_00012131",0.36573066104208,0.761638269485976,0.988674566924608,160,-20.1,"2 20","598 616",18,"77.78%","83.33%","P18031","Tyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1B) (PTP-1B)","Homo sapiens (Human)","actin cytoskeleton reorganization [GO:0031532]; cellular response to unfolded protein [GO:0034620]; endoplasmic reticulum unfolded protein response [GO:0030968]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; insulin receptor recycling [GO:0038020]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of signal transduction [GO:0009968]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor catabolic process [GO:2000646]; protein dephosphorylation [GO:0006470]; regulation of endocytosis [GO:0030100]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of intracellular protein transport [GO:0033157]; regulation of signal transduction [GO:0009966]; regulation of type I interferon-mediated signaling pathway [GO:0060338]","GO:0003723; GO:0004725; GO:0004726; GO:0005158; GO:0005737; GO:0005759; GO:0005769; GO:0005783; GO:0005829; GO:0006470; GO:0008270; GO:0008286; GO:0009966; GO:0009968; GO:0019899; GO:0019901; GO:0030061; GO:0030100; GO:0030948; GO:0030968; GO:0030971; GO:0031532; GO:0031904; GO:0032991; GO:0033157; GO:0034620; GO:0035335; GO:0035791; GO:0036498; GO:0038020; GO:0043407; GO:0043507; GO:0045296; GO:0046627; GO:0046875; GO:0051721; GO:0060338; GO:0060397; GO:0061098; GO:0070373; GO:0097443; GO:0098554; GO:1902202; GO:1902236; GO:1903896; GO:1903898; GO:1990264; GO:2000646"
"2664",2860,1043696,"Cluster_4115","Peve_00020566",-0.801164315679326,0.408428548977351,0.978262075707395,163,-23.54,"2 21","852 874",20,"75.00%","80.00%",NA,NA,NA,NA,NA
"2665",2861,1043871,"Cluster_2787","Peve_00005570",0.63485962450678,0.562115846035596,0.978262075707395,154,-20.6,"2 20","921 943",19,"63.16%","84.21%","Q6UWE0","E3 ubiquitin-protein ligase LRSAM1 (EC 2.3.2.27) (Leucine-rich repeat and sterile alpha motif-containing protein 1) (RING-type E3 ubiquitin transferase LRSAM1) (Tsg101-associated ligase) (hTAL)","Homo sapiens (Human)","autophagy [GO:0006914]; negative regulation of endocytosis [GO:0045806]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of xenophagy [GO:1904417]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent endocytosis [GO:0070086]; viral budding [GO:0046755]","GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006914; GO:0016020; GO:0030163; GO:0045806; GO:0046755; GO:0046872; GO:0051865; GO:0061630; GO:0070086; GO:1904417; GO:2000786"
"2666",2862,1044807,"Cluster_15726","Peve_00013857",-0.0608318153174933,0.961249338940758,0.999448381576871,155,-21.62,"2 16","290 311",14,"78.57%","85.71%",NA,NA,NA,NA,NA
"2667",2863,1044912,"Cluster_4629","Peve_00039919",0.363090644303078,0.763443057342335,0.98922491494753,155,-22.68,"2 21","563 586",21,"66.67%","76.19%",NA,NA,NA,NA,NA
"2668",2866,1045723,"Cluster_4735","Peve_00018943",-0.500943642233887,0.665972771890438,0.978262075707395,161,-20.99,"2 20","729 752",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"2669",2867,1045941,"Cluster_2787","Peve_00018946",-0.0172268228762817,0.989032521438514,0.999448381576871,154,-21.19,"2 21","909 932",21,"71.43%","76.19%","E9Q7E2","AT-rich interactive domain-containing protein 2 (ARID domain-containing protein 2) (BRG1-associated factor 200) (BAF200) (Zinc finger protein with activation potential) (Zipzap/p200)","Mus musculus (Mouse)","cardiac muscle cell proliferation [GO:0060038]; chromatin remodeling [GO:0006338]; circulatory system development [GO:0072359]; coronary artery morphogenesis [GO:0060982]; embryonic organ development [GO:0048568]; heart morphogenesis [GO:0003007]; homeostatic process [GO:0042592]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000776; GO:0000785; GO:0003007; GO:0003677; GO:0005654; GO:0005667; GO:0005886; GO:0006337; GO:0006338; GO:0006357; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0030336; GO:0042592; GO:0045582; GO:0045597; GO:0045663; GO:0045944; GO:0046872; GO:0048568; GO:0060038; GO:0060982; GO:0070316; GO:0072359; GO:1905168; GO:2000045; GO:2000781; GO:2000819"
"2670",2868,1046337,"Cluster_15726","Peve_00012817",-0.820556924545947,0.387326856078568,0.978262075707395,165,-20.8,"2 20","516 536",18,"83.33%","83.33%",NA,NA,NA,NA,NA
"2671",2869,1046565,"Cluster_16738","Peve_00030543",-0.898971724159883,0.288630750820838,0.978262075707395,159,-22.75,"2 21","569 594",23,"69.57%","73.91%","Q8K4L3","Supervillin (Archvillin) (p205/p250)","Mus musculus (Mouse)","actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; positive regulation of cytokinesis [GO:0032467]; skeletal muscle tissue development [GO:0007519]","GO:0002102; GO:0005546; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007519; GO:0008154; GO:0015629; GO:0030496; GO:0032154; GO:0032467; GO:0036449; GO:0042995; GO:0043034; GO:0051014; GO:0051015; GO:0051016; GO:0070161"
"2672",2872,1047472,"Cluster_2854","Peve_00035114",0.986771728613493,0.103663670288278,0.978262075707395,150,-21.46,"2 17","340 365",19,"73.68%","78.95%","Q8SQ75","Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment]","Pongo pygmaeus (Bornean orangutan)","complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508; GO:0006958; GO:0045087; GO:0046872"
"2673",2873,1047624,"Cluster_7855","Peve_00035111",0.0325945714784778,0.979245975351128,0.999448381576871,182,-21.38,"2 19","766 787",17,"94.12%","94.12%",NA,NA,NA,NA,NA
"2674",2874,1047705,"Cluster_5882","Peve_00035112",0.970922741092274,0.153896891887812,0.978262075707395,172,-20.53,"2 19","325 345",17,"88.24%","94.12%",NA,NA,NA,NA,NA
"2675",2875,1048851,"Cluster_11134","Peve_00033617",-0.741854096100617,0.467893371947486,0.978262075707395,168,-24.55,"2 21","464 485",19,"73.68%","84.21%","Q96ES7","SAGA-associated factor 29 (Coiled-coil domain-containing protein 101) (SAGA complex-associated factor 29)","Homo sapiens (Human)","chromatin organization [GO:0006325]; establishment of protein localization to chromatin [GO:0071169]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tubulin deacetylation [GO:0090043]","GO:0000124; GO:0005634; GO:0006282; GO:0006325; GO:0006355; GO:0006357; GO:0016573; GO:0031063; GO:0035064; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0044154; GO:0045893; GO:0045995; GO:0051302; GO:0051726; GO:0070461; GO:0071169; GO:0072686; GO:0090043; GO:0140672"
"2676",2876,1049074,"Cluster_10934","Peve_00016126",0.559024588731498,0.622351462632377,0.978262075707395,158,-20.33,"2 21","143 166",21,"71.43%","80.95%",NA,NA,NA,NA,NA
"2677",2877,1049426,"Cluster_8884","Peve_00032561",-0.900150283463785,0.286913018184418,0.978262075707395,155,-20.77,"2 12","404 424",10,"100.00%","100.00%","P97846","Contactin-associated protein 1 (Caspr) (Caspr1) (Neurexin IV) (Neurexin-4) (Paranodin) (p190)","Rattus norvegicus (Rat)","axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128]","GO:0002175; GO:0007005; GO:0007010; GO:0007155; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030424; GO:0030913; GO:0031175; GO:0033010; GO:0033270; GO:0042552; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0050905; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227"
"2678",2878,1049427,"Cluster_8887","Peve_00032561",-0.745123944878875,0.464780600457982,0.978262075707395,155,-20.77,"2 12","404 424",10,"100.00%","100.00%","P97846","Contactin-associated protein 1 (Caspr) (Caspr1) (Neurexin IV) (Neurexin-4) (Paranodin) (p190)","Rattus norvegicus (Rat)","axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128]","GO:0002175; GO:0007005; GO:0007010; GO:0007155; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030424; GO:0030913; GO:0031175; GO:0033010; GO:0033270; GO:0042552; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0050905; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227"
"2679",2879,1050463,"Cluster_8888","Peve_00038433",0.91188507812866,0.269253675772507,0.978262075707395,160,-20.98,"2 18","926 947",17,"70.59%","94.12%",NA,NA,NA,NA,NA
"2680",2880,1050487,"Cluster_2854","Peve_00038432",-0.932590278796827,0.235085990209153,0.978262075707395,154,-22.73,"2 21","943 967",22,"63.64%","81.82%","Q9TRY9","Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase)","Canis lupus familiaris (Dog) (Canis familiaris)","cellular carbohydrate metabolic process [GO:0044262]","GO:0004565; GO:0005615; GO:0005764; GO:0005773; GO:0005794; GO:0042803; GO:0044262"
"2681",2881,1051572,"Cluster_4629","Peve_00016785",-0.783020058608088,0.427356367644116,0.978262075707395,157,-20.41,"2 20","729 749",18,"66.67%","88.89%","A0JM23","Nephrocystin-3","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","cilium assembly [GO:0060271]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]","GO:0005929; GO:0016055; GO:0060271; GO:0090090; GO:2000095"
"2682",2882,1051577,"Cluster_6904","Peve_00016785",-0.99999862897499,0.0010541874922422,0.267974802126026,162,-24.85,"2 17","770 790",15,"86.67%","93.33%","A0JM23","Nephrocystin-3","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","cilium assembly [GO:0060271]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]","GO:0005929; GO:0016055; GO:0060271; GO:0090090; GO:2000095"
"2683",2883,1051579,"Cluster_6906","Peve_00016785",-0.876114646980344,0.32025367270917,0.978262075707395,158,-22.83,"2 17","770 790",15,"80.00%","93.33%","A0JM23","Nephrocystin-3","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","cilium assembly [GO:0060271]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]","GO:0005929; GO:0016055; GO:0060271; GO:0090090; GO:2000095"
"2684",2884,1052100,"Cluster_16738","Peve_00015787",-0.687359711759534,0.517539234888954,0.978262075707395,164,-20.17,"2 17","507 528",15,"80.00%","93.33%",NA,NA,NA,NA,NA
"2685",2885,1052597,"Cluster_589","Peve_00016878",-0.934753615028442,0.231240264998328,0.978262075707395,156,-20.25,"2 19","668 688",17,"76.47%","82.35%",NA,NA,NA,NA,NA
"2686",2886,1052694,"Cluster_4079","Peve_00016870",0.433230538745209,0.714747181663292,0.979987104665135,160,-20.11,"2 21","249 270",19,"68.42%","78.95%","Q9CPW0","Contactin-associated protein-like 2 (Cell recognition molecule Caspr2)","Mus musculus (Mouse)","action potential initiation [GO:0099610]; adult behavior [GO:0030534]; associative learning [GO:0008306]; axonogenesis [GO:0007409]; behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; central nervous system myelination [GO:0022010]; cerebellar Purkinje cell layer morphogenesis [GO:0021692]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle [GO:0042745]; clustering of voltage-gated potassium channels [GO:0045163]; dendrite arborization [GO:0140059]; dendritic spine development [GO:0060996]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; embryonic brain development [GO:1990403]; ERK1 and ERK2 cascade [GO:0070371]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; excitatory synapse assembly [GO:1904861]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; glial cell proliferation [GO:0014009]; glutamatergic neuron differentiation [GO:1905962]; grooming behavior [GO:0007625]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; inhibitory chemical synaptic transmission [GO:0098977]; inhibitory synapse assembly [GO:1904862]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; limbic system development [GO:0021761]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; maintenance of synapse structure [GO:0099558]; mitochondrion organization [GO:0007005]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; myelination [GO:0042552]; negative regulation of neuronal action potential [GO:1904456]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neural precursor cell proliferation [GO:0061351]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process [GO:0050905]; neuromuscular process controlling posture [GO:0050884]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuron recognition [GO:0008038]; neuronal action potential [GO:0019228]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of neuronal action potential [GO:1904457]; postsynaptic density organization [GO:0097106]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; protein localization to juxtaparanode region of axon [GO:0071205]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to dietary excess [GO:0002021]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to interleukin-17 [GO:0097396]; response to light intensity [GO:0009642]; response to mechanical stimulus [GO:0009612]; response to metformin [GO:1901558]; response to odorant [GO:1990834]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; rhythmic behavior [GO:0007622]; social behavior [GO:0035176]; TOR signaling [GO:0031929]; transmission of nerve impulse [GO:0019226]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]; walking behavior [GO:0090659]","GO:0000902; GO:0001701; GO:0002021; GO:0005769; GO:0005794; GO:0006954; GO:0007005; GO:0007155; GO:0007268; GO:0007409; GO:0007612; GO:0007622; GO:0007625; GO:0007626; GO:0008038; GO:0008076; GO:0008104; GO:0008283; GO:0008306; GO:0009408; GO:0009410; GO:0009612; GO:0009642; GO:0009725; GO:0009986; GO:0010033; GO:0010467; GO:0014009; GO:0016020; GO:0019226; GO:0019228; GO:0019899; GO:0021549; GO:0021692; GO:0021761; GO:0022010; GO:0030165; GO:0030424; GO:0030425; GO:0030534; GO:0030673; GO:0031175; GO:0031929; GO:0032229; GO:0033010; GO:0035176; GO:0035264; GO:0035556; GO:0042297; GO:0042552; GO:0042734; GO:0042745; GO:0043005; GO:0043025; GO:0043194; GO:0043491; GO:0044224; GO:0044309; GO:0044853; GO:0045163; GO:0045202; GO:0045444; GO:0045475; GO:0048265; GO:0048266; GO:0048787; GO:0048812; GO:0050884; GO:0050905; GO:0060076; GO:0060079; GO:0060996; GO:0061351; GO:0061744; GO:0070371; GO:0071205; GO:0071625; GO:0090659; GO:0097061; GO:0097062; GO:0097106; GO:0097396; GO:0098529; GO:0098793; GO:0098794; GO:0098976; GO:0098977; GO:0098978; GO:0098982; GO:0099072; GO:0099558; GO:0099610; GO:0140059; GO:0150048; GO:1901558; GO:1903598; GO:1904456; GO:1904457; GO:1904861; GO:1904862; GO:1905962; GO:1990403; GO:1990834"
"2687",2887,1052750,"Cluster_6914","Peve_00016873",0.881447631414119,0.313139039805045,0.978262075707395,146,-20.51,"2 20","668 691",21,"61.90%","71.43%","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"2688",2888,1052750,"Cluster_6914","Peve_00016873",0.881447631414119,0.313139039805045,0.978262075707395,146,-20.67,"2 20","788 811",21,"61.90%","71.43%","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"2689",2889,1054160,"Cluster_10965","Peve_00043623",0.536850726453611,0.639227662387693,0.978262075707395,151,-21.53,"2 17","441 465",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"2690",2890,1054260,"Cluster_16738","Peve_00043621",-0.950881142333799,0.200360980804941,0.978262075707395,166,-21.4,"2 19","246 267",17,"82.35%","82.35%","Q9DBT3","Coiled-coil domain-containing protein 97","Mus musculus (Mouse)","",""
"2691",2891,1054446,"Cluster_2787","Peve_00009291",0.867933894665659,0.330895275232091,0.978262075707395,155,-23.96,"2 21","542 566",22,"63.64%","77.27%",NA,NA,NA,NA,NA
"2692",2892,1055693,"Cluster_11997","Peve_00025524",-0.934796547541855,0.23116332637218,0.978262075707395,162,-20.67,"2 21","618 641",21,"71.43%","85.71%",NA,NA,NA,NA,NA
"2693",2893,1056286,"Cluster_29","Peve_00007732",0.570605907131823,0.613416796501126,0.978262075707395,156,-20.67,"2 21","379 398",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"2694",2894,1056347,"Cluster_6904","Peve_00007733",-0.975888346971901,0.140082900858926,0.978262075707395,154,-20.03,"2 16","142 165",16,"81.25%","81.25%","A1L1W9","Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10)","Danio rerio (Zebrafish) (Brachydanio rerio)","aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327]","GO:0005302; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016020; GO:0016323; GO:0070327"
"2695",2895,1056920,"Cluster_1167","Peve_00040548",0.739763115229939,0.469875105198538,0.978262075707395,152,-23.21,"2 13","120 141",11,"90.91%","90.91%","O00338","Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.1) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2)","Homo sapiens (Human)","amine metabolic process [GO:0009308]; sulfation [GO:0051923]","GO:0004062; GO:0005737; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051923"
"2696",2896,1057039,"Cluster_10934","Peve_00025520",0.43895417529269,0.710698084083712,0.97893480725409,150,-22.23,"2 21","192 219",25,"68.00%","68.00%",NA,NA,NA,NA,NA
"2697",2897,1057080,"Cluster_9149","Peve_00001293",-0.492856672172889,0.671905378723263,0.978262075707395,144,-20.63,"2 14","466 488",13,"76.92%","84.62%","Q2QCI8","Mediator of RNA polymerase II transcription subunit 12 (Mediator complex subunit 12) (Protein kohtalo) (Protein motionless) (Thyroid hormone receptor-associated protein complex 230 kDa component) (Trap230)","Danio rerio (Zebrafish) (Brachydanio rerio)","central nervous system neuron development [GO:0021954]; ear development [GO:0043583]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic pectoral fin morphogenesis [GO:0035118]; embryonic viscerocranium morphogenesis [GO:0048703]; endoderm development [GO:0007492]; forebrain development [GO:0030900]; habenula development [GO:0021986]; heart development [GO:0007507]; iridophore differentiation [GO:0050935]; kidney development [GO:0001822]; midbrain development [GO:0030901]; neural crest cell development [GO:0014032]; neuron differentiation [GO:0030182]; pineal gland development [GO:0021982]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of myeloid leukocyte differentiation [GO:0002761]; rhombomere boundary formation [GO:0021654]; ventricular system development [GO:0021591]","GO:0001822; GO:0002761; GO:0003700; GO:0003713; GO:0007492; GO:0007507; GO:0008013; GO:0014032; GO:0016592; GO:0021591; GO:0021654; GO:0021954; GO:0021982; GO:0021986; GO:0030182; GO:0030900; GO:0030901; GO:0035118; GO:0043583; GO:0045893; GO:0045944; GO:0048702; GO:0048703; GO:0050935"
"2698",2898,1057247,"Cluster_6904","Peve_00001299",-0.755081541572235,0.455194497748187,0.978262075707395,153,-20.83,"2 21","754 773",19,"68.42%","78.95%","P48039","Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor)","Homo sapiens (Human)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; mating behavior [GO:0007617]","GO:0004930; GO:0005886; GO:0007186; GO:0007187; GO:0007193; GO:0007617; GO:0007623; GO:0008502; GO:0042562; GO:0043235; GO:0097159"
"2699",2899,1057461,"Cluster_2787","Peve_00007194",0.0896966954143749,0.942820461707338,0.999448381576871,156,-20.29,"2 21","98 119",19,"57.89%","84.21%","Q9QYS2","Metabotropic glutamate receptor 3 (mGluR3)","Mus musculus (Mouse)","G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]; synaptic transmission, glutamatergic [GO:0035249]","GO:0001640; GO:0001641; GO:0005246; GO:0005886; GO:0007216; GO:0010467; GO:0014069; GO:0019233; GO:0030424; GO:0035249; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0048786; GO:0050804; GO:0051930; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170"
"2700",2900,1058934,"Cluster_13502","Peve_00037496",-0.993425673603804,0.0730396984946747,0.978262075707395,170,-22.55,"2 21","329 352",21,"80.95%","85.71%",NA,NA,NA,NA,NA
"2701",2901,1059550,"Cluster_8634","Peve_00029042",0.996142425511858,0.0559360751829932,0.978262075707395,173,-22.66,"2 19","862 884",18,"88.89%","88.89%","Q08174","Protocadherin-1 (Cadherin-like protein 1) (Protocadherin-42) (PC42)","Homo sapiens (Human)","cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]","GO:0005509; GO:0005654; GO:0005730; GO:0005886; GO:0005911; GO:0007155; GO:0007156; GO:0007267; GO:0007399; GO:0030054; GO:0043231"
"2702",2902,1060880,"Cluster_1167","Peve_00017251",0.722125106808762,0.486330966042341,0.978262075707395,147,-20.17,"2 20","713 734",18,"61.11%","72.22%",NA,NA,NA,NA,NA
"2703",2903,1061247,"Cluster_4629","Peve_00011946",-0.554554668634826,0.625777256211528,0.978262075707395,154,-22.13,"2 21","218 238",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"2704",2904,1061293,"Cluster_4735","Peve_00011947",-0.618506752746426,0.575475872672977,0.978262075707395,156,-22.03,"2 14","103 125",13,"92.31%","92.31%",NA,NA,NA,NA,NA
"2705",2905,1062688,"Cluster_4735","Peve_00002284",-0.826923151131902,0.380178261888473,0.978262075707395,167,-21.32,"2 21","609 631",20,"75.00%","85.00%","P24367","Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP)","Gallus gallus (Chicken)","chaperone-mediated protein folding [GO:0061077]; negative regulation of collagen fibril organization [GO:1904027]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]","GO:0000413; GO:0003755; GO:0005737; GO:0005788; GO:0006457; GO:0016018; GO:0032991; GO:0042470; GO:0043231; GO:0061077; GO:1904027"
"2706",2908,1064215,"Cluster_4080","Peve_00014903",-0.225484592778723,0.855206937901537,0.995934364227446,162,-20.21,"2 21","513 536",21,"76.19%","80.95%",NA,NA,NA,NA,NA
"2707",2909,1064307,"Cluster_4629","Peve_00014901",-0.816136953742052,0.392222923268794,0.978262075707395,160,-21.23,"2 13","847 868",11,"100.00%","100.00%",NA,NA,NA,NA,NA
"2708",2911,1064712,"Cluster_4629","Peve_00038385",-0.648080090166619,0.551144390907885,0.978262075707395,155,-24.23,"2 21","103 125",20,"65.00%","80.00%",NA,NA,NA,NA,NA
"2709",2912,1065115,"Cluster_4080","Peve_00010266",0.445058523585405,0.706365742796788,0.978262075707395,171,-21.47,"2 21","388 410",20,"70.00%","95.00%","P78357","Contactin-associated protein 1 (Caspr) (Caspr1) (Neurexin IV) (Neurexin-4) (p190)","Homo sapiens (Human)","axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128]; signal transduction [GO:0007165]","GO:0002175; GO:0005886; GO:0007005; GO:0007010; GO:0007155; GO:0007165; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030913; GO:0033010; GO:0033270; GO:0038023; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227"
"2710",2913,1066581,"Cluster_11134","Peve_00028324",0.0495627534557339,0.968434438880398,0.999448381576871,170,-26.98,"2 21","772 792",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"2711",2914,1066626,"Cluster_11134","Peve_00028325",0.709854436671619,0.497521409656858,0.978262075707395,170,-26.98,"2 21","166 186",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"2712",2915,1067050,"Cluster_4080","Peve_00033005",-0.477455495129792,0.683118357309565,0.978262075707395,163,-20.17,"2 21","961 983",20,"75.00%","80.00%","A6QQM4","Zinc finger protein 474","Bos taurus (Bovine)","","GO:0046872"
"2713",2916,1067136,"Cluster_2787","Peve_00033006",0.702555811986269,0.504084238656225,0.978262075707395,151,-20.1,"2 16","276 297",14,"78.57%","78.57%","Q78KK3","Solute carrier family 22 member 18 (Imprinted multi-membrane-spanning polyspecific transporter-related protein 1) (Multi-membrane-spanning polyspecific transporter) (Organic cation transporter-like protein 2) (ORCTL-2)","Mus musculus (Mouse)","anion transport [GO:0006820]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908]","GO:0005635; GO:0005737; GO:0005886; GO:0006820; GO:0008514; GO:0015293; GO:0016324; GO:0031625; GO:0042908; GO:1990961"
"2714",2917,1067570,"Cluster_10965","Peve_00001907",-0.91890719913632,0.25814620907438,0.978262075707395,173,-20.71,"2 18","446 467",16,"87.50%","93.75%","Q9CR41","Huntingtin-interacting protein K (Huntingtin yeast partner K)","Mus musculus (Mouse)","negative regulation of apoptotic process [GO:0043066]; protein stabilization [GO:0050821]","GO:0005634; GO:0005654; GO:0005737; GO:0015630; GO:0032991; GO:0043066; GO:0044183; GO:0047485; GO:0050821"
"2715",2918,1068419,"Cluster_8988","Peve_00029053",-0.245445855085225,0.842131289991688,0.995934364227446,152,-20.55,"2 21","55 76",19,"57.89%","78.95%",NA,NA,NA,NA,NA
"2716",2919,1068687,"Cluster_8887","Peve_00029582",-0.82015648142455,0.387772653207733,0.978262075707395,151,-21.82,"2 20","506 526",18,"61.11%","77.78%","Q24322","Semaphorin-1A (Semaphorin-I) (Sema I)","Drosophila melanogaster (Fruit fly)","axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite morphogenesis [GO:0048813]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell size [GO:0045792]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in regulation of photoreceptor cell axon guidance [GO:2000305]; synapse assembly [GO:0007416]; synaptic target recognition [GO:0008039]","GO:0005615; GO:0005886; GO:0007411; GO:0007416; GO:0008039; GO:0008045; GO:0008201; GO:0016020; GO:0016199; GO:0030215; GO:0030335; GO:0045499; GO:0045792; GO:0048813; GO:0048843; GO:0050919; GO:0071526; GO:2000305"
"2717",2920,1069371,"Cluster_11134","Peve_00032066",-0.0195622829453675,0.987545469442176,0.999448381576871,162,-21.82,"2 20","239 262",20,"70.00%","85.00%",NA,NA,NA,NA,NA
"2718",2921,1070000,"Cluster_10965","Peve_00009820",-0.514619540294106,0.655866356431622,0.978262075707395,162,-21.62,"2 21","83 108",23,"73.91%","78.26%","O15973","Rhodopsin, GQ-coupled (GQ-rhodopsin)","Mizuhopecten yessoensis (Japanese scallop) (Patinopecten yessoensis)","phototransduction [GO:0007602]; visual perception [GO:0007601]","GO:0004930; GO:0005886; GO:0007601; GO:0007602; GO:0009881"
"2719",2922,1070134,"Cluster_10934","Peve_00037653",0.0559926601654043,0.964335312993307,0.999448381576871,151,-25.68,"2 21","833 861",26,"61.54%","69.23%",NA,NA,NA,NA,NA
"2720",2923,1071161,"Cluster_8884","Peve_00015625",0.124721709217444,0.920392387451338,0.999448381576871,154,-20.09,"2 20","153 170",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"2721",2924,1071162,"Cluster_8887","Peve_00015625",0.393505003580829,0.742524805177773,0.986697151420032,154,-20.45,"2 20","153 170",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"2722",2925,1071163,"Cluster_8888","Peve_00015625",0.911789300774757,0.269402192307044,0.978262075707395,154,-22.08,"2 20","153 170",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"2723",2928,1072581,"Cluster_2787","Peve_00014578",-0.00382968334855694,0.997561941898757,0.999448381576871,157,-20.43,"2 19","298 320",18,"72.22%","83.33%","B1AS29","Glutamate receptor ionotropic, kainate 3 (GluK3) (Glutamate receptor 7) (GluR-7) (GluR7)","Mus musculus (Mouse)","G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; regulation of membrane potential [GO:0042391]; synaptic transmission, glutamatergic [GO:0035249]","GO:0001640; GO:0004970; GO:0005886; GO:0007215; GO:0007216; GO:0008066; GO:0015276; GO:0015277; GO:0030424; GO:0030425; GO:0032839; GO:0032983; GO:0035249; GO:0038023; GO:0042391; GO:0042734; GO:0043195; GO:0043204; GO:0045211; GO:0050804; GO:0051967; GO:0098978; GO:0099507; GO:1904315"
"2724",2929,1072623,"Cluster_796","Peve_00014579",-0.0696341159246928,0.955633640840684,0.999448381576871,142,-22.86,"2 21","318 338",19,"63.16%","68.42%","Q5R4M0","Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) (GluA2)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","ionotropic glutamate receptor signaling pathway [GO:0035235]","GO:0004970; GO:0004971; GO:0005789; GO:0005886; GO:0015277; GO:0032281; GO:0035235; GO:0098839"
"2725",2930,1072701,"Cluster_11134","Peve_00001129",0.127288751008612,0.918745027255254,0.999448381576871,159,-23.37,"2 21","7 29",20,"65.00%","85.00%","D3ZQL6","MICAL-like protein 1","Rattus norvegicus (Rat)","cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; neuron projection development [GO:0031175]; plasma membrane tubulation [GO:0097320]; protein localization to endosome [GO:0036010]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis [GO:0006898]; slow endocytic recycling [GO:0032458]","GO:0005770; GO:0006612; GO:0006897; GO:0006898; GO:0010008; GO:0019898; GO:0031175; GO:0031267; GO:0031902; GO:0032456; GO:0032458; GO:0036010; GO:0042802; GO:0046872; GO:0055038; GO:0070300; GO:0097320; GO:1990090"
"2726",2931,1072810,"Cluster_4080","Peve_00001121",-0.411813056064252,0.72979134287943,0.984464909489456,170,-22.11,"2 20","189 211",19,"84.21%","84.21%","Q6ZPR6","Inhibitor of Bruton tyrosine kinase (IBtk)","Mus musculus (Mouse)","negative regulation of protein phosphorylation [GO:0001933]; release of sequestered calcium ion into cytosol [GO:0051209]","GO:0001933; GO:0005654; GO:0005737; GO:0016020; GO:0019901; GO:0030292; GO:0051209"
"2727",2932,1073179,"Cluster_6906","Peve_00025347",-0.943169524057212,0.21565736881111,0.978262075707395,158,-20.37,"2 20","654 676",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"2728",2933,1073382,"Cluster_15726","Peve_00025349",-0.438024211102423,0.711356824061083,0.979198299065619,168,-20.22,"2 21","156 177",19,"73.68%","84.21%","Q8N972","Zinc finger protein 709","Homo sapiens (Human)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"2729",2934,1073831,"Cluster_14999","Peve_00036362",0.974231557726998,0.144835903235197,0.978262075707395,162,-20.92,"2 20","643 665",19,"68.42%","89.47%","A9H2B4","Putative hydro-lyase GDI0188/Gdia_2258 (EC 4.2.1.-)","Gluconacetobacter diazotrophicus (strain ATCC 49037 / DSM 5601 / CCUG 37298 / CIP 103539 / LMG 7603 / PAl5)","","GO:0016829"
"2730",2935,1074189,"Cluster_13502","Peve_00014373",0.873674980910763,0.323460601771292,0.978262075707395,166,-24.58,"2 21","789 809",19,"73.68%","89.47%",NA,NA,NA,NA,NA
"2731",2936,1074242,"Cluster_589","Peve_00007910",-0.870062090436839,0.32815715989334,0.978262075707395,152,-22.48,"2 20","18 39",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"2732",2938,1075125,"Cluster_9149","Peve_00030979",0.595505776968763,0.593903375607708,0.978262075707395,160,-22.39,"2 21","853 874",19,"73.68%","73.68%",NA,NA,NA,NA,NA
"2733",2939,1076266,"Cluster_29","Peve_00026936",-0.812297196498069,0.396433502373638,0.978262075707395,154,-20.75,"2 21","427 447",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"2734",2940,1076699,"Cluster_8988","Peve_00037355",0.175546272428036,0.887661673932514,0.999448381576871,168,-20.14,"2 21","351 372",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"2735",2941,1076699,"Cluster_8988","Peve_00037355",0.175546272428036,0.887661673932514,0.999448381576871,168,-20.14,"2 21","749 770",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"2736",2943,1077423,"Cluster_10061","Peve_00039405",-0.946095571578966,0.209979927171215,0.978262075707395,169,-21.82,"2 21","914 933",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"2737",2944,1077786,"Cluster_11134","Peve_00024577",0.625450189515442,0.569830691112795,0.978262075707395,158,-22.56,"2 21","597 620",21,"71.43%","80.95%","P30531","Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1)","Homo sapiens (Human)","associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid reuptake [GO:0051936]; inorganic anion import across plasma membrane [GO:0098658]; memory [GO:0007613]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; transport across blood-brain barrier [GO:0150104]","GO:0005332; GO:0005886; GO:0007268; GO:0007613; GO:0008306; GO:0009636; GO:0009744; GO:0009986; GO:0010035; GO:0010288; GO:0014054; GO:0014074; GO:0015185; GO:0015378; GO:0016020; GO:0030424; GO:0032229; GO:0032355; GO:0035725; GO:0042220; GO:0042734; GO:0042802; GO:0043005; GO:0043025; GO:0045211; GO:0046872; GO:0050808; GO:0051592; GO:0051936; GO:0051939; GO:0098658; GO:0098719; GO:0098982; GO:0150104; GO:1902476"
"2738",2945,1077977,"Cluster_589","Peve_00010068",0.159680919674548,0.897906931664995,0.999448381576871,167,-24.55,"2 20","180 201",18,"66.67%","94.44%",NA,NA,NA,NA,NA
"2739",2946,1078230,"Cluster_9149","Peve_00010062",-0.179926708757291,0.884827879685,0.999448381576871,147,-20.09,"2 12","814 835",10,"80.00%","100.00%","A6H584","Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain)","Mus musculus (Mouse)","cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]","GO:0005576; GO:0005581; GO:0007155; GO:0030198; GO:0031012; GO:0062023"
"2740",2947,1078250,"Cluster_1167","Peve_00010063",-0.0729883143337452,0.953492840559163,0.999448381576871,150,-20.34,"2 21","881 901",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"2741",2948,1078275,"Cluster_9149","Peve_00010063",-0.834696327082305,0.371286323056233,0.978262075707395,147,-20.09,"2 12","814 835",10,"80.00%","100.00%",NA,NA,NA,NA,NA
"2742",2949,1078369,"Cluster_10934","Peve_00012516",0.998758250045999,0.0317290557481559,0.903929377050813,143,-21.64,"2 21","280 304",22,"63.64%","63.64%",NA,NA,NA,NA,NA
"2743",2950,1078748,"Cluster_2882","Peve_00017591",-0.970956589153997,0.153806853652755,0.978262075707395,151,-20.19,"2 17","67 91",18,"72.22%","77.78%","Q7T3S3","Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4ST-1) (C4ST1) (zC4ST-1)","Danio rerio (Zebrafish) (Brachydanio rerio)","carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; motor neuron axon guidance [GO:0008045]; muscle organ development [GO:0007517]; proteoglycan biosynthetic process [GO:0030166]","GO:0000139; GO:0007517; GO:0008045; GO:0008146; GO:0016051; GO:0030166; GO:0030206; GO:0047756"
"2744",2951,1078766,"Cluster_8884","Peve_00017591",-0.993559712455409,0.0722904798161048,0.978262075707395,167,-20.58,"2 20","235 255",18,"77.78%","83.33%","Q7T3S3","Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4ST-1) (C4ST1) (zC4ST-1)","Danio rerio (Zebrafish) (Brachydanio rerio)","carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; motor neuron axon guidance [GO:0008045]; muscle organ development [GO:0007517]; proteoglycan biosynthetic process [GO:0030166]","GO:0000139; GO:0007517; GO:0008045; GO:0008146; GO:0016051; GO:0030166; GO:0030206; GO:0047756"
"2745",2952,1078767,"Cluster_8887","Peve_00017591",-0.923784490111638,0.25015806208967,0.978262075707395,167,-20.9,"2 20","235 255",18,"77.78%","83.33%","Q7T3S3","Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4ST-1) (C4ST1) (zC4ST-1)","Danio rerio (Zebrafish) (Brachydanio rerio)","carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; motor neuron axon guidance [GO:0008045]; muscle organ development [GO:0007517]; proteoglycan biosynthetic process [GO:0030166]","GO:0000139; GO:0007517; GO:0008045; GO:0008146; GO:0016051; GO:0030166; GO:0030206; GO:0047756"
"2746",2953,1078768,"Cluster_8888","Peve_00017591",-0.421110838597691,0.723280674960399,0.982490238143882,167,-22.53,"2 20","235 255",18,"77.78%","83.33%","Q7T3S3","Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4ST-1) (C4ST1) (zC4ST-1)","Danio rerio (Zebrafish) (Brachydanio rerio)","carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; motor neuron axon guidance [GO:0008045]; muscle organ development [GO:0007517]; proteoglycan biosynthetic process [GO:0030166]","GO:0000139; GO:0007517; GO:0008045; GO:0008146; GO:0016051; GO:0030166; GO:0030206; GO:0047756"
"2747",2954,1078986,"Cluster_7053","Peve_00009519",-0.599492520986274,0.590738213576683,0.978262075707395,163,-20.19,"2 20","57 75",18,"83.33%","83.33%",NA,NA,NA,NA,NA
"2748",2955,1079309,"Cluster_8988","Peve_00025624",0.819808378836323,0.388159818464786,0.978262075707395,164,-21.29,"2 18","269 292",18,"77.78%","88.89%",NA,NA,NA,NA,NA
"2749",2956,1080082,"Cluster_11135","Peve_00027546",0.869023195295724,0.329496376071386,0.978262075707395,160,-20.87,"2 18","177 199",17,"82.35%","82.35%","P51029","Protein Wnt-8b","Danio rerio (Zebrafish) (Brachydanio rerio)","canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; negative regulation of anterior neural cell fate commitment of the neural plate by Wnt signaling pathway [GO:0022002]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]","GO:0001654; GO:0005109; GO:0005125; GO:0005615; GO:0009880; GO:0021854; GO:0021879; GO:0022002; GO:0030182; GO:0030900; GO:0043049; GO:0045165; GO:0060070; GO:0060898; GO:0070654; GO:0071679"
"2750",2957,1080756,"Cluster_11134","Peve_00041365",0.875640822838247,0.320878802775509,0.978262075707395,160,-21.06,"2 19","839 859",17,"82.35%","82.35%",NA,NA,NA,NA,NA
"2751",2958,1080756,"Cluster_11134","Peve_00041365",0.875640822838247,0.320878802775509,0.978262075707395,161,-20.97,"2 18","299 320",16,"75.00%","87.50%",NA,NA,NA,NA,NA
"2752",2959,1080898,"Cluster_15890","Peve_00034005",-0.983370547075308,0.116261998782917,0.978262075707395,165,-20.37,"2 21","97 122",23,"78.26%","82.61%",NA,NA,NA,NA,NA
"2753",2960,1083952,"Cluster_11135","Peve_00015354",-0.849240512342616,0.354120453704146,0.978262075707395,161,-20.13,"2 20","479 499",18,"77.78%","83.33%","Q96PY6","Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; protein phosphorylation [GO:0006468]","GO:0000242; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007049; GO:0016301; GO:0034451; GO:0046872; GO:0051301; GO:0060271; GO:0071889; GO:0106310"
"2754",2961,1084660,"Cluster_8634","Peve_00018659",0.863267774685516,0.336827861128925,0.978262075707395,158,-20.76,"2 21","452 472",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"2755",2962,1084782,"Cluster_4629","Peve_00015971",-0.443383362280846,0.707556077121805,0.978262075707395,157,-22,"2 19","894 916",18,"77.78%","77.78%","Q8R151","NFX1-type zinc finger-containing protein 1","Mus musculus (Mouse)","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; RNA-mediated heterochromatin formation [GO:0031048]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607"
"2756",2963,1086977,"Cluster_589","Peve_00038025",0.775072695353894,0.435426401668339,0.978262075707395,154,-21.82,"2 20","476 498",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"2757",2964,1086982,"Cluster_2854","Peve_00038025",0.999962448044095,0.00551712420276166,0.551398425649056,157,-20.06,"2 21","561 583",21,"76.19%","76.19%",NA,NA,NA,NA,NA
"2758",2965,1087011,"Cluster_11134","Peve_00038025",-0.856078539892879,0.345787863891157,0.978262075707395,147,-20.17,"2 16","182 203",14,"71.43%","78.57%",NA,NA,NA,NA,NA
"2759",2966,1087281,"Cluster_11134","Peve_00035687",-0.0195622829453675,0.987545469442176,0.999448381576871,154,-22.32,"2 21","440 464",22,"68.18%","77.27%",NA,NA,NA,NA,NA
"2760",2967,1088420,"Cluster_1167","Peve_00034482",-0.511591173923624,0.65811249694873,0.978262075707395,160,-21.16,"2 21","492 513",19,"68.42%","78.95%","Q8K4L3","Supervillin (Archvillin) (p205/p250)","Mus musculus (Mouse)","actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; positive regulation of cytokinesis [GO:0032467]; skeletal muscle tissue development [GO:0007519]","GO:0002102; GO:0005546; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007519; GO:0008154; GO:0015629; GO:0030496; GO:0032154; GO:0032467; GO:0036449; GO:0042995; GO:0043034; GO:0051014; GO:0051015; GO:0051016; GO:0070161"
"2761",2968,1088465,"Cluster_1167","Peve_00034483",0.616035509807119,0.577475545958278,0.978262075707395,160,-21.16,"2 21","26 47",19,"68.42%","78.95%","O46385","Supervillin (Archvillin) (p205/p250)","Bos taurus (Bovine)","actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; positive regulation of cytokinesis [GO:0032467]","GO:0002102; GO:0005546; GO:0005737; GO:0008154; GO:0015629; GO:0030496; GO:0032154; GO:0032467; GO:0036449; GO:0042995; GO:0051014; GO:0051015; GO:0051016; GO:0060090; GO:0070161"
"2762",2969,1088927,"Cluster_6904","Peve_00004282",-0.852892981744431,0.349691841932808,0.978262075707395,148,-20.19,"2 20","977 998",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"2763",2970,1089524,"Cluster_8988","Peve_00039177",-0.999730689576333,0.0147751347211111,0.738007302447873,153,-22.68,"2 21","615 637",21,"66.67%","80.95%",NA,NA,NA,NA,NA
"2764",2971,1090801,"Cluster_29","Peve_00003334",-0.218170974953146,0.859981908511813,0.996184225941802,151,-20.11,"2 21","683 705",20,"65.00%","75.00%","P61315","Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)","Mus musculus (Mouse)","glycolipid biosynthetic process [GO:0009247]","GO:0001733; GO:0008146; GO:0009247; GO:0032580; GO:0050694"
"2765",2972,1090883,"Cluster_11997","Peve_00003335",-0.779397164454731,0.431050961777671,0.978262075707395,157,-20.09,"2 21","289 310",20,"70.00%","85.00%",NA,NA,NA,NA,NA
"2766",2973,1091442,"Cluster_4629","Peve_00019244",-0.462131905352726,0.694169319507964,0.978262075707395,150,-20.08,"2 20","711 734",20,"70.00%","70.00%","Q708S8","Acid-sensing ion channel 1B (ASIC1-B) (Acid-sensing ion channel 1.1-B) (Amiloride-sensitive cation channel 2-A, neuronal-B) (ZASIC1.1)","Danio rerio (Zebrafish) (Brachydanio rerio)","cellular response to pH [GO:0071467]; protein homotrimerization [GO:0070207]; sodium ion transmembrane transport [GO:0035725]","GO:0005886; GO:0015280; GO:0035725; GO:0044736; GO:0070207; GO:0071467"
"2767",2974,1091793,"Cluster_796","Peve_00037590",0.898740270652305,0.288966974174018,0.978262075707395,157,-24.09,"2 21","61 85",23,"73.91%","73.91%",NA,NA,NA,NA,NA
"2768",2978,1092392,"Cluster_6904","Peve_00008764",-0.995820122469223,0.0582275196072157,0.978262075707395,164,-22.76,"2 21","492 513",19,"68.42%","84.21%","Q9NWT6","Hypoxia-inducible factor 1-alpha inhibitor (EC 1.14.11.30) (EC 1.14.11.n4) (Factor inhibiting HIF-1) (FIH-1) (Hypoxia-inducible factor asparagine hydroxylase)","Homo sapiens (Human)","negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; peptidyl-aspartic acid hydroxylation [GO:0042264]; peptidyl-histidine hydroxylation [GO:0036138]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of vasculogenesis [GO:2001214]","GO:0005112; GO:0005654; GO:0005737; GO:0005829; GO:0008198; GO:0008270; GO:0016706; GO:0019826; GO:0031406; GO:0036138; GO:0036139; GO:0036140; GO:0042264; GO:0042803; GO:0043433; GO:0045663; GO:0045746; GO:0048471; GO:0051059; GO:0061428; GO:0062101; GO:0071532; GO:2001214"
"2769",2979,1092394,"Cluster_6906","Peve_00008764",-0.91714720676125,0.260971965609689,0.978262075707395,160,-20.26,"2 21","492 513",19,"63.16%","84.21%","Q9NWT6","Hypoxia-inducible factor 1-alpha inhibitor (EC 1.14.11.30) (EC 1.14.11.n4) (Factor inhibiting HIF-1) (FIH-1) (Hypoxia-inducible factor asparagine hydroxylase)","Homo sapiens (Human)","negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; peptidyl-aspartic acid hydroxylation [GO:0042264]; peptidyl-histidine hydroxylation [GO:0036138]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of vasculogenesis [GO:2001214]","GO:0005112; GO:0005654; GO:0005737; GO:0005829; GO:0008198; GO:0008270; GO:0016706; GO:0019826; GO:0031406; GO:0036138; GO:0036139; GO:0036140; GO:0042264; GO:0042803; GO:0043433; GO:0045663; GO:0045746; GO:0048471; GO:0051059; GO:0061428; GO:0062101; GO:0071532; GO:2001214"
"2770",2981,1094232,"Cluster_4629","Peve_00023277",-0.337388479923953,0.780912824485286,0.993780465556445,154,-27.55,"2 19","182 203",17,"70.59%","76.47%","Q63413","Spliceosome RNA helicase Ddx39b (EC 3.6.4.13) (56 kDa U2AF65-associated protein) (ATP-dependent RNA helicase p47) (DEAD box protein Uap56)","Rattus norvegicus (Rat)","liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of translation [GO:0045727]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]","GO:0000245; GO:0000346; GO:0000398; GO:0001889; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0005687; GO:0005688; GO:0005737; GO:0006406; GO:0008186; GO:0008380; GO:0010501; GO:0016363; GO:0016607; GO:0016887; GO:0017070; GO:0030621; GO:0032786; GO:0032991; GO:0042802; GO:0043008; GO:0044877; GO:0045727; GO:0046784; GO:0061051; GO:1904707; GO:2000002; GO:2000573"
"2771",2982,1094385,"Cluster_9149","Peve_00023272",-0.672763372967259,0.530214408912717,0.978262075707395,156,-22.86,"2 19","493 516",19,"78.95%","78.95%","Q69ZW3","EH domain-binding protein 1","Mus musculus (Mouse)","actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]; protein transport [GO:0015031]","GO:0005654; GO:0005768; GO:0005815; GO:0005829; GO:0005886; GO:0006897; GO:0015031; GO:0030036; GO:0031941"
"2772",2984,1095257,"Cluster_589","Peve_00021654",-0.881782730848516,0.312687037643998,0.978262075707395,166,-26.91,"2 20","337 359",19,"73.68%","89.47%","Q04400","Adenylate cyclase type 5 (EC 4.6.1.1) (ATP pyrophosphate-lyase 5) (Adenylate cyclase type V) (Adenylyl cyclase 5)","Rattus norvegicus (Rat)","adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aging [GO:0007568]; brain development [GO:0007420]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to morphine [GO:0043278]","GO:0001973; GO:0004016; GO:0005524; GO:0005768; GO:0005886; GO:0005929; GO:0006171; GO:0007189; GO:0007191; GO:0007193; GO:0007195; GO:0007204; GO:0007420; GO:0007507; GO:0007568; GO:0007626; GO:0008179; GO:0008294; GO:0016020; GO:0035556; GO:0043278; GO:0045121; GO:0046872; GO:0050885; GO:0061178; GO:0097110; GO:1904322"
"2773",2985,1095798,"Cluster_796","Peve_00007683",0.606976176093702,0.584764661191195,0.978262075707395,143,-20.31,"2 21","221 244",21,"61.90%","66.67%","Q5F479","Serine/threonine-protein kinase 11-interacting protein","Gallus gallus (Chicken)","protein localization [GO:0008104]","GO:0005737; GO:0008104; GO:0019901"
"2774",2986,1096233,"Cluster_10061","Peve_00026385",-0.087440984785273,0.944262157790605,0.999448381576871,178,-24.3,"2 19","903 924",17,"82.35%","100.00%",NA,NA,NA,NA,NA
"2775",2987,1096691,"Cluster_14999","Peve_00032289",0.358599961120695,0.766508447621425,0.990058974093783,166,-22.74,"2 20","551 573",19,"78.95%","84.21%","Q5UU75","Doublesex- and mab-3-related transcription factor A2 (Doublesex- and mab-3-related transcription factor 5)","Danio rerio (Zebrafish) (Brachydanio rerio)","corticotropin hormone secreting cell differentiation [GO:0060128]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; telencephalon development [GO:0021537]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007548; GO:0021537; GO:0046872; GO:0060128"
"2776",2988,1096822,"Cluster_11135","Peve_00012898",0.193975399368499,0.875723605605123,0.997692036753966,160,-20.87,"2 18","623 645",17,"82.35%","82.35%",NA,NA,NA,NA,NA
"2777",2990,1096967,"Cluster_589","Peve_00012893",0.159680919674548,0.897906931664995,0.999448381576871,151,-20.75,"2 16","837 858",14,"78.57%","78.57%",NA,NA,NA,NA,NA
"2778",2991,1096975,"Cluster_4080","Peve_00012893",-0.723721119815755,0.484860402263066,0.978262075707395,175,-26.57,"2 21","818 840",20,"80.00%","90.00%",NA,NA,NA,NA,NA
"2779",2992,1097337,"Cluster_4629","Peve_00032287",-0.980622420878099,0.125530333606602,0.978262075707395,152,-24.15,"2 13","952 973",11,"81.82%","100.00%",NA,NA,NA,NA,NA
"2780",2993,1097664,"Cluster_7855","Peve_00011279",0.757061468369413,0.453268624417658,0.978262075707395,170,-21.5,"2 21","927 950",21,"76.19%","90.48%",NA,NA,NA,NA,NA
"2781",2994,1097694,"Cluster_4079","Peve_00011272",-0.730316314598218,0.478745351346636,0.978262075707395,167,-22.7,"2 17","524 547",17,"88.24%","88.24%","P0CI65","Nephrocystin-3","Danio rerio (Zebrafish) (Brachydanio rerio)","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"2782",2995,1097912,"Cluster_589","Peve_00011277",-0.990043159202282,0.0899118455255787,0.978262075707395,155,-20.8,"2 20","612 633",18,"61.11%","83.33%","Q8IWV8","E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (RING-type E3 ubiquitin transferase UBR2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II)","Homo sapiens (Human)","cellular response to leucine [GO:0071233]; heterochromatin formation [GO:0031507]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]","GO:0000151; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010529; GO:0016567; GO:0031507; GO:0032007; GO:0033522; GO:0061630; GO:0070728; GO:0071233; GO:0071596"
"2783",2996,1097927,"Cluster_6904","Peve_00011277",-0.683828606790993,0.520627186583581,0.978262075707395,152,-20.25,"2 20","381 403",20,"70.00%","80.00%","Q8IWV8","E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (RING-type E3 ubiquitin transferase UBR2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II)","Homo sapiens (Human)","cellular response to leucine [GO:0071233]; heterochromatin formation [GO:0031507]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]","GO:0000151; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010529; GO:0016567; GO:0031507; GO:0032007; GO:0033522; GO:0061630; GO:0070728; GO:0071233; GO:0071596"
"2784",2997,1099135,"Cluster_4080","Peve_00012704",0.997873729717017,0.0415222938742972,0.909359886114279,159,-21.02,"2 21","191 215",22,"68.18%","77.27%","Q9DC58","DNA damage-regulated autophagy modulator protein 1 (Damage-regulated autophagy modulator)","Mus musculus (Mouse)","apoptotic process [GO:0006915]; autophagy [GO:0006914]; regulation of autophagy [GO:0010506]","GO:0005737; GO:0005764; GO:0005765; GO:0006914; GO:0006915; GO:0010506"
"2785",2998,1099380,"Cluster_9149","Peve_00012709",0.597021740795279,0.592701199926971,0.978262075707395,146,-21.38,"2 21","852 879",25,"60.00%","72.00%","P13914","Arylamine N-acetyltransferase, pineal gland isozyme NAT-3 (Arylamine acetylase) (EC 2.3.1.5)","Gallus gallus (Chicken)","","GO:0004060"
"2786",3000,1099578,"Cluster_796","Peve_00017368",-0.582780616608027,0.603929388886638,0.978262075707395,154,-22.16,"2 21","648 671",21,"71.43%","76.19%",NA,NA,NA,NA,NA
"2787",3001,1100156,"Cluster_14999","Peve_00008665",0.854838018514247,0.347312840291308,0.978262075707395,169,-20.78,"2 20","808 828",18,"83.33%","88.89%","Q58A42","Protein DD3-3","Dictyostelium discoideum (Social amoeba)","","GO:0016020"
"2788",3002,1101242,"Cluster_589","Peve_00016707",0.436129992893138,0.712697567792575,0.979587393916807,158,-26.52,"2 21","404 430",24,"70.83%","75.00%","Q3U481","Major facilitator superfamily domain-containing protein 12 (Protein grizzled)","Mus musculus (Mouse)","carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; organic substance transport [GO:0071702]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021]","GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0042470; GO:0043474; GO:0048021; GO:0048022; GO:0071702; GO:1903712"
"2789",3003,1102266,"Cluster_11134","Peve_00004483",-0.022073460672086,0.985946457098077,0.999448381576871,157,-20.41,"2 18","596 617",16,"75.00%","81.25%",NA,NA,NA,NA,NA
"2790",3004,1103543,"Cluster_2882","Peve_00029931",-0.820494161656803,0.387396757070617,0.978262075707395,156,-20.89,"2 17","111 132",15,"73.33%","86.67%","A6QLU6","Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)","Bos taurus (Bovine)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189"
"2791",3005,1103578,"Cluster_15890","Peve_00029931",-0.76410051656361,0.446366264050846,0.978262075707395,166,-20.77,"2 21","311 331",19,"78.95%","84.21%","A6QLU6","Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)","Bos taurus (Bovine)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189"
"2792",3006,1103590,"Cluster_4080","Peve_00004323",-0.502616685183679,0.664741444160619,0.978262075707395,162,-22.3,"2 20","634 656",19,"73.68%","84.21%","Q6RFZ7","Pleckstrin homology domain-containing family G member 5 (PH domain-containing family G member 5) (Neuronal RhoA GEF protein) (Transcript highly enriched in cortex and hippocampus)","Rattus norvegicus (Rat)","endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation protein catabolic process at presynapse [GO:0140251]; Rho protein signal transduction [GO:0007266]","GO:0005085; GO:0005737; GO:0005886; GO:0005911; GO:0007266; GO:0030027; GO:0030139; GO:0030424; GO:0035767; GO:0043542; GO:0045202; GO:0048471; GO:0098793; GO:0099575; GO:0140251"
"2793",3007,1103869,"Cluster_6906","Peve_00042319",-0.686063329690759,0.518674561276582,0.978262075707395,160,-21.03,"2 21","170 189",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"2794",3008,1104336,"Cluster_11134","Peve_00003913",0.937097079490441,0.227004139312974,0.978262075707395,159,-20.58,"2 21","689 712",21,"66.67%","80.95%","Q6NRI8","Centromere protein S (CENP-S) (Apoptosis-inducing TAF9-like domain-containing protein 1 homolog) (FANCM-interacting histone fold protein 1)","Xenopus laevis (African clawed frog)","cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712]","GO:0000712; GO:0000776; GO:0003677; GO:0003682; GO:0006281; GO:0006974; GO:0031297; GO:0043240; GO:0046982; GO:0051301; GO:0071821"
"2795",3009,1105371,"Cluster_11134","Peve_00030446",-0.968300691390792,0.160721500405001,0.978262075707395,153,-22.25,"2 19","605 629",20,"70.00%","75.00%","Q9NUN7","Alkaline ceramidase 3 (AlkCDase 3) (Alkaline CDase 3) (EC 3.5.1.-) (EC 3.5.1.23) (Alkaline dihydroceramidase SB89) (Alkaline phytoceramidase) (aPHC)","Homo sapiens (Human)","ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512]","GO:0000139; GO:0005509; GO:0005789; GO:0006954; GO:0008270; GO:0008284; GO:0016020; GO:0017040; GO:0030148; GO:0042552; GO:0043067; GO:0046512; GO:0046514; GO:0070774; GO:0071602; GO:0071633; GO:0102121"
"2796",3010,1105581,"Cluster_7053","Peve_00030443",-0.531365142810227,0.643358461010108,0.978262075707395,161,-20.82,"2 21","946 965",19,"68.42%","89.47%","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"2797",3011,1105657,"Cluster_2854","Peve_00034569",0.999603958340296,0.0179176022280377,0.782669382293497,159,-22.75,"2 21","832 856",22,"63.64%","81.82%",NA,NA,NA,NA,NA
"2798",3012,1105659,"Cluster_4079","Peve_00034569",0.914312982474787,0.265462787769544,0.978262075707395,150,-20.37,"2 21","590 610",19,"63.16%","78.95%",NA,NA,NA,NA,NA
"2799",3014,1106722,"Cluster_11135","Peve_00037144",0.926364403306054,0.245833300488982,0.978262075707395,170,-21.97,"2 20","562 584",19,"78.95%","89.47%","P26818","Beta-adrenergic receptor kinase 2 (Beta-ARK-2) (EC 2.7.11.15) (G-protein-coupled receptor kinase 3)","Bos taurus (Bovine)","desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled receptor signaling pathway [GO:0007186]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of signal transduction [GO:0009966]","GO:0001664; GO:0002029; GO:0004672; GO:0004703; GO:0005524; GO:0006468; GO:0007186; GO:0009966; GO:0031623; GO:0042995; GO:0047696; GO:0098793; GO:0098794"
"2800",3015,1106891,"Cluster_8884","Peve_00032234",-0.203320640991674,0.869653237709453,0.997440292838262,164,-21.71,"2 18","19 41",18,"77.78%","88.89%",NA,NA,NA,NA,NA
"2801",3016,1106892,"Cluster_8887","Peve_00032234",-0.465449101701132,0.691785655435888,0.978262075707395,164,-21.71,"2 18","19 41",18,"77.78%","88.89%",NA,NA,NA,NA,NA
"2802",3017,1106972,"Cluster_6904","Peve_00041065",-0.951310992493219,0.199475076059675,0.978262075707395,157,-22.91,"2 21","865 887",21,"71.43%","80.95%",NA,NA,NA,NA,NA
"2803",3018,1106974,"Cluster_6906","Peve_00041065",-0.686063329690759,0.518674561276582,0.978262075707395,157,-23.48,"2 21","865 887",21,"71.43%","80.95%",NA,NA,NA,NA,NA
"2804",3020,1107324,"Cluster_4079","Peve_00027365",-0.21571513796119,0.861583486127423,0.996549818373121,162,-23.61,"2 21","846 870",22,"77.27%","77.27%","Q5REB9","Myotubularin-related protein 2 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]","GO:0004438; GO:0005829; GO:0006661; GO:0030424; GO:0031901; GO:0046856; GO:0048471; GO:0052629"
"2805",3021,1107342,"Cluster_8887","Peve_00027365",-0.172917636379004,0.889361109641904,0.999448381576871,149,-20.67,"2 20","122 144",20,"65.00%","80.00%","Q5REB9","Myotubularin-related protein 2 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]","GO:0004438; GO:0005829; GO:0006661; GO:0030424; GO:0031901; GO:0046856; GO:0048471; GO:0052629"
"2806",3022,1109358,"Cluster_6905","Peve_00036237",0.707888973335431,0.499295389570945,0.978262075707395,168,-22.61,"2 17","383 404",15,"86.67%","93.33%",NA,NA,NA,NA,NA
"2807",3023,1109477,"Cluster_589","Peve_00009400",0.159680919674548,0.897906931664995,0.999448381576871,159,-21.52,"2 21","100 122",20,"75.00%","75.00%",NA,NA,NA,NA,NA
"2808",3024,1110057,"Cluster_15726","Peve_00023336",-0.998934950217099,0.0293845218273416,0.903929377050813,160,-21.55,"2 21","685 705",20,"80.00%","80.00%","Q9NYR8","Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 2)","Homo sapiens (Human)","estrogen biosynthetic process [GO:0006703]; response to stimulus [GO:0050896]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; visual perception [GO:0007601]","GO:0004303; GO:0004745; GO:0005829; GO:0005886; GO:0006694; GO:0006703; GO:0007601; GO:0016491; GO:0042572; GO:0050896; GO:0052650"
"2809",3025,1110411,"Cluster_11134","Peve_00025857",-0.187786033754204,0.879737691435898,0.998681933263738,157,-24.23,"2 15","184 206",14,"85.71%","92.86%","Q8WPA2","Allatostatin-A receptor (BAR)","Bombyx mori (Silk moth)","","GO:0004930; GO:0005886; GO:0042562; GO:0042923"
"2810",3026,1110601,"Cluster_29","Peve_00025859",-0.368569774287229,0.759695126986102,0.988219883885475,173,-24.81,"2 20","612 635",20,"85.00%","90.00%",NA,NA,NA,NA,NA
"2811",3027,1110916,"Cluster_29","Peve_00005180",-0.72802963227625,0.480872616506001,0.978262075707395,162,-21.65,"2 21","408 428",19,"73.68%","84.21%","Q5VTL8","Pre-mRNA-splicing factor 38B (Sarcoma antigen NY-SAR-27)","Homo sapiens (Human)","mRNA processing [GO:0006397]; RNA splicing [GO:0008380]","GO:0003723; GO:0006397; GO:0008380; GO:0071011"
"2812",3029,1111053,"Cluster_796","Peve_00031274",0.847076828363271,0.356720684812642,0.978262075707395,146,-20.78,"2 12","153 175",11,"90.91%","90.91%","P0CI65","Nephrocystin-3","Danio rerio (Zebrafish) (Brachydanio rerio)","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"2813",3030,1111115,"Cluster_6914","Peve_00031276",0.83220053081693,0.374161624785506,0.978262075707395,161,-21.18,"2 20","308 331",21,"76.19%","80.95%",NA,NA,NA,NA,NA
"2814",3031,1111350,"Cluster_9149","Peve_00025275",-0.467727104299906,0.690146013072338,0.978262075707395,151,-22.79,"2 12","940 961",10,"90.00%","100.00%",NA,NA,NA,NA,NA
"2815",3033,1112166,"Cluster_11134","Peve_00020733",-0.0195622829453675,0.987545469442176,0.999448381576871,165,-24.91,"2 21","691 712",20,"80.00%","85.00%","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"2816",3034,1112312,"Cluster_589","Peve_00034529",-0.851226154993355,0.351719063933253,0.978262075707395,171,-26.29,"2 20","551 572",18,"77.78%","88.89%","A0A2B4RNI3",NA,NA,NA,NA
"2817",3035,1113063,"Cluster_10061","Peve_00006768",-0.247617475153233,0.840704763249597,0.995934364227446,169,-22.19,"2 20","433 456",20,"80.00%","90.00%","Q9C0G6","Dynein axonemal heavy chain 6 (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)","Homo sapiens (Human)","microtubule-based movement [GO:0007018]","GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959"
"2818",3036,1114347,"Cluster_4629","Peve_00027824",-0.932483311680791,0.235274586467976,0.978262075707395,169,-30.53,"2 21","872 891",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"2819",3037,1114561,"Cluster_29","Peve_00012910",0.597835824264274,0.59205492546403,0.978262075707395,171,-20.45,"2 20","702 723",18,"77.78%","88.89%",NA,NA,NA,NA,NA
"2820",3038,1115070,"Cluster_5882","Peve_00011752",-0.27814091057559,0.820563558554478,0.995934364227446,166,-20.75,"2 19","268 289",17,"76.47%","88.24%",NA,NA,NA,NA,NA
"2821",3039,1116259,"Cluster_10934","Peve_00013663",-0.381401298728317,0.750883229244664,0.988219883885475,155,-21.89,"2 21","713 736",21,"66.67%","76.19%",NA,NA,NA,NA,NA
"2822",3040,1117251,"Cluster_11134","Peve_00034767",0.451245984038216,0.701959409636849,0.978262075707395,157,-20.04,"2 14","491 512",12,"83.33%","100.00%",NA,NA,NA,NA,NA
"2823",3041,1117458,"Cluster_6905","Peve_00017753",0.0612879879815807,0.960958387515361,0.999448381576871,172,-28.64,"2 21","467 488",19,"78.95%","84.21%","Q642T7","U3 small nucleolar RNA-associated protein 25 homolog (Digestive organ expansion factor homolog) (UTP25 small subunit processor component)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","digestive tract morphogenesis [GO:0048546]; embryonic organ development [GO:0048568]; exocrine pancreas development [GO:0031017]; inflammatory response to wounding [GO:0090594]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; organ growth [GO:0035265]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein localization to nucleolus [GO:1902570]; sympathetic nervous system development [GO:0048485]","GO:0000462; GO:0005730; GO:0030163; GO:0031017; GO:0031648; GO:0034511; GO:0035265; GO:0048485; GO:0048546; GO:0048568; GO:0090594; GO:1902570"
"2824",3042,1117774,"Cluster_6906","Peve_00035951",0.455847112866863,0.698672753153734,0.978262075707395,164,-22.23,"2 20","743 762",18,"83.33%","83.33%","P27926","Hexokinase-3 (EC 2.7.1.1) (Hexokinase type III) (HK III) (Hexokinase-C)","Rattus norvegicus (Rat)","carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]","GO:0001678; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005739; GO:0005829; GO:0006002; GO:0006006; GO:0006096; GO:0008865; GO:0019899; GO:0032991; GO:0042562; GO:0046835; GO:0051156; GO:1901299"
"2825",3046,1118917,"Cluster_11135","Peve_00002459",-0.807268852681121,0.401889524487299,0.978262075707395,179,-26.73,"2 20","875 896",18,"77.78%","100.00%","F6RIX4","DNA helicase MCM9 (EC 3.6.4.12) (Minichromosome maintenance 9)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]","GO:0000724; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006260; GO:0006974; GO:0016887; GO:0032508; GO:0097362"
"2826",3047,1119052,"Cluster_11135","Peve_00004850",0.963064282640398,0.173565851490462,0.978262075707395,166,-22.49,"2 20","238 260",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"2827",3049,1120410,"Cluster_16738","Peve_00042435",-0.502247974902483,0.665012926660878,0.978262075707395,163,-20.63,"2 21","842 864",20,"75.00%","80.00%",NA,NA,NA,NA,NA
"2828",3050,1120410,"Cluster_16738","Peve_00042435",-0.502247974902483,0.665012926660878,0.978262075707395,168,-21.99,"2 21","821 842",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"2829",3051,1120809,"Cluster_13502","Peve_00008119",-0.661654052192196,0.539709527340408,0.978262075707395,168,-23.11,"2 17","381 402",15,"80.00%","100.00%",NA,NA,NA,NA,NA
"2830",3052,1121064,"Cluster_7855","Peve_00001432",0.849267960462687,0.354087357982205,0.978262075707395,170,-20.42,"2 21","395 415",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"2831",3053,1121268,"Cluster_796","Peve_00009648",0.96774466946498,0.162132542670321,0.978262075707395,151,-22.95,"2 20","940 961",18,"66.67%","72.22%",NA,NA,NA,NA,NA
"2832",3054,1121606,"Cluster_8884","Peve_00009644",-0.987700020569761,0.0999524564088709,0.978262075707395,158,-20.56,"2 20","745 767",20,"65.00%","85.00%",NA,NA,NA,NA,NA
"2833",3055,1121607,"Cluster_8887","Peve_00009644",-0.99251983573429,0.0779151258646944,0.978262075707395,158,-20.19,"2 20","745 767",20,"65.00%","85.00%",NA,NA,NA,NA,NA
"2834",3056,1121608,"Cluster_8888","Peve_00009644",-0.648207666377256,0.551037738735423,0.978262075707395,158,-21.82,"2 20","745 767",20,"65.00%","85.00%",NA,NA,NA,NA,NA
"2835",3057,1121680,"Cluster_4080","Peve_00016930",-0.976243775383292,0.139042436004541,0.978262075707395,156,-21.1,"2 18","165 189",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"2836",3058,1122762,"Cluster_4629","Peve_00043745",-0.491396775468671,0.67297301129726,0.978262075707395,150,-23.2,"2 21","866 882",19,"73.68%","73.68%","Q8BNU0","Armadillo repeat-containing protein 6","Mus musculus (Mouse)","hematopoietic progenitor cell differentiation [GO:0002244]","GO:0002244; GO:0005829"
"2837",3059,1123385,"Cluster_1167","Peve_00028838",0.999909726776791,0.00855416971793915,0.573710369894872,150,-24.63,"2 20","439 461",19,"68.42%","73.68%","Q8CG08","Collagen triple helix repeat-containing protein 1","Rattus norvegicus (Rat)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005581; GO:0005615; GO:0005737; GO:0016477; GO:0016528; GO:0017147; GO:0031012; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0090090; GO:0090103; GO:0090177"
"2838",3060,1123467,"Cluster_15726","Peve_00028839",-0.938531589406843,0.224373329048821,0.978262075707395,169,-26.11,"2 19","448 471",19,"78.95%","89.47%","Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"2839",3061,1123625,"Cluster_6914","Peve_00028836",0.0244174697248888,0.984453810914684,0.999448381576871,170,-21.31,"2 20","576 597",19,"78.95%","89.47%","Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"2840",3062,1123792,"Cluster_2854","Peve_00018096",-0.507486347355159,0.661149542463894,0.978262075707395,162,-23.14,"2 21","770 795",23,"73.91%","78.26%",NA,NA,NA,NA,NA
"2841",3063,1123795,"Cluster_4080","Peve_00018096",-0.235777127616489,0.848472931070267,0.995934364227446,155,-22.85,"2 21","43 65",20,"65.00%","80.00%",NA,NA,NA,NA,NA
"2842",3064,1125171,"Cluster_11134","Peve_00031923",0.376793371831082,0.754053359862483,0.988219883885475,160,-21.12,"2 19","232 252",17,"76.47%","88.24%","Q64391","Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)","Cavia porcellus (Guinea pig)","arachidonic acid metabolic process [GO:0019369]; cholesterol metabolic process [GO:0008203]; estrogen metabolic process [GO:0008210]; retinol metabolic process [GO:0042572]","GO:0005506; GO:0005789; GO:0008203; GO:0008210; GO:0019369; GO:0020037; GO:0042572; GO:0070330; GO:0101020; GO:0101021; GO:0106256"
"2843",3065,1125281,"Cluster_4115","Peve_00009235",0.146754686511502,0.906234417440672,0.999448381576871,172,-22.43,"2 21","48 69",19,"73.68%","89.47%",NA,NA,NA,NA,NA
"2844",3066,1125762,"Cluster_15726","Peve_00033569",-0.5,0.666666666666667,0.978262075707395,154,-20.54,"2 21","170 195",23,"69.57%","73.91%","I3PB37","4-coumarate:CoA ligase 1 (Ph-4CL1) (Ph4CL1) (EC 6.2.1.12) ((E)-caffeate:CoA ligase 4CL1) (EC 6.2.1.-) (Benzoate:CoA ligase 4CL1) (EC 6.2.1.25) (Trans-cinnamate:CoA ligase 4CL1) (EC 6.2.1.-) (Trans-ferulate:CoA ligase 4CL1) (EC 6.2.1.-)","Petunia hybrida (Petunia)","cinnamic acid biosynthetic process [GO:0009800]; cinnamic acid metabolic process [GO:0009803]; circadian rhythm [GO:0007623]; ferulate metabolic process [GO:0033494]; phenylpropanoid metabolic process [GO:0009698]; phytoalexin biosynthetic process [GO:0052315]","GO:0005524; GO:0005829; GO:0007623; GO:0009698; GO:0009800; GO:0009803; GO:0016207; GO:0016405; GO:0018858; GO:0033494; GO:0050563; GO:0052315; GO:0106286; GO:0106290"
"2845",3067,1125905,"Cluster_1167","Peve_00033565",-0.505900277715137,0.662320743823743,0.978262075707395,149,-20.67,"2 19","740 762",18,"72.22%","72.22%","Q9UPM8","AP-4 complex subunit epsilon-1 (AP-4 adaptor complex subunit epsilon) (Adaptor-related protein complex 4 subunit epsilon-1) (Epsilon subunit of AP-4) (Epsilon-adaptin)","Homo sapiens (Human)","protein localization [GO:0008104]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192]","GO:0005802; GO:0006605; GO:0008104; GO:0016192; GO:0030124; GO:0031904; GO:0032588; GO:0140312"
"2846",3069,1126699,"Cluster_10934","Peve_00016265",-0.741243035479667,0.468473210679327,0.978262075707395,157,-28.54,"2 21","275 294",19,"63.16%","89.47%",NA,NA,NA,NA,NA
"2847",3070,1127245,"Cluster_14500","Peve_00027660",-0.883304657631542,0.310626572014886,0.978262075707395,166,-20.58,"2 20","709 731",19,"73.68%","89.47%","Q8WU66","Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR)","Homo sapiens (Human)","hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505]","GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170"
"2848",3071,1127649,"Cluster_13502","Peve_00036006",-0.091383302459838,0.941742306002755,0.999448381576871,161,-25.27,"2 19","573 596",19,"73.68%","84.21%","Q0IIF7","Ubiquitin carboxyl-terminal hydrolase 14 (EC 3.4.19.12) (Deubiquitinating enzyme 14) (Ubiquitin thioesterase 14) (Ubiquitin-specific-processing protease 14)","Bos taurus (Bovine)","innate immune response [GO:0045087]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; regulation of proteasomal protein catabolic process [GO:0061136]","GO:0000502; GO:0004843; GO:0005737; GO:0005886; GO:0016579; GO:0043161; GO:0045087; GO:0061136; GO:0070628"
"2849",3072,1129113,"Cluster_6905","Peve_00019437",-0.781455641484364,0.428955039423516,0.978262075707395,158,-24.13,"2 21","653 677",22,"72.73%","77.27%",NA,NA,NA,NA,NA
"2850",3073,1129737,"Cluster_4629","Peve_00005379",-0.554554668634826,0.625777256211528,0.978262075707395,159,-20.45,"2 20","301 322",18,"66.67%","83.33%",NA,NA,NA,NA,NA
"2851",3074,1130801,"Cluster_14999","Peve_00027493",0.218997454737702,0.859442716425877,0.996054723810868,158,-21.77,"2 21","240 263",21,"71.43%","80.95%",NA,NA,NA,NA,NA
"2852",3075,1131353,"Cluster_2882","Peve_00045179",0.829552508820929,0.377191141695678,0.978262075707395,151,-21.32,"2 12","736 757",10,"90.00%","100.00%",NA,NA,NA,NA,NA
"2853",3076,1131960,"Cluster_9149","Peve_00042181",0.113789280888992,0.927402249349817,0.999448381576871,158,-22.27,"2 20","8 31",20,"75.00%","75.00%","E9QAG8","Zinc finger protein 431 (Zinc finger protein 932)","Mus musculus (Mouse)","cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0006357; GO:0030154; GO:0042826; GO:0043433; GO:0045668; GO:0046872"
"2854",3077,1132517,"Cluster_589","Peve_00015169",0.891132771417583,0.299822918260325,0.978262075707395,157,-25.99,"2 20","73 96",20,"75.00%","80.00%","Q9H845","Complex I assembly factor ACAD9, mitochondrial (Acyl-CoA dehydrogenase family member 9) (ACAD-9) (EC 1.3.8.-)","Homo sapiens (Human)","long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981]","GO:0000062; GO:0001676; GO:0003995; GO:0004466; GO:0005634; GO:0005739; GO:0005743; GO:0017099; GO:0030425; GO:0031966; GO:0032981; GO:0050660; GO:0051791; GO:0070991"
"2855",3078,1132563,"Cluster_796","Peve_00039608",0.898740270652305,0.288966974174018,0.978262075707395,156,-22.33,"2 21","508 529",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"2856",3079,1132658,"Cluster_2882","Peve_00039604",0.864193488045222,0.335658451783819,0.978262075707395,148,-21.51,"2 19","160 184",20,"70.00%","75.00%",NA,NA,NA,NA,NA
"2857",3080,1132880,"Cluster_1167","Peve_00023378",0.0498642687681016,0.968242250633015,0.999448381576871,167,-24.29,"2 21","316 338",20,"80.00%","80.00%",NA,NA,NA,NA,NA
"2858",3081,1133110,"Cluster_4080","Peve_00039313",0.577127560896142,0.608347076173271,0.978262075707395,158,-20.07,"2 20","596 619",20,"70.00%","80.00%","O73792","Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)","Danio rerio (Zebrafish) (Brachydanio rerio)","angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; endothelial cell-cell adhesion [GO:0071603]; heart development [GO:0007507]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculature development [GO:0001944]","GO:0001525; GO:0001568; GO:0001944; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0007507; GO:0033674; GO:0043235; GO:0045766; GO:0071603"
"2859",3082,1133110,"Cluster_4080","Peve_00039313",0.577127560896142,0.608347076173271,0.978262075707395,176,-24.26,"2 21","566 587",19,"78.95%","89.47%","O73792","Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)","Danio rerio (Zebrafish) (Brachydanio rerio)","angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; endothelial cell-cell adhesion [GO:0071603]; heart development [GO:0007507]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculature development [GO:0001944]","GO:0001525; GO:0001568; GO:0001944; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0007507; GO:0033674; GO:0043235; GO:0045766; GO:0071603"
"2860",3083,1133362,"Cluster_11135","Peve_00010309",0.658398957655561,0.542467975423259,0.978262075707395,180,-23.61,"2 21","56 77",19,"84.21%","89.47%",NA,NA,NA,NA,NA
"2861",3084,1133928,"Cluster_6905","Peve_00000936",0.0372109528664323,0.976305301345919,0.999448381576871,162,-22.34,"2 15","743 764",13,"92.31%","92.31%","V6CLA2","E3 ubiquitin-protein ligase hecd-1 (EC 2.3.2.26)","Caenorhabditis elegans","anatomical structure development [GO:0048856]; determination of adult lifespan [GO:0008340]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of cell fate specification [GO:0042659]; regulation of germ cell proliferation [GO:1905936]; regulation of response to oxidative stress [GO:1902882]; regulation of vulval development [GO:0040028]","GO:0000209; GO:0008340; GO:0016607; GO:0032436; GO:0040028; GO:0042659; GO:0043161; GO:0045746; GO:0045747; GO:0046872; GO:0048856; GO:0061630; GO:0070534; GO:1902882; GO:1905936"
"2862",3085,1134005,"Cluster_1167","Peve_00035609",0.999615266464435,0.0176599336484992,0.782669382293497,148,-21.67,"2 14","99 121",13,"84.62%","84.62%",NA,NA,NA,NA,NA
"2863",3086,1134042,"Cluster_15726","Peve_00035609",-0.512335454030583,0.657560902736109,0.978262075707395,158,-25.11,"2 21","234 263",27,"70.37%","70.37%",NA,NA,NA,NA,NA
"2864",3087,1134277,"Cluster_2854","Peve_00030235",-0.616149330108741,0.577383553247614,0.978262075707395,154,-21.83,"2 21","933 958",23,"69.57%","73.91%",NA,NA,NA,NA,NA
"2865",3088,1134282,"Cluster_4629","Peve_00030235",0.977371360831482,0.135689648076963,0.978262075707395,167,-21.13,"2 16","346 367",14,"92.86%","92.86%",NA,NA,NA,NA,NA
"2866",3089,1134660,"Cluster_9149","Peve_00028206",-0.270271123160035,0.825773323436271,0.995934364227446,155,-20.75,"2 16","183 204",14,"78.57%","85.71%","A4FUP9","Glycosyltransferase 1 domain-containing protein 1 (EC 2.4.-.-)","Mus musculus (Mouse)","","GO:0005576; GO:0005829; GO:0016757"
"2867",3090,1135266,"Cluster_2787","Peve_00033761",0.932743658711832,0.234815310258035,0.978262075707395,163,-22.38,"2 21","100 124",22,"72.73%","77.27%","Q08BM0","tRNA methyltransferase 10 homolog B (EC 2.1.1.221) (RNA (guanine-9-)-methyltransferase domain-containing protein 3) (tRNA (guanine(9)-N(1))-methyltransferase TRMT10B)","Danio rerio (Zebrafish) (Brachydanio rerio)","tRNA N1-guanine methylation [GO:0002939]","GO:0000049; GO:0002939; GO:0005634; GO:0005654; GO:0009019; GO:0052905"
"2868",3091,1135492,"Cluster_2854","Peve_00017650",-0.899085180227327,0.288465804503742,0.978262075707395,165,-20.17,"2 21","409 430",20,"75.00%","90.00%",NA,NA,NA,NA,NA
"2869",3092,1135581,"Cluster_2787","Peve_00017656",-0.0279044575923058,0.982233164333636,0.999448381576871,159,-22.16,"2 21","10 32",20,"70.00%","80.00%","O75439","Mitochondrial-processing peptidase subunit beta (EC 3.4.24.64) (Beta-MPP) (P-52)","Homo sapiens (Human)","mitochondrial calcium ion transmembrane transport [GO:0006851]; protein processing involved in protein targeting to mitochondrion [GO:0006627]","GO:0004222; GO:0005739; GO:0005743; GO:0006627; GO:0006851; GO:0017087; GO:0046872"
"2870",3094,1137292,"Cluster_2854","Peve_00029154",-0.735132872748919,0.47423950143868,0.978262075707395,162,-20.97,"2 20","644 666",19,"73.68%","84.21%","Q9SKE2","Jasmonoyl--L-amino acid synthetase JAR1 (EC 6.3.2.52) (Jasmonate-amino acid synthetase JAR1) (Jasmonic acid-amido synthetase JAR1) (Protein FAR-RED INSENSITIVE 219) (Protein JASMONATE RESISTANT 1)","Arabidopsis thaliana (Mouse-ear cress)","cellular response to auxin stimulus [GO:0071365]; induced systemic resistance, jasmonic acid mediated signaling pathway [GO:0009864]; protein adenylylation [GO:0018117]; regulation of response to red or far red light [GO:2000030]; response to mycotoxin [GO:0010046]; response to UV-B [GO:0010224]","GO:0005524; GO:0005737; GO:0009864; GO:0010046; GO:0010224; GO:0016597; GO:0016881; GO:0018117; GO:0019899; GO:0070728; GO:0071365; GO:0102057; GO:0102058; GO:2000030"
"2871",3095,1137568,"Cluster_4735","Peve_00032145",-0.635137894625116,0.561886526623958,0.978262075707395,168,-23.14,"2 17","823 844",15,"86.67%","93.33%",NA,NA,NA,NA,NA
"2872",3096,1137592,"Cluster_11135","Peve_00032145",0.920369518441823,0.255775967538419,0.978262075707395,159,-24.5,"2 16","632 653",14,"78.57%","92.86%",NA,NA,NA,NA,NA
"2873",3097,1138090,"Cluster_14500","Peve_00002644",0.852133715774056,0.350616577093736,0.978262075707395,173,-20.84,"2 20","837 857",18,"88.89%","88.89%","Q9WYX8","Uncharacterized protein TM_0508","Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8)","DNA recombination [GO:0006310]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]","GO:0000731; GO:0003677; GO:0005524; GO:0006261; GO:0006310; GO:0008047; GO:0009378; GO:0017116"
"2874",3098,1139229,"Cluster_4079","Peve_00044680",0.999969908751759,0.00493874168584727,0.551398425649056,155,-20.12,"2 21","269 291",20,"60.00%","85.00%",NA,NA,NA,NA,NA
"2875",3099,1139256,"Cluster_11134","Peve_00044680",-0.595495610616513,0.593911431949576,0.978262075707395,146,-20.74,"2 20","289 312",20,"60.00%","75.00%",NA,NA,NA,NA,NA
"2876",3101,1139807,"Cluster_589","Peve_00023140",-0.97059636531463,0.154762439364557,0.978262075707395,162,-23.31,"2 21","149 169",19,"68.42%","89.47%",NA,NA,NA,NA,NA
"2877",3102,1139852,"Cluster_589","Peve_00023143",-0.140550090765459,0.910225790337676,0.999448381576871,168,-27.15,"2 18","813 835",17,"82.35%","94.12%",NA,NA,NA,NA,NA
"2878",3103,1140333,"Cluster_10061","Peve_00009051",-0.332396326122448,0.784285695205852,0.994573528886917,170,-20.23,"2 21","409 434",23,"78.26%","82.61%","Q8IYN6","UBA-like domain-containing protein 2","Homo sapiens (Human)","",""
"2879",3104,1140407,"Cluster_6904","Peve_00009056",0.208718150280978,0.866141742726342,0.996660710141104,163,-22.26,"2 20","143 164",18,"72.22%","83.33%",NA,NA,NA,NA,NA
"2880",3105,1140409,"Cluster_6906","Peve_00009056",-0.287038038235336,0.814658772056752,0.995934364227446,163,-22.92,"2 20","143 164",18,"72.22%","83.33%",NA,NA,NA,NA,NA
"2881",3107,1141770,"Cluster_9149","Peve_00006553",-0.736940212324771,0.472539813734743,0.978262075707395,168,-25.08,"2 21","247 268",19,"78.95%","78.95%","A9UMS3","Prohibitin-2","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","mitophagy [GO:0000423]","GO:0000423; GO:0005634; GO:0005737; GO:0005743; GO:0005886; GO:0009986; GO:0016363; GO:0035632; GO:0042803"
"2882",3108,1141905,"Cluster_9149","Peve_00006550",0.615580991958615,0.577842796254424,0.978262075707395,168,-25.08,"2 21","356 377",19,"78.95%","78.95%","Q6TDP4","Kelch-like protein 17 (Actinfilin)","Homo sapiens (Human)","actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252]","GO:0005615; GO:0007420; GO:0014069; GO:0015629; GO:0016567; GO:0030036; GO:0031208; GO:0032839; GO:0043025; GO:0051015; GO:0060090; GO:0098978; GO:0140252"
"2883",3109,1142252,"Cluster_6904","Peve_00030178",0.730889596490595,0.478210844503138,0.978262075707395,155,-20.16,"2 18","510 530",16,"81.25%","81.25%","Q9Y573","Actin-binding protein IPP (Intracisternal A particle-promoted polypeptide) (IPP) (Kelch-like protein 27)","Homo sapiens (Human)","","GO:0003779; GO:0005737; GO:0015629"
"2884",3110,1142715,"Cluster_9149","Peve_00007600",0.334991996162477,0.782532764043417,0.994152101824703,149,-22.17,"2 14","597 618",12,"66.67%","100.00%","Q8JGR4","60S ribosomal protein L24","Danio rerio (Zebrafish) (Brachydanio rerio)","chordate embryonic development [GO:0043009]; cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003729; GO:0003735; GO:0022625; GO:0043009"
"2885",3111,1142867,"Cluster_589","Peve_00023966",-0.992260720420171,0.079254855922648,0.978262075707395,148,-20.13,"2 14","18 41",14,"78.57%","85.71%",NA,NA,NA,NA,NA
"2886",3112,1143362,"Cluster_589","Peve_00026300",-0.489110914387784,0.674642652271671,0.978262075707395,151,-22.9,"2 12","45 66",10,"90.00%","100.00%","Q1LVF3","Nonsense-mediated mRNA decay factor SMG7 (SMG-7 homolog)","Danio rerio (Zebrafish) (Brachydanio rerio)","chordate embryonic development [GO:0043009]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]","GO:0000184; GO:0005697; GO:0005737; GO:0042162; GO:0043009; GO:0070034"
"2887",3113,1143446,"Cluster_14999","Peve_00026301",0.48478683847407,0.677794360095621,0.978262075707395,142,-20.13,"2 21","285 316",29,"62.07%","62.07%","Q8R4K8","Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A)","Mus musculus (Mouse)","cell surface receptor signaling pathway [GO:0007166]; female pregnancy [GO:0007565]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to dexamethasone [GO:0071548]; response to follicle-stimulating hormone [GO:0032354]","GO:0004175; GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0007166; GO:0007565; GO:0008237; GO:0030163; GO:0032354; GO:0046872; GO:0071548"
"2888",3114,1143775,"Cluster_4080","Peve_00026879",0.996568853739981,0.0527520075441396,0.966681125878338,170,-20.22,"2 21","873 893",19,"84.21%","84.21%","Q9D706","RNA polymerase II-associated protein 3","Mus musculus (Mouse)","","GO:0005829; GO:0097255; GO:0101031; GO:1990062"
"2889",3115,1143975,"Cluster_9149","Peve_00026873",-0.977527544291035,0.135218795916495,0.978262075707395,152,-20.7,"2 21","203 221",19,"68.42%","78.95%","P63079","Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3)","Rattus norvegicus (Rat)","brain development [GO:0007420]; cellular response to histamine [GO:0071420]; cellular response to zinc ion [GO:0071294]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; chemical synaptic transmission, postsynaptic [GO:0099565]; chloride transmembrane transport [GO:1902476]; circadian sleep/wake cycle, REM sleep [GO:0042747]; cochlea development [GO:0090102]; exploration behavior [GO:0035640]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hard palate development [GO:0060022]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; ion transmembrane transport [GO:0034220]; learning [GO:0007612]; memory [GO:0007613]; motor behavior [GO:0061744]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuron development [GO:0048666]; regulation of membrane potential [GO:0042391]; regulation of neuron apoptotic process [GO:0043523]; regulation of postsynaptic membrane potential [GO:0060078]; reproductive behavior [GO:0019098]; response to anesthetic [GO:0072347]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; social behavior [GO:0035176]; synaptic transmission, GABAergic [GO:0051932]","GO:0004890; GO:0005216; GO:0005231; GO:0005254; GO:0005886; GO:0007165; GO:0007214; GO:0007268; GO:0007399; GO:0007420; GO:0007605; GO:0007612; GO:0007613; GO:0009410; GO:0009986; GO:0019098; GO:0021549; GO:0022851; GO:0030594; GO:0030659; GO:0034220; GO:0034707; GO:0035176; GO:0035612; GO:0035640; GO:0042391; GO:0042747; GO:0042802; GO:0043005; GO:0043195; GO:0043523; GO:0043524; GO:0045202; GO:0045211; GO:0048666; GO:0050877; GO:0051932; GO:0060021; GO:0060022; GO:0060077; GO:0060078; GO:0060080; GO:0060119; GO:0060384; GO:0061744; GO:0071294; GO:0071420; GO:0072347; GO:0090102; GO:0098982; GO:0099565; GO:0099634; GO:1901215; GO:1902476; GO:1902711; GO:1904315; GO:1904862"
"2890",3116,1143988,"Cluster_15890","Peve_00026873",-0.62355013257252,0.571379444592403,0.978262075707395,172,-20.61,"2 21","96 117",19,"78.95%","84.21%","P63079","Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3)","Rattus norvegicus (Rat)","brain development [GO:0007420]; cellular response to histamine [GO:0071420]; cellular response to zinc ion [GO:0071294]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; chemical synaptic transmission, postsynaptic [GO:0099565]; chloride transmembrane transport [GO:1902476]; circadian sleep/wake cycle, REM sleep [GO:0042747]; cochlea development [GO:0090102]; exploration behavior [GO:0035640]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hard palate development [GO:0060022]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; ion transmembrane transport [GO:0034220]; learning [GO:0007612]; memory [GO:0007613]; motor behavior [GO:0061744]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuron development [GO:0048666]; regulation of membrane potential [GO:0042391]; regulation of neuron apoptotic process [GO:0043523]; regulation of postsynaptic membrane potential [GO:0060078]; reproductive behavior [GO:0019098]; response to anesthetic [GO:0072347]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; social behavior [GO:0035176]; synaptic transmission, GABAergic [GO:0051932]","GO:0004890; GO:0005216; GO:0005231; GO:0005254; GO:0005886; GO:0007165; GO:0007214; GO:0007268; GO:0007399; GO:0007420; GO:0007605; GO:0007612; GO:0007613; GO:0009410; GO:0009986; GO:0019098; GO:0021549; GO:0022851; GO:0030594; GO:0030659; GO:0034220; GO:0034707; GO:0035176; GO:0035612; GO:0035640; GO:0042391; GO:0042747; GO:0042802; GO:0043005; GO:0043195; GO:0043523; GO:0043524; GO:0045202; GO:0045211; GO:0048666; GO:0050877; GO:0051932; GO:0060021; GO:0060022; GO:0060077; GO:0060078; GO:0060080; GO:0060119; GO:0060384; GO:0061744; GO:0071294; GO:0071420; GO:0072347; GO:0090102; GO:0098982; GO:0099565; GO:0099634; GO:1901215; GO:1902476; GO:1902711; GO:1904315; GO:1904862"
"2891",3119,1145210,"Cluster_1167","Peve_00010142",0.900908197130369,0.285803292523774,0.978262075707395,154,-21.19,"2 21","744 764",19,"68.42%","78.95%","P58389","Serine/threonine-protein phosphatase 2A activator (EC 5.2.1.8) (PP2A, subunit B', PR53 isoform) (Phosphotyrosyl phosphatase activator) (PTPA) (Serine/threonine-protein phosphatase 2A regulatory subunit 4) (Serine/threonine-protein phosphatase 2A regulatory subunit B')","Mus musculus (Mouse)","mitotic spindle organization [GO:0007052]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of apoptotic process [GO:0043065]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of phosphoprotein phosphatase activity [GO:0043666]","GO:0000159; GO:0003755; GO:0004721; GO:0005102; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0007052; GO:0008160; GO:0019888; GO:0032515; GO:0032516; GO:0034704; GO:0035307; GO:0035308; GO:0042803; GO:0043065; GO:0043666; GO:0051721; GO:1904949"
"2892",3120,1145355,"Cluster_5882","Peve_00010145",-0.734982830771974,0.474380385024866,0.978262075707395,146,-20.8,"2 21","486 506",19,"57.89%","78.95%","A0A0R4IBK5","E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha)","Danio rerio (Zebrafish) (Brachydanio rerio)","blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]","GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051"
"2893",3121,1145622,"Cluster_4629","Peve_00023421",0.997938030915672,0.0408894104551393,0.909359886114279,155,-24.89,"2 12","259 280",10,"100.00%","100.00%","P48040","Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor)","Ovis aries (Sheep)","","GO:0005886; GO:0008502"
"2894",3122,1145665,"Cluster_4080","Peve_00023426",-0.826269217020761,0.38091797565177,0.978262075707395,169,-20.76,"2 20","733 753",18,"83.33%","88.89%",NA,NA,NA,NA,NA
"2895",3123,1145793,"Cluster_796","Peve_00024437",-0.0696341159246928,0.955633640840684,0.999448381576871,154,-25.14,"2 21","260 284",22,"72.73%","72.73%",NA,NA,NA,NA,NA
"2896",3124,1146287,"Cluster_589","Peve_00012786",-0.0338512783076741,0.978445488987232,0.999448381576871,155,-23.41,"2 12","824 845",10,"100.00%","100.00%","O75762","Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor)","Homo sapiens (Human)","calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular calcium ion homeostasis [GO:0006874]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to organic substance [GO:0071310]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; ion transport [GO:0006811]; protein homotetramerization [GO:0051289]; response to cold [GO:0009409]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]","GO:0005262; GO:0005886; GO:0006811; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0010033; GO:0014070; GO:0015267; GO:0015278; GO:0019233; GO:0032421; GO:0042802; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0051289; GO:0070301; GO:0070588; GO:0071310; GO:0097604"
"2897",3125,1146411,"Cluster_11134","Peve_00012784",-0.0195622829453675,0.987545469442176,0.999448381576871,156,-26.11,"2 13","66 87",11,"90.91%","100.00%","Q8BLA8","Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor)","Mus musculus (Mouse)","calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular calcium ion homeostasis [GO:0006874]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to organic substance [GO:0071310]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; positive regulation of anion transport [GO:1903793]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of sensory perception of pain [GO:1904058]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832]","GO:0005216; GO:0005245; GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0010033; GO:0014070; GO:0014832; GO:0015267; GO:0015278; GO:0016020; GO:0016324; GO:0019233; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042542; GO:0042802; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0050974; GO:0051289; GO:0070301; GO:0070417; GO:0070588; GO:0071244; GO:0071310; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1904058; GO:1990760"
"2898",3126,1147187,"Cluster_589","Peve_00019581",-0.565088478075204,0.617684048778298,0.978262075707395,157,-20.03,"2 20","363 383",18,"72.22%","83.33%",NA,NA,NA,NA,NA
"2899",3127,1147551,"Cluster_2787","Peve_00004587",0.787562819127872,0.422685189823145,0.978262075707395,156,-21.79,"2 19","700 720",17,"76.47%","82.35%","Q924H0","Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor)","Mus musculus (Mouse)","G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]","GO:0004930; GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0042277; GO:0043408; GO:0045761; GO:2000479"
"2900",3128,1148410,"Cluster_4080","Peve_00013558",0.319883783962208,0.79271225800757,0.995934364227446,158,-20.33,"2 17","915 935",15,"80.00%","93.33%","B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"2901",3129,1148721,"Cluster_2787","Peve_00041551",0.155678487633334,0.900487239773744,0.999448381576871,161,-21.28,"2 19","838 860",18,"72.22%","88.89%",NA,NA,NA,NA,NA
"2902",3130,1148727,"Cluster_4629","Peve_00041551",0.974933823899871,0.142840228782637,0.978262075707395,142,-22.09,"2 11","858 879",9,"77.78%","100.00%",NA,NA,NA,NA,NA
"2903",3134,1149786,"Cluster_11134","Peve_00043958",0.320664716910812,0.792187456651714,0.995934364227446,153,-22.54,"2 16","550 570",14,"78.57%","92.86%","C3ZQF9","QRFP-like peptide receptor","Branchiostoma floridae (Florida lancelet) (Amphioxus)","cellular response to peptide [GO:1901653]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:1901653"
"2904",3135,1149849,"Cluster_4079","Peve_00026463",-0.992818546029378,0.076341653074033,0.978262075707395,167,-22.27,"2 20","3 24",18,"77.78%","83.33%","Q92535","Phosphatidylinositol N-acetylglucosaminyltransferase subunit C (Phosphatidylinositol-glycan biosynthesis class C protein) (PIG-C)","Homo sapiens (Human)","GPI anchor biosynthetic process [GO:0006506]","GO:0000506; GO:0003824; GO:0005789; GO:0006506"
"2905",3136,1149887,"Cluster_589","Peve_00026462",-0.999999797342096,0.00040530027750834,0.219367948732634,156,-21.22,"2 21","265 286",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"2906",3137,1149984,"Cluster_4079","Peve_00026464",0.986011967099394,0.106605838502461,0.978262075707395,167,-22.27,"2 20","3 24",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"2907",3138,1150279,"Cluster_10934","Peve_00043953",-0.11031111331997,0.929630553407807,0.999448381576871,164,-22.31,"2 20","122 141",18,"83.33%","83.33%","Q7RTR2","NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","Homo sapiens (Human)","I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223"
"2908",3139,1150596,"Cluster_11134","Peve_00012209",0.462117104672857,0.694179944502878,0.978262075707395,150,-20.85,"2 21","863 883",19,"57.89%","84.21%","Q9NZJ4","Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)","Homo sapiens (Human)","negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]","GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0042802; GO:0051087; GO:0070628; GO:0070852; GO:0090084"
"2909",3140,1151051,"Cluster_14999","Peve_00042390",0.0701898482879195,0.955278982835448,0.999448381576871,159,-22.97,"2 21","362 384",20,"70.00%","80.00%","P09759","Ephrin type-B receptor 1 (EC 2.7.10.1) (ELK) (Tyrosine-protein kinase receptor EPH-2)","Rattus norvegicus (Rat)","angiogenesis [GO:0001525]; axon guidance [GO:0007411]; camera-type eye morphogenesis [GO:0048593]; cell chemotaxis [GO:0060326]; cell-substrate adhesion [GO:0031589]; central nervous system projection neuron axonogenesis [GO:0021952]; cranial nerve development [GO:0021545]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; hindbrain tangential cell migration [GO:0021934]; immunological synapse formation [GO:0001771]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; optic nerve morphogenesis [GO:0021631]; positive regulation of kinase activity [GO:0033674]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of neuron death [GO:1901214]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle satellite cell activation [GO:0014719]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0001525; GO:0001771; GO:0004713; GO:0004714; GO:0005005; GO:0005524; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0007169; GO:0007411; GO:0008046; GO:0014719; GO:0016020; GO:0021545; GO:0021631; GO:0021934; GO:0021952; GO:0022008; GO:0030010; GO:0030424; GO:0030425; GO:0031290; GO:0031589; GO:0031901; GO:0032433; GO:0033674; GO:0043005; GO:0043235; GO:0044877; GO:0045121; GO:0046328; GO:0046777; GO:0048013; GO:0048593; GO:0050804; GO:0050965; GO:0051965; GO:0060326; GO:0060996; GO:0060997; GO:0061351; GO:0070372; GO:0098978; GO:1901214; GO:1902723; GO:1902725"
"2910",3141,1151280,"Cluster_16738","Peve_00042396",0.185340257435285,0.881322546795224,0.999082389212776,160,-21.79,"2 13","979 1000",11,"100.00%","100.00%","Q07496","Ephrin type-A receptor 4 (EC 2.7.10.1) (EPH-like kinase 8) (EK8) (cEK8)","Gallus gallus (Chicken)","axon guidance [GO:0007411]; cell adhesion [GO:0007155]; fasciculation of sensory neuron axon [GO:0097155]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; positive regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001108]; protein autophosphorylation [GO:0046777]; regulation of GTPase activity [GO:0043087]; segmentation [GO:0035282]; somitogenesis [GO:0001756]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0001756; GO:0004672; GO:0004714; GO:0005004; GO:0005005; GO:0005524; GO:0005737; GO:0005886; GO:0007155; GO:0007169; GO:0007411; GO:0018108; GO:0031901; GO:0033674; GO:0035282; GO:0043005; GO:0043087; GO:0043197; GO:0043235; GO:0046777; GO:0097155; GO:0097161; GO:2001108"
"2911",3142,1152081,"Cluster_11134","Peve_00003991",-0.0195622829453675,0.987545469442176,0.999448381576871,155,-20.66,"2 18","789 812",18,"72.22%","88.89%",NA,NA,NA,NA,NA
"2912",3143,1152254,"Cluster_8988","Peve_00003995",0.739548734647534,0.470077901508507,0.978262075707395,169,-20.68,"2 20","689 709",18,"83.33%","88.89%",NA,NA,NA,NA,NA
"2913",3144,1152255,"Cluster_9149","Peve_00003995",-0.955064471002567,0.191571053306627,0.978262075707395,147,-20.29,"2 12","117 138",10,"80.00%","100.00%",NA,NA,NA,NA,NA
"2914",3145,1152447,"Cluster_15726","Peve_00043042",-0.816276480685389,0.392069181896162,0.978262075707395,180,-25.77,"2 21","892 913",19,"84.21%","89.47%","A6NNA5","Dorsal root ganglia homeobox protein (Paired-related homeobox protein-like 1)","Homo sapiens (Human)","axon guidance [GO:0007411]; detection of chemical stimulus [GO:0009593]; detection of temperature stimulus [GO:0016048]; dorsal spinal cord development [GO:0021516]; neuron migration [GO:0001764]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of mechanical stimulus [GO:0050954]; trigeminal nerve development [GO:0021559]","GO:0000785; GO:0000977; GO:0000981; GO:0001764; GO:0005634; GO:0006357; GO:0007411; GO:0009593; GO:0016048; GO:0021516; GO:0021559; GO:0050954; GO:1990837"
"2915",3146,1152462,"Cluster_4629","Peve_00043040",-0.0699489441598072,0.955432725047047,0.999448381576871,150,-21.02,"2 21","916 940",22,"68.18%","72.73%","P02459","Collagen alpha-1(II) chain (Alpha-1 type II collagen)","Bos taurus (Bovine)","anterior head development [GO:0097065]; cartilage condensation [GO:0001502]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to BMP stimulus [GO:0071773]; central nervous system development [GO:0007417]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; embryonic skeletal joint morphogenesis [GO:0060272]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; limb bud formation [GO:0060174]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; notochord development [GO:0030903]; otic vesicle development [GO:0071599]; proteoglycan metabolic process [GO:0006029]; regulation of gene expression [GO:0010468]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; tissue homeostasis [GO:0001894]; visual perception [GO:0007601]","GO:0001501; GO:0001502; GO:0001894; GO:0001958; GO:0002062; GO:0003007; GO:0005201; GO:0005576; GO:0005581; GO:0005585; GO:0005592; GO:0005604; GO:0005615; GO:0005737; GO:0006029; GO:0007417; GO:0007601; GO:0007605; GO:0010468; GO:0030198; GO:0030199; GO:0030903; GO:0031012; GO:0042289; GO:0042472; GO:0042802; GO:0043394; GO:0046872; GO:0048407; GO:0060021; GO:0060174; GO:0060272; GO:0060351; GO:0062023; GO:0071599; GO:0071773; GO:0097065; GO:0097192; GO:2001240"
"2916",3147,1152545,"Cluster_1167","Peve_00038149",-0.511591173923624,0.65811249694873,0.978262075707395,161,-22.89,"2 19","934 956",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"2917",3148,1152560,"Cluster_6914","Peve_00038149",-0.877975932427226,0.317787144248017,0.978262075707395,179,-26.23,"2 20","172 192",18,"88.89%","88.89%",NA,NA,NA,NA,NA
"2918",3149,1152635,"Cluster_1167","Peve_00041678",0.607494351110356,0.584349467597716,0.978262075707395,145,-23.18,"2 15","672 694",14,"78.57%","78.57%","Q9HAS0","Protein Njmu-R1","Homo sapiens (Human)","intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041]","GO:0005802; GO:0006886; GO:0031410; GO:0099041"
"2919",3150,1153142,"Cluster_6904","Peve_00030373",-0.858700681547652,0.342544366413565,0.978262075707395,153,-20.68,"2 19","281 303",18,"72.22%","77.78%","Q62825","Exocyst complex component 3 (Exocyst complex component Sec6) (rSec6)","Rattus norvegicus (Rat)","exocyst localization [GO:0051601]; exocytosis [GO:0006887]; protein transport [GO:0015031]","GO:0000145; GO:0000149; GO:0005794; GO:0006887; GO:0015031; GO:0016020; GO:0030426; GO:0030496; GO:0042734; GO:0048471; GO:0051601"
"2920",3151,1153287,"Cluster_8887","Peve_00030377",-0.599752430431469,0.590531457350519,0.978262075707395,154,-20.91,"2 20","603 624",19,"73.68%","73.68%","Q8C206","G-protein coupled receptor 157","Mus musculus (Mouse)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; circadian behavior [GO:0048512]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; radial glial cell differentiation [GO:0060019]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0048512; GO:0051482; GO:0060019; GO:0060170"
"2921",3152,1154073,"Cluster_796","Peve_00035474",-0.0696341159246928,0.955633640840684,0.999448381576871,154,-20.7,"2 21","225 248",21,"66.67%","80.95%","B3EWY9","Mucin-like protein","Acropora millepora (Staghorn coral) (Heteropora millepora)","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0007160; GO:0016020"
"2922",3153,1154190,"Cluster_9149","Peve_00035472",-0.498115076878255,0.66805141503306,0.978262075707395,158,-30.38,"2 20","110 132",19,"73.68%","78.95%","A7RV13","Proteasome assembly chaperone 1","Nematostella vectensis (Starlet sea anemone)","proteasome core complex assembly [GO:0080129]","GO:0005783; GO:0070628; GO:0080129"
"2923",3154,1155135,"Cluster_9149","Peve_00041949",-0.5,0.666666666666667,0.978262075707395,156,-24.72,"2 21","496 515",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"2924",3155,1155286,"Cluster_29","Peve_00041941",-0.984577161443364,0.111953334428221,0.978262075707395,159,-20.13,"2 21","741 764",21,"71.43%","76.19%",NA,NA,NA,NA,NA
"2925",3156,1155345,"Cluster_5882","Peve_00014600",-0.471895503264252,0.687139908217469,0.978262075707395,149,-20.74,"2 18","417 438",16,"68.75%","75.00%","Q96EX2","RING finger and transmembrane domain-containing protein 2 (Transmembrane protein 118)","Homo sapiens (Human)","positive regulation of ERAD pathway [GO:1904294]","GO:0016020; GO:0046872; GO:0061630; GO:1904294"
"2926",3157,1155383,"Cluster_2882","Peve_00041943",0.0688372031480257,0.956142191637655,0.999448381576871,148,-20.74,"2 14","766 789",14,"78.57%","85.71%",NA,NA,NA,NA,NA
"2927",3158,1156113,"Cluster_6905","Peve_00033132",-0.929945104908788,0.239708228175045,0.978262075707395,161,-20.88,"2 18","486 507",16,"75.00%","87.50%","A2AJ76","Hemicentin-2","Mus musculus (Mouse)","response to stimulus [GO:0050896]","GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023"
"2928",3159,1156242,"Cluster_4629","Peve_00006822",-0.820111503959452,0.387822696845469,0.978262075707395,155,-20.8,"2 21","221 244",21,"61.90%","80.95%",NA,NA,NA,NA,NA
"2929",3160,1156287,"Cluster_4629","Peve_00006821",0.336671643433437,0.781397535331979,0.993856006871016,155,-20.8,"2 21","349 372",21,"61.90%","80.95%",NA,NA,NA,NA,NA
"2930",3162,1156462,"Cluster_2854","Peve_00006824",0.999627383900334,0.0173795855218949,0.782669382293497,166,-26.08,"2 15","909 930",13,"92.31%","100.00%",NA,NA,NA,NA,NA
"2931",3164,1157232,"Cluster_4629","Peve_00002566",-0.166058540214551,0.893791858505381,0.999448381576871,153,-21.18,"2 20","862 882",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"2932",3165,1157385,"Cluster_9149","Peve_00002568",-0.5,0.666666666666667,0.978262075707395,149,-22.92,"2 14","925 946",12,"75.00%","91.67%",NA,NA,NA,NA,NA
"2933",3166,1157852,"Cluster_589","Peve_00032269",-0.95437101386909,0.193054926590372,0.978262075707395,161,-23.44,"2 19","750 772",18,"72.22%","88.89%","Q8TD19","Serine/threonine-protein kinase Nek9 (EC 2.7.11.1) (Nercc1 kinase) (Never in mitosis A-related kinase 9) (NimA-related protein kinase 9) (NimA-related kinase 8) (Nek8)","Homo sapiens (Human)","cell division [GO:0051301]; mitotic cell cycle [GO:0000278]; protein phosphorylation [GO:0006468]","GO:0000278; GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0006468; GO:0019901; GO:0030295; GO:0046872; GO:0051301; GO:0106310"
"2934",3167,1158510,"Cluster_9149","Peve_00016221",-0.156284500250484,0.900096659440875,0.999448381576871,153,-21.02,"2 21","967 986",19,"73.68%","73.68%","Q8K4Z4","Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor)","Cavia porcellus (Guinea pig)","activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone resorption [GO:0045453]; brown fat cell differentiation [GO:0050873]; cellular response to amyloid-beta [GO:1904646]; desensitization of G protein-coupled receptor signaling pathway by arrestin [GO:0002032]; diet induced thermogenesis [GO:0002024]; heat generation [GO:0031649]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of smooth muscle contraction [GO:0045986]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of lipophagy [GO:1904504]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor-mediated endocytosis [GO:0006898]; regulation of sodium ion transport [GO:0002028]; response to cold [GO:0009409]; smooth muscle contraction [GO:0006939]; transcription by RNA polymerase II [GO:0006366]","GO:0001540; GO:0002024; GO:0002025; GO:0002028; GO:0002032; GO:0004941; GO:0005634; GO:0005769; GO:0005794; GO:0006366; GO:0006898; GO:0006939; GO:0007189; GO:0007190; GO:0008179; GO:0009409; GO:0010739; GO:0015459; GO:0016324; GO:0030501; GO:0031649; GO:0040015; GO:0042803; GO:0043235; GO:0043410; GO:0044877; GO:0045453; GO:0045944; GO:0045986; GO:0050873; GO:0051380; GO:0061885; GO:0071902; GO:0098992; GO:0120162; GO:1901098; GO:1904504; GO:1904646; GO:2000969"
"2935",3168,1158585,"Cluster_5882","Peve_00016224",-0.267256867905856,0.827765561170921,0.995934364227446,156,-25.51,"2 18","175 198",18,"72.22%","83.33%","Q460N5","Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14)","Homo sapiens (Human)","innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein poly-ADP-ribosylation [GO:0070212]","GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016020; GO:0016779; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:1902216; GO:1990404"
"2936",3169,1158735,"Cluster_9149","Peve_00022174",-0.926152531586794,0.246191182495033,0.978262075707395,155,-20.59,"2 21","854 876",20,"65.00%","80.00%","Q58D55","Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase)","Bos taurus (Bovine)","carbohydrate metabolic process [GO:0005975]","GO:0004565; GO:0005764; GO:0005975"
"2937",3170,1159016,"Cluster_14999","Peve_00008680",0.781012531533716,0.429406938393966,0.978262075707395,163,-21.2,"2 21","516 541",23,"69.57%","78.26%","Q3SZB4","Medium-chain specific acyl-CoA dehydrogenase, mitochondrial (MCAD) (EC 1.3.8.7)","Bos taurus (Bovine)","cardiac muscle cell differentiation [GO:0055007]; carnitine biosynthetic process [GO:0045329]; carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; glycogen biosynthetic process [GO:0005978]; liver development [GO:0001889]; medium-chain fatty acid catabolic process [GO:0051793]; post-embryonic development [GO:0009791]; regulation of gluconeogenesis [GO:0006111]; response to cold [GO:0009409]; response to starvation [GO:0042594]","GO:0001889; GO:0003995; GO:0005737; GO:0005739; GO:0005759; GO:0005978; GO:0006111; GO:0006635; GO:0009409; GO:0009791; GO:0019254; GO:0030424; GO:0031966; GO:0033539; GO:0042594; GO:0042802; GO:0045329; GO:0050660; GO:0051793; GO:0055007; GO:0070991"
"2938",3171,1159438,"Cluster_4735","Peve_00037729",-0.500943642233887,0.665972771890438,0.978262075707395,159,-24.87,"2 21","684 707",21,"66.67%","80.95%",NA,NA,NA,NA,NA
"2939",3172,1159455,"Cluster_9149","Peve_00037729",-0.5,0.666666666666667,0.978262075707395,160,-21.44,"2 13","361 382",11,"100.00%","100.00%",NA,NA,NA,NA,NA
"2940",3173,1159545,"Cluster_9149","Peve_00008091",-0.993861069684774,0.0705771144742085,0.978262075707395,156,-22.06,"2 21","216 237",19,"63.16%","78.95%",NA,NA,NA,NA,NA
"2941",3174,1159724,"Cluster_8988","Peve_00037727",-0.273749745313153,0.823471988872095,0.995934364227446,162,-23.7,"2 21","785 811",24,"70.83%","79.17%","Q8IVB4","Sodium/hydrogen exchanger 9 (Na(+)/H(+) exchanger 9) (NHE-9) (Solute carrier family 9 member 9)","Homo sapiens (Human)","defense response to bacterium [GO:0042742]; ion transport [GO:0006811]; phagosome maturation [GO:0090382]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]","GO:0005769; GO:0005886; GO:0006811; GO:0015385; GO:0015386; GO:0030670; GO:0031902; GO:0032009; GO:0042742; GO:0051453; GO:0055037; GO:0055038; GO:0071805; GO:0090382; GO:0098719"
"2942",3175,1159835,"Cluster_1167","Peve_00037723",-0.511591173923624,0.65811249694873,0.978262075707395,147,-20.1,"2 19","577 596",17,"70.59%","76.47%",NA,NA,NA,NA,NA
"2943",3176,1160480,"Cluster_6914","Peve_00031765",0.40754311269983,0.732771220624217,0.985282504167073,161,-23.28,"2 20","940 959",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"2944",3177,1160944,"Cluster_10934","Peve_00015753",-0.723058111304067,0.485471728904339,0.978262075707395,160,-21.5,"2 21","780 799",19,"78.95%","84.21%","Q8N1E6","F-box/LRR-repeat protein 14 (F-box and leucine-rich repeat protein 14)","Homo sapiens (Human)","SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0019005; GO:0031146"
"2945",3178,1161502,"Cluster_2854","Peve_00005107",-0.727588935563992,0.481281722093011,0.978262075707395,172,-20.19,"2 21","549 570",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"2946",3179,1161945,"Cluster_16738","Peve_00018703",0.941976297612242,0.217931741733258,0.978262075707395,173,-22.96,"2 18","935 956",16,"81.25%","100.00%","Q8AV28","Pericentriolar material 1 protein (PCM-1)","Gallus gallus (Chicken)","centrosome cycle [GO:0007098]; cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule anchoring at centrosome [GO:0034454]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]","GO:0005737; GO:0005813; GO:0005814; GO:0007098; GO:0034451; GO:0034454; GO:0035735; GO:0036064; GO:0060271; GO:0071539; GO:0090316"
"2947",3180,1162785,"Cluster_9149","Peve_00031184",0.913922267764784,0.266076272594403,0.978262075707395,150,-21.5,"2 15","436 457",13,"76.92%","84.62%",NA,NA,NA,NA,NA
"2948",3182,1163190,"Cluster_9149","Peve_00006452",0.976165528760364,0.139272148110317,0.978262075707395,155,-23.16,"2 18","8 32",19,"78.95%","78.95%","Q9ES56","Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog)","Mus musculus (Mouse)","autophagy [GO:0006914]; COPII vesicle coating [GO:0048208]; dendrite development [GO:0016358]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005737; GO:0005783; GO:0005795; GO:0005886; GO:0006888; GO:0006901; GO:0006914; GO:0008021; GO:0016192; GO:0016358; GO:0030008; GO:0030425; GO:0045202; GO:0045211; GO:0048208; GO:0099022; GO:1990071; GO:1990072"
"2949",3183,1163325,"Cluster_9149","Peve_00006451",0.572486840347035,0.611957517879082,0.978262075707395,155,-23.16,"2 18","179 203",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"2950",3184,1163442,"Cluster_4629","Peve_00006454",-0.29281000667601,0.810819309517348,0.995934364227446,154,-22.66,"2 19","181 202",17,"64.71%","82.35%","Q6GQL0","E3 ubiquitin-protein ligase CBL-B-A (EC 2.3.2.27) (RING-type E3 ubiquitin transferase CBL-B-A) (SH3-binding protein CBL-B-A) (Signal transduction protein CBL-B-A)","Xenopus laevis (African clawed frog)","cell surface receptor signaling pathway [GO:0007166]; immune system process [GO:0002376]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]","GO:0001784; GO:0002376; GO:0004842; GO:0005509; GO:0005737; GO:0007166; GO:2000583"
"2951",3185,1163526,"Cluster_2787","Peve_00022915",0.85034082232141,0.352791572625091,0.978262075707395,158,-20.34,"2 20","609 631",19,"73.68%","78.95%","Q86TI4","WD repeat-containing protein 86","Homo sapiens (Human)","",""
"2952",3186,1163623,"Cluster_4735","Peve_00022917",-0.597644618443619,0.592206761495927,0.978262075707395,165,-22.03,"2 18","107 128",16,"75.00%","93.75%","Q9JJZ8","Cyclic nucleotide-gated cation channel alpha-3 (Cone photoreceptor cGMP-gated channel subunit alpha) (Cyclic nucleotide-gated channel alpha-3) (CNG channel alpha-3) (CNG-3) (CNG3)","Mus musculus (Mouse)","cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; inorganic cation import across plasma membrane [GO:0098659]; ion transmembrane transport [GO:0034220]; response to cAMP [GO:0051591]; response to magnesium ion [GO:0032026]; retinal cone cell development [GO:0046549]; visual perception [GO:0007601]","GO:0001750; GO:0005221; GO:0005222; GO:0005223; GO:0005737; GO:0005886; GO:0006812; GO:0007601; GO:0008022; GO:0017071; GO:0030425; GO:0030553; GO:0032026; GO:0034220; GO:0043025; GO:0043194; GO:0043204; GO:0044877; GO:0046549; GO:0051591; GO:0097386; GO:0098655; GO:0098659; GO:0120199; GO:1902495"
"2953",3187,1163675,"Cluster_6914","Peve_00022911",0.043468237845796,0.972318538349113,0.999448381576871,159,-20.34,"2 17","586 607",16,"81.25%","87.50%","Q6ZQL4","WD repeat-containing protein 43","Mus musculus (Mouse)","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription elongation by RNA polymerase II [GO:0034243]","GO:0000462; GO:0000785; GO:0000993; GO:0001650; GO:0003711; GO:0003723; GO:0005654; GO:0005730; GO:0034243; GO:0045943; GO:2000036; GO:2000234"
"2954",3188,1164216,"Cluster_7053","Peve_00021466",0.972608967804853,0.149346706783179,0.978262075707395,155,-20.38,"2 20","414 433",18,"72.22%","88.89%","Q9JI70","Molecular chaperone MKKS (McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin) (Protein Bbs6 homolog)","Mus musculus (Mouse)","artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; chaperone-mediated protein complex assembly [GO:0051131]; cilium assembly [GO:0060271]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; developmental process [GO:0032502]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of blood pressure [GO:0045776]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of stress fiber assembly [GO:0051492]; response to leptin [GO:0044321]; sensory perception of smell [GO:0007608]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; vasodilation [GO:0042311]","GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006457; GO:0007286; GO:0007608; GO:0010467; GO:0010629; GO:0014824; GO:0021756; GO:0021766; GO:0021987; GO:0030837; GO:0031514; GO:0032502; GO:0033210; GO:0034260; GO:0035176; GO:0036064; GO:0038108; GO:0040018; GO:0042311; GO:0044321; GO:0045444; GO:0045494; GO:0045776; GO:0046907; GO:0048854; GO:0050910; GO:0051082; GO:0051131; GO:0051216; GO:0051492; GO:0060271; GO:0060296; GO:0060324; GO:0061629; GO:1902636; GO:1905515"
"2955",3189,1164537,"Cluster_8887","Peve_00007411",0.154461906098421,0.901271223177584,0.999448381576871,159,-21.99,"2 20","783 800",18,"77.78%","83.33%","Q08623","Pseudouridine-5'-phosphatase (EC 3.1.3.96) (Haloacid dehalogenase-like hydrolase domain-containing protein 1) (Haloacid dehalogenase-like hydrolase domain-containing protein 1A) (Protein GS1) (Pseudouridine-5'-monophosphatase) (5'-PsiMPase)","Homo sapiens (Human)","nucleotide metabolic process [GO:0009117]","GO:0005829; GO:0009117; GO:0016791; GO:0046872; GO:1990738"
"2956",3190,1164538,"Cluster_8888","Peve_00007411",-0.554778289100327,0.625606163951687,0.978262075707395,159,-23.62,"2 20","783 800",18,"77.78%","83.33%","Q08623","Pseudouridine-5'-phosphatase (EC 3.1.3.96) (Haloacid dehalogenase-like hydrolase domain-containing protein 1) (Haloacid dehalogenase-like hydrolase domain-containing protein 1A) (Protein GS1) (Pseudouridine-5'-monophosphatase) (5'-PsiMPase)","Homo sapiens (Human)","nucleotide metabolic process [GO:0009117]","GO:0005829; GO:0009117; GO:0016791; GO:0046872; GO:1990738"
"2957",3191,1165536,"Cluster_11134","Peve_00018326",0.875640822838247,0.320878802775509,0.978262075707395,157,-23.74,"2 15","5 27",14,"85.71%","92.86%",NA,NA,NA,NA,NA
"2958",3192,1165828,"Cluster_4735","Peve_00011429",-0.540245913270132,0.636662435598039,0.978262075707395,163,-20.56,"2 21","37 60",21,"66.67%","85.71%",NA,NA,NA,NA,NA
"2959",3193,1166169,"Cluster_13502","Peve_00017863",0.329713556375212,0.786095661583928,0.994983969371078,170,-22.55,"2 21","732 755",21,"80.95%","85.71%",NA,NA,NA,NA,NA
"2960",3194,1166184,"Cluster_4079","Peve_00017869",-0.633349604157378,0.563359056728106,0.978262075707395,157,-22.9,"2 20","206 226",18,"66.67%","88.89%",NA,NA,NA,NA,NA
"2961",3195,1166448,"Cluster_796","Peve_00013379",0.906857142181024,0.276949088396139,0.978262075707395,145,-20.55,"2 21","639 664",23,"69.57%","69.57%",NA,NA,NA,NA,NA
"2962",3196,1166453,"Cluster_2882","Peve_00013379",-0.907193510129248,0.276440537599168,0.978262075707395,144,-20.99,"2 16","759 778",14,"78.57%","78.57%",NA,NA,NA,NA,NA
"2963",3197,1167050,"Cluster_6914","Peve_00012426",0.265302664472889,0.829056245106544,0.995934364227446,179,-26.46,"2 20","172 192",18,"88.89%","88.89%",NA,NA,NA,NA,NA
"2964",3198,1167437,"Cluster_589","Peve_00010483",-0.35318956261759,0.770194137929923,0.991071888744218,158,-22.25,"2 20","310 333",20,"70.00%","80.00%",NA,NA,NA,NA,NA
"2965",3199,1167825,"Cluster_9149","Peve_00017131",-0.5,0.666666666666667,0.978262075707395,162,-24.92,"2 21","397 417",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"2966",3200,1168473,"Cluster_796","Peve_00020475",0.749981109466341,0.460125093765748,0.978262075707395,154,-23.01,"2 19","856 877",17,"70.59%","76.47%",NA,NA,NA,NA,NA
"2967",3201,1169607,"Cluster_4629","Peve_00003765",-0.251379008795404,0.838231890782837,0.995934364227446,147,-20.37,"2 21","587 609",20,"65.00%","70.00%",NA,NA,NA,NA,NA
"2968",3202,1169690,"Cluster_1167","Peve_00041291",-0.999403063667998,0.0219978751741613,0.831331530166709,155,-26.97,"2 21","510 535",23,"65.22%","73.91%",NA,NA,NA,NA,NA
"2969",3203,1170394,"Cluster_10934","Peve_00021707",0.998758250045998,0.0317290557481587,0.903929377050813,172,-23.08,"2 21","819 840",19,"78.95%","84.21%","Q4I963","Cofilin (Actin-depolymerizing factor 1)","Gibberella zeae (strain ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1) (Wheat head blight fungus) (Fusarium graminearum)","actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301]","GO:0003779; GO:0005737; GO:0007049; GO:0015629; GO:0016363; GO:0030042; GO:0051301"
"2970",3204,1170727,"Cluster_2854","Peve_00015194",-0.204101171432156,0.869145693941443,0.997306721212908,154,-20.05,"2 20","238 260",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"2971",3205,1172583,"Cluster_6905","Peve_00029252",-0.157492750698866,0.899317818330453,0.999448381576871,153,-20.68,"2 19","453 475",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"2972",3206,1173051,"Cluster_11134","Peve_00038332",0.995709394212987,0.0589942701201762,0.978262075707395,157,-21.68,"2 15","154 176",14,"85.71%","92.86%",NA,NA,NA,NA,NA
"2973",3208,1173395,"Cluster_6914","Peve_00007253",0.588306849685468,0.599589456034201,0.978262075707395,157,-20.81,"2 20","513 535",20,"75.00%","80.00%","P16621","Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR)","Drosophila melanogaster (Fruit fly)","axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; hematopoietic stem cell homeostasis [GO:0061484]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; negative regulation of insulin receptor signaling pathway [GO:0046627]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; peptidyl-tyrosine dephosphorylation [GO:0035335]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; protein dephosphorylation [GO:0006470]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic assembly at neuromuscular junction [GO:0051124]","GO:0004725; GO:0005001; GO:0005158; GO:0005925; GO:0006470; GO:0007155; GO:0007283; GO:0007399; GO:0007411; GO:0007412; GO:0008045; GO:0008201; GO:0008594; GO:0009925; GO:0009986; GO:0030424; GO:0031252; GO:0031290; GO:0032093; GO:0035335; GO:0045467; GO:0046627; GO:0048477; GO:0048675; GO:0048841; GO:0051124; GO:0051491; GO:0060269; GO:0061484; GO:0120034; GO:1903386"
"2974",3209,1173567,"Cluster_4629","Peve_00007254",-0.513453039136598,0.656732112021973,0.978262075707395,146,-20.13,"2 11","347 368",9,"88.89%","100.00%",NA,NA,NA,NA,NA
"2975",3210,1173567,"Cluster_4629","Peve_00007254",-0.513453039136598,0.656732112021973,0.978262075707395,146,-20.13,"2 11","920 941",9,"88.89%","100.00%",NA,NA,NA,NA,NA
"2976",3211,1173782,"Cluster_589","Peve_00037027",-0.767874259939782,0.442629098510415,0.978262075707395,155,-23.55,"2 12","542 563",10,"100.00%","100.00%","A0A411L030","Proline hydroxylase buaE (EC 1.14.11.-) (2-oxoglutarate-dependent dioxygenase buaE) (Burnettramic acids biosynthesis cluster protein E)","Aspergillus burnettii","antibiotic biosynthetic process [GO:0017000]; organic acid biosynthetic process [GO:0016053]; organic cyclic compound biosynthetic process [GO:1901362]","GO:0016053; GO:0017000; GO:0046872; GO:0051213; GO:1901362"
"2977",3212,1174283,"Cluster_2882","Peve_00002154",-0.831624326968308,0.374822677774653,0.978262075707395,157,-21.79,"2 19","511 534",19,"68.42%","84.21%","A1L1W9","Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10)","Danio rerio (Zebrafish) (Brachydanio rerio)","aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327]","GO:0005302; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016020; GO:0016323; GO:0070327"
"2978",3213,1174673,"Cluster_11997","Peve_00033306",-0.938865349905881,0.223756982935975,0.978262075707395,162,-20.67,"2 21","618 641",21,"71.43%","85.71%",NA,NA,NA,NA,NA
"2979",3214,1174730,"Cluster_1167","Peve_00033304",0.999582222238082,0.018402757417117,0.782669382293497,142,-21.21,"2 11","413 434",9,"88.89%","88.89%","Q62868","Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (RhoA-binding kinase 2) (p150 ROK-alpha) (ROKalpha) (p164 ROCK-2)","Rattus norvegicus (Rat)","actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; blood vessel diameter maintenance [GO:0097746]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; chromosome condensation [GO:0030261]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; neural tube closure [GO:0001843]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; postsynaptic actin cytoskeleton organization [GO:0098974]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of cell junction assembly [GO:1901888]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; regulation of synapse maturation [GO:0090128]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; viral RNA genome replication [GO:0039694]","GO:0000281; GO:0001837; GO:0001843; GO:0001934; GO:0002931; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007249; GO:0007266; GO:0008625; GO:0010595; GO:0010613; GO:0010628; GO:0010629; GO:0010825; GO:0016301; GO:0016525; GO:0018105; GO:0018107; GO:0030036; GO:0030261; GO:0030335; GO:0030866; GO:0031032; GO:0031267; GO:0031616; GO:0031644; GO:0032723; GO:0035509; GO:0036464; GO:0039694; GO:0042752; GO:0043410; GO:0045019; GO:0045616; GO:0046872; GO:0048511; GO:0048598; GO:0048813; GO:0051246; GO:0051298; GO:0051496; GO:0061157; GO:0071394; GO:0071559; GO:0072518; GO:0072659; GO:0090128; GO:0090271; GO:0097746; GO:0098685; GO:0098974; GO:0098978; GO:0106310; GO:0110061; GO:0150033; GO:1900037; GO:1901888; GO:1902004; GO:1902961; GO:1902966; GO:1902993; GO:1903140; GO:1903347; GO:1905145; GO:1905205; GO:1990776"
"2980",3215,1174807,"Cluster_11135","Peve_00033308",0.496918350554821,0.668929685715652,0.978262075707395,163,-22.51,"2 16","264 285",14,"85.71%","92.86%","Q4V9P6","Adenosine deaminase-like protein (EC 3.5.4.-)","Danio rerio (Zebrafish) (Brachydanio rerio)","adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]","GO:0004000; GO:0006154; GO:0009117; GO:0046103; GO:0046872; GO:0062154"
"2981",3216,1175678,"Cluster_2882","Peve_00007927",-0.304094490350602,0.803292282456578,0.995934364227446,165,-23.05,"2 19","895 919",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"2982",3217,1175781,"Cluster_7053","Peve_00007929",0.88816753215989,0.303956939874986,0.978262075707395,164,-23.95,"2 21","526 547",19,"68.42%","84.21%","Q80TS3","Adhesion G protein-coupled receptor L3 (Latrophilin-3) (Lectomedin-3)","Mus musculus (Mouse)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; locomotion involved in locomotory behavior [GO:0031987]; maintenance of postsynaptic specialization structure [GO:0098880]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]","GO:0001764; GO:0004930; GO:0005509; GO:0005886; GO:0005911; GO:0007166; GO:0007189; GO:0007416; GO:0007420; GO:0030246; GO:0030424; GO:0031987; GO:0042220; GO:0045211; GO:0050808; GO:0051965; GO:0098685; GO:0098742; GO:0098880; GO:0098978"
"2983",3218,1177041,"Cluster_7053","Peve_00036082",0.470323090474376,0.688274765792363,0.978262075707395,156,-20.25,"2 21","428 449",19,"63.16%","78.95%","P35384","Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (BoPCaR1) (PCaR1)","Bos taurus (Bovine)","calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; detection of calcium ion [GO:0005513]; G protein-coupled receptor signaling pathway [GO:0007186]; JNK cascade [GO:0007254]; ossification [GO:0001503]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; regulation of calcium ion transport [GO:0051924]; vasodilation [GO:0042311]","GO:0001503; GO:0004930; GO:0005509; GO:0005513; GO:0005886; GO:0006816; GO:0006874; GO:0007186; GO:0007254; GO:0008284; GO:0010628; GO:0016597; GO:0032781; GO:0042311; GO:0042803; GO:0043679; GO:0051924; GO:0070509"
"2984",3219,1178067,"Cluster_4629","Peve_00029657",-0.551731524721151,0.627934621327169,0.978262075707395,149,-21.15,"2 15","232 257",17,"76.47%","76.47%","P47800","D(1)-like dopamine receptor","Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica)","regulation of biological quality [GO:0065008]","GO:0004930; GO:0005886; GO:0065008"
"2985",3220,1178343,"Cluster_6905","Peve_00023079",-0.801253037454186,0.408334158187758,0.978262075707395,145,-21.81,"2 20","44 69",22,"63.64%","72.73%",NA,NA,NA,NA,NA
"2986",3221,1180301,"Cluster_14999","Peve_00031538",0.584050076109654,0.602934327147311,0.978262075707395,163,-20.79,"2 21","169 191",20,"75.00%","80.00%",NA,NA,NA,NA,NA
"2987",3222,1180351,"Cluster_29","Peve_00010449",0.29174303629072,0.81152957872725,0.995934364227446,154,-20.66,"2 20","682 705",20,"65.00%","80.00%","Q8BH75","E3 ubiquitin-protein ligase NRDP1 (EC 2.3.2.27) (RING finger protein 41) (RING-type E3 ubiquitin transferase NRDP1)","Mus musculus (Mouse)","autophagy [GO:0006914]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitophagy [GO:1901525]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; proteasomal protein catabolic process [GO:0010498]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of lymphocyte differentiation [GO:0045619]; regulation of MAPK cascade [GO:0043408]; regulation of myeloid cell differentiation [GO:0045637]; regulation of protein kinase B signaling [GO:0051896]; regulation of reactive oxygen species metabolic process [GO:2000377]","GO:0000209; GO:0004842; GO:0005128; GO:0005135; GO:0006914; GO:0008270; GO:0008285; GO:0010498; GO:0016567; GO:0019904; GO:0030336; GO:0030971; GO:0031267; GO:0042802; GO:0043408; GO:0045619; GO:0045637; GO:0045732; GO:0048471; GO:0051865; GO:0051896; GO:0061630; GO:0071782; GO:0097191; GO:1901525; GO:2000377; GO:2000379"
"2988",3227,1181391,"Cluster_2787","Peve_00006649",0.158604863297147,0.898600813604561,0.999448381576871,159,-21.62,"2 21","394 417",21,"66.67%","80.95%",NA,NA,NA,NA,NA
"2989",3228,1181428,"Cluster_15890","Peve_00006649",-0.00158639234019864,0.998990070845892,0.999765059668532,166,-21.18,"2 21","355 375",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"2990",3229,1182681,"Cluster_11134","Peve_00043500",-0.040924889936937,0.973939127768475,0.999448381576871,159,-22.54,"2 21","679 701",20,"65.00%","85.00%","Q9Y376","Calcium-binding protein 39 (MO25alpha) (Protein Mo25)","Homo sapiens (Human)","activation of protein kinase activity [GO:0032147]; cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; response to activity [GO:0014823]; response to thyroid hormone [GO:0097066]; signal transduction [GO:0007165]","GO:0005576; GO:0005737; GO:0005829; GO:0007165; GO:0010800; GO:0014823; GO:0016020; GO:0018105; GO:0019900; GO:0030018; GO:0030295; GO:0032147; GO:0034774; GO:0035556; GO:0043539; GO:0070062; GO:0071476; GO:0071902; GO:0097066; GO:1901017; GO:1901380; GO:1902554; GO:1904813"
"2991",3230,1182837,"Cluster_4629","Peve_00027940",-0.427469157358853,0.718810517721719,0.981233547119836,162,-23.64,"2 20","79 101",19,"78.95%","78.95%","O15084","Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK)","Homo sapiens (Human)","","GO:0005654; GO:0005829"
"2992",3231,1182917,"Cluster_589","Peve_00027942",0.0305547493655457,0.980545214472054,0.999448381576871,143,-21.53,"2 18","164 188",19,"68.42%","73.68%","O19094","Peroxisomal carnitine O-octanoyltransferase (COT) (EC 2.3.1.137)","Bos taurus (Bovine)","carnitine metabolic process [GO:0009437]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; generation of precursor metabolites and energy [GO:0006091]; medium-chain fatty acid metabolic process [GO:0051791]","GO:0005777; GO:0006091; GO:0006631; GO:0006635; GO:0008458; GO:0009437; GO:0015936; GO:0051791"
"2993",3232,1182975,"Cluster_5882","Peve_00027945",-0.257595107191236,0.834139866331592,0.995934364227446,164,-25.26,"2 21","381 402",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"2994",3233,1183191,"Cluster_2787","Peve_00039680",0.867933894665659,0.330895275232091,0.978262075707395,158,-20.4,"2 21","341 364",21,"71.43%","80.95%","Q9VBW3","Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","Drosophila melanogaster (Fruit fly)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0014068; GO:0016339; GO:0033674; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0090303"
"2995",3234,1183659,"Cluster_7855","Peve_00010384",-0.868516018632791,0.330148371398498,0.978262075707395,172,-22.77,"2 20","275 296",19,"89.47%","89.47%","P07949","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Homo sapiens (Human)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; axon guidance [GO:0007411]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; posterior midgut development [GO:0007497]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0006468; GO:0006919; GO:0007156; GO:0007158; GO:0007165; GO:0007169; GO:0007411; GO:0007497; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0038023; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0097021; GO:0098797; GO:2001241"
"2996",3235,1184340,"Cluster_9149","Peve_00010520",-0.998460036492421,0.03533508044945,0.909359886114279,143,-20.42,"2 12","373 394",10,"80.00%","90.00%",NA,NA,NA,NA,NA
"2997",3236,1185317,"Cluster_6904","Peve_00002318",0.208718150280978,0.866141742726342,0.996660710141104,168,-23.18,"2 21","722 743",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"2998",3237,1185319,"Cluster_6906","Peve_00002318",-0.287038038235336,0.814658772056752,0.995934364227446,164,-21.16,"2 21","722 743",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"2999",3238,1185684,"Cluster_7855","Peve_00044694",0.966377015411844,0.165553237928931,0.978262075707395,165,-20.84,"2 21","379 398",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"3000",3239,1186090,"Cluster_8634","Peve_00000224",0.997367783055753,0.0462009887636632,0.936455415403062,170,-21.44,"2 20","157 179",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"3001",3240,1186135,"Cluster_8634","Peve_00000223",0.956227319072805,0.189057429551567,0.978262075707395,170,-21.44,"2 20","157 179",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"3002",3241,1186297,"Cluster_2854","Peve_00032414",-0.429475824203256,0.717396675205736,0.980879463431379,159,-20.26,"2 21","369 393",22,"68.18%","77.27%",NA,NA,NA,NA,NA
"3003",3242,1186894,"Cluster_6906","Peve_00044523",-0.146725216689888,0.906253383820891,0.999448381576871,163,-22.1,"2 19","338 357",17,"82.35%","88.24%","Q96RT1","Erbin (Densin-180-like protein) (Erbb2-interacting protein) (Protein LAP2)","Homo sapiens (Human)","basal protein localization [GO:0045175]; cell adhesion [GO:0007155]; cellular response to tumor necrosis factor [GO:0071356]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; positive regulation of Ras protein signal transduction [GO:0046579]; protein targeting [GO:0006605]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; signal transduction [GO:0007165]","GO:0005102; GO:0005176; GO:0005200; GO:0005604; GO:0005634; GO:0005737; GO:0005886; GO:0006605; GO:0007155; GO:0007165; GO:0007173; GO:0007229; GO:0009925; GO:0016323; GO:0016607; GO:0030054; GO:0030056; GO:0031965; GO:0032088; GO:0032495; GO:0032496; GO:0045104; GO:0045175; GO:0045197; GO:0046579; GO:0070433; GO:0071356; GO:0071638; GO:0098794; GO:0098978; GO:0099072"
"3004",3244,1187724,"Cluster_13502","Peve_00011705",-0.804188408588054,0.4052005766181,0.978262075707395,165,-23.3,"2 21","744 763",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"3005",3245,1189425,"Cluster_9149","Peve_00014631",-0.990422632274843,0.0881790526748118,0.978262075707395,147,-23.82,"2 12","218 239",10,"80.00%","100.00%","Q26534","Cathepsin L (EC 3.4.22.15) (SMCL1)","Schistosoma mansoni (Blood fluke)","proteolysis [GO:0006508]","GO:0004197; GO:0005764; GO:0006508"
"3006",3246,1190292,"Cluster_15726","Peve_00002889",-0.5,0.666666666666667,0.978262075707395,151,-20.23,"2 21","46 70",22,"63.64%","72.73%",NA,NA,NA,NA,NA
"3007",3247,1190337,"Cluster_15726","Peve_00002888",-0.629729408182914,0.566331537963887,0.978262075707395,151,-20.23,"2 21","170 194",22,"63.64%","72.73%","Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"3008",3248,1190745,"Cluster_16738","Peve_00002882",-0.411747953790457,0.72983682314407,0.984471224432621,165,-21.34,"2 21","824 843",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"3009",3249,1191147,"Cluster_15726","Peve_00015404",-0.642840214494356,0.555511837170791,0.978262075707395,151,-21.12,"2 21","368 390",20,"70.00%","70.00%","A7RSH7","Eukaryotic translation initiation factor 3 subunit J (eIF3j)","Nematostella vectensis (Starlet sea anemone)","formation of cytoplasmic translation initiation complex [GO:0001732]","GO:0001732; GO:0003743; GO:0005852; GO:0016282; GO:0033290"
"3010",3250,1191589,"Cluster_10934","Peve_00031803",-0.348516007502674,0.7733713962223,0.991811027979456,146,-21.57,"2 15","715 736",13,"69.23%","84.62%","G3M4F8","Octopamine receptor beta-2R (CsOA2B2)","Chilo suppressalis (Asiatic rice borer moth)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to amine stimulus [GO:0071418]; octopamine signaling pathway [GO:0071927]; tyramine signaling pathway [GO:0071928]","GO:0004989; GO:0005886; GO:0007189; GO:0008226; GO:0016020; GO:0071418; GO:0071927; GO:0071928"
"3011",3251,1193644,"Cluster_6906","Peve_00029354",0.987568035729913,0.100488405296765,0.978262075707395,149,-21.85,"2 16","935 960",18,"77.78%","77.78%","Q5ZLT0","Exportin-7","Gallus gallus (Chicken)","protein export from nucleus [GO:0006611]","GO:0005049; GO:0005643; GO:0005737; GO:0006611; GO:0031267"
"3012",3252,1194797,"Cluster_589","Peve_00030531",-0.373841262781967,0.756080956693425,0.988219883885475,155,-21.82,"2 12","610 631",10,"100.00%","100.00%","Q6GPE5","Protein fem-1 homolog B (FEM1b) (FEM1-beta)","Xenopus laevis (African clawed frog)","apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756; GO:2000001"
"3013",3253,1195147,"Cluster_11135","Peve_00014290",-0.886103284710592,0.306804453861767,0.978262075707395,169,-21.12,"2 18","136 157",16,"81.25%","93.75%",NA,NA,NA,NA,NA
"3014",3254,1195201,"Cluster_29","Peve_00027295",-0.96299356011642,0.173732977296154,0.978262075707395,163,-21.71,"2 21","156 178",20,"75.00%","80.00%","Q9NTJ4","Alpha-mannosidase 2C1 (EC 3.2.1.24) (Alpha mannosidase 6A8B) (Alpha-D-mannoside mannohydrolase) (Mannosidase alpha class 2C member 1)","Homo sapiens (Human)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0005654; GO:0005829; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"3015",3255,1195528,"Cluster_4735","Peve_00027292",-0.72213767361466,0.486319400869048,0.978262075707395,180,-23.64,"2 21","573 594",19,"84.21%","89.47%","Q13467","Frizzled-5 (Fz-5) (hFz5) (FzE5)","Homo sapiens (Human)","angiogenesis [GO:0001525]; anterior/posterior axis specification, embryo [GO:0008595]; apoptotic process involved in morphogenesis [GO:0060561]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; canonical Wnt signaling pathway [GO:0060070]; cellular response to molecule of bacterial origin [GO:0071219]; chorionic trophoblast cell differentiation [GO:0060718]; embryonic axis specification [GO:0000578]; embryonic camera-type eye morphogenesis [GO:0048596]; glandular epithelial cell maturation [GO:0002071]; intestinal epithelial cell maturation [GO:0060574]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of cell population proliferation [GO:0008285]; neuron differentiation [GO:0030182]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type II interferon production [GO:0032729]; post-embryonic camera-type eye development [GO:0031077]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of chorionic trophoblast cell proliferation [GO:1901382]; Spemann organizer formation [GO:0060061]; synapse assembly [GO:0007416]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]; T cell differentiation in thymus [GO:0033077]","GO:0000139; GO:0000578; GO:0001525; GO:0001540; GO:0002071; GO:0002726; GO:0004930; GO:0005886; GO:0005923; GO:0007416; GO:0008285; GO:0008289; GO:0008595; GO:0009986; GO:0016020; GO:0017147; GO:0019901; GO:0030182; GO:0030424; GO:0030425; GO:0030669; GO:0031077; GO:0031625; GO:0031901; GO:0032729; GO:0032731; GO:0032760; GO:0033077; GO:0042813; GO:0043204; GO:0043507; GO:0044877; GO:0045202; GO:0045944; GO:0048471; GO:0048596; GO:0060061; GO:0060070; GO:0060561; GO:0060574; GO:0060670; GO:0060715; GO:0060716; GO:0060718; GO:0071219; GO:1901382; GO:1903146; GO:1903955; GO:2000810"
"3016",3256,1195722,"Cluster_8887","Peve_00024925",-0.849595242001859,0.353692522985491,0.978262075707395,158,-20.17,"2 19","177 197",17,"58.82%","94.12%",NA,NA,NA,NA,NA
"3017",3257,1195723,"Cluster_8888","Peve_00024925",-0.268695189483284,0.826815135856221,0.995934364227446,158,-21.8,"2 19","177 197",17,"58.82%","94.12%",NA,NA,NA,NA,NA
"3018",3258,1196462,"Cluster_589","Peve_00017410",-0.934753615028442,0.231240264998328,0.978262075707395,158,-24.1,"2 21","219 239",19,"68.42%","84.21%","O15439","ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B) (Multidrug resistance-associated protein 4)","Homo sapiens (Human)","bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; leukotriene transport [GO:0071716]; platelet degranulation [GO:0002576]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate transport [GO:0015747]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]","GO:0001409; GO:0002576; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006805; GO:0006855; GO:0008559; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0043225; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359; GO:0150104"
"3019",3259,1196525,"Cluster_6914","Peve_00017411",0.685562414825316,0.519112733857652,0.978262075707395,170,-22.36,"2 20","695 716",19,"84.21%","84.21%","Q8BLD6","Ankyrin repeat domain-containing protein 55","Mus musculus (Mouse)","",""
"3020",3260,1196676,"Cluster_11134","Peve_00017414",-0.0692298160754335,0.955891648773855,0.999448381576871,159,-23.54,"2 21","663 685",20,"65.00%","85.00%","Q7TQ07","DNA polymerase nu (EC 2.7.7.7)","Mus musculus (Mouse)","DNA-templated DNA replication [GO:0006261]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; translesion synthesis [GO:0019985]","GO:0000724; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0006261; GO:0006302; GO:0019985; GO:0030332; GO:0036297"
"3021",3261,1197896,"Cluster_14999","Peve_00021191",-0.999571546587002,0.018636417521774,0.782669382293497,165,-22.61,"2 21","804 826",21,"80.95%","80.95%",NA,NA,NA,NA,NA
"3022",3262,1198761,"Cluster_2787","Peve_00020828",-0.00382968334855694,0.997561941898757,0.999448381576871,164,-20.49,"2 18","661 683",17,"82.35%","88.24%","Q15485","Ficolin-2 (37 kDa elastin-binding protein) (Collagen/fibrinogen domain-containing protein 2) (EBP-37) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35)","Homo sapiens (Human)","cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]","GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0042802; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0062023; GO:0070062; GO:0072562; GO:0097367; GO:1903028; GO:1905370; GO:2001065"
"3023",3263,1198834,"Cluster_10934","Peve_00030677",-0.329400730228517,0.786306596649879,0.995017249712956,150,-20.09,"2 21","299 323",22,"68.18%","72.73%","Q12882","Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase)","Homo sapiens (Human)","beta-alanine biosynthetic process [GO:0019483]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; purine nucleobase catabolic process [GO:0006145]; pyrimidine nucleobase catabolic process [GO:0006208]; thymidine catabolic process [GO:0006214]; thymine catabolic process [GO:0006210]; UMP catabolic process [GO:0046050]; uracil catabolic process [GO:0006212]","GO:0002058; GO:0005737; GO:0005829; GO:0006145; GO:0006208; GO:0006210; GO:0006212; GO:0006214; GO:0006248; GO:0006249; GO:0017113; GO:0019483; GO:0042803; GO:0046050; GO:0046079; GO:0046872; GO:0050660; GO:0050661; GO:0051536; GO:0051539"
"3024",3264,1198946,"Cluster_4115","Peve_00042064",-0.930026219102899,0.239567750774005,0.978262075707395,169,-20.58,"2 18","464 485",16,"81.25%","93.75%",NA,NA,NA,NA,NA
"3025",3265,1199194,"Cluster_10934","Peve_00013885",0.785019393291538,0.425305867334768,0.978262075707395,170,-33.23,"2 21","335 355",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"3026",3266,1199374,"Cluster_10934","Peve_00013881",-0.876727572926749,0.319443362800201,0.978262075707395,156,-20.45,"2 18","258 280",17,"76.47%","82.35%","Q6DE37","Glucoside xylosyltransferase 2 (EC 2.4.2.42) (Glycosyltransferase 8 domain-containing protein 4)","Xenopus laevis (African clawed frog)","O-glycan processing [GO:0016266]","GO:0016020; GO:0016266; GO:0035252; GO:0140563"
"3027",3267,1199657,"Cluster_589","Peve_00043338",0.0142454788832073,0.990930739715423,0.999448381576871,172,-25.63,"2 21","393 414",19,"73.68%","89.47%",NA,NA,NA,NA,NA
"3028",3268,1199751,"Cluster_2787","Peve_00039033",0.182398694842197,0.883227685823552,0.999448381576871,164,-21.33,"2 21","825 846",19,"68.42%","84.21%","O02824","Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor)","Oryctolagus cuniculus (Rabbit)","adult heart development [GO:0007512]; cell growth involved in cardiac muscle cell development [GO:0061049]; MAPK cascade [GO:0000165]; multicellular organism aging [GO:0010259]; negative regulation of autophagy [GO:0010507]; negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001985]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pilomotor reflex [GO:0097195]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; regulation of cardiac muscle contraction [GO:0055117]; regulation of vasoconstriction [GO:0019229]","GO:0000165; GO:0001985; GO:0001994; GO:0001996; GO:0001997; GO:0004937; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005901; GO:0007200; GO:0007512; GO:0010259; GO:0010507; GO:0010613; GO:0019229; GO:0031965; GO:0043410; GO:0045987; GO:0046982; GO:0055117; GO:0061049; GO:0097195; GO:0150099; GO:1903997"
"3029",3269,1200560,"Cluster_1167","Peve_00021645",0.999509218369495,0.0199460559964703,0.803582979632007,146,-21.9,"2 18","23 44",17,"76.47%","76.47%",NA,NA,NA,NA,NA
"3030",3270,1201378,"Cluster_4735","Peve_00014874",-0.860612348074305,0.340162144760091,0.978262075707395,151,-22,"2 21","285 308",21,"61.90%","76.19%","Q99J36","THUMP domain-containing protein 1","Mus musculus (Mouse)","tRNA modification [GO:0006400]","GO:0003723; GO:0006400"
"3031",3271,1203207,"Cluster_15726","Peve_00000244",-0.200266960175695,0.871638104813553,0.997476741937264,146,-20.81,"2 11","369 390",9,"88.89%","100.00%","Q12852","Mitogen-activated protein kinase kinase kinase 12 (EC 2.7.11.25) (Dual leucine zipper bearing kinase) (DLK) (Leucine-zipper protein kinase) (ZPK) (MAPK-upstream kinase) (MUK) (Mixed lineage kinase)","Homo sapiens (Human)","intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; negative regulation of motor neuron apoptotic process [GO:2000672]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of protein kinase activity [GO:0045860]; post-translational protein modification [GO:0043687]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]","GO:0004672; GO:0004674; GO:0004706; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007254; GO:0016020; GO:0018105; GO:0018107; GO:0019901; GO:0030426; GO:0035556; GO:0042803; GO:0043507; GO:0043539; GO:0043687; GO:0045860; GO:0045893; GO:0046777; GO:0070374; GO:0106310; GO:2000672"
"3032",3272,1203621,"Cluster_2787","Peve_00032379",0.851639124782828,0.35121778108632,0.978262075707395,149,-20.4,"2 19","469 494",21,"61.90%","76.19%",NA,NA,NA,NA,NA
"3033",3273,1203681,"Cluster_7053","Peve_00033649",0.211664809186567,0.864222975800529,0.996660710141104,161,-20.29,"2 19","228 251",19,"73.68%","84.21%","Q5ZI89","Trafficking protein particle complex subunit 11","Gallus gallus (Chicken)","vesicle-mediated transport [GO:0016192]","GO:0005794; GO:0016192"
"3034",3274,1203755,"Cluster_1167","Peve_00016117",0.782722663002069,0.427660663567845,0.978262075707395,152,-23.21,"2 13","583 604",11,"90.91%","90.91%","Q6AZW2","Aldo-keto reductase family 1 member A1-A (Alcohol dehydrogenase [NADP(+)] A) (EC 1.1.1.2) (Aldehyde reductase-A)","Danio rerio (Zebrafish) (Brachydanio rerio)","aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]","GO:0004032; GO:0005829; GO:0016324; GO:0046185; GO:0110095"
"3035",3275,1204561,"Cluster_29","Peve_00034340",-0.60262052230154,0.588246553575003,0.978262075707395,160,-20.08,"2 13","449 470",11,"100.00%","100.00%","O35738","Krueppel-like factor 12 (Transcriptional repressor AP-2rep)","Mus musculus (Mouse)","negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0045944; GO:0046872; GO:1990837"
"3036",3276,1204818,"Cluster_10061","Peve_00035747",-0.446077406355246,0.705641205133228,0.978262075707395,167,-20.59,"2 17","479 502",17,"88.24%","88.24%",NA,NA,NA,NA,NA
"3037",3277,1206120,"Cluster_9149","Peve_00038441",1,0,0,143,-23.7,"2 12","945 966",10,"80.00%","90.00%",NA,NA,NA,NA,NA
"3038",3278,1206872,"Cluster_6904","Peve_00003650",-0.951310992493219,0.199475076059675,0.978262075707395,158,-21.41,"2 18","674 693",16,"81.25%","87.50%",NA,NA,NA,NA,NA
"3039",3279,1207601,"Cluster_8884","Peve_00004920",0.195666758587174,0.874625817801006,0.997476741937264,169,-21.11,"2 19","96 117",18,"83.33%","88.89%",NA,NA,NA,NA,NA
"3040",3280,1207602,"Cluster_8887","Peve_00004920",-0.0823630340017489,0.947506599925429,0.999448381576871,169,-21.11,"2 19","96 117",18,"83.33%","88.89%",NA,NA,NA,NA,NA
"3041",3282,1208067,"Cluster_15726","Peve_00042509",0.850236899932042,0.352917274694769,0.978262075707395,161,-22.35,"2 18","131 152",16,"75.00%","87.50%","D3ZR10","Doublecortin domain-containing protein 2","Rattus norvegicus (Rat)","cilium assembly [GO:0060271]; dendrite morphogenesis [GO:0048813]; intracellular signal transduction [GO:0035556]; neuron migration [GO:0001764]; neuronal action potential [GO:0019228]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of cilium assembly [GO:1902017]; regulation of Wnt signaling pathway [GO:0030111]; sensory perception of sound [GO:0007605]; synaptic transmission, glutamatergic [GO:0035249]; visual learning [GO:0008542]","GO:0001764; GO:0005737; GO:0005815; GO:0005829; GO:0005856; GO:0005874; GO:0005929; GO:0005930; GO:0007605; GO:0008542; GO:0019228; GO:0019894; GO:0030111; GO:0034451; GO:0035249; GO:0035556; GO:0045202; GO:0045880; GO:0048813; GO:0060091; GO:0060271; GO:0072686; GO:1902017"
"3042",3283,1208075,"Cluster_1167","Peve_00016804",0.0447537926133212,0.971499331321768,0.999448381576871,143,-23.42,"2 17","207 229",16,"68.75%","75.00%","Q96H96","4-hydroxybenzoate polyprenyltransferase, mitochondrial (4-HB polyprenyltransferase) (EC 2.5.1.39) (4-hydroxybenzoate decaprenyltransferase) (COQ2 homolog) (hCOQ2) (Para-hydroxybenzoate--polyprenyltransferase) (PHB:PPT) (PHB:polyprenyltransferase)","Homo sapiens (Human)","glycerol metabolic process [GO:0006071]; isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744]","GO:0002083; GO:0004659; GO:0005743; GO:0006071; GO:0006744; GO:0008299; GO:0008412; GO:0016765; GO:0047293"
"3043",3284,1208982,"Cluster_4629","Peve_00019783",-0.536885542400611,0.639201390716446,0.978262075707395,143,-20.14,"2 20","190 211",18,"55.56%","72.22%","Q4V842","G patch domain-containing protein 4","Xenopus laevis (African clawed frog)","","GO:0003676"
"3044",3285,1209379,"Cluster_1140","Peve_00028907",0.36622864514177,0.761297608896258,0.988573333522262,171,-20.76,"2 21","396 418",20,"80.00%","85.00%",NA,NA,NA,NA,NA
"3045",3286,1209984,"Cluster_7855","Peve_00001724",-0.987459331375478,0.100927699888151,0.978262075707395,170,-21.76,"2 21","877 897",19,"78.95%","89.47%","Q9DBV3","Probable ATP-dependent RNA helicase DHX34 (EC 3.6.4.13) (DEAH box protein 34) (DExH-box helicase 34)","Mus musculus (Mouse)","negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of phosphorylation [GO:0042327]","GO:0000184; GO:0000956; GO:0003723; GO:0003724; GO:0005524; GO:0016887; GO:0042327; GO:0044877; GO:2000623"
"3046",3287,1210683,"Cluster_796","Peve_00009262",0.989459322504583,0.0925148827755738,0.978262075707395,159,-23.13,"2 18","63 83",16,"81.25%","87.50%","Q96BD0","Solute carrier organic anion transporter family member 4A1 (OATP4A1) (Colon organic anion transporter) (Organic anion transporter polypeptide-related protein 1) (OATP-RP1) (OATPRP1) (POAT) (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12)","Homo sapiens (Human)","sodium-independent organic anion transport [GO:0043252]","GO:0005886; GO:0008514; GO:0015132; GO:0015347; GO:0015349; GO:0043252"
"3047",3288,1210731,"Cluster_2787","Peve_00009264",-0.00382968334855694,0.997561941898757,0.999448381576871,165,-22.98,"2 18","944 965",16,"81.25%","87.50%","Q54IP4","Dual specificity protein kinase shkB (EC 2.7.11.1) (SH2 domain-containing protein 2) (SH2 domain-containing protein B)","Dictyostelium discoideum (Social amoeba)","MAPK cascade [GO:0000165]","GO:0000165; GO:0004674; GO:0004709; GO:0004713; GO:0005524; GO:0016020; GO:0106310"
"3048",3289,1210989,"Cluster_13502","Peve_00018789",0.992150427777663,0.0798183251899059,0.978262075707395,155,-20.48,"2 21","652 674",20,"70.00%","75.00%","P35067","Histone H2B","Acropora formosa (Staghorn coral)","","GO:0000786; GO:0003677; GO:0005634; GO:0030527; GO:0046982"
"3049",3290,1211184,"Cluster_4079","Peve_00018782",0.0984461889489942,0.937225531717993,0.999448381576871,146,-23.78,"2 21","384 404",19,"57.89%","78.95%",NA,NA,NA,NA,NA
"3050",3291,1211251,"Cluster_9983","Peve_00018785",0.498751907423741,0.667583764936494,0.978262075707395,152,-22.16,"2 20","217 237",19,"73.68%","78.95%","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"3051",3292,1211457,"Cluster_4629","Peve_00031109",-0.85653026233518,0.345231055735315,0.978262075707395,163,-26.13,"2 21","550 572",20,"75.00%","80.00%","P39057","Dynein beta chain, ciliary","Heliocidaris crassispina (Sea urchin) (Anthocidaris crassispina)","cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]","GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0008569; GO:0030030; GO:0030286; GO:0045505; GO:0051959; GO:0097729"
"3052",3293,1211523,"Cluster_10061","Peve_00031102",0.210587796116825,0.864924435404251,0.996660710141104,182,-21.87,"2 21","132 152",19,"89.47%","94.74%",NA,NA,NA,NA,NA
"3053",3294,1211587,"Cluster_2854","Peve_00031100",-0.410031805876223,0.731035190974532,0.984754300351916,159,-20.17,"2 21","313 330",19,"78.95%","78.95%","Q6ISB3","Grainyhead-like protein 2 homolog (Brother of mammalian grainyhead) (Transcription factor CP2-like 3)","Homo sapiens (Human)","anterior neural tube closure [GO:0061713]; bicellular tight junction assembly [GO:0070830]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cardiac ventricle morphogenesis [GO:0003208]; cell adhesion [GO:0007155]; cell junction assembly [GO:0034329]; cell population proliferation [GO:0008283]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; epithelial cell morphogenesis involved in placental branching [GO:0060672]; epithelium migration [GO:0090132]; face development [GO:0060324]; lung epithelial cell differentiation [GO:0060487]; lung lobe morphogenesis [GO:0060463]; multicellular organism growth [GO:0035264]; negative regulation of keratinocyte differentiation [GO:0045617]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA methylation [GO:0044030]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000785; GO:0000978; GO:0000981; GO:0001161; GO:0001228; GO:0001843; GO:0003208; GO:0003382; GO:0003700; GO:0005634; GO:0005654; GO:0005911; GO:0006357; GO:0007155; GO:0007420; GO:0008283; GO:0008544; GO:0016020; GO:0021915; GO:0031490; GO:0034329; GO:0035264; GO:0042733; GO:0043010; GO:0043565; GO:0044030; GO:0045617; GO:0045944; GO:0048701; GO:0051973; GO:0060324; GO:0060463; GO:0060487; GO:0060672; GO:0061713; GO:0070830; GO:0090132"
"3054",3296,1211796,"Cluster_11134","Peve_00031104",-0.374980314867206,0.755298931320386,0.988219883885475,158,-25.82,"2 21","791 814",21,"71.43%","80.95%","Q80ZQ5","Juxtaposed with another zinc finger protein 1","Mus musculus (Mouse)","lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]","GO:0000122; GO:0001650; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006629; GO:0017053; GO:0046872"
"3055",3297,1212354,"Cluster_4079","Peve_00005727",0.799159103512773,0.410556916500702,0.978262075707395,154,-25.85,"2 20","942 970",25,"64.00%","72.00%",NA,NA,NA,NA,NA
"3056",3298,1212426,"Cluster_11134","Peve_00007763",-0.441445493844879,0.708931713859261,0.978371401018449,151,-20.85,"2 21","765 787",20,"60.00%","80.00%","Q9CZL5","Pterin-4-alpha-carbinolamine dehydratase 2 (PHS 2) (EC 4.2.1.96) (4-alpha-hydroxy-tetrahydropterin dehydratase 2) (DcoH-like protein DCoHm) (Dimerization cofactor of hepatocyte nuclear factor 1 from muscle) (HNF-1-alpha dimerization cofactor)","Mus musculus (Mouse)","positive regulation of DNA-templated transcription [GO:0045893]; tetrahydrobiopterin biosynthetic process [GO:0006729]","GO:0004505; GO:0005634; GO:0005739; GO:0006729; GO:0008124; GO:0042802; GO:0045893"
"3057",3299,1213236,"Cluster_11134","Peve_00007495",0.48768105234402,0.675685805574821,0.978262075707395,167,-28.4,"2 18","57 77",16,"87.50%","93.75%","Q24292","Protein dachsous (Adherin)","Drosophila melanogaster (Fruit fly)","cell-cell adhesion [GO:0098609]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc morphogenesis [GO:0007560]; negative regulation of hippo signaling [GO:0035331]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]","GO:0001736; GO:0005509; GO:0005886; GO:0007156; GO:0007560; GO:0016327; GO:0035331; GO:0035332; GO:0042067; GO:0070161; GO:0090251; GO:0098609"
"3058",3300,1213610,"Cluster_1167","Peve_00042442",0.999909726776791,0.00855416971793915,0.573710369894872,149,-21.05,"2 14","426 447",12,"83.33%","83.33%",NA,NA,NA,NA,NA
"3059",3301,1213937,"Cluster_6904","Peve_00023169",-0.97388445374661,0.145812376801884,0.978262075707395,153,-20.16,"2 21","435 456",20,"70.00%","80.00%","Q5F478","Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (PP6-ARS-B) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B) (Ankyrin repeat domain-containing protein 44)","Gallus gallus (Chicken)","",""
"3060",3302,1213968,"Cluster_796","Peve_00024434",0.992682391647243,0.0770628188392379,0.978262075707395,151,-21.88,"2 14","370 390",12,"91.67%","91.67%",NA,NA,NA,NA,NA
"3061",3303,1213977,"Cluster_4629","Peve_00024434",-0.252215839158609,0.837681411546308,0.995934364227446,156,-23.55,"2 21","720 741",19,"57.89%","84.21%",NA,NA,NA,NA,NA
"3062",3304,1214711,"Cluster_8884","Peve_00037191",-0.483186216280068,0.678958817412358,0.978262075707395,154,-20.09,"2 20","356 373",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"3063",3305,1214712,"Cluster_8887","Peve_00037191",-0.70589368548661,0.501091235138794,0.978262075707395,154,-20.45,"2 20","356 373",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"3064",3306,1214713,"Cluster_8888","Peve_00037191",-0.999035100566406,0.0279686222680646,0.900066868667072,154,-22.08,"2 20","356 373",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"3065",3307,1214862,"Cluster_15726","Peve_00037195",-0.622764901220157,0.572018616303572,0.978262075707395,170,-21.57,"2 15","960 981",13,"100.00%","100.00%","Q8NDI1","EH domain-binding protein 1","Homo sapiens (Human)","actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]; protein transport [GO:0015031]","GO:0005654; GO:0005768; GO:0005815; GO:0005829; GO:0005886; GO:0006897; GO:0015031; GO:0030036; GO:0031941"
"3066",3308,1215462,"Cluster_4629","Peve_00023727",0.0417143738151293,0.973436097109933,0.999448381576871,145,-20.51,"2 10","856 877",8,"100.00%","100.00%","O88488","Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Protein-tyrosine phosphatase receptor-type expressed by glomerular mesangial cells protein 1) (rPTP-GMC1) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48)","Rattus norvegicus (Rat)","detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; regulation of fat cell differentiation [GO:0045598]; vestibular receptor cell morphogenesis [GO:0060116]","GO:0002244; GO:0004725; GO:0005886; GO:0032421; GO:0042472; GO:0043235; GO:0045598; GO:0050885; GO:0050910; GO:0060116; GO:1990264"
"3067",3309,1216284,"Cluster_7855","Peve_00023543",0.886752509917312,0.305911518575853,0.978262075707395,157,-22.27,"2 21","356 375",19,"68.42%","84.21%","Q5XI31","GPI transamidase component PIG-S (Phosphatidylinositol-glycan biosynthesis class S protein)","Rattus norvegicus (Rat)","attachment of GPI anchor to protein [GO:0016255]","GO:0016255; GO:0042765"
"3068",3311,1216666,"Cluster_29","Peve_00010770",-0.82768702264147,0.379312585878726,0.978262075707395,147,-21,"2 18","407 435",23,"69.57%","69.57%","Q9W704","RPA-interacting protein A (RPA-interacting protein alpha) (XRIPalpha)","Xenopus laevis (African clawed frog)","","GO:0005634; GO:0046872"
"3069",3312,1217121,"Cluster_2787","Peve_00036713",0.867933894665659,0.330895275232091,0.978262075707395,164,-20.34,"2 21","939 960",19,"68.42%","84.21%","Q9EQD2","Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor)","Rattus norvegicus (Rat)","G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]","GO:0004930; GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0042277; GO:0043408; GO:0045761; GO:2000479"
"3070",3313,1217798,"Cluster_2882","Peve_00020168",0.829552508820929,0.377191141695678,0.978262075707395,151,-21.67,"2 16","691 712",14,"71.43%","85.71%",NA,NA,NA,NA,NA
"3071",3314,1218000,"Cluster_9149","Peve_00017201",0.0947112047319669,0.939614465379726,0.999448381576871,141,-20.02,"2 10","50 71",8,"87.50%","100.00%",NA,NA,NA,NA,NA
"3072",3315,1218522,"Cluster_4629","Peve_00011917",0.237578803364246,0.847292407621627,0.995934364227446,153,-21.45,"2 19","90 113",19,"73.68%","73.68%",NA,NA,NA,NA,NA
"3073",3316,1218698,"Cluster_2882","Peve_00011918",-0.988642059033958,0.0960410369702061,0.978262075707395,156,-21.71,"2 20","538 559",19,"73.68%","84.21%","Q6ZAC1","4-coumarate--CoA ligase 5 (4CL 5) (Os4CL5) (EC 6.2.1.12) ((E)-ferulate--CoA ligase) (EC 6.2.1.34) (4-coumaroyl-CoA synthase 5)","Oryza sativa subsp. japonica (Rice)","phenylpropanoid metabolic process [GO:0009698]","GO:0005524; GO:0009698; GO:0016207; GO:0016405; GO:0106286; GO:0106290"
"3074",3317,1219440,"Cluster_9149","Peve_00041211",-0.5,0.666666666666667,0.978262075707395,161,-22.31,"2 19","558 580",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"3075",3318,1219849,"Cluster_10934","Peve_00044790",-0.299955771724092,0.806056147875003,0.995934364227446,155,-21.75,"2 16","596 617",14,"78.57%","85.71%","P07949","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Homo sapiens (Human)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; axon guidance [GO:0007411]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; posterior midgut development [GO:0007497]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0006468; GO:0006919; GO:0007156; GO:0007158; GO:0007165; GO:0007169; GO:0007411; GO:0007497; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0038023; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0097021; GO:0098797; GO:2001241"
"3076",3319,1220267,"Cluster_589","Peve_00042748",-0.85242228903962,0.350265372169963,0.978262075707395,155,-21.13,"2 12","32 53",10,"100.00%","100.00%","Q9H3S7","Tyrosine-protein phosphatase non-receptor type 23 (EC 3.1.3.48) (His domain-containing protein tyrosine phosphatase) (HD-PTP) (Protein tyrosine phosphatase TD14) (PTP-TD14)","Homo sapiens (Human)","cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein dephosphorylation [GO:0006470]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]","GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0006470; GO:0010633; GO:0016604; GO:0019901; GO:0032456; GO:0036064; GO:0043162; GO:0043231; GO:0043328; GO:0045022; GO:0060271; GO:0061357; GO:0070062; GO:1903387; GO:1903393; GO:2000643"
"3077",3320,1220554,"Cluster_6906","Peve_00042741",-0.686063329690759,0.518674561276582,0.978262075707395,150,-20.04,"2 15","876 897",13,"76.92%","84.62%","Q8N972","Zinc finger protein 709","Homo sapiens (Human)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"3078",3321,1220676,"Cluster_2787","Peve_00042744",0.49482436504166,0.67046478402797,0.978262075707395,154,-21.92,"2 16","491 513",15,"80.00%","86.67%","Q497V6","Bromo adjacent homology domain-containing 1 protein (BAH domain-containing protein 1)","Mus musculus (Mouse)","heterochromatin formation [GO:0031507]; negative regulation of DNA-templated transcription [GO:0045892]","GO:0000976; GO:0003682; GO:0005654; GO:0005677; GO:0005694; GO:0031507; GO:0045892"
"3079",3322,1220982,"Cluster_15726","Peve_00026787",-0.766453914217237,0.444038748322982,0.978262075707395,169,-21.56,"2 19","91 113",18,"83.33%","88.89%","F1LZF0","Kelch-like protein 2 (Mayven)","Rattus norvegicus (Rat)","protein ubiquitination [GO:0016567]","GO:0001726; GO:0003779; GO:0005737; GO:0005829; GO:0015629; GO:0016567; GO:0030027; GO:0031463; GO:0042802"
"3080",3323,1221002,"Cluster_6904","Peve_00026780",-0.971489221432164,0.152383145839597,0.978262075707395,147,-20.46,"2 17","369 393",18,"72.22%","72.22%",NA,NA,NA,NA,NA
"3081",3324,1221031,"Cluster_29","Peve_00026782",0.845765921359971,0.358287876611037,0.978262075707395,168,-20.55,"2 21","92 113",19,"78.95%","78.95%","P80010","Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Plasmin light chain B]","Equus caballus (Horse)","blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; proteolysis [GO:0006508]; tissue remodeling [GO:0048771]","GO:0004175; GO:0004252; GO:0005102; GO:0005615; GO:0006508; GO:0007596; GO:0019897; GO:0042730; GO:0048771"
"3082",3326,1221371,"Cluster_8884","Peve_00012322",-0.649662065298932,0.549820801227856,0.978262075707395,146,-20.12,"2 20","765 787",20,"65.00%","70.00%",NA,NA,NA,NA,NA
"3083",3327,1221371,"Cluster_8884","Peve_00012322",-0.649662065298932,0.549820801227856,0.978262075707395,146,-20.12,"2 20","85 107",20,"65.00%","70.00%",NA,NA,NA,NA,NA
"3084",3328,1221375,"Cluster_9149","Peve_00012322",0.0133958479636029,0.991471683239817,0.999448381576871,153,-20.66,"2 19","796 818",18,"66.67%","83.33%",NA,NA,NA,NA,NA
"3085",3329,1221452,"Cluster_6904","Peve_00015111",-0.28749280295166,0.814356520237481,0.995934364227446,147,-20.22,"2 13","296 318",12,"83.33%","91.67%","Q86TV6","Tetratricopeptide repeat protein 7B (TPR repeat protein 7B) (Tetratricopeptide repeat protein 7-like-1) (TPR repeat protein 7-like-1)","Homo sapiens (Human)","phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659]","GO:0005829; GO:0005886; GO:0046854; GO:0072659"
"3086",3330,1221915,"Cluster_9149","Peve_00001176",-0.781214490118773,0.429201023777014,0.978262075707395,174,-28.6,"2 20","356 378",19,"84.21%","89.47%","P0CI65","Nephrocystin-3","Danio rerio (Zebrafish) (Brachydanio rerio)","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"3087",3331,1221999,"Cluster_7855","Peve_00026256",-0.499097332039645,0.667330023155847,0.978262075707395,166,-20.33,"2 15","1 14",13,"92.31%","100.00%","Q6IE24","Inactive ubiquitin carboxyl-terminal hydrolase 54 (Inactive ubiquitin-specific peptidase 54)","Rattus norvegicus (Rat)","protein deubiquitination [GO:0016579]","GO:0004843; GO:0016579"
"3088",3332,1222218,"Cluster_6905","Peve_00026250",-0.929945104908788,0.239708228175045,0.978262075707395,143,-20.35,"2 18","714 734",16,"68.75%","75.00%",NA,NA,NA,NA,NA
"3089",3334,1222604,"Cluster_16498","Peve_00014248",-0.00254793453326163,0.998377932742355,0.999661203410867,157,-20.78,"2 21","276 295",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"3090",3335,1223187,"Cluster_15726","Peve_00011148",-0.5,0.666666666666667,0.978262075707395,175,-30.29,"2 21","244 266",20,"85.00%","85.00%",NA,NA,NA,NA,NA
"3091",3336,1223721,"Cluster_11134","Peve_00014936",-0.121551639103005,0.922425993975528,0.999448381576871,154,-22.61,"2 16","35 58",16,"81.25%","81.25%","Q1LZ71","Protein lifeguard 2 (Fas apoptotic inhibitory molecule 2)","Bos taurus (Bovine)","apoptotic signaling pathway [GO:0097190]; cerebellar granular layer development [GO:0021681]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum development [GO:0021549]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; regulation of neuron apoptotic process [GO:0043523]; response to ischemia [GO:0002931]","GO:0002931; GO:0005783; GO:0005794; GO:0016020; GO:0021549; GO:0021680; GO:0021681; GO:0021702; GO:0043523; GO:0043524; GO:0045121; GO:0045211; GO:0051402; GO:0097190; GO:1902042; GO:2001234"
"3092",3337,1223984,"Cluster_8988","Peve_00035738",0.944201287357313,0.213671999960123,0.978262075707395,158,-20.16,"2 20","74 98",21,"71.43%","76.19%",NA,NA,NA,NA,NA
"3093",3338,1224680,"Cluster_1167","Peve_00030529",0.826191577766456,0.381005715482744,0.978262075707395,147,-20.66,"2 12","175 196",10,"90.00%","90.00%","Q00610","Clathrin heavy chain 1 (Clathrin heavy chain on chromosome 17) (CLH-17)","Homo sapiens (Human)","amyloid-beta clearance by transcytosis [GO:0150093]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of protein localization to plasma membrane [GO:1903077]; osteoblast differentiation [GO:0001649]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; transferrin transport [GO:0033572]","GO:0000278; GO:0001649; GO:0003723; GO:0003725; GO:0005198; GO:0005764; GO:0005768; GO:0005819; GO:0005829; GO:0005886; GO:0005925; GO:0006886; GO:0006898; GO:0006914; GO:0016020; GO:0019901; GO:0030118; GO:0030130; GO:0030132; GO:0030136; GO:0030669; GO:0031623; GO:0032051; GO:0032588; GO:0032991; GO:0033572; GO:0036020; GO:0042147; GO:0042470; GO:0045334; GO:0048268; GO:0050750; GO:0051301; GO:0060236; GO:0070062; GO:0071439; GO:0072583; GO:0072686; GO:0097718; GO:0150093; GO:1900126; GO:1903077; GO:1903561; GO:1990381; GO:1990498"
"3094",3339,1224766,"Cluster_29","Peve_00022060",0.278903426048916,0.820058126046293,0.995934364227446,162,-20.17,"2 19","35 56",17,"70.59%","88.24%","Q54ND5","Multiple inositol polyphosphate phosphatase 1 (Ddmipp1) (EC 3.1.3.62) (2,3-bisphosphoglycerate 3-phosphatase) (2,3-BPG phosphatase) (EC 3.1.3.80) (Inositol (1,3,4,5)-tetrakisphosphate 3-phosphatase) (Ins(1,3,4,5)P(4) 3-phosphatase)","Dictyostelium discoideum (Social amoeba)","glucose catabolic process [GO:0006007]; inositol trisphosphate metabolic process [GO:0032957]; response to lithium ion [GO:0010226]","GO:0003993; GO:0004446; GO:0005829; GO:0006007; GO:0010226; GO:0016020; GO:0032957; GO:0034416; GO:0034417; GO:0052745; GO:0052826"
"3095",3340,1224902,"Cluster_589","Peve_00028372",0.775072695353894,0.435426401668339,0.978262075707395,164,-21.34,"2 21","278 299",19,"63.16%","89.47%",NA,NA,NA,NA,NA
"3096",3341,1225611,"Cluster_11134","Peve_00034066",0.990821252050139,0.0863216222112332,0.978262075707395,170,-29.41,"2 21","270 290",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"3097",3342,1227430,"Cluster_4080","Peve_00032384",-0.101352173370071,0.935366222827372,0.999448381576871,164,-21.58,"2 21","267 289",21,"80.95%","85.71%",NA,NA,NA,NA,NA
"3098",3343,1228237,"Cluster_2854","Peve_00022035",-0.220225776460922,0.858641174738862,0.995934364227446,159,-25.12,"2 21","593 617",22,"68.18%","77.27%","Q6AYP4","Zinc finger C2HC domain-containing protein 1C","Rattus norvegicus (Rat)","","GO:0046872"
"3099",3344,1228986,"Cluster_11134","Peve_00032030",-0.602892906564071,0.588029233395319,0.978262075707395,153,-25,"2 20","516 540",21,"66.67%","80.95%","Q9Y6A2","Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1)","Homo sapiens (Human)","bile acid biosynthetic process [GO:0006699]; cholesterol catabolic process [GO:0006707]; nervous system development [GO:0007399]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; sterol metabolic process [GO:0016125]; xenobiotic metabolic process [GO:0006805]","GO:0005506; GO:0005783; GO:0005789; GO:0006699; GO:0006707; GO:0006805; GO:0007399; GO:0008395; GO:0016125; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044"
"3100",3345,1229492,"Cluster_589","Peve_00009875",0.58843228328192,0.599490699808891,0.978262075707395,155,-23.41,"2 12","294 315",10,"100.00%","100.00%",NA,NA,NA,NA,NA
"3101",3346,1230545,"Cluster_6914","Peve_00008476",0.938185018212709,0.22501161999787,0.978262075707395,159,-24.84,"2 17","694 715",16,"81.25%","87.50%","Q90YQ1","40S ribosomal protein S23","Ictalurus punctatus (Channel catfish) (Silurus punctatus)","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003735; GO:0005791; GO:0022627; GO:0042788"
"3102",3347,1231207,"Cluster_2854","Peve_00023780",-0.246560482633971,0.841399198110659,0.995934364227446,153,-20.89,"2 15","350 372",14,"85.71%","85.71%","Q5F2L1","Alpha-(1,3)-fucosyltransferase 10 (EC 2.4.1.-) (Fucosyltransferase X) (Fuc-TX) (FucT-X) (Galactoside 3-L-fucosyltransferase 10) (Fucosyltransferase 10)","Rattus norvegicus (Rat)","cerebral cortex radially oriented cell migration [GO:0021799]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; neuroblast migration [GO:0097402]; neuronal stem cell division [GO:0036445]; neuronal stem cell population maintenance [GO:0097150]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]","GO:0000139; GO:0005789; GO:0006486; GO:0008417; GO:0009312; GO:0021799; GO:0036065; GO:0036071; GO:0036445; GO:0046920; GO:0097150; GO:0097402"
"3103",3348,1231505,"Cluster_10965","Peve_00023789",-0.830686603259741,0.375896294585429,0.978262075707395,184,-26.25,"2 21","171 192",19,"84.21%","94.74%",NA,NA,NA,NA,NA
"3104",3349,1231956,"Cluster_11134","Peve_00018061",0.236755373330256,0.847832015089854,0.995934364227446,155,-20.42,"2 20","182 201",18,"72.22%","88.89%","P56224","POU domain, class 3, transcription factor 3-A (Brain-specific homeobox/POU domain protein 1.1) (Brain-1.1) (zfBrn-1.1) (Class III POU domain protein taichi) (POU domain protein 12) (ZP-12)","Danio rerio (Zebrafish) (Brachydanio rerio)","brain development [GO:0007420]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007420"
"3105",3350,1232342,"Cluster_6904","Peve_00024061",0.703489828865617,0.503248129080124,0.978262075707395,157,-23.79,"2 19","60 85",21,"71.43%","76.19%","Q5R733","Cytoplasmic polyadenylation element-binding protein 1 (CPE-BP1) (CPE-binding protein 1) (CPEB-1)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; mRNA processing [GO:0006397]; negative regulation of cytoplasmic translation [GO:2000766]; positive regulation of mRNA polyadenylation [GO:1900365]","GO:0000900; GO:0000932; GO:0005634; GO:0005737; GO:0006397; GO:0014069; GO:0016020; GO:0030425; GO:0032869; GO:0035925; GO:0046872; GO:0071230; GO:0071456; GO:1900365; GO:1990904; GO:2000766"
"3106",3351,1232344,"Cluster_6906","Peve_00024061",0.958500008010955,0.184048643863218,0.978262075707395,153,-21.77,"2 19","60 85",21,"66.67%","76.19%","Q5R733","Cytoplasmic polyadenylation element-binding protein 1 (CPE-BP1) (CPE-binding protein 1) (CPEB-1)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; mRNA processing [GO:0006397]; negative regulation of cytoplasmic translation [GO:2000766]; positive regulation of mRNA polyadenylation [GO:1900365]","GO:0000900; GO:0000932; GO:0005634; GO:0005737; GO:0006397; GO:0014069; GO:0016020; GO:0030425; GO:0032869; GO:0035925; GO:0046872; GO:0071230; GO:0071456; GO:1900365; GO:1990904; GO:2000766"
"3107",3353,1235099,"Cluster_8988","Peve_00007511",0.141814314968795,0.909412817113639,0.999448381576871,169,-20.98,"2 18","106 127",16,"87.50%","87.50%","Q16832","Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b)","Homo sapiens (Human)","biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endochondral bone growth [GO:0003416]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of kinase activity [GO:0033673]; negative regulation of necrotic cell death [GO:0060547]; ossification [GO:0001503]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of hepatic stellate cell proliferation [GO:1904899]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; regulation of bone mineralization [GO:0030500]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of tissue remodeling [GO:0034103]; response to muscle stretch [GO:0035994]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0001503; GO:0003416; GO:0004714; GO:0005518; GO:0005524; GO:0005886; GO:0005925; GO:0007155; GO:0007165; GO:0007169; GO:0010715; GO:0010763; GO:0015629; GO:0016324; GO:0018108; GO:0030199; GO:0030500; GO:0031214; GO:0032967; GO:0033673; GO:0033674; GO:0034103; GO:0035988; GO:0035994; GO:0038062; GO:0038063; GO:0043066; GO:0043235; GO:0045669; GO:0045860; GO:0046777; GO:0048146; GO:0051091; GO:0060547; GO:0070374; GO:0071456; GO:0071560; GO:0090091; GO:0090303; GO:1900087; GO:1901216; GO:1901299; GO:1904385; GO:1904707; GO:1904754; GO:1904899; GO:2000491"
"3108",3354,1235296,"Cluster_29","Peve_00034254",-0.276498047415315,0.821652134261097,0.995934364227446,155,-20.08,"2 21","503 526",21,"61.90%","80.95%",NA,NA,NA,NA,NA
"3109",3355,1235557,"Cluster_11135","Peve_00037989",-0.334782669332918,0.782674191947198,0.994170199776539,168,-21.72,"2 17","225 246",15,"80.00%","100.00%","Q7T0W5","Dimethyladenosine transferase 1, mitochondrial (EC 2.1.1.-) (Mitochondrial 12S rRNA dimethylase 1) (Mitochondrial transcription factor B1) (mtTFB1) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 1)","Xenopus laevis (African clawed frog)","","GO:0000179; GO:0003677; GO:0003723; GO:0005739"
"3110",3356,1236055,"Cluster_14500","Peve_00037985",0.853069081866556,0.34947705016786,0.978262075707395,163,-20.34,"2 18","893 916",18,"83.33%","88.89%","Q640I9","Lysine-specific demethylase 2B (EC 1.14.11.27) (F-box and leucine-rich repeat protein 10) (F-box/LRR-repeat protein 10) (JmjC domain-containing histone demethylation protein 1B) ([Histone-H3]-lysine-36 demethylase 1B)","Xenopus laevis (African clawed frog)","chromatin organization [GO:0006325]; histone H3-K36 demethylation [GO:0070544]","GO:0005634; GO:0005694; GO:0005730; GO:0006325; GO:0008270; GO:0019843; GO:0045322; GO:0051864; GO:0070544; GO:0140680"
"3111",3357,1236229,"Cluster_10934","Peve_00008863",-0.456234386365879,0.698395722414825,0.978262075707395,170,-26.65,"2 21","740 760",19,"84.21%","84.21%",NA,NA,NA,NA,NA
"3112",3358,1237008,"Cluster_796","Peve_00026904",-0.861353368944291,0.339234662594128,0.978262075707395,153,-20.59,"2 21","118 139",20,"75.00%","75.00%","Q6DCF6","EF-hand calcium-binding domain-containing protein 7","Xenopus laevis (African clawed frog)","","GO:0005509; GO:0060170"
"3113",3359,1237097,"Cluster_589","Peve_00026908",0.617023530785295,0.576676653021589,0.978262075707395,148,-22.96,"2 18","140 166",21,"66.67%","71.43%",NA,NA,NA,NA,NA
"3114",3360,1237468,"Cluster_4735","Peve_00013236",-0.868065560352271,0.330726473489365,0.978262075707395,164,-29.38,"2 19","390 410",17,"82.35%","88.24%","Q8NCL4","Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6)","Homo sapiens (Human)","O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via threonine [GO:0018243]","GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016266; GO:0018243; GO:0030246; GO:0046872; GO:0048471"
"3115",3361,1237731,"Cluster_2787","Peve_00027052",-0.0173167889842213,0.98897523869054,0.999448381576871,166,-22.71,"2 21","942 962",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"3116",3362,1238211,"Cluster_11134","Peve_00039439",0.758822284119863,0.451550191370615,0.978262075707395,154,-20.57,"2 21","766 786",19,"63.16%","84.21%",NA,NA,NA,NA,NA
"3117",3364,1238925,"Cluster_9149","Peve_00014601",1,0,0,156,-22.38,"2 21","899 920",19,"63.16%","78.95%",NA,NA,NA,NA,NA
"3118",3365,1239702,"Cluster_15726","Peve_00020080",-0.5,0.666666666666667,0.978262075707395,155,-22.21,"2 21","84 107",21,"66.67%","76.19%",NA,NA,NA,NA,NA
"3119",3366,1240226,"Cluster_8884","Peve_00044615",-0.857944422829618,0.343482662652058,0.978262075707395,155,-20.59,"2 12","535 555",10,"100.00%","100.00%","Q9NYQ7","Cadherin EGF LAG seven-pass G-type receptor 3 (Cadherin family member 11) (Epidermal growth factor-like protein 1) (EGF-like protein 1) (Flamingo homolog 1) (hFmi1) (Multiple epidermal growth factor-like domains protein 2) (Multiple EGF-like domains protein 2)","Homo sapiens (Human)","cell-cell adhesion [GO:0098609]; G protein-coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0004930; GO:0005509; GO:0005886; GO:0007156; GO:0007186; GO:0016020; GO:0060071; GO:0098609"
"3120",3367,1240227,"Cluster_8887","Peve_00044615",-0.966352032827829,0.165615080378494,0.978262075707395,155,-22.38,"2 12","535 555",10,"100.00%","100.00%","Q9NYQ7","Cadherin EGF LAG seven-pass G-type receptor 3 (Cadherin family member 11) (Epidermal growth factor-like protein 1) (EGF-like protein 1) (Flamingo homolog 1) (hFmi1) (Multiple epidermal growth factor-like domains protein 2) (Multiple EGF-like domains protein 2)","Homo sapiens (Human)","cell-cell adhesion [GO:0098609]; G protein-coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0004930; GO:0005509; GO:0005886; GO:0007156; GO:0007186; GO:0016020; GO:0060071; GO:0098609"
"3121",3368,1241211,"Cluster_7053","Peve_00013799",-0.516039327874696,0.654811661772058,0.978262075707395,168,-20.6,"2 21","901 922",19,"73.68%","84.21%","Q9UBU6","Protein FAM8A1 (Autosomal highly conserved protein)","Homo sapiens (Human)","ubiquitin-dependent ERAD pathway [GO:0030433]","GO:0000836; GO:0030433"
"3122",3369,1241235,"Cluster_16738","Peve_00013799",-0.590299424612168,0.598019342682141,0.978262075707395,167,-20.39,"2 21","707 730",21,"76.19%","80.95%","Q9UBU6","Protein FAM8A1 (Autosomal highly conserved protein)","Homo sapiens (Human)","ubiquitin-dependent ERAD pathway [GO:0030433]","GO:0000836; GO:0030433"
"3123",3370,1241332,"Cluster_2854","Peve_00021065",0.254151007391496,0.836407953502285,0.995934364227446,150,-20.88,"2 21","255 281",24,"62.50%","75.00%","O70244","Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor)","Rattus norvegicus (Rat)","cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584]; vitamin metabolic process [GO:0006766]","GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006766; GO:0006898; GO:0007584; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0051649; GO:0070062"
"3124",3371,1241963,"Cluster_2882","Peve_00016670",-0.642394527808519,0.55588215521768,0.978262075707395,160,-20.25,"2 17","179 200",15,"73.33%","93.33%","Q9HAR2","Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3)","Homo sapiens (Human)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; synapse assembly [GO:0007416]","GO:0001764; GO:0004930; GO:0005509; GO:0005886; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0007420; GO:0016020; GO:0030246; GO:0030424; GO:0098742; GO:0098978"
"3125",3372,1242365,"Cluster_1167","Peve_00045253",0.85062770896903,0.352444352924125,0.978262075707395,150,-24.74,"2 21","336 361",23,"60.87%","78.26%","P25931","RYamide receptor (Neuropeptide Y-like receptor) (NPY-R)","Drosophila melanogaster (Fruit fly)","G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]","GO:0001653; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0016020"
"3126",3373,1243842,"Cluster_15726","Peve_00002803",-0.511037418664174,0.658522706520773,0.978262075707395,155,-20.01,"2 20","876 897",18,"66.67%","77.78%",NA,NA,NA,NA,NA
"3127",3374,1245456,"Cluster_11134","Peve_00028089",-0.0195622829453675,0.987545469442176,0.999448381576871,151,-22.66,"2 20","493 514",18,"66.67%","72.22%",NA,NA,NA,NA,NA
"3128",3375,1245726,"Cluster_11134","Peve_00001057",0.875640822838247,0.320878802775509,0.978262075707395,150,-20.85,"2 20","99 124",22,"68.18%","68.18%",NA,NA,NA,NA,NA
"3129",3376,1245771,"Cluster_11134","Peve_00001056",-0.985363246622836,0.109055769728543,0.978262075707395,150,-20.85,"2 20","312 337",22,"68.18%","68.18%","Q96LQ0","Protein phosphatase 1 regulatory subunit 36","Homo sapiens (Human)","negative regulation of phosphatase activity [GO:0010923]","GO:0004864; GO:0010923; GO:0019902"
"3130",3377,1246042,"Cluster_11135","Peve_00000989",0.855670925970895,0.346289610959178,0.978262075707395,161,-23.48,"2 19","196 218",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"3131",3378,1247043,"Cluster_796","Peve_00031885",0.95272044871775,0.196543156191565,0.978262075707395,170,-26.19,"2 15","177 198",13,"100.00%","100.00%","Q4L235","Beta-alanine-activating enzyme (EC 6.2.1.-) (Acyl-CoA synthetase family member 4) (Protein NRPS998)","Homo sapiens (Human)","amino acid activation for nonribosomal peptide biosynthetic process [GO:0043041]; beta-alanine metabolic process [GO:0019482]; fatty acid metabolic process [GO:0006631]","GO:0005524; GO:0006631; GO:0016878; GO:0019482; GO:0043041"
"3132",3379,1247053,"Cluster_4735","Peve_00031885",-0.96009068493056,0.180462641524854,0.978262075707395,147,-21.8,"2 14","8 28",12,"83.33%","91.67%","Q4L235","Beta-alanine-activating enzyme (EC 6.2.1.-) (Acyl-CoA synthetase family member 4) (Protein NRPS998)","Homo sapiens (Human)","amino acid activation for nonribosomal peptide biosynthetic process [GO:0043041]; beta-alanine metabolic process [GO:0019482]; fatty acid metabolic process [GO:0006631]","GO:0005524; GO:0006631; GO:0016878; GO:0019482; GO:0043041"
"3133",3380,1247529,"Cluster_13502","Peve_00033951",-0.759327675175824,0.451055966493269,0.978262075707395,188,-25.9,"2 21","59 80",19,"89.47%","94.74%",NA,NA,NA,NA,NA
"3134",3381,1247946,"Cluster_2787","Peve_00038560",0.951533405743249,0.199015193951622,0.978262075707395,166,-20.72,"2 20","313 335",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"3135",3383,1249037,"Cluster_6904","Peve_00006916",-0.956968370106019,0.187438508367866,0.978262075707395,184,-33.53,"2 21","152 173",19,"84.21%","94.74%",NA,NA,NA,NA,NA
"3136",3384,1249039,"Cluster_6906","Peve_00006916",-0.699695519347193,0.506637993584773,0.978262075707395,180,-31.51,"2 21","152 173",19,"78.95%","94.74%",NA,NA,NA,NA,NA
"3137",3385,1249467,"Cluster_15726","Peve_00007069",-0.5,0.666666666666667,0.978262075707395,157,-26.9,"2 21","493 519",24,"75.00%","75.00%",NA,NA,NA,NA,NA
"3138",3386,1249787,"Cluster_589","Peve_00033223",0.775072695353894,0.435426401668339,0.978262075707395,166,-24.63,"2 17","218 238",15,"93.33%","93.33%",NA,NA,NA,NA,NA
"3139",3388,1250226,"Cluster_11134","Peve_00028500",-0.0195622829453675,0.987545469442176,0.999448381576871,150,-22.18,"2 18","174 195",17,"76.47%","82.35%","P97292","Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I)","Mus musculus (Mouse)","chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonic acid secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; toxin transport [GO:1901998]; visual learning [GO:0008542]","GO:0001696; GO:0001697; GO:0001698; GO:0003382; GO:0004969; GO:0004993; GO:0005886; GO:0007187; GO:0007268; GO:0007613; GO:0008542; GO:0016020; GO:0030425; GO:0030594; GO:0045202; GO:0045907; GO:0048167; GO:0048565; GO:0048732; GO:1900139; GO:1901363; GO:1901998"
"3140",3389,1250466,"Cluster_2787","Peve_00042834",-0.565685358549523,0.617223362506528,0.978262075707395,152,-22.72,"2 21","592 614",21,"71.43%","80.95%",NA,NA,NA,NA,NA
"3141",3391,1251141,"Cluster_2787","Peve_00003366",0.643349843489677,0.555088168219444,0.978262075707395,159,-22.48,"2 21","202 226",22,"68.18%","77.27%","Q8BPN8","DmX-like protein 2 (Rabconnectin-3)","Mus musculus (Mouse)","brain development [GO:0007420]; chemical synaptic transmission [GO:0007268]; corpus callosum development [GO:0022038]; glucose homeostasis [GO:0042593]; sensory perception of smell [GO:0007608]; spermatogenesis [GO:0007283]; vacuolar acidification [GO:0007035]","GO:0007035; GO:0007268; GO:0007283; GO:0007420; GO:0007608; GO:0008021; GO:0022038; GO:0030672; GO:0031267; GO:0042593; GO:0043291; GO:0098992"
"3142",3392,1251141,"Cluster_2787","Peve_00003366",0.643349843489677,0.555088168219444,0.978262075707395,159,-22.48,"2 21","880 904",22,"68.18%","77.27%","Q8BPN8","DmX-like protein 2 (Rabconnectin-3)","Mus musculus (Mouse)","brain development [GO:0007420]; chemical synaptic transmission [GO:0007268]; corpus callosum development [GO:0022038]; glucose homeostasis [GO:0042593]; sensory perception of smell [GO:0007608]; spermatogenesis [GO:0007283]; vacuolar acidification [GO:0007035]","GO:0007035; GO:0007268; GO:0007283; GO:0007420; GO:0007608; GO:0008021; GO:0022038; GO:0030672; GO:0031267; GO:0042593; GO:0043291; GO:0098992"
"3143",3393,1251442,"Cluster_11135","Peve_00019270",0.992922024899726,0.0757889917572571,0.978262075707395,156,-20.5,"2 18","402 424",17,"76.47%","82.35%",NA,NA,NA,NA,NA
"3144",3394,1251971,"Cluster_8884","Peve_00016539",-0.345073229880753,0.775708154958226,0.992481548495727,178,-21.59,"2 19","833 853",17,"88.24%","94.12%",NA,NA,NA,NA,NA
"3145",3395,1251972,"Cluster_8887","Peve_00016539",-0.0728584472332032,0.953575737231791,0.999448381576871,178,-21.59,"2 19","833 853",17,"88.24%","94.12%",NA,NA,NA,NA,NA
"3146",3396,1251973,"Cluster_8888","Peve_00016539",0.621186782541089,0.57330164989748,0.978262075707395,178,-21.97,"2 19","833 853",17,"88.24%","94.12%",NA,NA,NA,NA,NA
"3147",3397,1252142,"Cluster_6904","Peve_00014122",-0.951310992493219,0.199475076059675,0.978262075707395,157,-20.68,"2 18","262 283",16,"75.00%","81.25%","P25931","RYamide receptor (Neuropeptide Y-like receptor) (NPY-R)","Drosophila melanogaster (Fruit fly)","G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]","GO:0001653; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0016020"
"3148",3398,1252144,"Cluster_6906","Peve_00014122",-0.686063329690759,0.518674561276582,0.978262075707395,157,-20.68,"2 18","262 283",16,"75.00%","81.25%","P25931","RYamide receptor (Neuropeptide Y-like receptor) (NPY-R)","Drosophila melanogaster (Fruit fly)","G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]","GO:0001653; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0016020"
"3149",3399,1252557,"Cluster_8887","Peve_00038827",-0.412507829449469,0.729305884626363,0.984292668049156,154,-20.3,"2 20","764 786",20,"70.00%","75.00%","P61315","Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)","Mus musculus (Mouse)","glycolipid biosynthetic process [GO:0009247]","GO:0001733; GO:0008146; GO:0009247; GO:0032580; GO:0050694"
"3150",3400,1252558,"Cluster_8888","Peve_00038827",0.312642708677453,0.797571502502908,0.995934364227446,154,-21.93,"2 20","764 786",20,"70.00%","75.00%","P61315","Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)","Mus musculus (Mouse)","glycolipid biosynthetic process [GO:0009247]","GO:0001733; GO:0008146; GO:0009247; GO:0032580; GO:0050694"
"3151",3401,1252647,"Cluster_8887","Peve_00038825",-0.0823630340017489,0.947506599925429,0.999448381576871,152,-21.42,"2 18","625 646",17,"70.59%","82.35%",NA,NA,NA,NA,NA
"3152",3402,1252678,"Cluster_4735","Peve_00022590",-0.0278612048620612,0.982260710586951,0.999448381576871,167,-25.76,"2 20","784 805",18,"77.78%","83.33%","Q9V9J3","Tyrosine-protein kinase Src42A (EC 2.7.10.2) (Tyrosine-protein kinase Src41) (Dsrc41)","Drosophila melanogaster (Fruit fly)","actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; hydrogen peroxide mediated signaling pathway [GO:0071588]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived wing morphogenesis [GO:0007476]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of sevenless signaling pathway [GO:0045874]; protein phosphorylation [GO:0006468]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007169; GO:0007391; GO:0007395; GO:0007411; GO:0007424; GO:0007435; GO:0007476; GO:0016477; GO:0018108; GO:0030154; GO:0031234; GO:0034332; GO:0036335; GO:0042059; GO:0042742; GO:0043277; GO:0045087; GO:0045742; GO:0045874; GO:0045886; GO:0046529; GO:0048167; GO:0048749; GO:0051017; GO:0070374; GO:0071588; GO:0090136; GO:0106016"
"3153",3403,1252797,"Cluster_15726","Peve_00022592",-0.844265213934194,0.36007450120789,0.978262075707395,151,-22.27,"2 21","603 626",21,"66.67%","71.43%","Q42371","LRR receptor-like serine/threonine-protein kinase ERECTA (EC 2.7.11.1) (Protein QUANTITATIVE RESISTANCE TO PLECTOSPHAERELLA 1) (Protein QUANTITATIVE RESISTANCE TO RALSTONIA SOLANACEARUM 1) (Protein TRANSPIRATION EFFICIENCY 1)","Arabidopsis thaliana (Mouse-ear cress)","cellular heat acclimation [GO:0070370]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; inflorescence morphogenesis [GO:0048281]; leaf morphogenesis [GO:0009965]; phloem or xylem histogenesis [GO:0010087]; plant-type cell wall organization [GO:0009664]; polarity specification of adaxial/abaxial axis [GO:0009944]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell division [GO:0051302]; regulation of cell growth [GO:0001558]; regulation of plant organ morphogenesis [GO:1905421]; stomatal complex morphogenesis [GO:0010103]; transpiration [GO:0010148]","GO:0001558; GO:0004674; GO:0005102; GO:0005524; GO:0005739; GO:0005886; GO:0006468; GO:0009664; GO:0009944; GO:0009965; GO:0010087; GO:0010103; GO:0010148; GO:0019199; GO:0030155; GO:0033612; GO:0042277; GO:0042742; GO:0048281; GO:0050832; GO:0051302; GO:0070370; GO:0106310; GO:1905421"
"3154",3404,1252911,"Cluster_7053","Peve_00022150",-0.0137519703230736,0.991244947814119,0.999448381576871,157,-20.89,"2 21","823 848",23,"73.91%","78.26%","Q6NWZ9","Cysteine dioxygenase type 1 (EC 1.13.11.20) (Cysteine dioxygenase type I) (CDO) (CDO-I)","Danio rerio (Zebrafish) (Brachydanio rerio)","L-cysteine catabolic process [GO:0019448]; taurine biosynthetic process [GO:0042412]","GO:0008198; GO:0008270; GO:0016151; GO:0016702; GO:0017172; GO:0019448; GO:0042412"
"3155",3405,1253170,"Cluster_4080","Peve_00024296",-0.303234002223661,0.803867236059286,0.995934364227446,167,-24.36,"2 16","904 925",14,"85.71%","100.00%","Q9UGM3","Deleted in malignant brain tumors 1 protein (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)","Homo sapiens (Human)","antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; detection of bacterial lipoprotein [GO:0042494]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]","GO:0001530; GO:0003677; GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006898; GO:0006952; GO:0015031; GO:0019898; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042494; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0050840; GO:0051607; GO:0061844; GO:0070062; GO:0070891; GO:1904399"
"3156",3406,1253399,"Cluster_5563","Peve_00024293",0.838131293927935,0.367296535645446,0.978262075707395,163,-21.03,"2 21","275 298",20,"70.00%","85.00%","B3EWY9","Mucin-like protein","Acropora millepora (Staghorn coral) (Heteropora millepora)","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0007160; GO:0016020"
"3157",3407,1254017,"Cluster_589","Peve_00033635",-0.854643471106139,0.347551452182342,0.978262075707395,150,-21.21,"2 21","759 784",23,"65.22%","73.91%","Q9K9H0","Isocitrate lyase (ICL) (EC 4.1.3.1) (Isocitrase) (Isocitratase)","Halalkalibacterium halodurans (strain ATCC BAA-125 / DSM 18197 / FERM 7344 / JCM 9153 / C-125) (Bacillus halodurans)","glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]","GO:0004451; GO:0006097; GO:0006099; GO:0046872"
"3158",3408,1254060,"Cluster_16738","Peve_00033635",-0.99145147429621,0.0833010736968463,0.978262075707395,163,-23.49,"2 21","382 405",21,"76.19%","76.19%","Q9K9H0","Isocitrate lyase (ICL) (EC 4.1.3.1) (Isocitrase) (Isocitratase)","Halalkalibacterium halodurans (strain ATCC BAA-125 / DSM 18197 / FERM 7344 / JCM 9153 / C-125) (Bacillus halodurans)","glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]","GO:0004451; GO:0006097; GO:0006099; GO:0046872"
"3159",3409,1254075,"Cluster_5882","Peve_00016200",-0.81266345773768,0.396033547435193,0.978262075707395,160,-22,"2 17","509 530",15,"80.00%","86.67%",NA,NA,NA,NA,NA
"3160",3410,1254152,"Cluster_589","Peve_00033630",0.825973951302646,0.381251559875879,0.978262075707395,150,-21.21,"2 21","759 784",23,"65.22%","73.91%","Q9K9H0","Isocitrate lyase (ICL) (EC 4.1.3.1) (Isocitrase) (Isocitratase)","Halalkalibacterium halodurans (strain ATCC BAA-125 / DSM 18197 / FERM 7344 / JCM 9153 / C-125) (Bacillus halodurans)","glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]","GO:0004451; GO:0006097; GO:0006099; GO:0046872"
"3161",3411,1254195,"Cluster_16738","Peve_00033630",0.996966316145993,0.0496009660033097,0.951817778779317,163,-23.49,"2 21","382 405",21,"76.19%","76.19%","Q9K9H0","Isocitrate lyase (ICL) (EC 4.1.3.1) (Isocitrase) (Isocitratase)","Halalkalibacterium halodurans (strain ATCC BAA-125 / DSM 18197 / FERM 7344 / JCM 9153 / C-125) (Bacillus halodurans)","glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]","GO:0004451; GO:0006097; GO:0006099; GO:0046872"
"3162",3412,1254236,"Cluster_14999","Peve_00033631",0.47443735243041,0.685303084188443,0.978262075707395,163,-20.76,"2 21","739 761",20,"75.00%","80.00%","O15439","ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B) (Multidrug resistance-associated protein 4)","Homo sapiens (Human)","bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; leukotriene transport [GO:0071716]; platelet degranulation [GO:0002576]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate transport [GO:0015747]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]","GO:0001409; GO:0002576; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006805; GO:0006855; GO:0008559; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0043225; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359; GO:0150104"
"3163",3413,1254522,"Cluster_4629","Peve_00020533",0.869287028892958,0.329156743585745,0.978262075707395,150,-22.07,"2 21","110 134",22,"63.64%","77.27%",NA,NA,NA,NA,NA
"3164",3414,1255150,"Cluster_4080","Peve_00021668",-0.00995834617610519,0.993660215136606,0.999448381576871,170,-28.11,"2 21","878 904",24,"79.17%","79.17%",NA,NA,NA,NA,NA
"3165",3415,1255275,"Cluster_16738","Peve_00021662",0.9276221140524,0.243698569045906,0.978262075707395,159,-21.43,"2 21","210 232",20,"75.00%","75.00%","P34275","Probable acyl-CoA dehydrogenase 6 (Probable isovaleryl-CoA dehydrogenase) (IVD) (EC 1.3.8.4)","Caenorhabditis elegans","fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; leucine catabolic process [GO:0006552]","GO:0003995; GO:0005737; GO:0006552; GO:0008470; GO:0033539; GO:0050660"
"3166",3417,1255971,"Cluster_7053","Peve_00013800",-0.978880816977233,0.131069300956898,0.978262075707395,168,-20.6,"2 21","780 801",19,"73.68%","84.21%","D3YYI7","E3 ubiquitin-protein ligase RNF217 (EC 2.3.2.31) (IBR domain-containing protein 1) (RING finger protein 217)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000209; GO:0005737; GO:0006511; GO:0016020; GO:0031624; GO:0032436; GO:0046872; GO:0061630"
"3167",3418,1255995,"Cluster_16738","Peve_00013800",0.190098854942304,0.878238296502699,0.998286328800453,167,-20.39,"2 21","586 609",21,"76.19%","80.95%","D3YYI7","E3 ubiquitin-protein ligase RNF217 (EC 2.3.2.31) (IBR domain-containing protein 1) (RING finger protein 217)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000209; GO:0005737; GO:0006511; GO:0016020; GO:0031624; GO:0032436; GO:0046872; GO:0061630"
"3168",3419,1256133,"Cluster_796","Peve_00039969",-0.975018995306725,0.142596325114252,0.978262075707395,156,-22.62,"2 15","629 649",13,"92.31%","92.31%",NA,NA,NA,NA,NA
"3169",3420,1256361,"Cluster_2787","Peve_00039966",0.867933894665659,0.330895275232091,0.978262075707395,168,-21.63,"2 21","478 499",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"3170",3421,1256507,"Cluster_6904","Peve_00007302",-0.999602697635797,0.0179460996686937,0.782669382293497,151,-22.2,"2 13","313 335",12,"91.67%","91.67%","B5DF45","TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6)","Rattus norvegicus (Rat)","activation of NF-kappaB-inducing kinase activity [GO:0007250]; activation of protein kinase activity [GO:0032147]; animal organ morphogenesis [GO:0009887]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; bone remodeling [GO:0046849]; bone resorption [GO:0045453]; cell development [GO:0048468]; cellular response to cytokine stimulus [GO:0071345]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; JNK cascade [GO:0007254]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; response to interleukin-1 [GO:0070555]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0000122; GO:0000209; GO:0001503; GO:0001701; GO:0001843; GO:0002637; GO:0002726; GO:0002931; GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0005938; GO:0006955; GO:0006974; GO:0007165; GO:0007249; GO:0007250; GO:0007254; GO:0008270; GO:0009887; GO:0009898; GO:0016567; GO:0019221; GO:0019886; GO:0019901; GO:0030316; GO:0031435; GO:0031624; GO:0031625; GO:0031666; GO:0031996; GO:0032147; GO:0032735; GO:0032743; GO:0032755; GO:0032813; GO:0032991; GO:0033209; GO:0035631; GO:0042088; GO:0042102; GO:0042475; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043122; GO:0043123; GO:0043422; GO:0043507; GO:0045453; GO:0045672; GO:0045892; GO:0045944; GO:0046330; GO:0046849; GO:0047485; GO:0048468; GO:0048471; GO:0048661; GO:0050852; GO:0051091; GO:0051092; GO:0051865; GO:0061630; GO:0070498; GO:0070534; GO:0070555; GO:0071222; GO:0071345; GO:0097400; GO:1901224; GO:1904996; GO:2000679"
"3171",3422,1256509,"Cluster_6906","Peve_00007302",-0.890110975308666,0.301253385548214,0.978262075707395,151,-22.61,"2 13","313 335",12,"91.67%","91.67%","B5DF45","TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6)","Rattus norvegicus (Rat)","activation of NF-kappaB-inducing kinase activity [GO:0007250]; activation of protein kinase activity [GO:0032147]; animal organ morphogenesis [GO:0009887]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; bone remodeling [GO:0046849]; bone resorption [GO:0045453]; cell development [GO:0048468]; cellular response to cytokine stimulus [GO:0071345]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; JNK cascade [GO:0007254]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; response to interleukin-1 [GO:0070555]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0000122; GO:0000209; GO:0001503; GO:0001701; GO:0001843; GO:0002637; GO:0002726; GO:0002931; GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0005938; GO:0006955; GO:0006974; GO:0007165; GO:0007249; GO:0007250; GO:0007254; GO:0008270; GO:0009887; GO:0009898; GO:0016567; GO:0019221; GO:0019886; GO:0019901; GO:0030316; GO:0031435; GO:0031624; GO:0031625; GO:0031666; GO:0031996; GO:0032147; GO:0032735; GO:0032743; GO:0032755; GO:0032813; GO:0032991; GO:0033209; GO:0035631; GO:0042088; GO:0042102; GO:0042475; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043122; GO:0043123; GO:0043422; GO:0043507; GO:0045453; GO:0045672; GO:0045892; GO:0045944; GO:0046330; GO:0046849; GO:0047485; GO:0048468; GO:0048471; GO:0048661; GO:0050852; GO:0051091; GO:0051092; GO:0051865; GO:0061630; GO:0070498; GO:0070534; GO:0070555; GO:0071222; GO:0071345; GO:0097400; GO:1901224; GO:1904996; GO:2000679"
"3172",3423,1256583,"Cluster_796","Peve_00007306",0.898740270652305,0.288966974174018,0.978262075707395,156,-23.78,"2 19","368 394",22,"72.73%","77.27%",NA,NA,NA,NA,NA
"3173",3424,1256745,"Cluster_9149","Peve_00022617",-0.96990987256945,0.156567706608174,0.978262075707395,159,-27.74,"2 21","344 367",21,"66.67%","80.95%","Q9ULI0","ATPase family AAA domain-containing protein 2B","Homo sapiens (Human)","positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0016887; GO:0042393; GO:0045944; GO:0070577"
"3174",3425,1257201,"Cluster_11134","Peve_00027156",-0.527738318211895,0.646080343492546,0.978262075707395,157,-21.03,"2 16","581 601",14,"85.71%","92.86%","A2RRP1","NBAS subunit of NRZ tethering complex (Neuroblastoma-amplified gene protein) (Neuroblastoma-amplified sequence)","Homo sapiens (Human)","negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0000149; GO:0000956; GO:0005783; GO:0005789; GO:0005829; GO:0006890; GO:0015031; GO:0016020; GO:0070939; GO:2000623"
"3175",3426,1257441,"Cluster_2787","Peve_00039121",0.960431824754908,0.179684516327457,0.978262075707395,158,-21.8,"2 21","666 691",23,"69.57%","78.26%","P69525","Transmembrane protease serine 9 (EC 3.4.21.-) (Polyserase-I) (Polyserine protease 1) (Polyserase-1) [Cleaved into: Serase-1; Serase-2; Serase-3]","Mus musculus (Mouse)","plasminogen activation [GO:0031639]; proteolysis [GO:0006508]","GO:0004252; GO:0005886; GO:0006508; GO:0008236; GO:0031639"
"3176",3427,1257980,"Cluster_1167","Peve_00010640",-0.94320471558976,0.215589941227942,0.978262075707395,140,-21.36,"2 9","664 685",7,"100.00%","100.00%","O60683","Peroxisome biogenesis factor 10 (EC 2.3.2.27) (Peroxin-10) (Peroxisomal biogenesis factor 10) (Peroxisome assembly protein 10) (RING finger protein 69)","Homo sapiens (Human)","peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, receptor recycling [GO:0016562]","GO:0005777; GO:0005778; GO:0007031; GO:0008022; GO:0008270; GO:0016558; GO:0016562; GO:0046872; GO:0061630"
"3177",3428,1258162,"Cluster_2854","Peve_00010648",-0.507486347355159,0.661149542463894,0.978262075707395,155,-21.23,"2 17","453 476",17,"76.47%","82.35%",NA,NA,NA,NA,NA
"3178",3429,1258194,"Cluster_13502","Peve_00010648",-0.44209200413486,0.708472937844906,0.978262075707395,166,-22.35,"2 21","289 312",21,"76.19%","85.71%",NA,NA,NA,NA,NA
"3179",3430,1258890,"Cluster_5882","Peve_00043658",-0.579329461459619,0.606628951778323,0.978262075707395,166,-21.48,"2 21","669 692",21,"76.19%","85.71%","Q14746","Conserved oligomeric Golgi complex subunit 2 (COG complex subunit 2) (Component of oligomeric Golgi complex 2) (Low density lipoprotein receptor defect C-complementing protein)","Homo sapiens (Human)","glycosylation [GO:0070085]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]","GO:0000139; GO:0000301; GO:0005795; GO:0005829; GO:0006891; GO:0007030; GO:0015031; GO:0017119; GO:0032588; GO:0044877; GO:0070085"
"3180",3431,1259382,"Cluster_4629","Peve_00039194",0.0674575503650427,0.957022552554819,0.999448381576871,157,-20.74,"2 21","449 470",20,"70.00%","85.00%","Q9IA79","Probable Bax inhibitor 1 (BI-1) (Testis-enhanced gene transcript protein homolog) (Transmembrane BAX inhibitor motif-containing protein 6)","Paralichthys olivaceus (Bastard halibut) (Hippoglossus olivaceus)","apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; response to unfolded protein [GO:0006986]","GO:0005789; GO:0006915; GO:0006986; GO:0043066"
"3181",3432,1259683,"Cluster_15890","Peve_00032510",0.282844301904356,0.817444054066439,0.995934364227446,167,-20.5,"2 21","444 466",20,"75.00%","85.00%","Q63185","Eukaryotic translation initiation factor 2-alpha kinase 1 (EC 2.7.11.1) (Heme-controlled repressor) (HCR) (Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase) (Heme-regulated inhibitor) (Hemin-sensitive initiation factor 2-alpha kinase)","Rattus norvegicus (Rat)","acute inflammatory response [GO:0002526]; establishment of localization in cell [GO:0051649]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; iron ion homeostasis [GO:0055072]; macrophage differentiation [GO:0030225]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hemoglobin biosynthetic process [GO:0046986]; negative regulation of translation [GO:0017148]; phagocytosis [GO:0006909]; protein autophosphorylation [GO:0046777]; protoporphyrinogen IX metabolic process [GO:0046501]; regulation of eIF2 alpha phosphorylation by heme [GO:0010999]; regulation of hemoglobin biosynthetic process [GO:0046984]; regulation of translation [GO:0006417]; response to iron ion starvation [GO:1990641]","GO:0002526; GO:0004672; GO:0004694; GO:0005524; GO:0005737; GO:0006417; GO:0006909; GO:0008285; GO:0010999; GO:0017148; GO:0020037; GO:0030225; GO:0042803; GO:0046501; GO:0046777; GO:0046984; GO:0046986; GO:0051649; GO:0055072; GO:0106310; GO:0140467; GO:0140468; GO:1990641"
"3182",3433,1259702,"Cluster_6904","Peve_00032511",0.208718150280978,0.866141742726342,0.996660710141104,159,-22.46,"2 16","709 730",14,"85.71%","85.71%",NA,NA,NA,NA,NA
"3183",3434,1259704,"Cluster_6906","Peve_00032511",-0.287038038235336,0.814658772056752,0.995934364227446,159,-22.63,"2 21","707 730",21,"71.43%","76.19%",NA,NA,NA,NA,NA
"3184",3435,1259832,"Cluster_4629","Peve_00032517",-0.0962108614183453,0.938655374179874,0.999448381576871,167,-21.3,"2 20","845 866",18,"77.78%","83.33%","B3EWZ6","MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576; GO:0016020"
"3185",3436,1260060,"Cluster_5882","Peve_00044402",-0.189622645497109,0.878547077259004,0.998359995424846,174,-23.65,"2 21","449 469",19,"78.95%","94.74%","Q66L32","Mitochondrial import inner membrane translocase subunit Tim8 A","Xenopus laevis (African clawed frog)","protein transport [GO:0015031]","GO:0005743; GO:0015031; GO:0046872"
"3186",3437,1260487,"Cluster_11135","Peve_00003165",0.53140980523281,0.643324897072298,0.978262075707395,156,-20.05,"2 17","751 772",15,"73.33%","86.67%","P10079","Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","Strongylocentrotus purpuratus (Purple sea urchin)","","GO:0005509; GO:0005615; GO:0009374; GO:0031410; GO:0032579"
"3187",3438,1260695,"Cluster_6914","Peve_00042588",0.863046642698975,0.337106663210255,0.978262075707395,173,-23.1,"2 20","576 598",20,"85.00%","90.00%",NA,NA,NA,NA,NA
"3188",3439,1260909,"Cluster_4079","Peve_00016739",-0.903103597147736,0.282565906538638,0.978262075707395,158,-22.29,"2 21","483 507",22,"72.73%","77.27%","Q568D2","Cilia- and flagella-associated protein 161","Danio rerio (Zebrafish) (Brachydanio rerio)","cilium assembly [GO:0060271]","GO:0005879; GO:0031514; GO:0060271"
"3189",3440,1261086,"Cluster_2787","Peve_00016736",-0.697968883356908,0.508174738589296,0.978262075707395,156,-22.44,"2 13","600 621",11,"90.91%","100.00%",NA,NA,NA,NA,NA
"3190",3442,1261805,"Cluster_1167","Peve_00043987",0.93195619779822,0.236201855066716,0.978262075707395,143,-20.99,"2 17","591 609",15,"80.00%","80.00%","F1PRN2","Unconventional myosin-Id (Unconventional myosin Myr 4)","Canis lupus familiaris (Dog) (Canis familiaris)","actin filament organization [GO:0007015]; early endosome to recycling endosome transport [GO:0061502]; endocytosis [GO:0006897]; protein transport [GO:0015031]; vesicle transport along actin filament [GO:0030050]","GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0005902; GO:0005903; GO:0005938; GO:0006897; GO:0007015; GO:0015031; GO:0015629; GO:0016459; GO:0019904; GO:0030050; GO:0030424; GO:0030425; GO:0031982; GO:0043204; GO:0043209; GO:0051015; GO:0061502"
"3191",3444,1263079,"Cluster_6906","Peve_00043672",-0.996921218382016,0.0499684699057156,0.953525644311219,159,-20.7,"2 17","859 882",17,"82.35%","82.35%","P26618","Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (Platelet-derived growth factor alpha receptor) (CD antigen CD140a)","Mus musculus (Mouse)","adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; animal organ morphogenesis [GO:0009887]; cardiac myofibril assembly [GO:0055003]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cellular response to amino acid stimulus [GO:0071230]; cellular response to reactive oxygen species [GO:0034614]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; estrogen metabolic process [GO:0008210]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; female gonad development [GO:0008585]; hematopoietic progenitor cell differentiation [GO:0002244]; in utero embryonic development [GO:0001701]; Leydig cell differentiation [GO:0033327]; lung development [GO:0030324]; lung growth [GO:0060437]; luteinization [GO:0001553]; male genitalia development [GO:0030539]; metanephric glomerular capillary formation [GO:0072277]; negative regulation of platelet activation [GO:0010544]; odontogenesis of dentin-containing tooth [GO:0042475]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet aggregation [GO:0070527]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; platelet-derived growth factor receptor-alpha signaling pathway [GO:0035790]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of kinase activity [GO:0033674]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phospholipase C activity [GO:0010863]; protein autophosphorylation [GO:0046777]; regulation of chemotaxis [GO:0050920]; regulation of mesenchymal stem cell differentiation [GO:2000739]; retina vasculature development in camera-type eye [GO:0061298]; roof of mouth development [GO:0060021]; signal transduction involved in regulation of gene expression [GO:0023019]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; white fat cell differentiation [GO:0050872]; wound healing [GO:0042060]","GO:0001553; GO:0001701; GO:0002244; GO:0004672; GO:0004714; GO:0005018; GO:0005021; GO:0005161; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0005902; GO:0005929; GO:0007169; GO:0007204; GO:0008210; GO:0008284; GO:0008585; GO:0009653; GO:0009887; GO:0009897; GO:0009986; GO:0010544; GO:0010863; GO:0016477; GO:0018108; GO:0019838; GO:0023019; GO:0030054; GO:0030198; GO:0030324; GO:0030325; GO:0030335; GO:0030424; GO:0030539; GO:0032991; GO:0033327; GO:0033674; GO:0034614; GO:0035790; GO:0038085; GO:0038091; GO:0042060; GO:0042475; GO:0042803; GO:0043235; GO:0043548; GO:0043552; GO:0046777; GO:0048008; GO:0048015; GO:0048146; GO:0048407; GO:0048557; GO:0048701; GO:0048705; GO:0050731; GO:0050872; GO:0050920; GO:0055003; GO:0060021; GO:0060325; GO:0060326; GO:0060437; GO:0061047; GO:0061298; GO:0062063; GO:0070374; GO:0070527; GO:0071230; GO:0072277; GO:2000739"
"3192",3446,1264223,"Cluster_11997","Peve_00000532",-0.838527957857818,0.366833327704515,0.978262075707395,160,-21.1,"2 21","438 457",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"3193",3447,1264710,"Cluster_9149","Peve_00010016",-0.624863221868907,0.570309455481832,0.978262075707395,141,-20.97,"2 19","384 401",17,"70.59%","70.59%","Q5E9S2","Nuclear transcription factor Y subunit alpha (CAAT box DNA-binding protein subunit A) (Nuclear transcription factor Y subunit A) (NF-YA)","Bos taurus (Bovine)","histone H3-K4 trimethylation [GO:0080182]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of histone acetylation [GO:0035065]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]","GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0016602; GO:0032993; GO:0035065; GO:0045893; GO:0045944; GO:0048511; GO:0080182"
"3194",3448,1265233,"Cluster_4735","Peve_00003948",-0.675122665079901,0.52818137137589,0.978262075707395,164,-22.7,"2 20","286 308",20,"80.00%","85.00%",NA,NA,NA,NA,NA
"3195",3449,1265727,"Cluster_4629","Peve_00040516",-0.335589762820473,0.782128832229071,0.9940447575394,162,-22.02,"2 15","92 113",13,"92.31%","92.31%","B0S5G3",NA,NA,NA,NA
"3196",3450,1265768,"Cluster_2882","Peve_00040511",0.829552508820929,0.377191141695678,0.978262075707395,179,-30.07,"2 21","12 34",20,"85.00%","90.00%",NA,NA,NA,NA,NA
"3197",3451,1265813,"Cluster_2882","Peve_00040513",-0.898389711968954,0.289475524970989,0.978262075707395,157,-24.15,"2 14","173 194",12,"91.67%","91.67%",NA,NA,NA,NA,NA
"3198",3452,1266033,"Cluster_796","Peve_00006277",0.986620573328057,0.104255573676217,0.978262075707395,153,-20.28,"2 18","208 229",16,"75.00%","75.00%","Q5ZMM5","Zinc finger protein 706","Gallus gallus (Chicken)","negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of stem cell population maintenance [GO:1902455]; regulation of translation [GO:0006417]","GO:0005634; GO:0005737; GO:0006417; GO:0045892; GO:0046872; GO:1902455"
"3199",3453,1266033,"Cluster_796","Peve_00006277",0.986620573328057,0.104255573676217,0.978262075707395,153,-20.28,"2 18","83 104",16,"75.00%","75.00%","Q5ZMM5","Zinc finger protein 706","Gallus gallus (Chicken)","negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of stem cell population maintenance [GO:1902455]; regulation of translation [GO:0006417]","GO:0005634; GO:0005737; GO:0006417; GO:0045892; GO:0046872; GO:1902455"
"3200",3454,1266126,"Cluster_2787","Peve_00006275",0.327274833045137,0.78773942043398,0.995344791098752,160,-22.5,"2 21","913 934",19,"68.42%","78.95%","Q95P04","GFP-like non-fluorescent chromoprotein (gtCP)","Goniopora tenuidens (Anemone coral) (Rhodaraea tenuidens)","bioluminescence [GO:0008218]","GO:0008218"
"3201",3455,1266882,"Cluster_15726","Peve_00034555",0.999999835926399,0.000364682128698326,0.201157207099209,171,-20.04,"2 20","598 619",18,"83.33%","83.33%","P10079","Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","Strongylocentrotus purpuratus (Purple sea urchin)","","GO:0005509; GO:0005615; GO:0009374; GO:0031410; GO:0032579"
"3202",3456,1269126,"Cluster_11134","Peve_00027397",-0.900435921834811,0.286495261044392,0.978262075707395,156,-20.1,"2 20","17 38",19,"78.95%","78.95%","Q9D2I5","LisH domain-containing protein ARMC9","Mus musculus (Mouse)","cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880]","GO:0005737; GO:0005814; GO:0005929; GO:0036064; GO:0045880; GO:0060271; GO:0097542"
"3203",3457,1269221,"Cluster_14999","Peve_00027399",0.525134194156591,0.64803024914489,0.978262075707395,172,-22.44,"2 17","567 588",15,"93.33%","93.33%","Q6NRV0","E3 ubiquitin-protein ligase TRAIP (EC 2.3.2.27) (TRAF-interacting protein)","Xenopus laevis (African clawed frog)","cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]","GO:0004842; GO:0005654; GO:0005730; GO:0005737; GO:0006281; GO:0006974; GO:0016567; GO:0036297; GO:0046872; GO:0090734; GO:0106300; GO:1904931"
"3204",3458,1269934,"Cluster_10934","Peve_00023890",-0.0568225454040981,0.96380614910398,0.999448381576871,157,-22.22,"2 20","856 876",18,"72.22%","83.33%","Q91813","Homeobox protein OTX2-A (xOTX2-A) (Orthodenticle 2-A) (Orthodenticle-A-like protein A)","Xenopus laevis (African clawed frog)","positive regulation of DNA-templated transcription [GO:0045893]","GO:0000981; GO:0005634; GO:0043565; GO:0045893"
"3205",3459,1270172,"Cluster_589","Peve_00015641",0.917812305643277,0.25990752470899,0.978262075707395,162,-26.3,"2 17","782 802",15,"86.67%","93.33%","Q96N21","AP-4 complex accessory subunit Tepsin (ENTH domain-containing protein 2) (Epsin for AP-4) (Tetra-epsin)","Homo sapiens (Human)","","GO:0005737; GO:0005794; GO:0005829; GO:0016607; GO:0030662; GO:0031312; GO:0031965; GO:0032588"
"3206",3460,1271577,"Cluster_4629","Peve_00015762",-0.682655437464945,0.52165001769238,0.978262075707395,159,-22.95,"2 21","148 173",23,"69.57%","73.91%","Q9WVD5","Mitochondrial ornithine transporter 1 (Solute carrier family 25 member 15)","Mus musculus (Mouse)","L-arginine transmembrane transport [GO:1903826]; L-lysine transmembrane transport [GO:1903401]; mitochondrial L-ornithine transmembrane transport [GO:1990575]","GO:0000064; GO:0005739; GO:0005743; GO:0015189; GO:0015297; GO:0022857; GO:0061459; GO:1903401; GO:1903826; GO:1990575"
"3207",3462,1271936,"Cluster_4115","Peve_00028438",-0.295091278394594,0.809299878858068,0.995934364227446,169,-22.8,"2 19","796 819",19,"78.95%","89.47%","Q5RA22","Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (EC 3.1.3.99) (Cytosolic nucleoside phosphotransferase 5'N) (EC 2.7.1.77)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","dGMP metabolic process [GO:0046054]; GMP metabolic process [GO:0046037]; IMP metabolic process [GO:0046040]","GO:0005524; GO:0005829; GO:0008253; GO:0042802; GO:0046037; GO:0046040; GO:0046054; GO:0046872; GO:0050146; GO:0050483; GO:0050484; GO:0106411"
"3208",3463,1272456,"Cluster_11134","Peve_00021252",-0.383590182423509,0.749375056516825,0.988219883885475,157,-20.6,"2 15","947 969",14,"85.71%","92.86%",NA,NA,NA,NA,NA
"3209",3465,1272662,"Cluster_6904","Peve_00005207",0.740970772782415,0.468731374468187,0.978262075707395,149,-20.17,"2 21","17 38",20,"70.00%","75.00%",NA,NA,NA,NA,NA
"3210",3466,1272928,"Cluster_4735","Peve_00029451",-0.170702408654881,0.890792654665333,0.999448381576871,172,-24.94,"2 17","624 645",15,"93.33%","93.33%","Q92820","Gamma-glutamyl hydrolase (EC 3.4.19.9) (Conjugase) (GH) (Gamma-Glu-X carboxypeptidase)","Homo sapiens (Human)","tetrahydrofolylpolyglutamate metabolic process [GO:0046900]","GO:0005576; GO:0005615; GO:0005634; GO:0005773; GO:0008238; GO:0008242; GO:0034722; GO:0035578; GO:0035580; GO:0042470; GO:0046900; GO:0070062; GO:1904724"
"3211",3467,1273146,"Cluster_2787","Peve_00020707",-0.00382968334855694,0.997561941898757,0.999448381576871,170,-25.44,"2 21","125 148",21,"80.95%","85.71%",NA,NA,NA,NA,NA
"3212",3468,1274050,"Cluster_4080","Peve_00011493",-0.273572214218133,0.823589494304696,0.995934364227446,170,-27.35,"2 20","731 754",20,"80.00%","85.00%","P33731","Signal recognition particle subunit SRP72 (SRP72) (Signal recognition particle 72 kDa protein)","Canis lupus familiaris (Dog) (Canis familiaris)","SRP-dependent cotranslational protein targeting to membrane [GO:0006614]","GO:0005047; GO:0005783; GO:0005786; GO:0005829; GO:0006614; GO:0008312; GO:0030911; GO:0043022"
"3213",3470,1274965,"Cluster_8634","Peve_00024837",-0.489394100226635,0.674435940900854,0.978262075707395,165,-20.33,"2 18","328 349",16,"75.00%","93.75%",NA,NA,NA,NA,NA
"3214",3471,1275223,"Cluster_4735","Peve_00035041",0.924593742975115,0.248809173067432,0.978262075707395,160,-20.52,"2 21","871 892",19,"63.16%","84.21%",NA,NA,NA,NA,NA
"3215",3472,1275567,"Cluster_15726","Peve_00017895",-0.225112904962294,0.855449805919123,0.995934364227446,164,-21.94,"2 19","144 164",17,"82.35%","88.24%","Q29496","Cytochrome P450 3A24 (EC 1.14.14.1) (CYPIIIA24)","Ovis aries (Sheep)","","GO:0004497; GO:0005506; GO:0005789; GO:0020037; GO:0070330"
"3216",3473,1275612,"Cluster_15726","Peve_00017896",0.74835822283985,0.461684871919011,0.978262075707395,164,-21.94,"2 19","144 164",17,"82.35%","88.24%",NA,NA,NA,NA,NA
"3217",3474,1276438,"Cluster_4735","Peve_00038650",-0.961201239131361,0.177917357154407,0.978262075707395,165,-20.95,"2 20","696 716",18,"83.33%","83.33%",NA,NA,NA,NA,NA
"3218",3476,1278795,"Cluster_9149","Peve_00022172",-0.796801575772814,0.41304720337848,0.978262075707395,163,-22.85,"2 21","303 325",20,"70.00%","85.00%","Q58D55","Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase)","Bos taurus (Bovine)","carbohydrate metabolic process [GO:0005975]","GO:0004565; GO:0005764; GO:0005975"
"3219",3477,1279037,"Cluster_589","Peve_00002406",-0.661285083116677,0.540022729719455,0.978262075707395,151,-22.23,"2 20","903 924",18,"66.67%","72.22%","P84104","Serine/arginine-rich splicing factor 3 (Pre-mRNA-splicing factor SRP20) (Protein X16) (Splicing factor, arginine/serine-rich 3)","Mus musculus (Mouse)","cellular response to leukemia inhibitory factor [GO:1990830]; insulin receptor signaling pathway [GO:0008286]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; primary miRNA processing [GO:0031053]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]","GO:0000398; GO:0003723; GO:0005634; GO:0005737; GO:0006406; GO:0008286; GO:0008380; GO:0016607; GO:0031053; GO:0043274; GO:0048024; GO:0070878; GO:1990825; GO:1990830"
"3220",3478,1279379,"Cluster_8988","Peve_00016226",0.0860148226113438,0.945173514868548,0.999448381576871,160,-21.38,"2 19","647 667",17,"70.59%","94.12%",NA,NA,NA,NA,NA
"3221",3479,1279855,"Cluster_4080","Peve_00008163",-0.942271725312902,0.217370766104004,0.978262075707395,165,-23.92,"2 21","95 121",24,"79.17%","79.17%",NA,NA,NA,NA,NA
"3222",3480,1279968,"Cluster_10061","Peve_00040821",0.581565898066299,0.604880498890822,0.978262075707395,168,-20.35,"2 20","117 136",18,"83.33%","88.89%","P19623","Spermidine synthase (SPDSY) (EC 2.5.1.16) (Putrescine aminopropyltransferase)","Homo sapiens (Human)","cellular response to leukemia inhibitory factor [GO:1990830]; polyamine biosynthetic process [GO:0006596]; polyamine metabolic process [GO:0006595]; spermidine biosynthetic process [GO:0008295]","GO:0004766; GO:0005829; GO:0006595; GO:0006596; GO:0008295; GO:0042802; GO:0042803; GO:1990830"
"3223",3481,1279982,"Cluster_589","Peve_00040822",-0.682987152600659,0.52136096673352,0.978262075707395,154,-21.63,"2 21","114 134",19,"73.68%","73.68%",NA,NA,NA,NA,NA
"3224",3482,1279995,"Cluster_5882","Peve_00040822",0.783528982976258,0.426835209713674,0.978262075707395,162,-21.87,"2 20","70 93",20,"75.00%","80.00%",NA,NA,NA,NA,NA
"3225",3483,1280428,"Cluster_15890","Peve_00042468",-0.980884059886753,0.124677250952872,0.978262075707395,166,-20.36,"2 21","246 266",19,"73.68%","89.47%",NA,NA,NA,NA,NA
"3226",3484,1281440,"Cluster_6914","Peve_00009691",0.239309700554936,0.846157756405894,0.995934364227446,161,-20.93,"2 20","10 32",20,"75.00%","85.00%","Q96NN9","Apoptosis-inducing factor 3 (EC 1.-.-.-) (Apoptosis-inducing factor-like protein)","Homo sapiens (Human)","execution phase of apoptosis [GO:0097194]","GO:0005737; GO:0005739; GO:0005743; GO:0005783; GO:0005829; GO:0016651; GO:0046872; GO:0050660; GO:0051537; GO:0097194"
"3227",3485,1281724,"Cluster_10934","Peve_00003462",-0.146236682309268,0.906567785769791,0.999448381576871,151,-20.55,"2 19","200 222",19,"68.42%","84.21%","O95755","Ras-related protein Rab-36","Homo sapiens (Human)","protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0003924; GO:0005525; GO:0005794; GO:0015031; GO:0016192"
"3228",3486,1282196,"Cluster_4115","Peve_00036558",-0.948466306453764,0.205269156668385,0.978262075707395,159,-20.58,"2 20","108 129",18,"66.67%","83.33%","O95602","DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (A190) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (RPA194)","Homo sapiens (Human)","negative regulation of protein localization to nucleolus [GO:1904750]","GO:0001054; GO:0003677; GO:0003682; GO:0005654; GO:0005694; GO:0005736; GO:0046872; GO:1904750"
"3229",3487,1282318,"Cluster_15890","Peve_00036551",-0.928268612505051,0.242594311559993,0.978262075707395,172,-20.78,"2 21","489 510",19,"78.95%","84.21%","Q05941","Neuronal acetylcholine receptor subunit alpha-7","Rattus norvegicus (Rat)","acetylcholine receptor signaling pathway [GO:0095500]; associative learning [GO:0008306]; B cell activation [GO:0042113]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; cation transmembrane transport [GO:0098655]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; dendrite arborization [GO:0140059]; dendritic spine organization [GO:0097061]; dopamine biosynthetic process [GO:0042416]; endocytosis [GO:0006897]; establishment of localization in cell [GO:0051649]; excitatory postsynaptic potential [GO:0060079]; flagellated sperm motility [GO:0030317]; generation of ovulation cycle rhythm [GO:0060112]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; learning or memory [GO:0007611]; membrane depolarization [GO:0051899]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; neuronal action potential [GO:0019228]; ovulation cycle [GO:0042698]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure [GO:0001988]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein phosphorylation [GO:0001934]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of inflammatory response [GO:0050727]; regulation of membrane potential [GO:0042391]; regulation of neuron death [GO:1901214]; regulation of nitric oxide metabolic process [GO:0080164]; regulation of norepinephrine secretion [GO:0014061]; regulation of response to drug [GO:2001023]; regulation of synaptic transmission, dopaminergic [GO:0032225]; response to acetylcholine [GO:1905144]; response to amyloid-beta [GO:1904645]; response to carbamate [GO:0046681]; response to cold [GO:0009409]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; synaptic transmission, cholinergic [GO:0007271]; T cell activation [GO:0042110]","GO:0001540; GO:0001666; GO:0001933; GO:0001934; GO:0001988; GO:0005216; GO:0005231; GO:0005737; GO:0005886; GO:0005892; GO:0006811; GO:0006816; GO:0006874; GO:0006897; GO:0007165; GO:0007268; GO:0007271; GO:0007611; GO:0007613; GO:0008179; GO:0008284; GO:0008306; GO:0009409; GO:0009897; GO:0010628; GO:0014061; GO:0014069; GO:0015464; GO:0015643; GO:0016020; GO:0016324; GO:0017081; GO:0019228; GO:0019901; GO:0022848; GO:0030317; GO:0030424; GO:0030425; GO:0030426; GO:0030594; GO:0030673; GO:0032094; GO:0032225; GO:0032279; GO:0032691; GO:0032715; GO:0032720; GO:0033138; GO:0034220; GO:0035094; GO:0035095; GO:0042110; GO:0042113; GO:0042166; GO:0042391; GO:0042416; GO:0042698; GO:0042734; GO:0042803; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0043410; GO:0044853; GO:0045121; GO:0045202; GO:0045211; GO:0045471; GO:0045766; GO:0046681; GO:0048149; GO:0050727; GO:0050728; GO:0050804; GO:0050808; GO:0050877; GO:0050890; GO:0050893; GO:0051117; GO:0051247; GO:0051649; GO:0051899; GO:0060079; GO:0060112; GO:0070373; GO:0070374; GO:0080164; GO:0095500; GO:0097061; GO:0097110; GO:0098655; GO:0098690; GO:0098815; GO:0098897; GO:0098981; GO:0099171; GO:0099634; GO:0140059; GO:1900273; GO:1901214; GO:1902004; GO:1902430; GO:1902991; GO:1904315; GO:1904645; GO:1905144; GO:1905906; GO:1905920; GO:2000463; GO:2001023"
"3230",3488,1282331,"Cluster_4115","Peve_00036552",-0.6842888023572,0.520225543059693,0.978262075707395,144,-21.09,"2 18","83 106",18,"61.11%","77.78%","Q866A2","Neuronal acetylcholine receptor subunit alpha-7","Macaca mulatta (Rhesus macaque)","associative learning [GO:0008306]; B cell activation [GO:0042113]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; dendrite arborization [GO:0140059]; dendritic spine organization [GO:0097061]; endocytosis [GO:0006897]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; generation of ovulation cycle rhythm [GO:0060112]; ion transmembrane transport [GO:0034220]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure [GO:0001988]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of amyloid fibril formation [GO:1905906]; regulation of membrane potential [GO:0042391]; regulation of neuron death [GO:1901214]; regulation of norepinephrine secretion [GO:0014061]; regulation of synaptic transmission, dopaminergic [GO:0032225]; response to amyloid-beta [GO:1904645]; response to cold [GO:0009409]; response to food [GO:0032094]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; short-term memory [GO:0007614]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]; T cell activation [GO:0042110]","GO:0001540; GO:0001666; GO:0001933; GO:0001988; GO:0005231; GO:0005886; GO:0005892; GO:0006816; GO:0006874; GO:0006897; GO:0007165; GO:0007268; GO:0007271; GO:0007614; GO:0008284; GO:0008306; GO:0009409; GO:0009897; GO:0014061; GO:0015464; GO:0015643; GO:0016324; GO:0017081; GO:0022848; GO:0030317; GO:0030594; GO:0030673; GO:0032094; GO:0032225; GO:0032691; GO:0032715; GO:0032720; GO:0033138; GO:0034220; GO:0035094; GO:0035095; GO:0042110; GO:0042113; GO:0042166; GO:0042391; GO:0042734; GO:0042803; GO:0043005; GO:0043410; GO:0045202; GO:0045766; GO:0048149; GO:0050728; GO:0050877; GO:0050890; GO:0050893; GO:0051649; GO:0060112; GO:0070374; GO:0097061; GO:0098839; GO:0098978; GO:0098981; GO:0140059; GO:1900273; GO:1901214; GO:1902004; GO:1904315; GO:1904645; GO:1905906; GO:1905920; GO:2000463"
"3231",3489,1282354,"Cluster_10934","Peve_00036552",-0.0328967258333084,0.979053514700512,0.999448381576871,146,-20.44,"2 21","495 512",19,"73.68%","73.68%","Q866A2","Neuronal acetylcholine receptor subunit alpha-7","Macaca mulatta (Rhesus macaque)","associative learning [GO:0008306]; B cell activation [GO:0042113]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; dendrite arborization [GO:0140059]; dendritic spine organization [GO:0097061]; endocytosis [GO:0006897]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; generation of ovulation cycle rhythm [GO:0060112]; ion transmembrane transport [GO:0034220]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure [GO:0001988]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of amyloid fibril formation [GO:1905906]; regulation of membrane potential [GO:0042391]; regulation of neuron death [GO:1901214]; regulation of norepinephrine secretion [GO:0014061]; regulation of synaptic transmission, dopaminergic [GO:0032225]; response to amyloid-beta [GO:1904645]; response to cold [GO:0009409]; response to food [GO:0032094]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; short-term memory [GO:0007614]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]; T cell activation [GO:0042110]","GO:0001540; GO:0001666; GO:0001933; GO:0001988; GO:0005231; GO:0005886; GO:0005892; GO:0006816; GO:0006874; GO:0006897; GO:0007165; GO:0007268; GO:0007271; GO:0007614; GO:0008284; GO:0008306; GO:0009409; GO:0009897; GO:0014061; GO:0015464; GO:0015643; GO:0016324; GO:0017081; GO:0022848; GO:0030317; GO:0030594; GO:0030673; GO:0032094; GO:0032225; GO:0032691; GO:0032715; GO:0032720; GO:0033138; GO:0034220; GO:0035094; GO:0035095; GO:0042110; GO:0042113; GO:0042166; GO:0042391; GO:0042734; GO:0042803; GO:0043005; GO:0043410; GO:0045202; GO:0045766; GO:0048149; GO:0050728; GO:0050877; GO:0050890; GO:0050893; GO:0051649; GO:0060112; GO:0070374; GO:0097061; GO:0098839; GO:0098978; GO:0098981; GO:0140059; GO:1900273; GO:1901214; GO:1902004; GO:1904315; GO:1904645; GO:1905906; GO:1905920; GO:2000463"
"3232",3490,1282967,"Cluster_6904","Peve_00001195",0.0434594594154328,0.9723241321576,0.999448381576871,166,-23.09,"2 19","584 605",17,"76.47%","88.24%","A4FV54","Ras-related protein Rab-8A (EC 3.6.5.2)","Bos taurus (Bovine)","autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; Golgi organization [GO:0007030]; Golgi vesicle fusion to target membrane [GO:0048210]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]","GO:0003924; GO:0005525; GO:0005768; GO:0005794; GO:0005813; GO:0005814; GO:0005886; GO:0005929; GO:0006904; GO:0006914; GO:0007030; GO:0007409; GO:0008021; GO:0009306; GO:0010506; GO:0017157; GO:0019003; GO:0030140; GO:0030496; GO:0030670; GO:0031267; GO:0031489; GO:0032456; GO:0032869; GO:0036064; GO:0043197; GO:0043231; GO:0045335; GO:0048210; GO:0055038; GO:0060170; GO:0060271; GO:0061512; GO:0072659; GO:0097546; GO:0097730; GO:0098969"
"3233",3491,1282969,"Cluster_6906","Peve_00001195",-0.442087150581613,0.708476382625494,0.978262075707395,162,-21.07,"2 19","584 605",17,"70.59%","88.24%","A4FV54","Ras-related protein Rab-8A (EC 3.6.5.2)","Bos taurus (Bovine)","autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; Golgi organization [GO:0007030]; Golgi vesicle fusion to target membrane [GO:0048210]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]","GO:0003924; GO:0005525; GO:0005768; GO:0005794; GO:0005813; GO:0005814; GO:0005886; GO:0005929; GO:0006904; GO:0006914; GO:0007030; GO:0007409; GO:0008021; GO:0009306; GO:0010506; GO:0017157; GO:0019003; GO:0030140; GO:0030496; GO:0030670; GO:0031267; GO:0031489; GO:0032456; GO:0032869; GO:0036064; GO:0043197; GO:0043231; GO:0045335; GO:0048210; GO:0055038; GO:0060170; GO:0060271; GO:0061512; GO:0072659; GO:0097546; GO:0097730; GO:0098969"
"3234",3492,1283121,"Cluster_11134","Peve_00004113",0.306231493242089,0.801863679627774,0.995934364227446,147,-21.2,"2 21","910 933",21,"61.90%","71.43%",NA,NA,NA,NA,NA
"3235",3493,1283357,"Cluster_589","Peve_00028860",-0.832937430915996,0.373314707764965,0.978262075707395,145,-20.94,"2 10","736 757",8,"100.00%","100.00%",NA,NA,NA,NA,NA
"3236",3494,1283408,"Cluster_2882","Peve_00028865",0.277203351029823,0.821184859633523,0.995934364227446,156,-21.61,"2 18","472 494",17,"76.47%","82.35%","Q6AZT7","Nephrocystin-3","Xenopus laevis (African clawed frog)","cilium assembly [GO:0060271]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]","GO:0005929; GO:0016055; GO:0060027; GO:0060271; GO:0090090; GO:2000095"
"3237",3495,1284302,"Cluster_589","Peve_00045100",-0.998993624634128,0.0285635082887394,0.903929377050813,159,-20.33,"2 21","24 46",20,"70.00%","80.00%",NA,NA,NA,NA,NA
"3238",3496,1284381,"Cluster_11134","Peve_00022891",-0.0195622829453675,0.987545469442176,0.999448381576871,163,-22.93,"2 21","49 71",20,"75.00%","80.00%","Q9H0J9","Protein mono-ADP-ribosyltransferase PARP12 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 12) (ARTD12) (Poly [ADP-ribose] polymerase 12) (PARP-12) (Zinc finger CCCH domain-containing protein 1)","Homo sapiens (Human)","protein auto-ADP-ribosylation [GO:0070213]","GO:0003723; GO:0003950; GO:0005634; GO:0016779; GO:0046872; GO:0070213; GO:0140803; GO:1990404"
"3239",3497,1284681,"Cluster_7053","Peve_00005448",0.992895983108058,0.0759284530899825,0.978262075707395,158,-22.11,"2 21","772 796",22,"68.18%","81.82%","Q9ZQ31","Serine/threonine-protein kinase STY13 (EC 2.7.11.1) (AtSTYPK) (Serine/threonine/tyrosine-protein kinase 13)","Arabidopsis thaliana (Mouse-ear cress)","protein phosphorylation [GO:0006468]; regulation of embryonic development [GO:0045995]; seed oilbody biogenesis [GO:0010344]; signal transduction [GO:0007165]","GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0010344; GO:0045995; GO:0106310"
"3240",3498,1284696,"Cluster_11134","Peve_00005448",0.875640822838247,0.320878802775509,0.978262075707395,152,-22.51,"2 20","267 292",22,"68.18%","81.82%","Q9ZQ31","Serine/threonine-protein kinase STY13 (EC 2.7.11.1) (AtSTYPK) (Serine/threonine/tyrosine-protein kinase 13)","Arabidopsis thaliana (Mouse-ear cress)","protein phosphorylation [GO:0006468]; regulation of embryonic development [GO:0045995]; seed oilbody biogenesis [GO:0010344]; signal transduction [GO:0007165]","GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0010344; GO:0045995; GO:0106310"
"3241",3499,1285067,"Cluster_589","Peve_00045107",-0.426100199232131,0.719774196383558,0.981369881295541,151,-20.43,"2 21","619 641",20,"70.00%","70.00%",NA,NA,NA,NA,NA
"3242",3500,1285571,"Cluster_4115","Peve_00028138",0.154731939169558,0.901097222888357,0.999448381576871,156,-21.26,"2 18","509 531",17,"76.47%","82.35%","P56965","N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH-1) (Dimethylarginine dimethylaminohydrolase 1) (EC 3.5.3.18) (DDAHI) (Dimethylargininase-1)","Bos taurus (Bovine)","arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein nitrosylation [GO:0017014]; regulation of systemic arterial blood pressure [GO:0003073]","GO:0000052; GO:0003073; GO:0006525; GO:0006527; GO:0006809; GO:0008270; GO:0008285; GO:0016403; GO:0016597; GO:0017014; GO:0043116; GO:0045429; GO:1900038"
"3243",3501,1285835,"Cluster_1167","Peve_00007592",0.984433979803311,0.112473156426065,0.978262075707395,148,-22.03,"2 20","269 290",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"3244",3502,1285916,"Cluster_14999","Peve_00007593",-0.596066517293766,0.593458898914095,0.978262075707395,166,-21.78,"2 17","510 530",15,"93.33%","93.33%","P80386","5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb) (5'-AMP-activated protein kinase 40 kDa subunit)","Rattus norvegicus (Rat)","cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; nail development [GO:0035878]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]","GO:0004672; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0006633; GO:0007165; GO:0010628; GO:0019901; GO:0031588; GO:0031669; GO:0032991; GO:0035878; GO:0120162"
"3245",3503,1286676,"Cluster_11134","Peve_00008535",0.274464635618282,0.822998750107073,0.995934364227446,173,-24.08,"2 19","309 331",18,"83.33%","94.44%","Q86XL3","Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4)","Homo sapiens (Human)","cell division [GO:0051301]; central nervous system development [GO:0007417]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of apoptotic process [GO:0043066]; negative regulation of phosphorylation [GO:0042326]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of catalytic activity [GO:0050790]","GO:0005783; GO:0005789; GO:0007084; GO:0007417; GO:0016020; GO:0019888; GO:0035307; GO:0042326; GO:0043066; GO:0050790; GO:0051301; GO:0051721"
"3246",3504,1287535,"Cluster_14500","Peve_00024635",-0.921214174406309,0.254397373541234,0.978262075707395,179,-23.83,"2 20","102 123",18,"83.33%","94.44%",NA,NA,NA,NA,NA
"3247",3505,1288178,"Cluster_2882","Peve_00009485",-0.891957144061294,0.298664217629718,0.978262075707395,149,-20.31,"2 14","548 569",12,"83.33%","83.33%",NA,NA,NA,NA,NA
"3248",3506,1288344,"Cluster_13502","Peve_00024638",0.997844556977271,0.0418062711782387,0.909359886114279,163,-20.88,"2 21","204 227",21,"71.43%","80.95%",NA,NA,NA,NA,NA
"3249",3507,1288524,"Cluster_13502","Peve_00024639",-0.180639393794111,0.884366612317586,0.999448381576871,163,-20.88,"2 21","204 227",21,"71.43%","80.95%",NA,NA,NA,NA,NA
"3250",3508,1288978,"Cluster_15890","Peve_00027583",-0.999998513833777,0.00109756150847525,0.276171237895402,166,-22.27,"2 21","702 726",22,"77.27%","81.82%",NA,NA,NA,NA,NA
"3251",3509,1289247,"Cluster_15726","Peve_00006253",-0.441553768846808,0.708854891202259,0.9783470600477,155,-25.63,"2 21","893 920",25,"64.00%","72.00%","Q8BHT6","Beta-1,3-glucosyltransferase (Beta3Glc-T) (EC 2.4.1.-) (Beta 3-glucosyltransferase) (Beta-3-glycosyltransferase-like)","Mus musculus (Mouse)","fucose metabolic process [GO:0006004]; protein glycosylation [GO:0006486]","GO:0005789; GO:0006004; GO:0006486; GO:0008375"
"3252",3510,1289567,"Cluster_589","Peve_00010030",0.8928778467698,0.297365181588074,0.978262075707395,155,-23.41,"2 12","812 833",10,"100.00%","100.00%",NA,NA,NA,NA,NA
"3253",3511,1289847,"Cluster_4629","Peve_00027636",-0.554554668634826,0.625777256211528,0.978262075707395,158,-24.75,"2 20","619 641",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"3254",3512,1290000,"Cluster_9149","Peve_00025983",0.496506377703391,0.669231869687137,0.978262075707395,154,-20.97,"2 15","456 477",13,"76.92%","92.31%","Q5T1B0","Axonemal dynein light chain domain-containing protein 1","Homo sapiens (Human)","",""
"3255",3513,1290070,"Cluster_4080","Peve_00025987",-0.293580587618078,0.810306192251576,0.995934364227446,170,-20.46,"2 21","225 248",21,"80.95%","85.71%","Q8N0W4","Neuroligin-4, X-linked (Neuroligin X) (HNLX)","Homo sapiens (Human)","adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]","GO:0003360; GO:0005886; GO:0007158; GO:0007268; GO:0007612; GO:0009986; GO:0016020; GO:0021549; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0038023; GO:0042043; GO:0042803; GO:0045202; GO:0045216; GO:0048488; GO:0050804; GO:0050808; GO:0050839; GO:0060076; GO:0071625; GO:0090394; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098839; GO:0098983; GO:0098985; GO:0099054; GO:0099634"
"3256",3514,1290225,"Cluster_9149","Peve_00025984",-0.203916745894886,0.869265625156007,0.997329001821281,150,-24.06,"2 21","466 486",19,"68.42%","73.68%","O18405","Surfeit locus protein 4 homolog","Drosophila melanogaster (Fruit fly)","Golgi organization [GO:0007030]; protein transport [GO:0015031]","GO:0005783; GO:0005789; GO:0005793; GO:0007030; GO:0012505; GO:0015031; GO:0045169"
"3257",3515,1290425,"Cluster_1167","Peve_00024588",0.99826145042459,0.037544956087,0.909359886114279,147,-21.7,"2 12","469 490",10,"90.00%","90.00%","O60268","Uncharacterized protein KIAA0513","Homo sapiens (Human)","","GO:0005737"
"3258",3516,1290695,"Cluster_1167","Peve_00024587",0.433277886776071,0.714713737042101,0.979987104665135,147,-21.7,"2 12","469 490",10,"90.00%","90.00%","Q9VCA2","Organic cation transporter protein","Drosophila melanogaster (Fruit fly)","apoptotic process [GO:0006915]; ion transport [GO:0006811]","GO:0006811; GO:0006915; GO:0016020; GO:0022857"
"3259",3517,1290775,"Cluster_14500","Peve_00024580",-0.712949274064184,0.494717935083851,0.978262075707395,162,-20.03,"2 15","141 162",13,"84.62%","100.00%",NA,NA,NA,NA,NA
"3260",3520,1291368,"Cluster_796","Peve_00028989",0.656220732113179,0.544308030389104,0.978262075707395,163,-24.92,"2 19","456 475",17,"82.35%","88.24%",NA,NA,NA,NA,NA
"3261",3521,1291416,"Cluster_2787","Peve_00025674",-0.864104211317102,0.335771391434576,0.978262075707395,152,-20.38,"2 18","226 248",17,"64.71%","88.24%",NA,NA,NA,NA,NA
"3262",3522,1291605,"Cluster_5882","Peve_00017566",-0.512117197922425,0.657722684272895,0.978262075707395,157,-24.03,"2 21","666 685",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"3263",3523,1291942,"Cluster_11135","Peve_00011814",0.638053275309291,0.55947989070093,0.978262075707395,168,-20.86,"2 21","790 811",19,"68.42%","89.47%",NA,NA,NA,NA,NA
"3264",3524,1292079,"Cluster_13502","Peve_00011813",-0.408047428324891,0.732419597952791,0.985193410741864,169,-20.53,"2 21","511 532",20,"85.00%","85.00%","P91685","Metabotropic glutamate receptor (DmGluRA)","Drosophila melanogaster (Fruit fly)","G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553]","GO:0001640; GO:0001641; GO:0004930; GO:0005886; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016020; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553"
"3265",3525,1292430,"Cluster_9149","Peve_00013717",-0.5,0.666666666666667,0.978262075707395,149,-26.28,"2 18","849 868",16,"75.00%","87.50%",NA,NA,NA,NA,NA
"3266",3526,1292884,"Cluster_10934","Peve_00041312",0.894775662633153,0.294670790003391,0.978262075707395,150,-20.02,"2 19","463 484",17,"64.71%","76.47%","Q93ZE5","Probable acylpyruvase FAHD1, mitochondrial (EC 3.7.1.5) (Fumarylacetoacetate hydrolase domain-containing protein 1) (FAH domain-containing protein 1)","Arabidopsis thaliana (Mouse-ear cress)","","GO:0005507; GO:0005739; GO:0005829; GO:0018773; GO:0047621"
"3267",3527,1293186,"Cluster_7053","Peve_00020919",-0.911448295946742,0.269930345913627,0.978262075707395,158,-21,"2 21","341 361",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"3268",3530,1294302,"Cluster_4629","Peve_00026514",-0.923291608260103,0.250976245034422,0.978262075707395,161,-22.55,"2 20","633 653",18,"77.78%","83.33%","Q08BY0","Protein arginine methyltransferase NDUFAF7, mitochondrial (EC 2.1.1.320) (NADH dehydrogenase [ubiquinone] complex I, assembly factor 7) (Protein midA homolog)","Danio rerio (Zebrafish) (Brachydanio rerio)","chordate embryonic development [GO:0043009]; mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine methylation, to symmetrical-dimethyl arginine [GO:0019918]","GO:0005739; GO:0019918; GO:0032981; GO:0035243; GO:0043009"
"3269",3531,1294485,"Cluster_5882","Peve_00026510",0.909842511832783,0.272404478909135,0.978262075707395,153,-20.52,"2 15","1 23",14,"78.57%","92.86%",NA,NA,NA,NA,NA
"3270",3532,1294530,"Cluster_5882","Peve_00026513",0.651708809544972,0.548104855228306,0.978262075707395,165,-20.08,"2 20","874 894",18,"72.22%","94.44%","Q6ITT3","Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVc) (GnT-IVc) (N-acetylglucosaminyltransferase IVc) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVc)","Sus scrofa (Pig)","protein N-linked glycosylation [GO:0006487]","GO:0000139; GO:0006487; GO:0008375; GO:0008454; GO:0046872"
"3271",3533,1295382,"Cluster_4629","Peve_00018887",0.898992347052381,0.288600775077132,0.978262075707395,164,-25.04,"2 21","359 380",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"3272",3534,1295429,"Cluster_5563","Peve_00018882",0.897017475586585,0.291458270758042,0.978262075707395,162,-24.77,"2 21","799 826",24,"70.83%","79.17%",NA,NA,NA,NA,NA
"3273",3535,1295631,"Cluster_11134","Peve_00038076",0.172662433089521,0.889526058145468,0.999448381576871,162,-23.59,"2 19","588 609",17,"70.59%","88.24%","Q99K70","Ras-related GTP-binding protein C (Rag C) (RagC) (EC 3.6.5.-) (GTPase-interacting protein 2) (TIB929)","Mus musculus (Mouse)","cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of TOR signaling [GO:0032006]; regulation of TORC1 signaling [GO:1903432]; response to amino acid [GO:0043200]","GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0009267; GO:0010506; GO:0019003; GO:0032006; GO:0032008; GO:0034198; GO:0043200; GO:0043231; GO:0046982; GO:0051020; GO:0071230; GO:1903432; GO:1990131"
"3274",3536,1295646,"Cluster_2787","Peve_00038071",0.499682111271694,0.666900323570828,0.978262075707395,161,-21.6,"2 19","536 558",18,"77.78%","83.33%","Q5BIZ0","Major facilitator superfamily domain-containing protein 4A (Major facilitator superfamily domain-containing protein 4)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0016020; GO:0022857"
"3275",3537,1295908,"Cluster_15890","Peve_00038078",-0.935162775453945,0.23050601799076,0.978262075707395,158,-21.58,"2 18","353 374",17,"82.35%","88.24%","P08510","Potassium voltage-gated channel protein Shaker (Protein minisleep)","Drosophila melanogaster (Fruit fly)","action potential [GO:0001508]; axon extension [GO:0048675]; behavioral response to ether [GO:0048150]; cellular response to dopamine [GO:1903351]; courtship behavior [GO:0007619]; detection of visible light [GO:0009584]; larval locomotory behavior [GO:0008345]; learning or memory [GO:0007611]; mating behavior, sex discrimination [GO:0048047]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of membrane potential [GO:0045838]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; proboscis extension reflex [GO:0007637]; protein homooligomerization [GO:0051260]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]; sensory perception of taste [GO:0050909]; sleep [GO:0030431]","GO:0001508; GO:0005249; GO:0005251; GO:0006813; GO:0007611; GO:0007619; GO:0007637; GO:0008076; GO:0008345; GO:0009584; GO:0016020; GO:0022843; GO:0030431; GO:0034765; GO:0045187; GO:0045838; GO:0045938; GO:0048047; GO:0048150; GO:0048675; GO:0050909; GO:0051260; GO:0060025; GO:0071805; GO:1903351"
"3276",3538,1296417,"Cluster_4629","Peve_00000905",0.997835542257382,0.0418936347438744,0.909769090275153,155,-24.56,"2 12","903 924",10,"100.00%","100.00%",NA,NA,NA,NA,NA
"3277",3539,1296423,"Cluster_6905","Peve_00000905",0.782427335215799,0.427962662780356,0.978262075707395,168,-22.61,"2 17","252 273",15,"86.67%","93.33%",NA,NA,NA,NA,NA
"3278",3540,1296639,"Cluster_4079","Peve_00030206",-0.996787107534329,0.0510457469100724,0.958334495488436,142,-20.04,"2 11","728 749",9,"88.89%","88.89%",NA,NA,NA,NA,NA
"3279",3541,1297728,"Cluster_6905","Peve_00034189",-0.111191180749743,0.929066817051331,0.999448381576871,167,-21.55,"2 21","806 828",20,"80.00%","80.00%","Q6P3D0","U8 snoRNA-decapping enzyme (EC 3.6.1.62) (IDP phosphatase) (IDPase) (EC 3.6.1.64) (Inosine diphosphate phosphatase) (Nucleoside diphosphate-linked moiety X motif 16) (Nudix motif 16) (m7GpppN-mRNA hydrolase)","Mus musculus (Mouse)","chromosome organization [GO:0051276]; dITP catabolic process [GO:0035863]; mRNA catabolic process [GO:0006402]; NAD-cap decapping [GO:0110155]; negative regulation of rRNA processing [GO:2000233]; positive regulation of cell cycle process [GO:0090068]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; sno(s)RNA catabolic process [GO:0016077]","GO:0000166; GO:0000287; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006402; GO:0008235; GO:0016077; GO:0030145; GO:0030515; GO:0031404; GO:0035863; GO:0035870; GO:0042802; GO:0042803; GO:0050072; GO:0050897; GO:0051276; GO:0090068; GO:0090502; GO:0097383; GO:0110152; GO:0110155; GO:0140933; GO:1990003; GO:1990174; GO:2000233"
"3280",3542,1297768,"Cluster_4735","Peve_00034188",-0.692289170466083,0.513204546330596,0.978262075707395,159,-25.02,"2 16","457 478",14,"78.57%","92.86%","Q6P3D0","U8 snoRNA-decapping enzyme (EC 3.6.1.62) (IDP phosphatase) (IDPase) (EC 3.6.1.64) (Inosine diphosphate phosphatase) (Nucleoside diphosphate-linked moiety X motif 16) (Nudix motif 16) (m7GpppN-mRNA hydrolase)","Mus musculus (Mouse)","chromosome organization [GO:0051276]; dITP catabolic process [GO:0035863]; mRNA catabolic process [GO:0006402]; NAD-cap decapping [GO:0110155]; negative regulation of rRNA processing [GO:2000233]; positive regulation of cell cycle process [GO:0090068]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; sno(s)RNA catabolic process [GO:0016077]","GO:0000166; GO:0000287; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006402; GO:0008235; GO:0016077; GO:0030145; GO:0030515; GO:0031404; GO:0035863; GO:0035870; GO:0042802; GO:0042803; GO:0050072; GO:0050897; GO:0051276; GO:0090068; GO:0090502; GO:0097383; GO:0110152; GO:0110155; GO:0140933; GO:1990003; GO:1990174; GO:2000233"
"3281",3544,1298172,"Cluster_4629","Peve_00035585",-0.413534101296605,0.728588491885374,0.98405108832934,159,-20.69,"2 20","98 119",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"3282",3545,1298302,"Cluster_2854","Peve_00041877",-0.408719052324024,0.731951188461376,0.985041570886699,156,-21.49,"2 21","36 61",23,"73.91%","82.61%","Q99LQ7","Plasmanylethanolamine desaturase (EC 1.14.19.77) (Plasmanylethanolamine desaturase 1) (Transmembrane protein 189)","Mus musculus (Mouse)","ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]","GO:0005783; GO:0005789; GO:0006631; GO:0008611; GO:0016491; GO:0050207"
"3283",3546,1298471,"Cluster_14999","Peve_00041870",0.589980860428087,0.598270555435843,0.978262075707395,162,-22.34,"2 21","52 79",25,"72.00%","76.00%","Q868Z9","Papilin","Drosophila melanogaster (Fruit fly)","extracellular matrix organization [GO:0030198]; negative regulation of peptidase activity [GO:0010466]","GO:0004222; GO:0004867; GO:0005201; GO:0005576; GO:0005604; GO:0010466; GO:0030198; GO:0031012"
"3284",3547,1298612,"Cluster_589","Peve_00028581",-0.934753615028442,0.231240264998328,0.978262075707395,160,-22.38,"2 21","642 663",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"3285",3548,1298692,"Cluster_11135","Peve_00028582",0.673714762256416,0.529395294771215,0.978262075707395,149,-20.36,"2 18","173 192",16,"75.00%","87.50%","Q98KK0","Probable gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase)","Mesorhizobium japonicum (strain LMG 29417 / CECT 9101 / MAFF 303099) (Mesorhizobium loti (strain MAFF 303099))","carnitine biosynthetic process [GO:0045329]","GO:0005506; GO:0005737; GO:0008336; GO:0045329"
"3286",3549,1298692,"Cluster_11135","Peve_00028582",0.673714762256416,0.529395294771215,0.978262075707395,149,-20.36,"2 18","795 814",16,"75.00%","87.50%","Q98KK0","Probable gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase)","Mesorhizobium japonicum (strain LMG 29417 / CECT 9101 / MAFF 303099) (Mesorhizobium loti (strain MAFF 303099))","carnitine biosynthetic process [GO:0045329]","GO:0005506; GO:0005737; GO:0008336; GO:0045329"
"3287",3550,1299705,"Cluster_5882","Peve_00002676",-0.27814091057559,0.820563558554478,0.995934364227446,161,-25.66,"2 20","817 840",20,"70.00%","90.00%",NA,NA,NA,NA,NA
"3288",3551,1299965,"Cluster_1167","Peve_00002670",0.737584593666321,0.471932617132505,0.978262075707395,152,-21.14,"2 13","8 29",11,"90.91%","90.91%",NA,NA,NA,NA,NA
"3289",3552,1299965,"Cluster_1167","Peve_00002670",0.737584593666321,0.471932617132505,0.978262075707395,158,-21.76,"2 21","330 353",21,"76.19%","76.19%",NA,NA,NA,NA,NA
"3290",3553,1300402,"Cluster_11135","Peve_00016020",0.844443877729655,0.359862212804899,0.978262075707395,170,-20.98,"2 15","629 650",13,"100.00%","100.00%",NA,NA,NA,NA,NA
"3291",3554,1300710,"Cluster_9149","Peve_00032177",1,9.48637384723993e-09,6.86838308108347e-06,156,-22.28,"2 18","853 876",18,"77.78%","77.78%",NA,NA,NA,NA,NA
"3292",3555,1301862,"Cluster_4629","Peve_00015592",0.778153105611109,0.432313498304679,0.978262075707395,161,-23.09,"2 14","294 315",12,"91.67%","100.00%","Q3TLD5","Unconventional prefoldin RPB5 interactor (Protein NNX3) (Protein phosphatase 1 regulatory subunit 19) (RNA polymerase II subunit 5-mediating protein) (RPB5-mediating protein)","Mus musculus (Mouse)","cellular response to growth factor stimulus [GO:0071363]; cellular response to steroid hormone stimulus [GO:0071383]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell growth [GO:0001558]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615]","GO:0000122; GO:0000993; GO:0001558; GO:0003682; GO:0003714; GO:0004864; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006357; GO:0009615; GO:0010923; GO:0019212; GO:0030425; GO:0051219; GO:0071363; GO:0071383; GO:1990062; GO:2001243"
"3293",3556,1302696,"Cluster_11134","Peve_00023134",0.93412027853565,0.232372428110622,0.978262075707395,149,-24.01,"2 19","19 42",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"3294",3557,1303475,"Cluster_1167","Peve_00019546",0.75720970241604,0.453124165780748,0.978262075707395,148,-20.99,"2 20","1 17",18,"72.22%","72.22%","B8V7S0","CUB and peptidase domain-containing protein 1","Acropora millepora (Staghorn coral) (Heteropora millepora)","proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508"
"3295",3558,1303495,"Cluster_8634","Peve_00019546",0.521512788159053,0.650735765050253,0.978262075707395,163,-21.27,"2 21","975 1000",23,"69.57%","78.26%","B8V7S0","CUB and peptidase domain-containing protein 1","Acropora millepora (Staghorn coral) (Heteropora millepora)","proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508"
"3296",3559,1303850,"Cluster_6914","Peve_00001655",-0.233434518018383,0.850007100862774,0.995934364227446,162,-20.45,"2 20","417 438",19,"73.68%","84.21%","Q7ZX53","Solute carrier family 22 member 15-like","Xenopus laevis (African clawed frog)","ion transport [GO:0006811]","GO:0006811; GO:0016020; GO:0022857"
"3297",3560,1304010,"Cluster_16738","Peve_00001659",-0.657389489296944,0.543321300144894,0.978262075707395,167,-21.85,"2 21","70 92",20,"70.00%","90.00%","Q7Z0Q2","Ribonuclease kappa-B (RNase K-B) (RNase kappa-B) (EC 3.1.-.-) (Cc RNase)","Ceratitis capitata (Mediterranean fruit fly) (Tephritis capitata)","","GO:0004521; GO:0016020"
"3298",3561,1304220,"Cluster_9149","Peve_00014313",-0.5,0.666666666666667,0.978262075707395,156,-21.23,"2 13","31 52",11,"90.91%","100.00%",NA,NA,NA,NA,NA
"3299",3562,1304261,"Cluster_8884","Peve_00043225",-0.947118896471404,0.207959151134339,0.978262075707395,167,-21.82,"2 16","504 524",14,"85.71%","100.00%",NA,NA,NA,NA,NA
"3300",3563,1304262,"Cluster_8887","Peve_00043225",-0.821901473199095,0.385826733407904,0.978262075707395,167,-21.82,"2 16","504 524",14,"85.71%","100.00%",NA,NA,NA,NA,NA
"3301",3564,1304850,"Cluster_9149","Peve_00041439",-0.5,0.666666666666667,0.978262075707395,151,-22.77,"2 20","829 848",18,"72.22%","83.33%",NA,NA,NA,NA,NA
"3302",3565,1305415,"Cluster_4080","Peve_00045224",-0.235777127616489,0.848472931070267,0.995934364227446,166,-20.93,"2 19","112 133",17,"70.59%","94.12%",NA,NA,NA,NA,NA
"3303",3567,1305642,"Cluster_4629","Peve_00006383",0.37226067005208,0.757165484604257,0.988219883885475,159,-22.38,"2 21","963 986",21,"71.43%","76.19%","P16157","Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)","Homo sapiens (Human)","cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]","GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030507; GO:0031430; GO:0043005; GO:0044325; GO:0045199; GO:0051117; GO:0072659"
"3304",3568,1305686,"Cluster_4115","Peve_00006381",-0.0114926294468954,0.992683403788265,0.999448381576871,168,-20.2,"2 17","643 664",15,"86.67%","93.33%",NA,NA,NA,NA,NA
"3305",3569,1306458,"Cluster_6905","Peve_00026350",-0.996397084195975,0.0540570893113363,0.97201664526994,148,-22.68,"2 18","407 429",17,"70.59%","76.47%","O02824","Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor)","Oryctolagus cuniculus (Rabbit)","adult heart development [GO:0007512]; cell growth involved in cardiac muscle cell development [GO:0061049]; MAPK cascade [GO:0000165]; multicellular organism aging [GO:0010259]; negative regulation of autophagy [GO:0010507]; negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001985]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pilomotor reflex [GO:0097195]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; regulation of cardiac muscle contraction [GO:0055117]; regulation of vasoconstriction [GO:0019229]","GO:0000165; GO:0001985; GO:0001994; GO:0001996; GO:0001997; GO:0004937; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005901; GO:0007200; GO:0007512; GO:0010259; GO:0010507; GO:0010613; GO:0019229; GO:0031965; GO:0043410; GO:0045987; GO:0046982; GO:0055117; GO:0061049; GO:0097195; GO:0150099; GO:1903997"
"3306",3570,1306470,"Cluster_9149","Peve_00026350",-0.229903619661596,0.852317805530376,0.995934364227446,147,-23.2,"2 14","822 842",12,"83.33%","91.67%","O02824","Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor)","Oryctolagus cuniculus (Rabbit)","adult heart development [GO:0007512]; cell growth involved in cardiac muscle cell development [GO:0061049]; MAPK cascade [GO:0000165]; multicellular organism aging [GO:0010259]; negative regulation of autophagy [GO:0010507]; negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001985]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pilomotor reflex [GO:0097195]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; regulation of cardiac muscle contraction [GO:0055117]; regulation of vasoconstriction [GO:0019229]","GO:0000165; GO:0001985; GO:0001994; GO:0001996; GO:0001997; GO:0004937; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005901; GO:0007200; GO:0007512; GO:0010259; GO:0010507; GO:0010613; GO:0019229; GO:0031965; GO:0043410; GO:0045987; GO:0046982; GO:0055117; GO:0061049; GO:0097195; GO:0150099; GO:1903997"
"3307",3571,1306521,"Cluster_11134","Peve_00026357",0.875640822838247,0.320878802775509,0.978262075707395,159,-21.25,"2 18","660 685",20,"80.00%","80.00%",NA,NA,NA,NA,NA
"3308",3572,1306545,"Cluster_5882","Peve_00026356",0.970922741092274,0.153896891887811,0.978262075707395,167,-20.17,"2 21","645 667",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"3309",3573,1307533,"Cluster_4735","Peve_00011226",-0.500943642233887,0.665972771890438,0.978262075707395,176,-21.52,"2 21","153 174",19,"78.95%","89.47%","Q5ZM55","Protein fem-1 homolog B (FEM1b) (FEM1-beta)","Gallus gallus (Chicken)","apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756; GO:2000001"
"3310",3574,1307710,"Cluster_4080","Peve_00026821",0.959498247432244,0.1818062644036,0.978262075707395,159,-20.78,"2 21","894 918",22,"68.18%","77.27%",NA,NA,NA,NA,NA
"3311",3575,1307791,"Cluster_29","Peve_00026822",-0.756793100149441,0.453530060919426,0.978262075707395,170,-23.15,"2 21","443 463",19,"84.21%","84.21%","P98069","Bone morphogenetic protein 1 homolog (EC 3.4.24.-) (SUBMP)","Strongylocentrotus purpuratus (Purple sea urchin)","dorsal/ventral pattern formation [GO:0009953]; protein processing [GO:0016485]","GO:0004222; GO:0005509; GO:0005615; GO:0008270; GO:0009953; GO:0016485"
"3312",3576,1308387,"Cluster_4629","Peve_00032454",-0.565485201968733,0.617377873494,0.978262075707395,159,-21.58,"2 16","180 201",14,"85.71%","85.71%","O60688","Protein yippee-like 1","Homo sapiens (Human)","","GO:0005634; GO:0046872"
"3313",3577,1308387,"Cluster_4629","Peve_00032454",-0.565485201968733,0.617377873494,0.978262075707395,163,-22.56,"2 21","354 376",20,"70.00%","85.00%","O60688","Protein yippee-like 1","Homo sapiens (Human)","","GO:0005634; GO:0046872"
"3314",3578,1308742,"Cluster_2854","Peve_00024468",-0.507486347355159,0.661149542463894,0.978262075707395,164,-20.61,"2 21","735 754",19,"78.95%","89.47%","O97967","Bombesin receptor subtype-3 (BRS-3)","Ovis aries (Sheep)","","GO:0004946; GO:0005886"
"3315",3579,1308744,"Cluster_4079","Peve_00024468",-0.796272454187231,0.413604356922386,0.978262075707395,160,-20.61,"2 18","102 125",18,"72.22%","88.89%","O97967","Bombesin receptor subtype-3 (BRS-3)","Ovis aries (Sheep)","","GO:0004946; GO:0005886"
"3316",3580,1310069,"Cluster_8988","Peve_00009905",0.0860148226113438,0.945173514868548,0.999448381576871,172,-21.02,"2 21","633 654",19,"73.68%","89.47%","A0A2B4SII1",NA,NA,NA,NA
"3317",3581,1311301,"Cluster_29","Peve_00018671",-0.52801862110726,0.645870238485428,0.978262075707395,159,-20.7,"2 21","955 974",20,"80.00%","80.00%",NA,NA,NA,NA,NA
"3318",3582,1311465,"Cluster_9149","Peve_00041509",-0.707053886179264,0.500047620457092,0.978262075707395,155,-22.35,"2 18","691 715",19,"78.95%","78.95%","Q9N0C5","Thymidine kinase 2, mitochondrial (EC 2.7.1.21) (2'-deoxyuridine kinase TK2) (EC 2.7.1.74) (Deoxycytidine kinase TK2) (EC 2.7.1.-)","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","carbohydrate derivative metabolic process [GO:1901135]; DNA biosynthetic process [GO:0071897]; phosphorylation [GO:0016310]","GO:0004797; GO:0005524; GO:0005739; GO:0016310; GO:0071897; GO:1901135"
"3319",3583,1311668,"Cluster_2882","Peve_00041507",-0.698807803988772,0.507428532939266,0.978262075707395,150,-21.86,"2 16","355 377",15,"73.33%","86.67%","Q5U2X7","Mitochondrial import inner membrane translocase subunit Tim21 (TIM21-like protein, mitochondrial)","Rattus norvegicus (Rat)","mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981]; protein import into mitochondrial matrix [GO:0030150]","GO:0005744; GO:0030150; GO:0032981; GO:0033617"
"3320",3584,1312150,"Cluster_14500","Peve_00044485",-0.892359012078568,0.298097859379402,0.978262075707395,167,-20.23,"2 21","923 947",22,"72.73%","81.82%",NA,NA,NA,NA,NA
"3321",3585,1312378,"Cluster_15890","Peve_00013528",-0.953627229784303,0.194634301575916,0.978262075707395,166,-21.18,"2 16","365 387",15,"93.33%","93.33%",NA,NA,NA,NA,NA
"3322",3586,1312428,"Cluster_796","Peve_00013524",0.898740270652305,0.288966974174018,0.978262075707395,165,-25.18,"2 20","486 510",21,"80.95%","80.95%",NA,NA,NA,NA,NA
"3323",3587,1313029,"Cluster_6906","Peve_00010953",0.947988743004738,0.206226445596868,0.978262075707395,150,-20.58,"2 16","862 886",17,"76.47%","76.47%","P22314","Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Protein A1S9) (Ubiquitin-activating enzyme E1)","Homo sapiens (Human)","cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0003723; GO:0004839; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0006974; GO:0016567; GO:0032446; GO:0070062"
"3324",3588,1314020,"Cluster_6914","Peve_00042364",0.617069233523641,0.57663967973829,0.978262075707395,156,-21.21,"2 20","563 581",18,"77.78%","77.78%",NA,NA,NA,NA,NA
"3325",3589,1314507,"Cluster_4629","Peve_00018431",-0.428926337651212,0.71778397651339,0.980946464673932,141,-20.01,"2 10","403 424",8,"87.50%","100.00%",NA,NA,NA,NA,NA
"3326",3590,1314948,"Cluster_796","Peve_00043013",0.421686150835438,0.722876810123783,0.982362820958635,161,-25.96,"2 21","768 789",20,"80.00%","80.00%","P09917","Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34)","Homo sapiens (Human)","arachidonic acid metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; hepoxilin biosynthetic process [GO:0051122]; humoral immune response [GO:0006959]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; linoleic acid metabolic process [GO:0043651]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426]","GO:0001937; GO:0002232; GO:0002523; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005576; GO:0005615; GO:0005635; GO:0005641; GO:0005654; GO:0005829; GO:0006691; GO:0006959; GO:0016363; GO:0016525; GO:0016702; GO:0016787; GO:0019369; GO:0019370; GO:0019372; GO:0030501; GO:0031965; GO:0034440; GO:0034774; GO:0036336; GO:0036403; GO:0042593; GO:0042759; GO:0043651; GO:0045598; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0051122; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904813; GO:1904999; GO:2001301"
"3327",3591,1315078,"Cluster_15890","Peve_00043015",-0.960790751581807,0.178862263233058,0.978262075707395,154,-21.82,"2 21","581 610",27,"66.67%","70.37%",NA,NA,NA,NA,NA
"3328",3592,1315245,"Cluster_9149","Peve_00043019",-0.998042064423258,0.0398442086073031,0.909359886114279,162,-24.46,"2 15","294 315",13,"84.62%","100.00%",NA,NA,NA,NA,NA
"3329",3593,1316064,"Cluster_13502","Peve_00034888",-0.44209200413486,0.708472937844906,0.978262075707395,154,-21.2,"2 20","263 288",22,"63.64%","77.27%","Q96PM5","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING finger protein 199) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363) (p53-induced RING-H2 protein) (hPirh2)","Homo sapiens (Human)","error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630; GO:0070987"
"3330",3594,1316802,"Cluster_4629","Peve_00040592",0.982490688297609,0.119306851544098,0.978262075707395,172,-33.92,"2 21","864 885",19,"78.95%","84.21%","Q15399","Toll-like receptor 1 (Toll/interleukin-1 receptor-like protein) (TIL) (CD antigen CD281)","Homo sapiens (Human)","cellular response to bacterial lipopeptide [GO:0071221]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; detection of triacyl bacterial lipopeptide [GO:0042495]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage activation [GO:0042116]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of tumor necrosis factor production [GO:0032760]; signal transduction [GO:0007165]; toll-like receptor signaling pathway [GO:0002224]","GO:0002224; GO:0004888; GO:0005794; GO:0005886; GO:0006954; GO:0006955; GO:0007165; GO:0016020; GO:0030670; GO:0032755; GO:0032757; GO:0032760; GO:0034137; GO:0035354; GO:0035663; GO:0038023; GO:0042116; GO:0042495; GO:0042802; GO:0043235; GO:0045087; GO:0045121; GO:0050135; GO:0061809; GO:0071221; GO:0071723; GO:0071727"
"3331",3595,1316861,"Cluster_8884","Peve_00040599",-0.947118896471403,0.20795915113434,0.978262075707395,164,-23.07,"2 19","715 738",20,"80.00%","85.00%",NA,NA,NA,NA,NA
"3332",3596,1316862,"Cluster_8887","Peve_00040599",-0.821901473199095,0.385826733407904,0.978262075707395,164,-23.07,"2 19","715 738",20,"80.00%","85.00%",NA,NA,NA,NA,NA
"3333",3597,1317752,"Cluster_6904","Peve_00007141",-0.951310992493219,0.199475076059675,0.978262075707395,150,-20.48,"2 21","166 190",22,"63.64%","77.27%",NA,NA,NA,NA,NA
"3334",3598,1317754,"Cluster_6906","Peve_00007141",-0.686063329690759,0.518674561276582,0.978262075707395,152,-21.49,"2 21","166 190",23,"69.57%","78.26%",NA,NA,NA,NA,NA
"3335",3599,1317813,"Cluster_10061","Peve_00007140",0.0928693490450575,0.940792218864392,0.999448381576871,177,-23.91,"2 19","475 498",19,"89.47%","89.47%",NA,NA,NA,NA,NA
"3336",3600,1318071,"Cluster_7053","Peve_00033148",-0.393403462121784,0.74259511975665,0.986697151420032,166,-24.87,"2 21","693 717",22,"72.73%","86.36%","P97527","Contactin-5 (Neural recognition molecule NB-2)","Rattus norvegicus (Rat)","axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; presynapse assembly [GO:0099054]; sensory perception of sound [GO:0007605]","GO:0005886; GO:0007155; GO:0007411; GO:0007420; GO:0007605; GO:0030424; GO:0042734; GO:0098609; GO:0098632; GO:0098982; GO:0099054"
"3337",3601,1318265,"Cluster_10965","Peve_00015507",-0.861501692342471,0.33904874167394,0.978262075707395,174,-21.35,"2 21","682 702",19,"84.21%","89.47%",NA,NA,NA,NA,NA
"3338",3602,1318416,"Cluster_2787","Peve_00015503",0.998952984103862,0.0291346401596183,0.903929377050813,146,-21.22,"2 16","123 146",16,"75.00%","75.00%",NA,NA,NA,NA,NA
"3339",3603,1319081,"Cluster_14999","Peve_00028791",-0.555788437875671,0.624832915470566,0.978262075707395,169,-21.59,"2 20","512 532",18,"83.33%","88.89%","P55115","Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15)","Caenorhabditis elegans","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"3340",3604,1319383,"Cluster_8888","Peve_00036248",0.435669322834298,0.713023426919638,0.979663631127656,150,-20.6,"2 20","60 84",22,"59.09%","77.27%",NA,NA,NA,NA,NA
"3341",3605,1319475,"Cluster_9149","Peve_00007859",0.992558682466051,0.0777122919585566,0.978262075707395,147,-20.9,"2 14","179 199",12,"83.33%","91.67%",NA,NA,NA,NA,NA
"3342",3607,1319722,"Cluster_2854","Peve_00036246",-0.507486347355159,0.661149542463894,0.978262075707395,175,-22.89,"2 20","645 666",18,"83.33%","88.89%",NA,NA,NA,NA,NA
"3343",3608,1320801,"Cluster_2787","Peve_00038948",0.971410877842835,0.152593372659828,0.978262075707395,149,-22.62,"2 20","108 133",22,"68.18%","72.73%","A9Y006","Aquaporin-3 (Aquaglyceroporin-3)","Sus scrofa (Pig)","glycerol transmembrane transport [GO:0015793]; polyol transmembrane transport [GO:0015791]; water transport [GO:0006833]","GO:0005886; GO:0006833; GO:0015166; GO:0015204; GO:0015250; GO:0015254; GO:0015791; GO:0015793; GO:0016323"
"3344",3609,1321083,"Cluster_6905","Peve_00008500",-0.929945104908788,0.239708228175045,0.978262075707395,150,-23.3,"2 20","212 234",19,"68.42%","73.68%","P07794","Late histone H2B.2.1","Psammechinus miliaris (Green sea urchin) (Echinus miliaris)","","GO:0000786; GO:0003677; GO:0005634; GO:0030527; GO:0044877; GO:0046982"
"3345",3610,1321242,"Cluster_15726","Peve_00008507",-0.5,0.666666666666667,0.978262075707395,155,-20.47,"2 17","81 103",16,"81.25%","81.25%","Q9NPF2","Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)","Homo sapiens (Human)","apoptotic process [GO:0006915]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0006915; GO:0007179; GO:0007585; GO:0008146; GO:0009791; GO:0016020; GO:0016051; GO:0030166; GO:0030206; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050659"
"3346",3611,1322012,"Cluster_589","Peve_00009459",-0.996976921072009,0.0495141506171131,0.951254322422111,160,-23.47,"2 19","358 378",17,"76.47%","88.24%",NA,NA,NA,NA,NA
"3347",3612,1322022,"Cluster_4629","Peve_00009459",-0.146292799879524,0.906531671826969,0.999448381576871,159,-21.5,"2 21","96 119",21,"71.43%","76.19%",NA,NA,NA,NA,NA
"3348",3613,1322147,"Cluster_589","Peve_00031353",-0.934753615028442,0.231240264998328,0.978262075707395,167,-28.91,"2 21","1 24",22,"72.73%","81.82%","P40313","Chymotrypsin-like protease CTRL-1 (EC 3.4.21.-)","Homo sapiens (Human)","protein catabolic process [GO:0030163]; proteolysis [GO:0006508]","GO:0004252; GO:0005615; GO:0006508; GO:0008236; GO:0030163"
"3349",3614,1322338,"Cluster_4735","Peve_00031737",0.699536300698555,0.506779853665592,0.978262075707395,160,-21.26,"2 21","127 146",19,"73.68%","89.47%","Q3ZCC3","TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6)","Bos taurus (Bovine)","activation of NF-kappaB-inducing kinase activity [GO:0007250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; bone resorption [GO:0045453]; cellular response to DNA damage stimulus [GO:0006974]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0000122; GO:0001503; GO:0001701; GO:0001843; GO:0002637; GO:0002726; GO:0004842; GO:0005164; GO:0005634; GO:0005811; GO:0005829; GO:0005938; GO:0006974; GO:0007249; GO:0007250; GO:0008270; GO:0009898; GO:0019886; GO:0030316; GO:0031435; GO:0031624; GO:0031625; GO:0031663; GO:0031666; GO:0031996; GO:0032735; GO:0032743; GO:0032755; GO:0032813; GO:0033209; GO:0035631; GO:0042088; GO:0042102; GO:0042475; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043122; GO:0043123; GO:0043422; GO:0043507; GO:0045453; GO:0045672; GO:0045944; GO:0046330; GO:0047485; GO:0048471; GO:0050852; GO:0051092; GO:0051865; GO:0061630; GO:0070498; GO:0070534; GO:0097400; GO:1901224; GO:1904996; GO:2000679"
"3350",3615,1322427,"Cluster_4629","Peve_00033241",-0.554554668634826,0.625777256211528,0.978262075707395,169,-23.16,"2 21","336 355",19,"84.21%","84.21%",NA,NA,NA,NA,NA
"3351",3616,1322472,"Cluster_4629","Peve_00033240",-0.563808613147849,0.618671109770969,0.978262075707395,169,-23.16,"2 21","297 316",19,"84.21%","84.21%",NA,NA,NA,NA,NA
"3352",3617,1322532,"Cluster_8887","Peve_00034219",-0.0823630340017489,0.947506599925429,0.999448381576871,165,-20.01,"2 19","609 630",18,"83.33%","83.33%",NA,NA,NA,NA,NA
"3353",3618,1322814,"Cluster_13502","Peve_00005176",-0.707193359378945,0.499922047468018,0.978262075707395,164,-21.83,"2 21","72 93",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"3354",3619,1322817,"Cluster_15726","Peve_00005176",-0.19475513922208,0.875217557043555,0.997608248562619,150,-22.18,"2 11","974 995",9,"100.00%","100.00%",NA,NA,NA,NA,NA
"3355",3620,1323472,"Cluster_7657","Peve_00025203",-0.549201875707433,0.629863605292151,0.978262075707395,177,-25.62,"2 21","525 544",19,"89.47%","89.47%","Q24JV9","Galectin-3-binding protein A (Lectin galactoside-binding soluble 3-binding protein A)","Danio rerio (Zebrafish) (Brachydanio rerio)","cell adhesion [GO:0007155]","GO:0005044; GO:0005576; GO:0007155; GO:0016020"
"3356",3621,1323473,"Cluster_7658","Peve_00025203",-0.215254944410015,0.861883502691059,0.996640086921214,177,-25.62,"2 21","525 544",19,"89.47%","89.47%","Q24JV9","Galectin-3-binding protein A (Lectin galactoside-binding soluble 3-binding protein A)","Danio rerio (Zebrafish) (Brachydanio rerio)","cell adhesion [GO:0007155]","GO:0005044; GO:0005576; GO:0007155; GO:0016020"
"3357",3622,1323978,"Cluster_10061","Peve_00005822",-0.918702294971201,0.258476692955254,0.978262075707395,150,-20.3,"2 20","554 584",27,"62.96%","66.67%",NA,NA,NA,NA,NA
"3358",3623,1324047,"Cluster_4629","Peve_00005826",-0.508189676011329,0.660629777403243,0.978262075707395,156,-27.42,"2 18","545 568",18,"72.22%","83.33%","B7PRF6","Acireductone dioxygenase (Acireductone dioxygenase (Fe(2+)-requiring)) (ARD') (Fe-ARD) (EC 1.13.11.54) (Acireductone dioxygenase (Ni(2+)-requiring)) (ARD) (Ni-ARD) (EC 1.13.11.53)","Ixodes scapularis (Black-legged tick) (Deer tick)","L-methionine salvage from methylthioadenosine [GO:0019509]; methionine metabolic process [GO:0006555]","GO:0005506; GO:0005634; GO:0005737; GO:0006555; GO:0010308; GO:0010309; GO:0016151; GO:0019509"
"3359",3625,1325392,"Cluster_2854","Peve_00021436",-0.44872619122057,0.703755699650075,0.978262075707395,154,-20.51,"2 16","1 22",15,"80.00%","86.67%","Q9P289","Serine/threonine-protein kinase 26 (EC 2.7.11.1) (MST3 and SOK1-related kinase) (Mammalian STE20-like protein kinase 4) (MST-4) (STE20-like kinase MST4) (Serine/threonine-protein kinase MASK)","Homo sapiens (Human)","apoptotic process [GO:0006915]; cellular response to starvation [GO:0009267]; microvillus assembly [GO:0030033]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide-induced cell death [GO:1903205]; response to hydrogen peroxide [GO:0042542]","GO:0000287; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005794; GO:0005798; GO:0005829; GO:0006468; GO:0006915; GO:0009267; GO:0012506; GO:0016020; GO:0016324; GO:0030033; GO:0030336; GO:0042542; GO:0042802; GO:0042803; GO:0042981; GO:0046777; GO:0048471; GO:0070062; GO:0071944; GO:0106310; GO:1903205"
"3360",3626,1325484,"Cluster_4079","Peve_00021434",-0.665998990061483,0.536010990045251,0.978262075707395,146,-20.12,"2 20","478 500",19,"63.16%","73.68%","Q62623","Cell division cycle protein 20 homolog (p55CDC)","Rattus norvegicus (Rat)","anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic nuclear division [GO:0040020]","GO:0000922; GO:0005654; GO:0005680; GO:0005813; GO:0005829; GO:0007064; GO:0008022; GO:0008284; GO:0010997; GO:0016567; GO:0019899; GO:0031145; GO:0031915; GO:0032991; GO:0033597; GO:0040020; GO:0042826; GO:0048471; GO:0050773; GO:0051301; GO:0051444; GO:0090129; GO:0090307; GO:1904668; GO:1905786; GO:1990757"
"3361",3627,1326032,"Cluster_6904","Peve_00039844",0.999999795128444,0.000407507833291957,0.220203561024059,155,-23.05,"2 21","24 48",22,"63.64%","77.27%","O04469","Enoyl-CoA delta isomerase 1, peroxisomal (EC 5.3.3.8) (Delta(3),Delta(2)-enoyl CoA isomerase 1) (AtECI1)","Arabidopsis thaliana (Mouse-ear cress)","fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]","GO:0004165; GO:0005777; GO:0006635; GO:0009062"
"3362",3628,1326034,"Cluster_6906","Peve_00039844",0.876603915905731,0.31960699305028,0.978262075707395,157,-21.02,"2 19","26 48",18,"72.22%","83.33%","O04469","Enoyl-CoA delta isomerase 1, peroxisomal (EC 5.3.3.8) (Delta(3),Delta(2)-enoyl CoA isomerase 1) (AtECI1)","Arabidopsis thaliana (Mouse-ear cress)","fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]","GO:0004165; GO:0005777; GO:0006635; GO:0009062"
"3363",3629,1326456,"Cluster_11134","Peve_00007461",0.0400812865517204,0.974476623441402,0.999448381576871,163,-22.51,"2 21","546 571",23,"69.57%","78.26%","O54701","Sodium/potassium/calcium exchanger 2 (Na(+)/K(+)/Ca(2+)-exchange protein 2) (Retinal cone Na-Ca+K exchanger) (Solute carrier family 24 member 2)","Rattus norvegicus (Rat)","calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to high light intensity [GO:0071486]; establishment of localization in cell [GO:0051649]; ion transmembrane transport [GO:0034220]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; neuron cellular homeostasis [GO:0070050]; potassium ion transmembrane transport [GO:0071805]; protein-containing complex assembly [GO:0065003]; sodium ion transmembrane transport [GO:0035725]","GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007612; GO:0007613; GO:0008273; GO:0015293; GO:0016020; GO:0034220; GO:0035725; GO:0051649; GO:0060291; GO:0060292; GO:0065003; GO:0070050; GO:0070509; GO:0070588; GO:0071486; GO:0071805; GO:0098703"
"3364",3631,1327680,"Cluster_16738","Peve_00017815",-0.470559174176981,0.688104445972386,0.978262075707395,188,-32.26,"2 21","53 74",19,"89.47%","94.74%","O35111","Potassium channel subfamily K member 3 (Acid-sensitive potassium channel protein TASK-1) (Cardiac two pore background K(+) channel) (TWIK-related acid-sensitive K(+) channel 1) (Two pore potassium channel KT3.1) (Two pore K(+) channel KT3.1) (cTBAK-1)","Mus musculus (Mouse)","brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to zinc ion [GO:0071294]; cochlea development [GO:0090102]; ion transmembrane transport [GO:0034220]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of resting membrane potential [GO:0060075]; response to xenobiotic stimulus [GO:0009410]; stabilization of membrane potential [GO:0030322]","GO:0005216; GO:0005252; GO:0005886; GO:0006813; GO:0007420; GO:0008022; GO:0009410; GO:0015271; GO:0022841; GO:0030322; GO:0034220; GO:0044548; GO:0051481; GO:0060075; GO:0071294; GO:0071456; GO:0071805; GO:0090102; GO:1903818"
"3365",3632,1327854,"Cluster_13502","Peve_00017812",-0.166600801924081,0.893441767273951,0.999448381576871,158,-27.08,"2 19","265 286",17,"64.71%","88.24%",NA,NA,NA,NA,NA
"3366",3633,1327935,"Cluster_9149","Peve_00010455",0.943008928985225,0.215964814797205,0.978262075707395,158,-21.22,"2 19","520 541",17,"76.47%","76.47%",NA,NA,NA,NA,NA
"3367",3634,1328040,"Cluster_16738","Peve_00010457",0.999924418203837,0.00782720053096207,0.573710369894872,166,-23.26,"2 21","323 343",19,"73.68%","89.47%","Q80T79","CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3)","Mus musculus (Mouse)","negative regulation of complement activation, classical pathway [GO:0045959]; regulation of dendrite development [GO:0050773]","GO:0005615; GO:0005886; GO:0045959; GO:0050773"
"3368",3635,1328176,"Cluster_29","Peve_00010453",0.0459085629570893,0.970763425145792,0.999448381576871,154,-20.66,"2 20","532 555",20,"65.00%","80.00%","A2AIV2","Protein virilizer homolog","Mus musculus (Mouse)","mRNA alternative polyadenylation [GO:0110104]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]","GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0008380; GO:0016604; GO:0016607; GO:0036396; GO:0080009; GO:0110104"
"3369",3636,1328471,"Cluster_8884","Peve_00039547",-0.915767864878908,0.263166550600431,0.978262075707395,155,-20.01,"2 12","775 795",10,"100.00%","100.00%",NA,NA,NA,NA,NA
"3370",3637,1328472,"Cluster_8887","Peve_00039547",-0.769476787394603,0.441034132873996,0.978262075707395,155,-20.37,"2 12","775 795",10,"100.00%","100.00%",NA,NA,NA,NA,NA
"3371",3638,1329258,"Cluster_796","Peve_00012164",0.28240545369113,0.817735307783542,0.995934364227446,151,-22.66,"2 13","96 118",12,"91.67%","91.67%",NA,NA,NA,NA,NA
"3372",3639,1329285,"Cluster_9149","Peve_00012164",-0.770477581287716,0.440035615290893,0.978262075707395,165,-25,"2 21","51 70",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"3373",3640,1330221,"Cluster_7053","Peve_00044725",0.846336500416608,0.357606501734946,0.978262075707395,155,-22.27,"2 17","298 320",16,"75.00%","87.50%",NA,NA,NA,NA,NA
"3374",3641,1330689,"Cluster_13502","Peve_00020429",-0.651359545838919,0.548397951109962,0.978262075707395,158,-21.65,"2 20","480 502",19,"68.42%","84.21%","P53461","Actin, nonmuscle (EC 3.6.4.-) [Cleaved into: Actin, nonmuscle, intermediate form]","Halocynthia roretzi (Sea squirt) (Cynthia roretzi)","","GO:0005524; GO:0005737; GO:0005856; GO:0016787"
"3375",3642,1331712,"Cluster_8887","Peve_00003756",-0.999888656727405,0.00950016485251684,0.60604832750937,154,-21.23,"2 20","549 570",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"3376",3643,1331877,"Cluster_4629","Peve_00003752",-0.429487529462421,0.717388423626739,0.980878365742004,146,-20.68,"2 21","560 580",19,"63.16%","73.68%",NA,NA,NA,NA,NA
"3377",3645,1332729,"Cluster_4079","Peve_00044905",-0.796272454187231,0.413604356922386,0.978262075707395,148,-20.56,"2 13","130 151",11,"81.82%","90.91%",NA,NA,NA,NA,NA
"3378",3646,1332844,"Cluster_10934","Peve_00043730",-0.654241081477023,0.545976336054938,0.978262075707395,168,-21.7,"2 17","618 639",15,"86.67%","93.33%",NA,NA,NA,NA,NA
"3379",3647,1332947,"Cluster_589","Peve_00008758",-0.763633609242351,0.446826838293114,0.978262075707395,157,-23,"2 14","228 249",12,"91.67%","91.67%","Q9CWU9","Nucleoporin Nup37 (Nup107-160 subcomplex subunit Nup37)","Mus musculus (Mouse)","cell division [GO:0051301]; chromosome segregation [GO:0007059]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]","GO:0000776; GO:0005635; GO:0005643; GO:0005654; GO:0006913; GO:0007059; GO:0015031; GO:0031080; GO:0051028; GO:0051301"
"3380",3648,1333100,"Cluster_6914","Peve_00043736",0.439685593215559,0.710179750316707,0.978784473286922,153,-21.57,"2 20","560 584",22,"68.18%","77.27%","Q1ZXJ0","Chloride channel protein D","Dictyostelium discoideum (Social amoeba)","regulation of ion transmembrane transport [GO:0034765]; sorocarp development [GO:0030587]","GO:0005247; GO:0015108; GO:0030587; GO:0034707; GO:0034765; GO:0043231"
"3381",3649,1333225,"Cluster_4080","Peve_00043739",-0.209088075378121,0.865900927836289,0.996660710141104,155,-20.77,"2 21","690 715",23,"60.87%","78.26%","P23049","Tyrosine-protein kinase transforming protein SEA (EC 2.7.10.2)","Avian erythroblastosis virus (strain S13)","","GO:0004715; GO:0005524"
"3382",3650,1334038,"Cluster_4735","Peve_00002937",-0.413938493328759,0.728305709722955,0.983979085434834,147,-20.67,"2 13","679 702",13,"84.62%","84.62%","O95376","E3 ubiquitin-protein ligase ARIH2 (ARI-2) (Protein ariadne-2 homolog) (EC 2.3.2.31) (RING-type E3 ubiquitin transferase ARIH2) (Triad1 protein)","Homo sapiens (Human)","developmental cell growth [GO:0048588]; hematopoietic stem cell proliferation [GO:0071425]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0031624; GO:0032436; GO:0048588; GO:0061630; GO:0070534; GO:0070936; GO:0071425; GO:1903955"
"3383",3651,1334441,"Cluster_4115","Peve_00004191",0.488842329343064,0.674838671027921,0.978262075707395,169,-23.57,"2 20","366 386",18,"83.33%","88.89%",NA,NA,NA,NA,NA
"3384",3652,1334622,"Cluster_4629","Peve_00004197",-0.659661298448949,0.541399482208474,0.978262075707395,153,-23.11,"2 19","99 121",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"3385",3653,1334894,"Cluster_5563","Peve_00000470",0.998070534296603,0.0395533713646997,0.909359886114279,161,-21.83,"2 20","946 970",20,"75.00%","85.00%","A7RR04","Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1)","Nematostella vectensis (Starlet sea anemone)","mitochondrial translational elongation [GO:0070125]","GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0070125"
"3386",3654,1335067,"Cluster_2854","Peve_00031977",-0.918100318179777,0.259445303642687,0.978262075707395,147,-20.22,"2 21","763 787",22,"59.09%","72.73%",NA,NA,NA,NA,NA
"3387",3655,1335657,"Cluster_4629","Peve_00006131",-0.582073856644994,0.60448289719042,0.978262075707395,151,-24.27,"2 12","639 660",10,"90.00%","100.00%","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"3388",3658,1336221,"Cluster_11134","Peve_00000107",0.999846092086893,0.0111694339890098,0.652903054366067,153,-21.65,"2 15","117 139",14,"78.57%","92.86%","Q6PE54","Probable ATP-dependent RNA helicase DHX40 (EC 3.6.4.13) (DEAH box protein 40)","Mus musculus (Mouse)","","GO:0003723; GO:0003724; GO:0005524; GO:0016887"
"3389",3659,1336410,"Cluster_16738","Peve_00040413",-0.981983947965624,0.121026123119509,0.978262075707395,160,-21.96,"2 13","329 350",11,"100.00%","100.00%","Q5ZMV7","WD repeat-containing protein 82","Gallus gallus (Chicken)","DNA-templated transcription termination [GO:0006353]; histone H3-K4 trimethylation [GO:0080182]; lncRNA catabolic process [GO:0110064]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of lncRNA transcription [GO:0140744]; nuclear RNA surveillance [GO:0071027]","GO:0003682; GO:0005694; GO:0006353; GO:0032785; GO:0048188; GO:0071027; GO:0080182; GO:0110064; GO:0140744"
"3390",3660,1337841,"Cluster_11134","Peve_00007269",-0.856078539892879,0.345787863891157,0.978262075707395,158,-23.11,"2 21","895 915",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"3391",3661,1338137,"Cluster_6904","Peve_00007264",-0.940119394213601,0.221426480202716,0.978262075707395,158,-22.77,"2 19","465 486",17,"70.59%","82.35%","Q5RDU7","Protein yippee-like 5","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","cell population proliferation [GO:0008283]","GO:0000151; GO:0005634; GO:0005737; GO:0005815; GO:0008283; GO:0030496; GO:0046872; GO:0097431"
"3392",3662,1338139,"Cluster_6906","Peve_00007264",-0.660573988414402,0.540625965419623,0.978262075707395,158,-20.68,"2 19","465 486",17,"70.59%","82.35%","Q5RDU7","Protein yippee-like 5","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","cell population proliferation [GO:0008283]","GO:0000151; GO:0005634; GO:0005737; GO:0005815; GO:0008283; GO:0030496; GO:0046872; GO:0097431"
"3393",3663,1338734,"Cluster_8988","Peve_00032664",0.415449158804329,0.72724882960925,0.983719834720853,166,-25.49,"2 21","269 289",19,"68.42%","94.74%","A7SWD3","Glucose-induced degradation protein 8 homolog","Nematostella vectensis (Starlet sea anemone)","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Wnt signaling pathway [GO:0016055]","GO:0005634; GO:0005737; GO:0016055; GO:0043161"
"3394",3664,1338869,"Cluster_8988","Peve_00032663",0.974632864478924,0.143698820134047,0.978262075707395,166,-25.62,"2 21","256 276",19,"68.42%","94.74%","A7SWD3","Glucose-induced degradation protein 8 homolog","Nematostella vectensis (Starlet sea anemone)","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Wnt signaling pathway [GO:0016055]","GO:0005634; GO:0005737; GO:0016055; GO:0043161"
"3395",3668,1340586,"Cluster_11134","Peve_00015020",-0.0195622829453675,0.987545469442176,0.999448381576871,162,-23.46,"2 21","174 194",19,"68.42%","89.47%",NA,NA,NA,NA,NA
"3396",3669,1341505,"Cluster_4080","Peve_00024363",-0.978511505629713,0.132214440302291,0.978262075707395,175,-20.64,"2 20","645 666",18,"83.33%","88.89%","Q9N0V4","Glutathione S-transferase Mu 1 (EC 2.5.1.18) (GST class-mu 1) (GSTM1-1)","Bos taurus (Bovine)","glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; prostaglandin metabolic process [GO:0006693]","GO:0004364; GO:0005737; GO:0006693; GO:0006749; GO:0051122; GO:1901687"
"3397",3670,1341895,"Cluster_14500","Peve_00031504",0.893071791254959,0.297090871236363,0.978262075707395,162,-23.72,"2 21","962 988",24,"70.83%","79.17%","Q8C9A2","Endonuclease V (EC 3.1.26.-)","Mus musculus (Mouse)","DNA repair [GO:0006281]","GO:0000287; GO:0003677; GO:0003727; GO:0005730; GO:0005737; GO:0006281; GO:0010494; GO:0016888; GO:0016891"
"3398",3671,1341940,"Cluster_14500","Peve_00031505",-0.947925195908348,0.206353504436749,0.978262075707395,162,-23.72,"2 21","130 156",24,"70.83%","79.17%","Q8K2H6","Anaphase-promoting complex subunit 10 (APC10) (Cyclosome subunit 10)","Mus musculus (Mouse)","anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]","GO:0005680; GO:0005737; GO:0007049; GO:0031145; GO:0051301; GO:0070979"
"3399",3672,1342017,"Cluster_8887","Peve_00031500",-0.86586063227075,0.3335430671048,0.978262075707395,153,-20.34,"2 14","741 761",12,"83.33%","91.67%","A3KQ55","7SK snRNA methylphosphate capping enzyme (MePCE) (EC 2.1.1.-) (Bicoid-interacting protein 3 homolog) (Bin3 homolog) (zBCDIN3)","Danio rerio (Zebrafish) (Brachydanio rerio)","positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; RNA methylation [GO:0001510]; snRNA metabolic process [GO:0016073]; snRNA modification [GO:0040031]","GO:0001510; GO:0005634; GO:0008171; GO:0008173; GO:0008757; GO:0016073; GO:0017069; GO:0040031; GO:1904871; GO:1905382; GO:1990276; GO:1990904"
"3400",3673,1342018,"Cluster_8888","Peve_00031500",-0.299042271224047,0.806665679975529,0.995934364227446,153,-21.97,"2 14","741 761",12,"83.33%","91.67%","A3KQ55","7SK snRNA methylphosphate capping enzyme (MePCE) (EC 2.1.1.-) (Bicoid-interacting protein 3 homolog) (Bin3 homolog) (zBCDIN3)","Danio rerio (Zebrafish) (Brachydanio rerio)","positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; RNA methylation [GO:0001510]; snRNA metabolic process [GO:0016073]; snRNA modification [GO:0040031]","GO:0001510; GO:0005634; GO:0008171; GO:0008173; GO:0008757; GO:0016073; GO:0017069; GO:0040031; GO:1904871; GO:1905382; GO:1990276; GO:1990904"
"3401",3674,1342045,"Cluster_4080","Peve_00020939",-0.609596428343284,0.582663024173763,0.978262075707395,171,-20.13,"2 20","678 699",18,"77.78%","88.89%","Q8K385","Ferric-chelate reductase 1 (EC 1.-.-.-) (Stromal cell-derived receptor 2) (SDR-2)","Mus musculus (Mouse)","cellular iron ion homeostasis [GO:0006879]","GO:0006879; GO:0016020; GO:0016722; GO:0046872"
"3402",3675,1342222,"Cluster_2854","Peve_00012315",0.982811970628433,0.11820400440701,0.978262075707395,161,-21.61,"2 21","732 754",21,"76.19%","80.95%","Q8BYI6","Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkenylglycerophosphocholine O-acyltransferase) (EC 2.3.1.25) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 1)","Mus musculus (Mouse)","membrane organization [GO:0061024]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; platelet activating factor biosynthetic process [GO:0006663]","GO:0000139; GO:0003841; GO:0005509; GO:0005783; GO:0005789; GO:0005795; GO:0005811; GO:0005886; GO:0006663; GO:0016020; GO:0036151; GO:0047159; GO:0047184; GO:0047192; GO:0050200; GO:0061024"
"3403",3676,1342897,"Cluster_2854","Peve_00025014",-0.86614725809016,0.33317815085166,0.978262075707395,158,-20.92,"2 18","412 431",16,"81.25%","87.50%","Q2T9V8","D-aminoacyl-tRNA deacylase 1 (DTD) (EC 3.1.1.96) (DNA-unwinding element-binding protein B) (DUE-B) (Gly-tRNA(Ala) deacylase)","Bos taurus (Bovine)","DNA replication [GO:0006260]; tRNA metabolic process [GO:0006399]","GO:0000049; GO:0003677; GO:0005634; GO:0005737; GO:0006260; GO:0006399; GO:0046872; GO:0051500"
"3404",3677,1343100,"Cluster_9149","Peve_00011744",-0.496568589823942,0.669186242073281,0.978262075707395,164,-27.41,"2 19","310 330",17,"82.35%","88.24%",NA,NA,NA,NA,NA
"3405",3678,1343847,"Cluster_4629","Peve_00020991",-0.143015390120981,0.908640314801678,0.999448381576871,154,-21.41,"2 20","546 568",19,"57.89%","89.47%",NA,NA,NA,NA,NA
"3406",3679,1343932,"Cluster_2854","Peve_00020995",-0.965673652857849,0.167285816609399,0.978262075707395,166,-24.49,"2 15","885 906",13,"92.31%","100.00%","Q3U4H6","Hexosaminidase D (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase D) (Hexosaminidase domain-containing protein) (N-acetyl-beta-galactosaminidase)","Mus musculus (Mouse)","carbohydrate metabolic process [GO:0005975]","GO:0004563; GO:0005634; GO:0005737; GO:0005975; GO:0015929; GO:0102148; GO:1903561"
"3407",3680,1343932,"Cluster_2854","Peve_00020995",-0.965673652857849,0.167285816609399,0.978262075707395,200,-38.33,"2 21","725 746",19,"100.00%","100.00%","Q3U4H6","Hexosaminidase D (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase D) (Hexosaminidase domain-containing protein) (N-acetyl-beta-galactosaminidase)","Mus musculus (Mouse)","carbohydrate metabolic process [GO:0005975]","GO:0004563; GO:0005634; GO:0005737; GO:0005975; GO:0015929; GO:0102148; GO:1903561"
"3408",3681,1343964,"Cluster_13502","Peve_00020995",0.746890617951841,0.463091703081801,0.978262075707395,200,-40.02,"2 21","696 717",19,"100.00%","100.00%","Q3U4H6","Hexosaminidase D (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase D) (Hexosaminidase domain-containing protein) (N-acetyl-beta-galactosaminidase)","Mus musculus (Mouse)","carbohydrate metabolic process [GO:0005975]","GO:0004563; GO:0005634; GO:0005737; GO:0005975; GO:0015929; GO:0102148; GO:1903561"
"3409",3682,1344321,"Cluster_11134","Peve_00026590",-0.0195622829453675,0.987545469442176,0.999448381576871,155,-21.15,"2 21","965 988",21,"66.67%","76.19%",NA,NA,NA,NA,NA
"3410",3683,1344558,"Cluster_796","Peve_00013972",-0.829106154727612,0.377699692492649,0.978262075707395,150,-21.4,"2 21","382 406",22,"68.18%","72.73%","Q9VBW3","Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","Drosophila melanogaster (Fruit fly)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0014068; GO:0016339; GO:0033674; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0090303"
"3411",3684,1344698,"Cluster_2882","Peve_00043537",0.708035349141169,0.499163445238738,0.978262075707395,158,-23.56,"2 17","887 910",17,"82.35%","88.24%",NA,NA,NA,NA,NA
"3412",3685,1345935,"Cluster_9149","Peve_00015983",-0.481924226415152,0.679876090428812,0.978262075707395,150,-22.2,"2 21","325 351",24,"62.50%","75.00%","Q2EMV9","Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14)","Mus musculus (Mouse)","innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein poly-ADP-ribosylation [GO:0070212]","GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016779; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:1902216; GO:1990404"
"3413",3686,1346500,"Cluster_4080","Peve_00035671",-0.818793436271186,0.389286734970055,0.978262075707395,167,-23.78,"2 21","572 595",21,"71.43%","85.71%",NA,NA,NA,NA,NA
"3414",3689,1346876,"Cluster_8884","Peve_00017607",-0.995455103893778,0.060718596348149,0.978262075707395,150,-20.04,"2 19","140 160",17,"64.71%","76.47%","Q6AZN6","Phosphatidylinositol 3-kinase catalytic subunit type 3 (PI3-kinase type 3) (PI3K type 3) (PtdIns-3-kinase type 3) (EC 2.7.1.137) (Phosphoinositide-3-kinase class 3)","Xenopus laevis (African clawed frog)","autophagy [GO:0006914]; cell cycle [GO:0007049]; cell division [GO:0051301]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; regulation of cytokinesis [GO:0032465]","GO:0005524; GO:0006914; GO:0007049; GO:0016303; GO:0016310; GO:0030496; GO:0032465; GO:0048015; GO:0051301"
"3415",3690,1347848,"Cluster_2882","Peve_00034083",-0.970305910527769,0.155528753337139,0.978262075707395,158,-21.12,"2 21","306 330",22,"72.73%","77.27%",NA,NA,NA,NA,NA
"3416",3692,1348442,"Cluster_6904","Peve_00002367",-0.998173851896017,0.0384794833063825,0.909359886114279,164,-23.3,"2 21","643 664",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"3417",3693,1348444,"Cluster_6906","Peve_00002367",-0.90434492757142,0.280720001910522,0.978262075707395,172,-23.45,"2 21","643 664",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"3418",3694,1349385,"Cluster_5882","Peve_00038753",0.354811113758801,0.769090350817023,0.990719257153337,155,-20.68,"2 16","524 545",14,"78.57%","85.71%",NA,NA,NA,NA,NA
"3419",3695,1349406,"Cluster_11134","Peve_00038753",0.58510262611287,0.602108439929326,0.978262075707395,165,-20.47,"2 18","137 158",16,"75.00%","93.75%",NA,NA,NA,NA,NA
"3420",3696,1349551,"Cluster_29","Peve_00000217",0.0905963363000613,0.942245391119879,0.999448381576871,158,-20.74,"2 21","201 225",22,"72.73%","77.27%",NA,NA,NA,NA,NA
"3421",3697,1349721,"Cluster_11134","Peve_00003095",0.875640822838247,0.320878802775509,0.978262075707395,160,-22.93,"2 19","233 253",17,"82.35%","82.35%",NA,NA,NA,NA,NA
"3422",3698,1350480,"Cluster_9149","Peve_00008041",-0.554988145430182,0.625445574754757,0.978262075707395,149,-20.8,"2 14","584 605",12,"75.00%","91.67%",NA,NA,NA,NA,NA
"3423",3699,1350495,"Cluster_16738","Peve_00008041",-0.560950361672205,0.620871698965606,0.978262075707395,159,-22.67,"2 21","47 69",20,"70.00%","80.00%",NA,NA,NA,NA,NA
"3424",3700,1350501,"Cluster_2787","Peve_00008040",0.54112789632398,0.635994970134668,0.978262075707395,163,-24.78,"2 18","773 793",16,"81.25%","93.75%","P33610","DNA primase large subunit (DNA primase 58 kDa subunit) (p58)","Mus musculus (Mouse)","DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]; positive regulation of DNA primase activity [GO:1903934]","GO:0003677; GO:0005658; GO:0006269; GO:0006270; GO:0046872; GO:0051539; GO:0071667; GO:1903934"
"3425",3701,1350517,"Cluster_7657","Peve_00008040",0.670894644963215,0.53182053854099,0.978262075707395,170,-20.56,"2 21","920 943",21,"80.95%","85.71%","P33610","DNA primase large subunit (DNA primase 58 kDa subunit) (p58)","Mus musculus (Mouse)","DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]; positive regulation of DNA primase activity [GO:1903934]","GO:0003677; GO:0005658; GO:0006269; GO:0006270; GO:0046872; GO:0051539; GO:0071667; GO:1903934"
"3426",3702,1350518,"Cluster_7658","Peve_00008040",-0.999314839069881,0.0235676465242015,0.851706337230628,170,-20.56,"2 21","920 943",21,"80.95%","85.71%","P33610","DNA primase large subunit (DNA primase 58 kDa subunit) (p58)","Mus musculus (Mouse)","DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]; positive regulation of DNA primase activity [GO:1903934]","GO:0003677; GO:0005658; GO:0006269; GO:0006270; GO:0046872; GO:0051539; GO:0071667; GO:1903934"
"3427",3703,1350631,"Cluster_29","Peve_00016421",0.989342177720748,0.0930284603194349,0.978262075707395,159,-23.28,"2 20","84 105",18,"66.67%","83.33%",NA,NA,NA,NA,NA
"3428",3704,1350711,"Cluster_11134","Peve_00034778",0.88486903227594,0.308495459158522,0.978262075707395,155,-22.55,"2 21","214 240",24,"62.50%","75.00%",NA,NA,NA,NA,NA
"3429",3705,1351443,"Cluster_796","Peve_00003541",0.998317429681288,0.036935386301087,0.909359886114279,163,-24.23,"2 21","376 398",20,"75.00%","80.00%","Q6TEK8","Vitamin K epoxide reductase complex subunit 1-like protein 1 (VKORC1-like protein 1) (EC 1.17.4.4)","Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)","vitamin K metabolic process [GO:0042373]","GO:0005789; GO:0042373; GO:0047057; GO:0048038"
"3430",3706,1351646,"Cluster_8884","Peve_00003762",-0.175744597536855,0.887533422383122,0.999448381576871,166,-20.33,"2 19","95 115",17,"76.47%","88.24%","Q5A761","CCR4-Not complex 3'-5'-exoribonuclease subunit Ccr4 (EC 3.1.13.4) (Carbon catabolite repressor protein 4) (Cytoplasmic deadenylase) (Glucose-repressible alcohol dehydrogenase transcriptional effector)","Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)","DNA replication checkpoint signaling [GO:0000076]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; replication fork protection [GO:0048478]; transcription elongation by RNA polymerase II promoter [GO:0006368]; traversing start control point of mitotic cell cycle [GO:0007089]","GO:0000076; GO:0000175; GO:0000289; GO:0000932; GO:0003723; GO:0004535; GO:0005634; GO:0005737; GO:0006368; GO:0007089; GO:0016593; GO:0030014; GO:0030015; GO:0032968; GO:0046872; GO:0048478"
"3431",3707,1351647,"Cluster_8887","Peve_00003762",-0.440410481324715,0.709665840109558,0.978599181026883,166,-20.33,"2 19","95 115",17,"76.47%","88.24%","Q5A761","CCR4-Not complex 3'-5'-exoribonuclease subunit Ccr4 (EC 3.1.13.4) (Carbon catabolite repressor protein 4) (Cytoplasmic deadenylase) (Glucose-repressible alcohol dehydrogenase transcriptional effector)","Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)","DNA replication checkpoint signaling [GO:0000076]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; replication fork protection [GO:0048478]; transcription elongation by RNA polymerase II promoter [GO:0006368]; traversing start control point of mitotic cell cycle [GO:0007089]","GO:0000076; GO:0000175; GO:0000289; GO:0000932; GO:0003723; GO:0004535; GO:0005634; GO:0005737; GO:0006368; GO:0007089; GO:0016593; GO:0030014; GO:0030015; GO:0032968; GO:0046872; GO:0048478"
"3432",3708,1351751,"Cluster_14999","Peve_00036618",-0.532959548764747,0.642159571413329,0.978262075707395,166,-22.04,"2 21","51 71",19,"73.68%","89.47%",NA,NA,NA,NA,NA
"3433",3709,1352246,"Cluster_14999","Peve_00004015",-0.989783756632969,0.0910775141207295,0.978262075707395,174,-23.86,"2 21","955 979",22,"81.82%","86.36%",NA,NA,NA,NA,NA
"3434",3710,1352342,"Cluster_589","Peve_00004010",-0.904030525307254,0.281188599959258,0.978262075707395,155,-21.36,"2 21","210 232",20,"65.00%","80.00%","Q2TBK4","HAUS augmin-like complex subunit 1 (Coiled-coil domain-containing protein 5)","Bos taurus (Bovine)","cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225]","GO:0000922; GO:0005813; GO:0005829; GO:0007098; GO:0051225; GO:0051301; GO:0070652; GO:1990498"
"3435",3711,1352387,"Cluster_589","Peve_00004011",-0.28440648820038,0.816406946587615,0.995934364227446,155,-21.36,"2 21","210 232",20,"65.00%","80.00%",NA,NA,NA,NA,NA
"3436",3712,1352595,"Cluster_9149","Peve_00041741",-0.841603643564736,0.363223890447609,0.978262075707395,152,-22.15,"2 14","579 601",13,"84.62%","92.31%",NA,NA,NA,NA,NA
"3437",3713,1352838,"Cluster_796","Peve_00031346",0.909161924857508,0.273446761421486,0.978262075707395,159,-23.86,"2 21","39 61",20,"75.00%","75.00%","Q5ZJQ8","Ubiquitin-associated domain-containing protein 2 (UBA domain-containing protein 2) (Phosphoglycerate dehydrogenase-like protein 1)","Gallus gallus (Chicken)","negative regulation of canonical Wnt signaling pathway [GO:0090090]; Wnt signaling pathway [GO:0016055]","GO:0005789; GO:0016055; GO:0090090"
"3438",3715,1353560,"Cluster_1167","Peve_00039704",-0.488318552853167,0.675220836384604,0.978262075707395,147,-22.25,"2 12","800 821",10,"90.00%","90.00%","O88871","Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51)","Rattus norvegicus (Rat)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]","GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007193; GO:0007214; GO:0016020; GO:0030425; GO:0038039; GO:0042734; GO:0043005; GO:0043204; GO:0045211; GO:0046982; GO:0051932; GO:0098978; GO:0098982; GO:0150099; GO:1902710; GO:1902712"
"3439",3716,1353567,"Cluster_4629","Peve_00039704",-0.443383362280846,0.707556077121805,0.978262075707395,151,-23.23,"2 21","21 43",20,"65.00%","75.00%","O88871","Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51)","Rattus norvegicus (Rat)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]","GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007193; GO:0007214; GO:0016020; GO:0030425; GO:0038039; GO:0042734; GO:0043005; GO:0043204; GO:0045211; GO:0046982; GO:0051932; GO:0098978; GO:0098982; GO:0150099; GO:1902710; GO:1902712"
"3440",3717,1353687,"Cluster_15726","Peve_00011154",-0.61300610796507,0.579920189078022,0.978262075707395,160,-21.22,"2 21","647 668",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"3441",3718,1353731,"Cluster_14999","Peve_00039702",-0.0600862787880968,0.961724832077315,0.999448381576871,153,-22.31,"2 21","141 170",27,"70.37%","70.37%","O75899","Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20)","Homo sapiens (Human)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]","GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712"
"3442",3719,1353850,"Cluster_8634","Peve_00005654",-0.731534230315743,0.477609237115099,0.978262075707395,167,-24,"2 21","615 637",20,"75.00%","85.00%","Q9HCF6","Transient receptor potential cation channel subfamily M member 3 (Long transient receptor potential channel 3) (LTrpC-3) (LTrpC3) (Melastatin-2) (MLSN2)","Homo sapiens (Human)","calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; protein tetramerization [GO:0051262]","GO:0005261; GO:0005262; GO:0005886; GO:0006812; GO:0051262; GO:0070588; GO:0098655"
"3443",3720,1354027,"Cluster_7657","Peve_00028072",-0.0248712752357638,0.98416482157971,0.999448381576871,165,-20.1,"2 20","800 820",18,"77.78%","88.89%","P51029","Protein Wnt-8b","Danio rerio (Zebrafish) (Brachydanio rerio)","canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; negative regulation of anterior neural cell fate commitment of the neural plate by Wnt signaling pathway [GO:0022002]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]","GO:0001654; GO:0005109; GO:0005125; GO:0005615; GO:0009880; GO:0021854; GO:0021879; GO:0022002; GO:0030182; GO:0030900; GO:0043049; GO:0045165; GO:0060070; GO:0060898; GO:0070654; GO:0071679"
"3444",3721,1354028,"Cluster_7658","Peve_00028072",-0.698635025371055,0.5075822864035,0.978262075707395,165,-20.1,"2 20","800 820",18,"77.78%","88.89%","P51029","Protein Wnt-8b","Danio rerio (Zebrafish) (Brachydanio rerio)","canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; negative regulation of anterior neural cell fate commitment of the neural plate by Wnt signaling pathway [GO:0022002]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]","GO:0001654; GO:0005109; GO:0005125; GO:0005615; GO:0009880; GO:0021854; GO:0021879; GO:0022002; GO:0030182; GO:0030900; GO:0043049; GO:0045165; GO:0060070; GO:0060898; GO:0070654; GO:0071679"
"3445",3722,1354656,"Cluster_7053","Peve_00031839",0.912675916261222,0.268024412466454,0.978262075707395,153,-20.3,"2 20","682 707",22,"68.18%","77.27%",NA,NA,NA,NA,NA
"3446",3723,1355174,"Cluster_16498","Peve_00033476",-0.886094470940728,0.306816559720446,0.978262075707395,188,-24.98,"2 21","378 399",19,"84.21%","100.00%","Q6GNL7","Cytosolic 10-formyltetrahydrofolate dehydrogenase (10-FTHFDH) (FDH) (EC 1.5.1.6) (Aldehyde dehydrogenase family 1 member L1)","Xenopus laevis (African clawed frog)","10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; NADPH regeneration [GO:0006740]; one-carbon metabolic process [GO:0006730]","GO:0005829; GO:0006730; GO:0006740; GO:0009058; GO:0009258; GO:0016155; GO:0016620; GO:0016742"
"3447",3724,1355732,"Cluster_6904","Peve_00006303",-0.951310992493219,0.199475076059675,0.978262075707395,159,-22.06,"2 20","446 467",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"3448",3725,1355980,"Cluster_14500","Peve_00021499",-0.892359012078568,0.298097859379402,0.978262075707395,161,-20.74,"2 19","823 845",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"3449",3726,1356522,"Cluster_15726","Peve_00001450",0.999108109553157,0.0268895268710568,0.889863763909286,158,-20.61,"2 21","969 993",22,"72.73%","77.27%",NA,NA,NA,NA,NA
"3450",3728,1356849,"Cluster_4079","Peve_00022386",-0.785459566363807,0.424853305233382,0.978262075707395,174,-23.41,"2 19","348 369",17,"76.47%","100.00%","Q8K3J1","NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial (EC 7.1.1.2) (Complex I-23kD) (CI-23kD) (NADH-ubiquinone oxidoreductase 23 kDa subunit)","Mus musculus (Mouse)","aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; response to oxidative stress [GO:0006979]","GO:0003954; GO:0005739; GO:0005747; GO:0006120; GO:0006979; GO:0008137; GO:0009060; GO:0032981; GO:0042776; GO:0046872; GO:0051539"
"3451",3729,1357152,"Cluster_15726","Peve_00019672",0.981605296896214,0.122295223512179,0.978262075707395,170,-25.87,"2 15","12 33",13,"100.00%","100.00%","D8VNS7","Ryncolin-1","Cerberus rynchops (Dog-faced water snake)","","GO:0005576; GO:0090729"
"3452",3731,1357297,"Cluster_2854","Peve_00024970",0.99495194837855,0.0639940916395789,0.978262075707395,162,-21.21,"2 21","974 994",19,"73.68%","84.21%","A7SMW7","L-2-hydroxyglutarate dehydrogenase, mitochondrial (EC 1.1.99.2)","Nematostella vectensis (Starlet sea anemone)","","GO:0005739; GO:0047545"
"3453",3732,1357792,"Cluster_2854","Peve_00009969",0.619596604607315,0.574592417933109,0.978262075707395,171,-23.1,"2 20","10 31",18,"77.78%","88.89%","B0BM20","Enolase 4 (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","glycolytic process [GO:0006096]","GO:0000015; GO:0000287; GO:0004634; GO:0006096"
"3454",3733,1357935,"Cluster_5882","Peve_00027777",-0.431249806547841,0.716145531306985,0.980509562631722,162,-20.86,"2 21","815 835",19,"73.68%","84.21%","Q14703","Membrane-bound transcription factor site-1 protease (EC 3.4.21.112) (Endopeptidase S1P) (Subtilisin/kexin-isozyme 1) (SKI-1)","Homo sapiens (Human)","ATF6-mediated unfolded protein response [GO:0036500]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976]","GO:0000139; GO:0004252; GO:0005788; GO:0005789; GO:0005794; GO:0005795; GO:0006508; GO:0007040; GO:0008203; GO:0016485; GO:0030968; GO:0031293; GO:0034976; GO:0036500; GO:0045540; GO:0060627"
"3455",3734,1359014,"Cluster_5563","Peve_00017448",-0.991078225194888,0.0851028625745626,0.978262075707395,154,-21.42,"2 22","927 956",27,"66.67%","74.07%",NA,NA,NA,NA,NA
"3456",3735,1359812,"Cluster_589","Peve_00020816",-0.599182965035619,0.59098439766376,0.978262075707395,167,-26.26,"2 20","590 611",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"3457",3736,1359840,"Cluster_9149","Peve_00020816",0.041474087436663,0.973589200667902,0.999448381576871,148,-20.08,"2 14","464 486",13,"76.92%","92.31%",NA,NA,NA,NA,NA
"3458",3738,1360080,"Cluster_16738","Peve_00005516",-0.328252497545377,0.787080627982975,0.995158456348467,166,-20.41,"2 21","423 443",19,"78.95%","84.21%","Q8T882","Tauropine dehydrogenase (TaDH) (EC 1.5.1.23) (NAD: tauropine oxidoreductase)","Arabella iricolor (Opal worm)","","GO:0050325"
"3459",3739,1360215,"Cluster_16738","Peve_00005515",-0.701686891517807,0.504861103215303,0.978262075707395,166,-20.41,"2 21","421 441",19,"78.95%","84.21%","Q8T882","Tauropine dehydrogenase (TaDH) (EC 1.5.1.23) (NAD: tauropine oxidoreductase)","Arabella iricolor (Opal worm)","","GO:0050325"
"3460",3740,1360232,"Cluster_6904","Peve_00005518",0.827490945601562,0.379534960443077,0.978262075707395,154,-20.3,"2 19","76 96",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"3461",3741,1360857,"Cluster_4629","Peve_00042051",-0.279467762529315,0.819683981217243,0.995934364227446,148,-21.56,"2 20","897 916",18,"66.67%","77.78%","Q6NRT5","COP9 signalosome complex subunit 1 (Signalosome subunit 1)","Xenopus laevis (African clawed frog)","","GO:0005737; GO:0008180"
"3462",3742,1362832,"Cluster_2854","Peve_00034803",-0.414700443723747,0.727772739815865,0.983829598486354,163,-22.72,"2 20","138 159",18,"72.22%","83.33%",NA,NA,NA,NA,NA
"3463",3743,1362867,"Cluster_15726","Peve_00034803",-0.422570721495147,0.722255615613093,0.982165212722872,159,-21.7,"2 20","720 741",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"3464",3744,1362990,"Cluster_9149","Peve_00034806",-0.926533685755694,0.245547001901346,0.978262075707395,148,-21.07,"2 18","124 146",17,"64.71%","82.35%",NA,NA,NA,NA,NA
"3465",3745,1363188,"Cluster_796","Peve_00038134",-0.150959653378432,0.903527289330279,0.999448381576871,159,-27.28,"2 21","282 304",20,"70.00%","80.00%","Q5EA19","ADP-ribosylation factor-like protein 15","Bos taurus (Bovine)","","GO:0003924; GO:0005525"
"3466",3746,1363333,"Cluster_4735","Peve_00000826",-0.699425846364145,0.506878247708819,0.978262075707395,157,-25.07,"2 19","161 183",18,"77.78%","77.78%",NA,NA,NA,NA,NA
"3467",3747,1363383,"Cluster_6905","Peve_00000821",-0.934146882862268,0.232324975824956,0.978262075707395,167,-20.6,"2 20","594 615",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"3468",3748,1363460,"Cluster_1167","Peve_00000823",0.685863314491673,0.518849557581423,0.978262075707395,149,-24.35,"2 21","928 947",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"3469",3749,1363485,"Cluster_9149","Peve_00000823",-0.969984946823956,0.156371278803181,0.978262075707395,150,-25.5,"2 17","202 222",15,"73.33%","86.67%",NA,NA,NA,NA,NA
"3470",3750,1363684,"Cluster_1140","Peve_00032773",-0.965158492987321,0.168543758907255,0.978262075707395,196,-29.08,"2 21","752 773",19,"94.74%","100.00%",NA,NA,NA,NA,NA
"3471",3751,1363689,"Cluster_4079","Peve_00032773",-0.796272454187231,0.413604356922386,0.978262075707395,150,-20.99,"2 20","687 711",21,"61.90%","76.19%",NA,NA,NA,NA,NA
"3472",3752,1364127,"Cluster_15726","Peve_00033678",0.999904013014523,0.0088207349235263,0.583683194376181,168,-20.13,"2 18","144 166",17,"88.24%","88.24%","Q61425","Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (HCDH) (EC 1.1.1.35) (Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase) (Short-chain 3-hydroxyacyl-CoA dehydrogenase)","Mus musculus (Mouse)","fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of insulin secretion [GO:0050796]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]","GO:0003857; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0006635; GO:0009410; GO:0014823; GO:0032868; GO:0042802; GO:0046676; GO:0050796; GO:0070403; GO:0120162"
"3473",3753,1364447,"Cluster_589","Peve_00030499",-0.180869269215413,0.884217818183068,0.999448381576871,157,-23.46,"2 14","300 321",12,"91.67%","91.67%","Q8N6R0","eEF1A lysine and N-terminal methyltransferase (eEF1A-KNMT) (Methyltransferase-like protein 13) [Includes: eEF1A lysine methyltransferase (EC 2.1.1.-); eEF1A N-terminal methyltransferase (EC 2.1.1.-)]","Homo sapiens (Human)","negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of transcription by RNA polymerase II [GO:0000122]","GO:0000122; GO:0005634; GO:0005737; GO:0005739; GO:0016279; GO:1902807"
"3474",3754,1364721,"Cluster_2787","Peve_00030490",0.675851573866951,0.52755205815685,0.978262075707395,162,-25.73,"2 21","290 310",19,"68.42%","89.47%","B8V7S0","CUB and peptidase domain-containing protein 1","Acropora millepora (Staghorn coral) (Heteropora millepora)","proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508"
"3475",3755,1364925,"Cluster_9149","Peve_00041933",1,0,0,143,-21.67,"2 16","888 909",14,"71.43%","71.43%",NA,NA,NA,NA,NA
"3476",3756,1365011,"Cluster_8884","Peve_00028469",0.19406408778159,0.875666051136111,0.99768078250456,162,-20.2,"2 19","680 700",17,"76.47%","82.35%","P18321","Profilin","Clypeaster japonicus (Sand dollar)","regulation of cellular component biogenesis [GO:0044087]","GO:0003779; GO:0005737; GO:0005856; GO:0044087"
"3477",3757,1365012,"Cluster_8887","Peve_00028469",-0.0839913663556981,0.946466366590324,0.999448381576871,162,-20.2,"2 19","680 700",17,"76.47%","82.35%","P18321","Profilin","Clypeaster japonicus (Sand dollar)","regulation of cellular component biogenesis [GO:0044087]","GO:0003779; GO:0005737; GO:0005856; GO:0044087"
"3478",3758,1365170,"Cluster_1167","Peve_00028463",-0.0553673082235301,0.964734042973992,0.999448381576871,148,-22.24,"2 19","570 596",22,"68.18%","72.73%",NA,NA,NA,NA,NA
"3479",3759,1365260,"Cluster_1167","Peve_00028461",0.91385372482327,0.266183758807636,0.978262075707395,152,-23.4,"2 14","715 738",14,"85.71%","85.71%","P07221","Calsequestrin-1 (Aspartactin) (Calsequestrin, skeletal muscle isoform) (Laminin-binding protein)","Oryctolagus cuniculus (Rabbit)","positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of store-operated calcium channel activity [GO:1901341]; protein polymerization [GO:0051258]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; regulation of store-operated calcium entry [GO:2001256]; sarcomere organization [GO:0045214]; sequestering of metal ion [GO:0051238]","GO:0000287; GO:0005509; GO:0005759; GO:0014809; GO:0016529; GO:0030955; GO:0033017; GO:0033018; GO:0042803; GO:0043167; GO:0045214; GO:0046872; GO:0051238; GO:0051258; GO:0051281; GO:1901341; GO:2001256"
"3480",3760,1365639,"Cluster_7855","Peve_00034373",0.424375346545165,0.720987430098003,0.981782014768518,171,-20.78,"2 21","500 522",20,"80.00%","85.00%","Q9SEE4","Pirin-like protein","Solanum lycopersicum (Tomato) (Lycopersicon esculentum)","","GO:0005634"
"3481",3761,1365848,"Cluster_2882","Peve_00002535",-0.481772785530261,0.679986115835351,0.978262075707395,146,-20.96,"2 15","465 486",13,"76.92%","76.92%",NA,NA,NA,NA,NA
"3482",3762,1365850,"Cluster_4080","Peve_00002535",0.366639528539533,0.761016478065371,0.988527331194745,175,-20.62,"2 20","327 348",18,"83.33%","88.89%",NA,NA,NA,NA,NA
"3483",3763,1365933,"Cluster_796","Peve_00002536",0.92990196060607,0.239782915590626,0.978262075707395,152,-22.33,"2 18","611 634",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"3484",3764,1366050,"Cluster_9149","Peve_00002530",-0.916343430117153,0.262252909771271,0.978262075707395,147,-22.51,"2 12","404 425",10,"80.00%","100.00%","Q8BTI9","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform (PI3-kinase subunit beta) (PI3K-beta) (PI3Kbeta) (PtdIns-3-kinase subunit beta) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit beta) (PtdIns-3-kinase subunit p110-beta) (p110beta) (Serine/threonine protein kinase PIK3CB) (EC 2.7.11.1)","Mus musculus (Mouse)","angiogenesis involved in wound healing [GO:0060055]; autophagy [GO:0006914]; cell migration [GO:0016477]; cellular calcium ion homeostasis [GO:0006874]; embryonic cleavage [GO:0040016]; endocytosis [GO:0006897]; endothelial cell proliferation [GO:0001935]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cell-matrix adhesion [GO:0001952]; response to ischemia [GO:0002931]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]","GO:0001935; GO:0001952; GO:0002931; GO:0003376; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0006874; GO:0006897; GO:0006914; GO:0007156; GO:0010595; GO:0010628; GO:0014065; GO:0016020; GO:0016301; GO:0016303; GO:0016310; GO:0016477; GO:0030168; GO:0030496; GO:0031526; GO:0033031; GO:0035005; GO:0035022; GO:0036092; GO:0040016; GO:0043231; GO:0043407; GO:0043560; GO:0046854; GO:0046934; GO:0048015; GO:0051000; GO:0051897; GO:0051898; GO:0052742; GO:0052812; GO:0060055; GO:0106310; GO:1900747; GO:1903298; GO:1903671"
"3485",3765,1366703,"Cluster_2882","Peve_00032237",-0.887221148439798,0.305265463759568,0.978262075707395,169,-20.62,"2 19","213 235",18,"83.33%","88.89%","Q04861","Nuclear factor NF-kappa-B p105 subunit (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit]","Gallus gallus (Chicken)","regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]","GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0007165; GO:0051059"
"3486",3766,1366923,"Cluster_796","Peve_00032232",0.998122772067377,0.0390140994983106,0.909359886114279,155,-21.08,"2 12","941 962",10,"100.00%","100.00%","Q5R5R4","RUN and FYVE domain-containing protein 2","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","","GO:0005634; GO:0046872"
"3487",3767,1368087,"Cluster_15726","Peve_00003663",-0.491483101273219,0.672909908770727,0.978262075707395,161,-26.24,"2 21","739 760",20,"80.00%","80.00%","P07949","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Homo sapiens (Human)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; axon guidance [GO:0007411]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; posterior midgut development [GO:0007497]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0006468; GO:0006919; GO:0007156; GO:0007158; GO:0007165; GO:0007169; GO:0007411; GO:0007497; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0038023; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0097021; GO:0098797; GO:2001241"
"3488",3768,1368181,"Cluster_29","Peve_00003667",-0.41173658260987,0.729844766868111,0.984474935384813,160,-20.3,"2 21","555 576",19,"63.16%","84.21%","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"3489",3769,1368276,"Cluster_2787","Peve_00003669",0.961304111495252,0.177679787316446,0.978262075707395,151,-22.13,"2 21","393 417",22,"68.18%","68.18%","Q5JPE7","BOS complex subunit NOMO2 (Nodal modulator 2) (pM5 protein 2)","Homo sapiens (Human)","","GO:0005789; GO:0030246; GO:0032991; GO:0043022"
"3490",3770,1368423,"Cluster_6905","Peve_00015498",-0.859575201047457,0.341456445569612,0.978262075707395,148,-23.55,"2 18","530 552",17,"70.59%","76.47%",NA,NA,NA,NA,NA
"3491",3772,1369986,"Cluster_2787","Peve_00009186",0.851818274659107,0.351000120684039,0.978262075707395,164,-20.49,"2 18","658 680",17,"82.35%","88.24%","O70165","Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin)","Mus musculus (Mouse)","cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of interleukin-8 production [GO:0032757]","GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0007186; GO:0030246; GO:0031232; GO:0032757; GO:0038187; GO:0046872; GO:0062023; GO:0097367"
"3492",3773,1369988,"Cluster_2882","Peve_00009186",-0.815958145669205,0.392419870945141,0.978262075707395,168,-26.8,"2 18","955 977",17,"88.24%","88.24%","O70165","Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin)","Mus musculus (Mouse)","cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of interleukin-8 production [GO:0032757]","GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0007186; GO:0030246; GO:0031232; GO:0032757; GO:0038187; GO:0046872; GO:0062023; GO:0097367"
"3493",3774,1370646,"Cluster_11134","Peve_00009230",0.881947514687546,0.312464547154721,0.978262075707395,151,-21.12,"2 12","366 387",10,"90.00%","100.00%",NA,NA,NA,NA,NA
"3494",3775,1370978,"Cluster_2882","Peve_00018778",-0.21360635134724,0.862958023980984,0.996660710141104,174,-22.14,"2 21","528 548",19,"84.21%","89.47%","Q6P3W7","SCY1-like protein 2 (Coated vesicle-associated kinase of 104 kDa)","Homo sapiens (Human)","brain development [GO:0007420]; endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of receptor internalization [GO:0002092]; protein phosphorylation [GO:0006468]; pyramidal neuron development [GO:0021860]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]","GO:0002092; GO:0004672; GO:0005102; GO:0005524; GO:0005794; GO:0006468; GO:0007420; GO:0008333; GO:0010008; GO:0021860; GO:0030136; GO:0090090; GO:2000286; GO:2000370"
"3495",3776,1371170,"Cluster_6914","Peve_00025539",0.35569410315058,0.768488996117479,0.990527675986719,145,-22.57,"2 20","663 687",22,"63.64%","72.73%",NA,NA,NA,NA,NA
"3496",3777,1371871,"Cluster_29","Peve_00011242",0.150077509493572,0.904095351418415,0.999448381576871,149,-20.64,"2 14","914 935",12,"75.00%","91.67%",NA,NA,NA,NA,NA
"3497",3778,1371989,"Cluster_8988","Peve_00011244",0.425693524803991,0.720060342579503,0.981421472131835,157,-23.37,"2 21","79 98",19,"63.16%","89.47%","Q19269","Zinc metalloproteinase nas-14 (EC 3.4.24.-) (Nematode astacin 14)","Caenorhabditis elegans","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"3498",3780,1373209,"Cluster_10934","Peve_00030688",0.756673235740581,0.453646789182601,0.978262075707395,162,-23.03,"2 21","848 868",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"3499",3781,1373357,"Cluster_589","Peve_00026168",0.159680919674548,0.897906931664995,0.999448381576871,160,-24.46,"2 21","974 995",19,"73.68%","73.68%",NA,NA,NA,NA,NA
"3500",3782,1374531,"Cluster_2787","Peve_00022264",-0.00382968334855694,0.997561941898757,0.999448381576871,171,-21.23,"2 21","196 218",20,"80.00%","85.00%",NA,NA,NA,NA,NA
"3501",3783,1374933,"Cluster_796","Peve_00037436",0.898740270652305,0.288966974174018,0.978262075707395,153,-20.59,"2 21","181 202",20,"75.00%","75.00%",NA,NA,NA,NA,NA
"3502",3784,1375191,"Cluster_11134","Peve_00018088",0.940899614932507,0.219964578369095,0.978262075707395,159,-27.02,"2 21","729 754",23,"69.57%","73.91%",NA,NA,NA,NA,NA
"3503",3785,1375297,"Cluster_2854","Peve_00022024",0.480831779805971,0.680669544851518,0.978262075707395,154,-20.86,"2 17","342 362",15,"73.33%","93.33%",NA,NA,NA,NA,NA
"3504",3786,1376081,"Cluster_8884","Peve_00000270",0.639928753671755,0.557927699492965,0.978262075707395,171,-22.22,"2 20","289 309",18,"77.78%","88.89%",NA,NA,NA,NA,NA
"3505",3787,1376082,"Cluster_8887","Peve_00000270",0.827027491981448,0.3800601172194,0.978262075707395,171,-22.22,"2 20","289 309",18,"77.78%","88.89%",NA,NA,NA,NA,NA
"3506",3788,1376912,"Cluster_589","Peve_00011929",0.159680919674548,0.897906931664995,0.999448381576871,150,-21.4,"2 20","550 574",21,"61.90%","76.19%",NA,NA,NA,NA,NA
"3507",3789,1377220,"Cluster_14500","Peve_00017182",0.669473691699707,0.533039365957341,0.978262075707395,166,-20.25,"2 20","597 620",20,"70.00%","90.00%",NA,NA,NA,NA,NA
"3508",3790,1377327,"Cluster_4629","Peve_00017181",-0.689729110320079,0.515459228587206,0.978262075707395,162,-20.3,"2 19","260 281",17,"70.59%","88.24%","B7W114","Cephalotoxin-like protein","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"3509",3791,1377582,"Cluster_15726","Peve_00013401",-0.0387794115730239,0.975306067894091,0.999448381576871,150,-23.48,"2 21","358 378",19,"68.42%","73.68%","P83088","Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase)","Drosophila melanogaster (Fruit fly)","fucosylation [GO:0036065]; protein glycosylation [GO:0006486]","GO:0006486; GO:0008417; GO:0032580; GO:0036065; GO:0046920"
"3510",3792,1377677,"Cluster_589","Peve_00013405",-0.934753615028442,0.231240264998328,0.978262075707395,162,-22.91,"2 19","29 50",17,"76.47%","82.35%",NA,NA,NA,NA,NA
"3511",3793,1377974,"Cluster_8988","Peve_00041262",0.0603871227758749,0.961532960429914,0.999448381576871,163,-20.4,"2 21","34 56",20,"70.00%","85.00%",NA,NA,NA,NA,NA
"3512",3794,1378356,"Cluster_2787","Peve_00021770",0.935016889993681,0.23076806865825,0.978262075707395,172,-23.55,"2 21","412 433",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"3513",3795,1378712,"Cluster_589","Peve_00021779",-0.862758595680632,0.337469518876067,0.978262075707395,155,-21.13,"2 12","678 699",10,"100.00%","100.00%",NA,NA,NA,NA,NA
"3514",3796,1378875,"Cluster_9149","Peve_00042799",-0.797598627927814,0.412206708684116,0.978262075707395,148,-23.58,"2 18","190 212",17,"70.59%","76.47%",NA,NA,NA,NA,NA
"3515",3797,1379667,"Cluster_4629","Peve_00026201",-0.443383362280846,0.707556077121805,0.978262075707395,156,-21.82,"2 21","311 332",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"3516",3798,1379758,"Cluster_4735","Peve_00026202",0.99999940598563,0.000693894776195108,0.239778920002343,159,-23.8,"2 21","946 968",20,"70.00%","80.00%",NA,NA,NA,NA,NA
"3517",3799,1381874,"Cluster_5563","Peve_00030518",0.0533239704113661,0.966036797687887,0.999448381576871,166,-25.16,"2 21","802 828",23,"73.91%","82.61%",NA,NA,NA,NA,NA
"3518",3800,1382687,"Cluster_6904","Peve_00040495",0.168809338023325,0.892015570280661,0.999448381576871,153,-20.29,"2 17","311 330",15,"80.00%","86.67%","B3EWY9","Mucin-like protein","Acropora millepora (Staghorn coral) (Heteropora millepora)","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0007160; GO:0016020"
"3519",3801,1382811,"Cluster_2787","Peve_00015640",0.978438609498862,0.132439319076876,0.978262075707395,167,-24.17,"2 21","76 100",22,"72.73%","81.82%",NA,NA,NA,NA,NA
"3520",3802,1383178,"Cluster_4735","Peve_00032918",0.906080327582833,0.278120218544356,0.978262075707395,155,-21.25,"2 20","364 382",18,"77.78%","77.78%","Q3B7M6","Protein NEDD1 (Neural precursor cell expressed developmentally down-regulated protein 1) (NEDD-1)","Bos taurus (Bovine)","cell division [GO:0051301]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]","GO:0000242; GO:0000278; GO:0000922; GO:0001650; GO:0005654; GO:0005814; GO:0005829; GO:0007020; GO:0036064; GO:0043015; GO:0045177; GO:0051301"
"3521",3803,1383358,"Cluster_4735","Peve_00032917",0.913576837639537,0.266617546780331,0.978262075707395,155,-21.25,"2 20","833 851",18,"77.78%","77.78%",NA,NA,NA,NA,NA
"3522",3804,1383645,"Cluster_9149","Peve_00028343",0.906711346912397,0.277169243189876,0.978262075707395,150,-20.77,"2 19","23 44",17,"64.71%","76.47%",NA,NA,NA,NA,NA
"3523",3805,1383685,"Cluster_8634","Peve_00028340",0.915164925662187,0.264120449535341,0.978262075707395,165,-22.16,"2 18","544 565",16,"81.25%","87.50%","Q0MQE9","NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 (Complex I-B22) (CI-B22) (NADH-ubiquinone oxidoreductase B22 subunit)","Gorilla gorilla gorilla (Western lowland gorilla)","mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]","GO:0005747; GO:0006120; GO:0032981"
"3524",3806,1383783,"Cluster_10061","Peve_00028346",0.154249095963946,0.901408345679126,0.999448381576871,163,-20.05,"2 21","641 664",21,"71.43%","80.95%","O15360","Fanconi anemia group A protein (Protein FACA)","Homo sapiens (Human)","DNA repair [GO:0006281]; female gonad development [GO:0008585]; interstrand cross-link repair [GO:0036297]; male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; protein monoubiquitination [GO:0006513]; protein-containing complex assembly [GO:0065003]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of germ cell proliferation [GO:1905936]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]","GO:0000785; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006513; GO:0007140; GO:0008584; GO:0008585; GO:0036297; GO:0043240; GO:0045589; GO:0050727; GO:0051090; GO:0065003; GO:1905936; GO:2000348"
"3525",3807,1383890,"Cluster_1167","Peve_00028345",-0.0323195258165185,0.979421167161489,0.999448381576871,149,-20.98,"2 21","730 751",20,"70.00%","75.00%",NA,NA,NA,NA,NA
"3526",3808,1383920,"Cluster_10965","Peve_00028345",0.523935458164469,0.648926595205486,0.978262075707395,177,-20.26,"2 18","448 469",16,"93.75%","93.75%",NA,NA,NA,NA,NA
"3527",3810,1384991,"Cluster_8884","Peve_00007954",-0.970469126194796,0.155098594202929,0.978262075707395,166,-22.14,"2 20","683 704",19,"73.68%","89.47%","Q1LZA7","LIM domain-containing protein 2","Bos taurus (Bovine)","","GO:0005654; GO:0005829; GO:0046872"
"3528",3811,1384992,"Cluster_8887","Peve_00007954",-0.866313624062576,0.332966176476495,0.978262075707395,166,-22.52,"2 20","683 704",19,"73.68%","89.47%","Q1LZA7","LIM domain-containing protein 2","Bos taurus (Bovine)","","GO:0005654; GO:0005829; GO:0046872"
"3529",3812,1384993,"Cluster_8888","Peve_00007954",-0.299906859192206,0.806088789347224,0.995934364227446,166,-22.9,"2 20","683 704",19,"73.68%","89.47%","Q1LZA7","LIM domain-containing protein 2","Bos taurus (Bovine)","","GO:0005654; GO:0005829; GO:0046872"
"3530",3813,1385958,"Cluster_796","Peve_00032001",0.180946875583947,0.884167583563657,0.999448381576871,161,-23.77,"2 19","420 442",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"3531",3814,1386605,"Cluster_6914","Peve_00009882",0.853558462702337,0.34887952241865,0.978262075707395,162,-23.32,"2 20","408 429",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"3532",3817,1387317,"Cluster_4629","Peve_00036582",0.998776265532991,0.0314980026586388,0.903929377050813,163,-24.32,"2 16","77 98",14,"85.71%","92.86%","P30975","Tachykinin-like peptides receptor 99D (Tachykinin-like receptor at 99D) (dTKR)","Drosophila melanogaster (Fruit fly)","detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic transmission [GO:0050805]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; positive regulation of sensory perception of pain [GO:1904058]; tachykinin receptor signaling pathway [GO:0007217]","GO:0004995; GO:0005886; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016020; GO:0042048; GO:0050805; GO:0050911; GO:1904058"
"3533",3818,1388639,"Cluster_8988","Peve_00000638",-0.241463767143404,0.84474500897504,0.995934364227446,164,-21.11,"2 21","433 452",19,"84.21%","84.21%","Q7ZXF5","Fatty acyl-CoA reductase 1 (EC 1.2.1.84)","Xenopus laevis (African clawed frog)","ether lipid biosynthetic process [GO:0008611]; wax biosynthetic process [GO:0010025]","GO:0005778; GO:0008611; GO:0010025; GO:0080019; GO:0102965"
"3534",3819,1388730,"Cluster_9149","Peve_00031673",0.999232747668771,0.0249397445505303,0.86745289293403,148,-20.42,"2 18","477 499",17,"64.71%","82.35%","P38062","Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M)","Rattus norvegicus (Rat)","N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein initiator methionine removal involved in protein maturation [GO:0035551]; protein processing [GO:0016485]","GO:0004177; GO:0005737; GO:0008235; GO:0016485; GO:0018206; GO:0031365; GO:0035551; GO:0046872; GO:0070006"
"3535",3821,1389090,"Cluster_9149","Peve_00042024",-0.510767137007238,0.658722868087276,0.978262075707395,153,-24.51,"2 20","9 29",18,"72.22%","77.78%","Q502W6","von Willebrand factor A domain-containing protein 3B (VWA domain-containing protein 3B)","Homo sapiens (Human)","","GO:0005654; GO:0005829"
"3536",3822,1389539,"Cluster_8988","Peve_00024051",-0.0566605102140451,0.963909470370619,0.999448381576871,159,-21.96,"2 21","434 459",23,"65.22%","78.26%","Q28WQ1","Kinesin-like protein unc-104","Drosophila pseudoobscura pseudoobscura (Fruit fly)","synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]","GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0005875; GO:0008017; GO:0047496; GO:0048489"
"3537",3823,1390293,"Cluster_6905","Peve_00005940",-0.938263049823691,0.224868058177197,0.978262075707395,151,-21.22,"2 21","44 62",19,"73.68%","78.95%","Q8AV58","Protein sidekick-1","Gallus gallus (Chicken)","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]","GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202"
"3538",3824,1390587,"Cluster_15726","Peve_00005949",0.237824238390402,0.84713154832085,0.995934364227446,145,-21.62,"2 21","419 438",19,"57.89%","78.95%","Q5R628","U6 snRNA-associated Sm-like protein LSm5","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","mRNA splicing, via spliceosome [GO:0000398]","GO:0000398; GO:0003723; GO:0005634; GO:0046540; GO:0071005; GO:0120115"
"3539",3825,1390759,"Cluster_10934","Peve_00022843",-0.620792320923648,0.573622032694341,0.978262075707395,160,-23.52,"2 21","891 912",19,"68.42%","78.95%","Q15751","Probable E3 ubiquitin-protein ligase HERC1 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 1) (HECT-type E3 ubiquitin transferase HERC1) (p532) (p619)","Homo sapiens (Human)","autophagy [GO:0006914]; cerebellar Purkinje cell differentiation [GO:0021702]; corpus callosum development [GO:0022038]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]","GO:0004842; GO:0005085; GO:0005737; GO:0005794; GO:0005829; GO:0006914; GO:0010507; GO:0016020; GO:0021702; GO:0022038; GO:0031175; GO:0050885"
"3540",3827,1391408,"Cluster_2882","Peve_00007548",-0.690096341902444,0.515136270581517,0.978262075707395,150,-20.49,"2 11","905 926",9,"100.00%","100.00%",NA,NA,NA,NA,NA
"3541",3828,1392400,"Cluster_4080","Peve_00013267",-0.98876299033309,0.0955274135984469,0.978262075707395,160,-20.11,"2 18","627 649",17,"76.47%","88.24%","Q8R4G6","Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)]","Mus musculus (Mouse)","negative regulation of protein tyrosine phosphatase activity [GO:1903614]; positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0000139; GO:0004864; GO:0005576; GO:0005794; GO:0006487; GO:0008375; GO:0016020; GO:0016757; GO:0018279; GO:0030144; GO:0030145; GO:0030335; GO:0043204; GO:1903614; GO:1904894"
"3542",3829,1393212,"Cluster_4629","Peve_00011685",-0.227773461740948,0.853710872372116,0.995934364227446,145,-21.13,"2 20","227 247",18,"61.11%","77.78%","Q91ZU0","Ankyrin repeat and SOCS box protein 7 (ASB-7)","Mus musculus (Mouse)","intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]","GO:0016567; GO:0035556"
"3543",3830,1393389,"Cluster_4079","Peve_00013195",-0.123591424554745,0.921117559977585,0.999448381576871,166,-24.77,"2 21","449 473",22,"77.27%","81.82%",NA,NA,NA,NA,NA
"3544",3831,1393479,"Cluster_4079","Peve_00013196",0.557771523683978,0.623313073027375,0.978262075707395,155,-20.64,"2 21","952 974",20,"65.00%","80.00%",NA,NA,NA,NA,NA
"3545",3832,1393752,"Cluster_4629","Peve_00039469",-0.443383362280846,0.707556077121805,0.978262075707395,157,-24.52,"2 21","777 796",19,"68.42%","84.21%","Q5H8A4","GPI ethanolamine phosphate transferase 2 (EC 2.-.-.-) (GPI7 homolog) (hGPI7) (Phosphatidylinositol-glycan biosynthesis class G protein) (PIG-G)","Homo sapiens (Human)","GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]","GO:0005783; GO:0005789; GO:0006506; GO:0016020; GO:0016254; GO:0016740; GO:0016780; GO:0051267"
"3546",3833,1393887,"Cluster_4629","Peve_00039463",0.717796412703106,0.490301704496502,0.978262075707395,152,-20.39,"2 21","246 267",19,"63.16%","73.68%",NA,NA,NA,NA,NA
"3547",3834,1394046,"Cluster_11134","Peve_00039464",-0.607504053052144,0.584341691832615,0.978262075707395,161,-21.31,"2 20","491 511",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"3548",3836,1394750,"Cluster_6914","Peve_00030930",-0.877975932427226,0.317787144248017,0.978262075707395,162,-21.05,"2 20","50 71",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"3549",3837,1394750,"Cluster_6914","Peve_00030930",-0.877975932427226,0.317787144248017,0.978262075707395,170,-24.04,"2 20","645 666",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"3550",3838,1395098,"Cluster_2882","Peve_00020302",-0.988298965934266,0.0974836156202946,0.978262075707395,158,-23.28,"2 20","921 944",20,"70.00%","80.00%",NA,NA,NA,NA,NA
"3551",3839,1395258,"Cluster_10061","Peve_00020301",0.979264428642125,0.129869281770092,0.978262075707395,167,-21.01,"2 18","458 478",16,"87.50%","93.75%",NA,NA,NA,NA,NA
"3552",3840,1395441,"Cluster_11134","Peve_00044577",-0.487000118498098,0.67618224399241,0.978262075707395,165,-24.75,"2 18","871 892",16,"81.25%","87.50%","Q1RMW1","NEDD8-conjugating enzyme UBE2F (EC 2.3.2.32) (NEDD8 carrier protein UBE2F) (NEDD8 protein ligase UBE2F) (NEDD8-conjugating enzyme 2) (RING-type E3 NEDD8 transferase UBE2F) (Ubiquitin-conjugating enzyme E2 F)","Bos taurus (Bovine)","protein neddylation [GO:0045116]","GO:0005524; GO:0005634; GO:0019788; GO:0045116; GO:0061654"
"3553",3841,1395856,"Cluster_29","Peve_00003014",-0.368569774287229,0.759695126986102,0.988219883885475,162,-21.82,"2 21","487 510",21,"71.43%","85.71%","G3M4F8","Octopamine receptor beta-2R (CsOA2B2)","Chilo suppressalis (Asiatic rice borer moth)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to amine stimulus [GO:0071418]; octopamine signaling pathway [GO:0071927]; tyramine signaling pathway [GO:0071928]","GO:0004989; GO:0005886; GO:0007189; GO:0008226; GO:0016020; GO:0071418; GO:0071927; GO:0071928"
"3554",3842,1395939,"Cluster_13502","Peve_00003017",-0.44209200413486,0.708472937844906,0.978262075707395,172,-22.15,"2 17","312 333",15,"93.33%","93.33%",NA,NA,NA,NA,NA
"3555",3843,1396074,"Cluster_13502","Peve_00002742",-0.44209200413486,0.708472937844906,0.978262075707395,168,-23,"2 21","883 904",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"3556",3844,1396458,"Cluster_6905","Peve_00001528",-0.908841159073813,0.27393670736465,0.978262075707395,155,-21.38,"2 21","14 36",20,"70.00%","75.00%",NA,NA,NA,NA,NA
"3557",3846,1398450,"Cluster_9149","Peve_00002876",-0.683347508454668,0.521046819604013,0.978262075707395,162,-23.03,"2 21","441 461",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"3558",3847,1399378,"Cluster_4735","Peve_00042166",-0.783103432884133,0.427271026013053,0.978262075707395,155,-21.51,"2 19","635 658",20,"75.00%","80.00%","Q5E9Q4","Adaptin ear-binding coat-associated protein 2 (NECAP endocytosis-associated protein 2) (NECAP-2)","Bos taurus (Bovine)","endocytosis [GO:0006897]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]","GO:0005886; GO:0006897; GO:0015031; GO:0016192; GO:0030125"
"3559",3848,1399503,"Cluster_796","Peve_00042168",0.0381998601613129,0.975675295384868,0.999448381576871,161,-23.83,"2 21","175 196",20,"80.00%","80.00%","Q9UPW0","Forkhead box protein J3","Homo sapiens (Human)","cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0007141; GO:0007283; GO:0030154; GO:0043565; GO:0045944; GO:1990837"
"3560",3849,1400136,"Cluster_2787","Peve_00036879",-0.00382968334855694,0.997561941898757,0.999448381576871,153,-20.25,"2 19","725 747",18,"72.22%","77.78%",NA,NA,NA,NA,NA
"3561",3850,1400497,"Cluster_2854","Peve_00003838",-0.496436256349909,0.669283295848422,0.978262075707395,155,-22.57,"2 21","99 123",22,"59.09%","81.82%",NA,NA,NA,NA,NA
"3562",3851,1401042,"Cluster_4629","Peve_00033969",-0.616555252266889,0.577055391028787,0.978262075707395,165,-23.01,"2 20","99 119",18,"77.78%","88.89%",NA,NA,NA,NA,NA
"3563",3852,1401977,"Cluster_589","Peve_00030703",0.775072695353894,0.435426401668339,0.978262075707395,156,-26.25,"2 21","219 240",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"3564",3853,1402434,"Cluster_4079","Peve_00044909",-0.796272454187231,0.413604356922386,0.978262075707395,161,-21.93,"2 20","552 572",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"3565",3854,1402454,"Cluster_8988","Peve_00044909",0.0860148226113438,0.945173514868548,0.999448381576871,158,-20.08,"2 21","316 342",24,"70.83%","75.00%",NA,NA,NA,NA,NA
"3566",3855,1402499,"Cluster_8988","Peve_00040281",-0.0359027829840121,0.977138665260236,0.999448381576871,162,-21.05,"2 21","98 123",23,"69.57%","82.61%",NA,NA,NA,NA,NA
"3567",3856,1402772,"Cluster_10060","Peve_00038556",-0.732992461699907,0.47624607954137,0.978262075707395,170,-21.61,"2 20","257 279",19,"78.95%","89.47%","Q6PFY8","Tripartite motif-containing protein 45","Mus musculus (Mouse)","bone development [GO:0060348]; positive regulation of DNA-templated transcription [GO:0045893]","GO:0000785; GO:0004842; GO:0005654; GO:0005829; GO:0008270; GO:0045171; GO:0045893; GO:0060348"
"3568",3857,1403501,"Cluster_14999","Peve_00002009",0.556268012296699,0.624465591108997,0.978262075707395,157,-20.47,"2 20","954 978",21,"76.19%","76.19%",NA,NA,NA,NA,NA
"3569",3858,1403732,"Cluster_589","Peve_00007033",-0.956102906815386,0.189327906775541,0.978262075707395,150,-20.63,"2 21","514 539",23,"65.22%","73.91%","Q3UQ28","Peroxidasin homolog (EC 1.11.2.-) [Cleaved into: PXDN active fragment]","Mus musculus (Mouse)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005201; GO:0005604; GO:0005615; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"3570",3859,1403954,"Cluster_16498","Peve_00007037",-0.363975227742761,0.762838554749854,0.989059663958609,171,-20.37,"2 21","181 203",20,"75.00%","90.00%","Q3UQ28","Peroxidasin homolog (EC 1.11.2.-) [Cleaved into: PXDN active fragment]","Mus musculus (Mouse)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005201; GO:0005604; GO:0005615; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"3571",3860,1405226,"Cluster_4115","Peve_00002246",-0.617261006313706,0.576484518162969,0.978262075707395,164,-20.56,"2 17","497 518",15,"73.33%","100.00%","Q4UMH6","Putative ankyrin repeat protein RF_0381","Rickettsia felis (strain ATCC VR-1525 / URRWXCal2) (Rickettsia azadi)","guanosine tetraphosphate metabolic process [GO:0015969]","GO:0015969"
"3572",3861,1405371,"Cluster_7053","Peve_00039168",-0.992056717918308,0.0802939845438118,0.978262075707395,167,-21.07,"2 20","79 100",18,"66.67%","94.44%",NA,NA,NA,NA,NA
"3573",3862,1406165,"Cluster_1167","Peve_00003359",0.94000581133588,0.221638529201622,0.978262075707395,151,-21.38,"2 20","861 882",18,"66.67%","72.22%","Q2MJT0","Myocyte-specific enhancer factor 2A","Rattus norvegicus (Rat)","apoptotic process [GO:0006915]; cardiac conduction [GO:0061337]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; cellular response to glucose stimulus [GO:0071333]; dendrite morphogenesis [GO:0048813]; DNA-templated transcription [GO:0006351]; DNA-templated transcription elongation [GO:0006354]; ERK5 cascade [GO:0070375]; heart development [GO:0007507]; MAPK cascade [GO:0000165]; mitochondrial genome maintenance [GO:0000002]; mitochondrion distribution [GO:0048311]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; ventricular cardiac myofibril assembly [GO:0055005]","GO:0000002; GO:0000122; GO:0000165; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006351; GO:0006354; GO:0006355; GO:0006357; GO:0006915; GO:0007507; GO:0010613; GO:0010628; GO:0019901; GO:0030154; GO:0035035; GO:0042826; GO:0043565; GO:0045893; GO:0045944; GO:0046326; GO:0046332; GO:0046982; GO:0048311; GO:0048813; GO:0055005; GO:0061337; GO:0061629; GO:0070375; GO:0071277; GO:0071333; GO:0140297"
"3574",3863,1406431,"Cluster_29","Peve_00037865",0.271118772528518,0.825212764706371,0.995934364227446,160,-20.4,"2 21","419 438",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"3575",3864,1406496,"Cluster_7053","Peve_00037864",-0.681203371034253,0.522913884251508,0.978262075707395,175,-24.12,"2 20","841 862",18,"77.78%","94.44%","Q8R4P9","ATP-binding cassette sub-family C member 10 (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 7)","Mus musculus (Mouse)","leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; lipid transport [GO:0006869]; transmembrane transport [GO:0055085]","GO:0005524; GO:0005886; GO:0006691; GO:0006869; GO:0008559; GO:0009925; GO:0015431; GO:0016020; GO:0016323; GO:0016887; GO:0042626; GO:0055085; GO:0071716; GO:0140359"
"3576",3865,1406750,"Cluster_1167","Peve_00024794",-0.54995011762567,0.629293434471703,0.978262075707395,146,-24.82,"2 21","403 428",23,"65.22%","69.57%",NA,NA,NA,NA,NA
"3577",3866,1407540,"Cluster_9149","Peve_00023210",-0.78823449539237,0.421990809998607,0.978262075707395,156,-23.59,"2 21","257 278",19,"57.89%","84.21%","Q9LP51","CBL-interacting serine/threonine-protein kinase 18 (EC 2.7.11.1) (SNF1-related kinase 3.20) (SOS2-like protein kinase PKS22)","Arabidopsis thaliana (Mouse-ear cress)","protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]","GO:0004674; GO:0005524; GO:0006468; GO:0007165; GO:0106310"
"3578",3867,1407887,"Cluster_6904","Peve_00024248",-0.817512855870807,0.390704549692094,0.978262075707395,160,-21.85,"2 17","803 824",15,"80.00%","86.67%",NA,NA,NA,NA,NA
"3579",3868,1407889,"Cluster_6906","Peve_00024248",-0.440074534981814,0.709904034909001,0.978677579990526,160,-21.86,"2 17","803 824",15,"80.00%","86.67%",NA,NA,NA,NA,NA
"3580",3870,1408517,"Cluster_6904","Peve_00014834",-0.218793788387637,0.859575597034824,0.996075279422565,150,-21.43,"2 17","408 428",15,"73.33%","86.67%",NA,NA,NA,NA,NA
"3581",3871,1408517,"Cluster_6904","Peve_00014834",-0.218793788387637,0.859575597034824,0.996075279422565,150,-21.43,"2 17","543 563",15,"73.33%","86.67%",NA,NA,NA,NA,NA
"3582",3872,1408519,"Cluster_6906","Peve_00014834",0.277142893219332,0.82122491774827,0.995934364227446,155,-22.02,"2 21","404 428",22,"63.64%","77.27%",NA,NA,NA,NA,NA
"3583",3873,1408519,"Cluster_6906","Peve_00014834",0.277142893219332,0.82122491774827,0.995934364227446,155,-22.02,"2 21","539 563",22,"63.64%","77.27%",NA,NA,NA,NA,NA
"3584",3874,1408519,"Cluster_6906","Peve_00014834",0.277142893219332,0.82122491774827,0.995934364227446,160,-21.88,"2 17","377 398",15,"73.33%","93.33%",NA,NA,NA,NA,NA
"3585",3875,1408519,"Cluster_6906","Peve_00014834",0.277142893219332,0.82122491774827,0.995934364227446,160,-21.88,"2 17","512 533",15,"73.33%","93.33%",NA,NA,NA,NA,NA
"3586",3876,1408740,"Cluster_5882","Peve_00025110",-0.847623240909482,0.35606562946029,0.978262075707395,172,-20.03,"2 21","565 586",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"3587",3877,1409091,"Cluster_2787","Peve_00027348",0.867933894665659,0.330895275232091,0.978262075707395,161,-24.48,"2 20","68 91",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"3588",3878,1410244,"Cluster_10934","Peve_00006027",-0.273135092965414,0.823878792672496,0.995934364227446,166,-21.26,"2 19","561 582",17,"76.47%","88.24%",NA,NA,NA,NA,NA
"3589",3879,1411333,"Cluster_15890","Peve_00022636",-0.515012093322858,0.655574851953699,0.978262075707395,154,-21.54,"2 21","568 594",24,"70.83%","70.83%","Q08D11","Phosphatidylserine synthase 2 (PSS-2) (PtdSer synthase 2) (EC 2.7.8.29) (Serine-exchange enzyme II)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","phosphatidylserine biosynthetic process [GO:0006659]","GO:0005789; GO:0006659; GO:0106245"
"3590",3880,1411385,"Cluster_1167","Peve_00039932",-0.950564789784708,0.201010559740851,0.978262075707395,142,-20.04,"2 11","950 971",9,"88.89%","88.89%",NA,NA,NA,NA,NA
"3591",3881,1411602,"Cluster_15726","Peve_00039934",0.00191736015861647,0.99877936986438,0.999738599811372,166,-29.17,"2 21","103 123",19,"78.95%","84.21%","Q9H3F6","BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 (hBACURD3) (BTB/POZ domain-containing protein KCTD10) (Potassium channel tetramerization domain-containing protein 10)","Homo sapiens (Human)","negative regulation of Rho protein signal transduction [GO:0035024]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005112; GO:0005654; GO:0005829; GO:0006511; GO:0016567; GO:0031463; GO:0035024; GO:0042802; GO:0043161; GO:0051260"
"3592",3882,1411707,"Cluster_4629","Peve_00000082",-0.970479698905835,0.155070689216609,0.978262075707395,170,-25.97,"2 19","500 521",17,"76.47%","94.12%","Q8VCY6","U3 small nucleolar RNA-associated protein 6 homolog (Multiple hat domains protein)","Mus musculus (Mouse)","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]","GO:0000462; GO:0005694; GO:0005730; GO:0030515; GO:0032040; GO:0034388"
"3593",3883,1412023,"Cluster_4735","Peve_00018929",0.999041921949982,0.0278695685926089,0.899642249848007,163,-20.67,"2 17","84 106",16,"87.50%","87.50%",NA,NA,NA,NA,NA
"3594",3884,1412202,"Cluster_4629","Peve_00015864",-0.554554668634826,0.625777256211528,0.978262075707395,150,-21.51,"2 21","386 406",19,"63.16%","78.95%",NA,NA,NA,NA,NA
"3595",3885,1413587,"Cluster_589","Peve_00040048",0.65730363247332,0.543393830654303,0.978262075707395,155,-21.51,"2 12","407 428",10,"100.00%","100.00%",NA,NA,NA,NA,NA
"3596",3886,1413846,"Cluster_11134","Peve_00034663",0.931363462424725,0.237240431863953,0.978262075707395,154,-23.47,"2 20","59 76",18,"77.78%","77.78%",NA,NA,NA,NA,NA
"3597",3887,1414217,"Cluster_589","Peve_00012768",-0.65532740845739,0.545061328209452,0.978262075707395,162,-27.02,"2 20","326 349",20,"75.00%","80.00%","Q9BRB3","Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q (N-acetylglucosamyl transferase component GPI1) (Phosphatidylinositol-glycan biosynthesis class Q protein) (PIG-Q)","Homo sapiens (Human)","carbohydrate metabolic process [GO:0005975]; GPI anchor biosynthetic process [GO:0006506]","GO:0000506; GO:0005783; GO:0005789; GO:0005975; GO:0006506"
"3598",3888,1414367,"Cluster_6904","Peve_00044298",0.972212601254298,0.150428418505535,0.978262075707395,164,-23.76,"2 18","491 513",17,"82.35%","88.24%",NA,NA,NA,NA,NA
"3599",3889,1414369,"Cluster_6906","Peve_00044298",0.740024335996367,0.469627903722442,0.978262075707395,164,-24.59,"2 18","491 513",17,"82.35%","88.24%",NA,NA,NA,NA,NA
"3600",3890,1414946,"Cluster_4115","Peve_00032544",-0.760086965521263,0.450312609150272,0.978262075707395,170,-20.09,"2 20","563 586",20,"80.00%","85.00%","Q17R14","Unconventional myosin-Id","Bos taurus (Bovine)","cellular localization [GO:0051641]; early endosome to recycling endosome transport [GO:0061502]; protein transport [GO:0015031]","GO:0000146; GO:0005516; GO:0005524; GO:0005768; GO:0005769; GO:0005790; GO:0005829; GO:0005903; GO:0005938; GO:0015031; GO:0016323; GO:0016459; GO:0030424; GO:0030673; GO:0031410; GO:0043005; GO:0043025; GO:0043204; GO:0043209; GO:0048306; GO:0051015; GO:0051641; GO:0061502; GO:0097440"
"3601",3892,1415244,"Cluster_13502","Peve_00044431",-0.720163334907291,0.488133696487754,0.978262075707395,165,-20.1,"2 19","397 419",18,"77.78%","88.89%",NA,NA,NA,NA,NA
"3602",3893,1415342,"Cluster_589","Peve_00044434",-0.854089100124888,0.348230580867882,0.978262075707395,162,-21.52,"2 21","688 708",19,"68.42%","89.47%","P0C6B8","Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1","Rattus norvegicus (Rat)","cell adhesion [GO:0007155]; epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193]","GO:0001945; GO:0003017; GO:0003682; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0007155; GO:0008544; GO:0010467; GO:0016020; GO:0031012; GO:0036303; GO:0048014; GO:0120193"
"3603",3894,1415652,"Cluster_15726","Peve_00004973",-0.549492231854076,0.629642389722916,0.978262075707395,147,-20.11,"2 16","113 134",14,"71.43%","78.57%","P53365","Arfaptin-2 (ADP-ribosylation factor-interacting protein 2) (Partner of RAC1) (POR1)","Homo sapiens (Human)","actin cytoskeleton organization [GO:0030036]; intracellular protein transport [GO:0006886]; lamellipodium assembly [GO:0030032]; mitophagy [GO:0000423]; protein localization to phagophore assembly site [GO:0034497]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; ruffle organization [GO:0031529]; small GTPase mediated signal transduction [GO:0007264]","GO:0000423; GO:0001726; GO:0005525; GO:0005543; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006886; GO:0007264; GO:0019904; GO:0030032; GO:0030036; GO:0030742; GO:0031267; GO:0031529; GO:0032588; GO:0034315; GO:0034497; GO:0042802; GO:0045296; GO:0070273; GO:0140090"
"3604",3895,1415782,"Cluster_11135","Peve_00004970",-0.392594484450984,0.743155195247471,0.986826807371645,158,-20.43,"2 15","177 198",13,"84.62%","92.31%",NA,NA,NA,NA,NA
"3605",3896,1416021,"Cluster_2787","Peve_00000084",0.623605979332622,0.571333966310103,0.978262075707395,175,-24.28,"2 21","708 730",20,"80.00%","90.00%","H2LRU7","Polycystin-2 (Polycystic kidney disease 2 protein homolog)","Oryzias latipes (Japanese rice fish) (Japanese killifish)","calcium ion transmembrane transport [GO:0070588]; cell-cell signaling by wnt [GO:0198738]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus [GO:0050982]; detection of nodal flow [GO:0003127]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; regulation of ion transmembrane transport [GO:0034765]; release of sequestered calcium ion into cytosol [GO:0051209]; Wnt signaling pathway [GO:0016055]","GO:0003127; GO:0005102; GO:0005245; GO:0005248; GO:0005261; GO:0005262; GO:0005267; GO:0005509; GO:0005789; GO:0005886; GO:0005929; GO:0015271; GO:0016020; GO:0016055; GO:0016323; GO:0030659; GO:0034703; GO:0034765; GO:0050982; GO:0051209; GO:0051262; GO:0051290; GO:0051371; GO:0060170; GO:0070588; GO:0071277; GO:0071805; GO:0098662; GO:0198738"
"3606",3897,1416129,"Cluster_7855","Peve_00044261",-0.999136681236325,0.0264552555081203,0.885091958128636,176,-20.97,"2 21","648 669",19,"84.21%","84.21%",NA,NA,NA,NA,NA
"3607",3898,1416795,"Cluster_5882","Peve_00040950",-0.0321266724325589,0.979544005228749,0.999448381576871,166,-22.57,"2 21","830 850",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"3608",3899,1416967,"Cluster_2854","Peve_00042556",-0.506926331207366,0.661563219845748,0.978262075707395,161,-22.55,"2 18","438 459",16,"75.00%","87.50%","Q3MI00","DnaJ homolog subfamily B member 1","Bos taurus (Bovine)","cellular response to heat [GO:0034605]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ATP-dependent activity [GO:0032781]","GO:0000122; GO:0001671; GO:0003714; GO:0005654; GO:0005730; GO:0005829; GO:0030544; GO:0032781; GO:0034605; GO:0044183; GO:0051082; GO:0051085; GO:0051087; GO:0051117; GO:0090084; GO:0140416"
"3609",3900,1417272,"Cluster_15726","Peve_00042550",-0.610703269943252,0.581773651680301,0.978262075707395,163,-20.28,"2 21","17 40",21,"76.19%","76.19%",NA,NA,NA,NA,NA
"3610",3901,1417282,"Cluster_2854","Peve_00042559",0.938718076908797,0.224029148162525,0.978262075707395,169,-21.69,"2 20","269 289",18,"83.33%","88.89%",NA,NA,NA,NA,NA
